PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bonetta, L				Bonetta, L			Protein purification - Fast forward	NATURE			English	Article																			0	8	8	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 23	2006	439	7079					1017	+		10.1038/4391017a	http://dx.doi.org/10.1038/4391017a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014NE	16496010	Bronze			2022-12-24	WOS:000235486100058
J	Kittel, RJ; Wichmann, C; Rasse, TM; Fouquet, W; Schmidt, M; Schmid, A; Wagh, DA; Pawlu, C; Kellner, RR; Willig, KI; Hell, SW; Buchner, E; Heckmann, M; Sigrist, SJ				Kittel, RJ; Wichmann, C; Rasse, TM; Fouquet, W; Schmidt, M; Schmid, A; Wagh, DA; Pawlu, C; Kellner, RR; Willig, KI; Hell, SW; Buchner, E; Heckmann, M; Sigrist, SJ			Bruchpilot promotes active zone assembly, Ca2+ channel clustering, and vesicle release	SCIENCE			English	Article							CRAYFISH NEUROMUSCULAR-JUNCTION; MOTOR-NERVE TERMINALS; NEUROTRANSMITTER RELEASE; PRESYNAPTIC TERMINALS; SYNAPTIC PLASTICITY; TRANSMITTER RELEASE; GLUTAMATE-RECEPTOR; CALCIUM-CHANNEL; DROSOPHILA; PROTEIN	The molecular organization of presynaptic active zones during calcium influx - triggered neurotransmitter release is the focus of intense investigation. The Drosophila coiled-coil domain protein Bruchpilot (BRP) was observed in donut-shaped structures centered at active zones of neuromuscular synapses by using subdiffraction resolution STED ( stimulated emission depletion) fluorescence microscopy. At brp mutant active zones, electron-dense projections (T-bars) were entirely lost, Ca2+ channels were reduced in density, evoked vesicle release was depressed, and short-term plasticity was altered. BRP-like proteins seem to establish proximity between Ca2+ channels and vesicles to allow efficient transmitter release and patterned synaptic plasticity.	Inst Klin Neurobiol, D-97080 Wurzburg, Germany; European Neurosci Inst Gottingen, D-37077 Gottingen, Germany; Lehrstuhl Genet & Neurobiol, D-97074 Wurzburg, Germany; Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany	Max Planck Society	Heckmann, M (corresponding author), Inst Klin Neurobiol, Josef Schneider Str 11, D-97080 Wurzburg, Germany.	Heckmann_M@klinik.uni-wuerzburg.de; ssigris@gwdg.de	Willig, Katrin/AAH-5418-2020; Kittel, Robert J/G-6404-2015	Willig, Katrin/0000-0002-1860-334X; Kittel, Robert J/0000-0002-9199-4826; Schmidt, Manuela/0000-0003-1972-3519; Heckmann, Manfred/0000-0002-4874-1735				ADLER EM, 1991, J NEUROSCI, V11, P1496; Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; ATWOOD HL, 1967, NATURE, V215, P57, DOI 10.1038/215057a0; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; Bennett MR, 2000, BIOPHYS J, V78, P2201, DOI 10.1016/S0006-3495(00)76769-5; Cao YQ, 2004, NEURON, V43, P387, DOI 10.1016/j.neuron.2004.07.014; Dittman JS, 2000, J NEUROSCI, V20, P1374; DUDEL J, 1981, PFLUG ARCH EUR J PHY, V391, P35, DOI 10.1007/BF00580691; Feeney CJ, 1998, J COMP NEUROL, V402, P197, DOI 10.1002/(SICI)1096-9861(19981214)402:2&lt;197::AID-CNE5&gt;3.0.CO;2-Q; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P496, DOI 10.1098/rspb.1965.0017; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Kawasaki F, 2000, J NEUROSCI, V20, P4885; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Koh YH, 2000, MICROSC RES TECHNIQ, V49, P14, DOI 10.1002/(SICI)1097-0029(20000401)49:1<14::AID-JEMT3>3.3.CO;2-7; Kuromi H, 2004, NEURON, V41, P101, DOI 10.1016/S0896-6273(03)00815-8; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Pawlu C, 2004, NEURON, V42, P607, DOI 10.1016/S0896-6273(04)00269-7; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Sakaba T, 2005, SCIENCE, V309, P491, DOI 10.1126/science.1112645; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Trommershauser J, 2003, BIOPHYS J, V84, P1563, DOI 10.1016/S0006-3495(03)74967-4; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; WOJTOWICZ JM, 1994, J NEUROSCI, V14, P3688; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	37	560	574	2	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1051	1054		10.1126/science.1126308	http://dx.doi.org/10.1126/science.1126308			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16614170	Green Published			2022-12-24	WOS:000237628800045
J	Petrasek, J; Mravec, J; Bouchard, R; Blakeslee, JJ; Abas, M; Seifertova, D; Wisniewska, J; Tadele, Z; Kubes, M; Covanova, M; Dhonukshe, P; Skupa, P; Benkova, E; Perry, L; Krecek, P; Lee, OR; Fink, GR; Geisler, M; Murphy, AS; Luschnig, C; Zazimalova, E; Friml, J				Petrasek, J; Mravec, J; Bouchard, R; Blakeslee, JJ; Abas, M; Seifertova, D; Wisniewska, J; Tadele, Z; Kubes, M; Covanova, M; Dhonukshe, P; Skupa, P; Benkova, E; Perry, L; Krecek, P; Lee, OR; Fink, GR; Geisler, M; Murphy, AS; Luschnig, C; Zazimalova, E; Friml, J			PIN proteins perform a rate-limiting function in cellular auxin efflux	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; TRANSGENIC PLANTS; TRANSPORT; GRADIENTS; GENE; GRAVITROPISM; EXPRESSION; REGULATOR	Intercellular flow of the phytohormone auxin underpins multiple developmental processes in plants. Plant-specific pin-formed ( PIN) proteins and several phosphoglycoprotein (PGP) transporters are crucial factors in auxin transport - related development, yet the molecular function of PINs remains unknown. Here, we show that PINs mediate auxin efflux from mammalian and yeast cells without needing additional plant-specific factors. Conditional gain-of-function alleles and quantitative measurements of auxin accumulation in Arabidopsis and tobacco cultured cells revealed that the action of PINs in auxin efflux is distinct from PGP, rate-limiting, specific to auxins, and sensitive to auxin transport inhibitors. This suggests a direct involvement of PINs in catalyzing cellular auxin efflux.	Acad Sci Czech Republ, Inst Expt Bot, CR-16502 Prague 6, Czech Republic; Charles Univ, Fac Sci, Dept Plant Physiol, CR-12844 Prague 2, Czech Republic; Univ Tubingen, Ctr Plant Mol Biol ZMBP, D-72076 Tubingen, Germany; Univ Zurich, Inst Plant Biol, Zurich Basel Plant Sci Ctr, CH-8007 Zurich, Switzerland; Purdue Univ, Dept Hort, W Lafayette, IN 47907 USA; Agr Univ Vienna, Univ Nat Resources & Appl Life Sci, Inst Appl Genet & Cell Biol, A-1190 Vienna, Austria; Inst Gen & Mol Biol, Dept Biotechnol, PL-87100 Torun, Poland; Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Masaryk Univ, Dept Funct Genom & Proteom, Lab Mol Plant Physiol, Brno 62500, Czech Republic	Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Charles University Prague; Eberhard Karls University of Tubingen; University of Zurich; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Natural Resources & Life Sciences, Vienna; Nicolaus Copernicus University; University of Bern; Massachusetts Institute of Technology (MIT); Whitehead Institute; Masaryk University Brno	Zazimalova, E (corresponding author), Acad Sci Czech Republ, Inst Expt Bot, CR-16502 Prague 6, Czech Republic.	eva.zazim@ueb.cas.cz	Covanova, Milada/F-7473-2014; Skupa, Petr/H-2176-2014; Kubes, Martin/F-9761-2014; Blakeslee, Joshua/G-4420-2011; Benkova, Eva/E-2910-2012; Friml, Jiri/D-9511-2012; Petrasek, Jan/AAW-1081-2021; Mravec, Jozef/J-7370-2016; Wisniewska, Justyna/D-4351-2009; Geisler, Markus/B-3921-2012; Eva, Zazimalova/G-7432-2014; Petrasek, Jan/C-8240-2009	Friml, Jiri/0000-0002-8302-7596; Petrasek, Jan/0000-0002-6719-2735; Mravec, Jozef/0000-0003-0331-3304; Geisler, Markus/0000-0002-6641-5810; Eva, Zazimalova/0000-0002-8325-7092; Petrasek, Jan/0000-0002-6719-2735; Skupa, Petr/0000-0001-9878-0639; Luschnig, Christian/0000-0003-2099-9280; Kubes, Martin/0000-0003-2182-4490; Tadele, Zerihun/0000-0002-3686-3698				Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; Blakeslee JJ, 2005, CURR OPIN PLANT BIOL, V8, P494, DOI 10.1016/j.pbi.2005.07.014; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Chen RJ, 1998, P NATL ACAD SCI USA, V95, P15112, DOI 10.1073/pnas.95.25.15112; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Kepinski S, 2005, CURR BIOL, V15, pR208, DOI 10.1016/j.cub.2005.03.012; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Paponov IA, 2005, TRENDS PLANT SCI, V10, P170, DOI 10.1016/j.tplants.2005.02.009; Petrasek J, 2003, PLANT PHYSIOL, V131, P254, DOI 10.1104/pp.012740; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	22	670	708	9	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					914	918		10.1126/science.1123542	http://dx.doi.org/10.1126/science.1123542			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16601150				2022-12-24	WOS:000237452900048
J	Forrest, G; Plumb, C; Sue, Z; Stein, A				Forrest, G; Plumb, C; Sue, Z; Stein, A			Breast cancer in the family - children's perceptions of their mother's cancer and its initial treatment: qualitative of their study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PARENTAL CANCER; COMMUNICATION; IMPACT	Objectives To explore how children of mothers newly diagnosed with breast cancer perceive their mothers illness and its initial treatment; to contrast, their accounts with the mothers' perceptions of their children's knowledge. Design Qualitative interview study with thematic analysis. Setting Home based interviews with mothers and children in Oxfordshire, England. Participants 37 mothers with early breast cancer and 31 of their children aged between 6 and 18 years. Results Awareness of cancer as a life threatening illness existed even among Most Of the youngest children interviewed. Children described specific aspects of their mother's treatment as especially stressful (seeing her immediately postoperatively, chemotherapy, and hair loss). Children suspected that something was wrong even before they were told the diagnosis. Parents sometimes misunderstood their children's reactions and Underestimated the emotional impact or did not recognise the children's need for more preparation and age appropriate information about the illness and its treatment. Conclusions As part Of their care, parents newly diagnosed with a life threatening illness need to be supported to think about how they will talk to their children. General practitioners and hospital specialists, as well as nurses, are well placed to be able to hell) with these concerns and if necessary to be involved in discussions with the children. The provision of appropriate information, including recommended websites, should be part of this care. More information specifically designed for young children is needed.	Univ Oxford, Pk Hosp Children, Sect Child & Adolescent Psychiat, Oxford OX3 7LQ, England; Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford; University of Oxford	Forrest, G (corresponding author), Univ Oxford, Pk Hosp Children, Sect Child & Adolescent Psychiat, Oxford OX3 7LQ, England.	gillian.forrest@psych.ox.ac.uk		Ziebland, Sue/0000-0002-6496-4859; Stein, Alan/0000-0001-8207-2822				Barnes J, 2000, BRIT MED J, V321, P479, DOI 10.1136/bmj.321.7259.479; Bloom Joan R., 1994, Journal of the National Cancer Institute Monographs, V0, P199; Bluebond-Langner M., 1978, PRIVATE WORLDS DYING; General Medical Council, 2003, TOM DOCT REC UND MED; Keeley D, 2000, BRIT MED J, V321, P462, DOI 10.1136/bmj.321.7259.462; Kroll L, 1998, BRIT MED J, V316, P880, DOI 10.1136/bmj.316.7135.880; MURRAY L, 1908, UNIPOLAR DEPRESSION, P17; OAKLEY A, 1995, BRIT MED J, V310, P1029, DOI 10.1136/bmj.310.6986.1029; *OFF NAT STAT, 1999, HLTH STAT Q, V4, P59; Pope C., 2020, QUALITATIVE RES HLTH, V4th ed.; Rutter M, 2000, DEV PSYCHOPATHOL, V12, P375, DOI 10.1017/S0954579400003072; SLAVIN LA, 1982, AM J PSYCHIAT, V139, P179; Visser A, 2004, CANCER TREAT REV, V30, P683, DOI 10.1016/j.ctrv.2004.06.001; Welch AS, 1996, CANCER, V77, P1409, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1409::AID-CNCR28>3.0.CO;2-4	14	72	74	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2006	332	7548					998	1001		10.1136/bmj.38793.567801.AE	http://dx.doi.org/10.1136/bmj.38793.567801.AE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040TK	16613935	Green Published, Bronze			2022-12-24	WOS:000237403100014
J	Lange, A; Giller, K; Hornig, S; Martin-Eauclaire, MF; Pongs, O; Becker, S; Baldus, M				Lange, A; Giller, K; Hornig, S; Martin-Eauclaire, MF; Pongs, O; Becker, S; Baldus, M			Toxin-induced conformational changes in a potassium channel revealed by solid-state NMR	NATURE			English	Article							SHAKER K+ CHANNEL; SELECTIVITY FILTER; PEPTIDE INHIBITOR; PROTEIN-STRUCTURE; STRUCTURAL BASIS; SCORPION TOXINS; MUTANT CYCLES; CHARYBDOTOXIN; PORE; VOLTAGE	The active site of potassium (K+) channels catalyses the transport of K+ ions across the plasma membrane(1)-similar to the catalytic function of the active site of an enzyme-and is inhibited by toxins from scorpion venom. On the basis of the conserved structures of K+ pore regions(2) and scorpion toxins(3,4), detailed structures for the K+ channel-scorpion toxin binding interface have been proposed. In these models and in previous solution-state nuclear magnetic resonance (NMR) studies using detergent-solubilized membrane proteins(5,6), scorpion toxins were docked to the extracellular entrance of the K+ channel pore assuming rigid, preformed binding sites(7-13). Using high-resolution solid-state NMR spectroscopy, here we show that high-affinity binding of the scorpion toxin kaliotoxin to a chimaeric K+ channel (KcsA- Kv1.3)(14,15) is associated with significant structural rearrangements in both molecules. Our approach involves a combined analysis of chemical shifts and proton-proton distances and demonstrates that solid-state NMR is a sensitive method for analysing the structure of a membrane protein-inhibitor complex. We propose that structural flexibility of the K+ channel and the toxin represents an important determinant for the high specificity of toxin-K+ channel interactions.	Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; Univ Hamburg, Zentrum Mol Neurobiol, Inst Neurale Signalverarbeitung, D-20251 Hamburg, Germany; Univ Mediterranee, CNRS, Inst Jean Roche, F-13916 Marseille 20, France	Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Baldus, M (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany.	maba@mpibpc.mpg.de	Baldus, Marc/C-2737-2009	Baldus, Marc/0000-0001-7068-5613; Lange, Adam/0000-0002-7534-5973				AIYAR J, 1995, NEURON, V15, P1169, DOI 10.1016/0896-6273(95)90104-3; Aiyar J, 1996, J BIOL CHEM, V271, P31013, DOI 10.1074/jbc.271.49.31013; ANDERSON CS, 1988, J GEN PHYSIOL, V91, P317, DOI 10.1085/jgp.91.3.317; CREUZET F, 1991, SCIENCE, V251, P783, DOI 10.1126/science.1990439; Eriksson MAL, 2002, BIOPHYS J, V83, P2595, DOI 10.1016/S0006-3495(02)75270-3; Garcia ML, 2001, TOXICON, V39, P739, DOI 10.1016/S0041-0101(00)00214-2; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; GROSS A, 1994, NEURON, V13, P961, DOI 10.1016/0896-6273(94)90261-5; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Lange A, 2005, ANGEW CHEM INT EDIT, V44, P2089, DOI 10.1002/anie.200462516; Lange A, 2002, J AM CHEM SOC, V124, P9704, DOI 10.1021/ja026691b; Legros C, 2000, J BIOL CHEM, V275, P16918, DOI 10.1074/jbc.275.22.16918; Legros C, 2002, BIOCHEMISTRY-US, V41, P15369, DOI 10.1021/bi026264a; Lenaeus MJ, 2005, NAT STRUCT MOL BIOL, V12, P454, DOI 10.1038/nsmb929; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Luca S, 2001, J BIOMOL NMR, V20, P325, DOI 10.1023/A:1011278317489; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; Opella SJ, 2004, CHEM REV, V104, P3587, DOI 10.1021/cr0304121; PARK CS, 1992, NEURON, V9, P307, DOI 10.1016/0896-6273(92)90169-E; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Takeuchi K, 2003, STRUCTURE, V11, P1381, DOI 10.1016/j.str.2003.10.003; Yu KQ, 2004, BIOPHYS J, V86, P3542, DOI 10.1529/biophysj.103.039461; Yu LP, 2005, BIOCHEMISTRY-US, V44, P15834, DOI 10.1021/bi051656d; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	29	341	346	2	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					959	962		10.1038/nature04649	http://dx.doi.org/10.1038/nature04649			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612389				2022-12-24	WOS:000236736700046
J	Raghoebarsing, AA; Pol, A; van de Pas-Schoonen, KT; Smolders, AJP; Ettwig, KF; Rijpstra, WIC; Schouten, S; Damste, JSS; Op den Camp, HJM; Jetten, MSM; Strous, M				Raghoebarsing, AA; Pol, A; van de Pas-Schoonen, KT; Smolders, AJP; Ettwig, KF; Rijpstra, WIC; Schouten, S; Damste, JSS; Op den Camp, HJM; Jetten, MSM; Strous, M			A microbial consortium couples anaerobic methane oxidation to denitrification	NATURE			English	Article							METHANOTROPHIC ARCHAEA; 16S RDNA; SEDIMENTS; DIVERSITY; AMMONIUM; CARBON; DONOR; SOIL	Modern agriculture has accelerated biological methane and nitrogen cycling on a global scale(1,2). Freshwater sediments often receive increased downward fluxes of nitrate from agricultural runoff and upward fluxes of methane generated by anaerobic decomposition(3). In theory, prokaryotes should be capable of using nitrate to oxidize methane anaerobically, but such organisms have neither been observed in nature nor isolated in the laboratory(4-8). Microbial oxidation of methane is thus believed to proceed only with oxygen or sulphate(9,10). Here we show that the direct, anaerobic oxidation of methane coupled to denitrification of nitrate is possible. A microbial consortium, enriched from anoxic sediments, oxidized methane to carbon dioxide coupled to denitrification in the complete absence of oxygen. This consortium consisted of two microorganisms, a bacterium representing a phylum without any cultured species and an archaeon distantly related to marine methanotrophic Archaea. The detection of relatives of these prokaryotes in different freshwater ecosystems worldwide(11-14) indicates that the reaction presented here may make a substantial contribution to biological methane and nitrogen cycles.	Univ Nijmegen St Radboud Hosp, Inst Water & Wetland Res, Dept Microbiol, NL-6525 ED Nijmegen, Netherlands; Univ Nijmegen St Radboud Hosp, Inst Water & Wetland Res, Dept Aquat Ecol & Environm Biol, NL-6525 ED Nijmegen, Netherlands; Dept Marine Biogeochem & Toxicol, Royal Netherlands Inst Sea Res NIOZ, NL-1790 AB Den Burg, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Strous, M (corresponding author), Univ Nijmegen St Radboud Hosp, Inst Water & Wetland Res, Dept Microbiol, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	m.strous@science.ru.nl	Ettwig, Katharina F/B-9395-2011; Jetten, Mike/B-8834-2011; Damste, Jaap S Sinninghe/F-6128-2011; Camp, Huub J.M. Op den/F-5114-2011; Strous, Marc/B-4064-2017; Smolders, Alfons J.P./H-2583-2012	Jetten, Mike/0000-0002-4691-7039; Damste, Jaap S Sinninghe/0000-0002-8683-1854; Camp, Huub J.M. Op den/0000-0003-1990-9030; Strous, Marc/0000-0001-9600-3828; 				Bakermans C, 2002, MICROB ECOL, V44, P95, DOI [10.1007/s00248-002-0005-8, 10.1007/s00248-002-3011-y]; Blumenberg M, 2005, APPL ENVIRON MICROB, V71, P4345, DOI 10.1128/AEM.71.8.4345-4351.2005; Blumenberg M, 2004, P NATL ACAD SCI USA, V101, P11111, DOI 10.1073/pnas.0401188101; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; Costa C, 2000, APPL MICROBIOL BIOT, V53, P754, DOI 10.1007/s002530000337; Eisentraeger A, 2001, WATER RES, V35, P2261, DOI 10.1016/S0043-1354(00)00516-9; Frankenberg C, 2005, SCIENCE, V308, P1010, DOI 10.1126/science.1106644; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; Islas-Lima S, 2004, WATER RES, V38, P13, DOI 10.1016/j.watres.2003.08.024; Kasai Y, 2005, ENVIRON MICROBIOL, V7, P806, DOI 10.1111/j.1462-2920.2005.00754.x; Knittel K, 2005, APPL ENVIRON MICROB, V71, P467, DOI 10.1128/AEM.71.1.467-479.2005; Knowles R, 2005, ECOL ENG, V24, P441, DOI 10.1016/j.ecoleng.2005.01.001; Koga Y, 1998, BIOSCI BIOTECH BIOCH, V62, P230, DOI 10.1271/bbb.62.230; Koizumi Y, 2003, FEMS MICROBIOL ECOL, V46, P147, DOI 10.1016/S0168-6496(03)00212-5; Kruger M, 2003, NATURE, V426, P878, DOI 10.1038/nature02207; MASON I, 1977, J WATER POLLUT CON F, V49, P855; Nauhaus K, 2005, ENVIRON MICROBIOL, V7, P98, DOI 10.1111/j.1462-2920.2004.00669.x; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Raghoebarsing AA, 2005, NATURE, V436, P1153, DOI 10.1038/nature03802; Shima S, 2005, CURR OPIN MICROBIOL, V8, P643, DOI 10.1016/j.mib.2005.10.002; Stein LY, 2001, ENVIRON MICROBIOL, V3, P10, DOI 10.1046/j.1462-2920.2001.00154.x; Strous M, 2004, ANNU REV MICROBIOL, V58, P99, DOI 10.1146/annurev.micro.58.030603.123605; Strous M, 2002, ANTON LEEUW INT J G, V81, P693, DOI 10.1023/A:1020590413079; Valentine DL, 2002, ANTON LEEUW INT J G, V81, P271, DOI 10.1023/A:1020587206351; Waki M, 2002, APPL MICROBIOL BIOT, V59, P338, DOI 10.1007/s00253-002-1003-y	28	875	984	45	914	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					918	921		10.1038/nature04617	http://dx.doi.org/10.1038/nature04617			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612380	Green Published			2022-12-24	WOS:000236736700037
J	Huizink, AC; Ferdinand, RF; van der Ende, J; Verhulst, FC				Huizink, AC; Ferdinand, RF; van der Ende, J; Verhulst, FC			Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study	BRITISH MEDICAL JOURNAL			English	Article							(ECSTASY)-INDUCED SEROTONIN NEUROTOXICITY; SUBSTANCE USE DISORDERS; GENDER-DIFFERENCES; MENTAL-DISORDERS; ECSTASY USERS; 3,4-METHYLENEDIOXYMETHAMPHETAMINE; HEALTH; MOOD; DRUG	Objective To investigate whether using ecstasy (3,4-methylenedioxymethamphetamine, MDMA) is preceded by symptoms of behavioural and emotional problems in childhood and early adolescence. Design Prospective, longitudinal, population based study. Setting The Dutch province of Zuid-Holland. Participants A sample of 1580 individuals, followed up across a 14 year period, From childhood into adulthood. Main outcome measures The first assessment took place in 1983 before MDMA appeared as a recreational drug in the Netherlands and included the child behaviour checklist to obtain standardised parent's reports of their children's behavioural and emotional problems. Use of the drug was assessed with the composite international diagnostic interview 14 years later. Results Eight syndrome scales of childhood behaviour were examined. Scores in the deviant range for the scales designated as anxious or depressed in in childhood were significantly related to use of MDMA in adolescents and adults, resulting in an increased risk (hazard ratio 2.22, 95% confidence interval 1.20 to 4.11, P=0.01). Conclusions Individuals with childhood Symptoms of anxiety and depression may have all increased tendency to use MDMA in adolescence or young adulthood. Its effects are supposed to include enhanced feelings of bonding with other people, euphoria, or relaxation. Especially individuals With Symptoms of anxiety or depression may be susceptible to these positive effects.	Sophia Childrens Univ Hosp, Erasmus Med Ctr Rotterdam, Dept Child & Adoelscent Psychiat, NL-3000 CB Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Huizink, AC (corresponding author), Sophia Childrens Univ Hosp, Erasmus Med Ctr Rotterdam, Dept Child & Adoelscent Psychiat, POB 2060, NL-3000 CB Rotterdam, Netherlands.	a.c.huizink@erasmusmc.nl	Ferdinand, Robert/AAK-5532-2020					Achenbach T.M., 1983, MANUAL CHILD BEHAV C; *AM PSYCH ASS, 1991, DIAGN STAT MAN MENT; Andrews G, 1998, SOC PSYCH PSYCH EPID, V33, P80, DOI 10.1007/s001270050026; [Anonymous], 1997, COMP INT DIAGN INT C; Brady KT, 1999, PSYCHIAT CLIN N AM, V22, P241, DOI 10.1016/S0193-953X(05)70074-5; *BUR NDM, 2002, NAT DRUGM JAARB; COX DR, 1972, J R STAT SOC B, V34, P187; de Win MML, 2004, PSYCHOPHARMACOLOGY, V173, P376, DOI 10.1007/s00213-003-1723-4; Fergusson DM, 2002, J ABNORM CHILD PSYCH, V30, P419, DOI 10.1023/A:1015774125952; Gowing LR, 2002, DRUG ALCOHOL REV, V21, P53, DOI 10.1080/09595230220119363; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; GRIFFITHS P, 1997, NEW TRENDS SYNTHETIC; Hofstra MB, 2002, J AM ACAD CHILD PSY, V41, P182, DOI 10.1097/00004583-200202000-00012; Kasius MC, 1997, J CHILD PSYCHOL PSYC, V38, P625, DOI 10.1111/j.1469-7610.1997.tb01689.x; Latimer WW, 2002, EXP CLIN PSYCHOPHARM, V10, P310, DOI 10.1037//1064-1297.10.3.310; Levy KB, 2005, SUBST USE MISUSE, V40, P1427, DOI 10.1081/JA-200066810; Lieb R, 2002, DRUG ALCOHOL DEPEN, V68, P195, DOI 10.1016/S0376-8716(02)00190-4; Lieb R, 2002, ARCH GEN PSYCHIAT, V59, P365, DOI 10.1001/archpsyc.59.4.365; Maes Michael, 1995, P933; McCann UD, 2000, NEUROPSYCHOBIOLOGY, V42, P11, DOI 10.1159/000026665; McCardle K, 2004, PSYCHOPHARMACOLOGY, V173, P434, DOI 10.1007/s00213-004-1791-0; Meltzer HY., 1987, PSYCHOPHARMACOLOGY 3, VVol. 1, P513; Parrott AC, 2002, HUM PSYCHOPHARM CLIN, V17, P309, DOI 10.1002/hup.415; Parrott AC, 2001, PSYCHOPHARMACOLOGY, V159, P77, DOI 10.1007/s002130100897; Pennings E J, 1998, Ned Tijdschr Geneeskd, V142, P1942; RICAURTE G, 1985, SCIENCE, V229, P986, DOI 10.1126/science.4023719; Ricaurte GA, 2000, NEUROPSYCHOBIOLOGY, V42, P5, DOI 10.1159/000026664; ROYS A, 2001, HLTH ED RES, V16, P457; Schifano F, 1998, DRUG ALCOHOL DEPEN, V52, P85, DOI 10.1016/S0376-8716(98)00051-9; Sprague JE, 1998, NEUROTOXICOLOGY, V19, P427; VANWESTERLAAK JH, 1975, BEROEPERKLAPPER; Verheyden SL, 2003, J PSYCHOPHARMACOL, V17, P371, DOI 10.1177/0269881103174014; Verhulst F C, 1985, Acta Psychiatr Scand Suppl, V324, P1; VERHULST FC, 1985, ACTA PSYCHIAT SCAND, V72, P1; VERHULST FC, 1996, HANDLEIDING CBCI 4; Vollenweider FX, 1998, NEUROPSYCHOPHARMACOL, V19, P241, DOI 10.1016/S0893-133X(98)00013-X	36	55	55	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 8	2006	332	7545					825	827		10.1136/bmj.38743.539398.3A	http://dx.doi.org/10.1136/bmj.38743.539398.3A			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	032ZQ	16500927	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000236815900020
J	Nissen, SE				Nissen, SE			ADHD drugs and cardiovascular risk	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; US FDA, Drug Safety & Risk Management Advisory Comm, Rockville, MD 20857 USA	Cleveland Clinic Foundation; US Food & Drug Administration (FDA)	Nissen, SE (corresponding author), Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA.							Food and Drug Administration, 2006, DRUG SAF RISK MAN AD; Kernan WN, 2000, NEW ENGL J MED, V343, P1826, DOI 10.1056/NEJM200012213432501; Kingston RL, 2003, ANN INTERN MED, V139, P385, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00017; Nissen SE, 2005, CIRCULATION, V112, P2043, DOI 10.1161/CIRCULATIONAHA.105.573105; Wilens TE, 2005, J CLIN PSYCHIAT, V66, P253, DOI 10.4088/JCP.v66n0215	5	227	231	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 6	2006	354	14					1445	1448		10.1056/NEJMp068049	http://dx.doi.org/10.1056/NEJMp068049			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	029DP	16549404				2022-12-24	WOS:000236539000001
J	Scantlebury, M; Speakman, JR; Oosthuizen, MK; Roper, TJ; Bennett, NC				Scantlebury, M; Speakman, JR; Oosthuizen, MK; Roper, TJ; Bennett, NC			Energetics reveals physiologically distinct castes in a eusocial mammal	NATURE			English	Article							DAMARALAND MOLE-RAT; CRYPTOMYS-DAMARENSIS RODENTIA; BATHYERGIDAE; DISPERSAL; NAMIBIA	Eusociality, which occurs among mammals only in two species of African mole-rat, is characterized by division of labour between morphologically distinct 'castes' (1). In Damaraland molerats (Cryptomys damarensis), colony labour is divided between 'infrequent worker' and 'frequent worker' castes(2). Frequent workers are active year-round and together perform more than 95% of the total work of the colony, whereas infrequent workers typically perform less than 5% of the total work(3). Anecdotal evidence suggests that infrequent workers may act as dispersers, with dispersal being limited to comparatively rare periods when the soil is softened by moisture(4,5). Here we show that infrequent workers and queens increase their daily energy expenditure after rainfall whereas frequent workers do not. Infrequent workers are also fatter than frequent workers. We suggest that infrequent workers constitute a physiologically distinct dispersing caste, the members of which, instead of contributing to the work of the colony and helping the queen to reproduce, build up their own body reserves in preparation for dispersal and reproduction when environmental conditions are suitable.	Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; Univ Aberdeen, Sch Biol Sci, ACERO, Aberdeen AB24 2TZ, Scotland; Univ Sussex, Dept Biol & Environm Sci, Brighton BN1 9QG, E Sussex, England	University of Pretoria; University of Aberdeen; University of Sussex	Scantlebury, M (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa.	m.scantlebury@zoology.up.ac.za	Bennett, Nigel Charles/E-4238-2010; Speakman, John R./A-9494-2008; Oosthuizen, Maria/U-7276-2019; Oosthuizen, Maria Kathleen/K-7923-2012	Bennett, Nigel Charles/0000-0001-9748-2947; Speakman, John R./0000-0002-2457-1823; Oosthuizen, Maria Kathleen/0000-0001-6305-8283				Bennett N., 2000, AFRICAN MOLE RATS EC, P273; BENNETT NC, 1988, J MAMMAL, V69, P293, DOI 10.2307/1381379; BENNETT NC, 1988, S AFR J ZOOL, V23, P189; Burland TM, 2002, P ROY SOC B-BIOL SCI, V269, P1025, DOI 10.1098/rspb.2002.1978; Emlen S.T., 1991, P301; Emlen Stephen T., 1997, P228; Hammond KA, 1997, NATURE, V386, P457, DOI 10.1038/386457a0; HARDY RN, 1972, STUDIES BIOL; Hazell RWA, 2000, J ZOOL, V252, P19; JACOBS DS, 1991, J ZOOL, V224, P553, DOI 10.1111/j.1469-7998.1991.tb03785.x; JARVIS JUM, 1994, TRENDS ECOL EVOL, V9, P46; KELLER L, 1994, TRENDS ECOL EVOL, V9, P98, DOI 10.1016/0169-5347(94)90204-6; Molteno AJ, 2002, J ZOOL, V256, P445, DOI 10.1017/S0952836902000481; ORiain MJ, 1996, NATURE, V380, P619, DOI 10.1038/380619a0; Scantlebury M, 2005, PHYSIOL BEHAV, V84, P739, DOI 10.1016/j.physbeh.2005.02.022; Solomon N. G., 1997, COOPERATIVE BREEDING; Speakman J.R., 1997, DOUBLY LABELLED WATE; Stacey P.B., 1990, COOPERATIVE BREEDING; Waterman JM, 1998, ANIM BEHAV, V56, P459, DOI 10.1006/anbe.1998.0780; [No title captured]	20	59	60	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2006	440	7085					795	797		10.1038/nature04578	http://dx.doi.org/10.1038/nature04578			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598257				2022-12-24	WOS:000236548400041
J	Schaer, BA; Luthy, C				Schaer, BA; Luthy, C			Exploring the heart of the human heart	LANCET			English	Editorial Material									Univ Hosp, Dept Cardiol, CH-4031 Basel, Switzerland; Radboud Univ Nijmegen, Fac Philosophy, NL-6500 HD Nijmegen, Netherlands	Radboud University Nijmegen	Schaer, BA (corresponding author), Univ Hosp, Dept Cardiol, CH-4031 Basel, Switzerland.	bschaer@uhbs.ch							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2006	367	9515					1007	1007		10.1016/S0140-6736(06)68428-6	http://dx.doi.org/10.1016/S0140-6736(06)68428-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028GE	16564363	Bronze			2022-12-24	WOS:000236474200029
J	Cai, L; Friedman, N; Xie, XS				Cai, L; Friedman, N; Xie, XS			Stochastic protein expression in individual cells at the single molecule level	NATURE			English	Article							EUKARYOTIC GENE-EXPRESSION; BETA-D-GALACTOSIDASE; ESCHERICHIA-COLI; TRANSCRIPTION; TRANSLATION; POPULATION; BACTERIA; NOISE; LACZ	In a living cell, gene expression - the transcription of DNA to messenger RNA followed by translation to protein - occurs stochastically, as a consequence of the low copy number of DNA and mRNA molecules involved(1-6). These stochastic events of protein production are difficult to observe directly with measurements on large ensembles of cells owing to lack of synchronization among cells. Measurements so far on single cells lack the sensitivity to resolve individual events of protein production. Here we demonstrate a microfluidic- based assay that allows real- time observation of the expression of beta-galactosidase in living Escherichia coli cells with single molecule sensitivity. We observe that protein production occurs in bursts, with the number of molecules per burst following an exponential distribution. We show that the two key parameters of protein expression - the burst size and frequency - can be either determined directly from real- time monitoring of protein production or extracted from a measurement of the steady- state copy number distribution in a population of cells. Application of this assay to probe gene expression in individual budding yeast and mouse embryonic stem cells demonstrates its generality. Many important proteins are expressed at low levels(7,8), and are thus inaccessible by current genomic and proteomic techniques. This microfluidic single cell assay opens up possibilities for system- wide characterization of the expression of these low copy number proteins.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu			NIH HHS [DP1 OD000277] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; BERG OG, 1978, J THEOR BIOL, V71, P587, DOI 10.1016/0022-5193(78)90326-0; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Efron Bradley., 1994, INTRO BOOTSTRAP; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; GUPTASARMA P, 1995, BIOESSAYS, V17, P987, DOI 10.1002/bies.950171112; KENNELL D, 1977, J MOL BIOL, V114, P1, DOI 10.1016/0022-2836(77)90279-0; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; MONOD J, 1952, BIOCHIM BIOPHYS ACTA, V9, P648, DOI 10.1016/0006-3002(52)90227-8; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rondelez Y, 2005, NAT BIOTECHNOL, V23, P361, DOI 10.1038/nbt1072; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; ROTMAN B, 1961, P NATL ACAD SCI USA, V47, P1981, DOI 10.1073/pnas.47.12.1981; RUSSOMARIE F, 1993, P NATL ACAD SCI USA, V90, P8194, DOI 10.1073/pnas.90.17.8194; SORENSEN MA, 1991, J MOL BIOL, V222, P265, DOI 10.1016/0022-2836(91)90211-N; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Wu HK, 2004, P NATL ACAD SCI USA, V101, P12809, DOI 10.1073/pnas.0405299101; YARCHUK O, 1992, J MOL BIOL, V226, P581, DOI 10.1016/0022-2836(92)90617-S; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	30	842	870	4	265	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2006	440	7082					358	362		10.1038/nature04599	http://dx.doi.org/10.1038/nature04599			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541077				2022-12-24	WOS:000235997600057
J	Gessler, D; Dye, C; Farmer, P; Murray, M; Navin, T; Reves, R; Shinnick, T; Small, PM; Yates, T; Simpson, G				Gessler, D; Dye, C; Farmer, P; Murray, M; Navin, T; Reves, R; Shinnick, T; Small, PM; Yates, T; Simpson, G			A national tuberculosis archive	SCIENCE			English	Editorial Material							NEW-YORK-CITY; RESISTANT MYCOBACTERIUM-TUBERCULOSIS; HANTAVIRUS PULMONARY SYNDROME; MOLECULAR EPIDEMIOLOGY; DISEASE; SPREAD; STRAIN		Natl Ctr Genome Resources, Santa Fe, NM 87505 USA; WHO, Stop TB, Geneva 27, Switzerland; Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA; US Dept HHS, Washington, DC 20201 USA; Denver Hlth & Hosp Author, Denver Publ Hlth, Denver, CO 80204 USA; Inst Syst Biol, Seattle, WA 98103 USA; Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Univ New Mexico, Museum SW Biol, Albuquerque, NM 87131 USA; New Mexico Dept Hlth, Santa Fe, NM 87502 USA	National Center for Genome Resources (NCGR); World Health Organization; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Centers for Disease Control & Prevention - USA; Denver Health Medical Center; Institute for Systems Biology (ISB); Bill & Melinda Gates Foundation; University of New Mexico; University of New Mexico; New Mexico Department of Health	Gessler, D (corresponding author), Natl Ctr Genome Resources, Santa Fe, NM 87505 USA.	ddg@ncgr.org	Dye, Christopher/AIC-4659-2022	Dye, Christopher/0000-0002-2957-1793				Agerton TB, 1999, CLIN INFECT DIS, V29, P85, DOI 10.1086/520187; AZIZ MA, 2004, ANTITUBERCULOSIS DRU; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; *CDC, 2004, TECHN NOT REP TUB US; CDC, 2005, REP TUB US; CDC, 2005, MMWR-MORBID MORTAL W, V54; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DeRiemer K, 2005, LANCET, V365, P1239, DOI 10.1016/S0140-6736(05)74812-1; DUCHIN JS, 1994, NEW ENGL J MED, V330, P949, DOI 10.1056/NEJM199404073301401; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Han LL, 2005, INT J TUBERC LUNG D, V9, P818; HUGHES JM, 1993, SCIENCE, V262, P850, DOI 10.1126/science.8235607; Kato-Maeda M, 2000, WESTERN J MED, V172, P256, DOI 10.1136/ewjm.172.4.256; Munsiff SS, 2003, J INFECT DIS, V188, P356, DOI 10.1086/376837; Munsiff SS, 2002, EMERG INFECT DIS, V8, P1230; National TB Controllers Association/Center for Disease Control and Prevention Advisory Group on Tubercolosis Genotyping, 2004, GUID APPL GEN TUB PR; PORTER JDH, 1994, ANNU REV PUBL HEALTH, V15, P303; Schwartzman K, 2005, NEW ENGL J MED, V353, P1008, DOI 10.1056/NEJMsa043194; Shin SS, 2005, MICROB DRUG RESIST, V11, P26, DOI 10.1089/mdr.2005.11.26; *US DEP HHS, 2004, REP TUB US 2003; *WHO, 2005, GLOB TUB CONTR SURV; *WHO, S E AS REG FACTS; World Health Organization (WHO), 2005, ADDR POV TB CONTR; Yates TL, 2002, BIOSCIENCE, V52, P989, DOI 10.1641/0006-3568(2002)052[0989:TEAEHO]2.0.CO;2	25	6	6	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2006	311	5765					1245	1246		10.1126/science.1125762	http://dx.doi.org/10.1126/science.1125762			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019XB	16513968				2022-12-24	WOS:000235870400025
J	Makadon, HJ				Makadon, HJ			Improving health care for the lesbian and gay communities	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Fenway Inst, Boston, MA USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Makadon, HJ (corresponding author), Fenway Inst, Boston, MA USA.							American Thoracic Society, 2003, MMWR Recomm Rep, V52, P1; Ciesielski Carol A., 2003, Curr Infect Dis Rep, V5, P145, DOI 10.1007/s11908-003-0051-5; Garofalo R, 1999, ARCH PEDIAT ADOL MED, V153, P487; Incorporating HIV prevention into the medical care of persons living with HIV, 2004, MMWR RECOMM REP; WHITE J, 2001, TXB PRIMARY CARE MED, P336; 1994, MMWR MORB MORTAL WKL, V42, P988	6	48	47	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2006	354	9					895	897		10.1056/NEJMp058259	http://dx.doi.org/10.1056/NEJMp058259			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	017FN	16510743				2022-12-24	WOS:000235679600002
J	Ji, Q; Luo, ZX; Yuan, CX; Tabrum, AR				Ji, Q; Luo, ZX; Yuan, CX; Tabrum, AR			A swimming mammaliaform from the Middle Jurassic and ecomorphological diversification of early mammals	SCIENCE			English	Article							INNER-MONGOLIA; EVOLUTION; DOCODONT; CHINA; DISCOVERY; ORIGIN; TEETH	A docodontan mammaliaform from the Middle Jurassic of China possesses swimming and burrowing skeletal adaptations and some dental features for aquatic feeding. It is the most primitive taxon in the mammalian lineage known to have fur and has a broad, flattened, partly scaly tail analogous to that of modern beavers. We infer that docodontans were semiaquatic, convergent to the modern platypus and many Cenozoic placentals. This fossil demonstrates that some mammaliaforms, or proximal relatives to modern mammals, developed diverse locomotory and feeding adaptations and were ecomorphologically different from the majority of generalized small terrestrial Mesozoic mammalian insectivores.	Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA; Chinese Acad Geol Sci, Beijing 100037, Peoples R China; Nanjing Univ, Dept Earth Sci, Nanjing 200017, Peoples R China	Chinese Academy of Geological Sciences; Nanjing University	Luo, ZX (corresponding author), Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA.	LuoZ@CarnegieMNH.org	Luo, Zhe-XI/AAU-2263-2021					Alibardi L, 2003, J MORPHOL, V258, P49, DOI 10.1002/jmor.10118; ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; Averianov AO, 2005, ACTA PALAEONTOL POL, V50, P789; BRINK A. S., 1955, PALAEONTOL AFRICANA, V3, P3; Butler PM, 2001, PALAEONTOLOGY, V44, P1, DOI 10.1111/1475-4983.00166; Butler PM, 1997, J VERTEBR PALEONTOL, V17, P435, DOI 10.1080/02724634.1997.10010988; [陈文 Chen Wen], 2004, [地质通报, Geological Bulletin of China], V23, P1165; CROMPTON AW, 1993, MAMMAL PHYLOGENY, P30; Fish FE, 2001, J EXP BIOL, V204, P797; Flynn JJ, 1999, NATURE, V401, P57, DOI 10.1038/43420; Gambaryan Petr P., 2002, Russian Journal of Theriology, V1, P1; Gao KQ, 2003, NATURE, V422, P424, DOI 10.1038/nature01491; Gingerich P.D., 1984, SIZE SCALING PRIMATE, P257; Jenkins Jr F. A., 1971, PEABODY MUS NAT HIST, V36, P1; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Ji Q., 2004, MESOZOIC JEHOL BIOTA; Kemp T.S., 2005, ORIGIN EVOLUTION MAM; KERMACK KA, 1987, ZOOL J LINN SOC-LOND, V89, P1, DOI 10.1111/j.1096-3642.1987.tb01342.x; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Lillegraven J.A., 1991, Contributions to Geology University of Wyoming, V28, P39; Liu YQ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022466; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Luo ZX, 2001, SCIENCE, V292, P1535, DOI 10.1126/science.1058476; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; Martin T, 2005, ZOOL J LINN SOC-LOND, V145, P219, DOI 10.1111/j.1096-3642.2005.00187.x; Martin T, 2005, J VERTEBR PALEONTOL, V25, P414, DOI 10.1671/0272-4634(2005)025[0414:MADOAP]2.0.CO;2; Martin T, 2004, J VERTEBR PALEONTOL, V24, P195, DOI 10.1671/15; Martin Thomas, 2000, P91; O'Leary MA, 1998, ADV VERT PALEOBIOL, P133; Pfretzschner HU, 2005, ACTA PALAEONTOL POL, V50, P799; [任东 Ren Dong], 2002, [地质通报, Geological Bulletin of China], V21, P584; Rybczynski N, 2005, J VERTEBR PALEONTOL, V25, p107A; Shen Yan-bin, 2003, Journal of Stratigraphy, V27, P311; Sigogneau-Russell D, 2003, ACTA PALAEONTOL POL, V48, P357; Sigogneau-Russell D, 1998, CR ACAD SCI II A, V327, P571, DOI 10.1016/S1251-8050(99)80040-8; Thewissen JGM, 1997, PALEOBIOLOGY, V23, P482, DOI 10.1017/S0094837300019850; Wang XL, 2002, CHINESE SCI BULL, V47, P226, DOI 10.1360/02tb9054; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y	40	217	248	0	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2006	311	5764					1123	1127		10.1126/science.1123026	http://dx.doi.org/10.1126/science.1123026			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017IU	16497926				2022-12-24	WOS:000235688100040
J	Hoelscher, MA; Garg, S; Bangari, DS; Belser, JA; Lu, XH; Stephenson, I; Bright, RA; Katz, JM; Mittal, SK; Sambhara, S				Hoelscher, MA; Garg, S; Bangari, DS; Belser, JA; Lu, XH; Stephenson, I; Bright, RA; Katz, JM; Mittal, SK; Sambhara, S			Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice	LANCET			English	Article							AVIAN INFLUENZA; MF59-ADJUVANTED INFLUENZA; RECOMBINANT ADENOVIRUS; REVERSE GENETICS; IMMUNOGENICITY; SAFETY; VIRUS; PROTECTION; CELLS; RESPONSES	Introduction Avian H5N1 influenza viruses currently circulating in southeast Asia could potentially cause the next pandemic. However, currently licensed human vaccines are subtype-specific and do not protect against these H5N1 viruses. We aimed to develop art influenza vaccine and assessed its immunogenicity and efficacy to confer protection in BALB/c mice. Methods We developed an egg-independent strategy to combat the avian influenza virus, because the virus is highly lethal to chickens and the maintenance of a constant supply of embryonated eggs would be difficult in a pandemic. We used a replication-incompetent, human adenoviral-vector-based, haemagglutinin subtype 5 influenza vaccine (HAd-H5HA), which induces both humoral and cell-mediated immune responses against avian H5N1 influenza viruses isolated from people. Findings Immunisation of mice with HAd-H5HA provided effective protection from H5N1 disease, death, and primary viral replication (p<0.0001) against antigenically distinct strains of H5N1 influenza viruses. Unlike the recombinant H5HA vaccine, which is based on a traditional subunit vaccine approach, HAd-H5HA vaccine induced a three-fold to eight-fold increase in HA-518-epitope-specific interferon-gamma-secreting CD8 T cells (p=0.01). Interpretation Our findings highlight the potential of an Ad-vector-based delivery system, which is both egg-independent and adjuvant-independent and offers stockpiling options for the development of a pandemic influenza vaccine.	Ctr Dis Control & Prevent, Influenza Branch, Div Viral & Rickettsial Dis, Atlanta, GA 30333 USA; Purdue Univ, Dept Vet Pathobiol, W Lafayette, IN 47907 USA	Centers for Disease Control & Prevention - USA; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Sambhara, S (corresponding author), Ctr Dis Control & Prevent, Influenza Branch, Div Viral & Rickettsial Dis, Atlanta, GA 30333 USA.	ssambhara@cdc.gov	Sambhara, Suryaprakash/AAC-4428-2021		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059374] Funding Source: NIH RePORTER; NIAID NIH HHS [AI059374, R01 AI059374-03, R01 AI059374] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Bangari DS, 2006, VACCINE, V24, P849, DOI 10.1016/j.vaccine.2005.08.101; Bangari DS, 2005, BIOCHEM BIOPH RES CO, V327, P960, DOI 10.1016/j.bbrc.2004.12.099; Bender B S, 1992, Semin Respir Infect, V7, P38; BUTLER D, BIRD FLU VACCINE NOT; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P547; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Fries LF, 2001, INFECT IMMUN, V69, P4545, DOI 10.1128/IAI.69.7.4545-4553.2001; Gao P, 1999, J VIROL, V73, P3184, DOI 10.1128/JVI.73.4.3184-3189.1999; Hien TT, 2004, NEW ENGL J MED, V351, P2363, DOI 10.1056/NEJMp048267; HOELSCHER M, 2001, P RES C ORH NOV 2 4, P36; Hoffmann E, 2005, P NATL ACAD SCI USA, V102, P12915, DOI 10.1073/pnas.0506416102; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; Lipatov AS, 2005, J INFECT DIS, V191, P1216, DOI 10.1086/428951; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Morelli AE, 2000, J VIROL, V74, P9617, DOI 10.1128/JVI.74.20.9617-9628.2000; Nanda A, 2005, J VIROL, V79, P14161, DOI 10.1128/JVI.79.22.14161-14168.2005; Ng P, 1999, HUM GENE THER, V10, P2667, DOI 10.1089/10430349950016708; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Noblitt LW, 2004, CANCER GENE THER, V11, P757, DOI 10.1038/sj.cgt.7700761; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Sailaja G, 2002, GENE THER, V9, P1722, DOI 10.1038/sj.gt.3301858; Sambhara S, 1998, J INFECT DIS, V177, P1266, DOI 10.1086/515285; Sambhara S, 2001, CELL IMMUNOL, V211, P143, DOI 10.1006/cimm.2001.1835; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tian GB, 2005, VIROLOGY, V341, P153, DOI 10.1016/j.virol.2005.07.011; Treanor JJ, 2001, VACCINE, V19, P1732, DOI 10.1016/S0264-410X(00)00395-9; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Van Kampen KR, 2005, VACCINE, V23, P1029, DOI 10.1016/j.vaccine.2004.07.043; Webby RJ, 2004, LANCET, V363, P1099, DOI 10.1016/S0140-6736(04)15892-3; *WHO, 2004, WKLY EPIDEMIOL REC, V79, P65; *WHO, AV INFL A H5N1 UPD 2; World Health Organization, CUM NUMB CONF HUM CA; YAP KL, 1978, NATURE, V273, P238, DOI 10.1038/273238a0	38	157	185	1	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2006	367	9509					475	481		10.1016/S0140-6736(06)68076-8	http://dx.doi.org/10.1016/S0140-6736(06)68076-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	013FF	16473124	Green Accepted			2022-12-24	WOS:000235394500028
J	Barluenga, M; Stolting, KN; Salzburger, W; Muschick, M; Meyer, A				Barluenga, M; Stolting, KN; Salzburger, W; Muschick, M; Meyer, A			Sympatric speciation in Nicaraguan crater lake cichlid fish	NATURE			English	Article							SEXUAL SELECTION; CICHLASOMA-CITRINELLUM; SPECIES COMPLEX; DIVERGENCE; EVOLUTION	Sympatric speciation, the formation of species in the absence of geographical barriers, remains one of the most contentious concepts in evolutionary biology. Although speciation under sympatric conditions seems theoretically possible(1-5), empirical studies are scarce and only a few credible examples of sympatric speciation exist(6). Here we present a convincing case of sympatric speciation in the Midas cichlid species complex (Amphilophus sp.) in a young and small volcanic crater lake in Nicaragua. Our study includes phylogeographic, population-genetic ( based on mitochondrial DNA, microsatellites and amplified fragment length polymorphisms), morphometric and ecological analyses. We find, first, that crater Lake Apoyo was seeded only once by the ancestral high-bodied benthic species Amphilophus citrinellus, the most common cichlid species in the area; second, that a new elongated limnetic species ( Amphilophus zaliosus) evolved in Lake Apoyo from the ancestral species ( A. citrinellus) within less than similar to 10,000 yr; third, that the two species in Lake Apoyo are reproductively isolated; and fourth, that the two species are eco-morphologically distinct.	Univ Konstanz, Lehrstuhl Zool & Evolut Biol, Dept Biol, D-78457 Constance, Germany; Univ Konstanz, Ctr Jr Res Fellows, D-78457 Constance, Germany	University of Konstanz; University of Konstanz	Meyer, A (corresponding author), Univ Konstanz, Lehrstuhl Zool & Evolut Biol, Dept Biol, Univ Str 10, D-78457 Constance, Germany.	Axel.Meyer@uni-konstanz.de	Muschick, Moritz/B-9843-2012; Salzburger, Walter/G-1598-2011; Barluenga, Marta/ABA-4194-2020; Meyer, Axel/C-9826-2009	Muschick, Moritz/0000-0002-7782-7503; Salzburger, Walter/0000-0002-9988-1674; Barluenga, Marta/0000-0003-1514-0586; Meyer, Axel/0000-0002-0888-8193; Stolting, Kai N./0000-0003-3498-3343				Arnegard ME, 2004, EVOLUTION, V58, P222, DOI 10.1111/j.0014-3820.2004.tb01640.x; Barlow G.W., 1976, P333; Barluenga M, 2004, MOL ECOL, V13, P2061, DOI 10.1111/j.1365-294X.2004.02211.x; BAYLIS JR, 1976, BEHAVIOUR, V59, P59, DOI 10.1163/156853976X00460; BICE DC, 1985, GEOL SOC AM BULL, V96, P553, DOI 10.1130/0016-7606(1985)96<553:QVSOMN>2.0.CO;2; Coyne J. A., 2004, SPECIATION; Darwin C., 1859, ORIGIN SPECIES MEANS; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Fryer G., 1972, CICHLID FISHES GREAT; GAVRILETS S, 2004, MONOGRAPHS POPULATIO, V41; Gislason D, 1999, CAN J FISH AQUAT SCI, V56, P2229, DOI 10.1139/cjfas-56-12-2229; Hammer O., 2004, PALAEONTOL ELECTRON, V4; Higashi M, 1999, NATURE, V402, P523, DOI 10.1038/990087; KAWECKI TJ, 2004, ADAPTIVE SPECIATION; Kirkpatrick M, 2004, P ROY SOC B-BIOL SCI, V271, P687, DOI 10.1098/rspb.2003.2645; Klingenberg CP, 2003, BIOL J LINN SOC, V80, P397, DOI 10.1046/j.1095-8312.2003.00246.x; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kondrashov AS, 1999, NATURE, V400, P351, DOI 10.1038/22514; LEVINS RICHARD, 1968; McKaye K.R., 2002, CUADERNOS INVESTIGAC, V12, P19; MEYER A, 1989, OECOLOGIA, V80, P431, DOI 10.1007/BF00379047; Rohlf FJ, 2018, TPSDIG; Schliewen U, 2001, MOL ECOL, V10, P1471, DOI 10.1046/j.1365-294X.2001.01276.x; SCHLIEWEN UK, 1994, NATURE, V368, P629, DOI 10.1038/368629a0; SCHLUTER D, 1993, TRENDS ECOL EVOL, V8, P197, DOI 10.1016/0169-5347(93)90098-A; Seehausen O, 1999, ECOL LETT, V2, P262; Van Oppen MJH, 1998, MOL ECOL, V7, P991, DOI 10.1046/j.1365-294x.1998.00417.x; Weiblen GD, 2002, MOL ECOL, V11, P1573, DOI 10.1046/j.1365-294X.2002.01529.x; [No title captured]	29	493	511	6	305	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2006	439	7077					719	723		10.1038/nature04325	http://dx.doi.org/10.1038/nature04325			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	010KH	16467837	Green Published			2022-12-24	WOS:000235193100043
J	Kang, SK				Kang, SK			Radiation recall reaction after antimicrobial therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Naval Med Ctr San Diego, San Diego, CA 92134 USA	United States Department of Defense; United States Navy; Naval Medical Center San Diego	Kang, SK (corresponding author), Naval Med Ctr San Diego, San Diego, CA 92134 USA.								0	21	21	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2006	354	6					622	622		10.1056/NEJMicm041058	http://dx.doi.org/10.1056/NEJMicm041058			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	010HF	16467549				2022-12-24	WOS:000235177500011
J	Rajan, R; Clement, JP; Bhalla, US				Rajan, R; Clement, JP; Bhalla, US			Rats smell in stereo	SCIENCE			English	Article							CHEMOTAXIS; MECHANISMS; OLFACTION	It has been hypothesized that rats and other mammals can use stereo cues to localize odor sources, but there is limited behavioral evidence to support this hypothesis. We found that rats trained on an odor-localization task can localize odors accurately in one or two sniffs. Bilateral sampling was essential for accurate odor localization, with internasal. intensity and timing differences as directional cues. If the stimulus arrived at the correct point of the respiration cycle, internasal. timing differences as short as 50 milliseconds sufficed. Neuronal recordings show that bulbar neurons responded differentially to stimuli from the left and stimuli from the right.	Univ Agr Sci Bangalore, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Agricultural Sciences Bangalore	Bhalla, US (corresponding author), Univ Agr Sci Bangalore, Natl Ctr Biol Sci, Gandhi Krishi Vignan Kendra Campus,Bellary Rd, Bangalore 560065, Karnataka, India.	bhalla@ncbs.res.in	Clement, James/Q-5628-2019	Clement, James/0000-0001-7625-6430				Atema J, 1996, BIOL BULL, V191, P129, DOI 10.2307/1543074; FORD N, 1986, CHEM SIGNALS VERTEBR; JOHNSEN PB, 1980, J COMP PHYSIOL, V140, P95, DOI 10.1007/BF00606301; KOBAL G, 1989, EXPERIENTIA, V45, P130, DOI 10.1007/BF01954845; Konishi M, 2003, ANNU REV NEUROSCI, V26, P31, DOI 10.1146/annurev.neuro.26.041002.131123; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; MEANS LW, 1971, J COMP PHYSIOL PSYCH, V76, P160, DOI 10.1037/h0031058; Neimark MA, 2003, J NEUROSCI, V23, P6499; Porter J, 2005, NEURON, V47, P581, DOI 10.1016/j.neuron.2005.06.028; Radil T, 1998, ANN NY ACAD SCI, V855, P641, DOI 10.1111/j.1749-6632.1998.tb10638.x; SILVER WL, 1982, PHYSIOL BEHAV, V28, P927, DOI 10.1016/0031-9384(82)90216-5; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Vickers NJ, 2000, BIOL BULL, V198, P203, DOI 10.2307/1542524; VONBEKESY G, 1964, J APPL PHYSIOL, V19, P369, DOI 10.1152/jappl.1964.19.3.369; Wallace DG, 2002, BEHAV BRAIN RES, V131, P185, DOI 10.1016/S0166-4328(01)00384-9; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; Wilson DA, 1999, PHYSIOL BEHAV, V66, P41, DOI 10.1016/S0031-9384(98)00269-8; Wilson DA, 1997, J NEUROPHYSIOL, V78, P160, DOI 10.1152/jn.1997.78.1.160	18	137	139	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 3	2006	311	5761					666	670		10.1126/science.1122096	http://dx.doi.org/10.1126/science.1122096			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011GY	16456082				2022-12-24	WOS:000235257400050
J	Lesurtel, M; Graf, R; Aleil, B; Walther, DJ; Tian, YH; Jochum, W; Gachet, C; Bader, M; Clavien, PA				Lesurtel, M; Graf, R; Aleil, B; Walther, DJ; Tian, YH; Jochum, W; Gachet, C; Bader, M; Clavien, PA			Platelet-derived serotonin mediates liver regeneration	SCIENCE			English	Article							TRYPTOPHAN-HYDROXYLASE ISOFORM; ENDOTHELIAL-CELL APOPTOSIS; ISCHEMIC RAT-LIVER; REPERFUSION INJURY; 5-HT2B RECEPTOR; GROWTH-FACTOR; ALPHA; THROMBOCYTOPENIA; INFLAMMATION; SYSTEM	The liver can regenerate its volume after major tissue loss. In a mouse model of liver regeneration, thrombocytopenia, or impaired platelet activity resulted in the failure to initiate cellular proliferation in the liver. Platelets are major carriers of serotonin in the blood. In thrombocytopenic mice, a serotonin agonist reconstituted liver proliferation. The expression of 5-HT2A and 2B subtype serotonin receptors in the liver increased after hepatectomy. Antagonists of 5-HT2A and 2B receptors inhibited liver regeneration. Liver regeneration was also blunted in mice lacking tryptophan hydroxylase 1, which is the rate-limiting enzyme for the synthesis of peripheral serotonin. This failure of regeneration was rescued by reloading serotonin-free platelets with a serotonin precursor molecule. These results suggest that platelet-derived serotonin is involved in the initiation of liver regeneration.	Univ Zurich Hosp, Dept Visceral & Transplantat Surg, Zurich, Switzerland; Univ Zurich Hosp, Dept Pathol, Zurich, Switzerland; INSERM, U311, Estab Francais Sang Alsace, Strasbourg, France; Max Planck Inst Mol Genet, Berlin, Germany; Max Delbruck Ctr Mol Med, Berlin, Germany	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Clavien, PA (corresponding author), Univ Zurich Hosp, Dept Visceral & Transplantat Surg, Zurich, Switzerland.	clavien@chir.unizh.ch	Bader, Michael/K-2124-2013; Gachet, Christian/H-9156-2016; Lesurtel, Mickaël/J-3710-2019	Lesurtel, Mickaël/0000-0003-2397-4599; Bader, Michael/0000-0003-4780-4164; Graf, Rolf/0000-0001-7449-7302				Balasubramanian S, 1998, HEPATOLOGY, V27, P62, DOI 10.1002/hep.510270111; BONHAUS DW, 1995, BRIT J PHARMACOL, V115, P622, DOI 10.1111/j.1476-5381.1995.tb14977.x; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; CYWES R, 1993, HEPATOLOGY, V18, P635, DOI 10.1002/hep.1840180324; Durk T, 2005, INT IMMUNOL, V17, P599, DOI 10.1093/intimm/dxh242; Eddahibi S, 1997, AM J PHYSIOL-HEART C, V272, pH1173, DOI 10.1152/ajpheart.1997.272.3.H1173; EVENSEN SA, 1968, THROMB DIATH HAEMOST, V19, P570, DOI 10.1055/s-0038-1651236; FANBURG BL, 1997, AM J PHYSIOL, V272, P795; Fiorica-Howells E, 2000, J NEUROSCI, V20, P294, DOI 10.1523/JNEUROSCI.20-01-00294.2000; Gachet C, 2001, THROMB HAEMOSTASIS, V86, P222; Gawaz M., 2001, BLOOD PLATELETS PHYS, V1st ed, pp. 200; George JN, 2000, LANCET, V355, P1531, DOI 10.1016/S0140-6736(00)02175-9; JULIUS D, 1990, P NATL ACAD SCI USA, V87, P928, DOI 10.1073/pnas.87.3.928; JULIUS D, 1989, SCIENCE, V244, P1057, DOI 10.1126/science.2727693; Kohli V, 1999, TRANSPLANTATION, V67, P1099, DOI 10.1097/00007890-199904270-00003; LOPEZ JA, 1987, P NATL ACAD SCI USA, V84, P5615, DOI 10.1073/pnas.84.16.5615; Mannaioni PF, 1997, INFLAMM RES, V46, P4, DOI 10.1007/PL00000158; Marcos E, 2004, CIRC RES, V94, P1263, DOI 10.1161/01.RES.0000126847.27660.69; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; Moritani C, 1998, CHEST, V113, P452, DOI 10.1378/chest.113.2.452; MULLANE KM, 1985, J CARDIOVASC PHARM, V7, P733, DOI 10.1097/00005344-198507000-00018; MUNRO JM, 1988, LAB INVEST, V58, P249; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P2591, DOI 10.1073/pnas.050282397; Okada Y, 1997, TRANSPLANTATION, V64, P801, DOI 10.1097/00007890-199709270-00002; ROSEN R, 1987, CARDIOVASC RES, V21, P293, DOI 10.1093/cvr/21.4.293; ROUSSEAU G, 1993, AM HEART J, V125, P1553, DOI 10.1016/0002-8703(93)90740-Z; Rudiger HA, 2002, GASTROENTEROLOGY, V122, P202, DOI 10.1053/gast.2002.30304; Selleng K, 2005, AM J HEMATOL, V78, P188, DOI 10.1002/ajh.20305; Selzner M, 1999, HEPATOLOGY, V30, P469, DOI 10.1002/hep.510300215; SEUWEN K, 1990, BIOCHEM PHARMACOL, V39, P985, DOI 10.1016/0006-2952(90)90276-Q; Sindram D, 2000, GASTROENTEROLOGY, V118, P183, DOI 10.1016/S0016-5085(00)70427-6; Sindram D, 2001, FASEB J, V15, P1230, DOI 10.1096/fj.00-0554fje; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Veenstra-VanderWeele J, 2000, EUR J PHARMACOL, V410, P165, DOI 10.1016/S0014-2999(00)00814-1; Vitalis T, 2003, DEV NEUROSCI-BASEL, V25, P245, DOI 10.1159/000072272; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Welsh DJ, 2004, AM J RESP CRIT CARE, V170, P252, DOI 10.1164/rccm.200302-264OC; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yeaman MR, 1997, CLIN INFECT DIS, V25, P951, DOI 10.1086/516120	41	574	600	5	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2006	312	5770					104	107		10.1126/science.1123842	http://dx.doi.org/10.1126/science.1123842			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601191				2022-12-24	WOS:000236584400041
J	Telford, K; Waters, L; Vyas, H; Manktelow, BN; Draper, ES; Marlow, N				Telford, K; Waters, L; Vyas, H; Manktelow, BN; Draper, ES; Marlow, N			Outcome after neonatal continuous negative-pressure ventilation: follow-up assessment	LANCET			English	Article							PRETERM INFANTS; AGE	Background A previous randomised trial of continuous negative extrathoracic pressure (CNEP) versus standard treatment for newborn infants with respiratory distress syndrome raised public concerns about mortality and neonatal morbidity. We studied the outcome in late childhood of children entered into the trial to establish whether there were long-term sequelae attributable to either mode of ventilation. Methods Outpatient assessment of neurological outcome, cognitive function, and disability was done by a paediatrician and a psychologist using standardised tests. 133 of 205 survivors from the original trial were assessed at 9-15 years of age. Of the original pairs randomly assigned to each ventilation mode, the results from 65 complete pairs were available. The primary outcome was death or severe disability. Findings Primary outcome was equally distributed between groups (odds ratio for the CNEP group 1.0; 95% CI 0.41-2.41). In impaired analysis there was no significant difference between treatment modalities (1.05; 0.54-2.06). Full IQ did not differ significantly between the groups, but mean performance IQ was 6.8 points higher in the CNEP group than in the conventional-treatment group (95% CI 1.5-12.1). Results of neuropsychological testing were consistent with this finding, with scores on language production and visuospatial skills being significantly higher in the CNEP group. Interpretation We saw no evidence of poorer long-term outcome after neonatal CNEP whether analysis was by original pairing or by impaired comparisons, despite small differences in adverse neonatal outcomes. The experience of our study indicates that future studies of neonatal interventions with the potential to influence later morbidity should be designed with longer-term outcomes in mind.	Univ Nottingham, Queens Med Ctr, Sch Human Dev, Acad Div Child Hlth, Nottingham NG7 2UH, England; Queens Med Ctr, Childrens Serv, Nottingham NG7 2UH, England; Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	University of Nottingham; University of Nottingham; University of Leicester	Marlow, N (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Human Dev, Acad Div Child Hlth, Nottingham NG7 2UH, England.	neil.marlow@nottingham.ac.uk	Draper, Elizabeth S/I-6304-2018; Draper, Elizabeth/S-6874-2019; Manktelow, Bradley N/G-2794-2011; Marlow, Neil/D-2918-2009	Draper, Elizabeth S/0000-0001-9340-8176; Draper, Elizabeth/0000-0001-9340-8176; Manktelow, Bradley N/0000-0002-3264-0323; Marlow, Neil/0000-0001-5890-2953				Bennett CC, 2001, LANCET, V357, P1094, DOI 10.1016/S0140-6736(00)04310-5; Feeny DH., 1996, QUALITY LIFE PHARMAE, V2, P239; FLEISS JL, 2003, STAT METHODS RATES P, P425; Furlong WJ, 2002, HLTH UTILITIES INDEX; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; GRIFFITHS, REPORT REV RES FRAME; HIFI Study Group, 1989, N Engl J Med, V320, P88; Jobe AH, 2004, NEW ENGL J MED, V350, P1349, DOI 10.1056/NEJMe048031; Korkman M., 1998, NEPSY DEV NEUROPSYCH; LYNN HS, 1992, BIOMETRICS, V48, P397, DOI 10.2307/2532299; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Marlow N, 2004, ARCH DIS CHILD-FETAL, V89, pF224, DOI 10.1136/adc.2002.019752; Moriette G, 2001, PEDIATRICS, V107, P363, DOI 10.1542/peds.107.2.363; *OFF POP CENS SURV, 1990, SOC OCC CLASS; Saigal S, 1996, JAMA-J AM MED ASSOC, V276, P453, DOI 10.1001/jama.276.6.453; Samuels MP, 1996, PEDIATRICS, V98, P1154; Schmidt B, 2001, NEW ENGL J MED, V344, P1966, DOI 10.1056/NEJM200106283442602; SHAH PS, 2003, COCHRANE DB SYST REV, V3; Wechsler D., 2011, WECHSLER ABBREVIATED	19	16	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2006	367	9516					1080	1085		10.1016/S0140-6736(06)68475-4	http://dx.doi.org/10.1016/S0140-6736(06)68475-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZF	16581407				2022-12-24	WOS:000236673200032
J	Kalab, P; Pralle, A; Isacoff, EY; Heald, R; Weis, K				Kalab, P; Pralle, A; Isacoff, EY; Heald, R; Weis, K			Analysis of a RanGTP-regulated gradient in mitotic somatic cells	NATURE			English	Article							IMPORTIN-BETA; NUCLEAR IMPORT; GTP; TRANSPORT	The RanGTPase cycle provides directionality to nucleocytoplasmic transport, regulating interactions between cargoes and nuclear transport receptors of the importin-beta family(1,2). The Ran importin-beta system also functions in mitotic spindle assembly and nuclear pore and nuclear envelope formation(1,3,4). The common principle underlying these diverse functions throughout the cell cycle is thought to be anisotropy of the distribution of RanGTP ( the RanGTP gradient), driven by the chromatin-associated guanine nucleotide exchange factor RCC1 ( refs 1, 4, 5). However, the existence and function of a RanGTP gradient during mitosis in cells is unclear. Here we examine the Ran - importin-beta system in cells by conventional and fluorescence lifetime microscopy using a biosensor, termed Rango, that increases its fluorescence resonance energy transfer signal when released from importin-beta by RanGTP. Rango is predominantly free in mitotic cells, but is further liberated around mitotic chromatin. In vitro experiments and modelling show that this localized increase of free cargoes corresponds to changes in RanGTP concentration sufficient to stabilize microtubules in extracts. In cells, the Ran - importin- beta - cargo gradient kinetically promotes spindle formation but is largely dispensable once the spindle has been established. Consistent with previous reports(6-8), we observe that the Ran system also affects spindle pole formation and chromosome congression in vivo. Our results demonstrate that conserved Ran-regulated pathways are involved in multiple, parallel processes required for spindle function, but that their relative contribution differs in chromatin-versus centrosome/ kinetochore-driven spindle assembly systems.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Heald, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	heald@socrates.berkeley.edu; kweis@berkeley.edu	Weis, Karsten/F-5719-2011; isacoff, ehud/AAP-1459-2020; Kalab, Petr/B-2478-2009; Pralle, Arnd/M-9832-2013	Weis, Karsten/0000-0001-7224-925X; Pralle, Arnd/0000-0002-6079-109X; Isacoff, Ehud Y./0000-0003-4775-9359; Heald, Rebecca/0000-0001-6671-6528				Arnaoutov A, 2005, NAT CELL BIOL, V7, P626, DOI 10.1038/ncb1263; Arnaoutov A, 2003, DEV CELL, V5, P99, DOI 10.1016/S1534-5807(03)00194-1; Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Ciciarello M, 2004, J CELL SCI, V117, P6511, DOI 10.1242/jcs.01569; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer M, 2002, NAT CELL BIOL, V4, pE177, DOI 10.1038/ncb0702-e177; Huber J, 2002, J CELL BIOL, V156, P467, DOI 10.1083/jcb.200108114; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Shelby RD, 1996, J CELL BIOL, V135, P545, DOI 10.1083/jcb.135.3.545; Suhling K, 2005, PHOTOCH PHOTOBIO SCI, V4, P13, DOI 10.1039/b412924p; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019	18	279	284	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					697	701		10.1038/nature04589	http://dx.doi.org/10.1038/nature04589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572176				2022-12-24	WOS:000236350400050
J	Clarke, MF; Fuller, M				Clarke, MF; Fuller, M			Stem cells and cancer: Two faces of eve	CELL			English	Editorial Material							SOMATIC SUPPORT CELLS; SELF-RENEWAL; BMI-1; IDENTIFICATION; GERMLINE; NICHE; PROLIFERATION	Recent evidence suggests that a subset of cancer cells within some tumors, the so-called cancer stem cells, may drive the growth and metastasis of these tumors. Understanding the pathways that regulate proliferation, self-renewal, survival, and differentiation of malignant and normal stem cells may shed light on mechanisms that lead to cancer and suggest better, modes of treatment.	Stanford Inst Stem Biol & Regenerat Med, Stanford, CA USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Clarke, MF (corresponding author), Stanford Inst Stem Biol & Regenerat Med, Stanford, CA USA.	mfclarke@stanford.edu		Fuller, Margaret T/0000-0002-3804-4987				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 2002, J IMMUNOL, V168, P635, DOI 10.4049/jimmunol.168.2.635; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Schulz C, 2002, DEVELOPMENT, V129, P4523; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	23	683	732	0	58	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 24	2006	124	6					1111	1115		10.1016/j.cell.2006.03.011	http://dx.doi.org/10.1016/j.cell.2006.03.011			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564000	Bronze			2022-12-24	WOS:000237241400007
J	Jeffcoate, W				Jeffcoate, W			Drive to eliminate the burden of type 1 diabetes	LANCET			English	Editorial Material							ISLET; CELL		Lancet, London NW1 7BY, England		Jeffcoate, W (corresponding author), Lancet, London NW1 7BY, England.	william.jeffcoate@lancet.com						*ET1DGN, EUR TYP 1 DIAB GEN N; Gale EAM, 2005, DIABETOLOGIA, V48, P2445, DOI 10.1007/s00125-005-0028-z; *IDF, 2005, DIAB ATL; *INT DIAB FED, NAT DIAB RES NETW LA; *ISCF, 2006, INT STEM CELL FOR HO; *JDRF, 2006, JUV DIAB RES FDN HOM; *JDRF, 2006, BET CELL THER; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Shapiro AMJ, 2005, TRANSPLANTATION, V79, P1304, DOI 10.1097/01.TP.0000157300.53976.2A; Stainier D, 2006, NEW ENGL J MED, V354, P521, DOI 10.1056/NEJMcibr055048; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0	11	5	5	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2006	367	9513					795	797		10.1016/S0140-6736(06)68314-1	http://dx.doi.org/10.1016/S0140-6736(06)68314-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021WL	16530560				2022-12-24	WOS:000236016500007
J	Wolff, S; Ma, H; Burch, D; Maciel, GA; Hunter, T; Dillin, A				Wolff, S; Ma, H; Burch, D; Maciel, GA; Hunter, T; Dillin, A			SMK-1, an essential regulator of DAF-16-mediated longevity	CELL			English	Article							C-ELEGANS DAF-16; AGE-1 PI3 KINASE; CAENORHABDITIS-ELEGANS; LIFE-SPAN; TRANSCRIPTION FACTORS; SIGNALING PATHWAY; CONSERVED PROTEIN; GENE-EXPRESSION; CLK-1 MUTANTS; LONG	Insulin/IGF-1 signaling (IIS) regulates aging in worms, flies, and mice through a well-characterized, highly conserved core set of components. IIS also regulates early developmental decisions, the reproductive status of the animal, innate immunity, and stress-resistance functions. In C. elegans, the sole insulin/IGF-1 receptor, DAF-2, negatively regulates the FOXO transcription factor, DAF-16. We report here on a new component of the IIS longevity pathway, SMK-11, which specifically influences DAF-16-dependent regulation of the aging process in C. elegans by regulating the transcriptional specificity of DAF-16 activity. Localization analysis of DAF-16 places SMK-1 downstream of DAF-16's phosphorylation-dependent relocation to the nucleus. Physiological and transcription analyses indicate that smk-1 is required for the innate immune, UV, and oxidative stress but not the thermal stress functions of DAF-16. SMK-11 therefore plays a role in longevity by modulating DAF-16 transcriptional specificity without affecting other processes regulated by IIS.	Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dillin@salk.edu	Maciel, Gustavo A/D-2291-2009	Maciel, Gustavo A/0000-0001-9097-8528	NCI NIH HHS [CA82863] Funding Source: Medline; NIDDK NIH HHS [DK60367-02, DK070696] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070696, F32DK060367] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRENNER S, 1974, GENETICS, V77, P71; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cohen PTW, 2005, FEBS LETT, V579, P3278, DOI 10.1016/j.febslet.2005.04.070; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; DORMAN JB, 1995, GENETICS, V141, P1399; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Friedman D.B., 1988, Journals of Gerontology, V43, P102; FRIEDMAN DB, 1988, GENETICS, V118, P75; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gems D, 1998, GENETICS, V150, P129; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; GOTTLIEB S, 1994, GENETICS, V137, P107; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mendoza MC, 2005, MOL CELL BIOL, V25, P7839, DOI 10.1128/MCB.25.17.7839-7853.2005; Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200; Moilanen LH, 1999, J BIOL CHEM, V274, P29655, DOI 10.1074/jbc.274.42.29655; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Riddle DL, 1997, C ELEGANS; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Spradling AC, 1999, GENETICS, V153, P135; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tissenbaum HA, 1998, GENETICS, V148, P703; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Wu HI, 2004, CANCER RES, V64, P3940, DOI 10.1158/0008-5472.CAN-03-3113	52	164	182	3	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 10	2006	124	5					1039	1053		10.1016/j.cell.2005.12.042	http://dx.doi.org/10.1016/j.cell.2005.12.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530049	Bronze			2022-12-24	WOS:000237241200024
J	Bjorklund, M; Taipale, M; Varjosalo, M; Saharinen, J; Lahdenpera, J; Taipale, J				Bjorklund, M; Taipale, M; Varjosalo, M; Saharinen, J; Lahdenpera, J; Taipale, J			Identification of pathways regulating cell size and cell-cycle progression by RNAi	NATURE			English	Article							DNA-DAMAGE; DROSOPHILA-MELANOGASTER; CHECKPOINT KINASE; COP9 SIGNALOSOME; GENOME; GROWTH; SCREEN; CDC25; MAP	Many high-throughput loss-of-function analyses of the eukaryotic cell cycle have relied on the unicellular yeast species Saccharomyces cerevisiae and Schizosaccharomyces pombe. In multicellular organisms, however, additional control mechanisms regulate the cell cycle to specify the size of the organism and its constituent organs(1). To identify such genes, here we analysed the effect of the loss of function of 70% of Drosophila genes (including 90% of genes conserved in human) on cell-cycle progression of S2 cells using flow cytometry. To address redundancy, we also targeted genes involved in protein phosphorylation simultaneously with their homologues. We identify genes that control cell size, cytokinesis, cell death and/or apoptosis, and the G1 and G2/M phases of the cell cycle. Classification of the genes into pathways by unsupervised hierarchical clustering on the basis of these phenotypes shows that, in addition to classical regulatory mechanisms such asMyc/Max, Cyclin/Cdk and E2F, cell-cycle progression in S2 cells is controlled by vesicular and nuclear transport proteins, COP9 signalosome activity and four extracellular-signal-regulated pathways (Wnt, p38 beta MAPK, FRAP/TOR and JAK/STAT). In addition, by simultaneously analysing several phenotypes, we identify a translational regulator, eIF-3p66, that specifically affects the Cyclin/Cdk pathway activity.	Univ Helsinki, Biomedicum Helsinki, Mol & Canc Biol Program, FI-00014 Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, High Throughput Ctr, FI-00014 Helsinki, Finland; Natl Publ Hlth Inst, Dept Mol Med, FI-00251 Helsinki, Finland; Biomedicum, Biomedicum Bioinformat Unit, FI-00251 Helsinki, Finland	University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki	Taipale, M (corresponding author), Univ Helsinki, Biomedicum Helsinki, Mol & Canc Biol Program, POB 63,Haartmaninkatu 8, FI-00014 Helsinki, Finland.	minna.taipale@helsinki.fi	Bjorklund, Mikael/AAA-2894-2020; Björklund, Mikael/D-3362-2009; Varjosalo, Markku/K-6424-2015	Björklund, Mikael/0000-0002-2176-681X; Varjosalo, Markku/0000-0002-1340-9732; Taipale, Minna/0000-0002-1905-2551				Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Brumby A, 2004, GENETICS, V168, P227, DOI 10.1534/genetics.104.026617; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Huang JY, 2002, J CELL SCI, V115, P2847; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim YO, 2004, P NATL ACAD SCI USA, V101, P159, DOI 10.1073/pnas.0307205101; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Neufeld TP, 1998, CURR OPIN CELL BIOL, V10, P784, DOI 10.1016/S0955-0674(98)80122-1; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Reis T, 2004, CELL, V117, P253, DOI 10.1016/S0092-8674(04)00247-8; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Stapleton M., 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-12-research0080, DOI 10.1186/GB-2002-3-12-RESEARCH0080]; Sveiczer Akos, 2004, Theor Biol Med Model, V1, P12, DOI 10.1186/1742-4682-1-12; Tomoda K, 2004, J BIOL CHEM, V279, P43013, DOI 10.1074/jbc.M406559200; Yandell M, 2005, P NATL ACAD SCI USA, V102, P1566, DOI 10.1073/pnas.0409421102	30	212	217	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 23	2006	439	7079					1009	1013		10.1038/nature04469	http://dx.doi.org/10.1038/nature04469			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014NE	16496002				2022-12-24	WOS:000235486100054
J	Gu, DF; He, J; Duan, XF; Reynolds, K; Wu, XG; Chen, J; Huang, GY; Chen, CS; Whelton, PK				Gu, DF; He, J; Duan, XF; Reynolds, K; Wu, XG; Chen, J; Huang, GY; Chen, CS; Whelton, PK			Body weight and mortality among men and women in China	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MASS INDEX; WAIST CIRCUMFERENCE; PROSPECTIVE COHORT; OVERWEIGHT; OBESITY; PREVALENCE; METAANALYSIS; UNDERWEIGHT; ADIPOSITY; DISEASE	Context The effect of underweight and obesity on mortality has not been well characterized in Asian populations. Objective To examine the relationship between body mass index (BMI) and mortality in Chinese adults. Design, Setting, and Participants A prospective cohort study in a nationally representative sample of 169 871 Chinese men and women aged 40 years or older. Data on body weight and covariables were obtained at a baseline examination in 1991 using a standard protocol. Follow-up evaluation was conducted in 1999-2000, with a response rate of 93.4% (n = 158 666). Main Outcome Measures Body mass index and all-cause mortality. Results After excluding those participants with missing body weight or height values, 154 736 adults were included in the analysis. After adjustment for age, sex, cigarette smoking, alcohol consumption, physical activity, education, geographic region (north vs south), and urbanization (urban vs rural), a U-shaped association between BMI and all-cause mortality was observed (P<.001). Using those participants with a BMI of 24.0 to 24.9 as the reference group, the relative risks of all-cause mortality across categories of BMI were 1.65 (95% confidence interval [CI], 1.54-1.77) for BMI less than 18.5, 1.31 (95% CI, 1.22-1.41) for BMI 18.5 to 19.9, 1.20 (95% CI, 1.11-1.29) for BMI 20.0 to 20.9, 1.12 (95% CI, 1.04-1.21) for BMI 21.0 to 21.9, 1.11 (95% CI, 1.03-1.20) for BMI 22.0 to 22.9, 1.09 (95% CI, 1.01-1.19) for BMI 23.0 to 23.9, 1.00 ( 95% CI, 0.92-1.08) for BMI 25.0 to 26.9, 1.15 (95% CI, 1.06-1.24) for BMI 27.0 to 29.9, and 1.29 (95% CI, 1.16-1.42) for BMI 30.0 or more. The U-shaped association existed even after excluding participants who were current or former smokers, heavy alcohol drinkers, or who had prevalent chronic illness at the baseline examination, or who died during the first 3 years of follow-up. A similar association was observed between BMI and mortality from cardiovascular disease, cancer, and other causes. Conclusions Our results indicate that both underweight and obesity were associated with increased mortality in the Chinese adult population. Furthermore, our findings support the use of a single common recommendation for defining overweight and obesity among all racial and ethnic groups.	Chinese Acad Med Sci, Cardiovasc Inst, Div Populat Genet & Prevent, Beijing 100037, Peoples R China; Chinese Acad Med Sci, Fu Wai Hosp, Beijing 100037, Peoples R China; Peking Union Med Coll, Beijing, Peoples R China; Chinese Natl Ctr Cardiovasc Dis Control & Res, Beijing, Peoples R China; Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tulane University; Tulane University	Gu, DF (corresponding author), Chinese Acad Med Sci, Cardiovasc Inst, Div Populat Genet & Prevent, 167 Beilishi Rd, Beijing 100037, Peoples R China.	gudongfeng@vip.sina.com; jhe@tulane.edu	He, Jiang/AAF-5303-2020; Reynolds, Kristi/AAN-1434-2021	He, Jiang/0000-0002-8286-9652; Reynolds, Kristi/0000-0001-7619-1649	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072507] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL072507] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abelson P, 2004, SCIENCE, V304, P1413, DOI 10.1126/science.304.5676.1413; Aekplakorn Wichai, 2004, Journal of the Medical Association of Thailand, V87, P685; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Bender R, 1999, JAMA-J AM MED ASSOC, V281, P1498, DOI 10.1001/jama.281.16.1498; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Deurenberg-Yap M, 2002, Obes Rev, V3, P209, DOI 10.1046/j.1467-789X.2002.00069.x; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Hart CL, 1999, BMJ-BRIT MED J, V318, P1725, DOI 10.1136/bmj.318.7200.1725; He M, 2001, INT J OBESITY, V25, P748, DOI 10.1038/sj.ijo.0801612; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; INGRAM DD, 1994, VITAL HLTH STAT 2, V121, P1; James PT, 2001, OBES RES, V9, p228S, DOI 10.1038/oby.2001.123; Krauss R M, 1998, Circulation, V98, P1472; Laatikainen T, 2003, J EPIDEMIOL COMMUN H, V57, P379, DOI 10.1136/jech.57.5.379; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Misra A, 2004, NUTRITION, V20, P482, DOI 10.1016/j.nut.2004.01.020; Miyazaki Motonobu, 2002, J Epidemiol, V12, P40; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Pan WH, 2004, AM J CLIN NUTR, V79, P31; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Song YM, 2001, EPIDEMIOLOGY, V12, P173, DOI 10.1097/00001648-200103000-00008; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Tsugane S, 2002, INT J OBESITY, V26, P529, DOI 10.1038/sj.ijo.0801961; *WHO W PAC REG INT, 2000, AS PAC PERSP RED OB; Wildman RP, 2004, AM J CLIN NUTR, V80, P1129, DOI 10.1093/ajcn/80.5.1129; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z; Yuan JM, 1998, INT J EPIDEMIOL, V27, P824, DOI 10.1093/ije/27.5.824; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	31	285	307	1	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2006	295	7					776	783		10.1001/jama.295.7.776	http://dx.doi.org/10.1001/jama.295.7.776			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011YZ	16478900				2022-12-24	WOS:000235306700022
J	Chen, JZ; Raymond, K				Chen, JZ; Raymond, K			Nuclear receptors, bile-acid detoxification, and cholestasis	LANCET			English	Editorial Material							PRIMARY BILIARY-CIRRHOSIS; URSODEOXYCHOLIC-ACID; CONTROLLED-TRIAL; METABOLISM; RIFAMPICIN; EXPRESSION		La Trobe Univ, Fac Sci Technol & Engn, Sch Pharm & Appl Sci, Bendigo, Vic 3550, Australia	La Trobe University	Raymond, K (corresponding author), La Trobe Univ, Fac Sci Technol & Engn, Sch Pharm & Appl Sci, Bendigo, Vic 3550, Australia.	K.Raymond@latrobe.edu.au		Chen, Jiezhong/0000-0003-1977-6143				BACHS L, 1989, LANCET, V1, P574; Chen JH, 1998, HEPATOLOGY, V28, P624, DOI 10.1002/hep.510280304; Chen JZ, 1996, J GASTROEN HEPATOL, V11, P870, DOI 10.1111/j.1440-1746.1996.tb00095.x; Chitturi S, 2001, Semin Gastrointest Dis, V12, P113; Denson LA, 2001, GASTROENTEROLOGY, V121, P140, DOI 10.1053/gast.2001.25503; Dilger K, 2005, HEPATOLOGY, V41, P595, DOI 10.1002/hep.20568; Fiorucci S, 2005, J PHARMACOL EXP THER, V313, P604, DOI 10.1124/jpet.104.079665; Gnerre C, 2004, PHARMACOGENETICS, V14, P635, DOI 10.1097/00008571-200410000-00001; Goulis J, 1999, LANCET, V354, P1053, DOI 10.1016/S0140-6736(98)11293-X; Huang L, 2003, J BIOL CHEM, V278, P51085, DOI 10.1074/jbc.M308321200; Liu YP, 2003, J CLIN INVEST, V112, P1678, DOI 10.1172/JCI200318945; Marschall HU, 2005, GASTROENTEROLOGY, V129, P476, DOI 10.1053/j.gastro.2005.05.009; Papatheodoridis GV, 2002, AM J GASTROENTEROL, V97, P2063; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Payen L, 2002, CELL BIOL TOXICOL, V18, P221, DOI 10.1023/A:1016020626941; Roncaglia N, 2004, BJOG-INT J OBSTET GY, V111, P17, DOI 10.1046/j.1471-0528.2003.00029.x; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Talwalkar JA, 2003, LANCET, V362, P53, DOI 10.1016/S0140-6736(03)13808-1; Trauner M, 2003, CURR OPIN GASTROEN, V19, P216, DOI 10.1097/00001574-200305000-00005; Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398	20	28	31	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2006	367	9509					454	456		10.1016/S0140-6736(06)68156-7	http://dx.doi.org/10.1016/S0140-6736(06)68156-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	013FF	16473109				2022-12-24	WOS:000235394500007
J	Peers, G; Price, NM				Peers, G; Price, NM			Copper-containing plastocyanin used for electron transport by an oceanic diatom	NATURE			English	Article							TRACE-METALS; IRON REQUIREMENT; CENTRIC DIATOMS; COASTAL; PHYTOPLANKTON; CADMIUM; GROWTH; GENE; ZINC; LIMITATION	The supply of some essential metals to pelagic ecosystems is less than the demand, so many phytoplankton have slow rates of photosynthetic production and restricted growth(1). The types and amounts of metals required by phytoplankton depends on their evolutionary history(2) and on their adaptations to metal availability(3,4), which varies widely among ocean habitats. Diatoms, for example, need considerably less iron ( Fe) to grow than chlorophyll-b-containing taxa(2), and the oceanic species demand roughly one-tenth the amount of coastal strains(5-7). Like Fe, copper (Cu) is scarce in the open sea, but notably higher concentrations of it are required for the growth of oceanic than of coastal isolates(8). Here we report that the greater Cu requirement in an oceanic diatom, Thalassiosira oceanica, is entirely due to a single Cu-containing protein, plastocyanin, which - until now - was only known to exist in organisms with chlorophyll b and cyanobacteria. Algae containing chlorophyll c, including the closely related coastal species T. weissflogii, are thought to lack plastocyanin and contain a functionally equivalent Fe-containing homologue, cytochrome c(6) (ref. 9). Copper deficiency in T. oceanica inhibits electron transport regardless of Fe status, implying a constitutive role for plastocyanin in the light reactions of photosynthesis in this species. The results suggest that selection pressure imposed by Fe limitation has resulted in the use of a Cu protein for photosynthesis in an oceanic diatom. This biochemical switch reduces the need for Fe and increases the requirement for Cu, which is relatively more abundant in the open sea.	McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Peers, G (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	graham.peers@mail.mcgill.ca	Price, Neil M./A-8963-2008	Price, Neil M./0000-0001-9986-9213; Peers, Graham/0000-0002-3590-7820				Archibald JM, 2003, P NATL ACAD SCI USA, V100, P7678, DOI 10.1073/pnas.1230951100; Armbrust EV, 2001, APPL ENVIRON MICROB, V67, P3501, DOI 10.1128/AEM.67.8.3501-3513.2001; BRAND LE, 1983, LIMNOL OCEANOGR, V28, P1182, DOI 10.4319/lo.1983.28.6.1182; BRULAND KW, 1991, LIMNOL OCEANOGR, V36, P1555, DOI 10.4319/lo.1991.36.8.1555; BRULAND KW, 1980, EARTH PLANET SC LETT, V47, P176, DOI 10.1016/0012-821X(80)90035-7; Chang SI, 2000, ENVIRON SCI TECHNOL, V34, P4931, DOI 10.1021/es001213r; COALE KH, 1988, LIMNOL OCEANOGR, V33, P1084, DOI 10.4319/lo.1988.33.5.1084; Cullen JT, 1999, NATURE, V402, P165, DOI 10.1038/46007; da Silva J. J. R. Frausto, 2001, BIOL CHEM ELEMENTS; Inda LA, 1999, PHYTOCHEMISTRY, V51, P1, DOI 10.1016/S0031-9422(98)00493-2; La Fontaine S, 2002, EUKARYOT CELL, V1, P736, DOI 10.1128/EC.1.5.736-757.2002; Maldonado MT, 1996, MAR ECOL PROG SER, V141, P161, DOI 10.3354/meps141161; MOFFETT JW, 1990, DEEP-SEA RES, V37, P27, DOI 10.1016/0198-0149(90)90027-S; Moffett JW, 1997, LIMNOL OCEANOGR, V42, P789, DOI 10.4319/lo.1997.42.5.0789; Morel FMM, 2003, SCIENCE, V300, P944, DOI 10.1126/science.1083545; Navarro JA, 2004, METH MOL B, V274, P79; Papageorgiou G.C., 2004, CHLOROPHYLL FLUORESC; Peers G, 2005, LIMNOL OCEANOGR, V50, P1149, DOI 10.4319/lo.2005.50.4.1149; Peers G, 2004, LIMNOL OCEANOGR, V49, P1774, DOI 10.4319/lo.2004.49.5.1774; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; Quinn JM, 1998, METHOD ENZYMOL, V297, P263; Raven JA, 1999, PHOTOSYNTH RES, V60, P111, DOI 10.1023/A:1006282714942; RYTHER JH, 1961, ECOLOGY, V42, P444, DOI 10.2307/1932105; Schottler MA, 2004, PLANT PHYSIOL, V136, P4265, DOI 10.1104/pp.104.052324; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; STRZEPEK RF, 2003, THESIS U BRIT COLUMB; SUNDA WG, 1995, LIMNOL OCEANOGR, V40, P132, DOI 10.4319/lo.1995.40.1.0132; SUNDA WG, 1991, NATURE, V351, P55, DOI 10.1038/351055a0; Tortell PD, 1996, MAR ECOL PROG SER, V138, P245, DOI 10.3354/meps138245; Weigel M, 2003, J BIOL CHEM, V278, P31286, DOI 10.1074/jbc.M302876200	30	258	269	5	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					341	344		10.1038/nature04630	http://dx.doi.org/10.1038/nature04630			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16572122				2022-12-24	WOS:000237593200046
J	Stellwagen, D; Malenka, RC				Stellwagen, D; Malenka, RC			Synaptic scaling mediated by glial TNF-alpha	NATURE			English	Article							QUANTAL AMPLITUDE; AMPA RECEPTORS; HOMEOSTATIC PLASTICITY; NEOCORTICAL SYNAPSES; DEFICIENT MICE; REQUIREMENT; REDISTRIBUTION; TRAFFICKING; ASTROCYTES; RESPONSES	Two general forms of synaptic plasticity that operate on different timescales are thought to contribute to the activity-dependent refinement of neural circuitry during development: (1) long-term potentiation (LTP) and long-term depression (LTD), which involve rapid adjustments in the strengths of individual synapses in response to specific patterns of correlated synaptic activity, and (2) homeostatic synaptic scaling, which entails uniform adjustments in the strength of all synapses on a cell in response to prolonged changes in the cell's electrical activity(1,2). Without homeostatic synaptic scaling, neural networks can become unstable and perform suboptimally(1-3). Although much is known about the mechanisms underlying LTP and LTD4, little is known about the mechanisms responsible for synaptic scaling except that such scaling is due, at least in part, to alterations in receptor content at synapses(5-7). Here we show that synaptic scaling in response to prolonged blockade of activity is mediated by the pro-inflammatory cytokine tumour-necrosis factor-alpha (TNF-alpha). Using mixtures of wild-type and TNF-alpha-deficient neurons and glia, we also show that glia are the source of the TNF-alpha that is required for this form of synaptic scaling. We suggest that by modulating TNF-alpha levels, glia actively participate in the homeostatic activity-dependent regulation of synaptic connectivity.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA.	malenka@stanford.edu						Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Aguado F, 2002, J NEUROSCI, V22, P9430; Auld DS, 2003, NEURON, V40, P389, DOI 10.1016/S0896-6273(03)00607-X; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Diamond JS, 2005, J NEUROSCI, V25, P2906, DOI 10.1523/JNEUROSCI.5125-04.2005; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Leslie KR, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0005.2001; Lin SC, 2004, GLIA, V47, P290, DOI 10.1002/glia.20060; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Peschon JJ, 1998, J IMMUNOL, V160, P943; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; TROST LC, 1994, ANAL BIOCHEM, V220, P149, DOI 10.1006/abio.1994.1311; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005	30	1201	1224	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1054	1059		10.1038/nature04671	http://dx.doi.org/10.1038/nature04671			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16547515				2022-12-24	WOS:000236906000037
J	Herbert, A; Gerry, NP; McQueen, MB; Heid, IM; Pfeufer, A; Illig, T; Wichmann, HE; Meitinger, T; Hunter, D; Hu, FB; Colditz, G; Hinney, A; Hebebrand, J; Koberwitz, K; Zhu, XF; Cooper, R; Ardlie, K; Lyon, H; Hirschhorn, JN; Laird, NM; Lenburg, ME; Lange, C; Christman, MF				Herbert, A; Gerry, NP; McQueen, MB; Heid, IM; Pfeufer, A; Illig, T; Wichmann, HE; Meitinger, T; Hunter, D; Hu, FB; Colditz, G; Hinney, A; Hebebrand, J; Koberwitz, K; Zhu, XF; Cooper, R; Ardlie, K; Lyon, H; Hirschhorn, JN; Laird, NM; Lenburg, ME; Lange, C; Christman, MF			A common genetic variant is associated with adult and childhood obesity	SCIENCE			English	Article							QUANTITATIVE-TRAIT LOCI; BODY-MASS; DISEQUILIBRIUM; POWERFUL; TESTS; RISK	Obesity is a heritable trait and a risk factor for many common diseases such as type 2 diabetes, heart disease, and hypertension. We used a dense whole-genome scan of DNA samples from the Framingham Heart Study participants to identify a common genetic variant near the INSIG2 gene associated with obesity. We have replicated the finding in four separate samples composed of individuals of Western European ancestry, African Americans, and children. The obesity-predisposing genotype is present in 10% of individuals. Our study suggests that common genetic polymorphisms are important determinants of obesity.	Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Forschungszentrum Umwelt & Gesundheit, Inst Human Genet, D-85764 Neuherberg, Germany; Tech Univ Munich, Inst Human Genet, D-81671 Munich, Germany; Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; Brigham & Womens Hosp, Nurses Hlth Study, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Duisburg Essen, Dept Child & Adolescent Psychiat, D-45147 Essen, Germany; Loyola Univ, Med Ctr, Dept Epidemiol & Prevent Med, Maywood, IL 60153 USA; SeraCare Life Sci, Genom Collaborat, Cambridge, MA USA; Childrens Hosp, Program Genom, Boston, MA 02115 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02139 USA; MIT, Cambridge, MA 02139 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Technical University of Munich; University of Munich; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Duisburg Essen; Loyola University Chicago; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard T.H. Chan School of Public Health	Herbert, A (corresponding author), Boston Univ, Sch Med, Dept Genet & Genom, E613,715 Albany St, Boston, MA 02118 USA.	aherbert@bu.edu; mfc@bu.edu	Colditz, Graham/A-3963-2009; Lenburg, Marc/B-8027-2008; Zhu, Xiaofeng/O-6874-2019; Herbert, Alan/AAY-4286-2020; Genetic Epidemiology, Innsbruck Med.Univ./C-2095-2008; McQueen, Matthew/X-5845-2019; Hinney, Anke/D-6953-2011; Pfeufer, Arne/B-6634-2013; Meitinger, Thomas/O-1318-2015; Wichmann, Heinz Erich/AAA-5695-2022	Colditz, Graham/0000-0002-7307-0291; Lenburg, Marc/0000-0002-5760-4708; Hinney, Anke/0000-0001-5659-0706; Herbert, Alan/0000-0002-0093-1572; Meitinger, Thomas/0000-0002-8838-8403; Zhu, Xiaofeng/0000-0003-0037-411X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060726] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074166, R01HL066289, U01HL065899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK067288, P30DK046200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059532] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969] Funding Source: Medline; NHLBI NIH HHS [R01HL074166, U01 HL065899, R01HL66289, R01HL54485, U01HL65899] Funding Source: Medline; NICHD NIH HHS [R01 HD060726] Funding Source: Medline; NIDDK NIH HHS [P30DK46200, K23DK067288] Funding Source: Medline; NIGMS NIH HHS [R01GM046877] Funding Source: Medline; NIMH NIH HHS [R01MH59532] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Atwood LD, 2002, AM J HUM GENET, V71, P1044, DOI 10.1086/343822; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; Cheverud JM, 2004, DIABETES, V53, P3328, DOI 10.2337/diabetes.53.12.3328; Deng HW, 2002, AM J HUM GENET, V70, P1138, DOI 10.1086/339934; Farooqi IS, 2005, INT J OBESITY, V29, P1149, DOI 10.1038/sj.ijo.0803056; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; Hebebrand J, 2003, Obes Rev, V4, P139; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Heid IM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027011; Hinney A, 2003, J CLIN ENDOCR METAB, V88, P4258, DOI 10.1210/jc.2003-030233; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Hu FB, 2004, DIABETES, V53, P209, DOI 10.2337/diabetes.53.1.209; Kannel W B, 2000, J Atheroscler Thromb, V6, P60; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lange C, 2003, HUM HERED, V56, P10, DOI 10.1159/000073728; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Lange C, 2003, AM J HUM GENET, V73, P801, DOI 10.1086/378591; Lange C, 2002, AM J HUM GENET, V71, P1330, DOI 10.1086/344696; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lyon HN, 2005, AM J CLIN NUTR, V82, p215S, DOI 10.1093/ajcn/82.1.215S; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; *NIH, 1998, NIH PUBL; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Setiawan VW, 2004, CANCER EPIDEM BIOMAR, V13, P213, DOI 10.1158/1055-9965.EPI-03-0241; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Takaishi K, 2004, P NATL ACAD SCI USA, V101, P7106, DOI 10.1073/pnas.0401715101; Van Steen K, 2005, NAT GENET, V37, P683, DOI 10.1038/ng1582; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899	34	526	566	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2006	312	5771					279	283		10.1126/science.1124779	http://dx.doi.org/10.1126/science.1124779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614226				2022-12-24	WOS:000236765300053
J	Cook, G; Depares, J; Singh, M; McElduff, P				Cook, G; Depares, J; Singh, M; McElduff, P			Readmission after hysterectomy and prophylactic low molecular weight heparin: retrospective case-control study	BRITISH MEDICAL JOURNAL			English	Article								Objective To determine whether use of tinzaparin, a low molecular weight heparin introduced for prophylactic management of deep vein thrombosis increases the risk of serious postoperative bleeding leading to a higher than expected 28 day readmission rate after discharge for hysterectomy. Design Retrospective case-control study using computerised hospital inpatient data and review of case notes. Setting District general hospital. Subjects 2108 patients undergoing hysterectomy between August 1997 and March 2003. Main outcome measures Readmission and reoperation associated with bleeding. Results 54 cases of serious postoperative bleeding were identified, 46 of which were readmissions. These 54 cases were compared with 179 controls. Regression analysis indicated a positive relation between prophylaxis with tinzaparin and serious postoperative bleeding. There was a significant twofold increase in odds (odds ratio 2.02, 95% confidence interval 1.02 to 4.05) after adjustment for type of operation, age, and type of pain relief. Conclusions In the prophylactic treatment of thromboembolic disease after hysterectomy, compared with calci-heparin, tinzaperin is associated with a twofold increase in risk of serious postoperative bleeding.	Stepping Hill Hosp, Stockport NHS Trust, Dept Obstet & Gynaecol, Stockport SK2 7JE, Lancs, England; Hunter New England Populat Hlth, Hunter New England Area Hlth Serv, Wallsend, Australia		Cook, G (corresponding author), Stepping Hill Hosp, Stockport NHS Trust, Dept Obstet & Gynaecol, Stockport SK2 7JE, Lancs, England.	Gary.cook@stockport.nhs.uk		Singh, Maneesh/0000-0003-0852-7475				[Anonymous], EM READM HOSP FOLL D; Levine M N, 1988, Acta Chir Scand Suppl, V543, P73; *NHS EX, 2001, QUAL PERF NHS PERF I; STEINER RA, 1989, ARCH GYNECOL OBSTET, V244, P141, DOI 10.1007/BF00931291; VALLANO FA, 2002, REV CLIN ESP, V202, P583	5	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 8	2006	332	7545					819	820		10.1136/bmj.38783.624444.55	http://dx.doi.org/10.1136/bmj.38783.624444.55			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032ZQ	16540480	Bronze, Green Published			2022-12-24	WOS:000236815900017
J	Ponton, F; Lebarbenchon, C; Lefevre, T; Biron, DG; Duneau, D; Hughes, DP; Thomas, F				Ponton, F; Lebarbenchon, C; Lefevre, T; Biron, DG; Duneau, D; Hughes, DP; Thomas, F			Parasitology - Parasite survives predation on its host	NATURE			English	Editorial Material							TROPHIC TRANSMISSION; EVOLUTION; VIRULENCE		IRD, UMR CNRS IRD 2724, GEMI, F-34394 Montpellier 5, France; Stn Biol Tour Valat, F-13200 Arles, France; Inst Biol, Ctr Social Evolut, DK-21000 Copenhagen, Denmark	Institut de Recherche pour le Developpement (IRD)	Ponton, F (corresponding author), IRD, UMR CNRS IRD 2724, GEMI, BP 64501, F-34394 Montpellier 5, France.		PONTON, FLEUR/A-5516-2011; Lefèvre, Thierry/E-2157-2011; Lebarbenchon, Camille/H-7245-2013; duneau, david/E-2114-2011; Lebarbenchon, Camille/GLQ-7287-2022	Lefèvre, Thierry/0000-0002-9736-6142; Lebarbenchon, Camille/0000-0002-0922-7573; duneau, david/0000-0002-8323-1511; Lebarbenchon, Camille/0000-0002-0922-7573; Ponton, Fleur/0000-0001-7156-3896; THOMAS, Frederic/0000-0003-2238-1978				Brodeur Jacques, 1994, Norwegian Journal of Agricultural Sciences Supplement, V16, P147; Choisy M, 2003, AM NAT, V162, P172, DOI 10.1086/375681; Day T, 2002, P ROY SOC B-BIOL SCI, V269, P1317, DOI 10.1098/rspb.2002.2021; Ebert D, 1996, PARASITOL TODAY, V12, P96, DOI 10.1016/0169-4758(96)80668-5; Harvey JA, 2002, ECOLOGY, V83, P2439, DOI 10.1890/0012-9658(2002)083[2439:TDSOEW]2.0.CO;2; Lafferty KD, 1999, PARASITOL TODAY, V15, P111, DOI 10.1016/S0169-4758(99)01397-6; Moore J., 2002, PARASITES BEHAV ANIM; Parker GA, 2003, NATURE, V425, P480, DOI 10.1038/nature02012; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Thomas F, 2002, J EVOLUTION BIOL, V15, P356, DOI 10.1046/j.1420-9101.2002.00410.x	10	35	37	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2006	440	7085					756	756		10.1038/440756a	http://dx.doi.org/10.1038/440756a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598248	Green Published			2022-12-24	WOS:000236548400032
J	Ramzy, RMR; El Setouhy, M; Helmy, H; Ahmed, ES; Abd Elaziz, KM; Farid, HA; Shannon, WD; Weil, GJ				Ramzy, RMR; El Setouhy, M; Helmy, H; Ahmed, ES; Abd Elaziz, KM; Farid, HA; Shannon, WD; Weil, GJ			Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment	LANCET			English	Article							POLYMERASE-CHAIN-REACTION; WUCHERERIA-BANCROFTI; LYMPHATIC FILARIASIS; CULEX-PIPIENS; HUMAN BLOOD; DIAGNOSIS; INFECTION; PROGRAM; MICROFILAREMIA; TRANSMISSION	Background Egypt was one of the first countries to implement a national programme to eliminate lymphatic filariasis based on WHO's strategy of repeated rounds of mass drug administration (MDA) with diethylcarbamazine and albendazole (target population, 2.5 million in 181 localities). We assessed the effect of five yearly rounds of MDA on filariasis in four sentinel villages in Egypt. Methods We studied two areas with different infection rates before MDA: the Qalubyia study area had a low infection rate because of previous treatment with diethylcarbamazine; this was typical of most filariasis-endemic villages in Egypt before MDA. The Giza study area had a high baseline infection rate. We undertook repeated surveys in villages for treatment compliance and tests for microfilaraemia. and circulating filarial antigenaemia, antibodies to filarial antigen Bm14 in schoolchildren, and infections in indoor-resting mosquitoes (assessed by PCR). Findings MDA compliance rates were excellent (>80%). In Giza after MDA, prevalence rates of microfilaraemia and circulating filarial antigenaemia fell from 11.5% to 1.2%, and from 19.0% to 4.8%, respectively (p<0.0001). Corresponding rates in Qalubyia fell from 3.1% to 0% and 13.6% to 3.1%, respectively (p<0.0001). Rates of antifilarial antibody and circulating filarial antigenaemia in schoolchildren (aged about 7-8 years), fell from 18.3% to 0.2% (p<0.0001) and from 10.0% to 0.4% (p<0.0001) in Giza, respectively, and from 1.7% to 0% and 1.7% to 0% (both p=0.13) in Qalubyia, respectively. Mosquito infection rates fell from 3.07% (95% CI 2.38-3.88) to 0.19% (0.08-0.38) in Giza and from 4.37% (3.07-5.99) to 0% (0-0.05) in Qalubyia. Interpretation MDA greatly affects variables related to infection (microfilaraemia and circulating filarial antigenaemia prevalence rates) and transmission (antifilarial antibodies in young children and mosquito infection rates). Our results suggest that after five rounds of MDA filariasis is likely to have been eliminated in most endemic localities in Egypt.	Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA; Ain Shams Univ, Res & Traiing Ctr Vectors Dis, Cairo, Egypt	Washington University (WUSTL); Egyptian Knowledge Bank (EKB); Ain Shams University	Weil, GJ (corresponding author), Washington Univ, Sch Med, Div Infect Dis, Campus Box 8051, St Louis, MO 63110 USA.	gweil@im.wustl.edu	Elaziz, Khaled Abd/R-1620-2019; El-Setouhy, Maged/B-6021-2019; Ramzy, Reda/AAE-4906-2020	Elaziz, Khaled Abd/0000-0002-4437-128X; Ramzy, Reda/0000-0003-0225-2669; Farid, Hoda/0000-0001-6384-7151	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035855] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-35855] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bockarie MJ, 2002, NEW ENGL J MED, V347, P1841, DOI 10.1056/NEJMoa021309; CHANDRASHEKAR R, 1994, MOL BIOCHEM PARASIT, V64, P261, DOI 10.1016/0166-6851(94)00035-2; De Rochars MB, 2005, AM J TROP MED HYG, V73, P888, DOI 10.4269/ajtmh.2005.73.888; Dean A.G., 1994, EPI INFO VERSION 6 W; El Setouhy M, 2004, AM J TROP MED HYG, V70, P191, DOI 10.4269/ajtmh.2004.70.191; Farid HA, 2003, AM J TROP MED HYG, V68, P286, DOI 10.4269/ajtmh.2003.68.286; Farid HA, 2001, T ROY SOC TROP MED H, V95, P29, DOI 10.1016/S0035-9203(01)90322-0; FARIS R, 1993, T ROY SOC TROP MED H, V87, P659, DOI 10.1016/0035-9203(93)90277-W; Fraser M, 2005, AM J TROP MED HYG, V73, P753, DOI 10.4269/ajtmh.2005.73.753; HARB M, 1993, B WORLD HEALTH ORGAN, V71, P49; Ismail MM, 2001, T ROY SOC TROP MED H, V95, P332, DOI 10.1016/S0035-9203(01)90257-3; Lammie Patrick J, 2004, Filaria J, V3, P9, DOI 10.1186/1475-2883-3-9; Michael E, 2004, LANCET INFECT DIS, V4, P223, DOI 10.1016/S1473-3099(04)00973-9; Michael E, 1996, PARASITOLOGY, V112, P409, DOI 10.1017/S0031182000066646; MICHAEL E, IN PRESS TRENDS PARA; MOLYNEUX D, 2001, T R SOC TROP MED HYG, V94, P589; Ottesen EA, 1997, B WORLD HEALTH ORGAN, V75, P491; Rajendran R, 2004, T ROY SOC TROP MED H, V98, P174, DOI 10.1016/S0035-9203(03)00042-7; Ramzy R M, 1999, East Mediterr Health J, V5, P880; Ramzy RMR, 1997, T ROY SOC TROP MED H, V91, P156, DOI 10.1016/S0035-9203(97)90205-4; RAMZY RMR, 1995, ANN TROP MED PARASIT, V89, P443, DOI 10.1080/00034983.1995.11812974; Ramzy RMR, 2002, AM J TROP MED HYG, V67, P196, DOI 10.4269/ajtmh.2002.67.196; REMME J, 1986, B WORLD HEALTH ORGAN, V64, P667; Simonsen PE, 2004, AM J TROP MED HYG, V70, P63, DOI 10.4269/ajtmh.2004.70.63; Southgate B A, 1979, Trop Dis Bull, V76, P1045; Stolk WA, 2003, J INFECT DIS, V188, P1371, DOI 10.1086/378354; Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7; WHO, 2005, WHOCDSCPECEE200550; World Health Organization, 2005, Wkly Epidemiol Rec, V80, P202; Xu BL, 1997, CHINESE MED J-PEKING, V110, P807; 2003, GLOBAL ELIMINATION L	32	140	143	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2006	367	9515					992	999		10.1016/S0140-6736(06)68426-2	http://dx.doi.org/10.1016/S0140-6736(06)68426-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028GE	16564361				2022-12-24	WOS:000236474200027
J	Latch, DE; McNeill, K				Latch, DE; McNeill, K			Microheterogeneity of singlet oxygen distributions in irradiated humic acid solutions	SCIENCE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; ORGANIC-COMPOUNDS; INTRAHUMIC DECHLORINATION; SORPTION KINETICS; MOLECULAR-WEIGHT; RATE CONSTANTS; SUBSTANCES; BINDING; SOIL; TRANSPORT	Singlet oxygen (O-1(2)) is a highly reactive species formed through solar irradiation of organic matter in environmental waters. Implicated in a range of reactions, it has proven difficult to quantify its spatial distribution in natural waters. We assessed the microheterogeneous distribution of O-1(2) in irradiated solutions containing chromophoric dissolved organic matter (CDOM) by using molecular probes of varying hydrophobicity. The apparent O-1(2) concentrations ([O-1(2)](app)), measured by recently developed hydrophobic trap-and-trigger chemiluminescent probe molecules, were orders of magnitude higher than those measured by the conventional hydrophilic probe molecule furfuryl alcohol. The differential [O-1(2)](app) values measured by these probes reflect a steep concentration gradient between the CDOM macromolecules and the aqueous phase. A detailed kinetic model based on the data predicts probabilistic O-1(2) distributions under different solvent conditions.	Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	McNeill, K (corresponding author), Univ Minnesota, Dept Chem, 76 Kolthoff Hall, Minneapolis, MN 55455 USA.	mcneill@chem.umn.edu	McNeill, Kristopher/A-9834-2009	McNeill, Kristopher/0000-0002-2981-2227				BACKHUS DA, 1990, ENVIRON SCI TECHNOL, V24, P1214, DOI 10.1021/es00078a009; Battino R., 1981, IUPAC SOLUBILITY DAT; BLOUGH NV, 1988, ENVIRON SCI TECHNOL, V22, P77, DOI 10.1021/es00166a008; Blough NV, 1995, ACTIVE OXYGEN CHEM, P280, DOI DOI 10.1007/978-94-007-0874-7_8; Briviba K, 1997, BIOL CHEM, V378, P1259; Burns SE, 1996, ENVIRON SCI TECHNOL, V30, P2934, DOI 10.1021/es950906i; Burns SE, 1997, ENVIRON SCI TECHNOL, V31, P1365, DOI 10.1021/es960581l; Chin YP, 1997, ENVIRON SCI TECHNOL, V31, P1630, DOI 10.1021/es960404k; CHIN YP, 1994, ENVIRON SCI TECHNOL, V28, P1853, DOI 10.1021/es00060a015; CHIOU CT, 1983, ENVIRON SCI TECHNOL, V17, P227, DOI 10.1021/es00110a009; Cooper W.J., 1989, ADV CHEM SER, P333; FU YX, 1995, PHOTOCHEM PHOTOBIOL, V62, P692, DOI 10.1111/j.1751-1097.1995.tb08718.x; GAUTHIER TD, 1986, ENVIRON SCI TECHNOL, V20, P1162, DOI 10.1021/es00153a012; HAAG WR, 1984, CHEMOSPHERE, V13, P641, DOI 10.1016/0045-6535(84)90200-5; HAAG WR, 1987, PHOTOCHEM PHOTOBIOL, V45, P317, DOI 10.1111/j.1751-1097.1987.tb05381.x; Hecht S, 2001, J AM CHEM SOC, V123, P6959, DOI 10.1021/ja016076s; Hessler DP, 1996, J PHOTOCH PHOTOBIO B, V36, P55, DOI 10.1016/S1011-1344(96)07322-8; KARICKHOFF SW, 1979, WATER RES, V13, P241, DOI 10.1016/0043-1354(79)90201-X; Larson R. A., 1994, REACTION MECH ENV OR; MacCarthy P., 1985, Humic substances in soil, sediment and water: geochemistry, isolation and characterization., P527; MacManus-Spencer LA, 2005, J AM CHEM SOC, V127, P8954, DOI 10.1021/ja052045b; MacManus-Spencer LA, 2005, ANAL CHEM, V77, P1200, DOI 10.1021/ac048293s; MALCOLM RL, 1986, ENVIRON SCI TECHNOL, V20, P904, DOI 10.1021/es00151a009; MEANS JC, 1982, SCIENCE, V215, P968, DOI 10.1126/science.215.4535.968; MERKEL PB, 1972, J AM CHEM SOC, V94, P1030, DOI 10.1021/ja00758a072; NECKERS DC, 1986, J AM CHEM SOC, V108, P291, DOI 10.1021/ja00262a016; OGNER G, 1970, SCIENCE, V170, P317, DOI 10.1126/science.170.3955.317; Siegel DA, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000965; VEITH GD, 1979, WATER RES, V13, P43, DOI 10.1016/0043-1354(79)90252-5; Wershaw RL, 1999, SOIL SCI, V164, P803, DOI 10.1097/00010694-199911000-00004; WILKINSON F, 1995, J PHYS CHEM REF DATA, V24, P663, DOI 10.1063/1.555965; WU SC, 1986, ENVIRON SCI TECHNOL, V20, P717, DOI 10.1021/es00149a011; WU SC, 1988, WATER RESOUR RES, V24, P1373, DOI 10.1029/WR024i008p01373; ZEPP RG, 1977, NATURE, V267, P421, DOI 10.1038/267421a0	34	265	279	11	246	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1743	1747		10.1126/science.1121636	http://dx.doi.org/10.1126/science.1121636			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16497888				2022-12-24	WOS:000236204300035
J	Qian, SB; McDonough, H; Boellmann, F; Cyr, DM; Patterson, C				Qian, SB; McDonough, H; Boellmann, F; Cyr, DM; Patterson, C			CHIP-mediated stress recovery by sequential ubiquitination of substrates and Hsp70	NATURE			English	Article							HEAT-SHOCK FACTOR-1; TRANSCRIPTIONAL ACTIVITY; CHAPERONE; PROTEIN; LIGASE; DEGRADATION; ACTIVATION; PROTECTION; THERMOTOLERANCE; IDENTIFICATION	Exposure of cells to various stresses often leads to the induction of a group of proteins called heat shock proteins (HSPs, molecular chaperones)(1,2). Hsp70 is one of the most highly inducible molecular chaperones, but its expression must be maintained at low levels under physiological conditions to permit constitutive cellular activities to proceed(3,4). Heat shock transcription factor 1 (HSF1) is the transcriptional regulator of HSP gene expression(5), but it remains poorly understood how newly synthesized HSPs return to basal levels when HSF1 activity is attenuated. CHIP (carboxy terminus of Hsp70-binding protein), a dual-function co-chaperone/ubiquitin ligase, targets a broad range of chaperone substrates for proteasomal degradation(6-11). Here we show that CHIP not only enhances Hsp70 induction during acute stress but also mediates its turnover during the stress recovery process. Central to this dual-phase regulation is its substrate dependence: CHIP preferentially ubiquitinates chaperone-bound substrates, whereas degradation of Hsp70 by CHIP-dependent targeting to the ubiquitin-proteasome system occurs when misfolded substrates have been depleted. The sequential catalysis of the CHIP-associated chaperone adaptor and its bound substrate provides an elegant mechanism for maintaining homeostasis by tuning chaperone levels appropriately to reflect the status of protein folding within the cytoplasm.	Univ N Carolina, Sch Med, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Patterson, C (corresponding author), Univ N Carolina, Sch Med, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA.	cpatters@med.unc.edu		Cyr, Douglas/0000-0002-4928-3414	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061728] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM061728] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Boellmann F, 2004, P NATL ACAD SCI USA, V101, P4100, DOI 10.1073/pnas.0304768101; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Guo YL, 2001, J BIOL CHEM, V276, P45791, DOI 10.1074/jbc.M105931200; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Volloch VZ, 1999, ONCOGENE, V18, P3648, DOI 10.1038/sj.onc.1202525; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cb.11.110195.002301; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	26	274	289	3	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					551	555		10.1038/nature04600	http://dx.doi.org/10.1038/nature04600			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554822	Green Accepted, Green Published			2022-12-24	WOS:000236176100060
J	Mant, J; McManus, RJ; Hare, R				Mant, J; McManus, RJ; Hare, R			Applicability to primary care of national clinical guidelines on blood pressure lowering for people with stroke: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HYPERTENSION; SOCIETY; RISK	Objective To compare the characteristics of patients with cerebrovascular disease in primary care with those of the participants in the PROGRESS trial, on which national guidelines for blood pressure lowering are based. Design Population based cross sectional survey of patients with confirmed stroke or transient ischaemic attack. Setting Seven general practices in south Birmingham, England. Participants All patients with a validated history of stroke (n = 413) or transient ischaemic attack (n = 107). Main outcome measures Patient characteristics: age, sex, time since last cerebrovascular event, blood pressure, and whether receiving antihypertensive treatment. Results Patients were 12 years older than the participants in PROGRESS and twice as likely to be women. The median time that had elapsed since their cerebrovascular event was two and a half years, compared with eight months in PROGRESS. The systolic blood pressure of 315 (61%) patients was over 140 mm Hg, and for 399 (77%) it was over 130 mm Hg. One hundred and forty seven (28%) patients were receiving a thiazide diuretic, and 136 (26%) were receiving an angiotensin converting enzyme inhibitor. Conclusions Important differences exist between the PROGRESS trial participants and a typical primary care stroke population, which undermine the applicability of the trial's findings. Research in appropriate populations is urgently needed before the international guidelines are implemented in primary care.	Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Mant, J (corresponding author), Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.	j.w.mant@bham.ac.uk		Mant, Jonathan/0000-0002-9531-0268				Chalmers J, 2003, J HYPERTENS, V21, P651, DOI 10.1097/01.hjh.0000052490.18130.95; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Gueyffier F, 1999, LANCET, V353, P793, DOI 10.1016/S0140-6736(98)08127-6; *INT STROK WORK PA, 2004, NAT CLIN GUID STROK; Lovett JK, 2003, STROKE, V34, pE138, DOI 10.1161/01.STR.0000080935.01264.91; Mant J, 2003, BRIT J GEN PRACT, V53, P520; *OFF NAT STAT, 2000, KEY HLTH STAT GEN PR; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Sproston K., 2006, HLTH SURVEY ENGLAND; *W MIDL PUBL HLTH, 2002, 31 DEP PUBL HLTH EP; Wennberg R, 2004, BMJ-BRIT MED J, V329, P968, DOI 10.1136/bmj.329.7472.968; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683	13	36	36	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2006	332	7542					635	637		10.1136/bmj.38758.600116.AE	http://dx.doi.org/10.1136/bmj.38758.600116.AE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026CQ	16500926	Green Published, Bronze			2022-12-24	WOS:000236314700015
J	Pompilio, L; Kacelnik, A; Behmer, ST				Pompilio, L; Kacelnik, A; Behmer, ST			State-dependent learned valuation drives choice in an invertebrate	SCIENCE			English	Article							PHYTOPHAGOUS INSECTS; DIETARY SELECTION; HUNGRY LOCUST; STARLINGS; SENSITIVITY	Humans and other vertebrates occasionally show a preference for items remembered to be costly or experienced when the subject was in a poor condition (this is known as a sunk-costs fallacy or state-dependent valuation). Whether these mechanisms shared across vertebrates are the result of convergence toward an adaptive solution or evolutionary relicts reflecting common ancestral traits is unknown. Here we show that state-dependent valuation also occurs in an invertebrate, the desert locust Schistocerca gregaria (Orthoptera: Acrididae). Given the latter's phylogenetic and neurobiological distance from those groups in which the phenomenon was already known, we suggest that state-dependent valuation mechanisms are probably ecologically rational solutions to widespread problems of choice.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Kacelnik, A (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	alex.kacelnik@zoo.ox.ac.uk		Behmer, Spencer/0000-0002-5038-1046				ABISGOLD JD, 1988, J EXP BIOL, V135, P215; BALLEINE BW, 2006, BEHAV LAB RATS HDB T, P436; Behmer ST, 2005, J EXP BIOL, V208, P3463, DOI 10.1242/jeb.01767; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Burrows M., 1996, NEUROBIOLOGY INSECT; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; Clement TS, 2000, PSYCHON B REV, V7, P100, DOI 10.3758/BF03210727; Dickinson A, 2002, STEVENS HDB EXPT PSY, P497, DOI DOI 10.1002/0471214426.PAS0312; Dukas R, 2000, P NATL ACAD SCI USA, V97, P2637, DOI 10.1073/pnas.050461497; Gigerenzer G, 2004, BEHAV BRAIN SCI, V27, P336, DOI 10.1017/S0140525X04310083; Kacelnik A, 2002, ANIM BEHAV, V63, P245, DOI 10.1006/anbe.2001.1900; Marsh B, 2004, BEHAV ECOL, V15, P396, DOI 10.1093/beheco/arh034; Pompilio L, 2005, ANIM BEHAV, V70, P571, DOI 10.1016/j.anbehav.2004.12.009; REAL LA, 1992, AM NAT, V140, P108; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Sibly R.M., 1981, P109; SIMPSON CL, 1990, ENTOMOL EXP APPL, V56, P259, DOI 10.1007/BF00163697; Simpson SJ, 2000, ADV STUD BEHAV, V29, P1, DOI 10.1016/S0065-3454(08)60102-3; SIMPSON SJ, 1992, J EXP BIOL, V168, P269; SIMPSON SJ, 1991, APPETITE, V17, P141, DOI 10.1016/0195-6663(91)90069-5	20	106	108	1	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1613	1615		10.1126/science.1123924	http://dx.doi.org/10.1126/science.1123924			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543461				2022-12-24	WOS:000236029500047
J	Grebmeier, JM; Overland, JE; Moore, SE; Farley, EV; Carmack, EC; Cooper, LW; Frey, KE; Helle, JH; McLaughlin, FA; McNutt, SL				Grebmeier, JM; Overland, JE; Moore, SE; Farley, EV; Carmack, EC; Cooper, LW; Frey, KE; Helle, JH; McLaughlin, FA; McNutt, SL			A major ecosystem shift in the northern Bering Sea	SCIENCE			English	Article							LATE WINTER; ICE COVER; PACK ICE; SHELF; WATER; POLYNYA; SUMMER		Univ Tennessee, Dept Ecol & Evolutionary Biol, Marine Biogeochem & Ecol Grp, Knoxville, TN 37932 USA; NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; NOAA, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA; NOAA, Auke Bay Lab, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Juneau, AK 99801 USA; Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC V8L 4B2, Canada; Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA; Univ Alaska Fairbanks, Inst Geophys, Fairbanks, AK 99775 USA	University of Tennessee System; University of Tennessee Knoxville; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; Fisheries & Oceans Canada; University of California System; University of California Los Angeles; University of Alaska System; University of Alaska Fairbanks	Grebmeier, JM (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Marine Biogeochem & Ecol Grp, 10515 Res Dr,Bldg A,Suite 100, Knoxville, TN 37932 USA.	jgrebmei@utk.edu	Cooper, Lee W./E-5251-2012; Farley, E/HHM-4227-2022; Grebmeier, Jacqueline/L-9805-2013; Moore, Sue E/M-2103-2018	Cooper, Lee W./0000-0001-7734-8388; Grebmeier, Jacqueline/0000-0001-7624-3568; 				Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; Clement JL, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002047; Cooper LW, 2002, MAR ECOL PROG SER, V226, P13, DOI 10.3354/meps226013; COOPER LW, IN PRESS AQUAT MAMMA; GREBMEIER JM, 1989, MAR ECOL PROG SER, V51, P253, DOI 10.3354/meps051253; Grebmeier JM, 2005, DEEP-SEA RES PT II, V52, P3109, DOI 10.1016/j.dsr2.2005.10.004; GREBMEIER JM, 1995, J GEOPHYS RES-OCEANS, V100, P4439, DOI 10.1029/94JC02198; GREBMEIER JM, 1995, ARCTIC OCEANOGRAPHY, P231, DOI DOI 10.1029/CE049P0231; GREBMEIER JM, 2004, ARCTIC CLIMATE IMPAC; Grebmeier JM, 2000, IMPACTS CHANGES SEA, P80; GREBMEIER JM, IN PRESS POLYNYAS WI; HIGHSMITH RC, 1990, NATURE, V344, P862, DOI 10.1038/344862a0; Krupnik Igor, 2002, EARTH IS FASTER NOW, P156; LEAN C, COMMUNICATION; Lovvorn JR, 2005, MAR ECOL PROG SER, V291, P135, DOI 10.3354/meps291135; Lovvorn JR, 2003, POLAR BIOL, V26, P259, DOI 10.1007/s00300-003-0477-0; Moore SE, 2006, BIOSCIENCE, V56, P49, DOI 10.1641/0006-3568(2006)056[0049:LFLWIT]2.0.CO;2; Moore SE, 2003, CAN J ZOOL, V81, P734, DOI 10.1139/Z03-043; MOORE SE, IN PRESS ECOL APPL; Osterkamp TE, 1999, PERMAFROST PERIGLAC, V10, P17, DOI 10.1002/(SICI)1099-1530(199901/03)10:1&lt;17::AID-PPP303&gt;3.0.CO;2-4; Overland J.E., 2004, EOS T AGU, V85, P309, DOI DOI 10.1029/2004E0330001; Overland JE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024254; Pungowiyi Caleb, 2000, IMPACTS CHANGES SEA, P18; Ray C, 1989, RAPPORTS PROCES VERB, V188, P22; SCHUMACHER JD, 1983, J GEOPHYS RES-OCEANS, V88, P2723, DOI 10.1029/JC088iC05p02723; Stroeve JC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021810; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; Wyllie-Echeverria T, 1998, FISH OCEANOGR, V7, P159, DOI 10.1046/j.1365-2419.1998.00058.x	29	642	674	2	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2006	311	5766					1461	1464		10.1126/science.1121365	http://dx.doi.org/10.1126/science.1121365			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527980				2022-12-24	WOS:000236029400049
J	Olson, VG; Heusner, CL; Bland, RJ; During, MJ; Weinshenker, D; Palmiter, RD				Olson, VG; Heusner, CL; Bland, RJ; During, MJ; Weinshenker, D; Palmiter, RD			Role of noradrenergic signaling by the nucleus tractus solitarius in mediating opiate reward	SCIENCE			English	Article							CONDITIONED PLACE PREFERENCE; MORPHINE-WITHDRAWAL; DOPAMINE RELEASE; MICE; RATS; NOREPINEPHRINE; NORADRENALINE; LOCOMOTOR; LOCUS; PSYCHOSTIMULANTS	Norepinephrine (NE) is widely implicated in opiate withdrawal, but much less is known about its role in opiate-induced locomotion and reward. in mice lacking dopamine beta-hydroxytase (DBH), an enzyme critical for NE synthesis, we found that NE was necessary for morphine-induced conditioned place preference (CPP; a measure of reward) and locomotion. These deficits were rescued by systemic NE restoration. Viral restoration of DBH expression in the nucleus tractus solitarius, but not in the locus coeruleus, restored CPP for morphine. Morphine-induced locomotion was partially restored by DBH expression in either brain region. These data suggest that NE signaling by the nucleus tractus solitarius is necessary for morphine reward.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Neurologix, New York, NY 10032 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Palmiter, RD (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	palmiter@u.washington.edu	During, Matthew/AAC-1388-2020; Weinshenker, David/V-3998-2019					Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.biopsych.2004.08.019; Auclair A, 2004, EUR J NEUROSCI, V20, P3073, DOI 10.1111/j.1460-9568.2004.03805.x; Christie MJ, 1997, TRENDS PHARMACOL SCI, V18, P134, DOI 10.1016/S0165-6147(97)01045-6; DAVIS WM, 1975, PHARMACOL BIOCHEM BE, V3, P477, DOI 10.1016/0091-3057(75)90059-3; Delfs JM, 1998, BRAIN RES, V806, P127, DOI 10.1016/S0006-8993(98)00672-6; Delfs JM, 2000, NATURE, V403, P430, DOI 10.1038/35000212; Drouin C, 2002, J NEUROSCI, V22, P2873, DOI 10.1523/JNEUROSCI.22-07-02873.2002; Drouin C, 2001, NEUROREPORT, V12, P3483, DOI 10.1097/00001756-200111160-00022; GRENHOFF J, 1993, J NEURAL TRANSM-GEN, V93, P11, DOI 10.1007/BF01244934; Hnasko TS, 2005, NATURE, V438, P854, DOI 10.1038/nature04172; Knauber J, 2000, EUR NEUROPSYCHOPHARM, V10, P423, DOI 10.1016/S0924-977X(00)00100-0; Laorden ML, 2002, BRIT J PHARMACOL, V136, P67, DOI 10.1038/sj.bjp.0704684; Maldonado R, 1997, NEUROSCI BIOBEHAV R, V21, P91, DOI 10.1016/0149-7634(95)00061-5; MILNER PM, 1991, CAN J PSYCHOL, V45, P1, DOI 10.1037/h0084275; MOORE RY, 1979, ANNU REV NEUROSCI, V2, P113, DOI 10.1146/annurev.ne.02.030179.000553; Nader K, 1996, BEHAV NEUROSCI, V110, P389, DOI 10.1037/0735-7044.110.2.389; Sahraei H, 2004, PHARMACOL BIOCHEM BE, V78, P135, DOI 10.1016/j.pbb.2004.03.004; SCHANK JR, 2005, NEUROPSYCHOPHARMACOL; Shaham Y, 2000, EUR J NEUROSCI, V12, P292, DOI 10.1046/j.1460-9568.2000.00899.x; Spreng M, 2001, NEUROBIOL LEARN MEM, V75, P214, DOI 10.1006/nlme.2000.3965; STEIN L, 1978, PSYCHOPHARMACOLOGY G, P569; Thomas SA, 1998, J NEUROCHEM, V70, P2468; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; Ventura R, 2005, CEREB CORTEX, V15, P1877, DOI 10.1093/cercor/bhi066; Wang XY, 2001, EUR J PHARMACOL, V432, P153, DOI 10.1016/S0014-2999(01)01487-X; Watanabe T, 2003, PSYCHOPHARMACOLOGY, V170, P80, DOI 10.1007/s00213-003-1504-0; Zarrindast MR, 2002, PHARMACOL BIOCHEM BE, V73, P941, DOI 10.1016/S0091-3057(02)00951-6	28	102	106	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2006	311	5763					1017	1020		10.1126/science.1119311	http://dx.doi.org/10.1126/science.1119311			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014CS	16484499				2022-12-24	WOS:000235456900050
J	Gedney, N; Cox, PM; Betts, RA; Boucher, O; Huntingford, C; Stott, PA				Gedney, N; Cox, PM; Betts, RA; Boucher, O; Huntingford, C; Stott, PA			Detection of a direct carbon dioxide effect in continental river runoff records	NATURE			English	Article							LAND-SURFACE SCHEME; CLIMATE; MODEL; TRANSPIRATION; SIMULATION; RADIATION; DATABASE; IMPACT; SCALE; CO2	Continental runoff has increased through the twentieth century(1,2) despite more intensive human water consumption(3). Possible reasons for the increase include: climate change and variability, deforestation, solar dimming(4), and direct atmospheric carbon dioxide (CO2) effects on plant transpiration(5). All of these mechanisms have the potential to affect precipitation and/or evaporation and thereby modify runoff. Here we use a mechanistic land-surface model(6) and optimal fingerprinting statistical techniques(7) to attribute observational runoff changes(1) into contributions due to these factors. The model successfully captures the climate-driven inter-annual runoff variability, but twentieth-century climate alone is insufficient to explain the runoff trends. Instead we find that the trends are consistent with a suppression of plant transpiration due to CO2-induced stomatal closure. This result will affect projections of freshwater availability, and also represents the detection of a direct CO2 effect on the functioning of the terrestrial biosphere.	Hadley Ctr Climate Predict & Res JCHMR, Met Off, Wallingford OX10 8BB, Oxon, England; Winfrith Technol Ctr, Ctr Ecol & Hydrol Dorset, Dorchester DT2 8ZD, Dorchester, England; Hadley Ctr Climate Predict & Res, Met Off, Exeter EX1 3PB, Devon, England; Ctr Ecol & Hydrol Wallingford, Wallingford OX10 8BB, Oxon, England; Univ Reading, Hadley Ctr Climate Predict & Res, Reading Unit, Met Off, Reading RG6 6BB, Berks, England	Met Office - UK; Hadley Centre; UK Centre for Ecology & Hydrology (UKCEH); Met Office - UK; Hadley Centre; UK Centre for Ecology & Hydrology (UKCEH); Met Office - UK; Hadley Centre; University of Reading	Gedney, N (corresponding author), Hadley Ctr Climate Predict & Res JCHMR, Met Off, Maclean Bldg, Wallingford OX10 8BB, Oxon, England.	nicola.gedney@metoffice.gov.uk	Cox, Peter Michae;/B-3299-2012; Boucher, Olivier/K-7483-2012; Huntingford, Christopher/A-4307-2008; Boucher, Olivier/J-5810-2012; Stott, Peter/N-1228-2016; Betts, Richard A/P-8976-2015; Scott, Peter/GYA-5335-2022	Cox, Peter Michae;/0000-0002-0679-2219; Boucher, Olivier/0000-0003-2328-5769; Huntingford, Christopher/0000-0002-5941-7770; Boucher, Olivier/0000-0003-2328-5769; Stott, Peter/0000-0003-4853-7686; Betts, Richard A/0000-0002-4929-0307; 	Natural Environment Research Council [ceh010022] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Betts RA, 1997, NATURE, V387, P796, DOI 10.1038/42924; Boucher O, 2004, CLIM DYNAM, V22, P597, DOI 10.1007/s00382-004-0402-4; Compagnucci R, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, P191; Cox PM, 1999, CLIM DYNAM, V15, P183, DOI 10.1007/s003820050276; Cox PM, 1998, J HYDROL, V212, P79, DOI 10.1016/S0022-1694(98)00203-0; Dirmeyer P, 2003, COLA TECHNIC REP, V159, P1; Essery RLH, 2003, J HYDROMETEOROL, V4, P530, DOI 10.1175/1525-7541(2003)004<0530:EROSHI>2.0.CO;2; Fekete BM, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/1999GB001254; FIELD CB, 1995, PLANT CELL ENVIRON, V18, P1214, DOI 10.1111/j.1365-3040.1995.tb00630.x; Goldewijk KK, 2001, GLOBAL BIOGEOCHEM CY, V15, P417, DOI 10.1029/1999GB001232; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Harding RJ, 2000, AGR FOREST METEOROL, V100, P309, DOI 10.1016/S0168-1923(99)00152-5; HENNING D, 1989, ATLAS SURFACE HEAT B, P6; Labat D, 2004, ADV WATER RESOUR, V27, P631, DOI 10.1016/j.advwatres.2004.02.020; Lambert FH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019545; Liepert BG, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014910; Loveland TR, 2000, INT J REMOTE SENS, V21, P1303, DOI 10.1080/014311600210191; MCNAUGHTON KG, 1991, AGR FOREST METEOROL, V54, P279, DOI 10.1016/0168-1923(91)90010-N; MITCHELL JFB, 2001, CLIMATE CHANGE 2001, P697; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Pope VD, 2000, CLIM DYNAM, V16, P123, DOI 10.1007/s003820050009; PROBST JL, 1987, J HYDROL, V94, P289, DOI 10.1016/0022-1694(87)90057-6; Roderick ML, 2002, SCIENCE, V298, P1410; Sellers PJ, 1996, SCIENCE, V271, P1402, DOI 10.1126/science.271.5254.1402; Shiklomanov IA, 2000, WATER INT, V25, P11, DOI 10.1080/02508060008686794; Stanhill G, 2001, AGR FOREST METEOROL, V107, P255, DOI 10.1016/S0168-1923(00)00241-0; STOTT PA, IN PRESS J CLIM; Tett SFB, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000028; *UN FAO, 2005, FAOSTAT STAT DAT POP; *UN FAO, 2005, FAOSTAT STAT DAT LAN	30	604	630	10	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2006	439	7078					835	838		10.1038/nature04504	http://dx.doi.org/10.1038/nature04504			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012JA	16482155				2022-12-24	WOS:000235333600047
J	Bomback, A				Bomback, A			Errands	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												abomback@unch.unc.edu	Bomback, Andrew/A-8063-2009						0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2006	295	7					731	733		10.1001/jama.295.7.731	http://dx.doi.org/10.1001/jama.295.7.731			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011YZ	16478890				2022-12-24	WOS:000235306700001
J	Berton, O; McClung, CA; DiLeone, RJ; Krishnan, V; Renthal, W; Russo, SJ; Graham, D; Tsankova, NM; Bolanos, CA; Rios, M; Monteggia, LM; Self, DW; Nestler, EJ				Berton, O; McClung, CA; DiLeone, RJ; Krishnan, V; Renthal, W; Russo, SJ; Graham, D; Tsankova, NM; Bolanos, CA; Rios, M; Monteggia, LM; Self, DW; Nestler, EJ			Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress	SCIENCE			English	Article							NEUROTROPHIC FACTOR; BEHAVIORAL SENSITIZATION; NUCLEUS-ACCUMBENS; DRUG-ADDICTION; BRAIN; NEURONS; COCAINE; REWARD; MECHANISMS; EXPRESSION	Mice experiencing repeated aggression develop a long-tasting aversion to social contact, which can be normalized by chronic, but not acute, administration of antidepressant. Using viral-mediated, mesolimbic dopamine pathway-specific knockdown of brain-derived neurotrophic factor (BDNF), we showed that BDNF is required for the development of this experience-dependent social aversion. Gene profiling in the nucleus accumbens indicates that local knockdown of BDNF obliterates most of the effects of repeated aggression on gene expression within this circuit, with similar effects being produced by chronic treatment with antidepressant. These results establish an essential rote for BDNF in mediating long-term neural and behavioral plasticity in response to aversive social experiences.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Tufts University	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu	Russo, Scott/R-7107-2019; Graham, Danielle L/K-8459-2014; Winwood, Peter/A-6363-2008; McClung, Colleen/AAA-5943-2019	Russo, Scott/0000-0002-6470-1805; Renthal, William/0000-0003-0206-2101; DiLeone, Ralph/0000-0002-4770-2590; Krishnan, Vaishnav/0000-0002-2847-0069				Avgustinovich D F, 2005, Neurosci Behav Physiol, V35, P917, DOI 10.1007/s11055-005-0146-6; Baquet ZC, 2005, J NEUROSCI, V25, P6251, DOI 10.1523/JNEUROSCI.4601-04.2005; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bolanos CA, 2004, NEUROMOL MED, V5, P69, DOI 10.1385/NMM:5:1:069; Buwalda B, 2005, NEUROSCI BIOBEHAV R, V29, P83, DOI 10.1016/j.neubiorev.2004.05.005; Cabib S, 2000, BEHAV BRAIN RES, V112, P13, DOI 10.1016/S0166-4328(00)00157-1; Conner JM, 1997, J NEUROSCI, V17, P2295; Duman RS, 2004, BIOL PSYCHIAT, V56, P140, DOI 10.1016/j.biopsych.2004.02.033; Eisch AJ, 2003, BIOL PSYCHIAT, V54, P994, DOI 10.1016/j.biopsych.2003.08.003; Goggi J, 2003, BRAIN RES, V968, P156, DOI 10.1016/S0006-8993(03)02234-0; Grimm JW, 2003, J NEUROSCI, V23, P742; Guillin O, 2001, NATURE, V411, P86, DOI 10.1038/35075076; Horger BA, 1999, J NEUROSCI, V19, P4110; Huhman KL, 2003, HORM BEHAV, V44, P293, DOI 10.1016/j.yhbeh.2003.05.001; Hung H C, 1996, Brain Res Mol Brain Res, V41, P14; Insel TR, 2004, ANNU REV NEUROSCI, V27, P697, DOI 10.1146/annurev.neuro.27.070203.144148; Isovich E, 2001, EUR J NEUROSCI, V13, P1254, DOI 10.1046/j.0953-816x.2001.01492.x; Izzo E, 2002, NAT NEUROSCI, V5, P1263, DOI 10.1038/nn977; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P843, DOI 10.1016/j.biopsych.2005.05.019; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; LOUILOT A, 1986, BRAIN RES, V397, P395, DOI 10.1016/0006-8993(86)90646-3; Nikulina EM, 2004, NEUROSCIENCE, V123, P857, DOI 10.1016/j.neuroscience.2003.10.029; Ochsner KN, 2004, CURR OPIN NEUROBIOL, V14, P254, DOI 10.1016/j.conb.2004.03.011; Porritt MJ, 2005, EXP NEUROL, V192, P226, DOI 10.1016/j.expneurol.2004.11.030; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Robbins TW, 2002, NEUROBIOL LEARN MEM, V78, P625, DOI 10.1006/nlme.2002.4103; Robinson R, 2004, HIGH EDUC, V47, P1, DOI 10.1023/B:HIGH.0000009803.70418.9c; Scammell TE, 2003, J NEUROSCI, V23, P5762; Schneier FR, 2000, AM J PSYCHIAT, V157, P457, DOI 10.1176/appi.ajp.157.3.457; Schneier FR, 2002, PSYCHIAT CLIN N AM, V25, P757, DOI 10.1016/S0193-953X(02)00018-7; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; SEROOGY KB, 1994, J COMP NEUROL, V342, P321, DOI 10.1002/cne.903420302; SIEGFRIED B, 1984, BEHAV NEURAL BIOL, V42, P91, DOI 10.1016/S0163-1047(84)90484-9; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Tidey JW, 1996, BRAIN RES, V721, P140, DOI 10.1016/0006-8993(96)00159-X; Tiihonen J, 1997, AM J PSYCHIAT, V154, P239; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	39	1480	1517	8	222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2006	311	5762					864	868		10.1126/science.1120972	http://dx.doi.org/10.1126/science.1120972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012XT	16469931				2022-12-24	WOS:000235374900053
J	Habashi, JP; Judge, DP; Holm, TM; Cohn, RD; Loeys, BL; Cooper, TK; Myers, L; Klein, EC; Liu, GS; Calvi, C; Podowski, M; Neptune, ER; Halushka, MK; Bedja, D; Gabrielson, K; Rifkin, DB; Carta, L; Ramirez, F; Huso, DL; Dietz, HC				Habashi, JP; Judge, DP; Holm, TM; Cohn, RD; Loeys, BL; Cooper, TK; Myers, L; Klein, EC; Liu, GS; Calvi, C; Podowski, M; Neptune, ER; Halushka, MK; Bedja, D; Gabrielson, K; Rifkin, DB; Carta, L; Ramirez, F; Huso, DL; Dietz, HC			Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome	SCIENCE			English	Article							GROWTH-FACTOR-BETA; SMOOTH-MUSCLE-CELLS; RECEPTOR; PATHOGENESIS; FIBRILLIN; BLOCKADE; RATS; CONTRIBUTES; DILATATION; ACTIVATION	Aortic aneurysm and dissection are manifestations of Marfan syndrome (MFS), a disorder caused by mutations in the gene that encodes fibrillin-1. Selected manifestations of MFS reflect excessive signaling by the transforming growth factor-beta (TGF-beta) family of cytokines. We show that aortic aneurysm in a mouse model of MFS is associated with increased TGF-beta signaling and can be prevented by TGF-beta antagonists such as TGF-beta-neutralizing antibody or the angiotensin II type 1 receptor (AT1) blocker, losartan. AT1 antagonism also partially reversed noncardiovascular manifestations of MFS, including impaired alveolar septation. These data suggest that losartan, a drug already in clinical use for hypertension, merits investigation as a therapeutic strategy for patients with MFS and has the potential to prevent the major life-threatening manifestation of this disorder.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Med, New York, NY 10016 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ 08903 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; New York University; New York University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	hdietz@jhmi.edu	Loeys, Bart/B-3236-2017; Cohn, Ronald/AAC-5835-2021	Loeys, Bart/0000-0003-3703-9518; Halushka, Marc/0000-0002-7112-7389; Judge, Daniel/0000-0002-3407-0248; Steinbach, Erin/0000-0002-6165-8928	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL067056] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL067056] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		COUCKE PJ, IN PRESS NAT GENET; Daugherty A, 2001, BRIT J PHARMACOL, V134, P865, DOI 10.1038/sj.bjp.0704331; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; EVERETT AD, 1994, HYPERTENSION, V23, P587, DOI 10.1161/01.HYP.23.5.587; Fukuda N, 2000, AM J HYPERTENS, V13, P191, DOI 10.1016/S0895-7061(99)00152-1; Gadson PF, 1997, EXP CELL RES, V230, P169, DOI 10.1006/excr.1996.3398; Gott VL, 1999, NEW ENGL J MED, V340, P1307, DOI 10.1056/NEJM199904293401702; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jones ES, 2004, J MOL CELL CARDIOL, V37, P1023, DOI 10.1016/j.yjmcc.2004.08.004; Jones KB, 2005, SPINE, V30, P291, DOI 10.1097/01.brs.0000152166.88174.1c; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Lavoie P, 2005, J HYPERTENS, V23, P1895, DOI 10.1097/01.hjh.0000182521.44440.c5; Lim DS, 2001, CIRCULATION, V103, P789, DOI 10.1161/01.CIR.103.6.789; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; NABEL EG, 1993, P NATL ACAD SCI USA, V90, P10759, DOI 10.1073/pnas.90.22.10759; Nagashima H, 2001, CIRCULATION, V104, pI282; Naito T, 2004, AM J PHYSIOL-RENAL, V286, pF278, DOI 10.1152/ajprenal.00139.2003; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Nollen GJ, 2002, HEART, V87, P470, DOI 10.1136/heart.87.5.470; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; ROSSI P, 1988, CELL, V52, P405, DOI 10.1016/S0092-8674(88)80033-3; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; SCHLUMBERGER W, 1991, ARTERIOSCLER THROMB, V11, P1660, DOI 10.1161/01.ATV.11.6.1660; SHORES J, 1994, NEW ENGL J MED, V330, P1335, DOI 10.1056/NEJM199405123301902; SPENCE SG, 1995, TERATOLOGY, V51, P367, DOI 10.1002/tera.1420510603; Suzuki J, 2002, CIRCULATION, V106, P847, DOI 10.1161/01.CIR.0000024103.04821.86; Topouzis S, 1996, DEV BIOL, V178, P430, DOI 10.1006/dbio.1996.0229; Visconti RP, 2003, MATRIX BIOL, V22, P109, DOI 10.1016/S0945-053X(03)00014-3; Wolf G, 1999, J MOL MED-JMM, V77, P556, DOI 10.1007/s001099900028	31	1262	1303	7	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2006	312	5770					117	121		10.1126/science.1124287	http://dx.doi.org/10.1126/science.1124287			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601194	Green Accepted			2022-12-24	WOS:000236584400045
J	Lunin, VV; Dobrovetsky, E; Khutoreskaya, G; Zhang, RG; Joachimiak, A; Doyle, DA; Bochkarev, A; Maguire, ME; Edwards, AM; Koth, CM				Lunin, VV; Dobrovetsky, E; Khutoreskaya, G; Zhang, RG; Joachimiak, A; Doyle, DA; Bochkarev, A; Maguire, ME; Edwards, AM; Koth, CM			Crystal structure of the CorA Mg2+ transporter	NATURE			English	Article							GATED ION CHANNELS; MAGNESIUM TRANSPORT; SALMONELLA-TYPHIMURIUM; TRANSMEMBRANE HELICES; POTASSIUM CHANNEL; CONDUCTION; MEMBRANE; PROTEINS; RECEPTOR; HOMOLOG	The magnesium ion, Mg2+, is essential for myriad biochemical processes and remains the only major biological ion whose transport mechanisms remain unknown. The CorA family of magnesium transporters is the primary Mg2+ uptake system of most prokaryotes(1-3) and a functional homologue of the eukaryotic mitochondrial magnesium transporter(4). Here we determine crystal structures of the full-length Thermotoga maritima CorA in an apparent closed state and its isolated cytoplasmic domain at 3.9 angstrom and 1.85 angstrom resolution, respectively. The transporter is a funnel-shaped homopentamer with two transmembrane helices per monomer. The channel is formed by an inner group of five helices and putatively gated by bulky hydrophobic residues. The large cytoplasmic domain forms a funnel whose wide mouth points into the cell and whose walls are formed by five long helices that are extensions of the transmembrane helices. The cytoplasmic neck of the pore is surrounded, on the outside of the funnel, by a ring of highly conserved positively charged residues. Two negatively charged helices in the cytoplasmic domain extend back towards the membrane on the outside of the funnel and abut the ring of positive charge. An apparent Mg2+ ion was bound between monomers at a conserved site in the cytoplasmic domain, suggesting a mechanism to link gating of the pore to the intracellular concentration of Mg2+.	Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L6, Canada; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5G 1L6, Canada; Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA; Argonne Natl Lab, Midwest Ctr Struct Genom, Biosci Div, Argonne, IL 60439 USA; Botnar Res Ctr, Struct Genom Consortium, Oxford OX3 7LD, England; Banting & Best Inst, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada; Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	University of Toronto; University of Toronto; University of Toronto; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Oxford; University of Toronto; Structural Genomics Consortium; Case Western Reserve University	Maguire, ME (corresponding author), Univ Toronto, Dept Med Biophys, 112 Coll St, Toronto, ON M5G 1L6, Canada.	mem6@cwru.edu; aled.edwards@utoronto.ca		Edwards, Aled/0000-0002-4782-6016; Koth, Christopher/0000-0003-3939-8856	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942] Funding Source: NIH RePORTER; NIGMS NIH HHS [U54 GM074942] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; DeLano W., PYMOL; Doyle DA, 2004, MOL MEMBR BIOL, V21, P221, DOI 10.1080/09687680410001716844; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gardner RC, 2003, CURR OPIN PLANT BIOL, V6, P263, DOI 10.1016/S1369-5266(03)00032-3; HMIEL SP, 1986, J BACTERIOL, V168, P1444, DOI 10.1128/jb.168.3.1444-1450.1986; Kehres D G, 1998, Microb Comp Genomics, V3, P151, DOI 10.1089/omi.1.1998.3.151; Kehres DG, 2002, BIOMETALS, V15, P261, DOI 10.1023/A:1016078832697; Knoop V, 2005, MOL GENET GENOMICS, V274, P205, DOI 10.1007/s00438-005-0011-x; Korolev S, 2002, NAT STRUCT BIOL, V9, P27, DOI 10.1038/nsb737; Kucharski LM, 2000, J BIOL CHEM, V275, P16767, DOI 10.1074/jbc.M001507200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; LESTER HA, 1992, ANNU REV BIOPH BIOM, V21, P267, DOI 10.1146/annurev.bb.21.060192.001411; MacKinnon R, 2004, BIOSCIENCE REP, V24, P75, DOI 10.1007/s10540-004-7190-2; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; NELSON DL, 1971, J BIOL CHEM, V246, P3042; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; SNAVELY MD, 1989, J BACTERIOL, V171, P4761, DOI 10.1128/jb.171.9.4761-4766.1989; Szegedy MA, 1999, J BIOL CHEM, V274, P36973, DOI 10.1074/jbc.274.52.36973; Tieleman DP, 2001, PROTEINS, V44, P63, DOI 10.1002/prot.1073; Worlock AJ, 2002, J BACTERIOL, V184, P4369, DOI 10.1128/JB.184.16.4369-4373.2002	25	185	196	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					833	837		10.1038/nature04642	http://dx.doi.org/10.1038/nature04642			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598263	Green Accepted			2022-12-24	WOS:000236548400049
J	Pal, C; Papp, B; Lercher, MJ; Csermely, P; Oliver, SG; Hurst, LD				Pal, C; Papp, B; Lercher, MJ; Csermely, P; Oliver, SG; Hurst, LD			Chance and necessity in the evolution of minimal metabolic networks	NATURE			English	Article							GENOME SEQUENCE; GENE-SETS; BUCHNERA; SYMBIONTS; BACTERIA; SIZE	It is possible to infer aspects of an organism's lifestyle from its gene content(1). Can the reverse also be done? Here we consider this issue by modelling evolution of the reduced genomes of endosymbiotic bacteria. The diversity of gene content in these bacteria may reflect both variation in selective forces and contingency-dependent loss of alternative pathways. Using an in silico representation of the metabolic network of Escherichia coli, we examine the role of contingency by repeatedly simulating the successive loss of genes while controlling for the environment. The minimal networks that result are variable in both gene content and number. Partially different metabolisms can thus evolve owing to contingency alone. The simulation outcomes do preserve a core metabolism, however, which is over-represented in strict intracellular bacteria. Moreover, differences between minimal networks based on lifestyle are predictable: by simulating their respective environmental conditions, we can model evolution of the gene content in Buchnera aphidicola and Wigglesworthia glossinidia with over 80% accuracy. We conclude that, at least for the particular cases considered here, gene content of an organism can be predicted with knowledge of its distant ancestors and its current lifestyle.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; European Mol Biol Lab, D-69012 Heidelberg, Germany; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Semmelweis Univ, Dept Med Chem, H-1444 Budapest, Hungary	University of Bath; European Molecular Biology Laboratory (EMBL); University of Oxford; University of Manchester; Semmelweis University	Hurst, LD (corresponding author), Univ Bath, Dept Biol & Biochem, Claverton Down, Bath BA2 7AY, Avon, England.	l.d.hurst@bath.ac.uk	Csermely, Peter/J-2067-2017; Lercher, Martin/K-7939-2013; Hurst, Laurence/F-9215-2010	Csermely, Peter/0000-0001-9234-0659; Lercher, Martin/0000-0003-3940-1621; Papp, Balazs/0000-0003-3093-8852; Hurst, Laurence/0000-0002-1002-1054	Biotechnology and Biological Sciences Research Council [E19354] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; Burgard AP, 2001, BIOTECHNOL PROGR, V17, P791, DOI 10.1021/bp0100880; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Cormen T. H., 2022, INTRO ALGORITHMS; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Gil R, 2004, ENVIRON MICROBIOL, V6, P1109, DOI 10.1111/j.1462-2920.2004.00691.x; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Klasson L, 2004, TRENDS MICROBIOL, V12, P37, DOI 10.1016/j.tim.2003.11.006; Kolisnychenko V, 2002, GENOME RES, V12, P640, DOI 10.1101/gr.217202; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; KUMARI S, 1995, J BACTERIOL, V177, P2878, DOI 10.1128/jb.177.10.2878-2886.1995; Mira A, 2002, MICROBIAL ECOL, V44, P137, DOI 10.1007/s00248-002-0012-9; Moran NA, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-12-research0054; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Nakabachi A, 1999, J INSECT PHYSIOL, V45, P1, DOI 10.1016/S0022-1910(98)00104-8; Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102; NOGGE G, 1981, PARASITOLOGY, V82, P101; Oliver SG, 1996, NATURE, V379, P597, DOI 10.1038/379597a0; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Westers H, 2003, MOL BIOL EVOL, V20, P2076, DOI 10.1093/molbev/msg219; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	30	172	182	0	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					667	670		10.1038/nature04568	http://dx.doi.org/10.1038/nature04568			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572170				2022-12-24	WOS:000236350400043
J	Feng, AS; Narins, PM; Xu, CH; Lin, WY; Yu, ZL; Qiu, Q; Xu, ZM; Shen, JX				Feng, AS; Narins, PM; Xu, CH; Lin, WY; Yu, ZL; Qiu, Q; Xu, ZM; Shen, JX			Ultrasonic communication in frogs	NATURE			English	Article							BULLFROG RANA-CATESBEIANA; MIDDLE-EAR; AUDITORY-CORTEX; FREQUENCY; NOISE	Among vertebrates, only microchiropteran bats, cetaceans and some rodents are known to produce and detect ultrasounds ( frequencies greater than 20 kHz) for the purpose of communication and/ or echolocation, suggesting that this capacity might be restricted to mammals(1,2). Amphibians, reptiles and most birds generally have limited hearing capacity, with the ability to detect and produce sounds below similar to 12 kHz. Here we report evidence of ultrasonic communication in an amphibian, the concave- eared torrent frog ( Amolops tormotus) from Huangshan Hot Springs, China. Males of A. tormotus produce diverse bird- like melodic calls with pronounced frequency modulations that often contain spectral energy in the ultrasonic range(3,4). To determine whether A. tormotus communicates using ultrasound to avoid masking by the wideband background noise of local fast- flowing streams, or whether the ultrasound is simply a by- product of the sound-production mechanism, we conducted acoustic playback experiments in the frogs' natural habitat. We found that the audible as well as the ultrasonic components of an A. tormotus call can evoke male vocal responses. Electrophysiological recordings from the auditory midbrain confirmed the ultrasonic hearing capacity of these frogs and that of a sympatric species facing similar environmental constraints. This extraordinary upward extension into the ultrasonic range of both the harmonic content of the advertisement calls and the frog's hearing sensitivity is likely to have co-evolved in response to the intense, predominantly low- frequency ambient noise from local streams. Because amphibians are a distinct evolutionary lineage from microchiropterans and cetaceans ( which have evolved ultrasonic hearing to minimize congestion in the frequency bands used for sound communication(5) and to increase hunting efficacy in darkness(2)), ultrasonic perception in these animals represents a new example of independent evolution.	Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; Univ Calif Los Angeles, Dept Physiol Sci & Ecol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Evolutionary Biol, Los Angeles, CA 90095 USA; Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China; Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Feng, AS (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	afeng1@uiuc.edu	YU, ZULIN/D-7979-2012					ANSON M, 1985, J ACOUST SOC AM, V78, P916, DOI 10.1121/1.392922; Bradbury Jack W., 1998, pi; CHEN BH, 1991, AMPHIBIAN REPTILIAN; CORSO JF, 1963, J ACOUST SOC AM, V35, P1738, DOI 10.1121/1.1918804; DIEROFF HG, 1975, ARCH OTO-RHINO-LARYN, V209, P277, DOI 10.1007/BF00456548; FEI L, 1999, ATLAS AMPHIBIANS CHI, P162; FENG AS, 1975, J COMP PHYSIOL, V100, P221, DOI 10.1007/BF00614532; Feng AS, 2002, NATURWISSENSCHAFTEN, V89, P352, DOI 10.1007/s00114-002-0335-x; HAUSER MD, 1996, EVOLUTION COMMUNICAT, P124; Hosoi H, 1998, LANCET, V351, P496, DOI 10.1016/S0140-6736(05)78683-9; Imaizumi S, 2001, NEUROREPORT, V12, P583, DOI 10.1097/00001756-200103050-00030; Jorgensen MB, 1998, J COMP PHYSIOL A, V182, P59; KINSLER LE, 1962, FUNDAMENTALS ACOUSTI, P186; LEWIS ER, 1999, COMP HEARING FISH AM, P218; LOFTUSHILLS JJ, 1970, J ACOUST SOC AM, V47, P1131, DOI 10.1121/1.1912015; MANLEY GA, 1972, J COMP PHYSIOL, V81, P239, DOI 10.1007/BF00693629; Mason MJ, 2002, J EXP BIOL, V205, P3167; Mason MJ, 2002, J EXP BIOL, V205, P3153; Narins PM, 2004, J ACOUST SOC AM, V115, P910, DOI 10.1121/1.1636851; OHR EA, 1976, COMP BIOCHEM PHYS C, V54, P13, DOI 10.1016/0306-4492(76)90018-6; PUMPHREY RJ, 1950, NATURE, V166, P571, DOI 10.1038/166571b0; Purgue AP, 1997, J COMP PHYSIOL A, V181, P438, DOI 10.1007/s003590050127; Rand A.S., 1988, P415; SALES G, 1974, ULTRASONIC COMMUNICA, P23; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a	26	217	240	7	122	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 16	2006	440	7082					333	336		10.1038/nature04416	http://dx.doi.org/10.1038/nature04416			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541072				2022-12-24	WOS:000235997600052
J	Annas, GJ				Annas, GJ			Congress, controlled substances, and physician-assisted suicide - Elephants in mouseholes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SCHIAVO,TERRI; CARE		Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				ANNAS GJ, 1994, NEW ENGL J MED, V331, P1240, DOI 10.1056/NEJM199411033311822; Annas GJ, 2005, NEW ENGL J MED, V353, P2291, DOI 10.1056/NEJMlim053151; Annas GJ, 2005, NEW ENGL J MED, V352, P1710, DOI 10.1056/NEJMlim050643; [Anonymous], 2001, FED REG; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Blendon RJ, 2005, ARCH INTERN MED, V165, P2580, DOI 10.1001/archinte.165.22.2580; Fins J. J, 2005, PALLIATIVE ETHICS CA; Johnson SH, 2005, J LAW MED ETHICS, V33, P741, DOI 10.1111/j.1748-720X.2005.tb00541.x; Quill TE, 2006, NEW ENGL J MED, V354, P1, DOI 10.1056/NEJMp058289	9	6	6	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2006	354	10					1079	1084		10.1056/NEJMlim060731	http://dx.doi.org/10.1056/NEJMlim060731			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	019FY	16525147	Green Published			2022-12-24	WOS:000235822200015
J	Yousry, TA; Major, EO; Ryschkewitsch, C; Fahle, G; Fischer, S; Hou, J; Curfman, B; Miszkiel, K; Mueller-Lenke, N; Sanchez, E; Barkhof, F; Radue, EW; Jager, HR; Clifford, DB				Yousry, TA; Major, EO; Ryschkewitsch, C; Fahle, G; Fischer, S; Hou, J; Curfman, B; Miszkiel, K; Mueller-Lenke, N; Sanchez, E; Barkhof, F; Radue, EW; Jager, HR; Clifford, DB			Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							JC VIRUS-DNA; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS; CROHNS-DISEASE; THERAPY	Background: Progressive multifocal leukoencephalopathy (PML) was reported to have developed in three patients treated with natalizumab. We conducted an evaluation to determine whether PML had developed in any other treated patients. Methods: We invited patients who had participated in clinical trials in which they received recent or long-term treatment with natalizumab for multiple sclerosis, Crohn's disease, or rheumatoid arthritis to participate. The clinical history, physical examination, brain magnetic resonance imaging (MRI), and testing of cerebrospinal fluid for JC virus DNA were used by an expert panel to evaluate patients for PML. We estimated the risk of PML in patients who completed at least a clinical examination for PML or had an MRI. Results: Of 3417 patients who had recently received natalizumab while participating in clinical trials, 3116 (91 percent) who were exposed to a mean of 17.9 monthly doses underwent evaluation for PML. Of these, 44 patients were referred to the expert panel because of clinical findings of possible PML, abnormalities on MRI, or a high plasma viral load of JC virus. No patient had detectable JC virus DNA in the cerebrospinal fluid. PML was ruled out in 43 of the 44 patients, but it could not be ruled out in one patient who had multiple sclerosis and progression of neurologic disease because data on cerebrospinal fluid testing and follow-up MRI were not available. Only the three previously reported cases of PML were confirmed (1.0 per 1000 treated patients; 95 percent confidence interval, 0.2 to 2.8 per 1000). Conclusions: A detailed review of possible cases of PML in patients exposed to natalizumab found no new cases and suggested a risk of PML of roughly 1 in 1000 patients treated with natalizumab for a mean of 17.9 months. The risk associated with longer treatment is not known.	Natl Inst Neurol Disorders & Stroke, Lab Mol Med & Neurosci, NIH, Bethesda, MD 20892 USA; Inst Neurol, London WC1N 3BG, England; NIH, Dept Lab Med, Ctr Clin, Bethesda, MD USA; Univ Basel, Dept Neuroradiol, Basel, Switzerland; Vrije Univ Amsterdam, Med Ctr, Dept Radiol, Amsterdam, Netherlands; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of London; University College London; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of Basel; Vrije Universiteit Amsterdam; Washington University (WUSTL); Washington University (WUSTL)	Major, EO (corresponding author), Natl Inst Neurol Disorders & Stroke, Lab Mol Med & Neurosci, NIH, 10 Ctr Dr,Bldg 10,Rm 3B14, Bethesda, MD 20892 USA.	majorg@ninds.nih.gov	Barkhof, Frederik/AAJ-6226-2020; Yousry, Tarek A/B-3417-2009; Jäger, Hans Rolf/K-1868-2013	Barkhof, Frederik/0000-0003-3543-3706; Jäger, Hans Rolf/0000-0002-6403-4184	Intramural NIH HHS Funding Source: Medline; Multiple Sclerosis Society [748] Funding Source: Medline; NINDS NIH HHS [U01 NS032228] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS001983, U01NS032228, Z01NS003049] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Sclerosis Society(National Multiple Sclerosis Society); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adelman B, 2005, NEW ENGL J MED, V353, P432, DOI 10.1056/NEJMc055235; GEISSLER A, 1995, LANCET, V345, P897; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P1745; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Koralnik IJ, 2004, CURR OPIN NEUROL, V17, P365, DOI 10.1097/00019052-200406000-00019; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Major EO, 2005, MULT SCLER J, V11, pS181; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Rice GPA, 2005, NEUROLOGY, V64, P1336, DOI 10.1212/01.WNL.0000158329.30470.D0; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Ryschkewitsch C, 2004, J VIROL METHODS, V121, P217, DOI 10.1016/j.jviromet.2004.06.021; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Thurnher MM, 2001, AM J NEURORADIOL, V22, P977; Van Assche G, 2005, NEW ENGL J MED, V353, P362, DOI 10.1056/NEJMoa051586; WHITEMAN MLH, 1993, RADIOLOGY, V187, P233, DOI 10.1148/radiology.187.1.8451420; Yiannoutsos CT, 1999, ANN NEUROL, V45, P816, DOI 10.1002/1531-8249(199906)45:6<816::AID-ANA21>3.0.CO;2-W	16	559	589	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2006	354	9					924	933		10.1056/NEJMoa054693	http://dx.doi.org/10.1056/NEJMoa054693			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017FN	16510746	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000235679600005
J	Fauci, AS				Fauci, AS			Emerging and re-emerging infectious diseases: Influenza as a prototype of the host-pathogen balancing act	CELL			English	Editorial Material								To respond to emerging and re-emerging infections, it is necessary to understand the interactions between microbial pathogens and their hosts and the impact of environmental and social factors on these interactions. The importance of understanding host-pathogen interactions is underscored by the emergence of virulent H5N1 avian influenza viruses and their transmission to humans, and the potential pandemic threat they pose.	NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov						[Anonymous], FIELDS VIROLOGY; *FAO, 2006, AN HLTH AV INFL; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; *WHO, 2002, AV INFL; Zheng B., 2006, P NATL ACAD SCI US, DOI [10.1073/pnas.0607974103, DOI 10.1073/PNAS.0607974103, DOI 10.1073/PNAS.051120103]	7	60	68	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 24	2006	124	4					665	670		10.1016/j.cell.2006.02.010	http://dx.doi.org/10.1016/j.cell.2006.02.010			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RO	16497575	Green Published, Bronze			2022-12-24	WOS:000237240900008
J	Tsukamoto, K				Tsukamoto, K			Spawning of eels near a seamount	NATURE			English	Editorial Material									Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan	University of Tokyo	Tsukamoto, K (corresponding author), Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan.	ktpc@ori.u-tokyo.ac.jp						[Anonymous], 2003, FISHERIES, V28, P28; Aoyama J, 1999, MAR ECOL PROG SER, V188, P193, DOI 10.3354/meps188193; Kimura S, 2001, FISH OCEANOGR, V10, P51, DOI 10.1046/j.1365-2419.2001.00159.x; McCleave JD, 1987, AM FISH SOC S SERIES, V1, P286; Schmidt J., 1925, Annual Report Smithsonian Institution, V1924, P279; Tsukamoto K, 2003, ENVIRON BIOL FISH, V66, P221, DOI 10.1023/A:1023926705906; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; Watanabe S, 2004, MAR BIOTECHNOL, V6, P566, DOI 10.1007/s10126-004-1000-5	8	183	212	5	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2006	439	7079					929	929		10.1038/439929a	http://dx.doi.org/10.1038/439929a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014NE	16495988				2022-12-24	WOS:000235486100036
J	Clevers, H				Clevers, H			Colon cancer - Understanding how NSAIDs work	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Netherlands Inst Dev Biol, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Clevers, H (corresponding author), Netherlands Inst Dev Biol, Utrecht, Netherlands.							Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Koehne CH, 2004, SEMIN ONCOL, V31, P12, DOI 10.1053/j.seminoncol.2004.03.041; Oshima M, 2002, CURR PHARM DESIGN, V8, P1021, DOI 10.2174/1381612023394953	4	69	75	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2006	354	7					761	763		10.1056/NEJMcibr055457	http://dx.doi.org/10.1056/NEJMcibr055457			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	012CP	16481647				2022-12-24	WOS:000235316100017
J	Paton, JJ; Belova, MA; Morrison, SE; Salzman, CD				Paton, JJ; Belova, MA; Morrison, SE; Salzman, CD			The primate amygdala represents the positive and negative value of visual stimuli during learning	NATURE			English	Article							ORBITOFRONTAL CORTEX; BASOLATERAL AMYGDALA; REWARD PREFERENCE; NEURONAL-ACTIVITY; MACAQUE MONKEY; ALERT MONKEY; ORGANIZATION; CONNECTIONS; CIRCUITRY; RESPONSES	Visual stimuli can acquire positive or negative value through their association with rewards and punishments, a process called reinforcement learning. Although we now know a great deal about how the brain analyses visual information, we know little about how visual representations become linked with values. To study this process, we turned to the amygdala, a brain structure implicated in reinforcement learning(1-5). We recorded the activity of individual amygdala neurons in monkeys while abstract images acquired either positive or negative value through conditioning. After monkeys had learned the initial associations, we reversed image value assignments. We examined neural responses in relation to these reversals in order to estimate the relative contribution to neural activity of the sensory properties of images and their conditioned values. Here we show that changes in the values of images modulate neural activity, and that this modulation occurs rapidly enough to account for, and correlates with, monkeys' learning. Furthermore, distinct populations of neurons encode the positive and negative values of visual stimuli. Behavioural and physiological responses to visual stimuli may therefore be based in part on the plastic representation of value provided by the amygdala.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, WM Keck Ctr Brain Plast & Cognit, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Salzman, CD (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, 1051 Riverside Dr,Unit 87, New York, NY 10032 USA.	cds2005@columbia.edu		Paton, Joseph/0000-0002-1663-6455; Morrison, Sara/0000-0003-0334-1284	NIMH NIH HHS [K01 MH001724-06, K01 MH001724, K01 MH001724-02, K01 MH001724-05, K01 MH001724-04, K01 MH001724-01A1, K01 MH001724-03] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH001724] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMARAL D G, 1992, P1; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Davis M., 2000, AMYGDALA, P213; Everitt BJ, 2003, ANN NY ACAD SCI, V985, P233; Freese JL, 2005, J COMP NEUROL, V486, P295, DOI 10.1002/cne.20520; Fudge JL, 2000, NEUROSCIENCE, V97, P479, DOI 10.1016/S0306-4522(00)00092-0; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Green DM, 1966, SIGNAL DETECTION THE; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee HJJ, 2005, J NEUROSCI, V25, P3881, DOI 10.1523/JNEUROSCI.0416-05.2005; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; NISHIJO H, 1988, J NEUROSCI, V8, P3570; Pavlov I.P., 1927, CONDITIONED REFLEXES; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rolls E. T., 2000, AMYGDALA FUNCTIONAL, P447; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; Saddoris MP, 2005, NEURON, V46, P321, DOI 10.1016/j.neuron.2005.02.018; SANGHERA MK, 1979, EXP NEUROL, V63, P610, DOI 10.1016/0014-4886(79)90175-4; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Stefanacci L, 1996, J COMP NEUROL, V375, P552; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x	30	629	633	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2006	439	7078					865	870		10.1038/nature04490	http://dx.doi.org/10.1038/nature04490			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012JA	16482160	Green Accepted			2022-12-24	WOS:000235333600054
J	Rehmann, H; Das, J; Knipscheer, P; Wittinghofer, A; Bos, JL				Rehmann, H; Das, J; Knipscheer, P; Wittinghofer, A; Bos, JL			Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state	NATURE			English	Article							CAMP-BINDING DOMAINS; REGULATORY SUBUNIT; RAS-GTP; ACTIVATION; RAP1; FAMILY; GEF; SOS	Epac proteins ( exchange proteins directly activated by cAMP) are guanine-nucleotide-exchange factors ( GEFs) for the small GTP-binding proteins Rap1 and Rap2 that are directly regulated by the second messenger cyclic AMP(1,2) and function in the control of diverse cellular processes, including cell adhesion and insulin secretion(3). Here we report the three-dimensional structure of full-length Epac2, a 110-kDa protein that contains an amino-terminal regulatory region with two cyclic-nucleotide-binding domains and a carboxy-terminal catalytic region. The structure was solved in the absence of cAMP and shows the auto-inhibited state of Epac. The regulatory region is positioned with respect to the catalytic region by a rigid, tripartite beta-sheet-like structure we refer to as the 'switchboard' and an ionic interaction we call the 'ionic latch'. As a consequence of this arrangement, the access of Rap to the catalytic site is sterically blocked. Mutational analysis suggests a model for cAMP-induced Epac activation with rigid body movement of the regulatory region, the features of which are universally conserved in cAMP-regulated proteins.	Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; Univ Med Ctr Utrecht, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands; Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute; Netherlands Cancer Institute; Max Planck Society	Bos, JL (corresponding author), Univ Med Ctr Utrecht, Dept Physiol Chem, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	J.L.Bos@med.uu.nl						Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Canaves JM, 2002, J MOL EVOL, V54, P17, DOI 10.1007/s00239-001-0013-1; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Liao YH, 1999, J BIOL CHEM, V274, P37815, DOI 10.1074/jbc.274.53.37815; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Rehmann H, 2003, J BIOL CHEM, V278, P23508, DOI 10.1074/jbc.M301680200; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	20	161	163	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2006	439	7076					625	628		10.1038/nature04468	http://dx.doi.org/10.1038/nature04468			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008IO	16452984				2022-12-24	WOS:000235033900049
J	Feske, S; Gwack, Y; Prakriya, M; Srikanth, S; Puppel, SH; Tanasa, B; Hogan, PG; Lewis, RS; Daly, M; Rao, A				Feske, S; Gwack, Y; Prakriya, M; Srikanth, S; Puppel, SH; Tanasa, B; Hogan, PG; Lewis, RS; Daly, M; Rao, A			A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function	NATURE			English	Article							T-CELL-RECEPTOR; SEVERE COMBINED IMMUNODEFICIENCY; ANHIDROTIC ECTODERMAL DYSPLASIA; ACTIVATED CALCIUM-CHANNEL; KAPPA-B; LINKAGE ANALYSIS; PORE PROPERTIES; NUCLEAR-FACTOR; CA2+ CHANNELS; I-CRAC	Antigen stimulation of immune cells triggers Ca(2+) entry through Ca(2+) release-activated Ca(2+) ( CRAC) channels, promoting the immune response to pathogens by activating the transcription factor NFAT. We have previously shown that cells from patients with one form of hereditary severe combined immune deficiency ( SCID) syndrome are defective in store-operated Ca(2+) entry and CRAC channel function. Here we identify the genetic defect in these patients, using a combination of two unbiased genome-wide approaches: a modified linkage analysis with single-nucleotide polymorphism arrays, and a Drosophila RNA interference screen designed to identify regulators of store-operated Ca(2+) entry and NFAT nuclear import. Both approaches converged on a novel protein that we call Orai1, which contains four putative transmembrane segments. The SCID patients are homozygous for a single missense mutation in ORAI1, and expression of wild-type Orai1 in SCID T cells restores store-operated Ca(2+) influx and the CRAC current ( I CRAC). We propose that Orai1 is an essential component or regulator of the CRAC channel complex.	Harvard Univ, Sch Med, Ctr Blood Res, Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Northwestern Univ, Feinberg Sch Med, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Broad Inst, Cambridge, MA 02139 USA; MIT, Broad Inst, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Northwestern University; Feinberg School of Medicine; Stanford University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Rao, A (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Inst Biomed Res, 200 Longwood Ave, Boston, MA 02115 USA.	arao@cbr.med.harvard.edu	Feske, stefan/ABB-3554-2021	Feske, stefan/0000-0001-5431-8178; Lewis, Richard/0000-0002-6010-7403; Puppel, Sven-Holger/0000-0003-2745-5120; Prakriya, Murali/0000-0003-0781-4480	NIGMS NIH HHS [R01 GM045374] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045374] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Armknecht S, 2005, METHOD ENZYMOL, V392, P55, DOI 10.1016/S0076-6879(04)92004-6; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Courtois G, 2003, J CLIN INVEST, V112, P1108, DOI 10.1172/JCI200318714; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Cui J, 2002, J BIOL CHEM, V277, P47175, DOI 10.1074/jbc.M205870200; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Feske S, 2003, BIOCHEM BIOPH RES CO, V311, P1117, DOI 10.1016/j.bbrc.2003.09.174; Feske S, 2000, IMMUNOBIOLOGY, V202, P134, DOI 10.1016/S0171-2985(00)80060-1; Feske S, 2000, J IMMUNOL, V165, P297, DOI 10.4049/jimmunol.165.1.297; Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; GWACK Y, 2006, NATURE          0301, DOI DOI 10.1038/NATURE04631; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Homer, 1990, ILIAD; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Kanno T, 1996, J IMMUNOL, V157, P5277; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEDEIST F, 1995, BLOOD, V85, P1053, DOI 10.1182/blood.V85.4.1053.bloodjournal8541053; LeppleWienhues A, 1996, BIOPHYS J, V71, P787, DOI 10.1016/S0006-3495(96)79278-0; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Leykin I, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-7; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Mori Y, 2002, J EXP MED, V195, P673, DOI 10.1084/jem.20011758; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Putney JW, 2005, J CELL BIOL, V169, P381, DOI 10.1083/jcb.200503161; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schlesier M, 1993, Immunodeficiency, V4, P133; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; Smahi A, 2002, HUM MOL GENET, V11, P2371, DOI 10.1093/hmg/11.20.2371; STEWART M, 2005, GREEK MYTHOLOGY ILIA; Voets T, 2001, J BIOL CHEM, V276, P47767, DOI 10.1074/jbc.C100607200; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	47	1711	1777	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 11	2006	441	7090					179	185		10.1038/nature04702	http://dx.doi.org/10.1038/nature04702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16582901				2022-12-24	WOS:000237418800037
J	Lavallo, V; Canac, Y; Donnadieu, B; Schoeller, WW; Bertrand, G				Lavallo, V; Canac, Y; Donnadieu, B; Schoeller, WW; Bertrand, G			Cyclopropenylidenes: From interstellar space to an isolated derivative in the laboratory	SCIENCE			English	Article							FUNCTIONAL CYCLO C-3-DERIVATIVES; HETEROCYCLIC CARBENES; C3H2 ISOMERS; SE REACTIONS; SMALL RINGS; IDENTIFICATION; DIAMINOCARBENES; ATTACK	Like many of the molecular species that have been detected in the interstellar medium, the singlet carbene cyclopropenylidene (C3H2) has been presumed to be too unstable to isolate in the laboratory. However, by appending pi-electron-donating amino groups to the triangular skeleton, we prepared a cyclopropenylidene derivative that is stable at room temperature. In contrast to previously isolated carbenes, this compound does not require a heteroatom adjacent to the electron-deficient carbon to confer stability. Despite the presence of amino groups, the geometric parameters of the cyclic skeleton, revealed by x-ray crystallography, are only slightly perturbed relative to those of the calculated structure of unsubstituted cyclopropenylidene. Stable cyclopropenylidene derivatives might thus serve as models for a better understanding of the formation of carbon-bearing molecules in the interstellar medium.	Univ Calif Riverside, CNRS,Unite Mixte Int 2957, Joint Res Chem Lab, Dept Chem, Riverside, CA 92521 USA; Univ Bielefeld, Fak Chem, D-33615 Bielefeld, Germany	University of California System; University of California Riverside; University of Bielefeld	Bertrand, G (corresponding author), Univ Calif Riverside, CNRS,Unite Mixte Int 2957, Joint Res Chem Lab, Dept Chem, Riverside, CA 92521 USA.	gbertran@mail.ucr.edu	Schoeller, Wolfgang W/A-5755-2011		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068825] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM068825-01A2, R01 GM068825, R01 GM 68825] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alder RW, 2004, ANGEW CHEM INT EDIT, V43, P5896, DOI 10.1002/anie.200400654; Alder RW, 1996, ANGEW CHEM INT EDIT, V35, P1121, DOI 10.1002/anie.199611211; ARDUENGO AJ, 1991, J AM CHEM SOC, V113, P361, DOI 10.1021/ja00001a054; ARDUENGO AJ, 1995, J AM CHEM SOC, V117, P11027, DOI 10.1021/ja00149a034; Bourissou D, 2000, CHEM REV, V100, P39, DOI 10.1021/cr940472u; BRESLOW R, 1957, J AM CHEM SOC, V79, P5318, DOI 10.1021/ja01576a067; Brinker U.H., 2001, ADV CARBENE CHEM; Driess M, 1996, ANGEW CHEM INT EDIT, V35, P829; Hahn FE, 2006, ANGEW CHEM INT EDIT, V45, P1348, DOI 10.1002/anie.200503858; Halton B, 2005, EUR J ORG CHEM, V2005, P3391, DOI 10.1002/ejoc.200500231; HEINEMANN C, 1994, CHEM PHYS LETT, V217, P11, DOI 10.1016/0009-2614(93)E1360-S; IGAU A, 1988, J AM CHEM SOC, V110, P6463, DOI 10.1021/ja00227a028; Itoh T, 2006, J AM CHEM SOC, V128, P957, DOI 10.1021/ja056575j; Jones M. Jr., 2004, REACTIVE INTERMEDIAT, P273; Kaiser RI, 2002, CHEM REV, V102, P1309, DOI 10.1021/cr970004v; Kirmse W, 2004, ANGEW CHEM INT EDIT, V43, P1767, DOI 10.1002/anie.200301729; Komatsu K, 2003, CHEM REV, V103, P1371, DOI 10.1021/cr010011q; MAIER G, 1994, J AM CHEM SOC, V116, P2014, DOI 10.1021/ja00084a047; Nyulaszi L, 1998, J MOL STRUC-THEOCHEM, V453, P91, DOI 10.1016/S0166-1280(98)00190-0; OFELE K, 1968, ANGEW CHEM INT EDIT, V7, P950, DOI 10.1002/anie.196809501; Peris E, 2004, COORDIN CHEM REV, V248, P2239, DOI 10.1016/j.ccr.2004.04.014; REISENAUER HP, 1984, ANGEW CHEM INT EDIT, V23, P641, DOI 10.1002/anie.198406411; Schumann H, 1997, ANGEW CHEM INT EDIT, V36, P2232, DOI 10.1002/anie.199722321; Scott NM, 2005, EUR J INORG CHEM, P1815; Seburg RA, 1997, J AM CHEM SOC, V119, P5847, DOI 10.1021/ja9638869; Taatjes CA, 2005, PHYS CHEM CHEM PHYS, V7, P806, DOI 10.1039/b417160h; TAMM M, 1995, J ORGANOMET CHEM, V501, P309, DOI 10.1016/0022-328X(95)05702-Q; THADDEUS P, 1985, ASTROPHYS J, V299, pL63, DOI 10.1086/184581; WEISS R, 1978, ANGEW CHEM INT EDIT, V17, P445, DOI 10.1002/anie.197804451; WEISS R, 1978, ANGEW CHEM INT EDIT, V17, P446, DOI 10.1002/anie.197804461; WEISS R, 1979, ANGEW CHEM INT EDIT, V18, P473, DOI 10.1002/anie.197904731; YOSHIDA Z, 1982, PURE APPL CHEM, V54, P1059, DOI 10.1351/pac198254051059	32	202	202	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					722	724		10.1126/science.1126675	http://dx.doi.org/10.1126/science.1126675			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	039NF	16614171	Green Accepted			2022-12-24	WOS:000237312100043
J	Whetstine, JR; Nottke, A; Lan, F; Huarte, M; Smolikov, S; Chen, ZZ; Spooner, E; Li, E; Zhang, GY; Colaiacovo, M; Shi, Y				Whetstine, Johnathan R.; Nottke, Amanda; Lan, Fei; Huarte, Maite; Smolikov, Sarit; Chen, Zhongzhou; Spooner, Eric; Li, En; Zhang, Gongyi; Colaiacovo, Monica; Shi, Yang			Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases	CELL			English	Article							DAMAGE-INDUCED APOPTOSIS; RNA-POLYMERASE-II; CAENORHABDITIS-ELEGANS; C-ELEGANS; DNA-DAMAGE; H3 METHYLATION; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTIONAL ELONGATION; COVALENT MODIFICATIONS; MAMMALIAN CHROMATIN	Histone methylation regulates chromatin structure, transcription, and epigenetic state of the cell. Histone methylation is dynamically regulated by histone methylases and demethylases such as LSD1 and JHDM1, which mediate demethylation of di- and monomethylated histones. It has been unclear whether demethylases exist that reverse lysine trimethylation. We show the JmjC domain-containing protein JMJD2A reversed trimethylated H3-K9/K36 to di- but not mono- or unmethylated products. Overexpression of JMJD2A but not a catalytically inactive mutant reduced H3-K9/K36 trimethylation levels in cultured cells. In contrast, RNAi depletion of the C. elegans JMJD2A homolog resulted in an increase in general H3-K9Me3 and localized H3-K36Me3 levels on meiotic chromosomes and triggered p53-dependent germline apoptosis. Additionally, other human JMJD2 subfamily members also functioned as trimethylation-specific demethylases, converting H3-K9Me3 to H3-K9Me2 and H3-K9Me1, respectively. Our finding that this family of demethylases generates different methylated states at the same lysine residue provides a mechanism for fine-tuning histone methylation.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; MIT, Whitehead Inst, Nine Cambridge Ctr, Cambridge, MA 02142 USA; Novartis Biomed Res Inst, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Massachusetts Institute of Technology (MIT); Whitehead Institute; Novartis	Shi, Y (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	yang_shi@hms.harvard.edu	chen, zhong/E-3900-2015; Huarte, Maite/J-6903-2014	chen, zhong/0000-0003-1319-9664; Huarte, Maite/0000-0003-3753-6493	NIAID NIH HHS [R37 AI033456] Funding Source: Medline; NIGMS NIH HHS [GM 072551, GM 58012, GM 071004] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071004, R01GM072551] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alpi A, 2003, CHROMOSOMA, V112, P6, DOI 10.1007/s00412-003-0237-5; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bean CJ, 2004, NAT GENET, V36, P100, DOI 10.1038/ng1283; BRENNER S, 1974, GENETICS, V77, P71; BYVOET P, 1972, ARCH BIOCHEM BIOPHYS, V148, P558, DOI 10.1016/0003-9861(72)90174-9; Canaani E, 2004, BRIT J CANCER, V90, P756, DOI 10.1038/sj.bjc.6601639; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Clissold PM, 2001, TRENDS BIOCHEM SCI, V26, P7, DOI 10.1016/S0968-0004(00)01700-X; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Ehrbrecht A, 2006, J PATHOL, V208, P554, DOI 10.1002/path.1925; Felsenstein J, 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fong YY, 2002, SCIENCE, V296, P2235, DOI 10.1126/science.1070790; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gray SG, 2005, J BIOL CHEM, V280, P28507, DOI 10.1074/jbc.M413687200; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hake SB, 2004, BRIT J CANCER, V90, P761, DOI 10.1038/sj.bjc.6601575; Hess JL, 2004, CRIT REV EUKAR GENE, V14, P235, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.10; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Jaju RJ, 2001, BLOOD, V98, P1264, DOI 10.1182/blood.V98.4.1264; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Katoh M, 2004, INT J ONCOL, V24, P1623; Kelly KO, 2000, GENETICS, V156, P617; Kelly WG, 2002, DEVELOPMENT, V129, P479; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; KIM J, 2006, IN PRESS EMBO REP; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee C, 2003, J BIOL CHEM, V278, P7558, DOI 10.1074/jbc.M210385200; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Piacentini L, 2003, J CELL BIOL, V161, P707, DOI 10.1083/jcb.200303012; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; POGRIBNY IP, IN PRESS CARCINOGENE; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Reuben M, 2002, DEV BIOL, V245, P71, DOI 10.1006/dbio.2002.0634; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Rinaldo C, 1998, MOL GEN GENET, V260, P289, DOI 10.1007/s004380050897; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Sarmento OF, 2004, J CELL SCI, V117, P4449, DOI 10.1242/jcs.01328; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Schaner CE, 2003, DEV CELL, V5, P747, DOI 10.1016/S1534-5807(03)00327-7; Schaner CE, 2006, GERMLINE CHROMATIN; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta Gunnar, 2004, Novartis Found Symp, V259, P22; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Stergiou L, 2004, CELL DEATH DIFFER, V11, P21, DOI 10.1038/sj.cdd.4401340; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Takanami T, 1998, DNA Res, V5, P373, DOI 10.1093/dnares/5.6.373; Thomas CE, 2006, J PROTEOME RES, V5, P240, DOI 10.1021/pr050266a; THOMAS G, 1972, H-S Z PHYSIOL CHEM, V353, P1423, DOI 10.1515/bchm2.1972.353.2.1423; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Yang ZQ, 2000, CANCER RES, V60, P4735; Yeo S, 2005, MOL CELLS, V20, P423; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang DZ, 2005, MOL CELL BIOL, V25, P6404, DOI 10.1128/MCB.25.15.6404-6414.2005; Zhang KL, 2004, PROTEOMICS, V4, P3765, DOI 10.1002/pmic.200400819; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	88	765	810	3	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					467	481		10.1016/j.cell.2006.03.028	http://dx.doi.org/10.1016/j.cell.2006.03.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16603238	Bronze			2022-12-24	WOS:000237506100014
J	Ngo, VN; Davis, RE; Lamy, L; Yu, X; Zhao, H; Lenz, G; Lam, LT; Dave, S; Yang, LM; Powell, J; Staudt, LM				Ngo, VN; Davis, RE; Lamy, L; Yu, X; Zhao, H; Lenz, G; Lam, LT; Dave, S; Yang, LM; Powell, J; Staudt, LM			A loss-of-function RNA interference screen for molecular targets in cancer	NATURE			English	Article							NF-KAPPA-B; CELL LYMPHOMA; HODGKIN LYMPHOMA; GENETIC SCREEN; MALT LYMPHOMA; ACTIVATION; BCL10; CARMA1; KINASE; TUMORIGENICITY	The pursuit of novel therapeutic agents in cancer relies on the identification and validation of molecular targets. Hallmarks of cancer include self-sufficiency in growth signals and evasion from apoptosis(1); genes that regulate these processes may be optimal for therapeutic attack. Here we describe a loss-of-function screen for genes required for the proliferation and survival of cancer cells using an RNA interference library. We used a doxycycline-inducible retroviral vector for the expression of small hairpin RNAs (shRNAs) to construct a library targeting 2,500 human genes. We used retroviral pools from this library to infect cell lines representing two distinct molecular subgroups of diffuse large B-cell lymphoma (DLBCL), termed activated B-cell-like DLBCL and germinal centre B-cell-like DLBCL. Each vector was engineered to contain a unique 60-base-pair 'bar code', allowing the abundance of an individual shRNA vector within a population of transduced cells to be measured using microarrays of the bar-code sequences. We observed that a subset of shRNA vectors was depleted from the transduced cells after three weeks in culture only if shRNA expression was induced. In activated B-cell-like DLBCL cells, but not germinal centre B-cell-like DLBCL cells, shRNAs targeting the NF-kappa B pathway were depleted, in keeping with the essential role of this pathway in the survival of activated B-cell-like DLBCL. This screen uncovered CARD11 as a key upstream signalling component responsible for the constitutive I kappa B kinase activity in activated B-cell-like DLBCL. The methodology that we describe can be used to establish a functional taxonomy of cancer and help reveal new classes of therapeutic targets distinct from known oncogenes.	NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; CIT, Bioinformat & Mol Anal Sect, Computat Biosci & Engn Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Staudt, Louis/AAC-5324-2019; Lenz, Georg/I-6844-2012	Ngo, Vu/0000-0002-9501-6990	Intramural NIH HHS Funding Source: Medline; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000260, Z01CT000260] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01SC004024] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Lam LT, 2005, CLIN CANCER RES, V11, P28; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	30	486	529	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					106	110		10.1038/nature04687	http://dx.doi.org/10.1038/nature04687			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16572121				2022-12-24	WOS:000237248600042
J	Riedel, CG; Katis, VL; Katou, Y; Mori, S; Itoh, T; Helmhart, W; Galova, M; Petronczki, M; Gregan, J; Cetin, B; Mudrak, I; Ogris, E; Mechtler, K; Pelletier, L; Buchholz, F; Shirahige, K; Nasmyth, K				Riedel, CG; Katis, VL; Katou, Y; Mori, S; Itoh, T; Helmhart, W; Galova, M; Petronczki, M; Gregan, J; Cetin, B; Mudrak, I; Ogris, E; Mechtler, K; Pelletier, L; Buchholz, F; Shirahige, K; Nasmyth, K			Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis I	NATURE			English	Article							FISSION YEAST; CHROMOSOME SEGREGATION; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; REGULATORY SUBUNITS; HUMAN OOCYTES; KINASE CDC5; MORPHOGENESIS; HOMOLOGS; MEI-S332	Segregation of homologous maternal and paternal centromeres to opposite poles during meiosis I depends on post-replicative crossing over between homologous non-sister chromatids, which creates chiasmata and therefore bivalent chromosomes. Destruction of sister chromatid cohesion along chromosome arms due to proteolytic cleavage of cohesin's Rec8 subunit by separase resolves chiasmata and thereby triggers the first meiotic division. This produces univalent chromosomes, the chromatids of which are held together by centromeric cohesin that has been protected from separase by shugoshin (Sgo1/MEI-S332) proteins. Here we show in both fission and budding yeast that Sgo1 recruits to centromeres a specific form of protein phosphatase 2A (PP2A). Its inactivation causes loss of centromeric cohesin at anaphase I and random segregation of sister centromeres at the second meiotic division. Artificial recruitment of PP2A to chromosome arms prevents Rec8 phosphorylation and hinders resolution of chiasmata. Our data are consistent with the notion that efficient cleavage of Rec8 requires phosphorylation of cohesin and that this is blocked by PP2A at meiosis I centromeres.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Tokyo Inst Technol, Lab Genome Struct & Funct, Div Gene Res, Ctr Biol Resources & Informat,Midori Ku, Yokohama, Kanagawa 2268501, Japan; Mitsubishi Res Inst Inc, Adv Sci & Technol Res Ctr, Chiyoda Ku, Tokyo 1008141, Japan; Med Univ Vienna, Dept Biochem Med, Max F Perutz Labs, Vienna Bioctr, A-1030 Vienna, Austria; MPI CBG, D-01307 Dresden, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Tokyo Institute of Technology; Mitsubishi Research Institute; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Max Planck Society	Nasmyth, K (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	kim.nasmyth@bioch.ox.ac.uk	Mechtler, Karl/AAF-2717-2019; Gregan, Juraj/I-4161-2014; Itoh, Takehiko/E-8873-2014; Pelletier, Laurence/F-8858-2013; Buchholz, Frank/B-4700-2017	Mechtler, Karl/0000-0002-3392-9946; Gregan, Juraj/0000-0002-2989-8374; Itoh, Takehiko/0000-0002-6113-557X; Buchholz, Frank/0000-0002-4577-3344; Ogris, Egon/0000-0001-5950-9264; Shirahige, Katsuhiko/0000-0002-7862-1144; Riedel, Christian/0000-0002-3689-8022; Nasmyth, Kim/0000-0001-7030-4403; Petronczki, Mark/0000-0003-0139-5692				Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Angell R, 1997, AM J HUM GENET, V61, P23, DOI 10.1086/513890; Bernard P, 2001, NAT CELL BIOL, V3, P522, DOI 10.1038/35074598; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Izawa D, 2005, NATURE, V434, P529, DOI 10.1038/nature03406; Jiang W, 2000, GENETICS, V154, P1025; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; KERREBROCK AW, 1995, CELL, V83, P247, DOI 10.1016/0092-8674(95)90166-3; Kinoshita K, 1996, GENES CELLS, V1, P29, DOI 10.1046/j.1365-2443.1996.02002.x; KINOSHITA N, 1993, GENE DEV, V7, P1059, DOI 10.1101/gad.7.6.1059; KINOSHITA N, 1990, CELL, V63, P405, DOI 10.1016/0092-8674(90)90173-C; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; Kitajima TS, 2003, SCIENCE, V300, P1152, DOI 10.1126/science.1083634; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Kuliev Anver, 2003, Reprod Biomed Online, V6, P54; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Mailhes JB, 2003, CHROMOSOME RES, V11, P619, DOI 10.1023/A:1024909119593; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Meluh PB, 1997, GENE DEV, V11, P3401, DOI 10.1101/gad.11.24.3401; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Nasmyth K, 2005, PHILOS T R SOC B, V360, P483, DOI 10.1098/rstb.2004.1604; Pellestor F, 2003, HUM GENET, V112, P195, DOI 10.1007/s00439-002-0852-x; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; RONNE H, 1991, MOL CELL BIOL, V11, P4876, DOI 10.1128/MCB.11.10.4876; SHIMODA C, 1985, MOL GEN GENET, V200, P252, DOI 10.1007/BF00425432; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Yamamoto M, 1996, TRENDS BIOCHEM SCI, V21, P18, DOI 10.1016/0968-0004(96)80880-2; Yokobayashi S, 2003, MOL CELL BIOL, V23, P3965, DOI 10.1128/MCB.23.11.3965-3973.2003; Yu HG, 2005, CELL, V123, P397, DOI 10.1016/j.cell.2005.09.014; Zhao Y, 1997, J BIOL CHEM, V272, P8256, DOI 10.1074/jbc.272.13.8256	46	350	357	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2006	441	7089					53	61		10.1038/nature04664	http://dx.doi.org/10.1038/nature04664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16541024				2022-12-24	WOS:000237248600030
J	Koglin, A; Mofid, MR; Lohr, F; Schafer, B; Rogov, VV; Blum, MM; Mittag, T; Marahiel, MA; Bernhard, F; Dotsch, V				Koglin, A; Mofid, MR; Lohr, F; Schafer, B; Rogov, VV; Blum, MM; Mittag, T; Marahiel, MA; Bernhard, F; Dotsch, V			Conformational switches modulate protein interactions in peptide antibiotic synthetases	SCIENCE			English	Article							ACYL CARRIER PROTEIN; FATTY-ACID SYNTHASE; MUTATIONAL ANALYSIS; TRANSFERASES; RECOGNITION; DYNAMICS; SFP; ARCHITECTURE; SUPERFAMILY; RESOLUTION	Protein dynamics plays an important role in protein function. Many functionally important motions occur on the microsecond and low millisecond time scale and can be characterized by nuclear magnetic resonance relaxation experiments. We describe the different states of a peptidyl carrier protein (PCP) that play a crucial role in its function as a peptide shuttle in the nonribosomal peptide synthetases of the tyrocidine A system. Both apo-PCP ( without the bound 4'-phosphopantetheine cofactor) and holo-PCP exist in two different stable conformations. We show that one of the apo conformations and one of the holo conformations are identical, whereas the two remaining conformations are only detectable by nuclear magnetic resonance spectroscopy in either the apo or holo form. We further demonstrate that this conformational diversity is an essential prerequisite for the directed movement of the 4'-PP cofactor and its interaction with externally acting proteins such as thioesterases and 4'-PP transferase.	Univ Frankfurt, BMRZ, Inst Biophys Chem, D-60439 Frankfurt, Germany; Univ Marburg, Fachbereich Chem Biochem, D-35032 Marburg, Germany; Inst Prot Res, Pushchino, Russia	Goethe University Frankfurt; Philipps University Marburg	Dotsch, V (corresponding author), Univ Frankfurt, BMRZ, Inst Biophys Chem, Marie Curie Str, D-60439 Frankfurt, Germany.	vdoetsch@em.uni-frankfurt.de	Blum, Marc-Michael/M-7691-2014; Doetsch, Volker/D-5697-2011	Blum, Marc-Michael/0000-0003-1856-2071; Bernhard, Frank/0000-0002-4860-1783; mofid, mohammad reza/0000-0002-0347-8152; Dotsch, Volker/0000-0001-5720-212X; Mittag, Tanja/0000-0002-1827-3811				ANDREC M, 1995, PROTEIN SCI, V4, P983; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Finking R, 2004, BIOCHEMISTRY-US, V43, P8946, DOI 10.1021/bi0496891; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; KIM Y, 1989, BIOCHEMISTRY-US, V28, P8792, DOI 10.1021/bi00448a017; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Mittag T, 2003, BIOCHEMISTRY-US, V42, P11128, DOI 10.1021/bi0347499; Mofid MR, 2004, BIOCHEMISTRY-US, V43, P4128, DOI 10.1021/bi036013h; Mofid MR, 2002, J BIOL CHEM, V277, P17023, DOI 10.1074/jbc.M200120200; Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Reed MAC, 2003, ORG BIOMOL CHEM, V1, P463, DOI 10.1039/b208941f; Reuter K, 1999, EMBO J, V18, P6823, DOI 10.1093/emboj/18.23.6823; Schwarzer D, 2002, P NATL ACAD SCI USA, V99, P14083, DOI 10.1073/pnas.212382199; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Stachelhaus T, 1996, CHEM BIOL, V3, P913, DOI 10.1016/S1074-5521(96)90180-5; Stein T, 1996, J BIOL CHEM, V271, P15428, DOI 10.1074/jbc.271.26.15428; VANGUNSTEREN WF, 1995, COMPUT PHYS COMMUN, V91, P305, DOI 10.1016/0010-4655(95)00055-K; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Weber T, 2000, STRUCT FOLD DES, V8, P407, DOI 10.1016/S0969-2126(00)00120-9; Wong HC, 2002, J BIOL CHEM, V277, P15874, DOI 10.1074/jbc.M112300200; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	27	122	125	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					273	276		10.1126/science.1122928	http://dx.doi.org/10.1126/science.1122928			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614225				2022-12-24	WOS:000236765300051
J	Reich, PB; Hobbie, SE; Lee, T; Ellsworth, DS; West, JB; Tilman, D; Knops, JMH; Naeem, S; Trost, J				Reich, PB; Hobbie, SE; Lee, T; Ellsworth, DS; West, JB; Tilman, D; Knops, JMH; Naeem, S; Trost, J			Nitrogen limitation constrains sustainability of ecosystem response to CO2	NATURE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; ELEVATED CO2; PLANT DIVERSITY; GRASSLAND RESPONSES; FOREST ECOSYSTEMS; FERTILE GRASSLAND; LONG-TERM; SOIL; PHOTOSYNTHESIS; GROWTH	Enhanced plant biomass accumulation in response to elevated atmospheric CO2 concentration could dampen the future rate of increase in CO2 levels and associated climate warming. However, it is unknown whether CO2-induced stimulation of plant growth and biomass accumulation will be sustained or whether limited nitrogen (N) availability constrains greater plant growth in a CO2-enriched world(1-9). Here we show, after a six-year field study of perennial grassland species grown under ambient and elevated levels of CO2 and N, that low availability of N progressively suppresses the positive response of plant biomass to elevated CO2. Initially, the stimulation of total plant biomass by elevated CO2 was no greater at enriched than at ambient N supply. After four to six years, however, elevated CO2 stimulated plant biomass much less under ambient than enriched N supply. This response was consistent with the temporally divergent effects of elevated CO2 on soil and plant N dynamics at differing levels of N supply. Our results indicate that variability in availability of soil N and deposition of atmospheric N are both likely to influence the response of plant biomass accumulation to elevated atmospheric CO2. Given that limitations to productivity resulting from the insufficient availability of N are widespread in both unmanaged and managed vegetation(5,7-9), soil N supply is probably an important constraint on global terrestrial responses to elevated CO2.	Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Wisconsin, Dept Biol, Eau Claire, WI 54701 USA; Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Lincoln; Columbia University	Reich, PB (corresponding author), Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA.	preich@umn.edu	Tilman, David/ABD-5309-2021; Knops, Johannes/AAA-8546-2020; West, Jason B/G-8833-2012	Lee, Tali/0000-0002-3933-6607; Ellsworth, David/0000-0002-9699-2272; Trost, Jared/0000-0003-0431-2151; West, Jason/0000-0002-7811-8020; Reich, Peter/0000-0003-4424-662X; Hobbie, Sarah/0000-0001-5159-031X				Cannell MGR, 1998, GLOBAL CHANGE BIOL, V4, P431, DOI 10.1046/j.1365-2486.1998.00167.x; Craine JM, 2001, GLOBAL CHANGE BIOL, V7, P947, DOI 10.1046/j.1354-1013.2001.00455.x; Dijkstra FA, 2005, PLANT SOIL, V272, P41, DOI 10.1007/s11104-004-3848-6; Finzi AC, 2003, ECOSYSTEMS, V6, P444, DOI 10.1007/s10021-003-0205-1; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Gill RA, 2002, NATURE, V417, P279, DOI 10.1038/417279a; Hungate BA, 2004, SCIENCE, V304, P1291, DOI 10.1126/science.1095549; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; Lee TD, 2001, NEW PHYTOL, V150, P405, DOI 10.1046/j.1469-8137.2001.00095.x; Lloyd J, 1996, FUNCT ECOL, V10, P4, DOI 10.2307/2390258; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; LUO Y, 1994, PLANT CELL ENVIRON, V17, P1195, DOI 10.1111/j.1365-3040.1994.tb02017.x; Luscher A, 2000, GLOB CHANGE BIOL, V6, P655, DOI 10.1046/j.1365-2486.2000.00345.x; McMurtrie RE, 2000, PLANT SOIL, V224, P135, DOI 10.1023/A:1004711707787; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; OWENSBY CE, 1994, PLANT SOIL, V165, P105, DOI 10.1007/BF00009967; Peterson AG, 1999, GLOB CHANGE BIOL, V5, P331, DOI 10.1046/j.1365-2486.1999.00234.x; Rastetter EB, 1997, ECOL APPL, V7, P444; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Reich PB, 2001, NEW PHYTOL, V150, P435, DOI 10.1046/j.1469-8137.2001.00114.x; Schneider MK, 2004, GLOBAL CHANGE BIOL, V10, P1377, DOI 10.1111/j.1365-2486.2004.00803.x; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Williams MA, 2000, PLANT SOIL, V227, P127, DOI 10.1023/A:1026590001307; Zak DR, 2003, ECOL APPL, V13, P1508, DOI 10.1890/03-5055; Zak DR, 2000, ECOL APPL, V10, P47, DOI 10.2307/2640985; Zanetti S, 1997, OECOLOGIA, V112, P17, DOI 10.1007/s004420050278	29	664	744	19	504	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 13	2006	440	7086					922	925		10.1038/nature04486	http://dx.doi.org/10.1038/nature04486			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612381	Green Published			2022-12-24	WOS:000236736700038
J	Kuiken, T; Osterhaus, A; Roeder, P				Kuiken, T; Osterhaus, A; Roeder, P			Feline friend or potential foe?	NATURE			English	Editorial Material							AVIAN INFLUENZA H5N1; CATS; SPREAD		Erasmus Med Ctr, Dept Virol, Rotterdam, Netherlands; UN, Food & Agr Org, Anim Prod & Hlth Div, Rome, Italy	Erasmus University Rotterdam; Erasmus MC; Food & Agriculture Organization of the United Nations (FAO)	Kuiken, T (corresponding author), Erasmus Med Ctr, Dept Virol, Rotterdam, Netherlands.		Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869; Kuiken, Thijs/0000-0001-5501-9049; Osterhaus, Albert/0000-0002-6074-1172				Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Butler D, 2006, NATURE, V440, P135, DOI 10.1038/440135a; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; Kuiken T, 2004, SCIENCE, V306, P241, DOI 10.1126/science.1102287; Munster VJ, 2006, SCIENCE; Rimmelzwaan GF, 2006, AM J PATHOL, V168, P176, DOI 10.2353/ajpath.2006.050466; Songserm T, 2006, EMERG INFECT DIS, V12, P681, DOI 10.3201/eid1204.051396; Thanawongnuwech R, 2005, EMERG INFECT DIS, V11, P699, DOI 10.3201/eid1105.050007	8	34	38	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2006	440	7085					741	742		10.1038/440741a	http://dx.doi.org/10.1038/440741a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598234				2022-12-24	WOS:000236548400019
J	Brown, MD				Brown, MD			Enterobius vermicularis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Rush Univ, Med Ctr, Chicago, IL 60612 USA	Rush University	Brown, MD (corresponding author), Rush Univ, Med Ctr, Chicago, IL 60612 USA.								0	3	3	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2006	354	13					E12	E12		10.1056/NEJMicm040931	http://dx.doi.org/10.1056/NEJMicm040931			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026KO	16571876				2022-12-24	WOS:000236338000010
J	Ma, JF; Tamai, K; Yamaji, N; Mitani, N; Konishi, S; Katsuhara, M; Ishiguro, M; Murata, Y; Yano, M				Ma, JF; Tamai, K; Yamaji, N; Mitani, N; Konishi, S; Katsuhara, M; Ishiguro, M; Murata, Y; Yano, M			A silicon transporter in rice	NATURE			English	Article							GENE; AQUAPORINS; RESISTANCE; FAMILY	Silicon is beneficial to plant growth and helps plants to overcome abiotic and biotic stresses by preventing lodging ( falling over) and increasing resistance to pests and diseases, as well as other stresses(1-3). Silicon is essential for high and sustainable production of rice(4), but the molecular mechanism responsible for the uptake of silicon is unknown. Here we describe the Low silicon rice 1 (Lsi1) gene, which controls silicon accumulation in rice, a typical silicon-accumulating plant. This gene belongs to the aquaporin family(5) and is constitutively expressed in the roots. Lsi1 is localized on the plasma membrane of the distal side of both exodermis and endodermis cells, where casparian strips are located. Suppression of Lsi1 expression resulted in reduced silicon uptake. Furthermore, expression of Lsi1 in Xenopus oocytes showed transport activity for silicon only. The identification of a silicon transporter provides both an insight into the silicon uptake system in plants, and a new strategy for producing crops with high resistance to multiple stresses by genetic modification of the root's silicon uptake capacity.	Okayama Univ, Bioresources Res Inst, Kurashiki, Okayama 7100046, Japan; Inst Soc Technoinnovat Agr Forestry & Fisheries, Tsukuba, Ibaraki 3050854, Japan; Suntory Inst Bioorgan Res, Shimamoto, Osaka 6188503, Japan; Natl Inst Agrobiol Sci, Dept Mol Genet, Tsukuba, Ibaraki 3058602, Japan	Okayama University; Suntory Holdings Ltd; National Institute of Agrobiological Sciences - Japan	Ma, JF (corresponding author), Okayama Univ, Bioresources Res Inst, Chuo 2-20-1, Kurashiki, Okayama 7100046, Japan.	maj@rib.okayama-u.ac.jp	YAMAJI, Naoki/B-2524-2011; Ma, Jianfeng/GZB-0110-2022; Yano, Masahiro/AAC-5441-2019; Feng, Jian/C-7213-2009	YAMAJI, Naoki/0000-0002-7499-3004; Feng, Jian/0000-0003-3411-827X; Katsuhara, Maki/0000-0002-8264-3063; Yano, Masahiro/0000-0003-1510-4622				Casey WH, 2004, PLANT CELL ENVIRON, V27, P51, DOI 10.1046/j.0016-8025.2003.01124.x; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11; Fauteux F, 2005, FEMS MICROBIOL LETT, V249, P1, DOI 10.1016/j.femsle.2005.06.034; Helliwell CA, 2002, FUNCT PLANT BIOL, V29, P1217, DOI 10.1071/FP02033; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HILDEBRAND M, 1993, GENE, V132, P213, DOI 10.1016/0378-1119(93)90198-C; Hildebrand M, 1997, NATURE, V385, P688, DOI 10.1038/385688b0; Luu DT, 2005, PLANT CELL ENVIRON, V28, P85, DOI 10.1111/j.1365-3040.2004.01295.x; Ma J.F., 2002, SOIL FERTILIZER PLAN; Ma J. F., 2003, FERTILIZER, V94, P26; Ma JF, 2004, PLANT PHYSIOL, V136, P3284, DOI 10.1104/pp.104.047365; Ma JF, 2004, SOIL SCI PLANT NUTR, V50, P11, DOI 10.1080/00380768.2004.10408447; Ma JF, 2003, PLANT SOIL, V249, P383, DOI 10.1023/A:1022842421926; Ma JF, 2002, PLANT PHYSIOL, V130, P2111, DOI 10.1104/pp.010348; Ma JF, 2001, PLANT PHYSIOL, V127, P1773, DOI 10.1104/pp.010271; Mitani N, 2005, PLANT CELL PHYSIOL, V46, P279, DOI 10.1093/pcp/pci018; Raven J.A., 2001, SILICON AGR, P41, DOI DOI 10.1016/S0928-3420(01)80007-0; Richmond KE, 2003, CURR OPIN PLANT BIOL, V6, P268, DOI 10.1016/S1369-5266(03)00041-4; Savant NK, 1997, ADV AGRON, V58, P151; Sripanyakorn S, 2005, NUTR BULL, V30, P222, DOI 10.1111/j.1467-3010.2005.00507.x; Taiz L, 1998, PLANT PHYSIOL, P103; Takahashi E., 1990, Comments on Agricultural and Food Chemistry, V2, P99; Takahashi E., 1978, J SCI SOIL MANURE, V49, P357; Tallberg P, 2002, WATER RES, V36, P956, DOI 10.1016/S0043-1354(01)00312-8; Tamai K, 2003, NEW PHYTOL, V158, P431, DOI 10.1046/j.1469-8137.2003.00773.x; YOSHIDA SHOICHI, 1965, BULL NAT INST AGR SCI SER B [JAP], V15, P1	27	1055	1169	17	416	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					688	691		10.1038/nature04590	http://dx.doi.org/10.1038/nature04590			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572174				2022-12-24	WOS:000236350400048
J	Akala, FA; El-Saharty, S				Akala, FA; El-Saharty, S			Public-health challenges in the Middle East and North Africa	LANCET			English	Editorial Material									World Bank, Middle E & N Africa Reg, Human Dev Sector, Washington, DC 20433 USA	The World Bank	Akala, FA (corresponding author), World Bank, Middle E & N Africa Reg, Human Dev Sector, 1818 H St NW, Washington, DC 20433 USA.	fakala@worldbank.org						*HARV SCH PUBL HLT, GLOB BURD DIS PUBL S; Jenkins C, 2003, HIV AIDS MIDDLE E N; KHALEGIAN P, 2004, PUBLIC MANAGEMENT ES; *MIDD E FOR, 2002, AR COMP AR HUM DEV R; Peden M., 2004, WORLD REPORT ROAD TR; Pierre-Lewis A, 2004, PUBLIC HLTH MIDDLE E; [Population Reference Bureau Population Reference Bureau.], 2001, POP TRENDS CHALL MID; PRABHAT P, 2002, AM J PUBLIC HEALTH, V92, P1002; (The) World Bank, 2004, BETT GOV DEV MIDDL E; UNDP, 2005, AR HUM DEV REP 2004; *WORLD BANK, PUBL HLTH MIDDL E N; *WORLD BANK, IN PRESS SUST GAINS	12	47	49	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2006	367	9515					961	964		10.1016/S0140-6736(06)68402-X	http://dx.doi.org/10.1016/S0140-6736(06)68402-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028GE	16564342				2022-12-24	WOS:000236474200005
J	Betschinger, J; Mechtler, K; Knoblich, JA				Betschinger, J; Mechtler, K; Knoblich, JA			Asymmetric segregation of the tumor suppressor brat regulates self-renewal in Drosophila neural stem cells	CELL			English	Article							DAUGHTER-CELL; NEUROBLAST LINEAGES; AXONAL OUTGROWTH; PROTEIN; PROSPERO; DIVISION; LOCALIZATION; MIRANDA; IDENTIFICATION; PROLIFERATION	How stem cells generate both differentiating and self-renewing daughter cells is unclear. Here, we show that Drosophila larval neuroblasts-stem cell-like precursors of the adult brain-regulate proliferation by segregating the growth inhibitor Brat and the transcription factor Prospero into only one daughter cell. Like Prospero, Brat binds and cosegregates with the adaptor protein Miranda. In larval neuroblasts, both Brat and Prospero are required to inhibit self-renewal in one of the two daughter cells. While Prospero regulates cell-cycle gene transcription, Brat acts as a posttranscriptional inhibitor of dMyc. In brat or prospero mutants, both daughter cells grow and behave like neuroblasts leading to the formation of larval brain tumors. Similar defects are seen in lethal giant larvae, (Igl) mutants where Brat and Prospero are not asymmetric. We have identified a molecular mechanism that may control self-renewal and prevent tumor formation in other stem cells as well.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; Res Inst Mol Pathol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015; Mechtler, Karl/AAF-2717-2019	Knoblich, Juergen A/0000-0002-6751-3404; Mechtler, Karl/0000-0002-3392-9946; Betschinger, Joerg/0000-0002-2627-8479				Akong K, 2002, DEV BIOL, V250, P71, DOI 10.1006/dbio.2002.0777; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Arama E, 2000, ONCOGENE, V19, P3706, DOI 10.1038/sj.onc.1203706; Betschinger J, 2005, CURR BIOL, V15, P276, DOI 10.1016/j.cub.2005.01.012; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; Broadus J, 1998, NATURE, V391, P792, DOI 10.1038/35861; Cai Y, 2001, EMBO J, V20, P1704, DOI 10.1093/emboj/20.7.1704; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Ceron J, 2001, DEV BIOL, V230, P125, DOI 10.1006/dbio.2000.0110; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Frank DJ, 1998, J CELL BIOL, V140, P1321, DOI 10.1083/jcb.140.6.1321; Frank DJ, 2002, DEVELOPMENT, V129, P399; Fuerstenberg S, 1998, MOL CELL NEUROSCI, V12, P325, DOI 10.1006/mcne.1998.0724; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Grifoni D, 2004, ONCOGENE, V23, P8688, DOI 10.1038/sj.onc.1208023; HADORN E, 1938, REV SUISSE ZOOL, V46, P425; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Li L, 2000, GENE DEV, V14, P147; Liu TH, 2002, MECH DEVELOP, V112, P25, DOI 10.1016/S0925-4773(01)00626-8; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Luschnig S, 2004, GENETICS, V167, P325, DOI 10.1534/genetics.167.1.325; Matsuzaki F, 1998, DEVELOPMENT, V125, P4089; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Page SL, 2000, GENETICS, V155, P1757; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodriguez A, 1996, GENETICS, V143, P929; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Schimanski CC, 2005, ONCOGENE, V24, P3100, DOI 10.1038/sj.onc.1208520; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Shen CP, 1998, GENE DEV, V12, P1837, DOI 10.1101/gad.12.12.1837; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128	59	382	394	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1241	1253		10.1016/j.cell.2006.01.038	http://dx.doi.org/10.1016/j.cell.2006.01.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564014	Bronze			2022-12-24	WOS:000237241400023
J	Mayer, ML				Mayer, ML			Glutamate receptors at atomic resolution	NATURE			English	Review							PARTIAL AGONIST ACTION; LIGAND-BINDING; CRYSTAL-STRUCTURES; KAINATE RECEPTORS; STRUCTURAL BASIS; NMDA RECEPTORS; K+ CHANNELS; AMPA; MECHANISM; DESENSITIZATION	At synapses throughout the brain and spinal cord, the amino-acid glutamate is the major excitatory neurotransmitter. During evolution, a family of glutamate-receptor ion channels seems to have been assembled from a kit consisting of discrete ligand-binding, ion-channel, modulatory and cytoplasmic domains. Crystallographic studies that exploit this unique architecture have greatly aided structural analysis of the ligand-binding core, but the results also pose a formidable challenge, namely that of resolving the allosteric mechanisms by which individual domains communicate and function in an intact receptor.	Porter Neurosci Res Ctr, Bethesda, MD 20892 USA		Mayer, ML (corresponding author), Porter Neurosci Res Ctr, Bldg 35,Room 3B1002,35 Lincoln Dr, Bethesda, MD 20892 USA.	mayerm@mail.nih.gov	Mayer, Mark L/H-5500-2013; Mayer, Mark/AAE-7356-2019	Mayer, Mark/0000-0003-4378-8451	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000707] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000707] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arinaminpathy Y, 2006, MOL PHARMACOL, V69, P5, DOI 10.1124/mol.105.016691; Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Ayalon G, 2005, J BIOL CHEM, V280, P15053, DOI 10.1074/jbc.M408413200; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Balannik V, 2005, NEURON, V48, P279, DOI 10.1016/j.neuron.2005.09.024; Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; Beck C, 1999, NEURON, V22, P559, DOI 10.1016/S0896-6273(00)80710-2; Chen GQ, 1998, PROTEIN SCI, V7, P2623, DOI 10.1002/pro.5560071216; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Chen PE, 2005, MOL PHARMACOL, V67, P1470, DOI 10.1124/mol.104.008185; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; COLQUHOUN D, 1988, J PHYSIOL-LONDON, V395, P31; Erreger K, 2005, J NEUROSCI, V25, P7858, DOI 10.1523/JNEUROSCI.1613-05.2005; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hogner A, 2002, J MOL BIOL, V322, P93, DOI 10.1016/S0022-2836(02)00650-2; Hollmann M, 1999, HANDB EXP PHARM, V141, P3; Holm MM, 2005, J BIOL CHEM, V280, P35469, DOI 10.1074/jbc.M507800200; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2005, J NEUROSCI, V25, P9027, DOI 10.1523/JNEUROSCI.2567-05.2005; Klein RM, 2004, J NEUROSCI, V24, P4941, DOI 10.1523/JNEUROSCI.0660-04.2004; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; Kuner T, 2003, TRENDS NEUROSCI, V26, P27, DOI 10.1016/S0166-2236(02)00010-3; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; LAURIE DJ, 1994, EUR J PHARM-MOLEC PH, V268, P335, DOI 10.1016/0922-4106(94)90058-2; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Mamonova T, 2005, PHYS BIOL, V2, pS137, DOI 10.1088/1478-3975/2/4/S08; Mano I, 1996, J BIOL CHEM, V271, P15299, DOI 10.1074/jbc.271.26.15299; Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Panchenko VA, 2001, J GEN PHYSIOL, V117, P345, DOI 10.1085/jgp.117.4.345; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paoletti P, 1997, J NEUROSCI, V17, P5711; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; PERL TM, 1990, NEW ENGL J MED, V322, P1775, DOI 10.1056/NEJM199006213222504; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; PUCHALSKI RB, 1994, NEURON, V13, P131, DOI 10.1016/0896-6273(94)90464-2; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Schorge S, 2005, J PHYSIOL-LONDON, V569, P395, DOI 10.1113/jphysiol.2005.095349; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Sobolevsky AI, 2005, BIOPHYS J, V88, P235, DOI 10.1529/biophysj.104.049411; Sobolevsky AI, 2004, NEURON, V41, P367, DOI 10.1016/S0896-6273(04)00008-X; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Vissel B, 2002, MOL PHARMACOL, V61, P595, DOI 10.1124/mol.61.3.595; Watanabe J, 2002, J NEUROSCI, V22, P10209; Watkins JC, 2006, BRIT J PHARMACOL, V147, pS100, DOI 10.1038/sj.bjp.0706444; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	75	232	239	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					456	462		10.1038/nature04709	http://dx.doi.org/10.1038/nature04709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554805				2022-12-24	WOS:000236176100042
J	Mollicone, D; Eva, HD; Achard, F				Mollicone, D; Eva, HD; Achard, F			Ecology - Human role in Russian wild fires	NATURE			English	Editorial Material							PRODUCTS		Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, I-21020 Ispra, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site	Mollicone, D (corresponding author), Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, TP 440, I-21020 Ispra, Italy.	frederic.achard@jrc.it	EVA, Hugh D/F-8412-2011					ACHARD F, 2005, IDENTIFICATION HOT S; AKSENOV D, 2002, ATLAS RUSSIAS INTACT; Bartalev SA, 2003, INT J REMOTE SENS, V24, P1977, DOI 10.1080/0143116031000066297; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Dienes L, 2004, EURASIAN GEOGR ECON, V45, P319, DOI 10.2747/1538-7216.45.5.319; GOLDAMMER JG, 2003, INT FOREST FIRE NEWS, V29; Justice CO, 2002, REMOTE SENS ENVIRON, V83, P244, DOI 10.1016/S0034-4257(02)00076-7; Karpachevskiy M., 2004, FOREST FIRES RUSSIAN; Mouillot F, 2005, GLOBAL CHANGE BIOL, V11, P398, DOI 10.1111/j.1365-2486.2005.00920.x; Schiermeier Q, 2005, NATURE, V435, P732, DOI 10.1038/435732a; Sukhinin AI, 2004, REMOTE SENS ENVIRON, V93, P546, DOI 10.1016/j.rse.2004.08.011; Thompson DWJ, 2001, SCIENCE, V293, P85, DOI 10.1126/science.1058958	12	119	131	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					436	437		10.1038/440436a	http://dx.doi.org/10.1038/440436a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554800				2022-12-24	WOS:000236176100037
J	Migeon, BR				Migeon, BR			The role of X inactivation and cellular mosaicism in women's health and sex-specific diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LESCH-NYHAN-DISEASE; CHROMOSOME INACTIVATION; MONOZYGOTIC TWIN; CELLS; FEMALES; GENE; ADRENOLEUKODYSTROPHY; FIBROBLASTS; INFECTIONS; MUTATIONS	Sex-specific manifestations of disease are most often attributed to differences in the reproductive apparatus or in life experiences. However, a good deal of sex differences in health issues have their origins in the genes on the sex chromosomes themselves and in X inactivation - the developmental program that equalizes their expression in males and females. Most females are mosaics, having a mixture of cells expressing either their mother's or father's X-linked genes. Often, cell mosaicism is advantageous, ameliorating the deleterious effects of X-linked mutations and contributing to physiological diversity. As a consequence, most X-linked mutations produce male-only diseases. Yet, in some cases the dynamic interactions between cells in mosaic females lead to female-specific disease manifestations.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Migeon, BR (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, 459 Broadway Res Bldg,733 N Broadway, Baltimore, MD 21205 USA.	bmigeon@jhmi.edu						Azim E, 2005, P NATL ACAD SCI USA, V102, P16496, DOI 10.1073/pnas.0408456102; Bicocchi MP, 2005, EUR J HUM GENET, V13, P635, DOI 10.1038/sj.ejhg.5201386; Brix TH, 2005, J CLIN ENDOCR METAB, V90, P5949, DOI 10.1210/jc.2005-1366; BROOKS D, 2005, NY TIMES        1016, P12; COX RP, 1970, P NATL ACAD SCI USA, V67, P1573, DOI 10.1073/pnas.67.3.1573; De Gregorio L, 2005, MOL GENET METAB, V85, P70, DOI 10.1016/j.ymgme.2004.11.009; FRATANTONI JC, 1968, SCIENCE, V162, P570, DOI 10.1126/science.162.3853.570; LYON MF, 1962, AM J HUM GENET, V14, P135; Masuzaki H, 2004, EUR J OBSTET GYN R B, V117, P102, DOI 10.1016/j.ejogrb.2003.12.028; Mehta A, 2004, EUR J CLIN INVEST, V34, P236, DOI 10.1111/j.1365-2362.2004.01309.x; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P5066, DOI 10.1073/pnas.78.8.5066; Migeon BR, 1998, CYTOGENET CELL GENET, V80, P142, DOI 10.1159/000014971; Migeon BR, 2002, CYTOGENET GENOME RES, V99, P8, DOI 10.1159/000071568; MIGEON BR, 1978, GENETIC MOSAICS CHIM, P417; MIGEON BR, FEMALES ARE MOSAICS, V10; Moser H, 2004, CURR OPIN NEUROL, V17, P263, DOI 10.1097/00019052-200406000-00005; National Center for Biotechnology Information, OMIM ONL MEND INH MA OMIM ONL MEND INH MA; Ozbalkan Z, 2005, ARTHRITIS RHEUM-US, V52, P1564, DOI 10.1002/art.21026; OZCELIK T, IN PRESS EUR J HUM G; Plenge RM, 1997, NAT GENET, V17, P353, DOI 10.1038/ng1197-353; Puck JM, 1998, NEW ENGL J MED, V338, P325, DOI 10.1056/NEJM199801293380611; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; SCHMIDT M, 1992, AM J MED GENET, V42, P161, DOI 10.1002/ajmg.1320420205; Smallwood PM, 2003, P NATL ACAD SCI USA, V100, P11706, DOI 10.1073/pnas.1934712100; Stewart JJ, 1998, IMMUNOL TODAY, V19, P352, DOI 10.1016/S0167-5699(98)01298-5; Twigg SRF, 2004, P NATL ACAD SCI USA, V101, P8652, DOI 10.1073/pnas.0402819101; WASHBURN TC, 1965, PEDIATRICS, V35, P57; Winkelstein JA, 2001, JAMA-J AM MED ASSOC, V285, P1348, DOI 10.1001/jama.285.10.1348	29	135	137	1	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2006	295	12					1428	1433		10.1001/jama.295.12.1428	http://dx.doi.org/10.1001/jama.295.12.1428			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023WU	16551715				2022-12-24	WOS:000236157700021
J	Doherty, TM; Rook, G				Doherty, TM; Rook, G			Progress and hindrances in tuberculosis vaccine development	LANCET			English	Editorial Material							REGULATORY T-CELLS; PULMONARY TUBERCULOSIS; TGF-BETA; INFECTION		UCL Royal Free & Univ Coll Med Sch, Windeyer Inst Med Sci, Ctr Infect Dis & Int Hlth, London W1T 4JF, England; Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark	University of London; University College London; UCL Medical School; Statens Serum Institut	Rook, G (corresponding author), UCL Royal Free & Univ Coll Med Sch, Windeyer Inst Med Sci, Ctr Infect Dis & Int Hlth, London W1T 4JF, England.	G.Rook@ucl.ac.uk		Rook, Graham/0000-0002-8041-8110				Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Demissie A, 2004, J IMMUNOL, V172, P6938, DOI 10.4049/jimmunol.172.11.6938; Dheda K, 2005, AM J RESP CRIT CARE, V172, P501, DOI 10.1164/rccm.200502-278OC; Doherty TM, 2005, CLIN MICROBIOL REV, V18, P687, DOI 10.1128/CMR.18.4.687-702.2005; Gerosa F, 1999, CLIN IMMUNOL, V92, P224, DOI 10.1006/clim.1999.4752; GUYOTREVOL V, 2005, AM J RESP CRIT CARE; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Olobo JO, 2001, SCAND J IMMUNOL, V53, P85, DOI 10.1046/j.1365-3083.2001.00844.x; Rook GAW, 2005, NAT REV IMMUNOL, V5, P661, DOI 10.1038/nri1666; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006	11	15	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					947	949		10.1016/S0140-6736(06)68389-X	http://dx.doi.org/10.1016/S0140-6736(06)68389-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546547				2022-12-24	WOS:000236242100035
J	Nisbet, AC				Nisbet, AC			Intramuscular gluteal injections in the increasingly obese population: retrospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PLASMA-LEVELS; ABSORPTION	Aims To examine depth of subcutaneous fat at gluteal intramuscular injection sites. Design Retrospective study. Setting General hospital. Participants 100 consecutive adults who had computed tomography of the pelvis. Main outcome measures Minimum distance between the surface of the skin and the nearest edge of muscle at intramuscular injection sites. Results 12 patients had a ventrogluteal site depth of more than 35 mm, the maximum depth of a green needle, and 26 had a ventrogluteal depth of more than 25 mm, the maximum depth of a blue needle. 43 patients had a dorsogluteal site depth of more than 35 mm, and 72 had a dorsogluteal depth of more than 25 mm. The intramuscular site was likely to be deeper in women. Conclusion Standard green and blue needles do not reach the gluteal muscles in a considerable number of patients.	Jersey Gen Hosp, St Helier LE2 3QS, Jersey, England		Nisbet, AC (corresponding author), Les Grupieaux, Le Grupe, St Peter JE3 7ED, Jersey, England.	kaltarn@yahoo.co.uk						COHEN LS, 1972, AM J CARDIOL, V29, P520, DOI 10.1016/0002-9149(72)90442-0; EVANS EF, 1975, CLIN PHARMACOL THER, V17, P44; Grabinski P Y, 1983, PRN Forum, V2, P2; GRABINSKI PY, 1983, J CLIN PHARMACOL, V23, P48, DOI 10.1002/j.1552-4604.1983.tb02704.x; Greenway Kathleen, 2004, Nurs Stand, V18, P39; LINDSAY KL, 1985, HEPATOLOGY, V5, P1088, DOI 10.1002/hep.1840050605; VUKOVICH RA, 1975, CLIN PHARMACOL THER, V18, P215	7	49	51	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2006	332	7542					637	638		10.1136/bmj.38706.742731.47	http://dx.doi.org/10.1136/bmj.38706.742731.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026CQ	16524934	Green Published, Bronze			2022-12-24	WOS:000236314700016
J	Chiang, KH; Chou, AS				Chiang, KH; Chou, AS			Pneumomediastinum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Buddhist Tzu Chi Med Ctr, Hualien, Taiwan	Buddhist Tzu Chi General Hospital	Chiang, KH (corresponding author), Buddhist Tzu Chi Med Ctr, Hualien, Taiwan.								0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1177	1177		10.1056/NEJMicm050132	http://dx.doi.org/10.1056/NEJMicm050132			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021KI	16540618				2022-12-24	WOS:000235981700011
J	Wadman, M				Wadman, M			Make or break time in Vioxx drama	NATURE			English	Article																		Khamsi R, 2005, NATURE, V436, P1070, DOI 10.1038/4361070a	1	13	13	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2006	440	7082					277	277		10.1038/440277a	http://dx.doi.org/10.1038/440277a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541045	Bronze			2022-12-24	WOS:000235997600023
J	Grimaud, C; Bantignies, F; Pal-Bhadra, M; Ghana, P; Bhadra, U; Cavalli, G				Grimaud, C; Bantignies, F; Pal-Bhadra, M; Ghana, P; Bhadra, U; Cavalli, G			RNAi components are required for nuclear clustering of polycomb group response elements	CELL			English	Article							BITHORAX COMPLEX; GROUP PROTEINS; EPIGENETIC INHERITANCE; DISTINCT ROLES; DROSOPHILA; HETEROCHROMATIN; CHROMATIN; GENE; INTERFERENCE; TRITHORAX	Drosophila Polycomb group (PcG) proteins silence homeotic genes through binding to Polycomb group response elements (PREs). Fab-7 is a PRE-containing regulatory element from the homeotic gene Abdominai-B. When present in multiple copies in the genome, Fab-7 can induce long-distance gene contacts that enhance PcG-dependent silencing. We show here that components of the RNA interference (RNAi) machinery are involved in PcG-mediated silencing at Fab-7 and in the production of small RNAs at transgenic Fab-7 copies. In general, these mutations do not affect the recruitment of PcG components, but they are specifically required for the maintenance of long-range contacts between Fab-7 copies. Dicer-2, PIWI, and Argonaute1, three RNAi components, frequently colocalize with PcG bodies, and their mutation significantly reduces the frequency of PcG-dependent chromosomal associations of endogenous homeotic genes. This suggests a novel role for the RNAi machinery in regulating the nuclear organization of PcG chromatin targets.	Inst Human Genet, CNRS, F-34396 Montpellier 5, France; Indian Inst Chem Technol, Dept Biol Chem, Hyderabad 500007, Andhra Pradesh, India; Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Cavalli, G (corresponding author), Inst Human Genet, CNRS, 141 Rue Cardonille, F-34396 Montpellier 5, France.	giacomo.cavalli@igh.cnrs.fr	cavalli, giacomo/Z-2754-2019; grimaud, charlotte/Y-6689-2019; Cavalli, Giacomo/A-7958-2008	cavalli, giacomo/0000-0003-3709-3469; grimaud, charlotte/0000-0001-7944-5931; Cavalli, Giacomo/0000-0003-3709-3469				Abranches R, 2000, PLANT J, V24, P713, DOI 10.1046/j.1365-313x.2000.00908.x; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Bae E, 2002, P NATL ACAD SCI USA, V99, P16847, DOI 10.1073/pnas.222671299; Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; Cox DN, 2000, DEVELOPMENT, V127, P503; Dejardin J, 2005, PROG MOLEC, V38, P31; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; FAUVARQUE MO, 1993, GENE DEV, V7, P1508, DOI 10.1101/gad.7.8.1508; Ficz G, 2005, DEVELOPMENT, V132, P3963, DOI 10.1242/dev.01950; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harris AN, 2001, DEVELOPMENT, V128, P2823; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kassis JA, 2002, ADV GENET, V46, P421; Lavrov S, 2004, METH MOL B, V247, P289; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; MARTIN CH, 1995, P NATL ACAD SCI USA, V92, P8398, DOI 10.1073/pnas.92.18.8398; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Mihaly J, 1997, DEVELOPMENT, V124, P1809; Mohd-Sarip A, 2005, GENE DEV, V19, P1755, DOI 10.1101/gad.347005; Muller M, 1999, GENETICS, V153, P1333; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 1999, CELL, V99, P35, DOI 10.1016/S0092-8674(00)80060-4; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; PalBhadra M, 1997, CELL, V90, P479, DOI 10.1016/S0092-8674(00)80508-5; PARO R, 1993, MECH DEVELOP, V40, P37, DOI 10.1016/0925-4773(93)90086-D; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Saurin AJ, 1998, J CELL BIOL, V142, P887, DOI 10.1083/jcb.142.4.887; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Tillib S, 1999, MOL CELL BIOL, V19, P5189; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; ZINK D, 1995, EMBO J, V14, P5660, DOI 10.1002/j.1460-2075.1995.tb00253.x	55	239	256	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					957	971		10.1016/j.cell.2006.01.036	http://dx.doi.org/10.1016/j.cell.2006.01.036			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530043	Bronze			2022-12-24	WOS:000237241200018
J	Lam, H; Schofield, WB; Jacobs-Wagner, C				Lam, H; Schofield, WB; Jacobs-Wagner, C			A landmark protein essential for establishing and perpetuating the polarity of a bacterial cell	CELL			English	Article							CAULOBACTER-CRESCENTUS; TOPOLOGY PREDICTION; RESPONSE REGULATOR; HISTIDINE KINASE; DNA-REPLICATION; CYCLE; MREB; DIVISION; DIFFERENTIATION; PROTEOLYSIS	Polarity is often an intrinsic property of the cell, yet little is known about its origin or its maintenance over generations. Here we identify a landmark protein, TipN, which acts as a spatial and temporal cue for setting up the correct polarity in the bacterium Caulobacter crescentus. TipN marks the new pole throughout most of the cell cycle, and its relocation to the nascent poles at the end of division provides a preexisting reference point for orienting the polarity axis in the progeny. Deletion of tipN causes pleiotropic polarity defects, including frequently reversed asymmetry in progeny size and mislocalization of proteins and organelles. Ectopic localization of TipN along the lateral side of the cell creates new axes of polarity leading to cell branching and formation of competent cell poles. Localization defects of the actin-like protein MreB in the Delta tipN mutant suggest that TipN is upstream of MreB in regulating cell polarity.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Jacobs-Wagner, C (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	christine.jacobs-wagner@yale.edu		Jacobs-Wagner, Christine/0000-0003-0980-5334	NIGMS NIH HHS [GM065835] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065835] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Awram P, 2001, MICROBIOL-SGM, V147, P1451, DOI 10.1099/00221287-147-6-1451; Burton GJ, 1997, J BACTERIOL, V179, P5849, DOI 10.1128/jb.179.18.5849-5853.1997; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; ELY B, 1991, METHOD ENZYMOL, V204, P372; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Figge RM, 2004, MOL MICROBIOL, V51, P1321, DOI 10.1111/j.1365-2958.2003.03936.x; Flardh K, 2003, MOL MICROBIOL, V49, P1523, DOI 10.1046/j.1365-2958.2003.03660.x; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Gorbatyuk B, 2001, MOL MICROBIOL, V40, P485, DOI 10.1046/j.1365-2958.2001.02404.x; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; Judd EM, 2003, P NATL ACAD SCI USA, V100, P8235, DOI 10.1073/pnas.1433105100; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019; NIEMAN WC, 2001, P NATL ACAD SCI USA, V98, P4136; Nilsen T, 2005, J BACTERIOL, V187, P6187, DOI 10.1128/JB.187.17.6187-6196.2005; Ohta N, 1996, TRENDS MICROBIOL, V4, P326, DOI 10.1016/0966-842X(96)10050-0; Roberts RC, 1996, J BACTERIOL, V178, P1829, DOI 10.1128/jb.178.7.1829-1841.1996; Ryan KR, 2004, P NATL ACAD SCI USA, V101, P7415, DOI 10.1073/pnas.0402153101; Ryan KR, 2002, J MOL BIOL, V324, P443, DOI 10.1016/S0022-2836(02)01042-2; Shih YL, 2005, MOL MICROBIOL, V58, P917, DOI 10.1111/j.1365-2958.2005.04841.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; TERRANA B, 1975, DEV BIOL, V44, P380, DOI 10.1016/0012-1606(75)90409-1; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Viollier PH, 2002, EMBO J, V21, P4420, DOI 10.1093/emboj/cdf454; Wagner JK, 2005, J BACTERIOL, V187, P544, DOI 10.1128/JB.187.2.544-553.2005; Wang Y, 2001, MOL MICROBIOL, V40, P347, DOI 10.1046/j.1365-2958.2001.02395.x; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2	31	144	145	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					1011	1023		10.1016/j.cell.2005.12.040	http://dx.doi.org/10.1016/j.cell.2005.12.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530047	Bronze			2022-12-24	WOS:000237241200022
J	Sazanov, LA; Hinchliffe, P				Sazanov, LA; Hinchliffe, P			Structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus	SCIENCE			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; BOVINE HEART-MITOCHONDRIA; IRON-SULFUR CLUSTERS; NITRATE REDUCTASE-A; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; 49-KDA SUBUNIT; QUINONE OXIDOREDUCTASE; ELECTRON-TRANSFER; AQUIFEX-AEOLICUS	Respiratory complex I plays a central role in cellular energy production in bacteria and mitochondria. Its dysfunction is implicated in many human neurodegenerative diseases, as well as in aging. The crystal structure of the hydrophilic domain ( peripheral arm) of complex I from Thermus thermophilus has been solved at 3.3 angstrom resolution. This subcomplex consists of eight subunits and contains all the redox centers of the enzyme, including nine iron-sulfur clusters. The primary electron acceptor, flavin-mononucleotide, is within electron transfer distance of cluster N3, leading to the main redox pathway, and of the distal cluster N1a, a possible antioxidant. The structure reveals new aspects of the mechanism and evolution of the enzyme. The terminal cluster N2 is coordinated, uniquely, by two consecutive cysteines. The novel subunit Nqo15 has a similar fold to the mitochondrial iron chaperone frataxin, and it may be involved in iron-sulfur cluster regeneration in the complex.	MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Sazanov, LA (corresponding author), MRC, Dunn Human Nutr Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	sazanov@mrc-dunn.cam.ac.uk	Sazanov, Leonid A/ABF-2125-2021	Sazanov, Leonid A/0000-0002-0977-7989; Hinchliffe, Philip/0000-0001-8611-4743	Medical Research Council [MC_U105674180] Funding Source: Medline; MRC [MC_U105674180] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; BELOGRUDOV G, 1994, BIOCHEMISTRY-US, V33, P4571, DOI 10.1021/bi00181a018; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Chen YR, 2005, J BIOL CHEM, V280, P37339, DOI 10.1074/jbc.M503936200; Cho SJ, 2000, P NATL ACAD SCI USA, V97, P8932, DOI 10.1073/pnas.160270897; Darrouzet E, 1998, FEBS LETT, V431, P34, DOI 10.1016/S0014-5793(98)00719-4; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; Dias JM, 1999, STRUCTURE, V7, P65, DOI 10.1016/S0969-2126(99)80010-0; Duff JLC, 1996, J AM CHEM SOC, V118, P8593, DOI 10.1021/ja961465l; FINEL M, 1992, BIOCHEMISTRY-US, V31, P11425, DOI 10.1021/bi00161a022; Finel M, 1998, BBA-BIOENERGETICS, V1364, P112, DOI 10.1016/S0005-2728(98)00022-X; Flemming D, 2003, J BIOL CHEM, V278, P47602, DOI 10.1074/jbc.M308967200; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; Fritz G, 2002, P NATL ACAD SCI USA, V99, P1836, DOI 10.1073/pnas.042664399; Grgic L, 2004, J BIOL CHEM, V279, P21193, DOI 10.1074/jbc.M313180200; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Grivennikova VG, 2003, BBA-BIOENERGETICS, V1607, P79, DOI 10.1016/j.bbabio.2003.09.001; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; HINCHLIFFE P, UNPUB; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Holt PJ, 2003, J BIOL CHEM, V278, P43114, DOI 10.1074/jbc.M308247200; Kashani-Poor N, 2001, J BIOL CHEM, V276, P24082, DOI 10.1074/jbc.M102296200; KOTLYAR AB, 1990, FEBS LETT, V264, P17, DOI 10.1016/0014-5793(90)80753-6; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; Lesk AM, 1995, CURR OPIN STRUC BIOL, V5, P775, DOI 10.1016/0959-440X(95)80010-7; Mamedova AA, 2004, J BIOL CHEM, V279, P23830, DOI 10.1074/jbc.M401539200; MORGAN D, UNPUB; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nakamaru-Ogiso E, 2005, J BIOL CHEM, V280, P301, DOI 10.1074/jbc.M410377200; Oh JI, 1998, J BIOL CHEM, V273, P26349, DOI 10.1074/jbc.273.41.26349; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Peng GH, 2003, BIOCHEMISTRY-US, V42, P3032, DOI 10.1021/bi026876v; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Rothery RA, 2004, BIOCHEMISTRY-US, V43, P5324, DOI 10.1021/bi049938l; Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2; SLED VD, 1994, BIOCHEMISTRY-US, V33, P10069, DOI 10.1021/bi00199a034; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1016/S0168-6445(01)00063-8; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yano T, 2005, BIOCHEMISTRY-US, V44, P1744, DOI 10.1021/bi048132i; Yano T, 2003, J BIOL CHEM, V278, P15514, DOI 10.1074/jbc.M212275200; Yeh AP, 2000, J MOL BIOL, V300, P587, DOI 10.1006/jmbi.2000.3871; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200	51	619	646	3	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2006	311	5766					1430	1436		10.1126/science.1123809	http://dx.doi.org/10.1126/science.1123809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16469879				2022-12-24	WOS:000236029400040
J	Waite, JH; Combi, MR; Ip, WH; Cravens, TE; McNutt, RL; Kasprzak, W; Yelle, R; Luhmann, J; Niemann, H; Gell, D; Magee, B; Fletcher, G; Lunine, J; Tseng, WL				Waite, JH; Combi, MR; Ip, WH; Cravens, TE; McNutt, RL; Kasprzak, W; Yelle, R; Luhmann, J; Niemann, H; Gell, D; Magee, B; Fletcher, G; Lunine, J; Tseng, WL			Cassini ion and neutral mass spectrometer: Enceladus plume composition and structure	SCIENCE			English	Article							SPECTROSCOPY; DISCOVERY; PARTICLES; ORIGIN; SATURN; ICE		Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; Natl Cent Univ, Inst Astron, Chungli 32054, Taiwan; Natl Cent Univ, Inst Space Sci, Chungli 32054, Taiwan; Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Ist Fis Spazio Interplanetario, I-00133 Rome, Italy	University of Michigan System; University of Michigan; National Central University; National Central University; University of Kansas; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Arizona; University of California System; University of California Berkeley; Istituto Nazionale Astrofisica (INAF)	Waite, JH (corresponding author), Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA.		McNutt, Ralph L/E-8006-2010; Combi, Michael/J-1697-2012	McNutt, Ralph L/0000-0002-4722-9166; Combi, Michael/0000-0002-9805-0078; Lunine, Jonathan/0000-0003-2279-4131				Bockelee-Morvan D, 2004, SPACE SCI S, P391; BOONE S, 1991, LUN PLAN SCI C 21 HO, P603; Brown RH, 2006, SCIENCE, V311, P1425, DOI 10.1126/science.1121031; Combi MR, 2004, SPACE SCI S, P523; Combi MR, 1996, ICARUS, V123, P207, DOI 10.1006/icar.1996.0150; Cruikshank DP, 2005, ICARUS, V175, P268, DOI 10.1016/j.icarus.2004.09.003; Davidsson BJR, 2004, ICARUS, V168, P163, DOI 10.1016/j.icarus.2003.11.002; Emery JP, 2005, ASTRON ASTROPHYS, V435, P353, DOI 10.1051/0004-6361:20042482; Esposito LW, 2005, SCIENCE, V307, P1251, DOI 10.1126/science.1105606; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; Jurac S, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010635; Jurac S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015855; Kasprzak W, 1996, P SOC PHOTO-OPT INS, V2803, P129, DOI 10.1117/12.253413; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Press WH, 1986, NUMERICAL RECIPIES; Roddier C, 1998, ICARUS, V136, P50, DOI 10.1006/icar.1998.6014; SHEMANSKY DE, 1993, NATURE, V363, P329, DOI 10.1038/363329a0; Spahn F, 2006, SCIENCE, V311, P1416, DOI 10.1126/science.1121375; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; SQUYRES SW, 1983, ICARUS, V53, P319, DOI 10.1016/0019-1035(83)90152-5; Waite JH, 2004, SPACE SCI REV, V114, P113, DOI 10.1007/s11214-004-1408-2; YAMAMOTO T, 1985, ASTRON ASTROPHYS, V152, pL17; Yelle RV, 2004, ICARUS, V167, P30, DOI 10.1016/j.icarus.2003.08.020	23	472	478	3	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2006	311	5766					1419	1422		10.1126/science.1121290	http://dx.doi.org/10.1126/science.1121290			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527970				2022-12-24	WOS:000236029400036
J	Young, D; Dye, C				Young, D; Dye, C			The development and impact of tuberculosis vaccines	CELL			English	Editorial Material							MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSES; BCG; EFFICACY; STRAINS	Vaccination is expected to make a major contribution to the goal of eliminating tuberculosis worldwide by 2050. But developing a new effective vaccine will require innovation in scientific research, a proactive approach to clinical trials of new vaccine candidates, and application of vaccines as part of an integrated approach to disease control.	Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; WHO, StopTB Dept, CH-1211 Geneva 12, Switzerland	Imperial College London; World Health Organization	Young, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, S Kensington Campus, London SW7 2AZ, England.	d.young@imperial.ac.uk	Dye, Christopher/AIC-4659-2022	Dye, Christopher/0000-0002-2957-1793	MRC [MC_U117581288] Funding Source: UKRI; Medical Research Council [MC_U117581288] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aronson NE, 2004, JAMA-J AM MED ASSOC, V291, P2086, DOI 10.1001/jama.291.17.2086; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Kaufmann SHE, 2005, TRENDS IMMUNOL, V26, P660, DOI 10.1016/j.it.2005.09.012; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Orme IM, 2006, VACCINE, V24, P2, DOI 10.1016/j.vaccine.2005.07.078; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rook GAW, 2005, NAT REV IMMUNOL, V5, P661, DOI 10.1038/nri1666; Skeiky YAW, 2004, J IMMUNOL, V172, P7618, DOI 10.4049/jimmunol.172.12.7618; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; *STOP TB PARTN WHO, 2006, WHOHTMSTB200635 STOP; *WHO, 2006, GLOB TUB CONTR SURV	15	99	113	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 24	2006	124	4					683	687		10.1016/j.cell.2006.02.013	http://dx.doi.org/10.1016/j.cell.2006.02.013			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RO	16497578	Bronze			2022-12-24	WOS:000237240900011
J	Zuk, M				Zuk, M			Family values in black and white	NATURE			English	Editorial Material									Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Zuk, M (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.								0	11	12	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 23	2006	439	7079					917	917		10.1038/439917a	http://dx.doi.org/10.1038/439917a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014NE	16495977				2022-12-24	WOS:000235486100024
J	Bright, RA; Shay, DK; Shu, B; Cox, NJ; Klimov, AI				Bright, RA; Shay, DK; Shu, B; Cox, NJ; Klimov, AI			Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEURAMINIDASE INHIBITORS; H3N2 VIRUSES; AMANTADINE; RIMANTADINE; SUSCEPTIBILITY; PROPHYLAXIS; EMERGENCE	Context The adamantanes, amantadine and rimantadine, have been used as first-choice antiviral drugs against community outbreaks of influenza A viruses for many years. Rates of viruses resistant to these drugs have been increasing globally. Rapid surveillance for the emergence and spread of resistant viruses has become critical for appropriate treatment of patients. Objective To investigate the frequency of adamantane-resistant influenza A viruses circulating in the United States during the initial months of the 2005-2006 influenza season. Design and Setting Influenza isolates collected from 26 states from October 1 through December 31, 2005, and submitted to the US Centers for Disease Control and Prevention were tested for drug resistance as part of ongoing surveillance. Isolates were submitted from World Health Organization collaborating laboratories and National Respiratory and Enteric Virus Surveillance System laboratories. Main Outcome Measures Using pyrosequencing and confirmatory assays, we identified viruses containing mutations within the M2 gene that are known to confer resistance to both amantadine and rimantadine. Results A total of 209 influenza A(H3N2) viruses isolated from patients in 26 states were screened, of which 193 (92.3%) contained a change at amino acid 31 (serine to asparagine [S31N]) in the M2 gene known to be correlated with adamantane resistance. Two of 8 influenza A(H1N1) viruses contained the same mutation. Drug-resistant viruses were distributed across the United States. Conclusions The high proportion of influenza A viruses currently circulating in the United States demonstrating adamantane resistance highlights the clinical importance of rapid surveillance for antiviral resistance. Our results indicate that these drugs should not be used for the treatment or prophylaxis of influenza in the United States until susceptibility to adamantanes has been reestablished among circulating influenza A isolates.	Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Influenza Branch, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Bright, RA (corresponding author), Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Influenza Branch, 1600 Clifton Rd NE,Mailstop G16, Atlanta, GA 30333 USA.			Shay, David/0000-0001-9619-4820				BELSHE RB, 1988, J VIROL, V62, P1508, DOI 10.1128/JVI.62.5.1508-1512.1988; Boivin G, 2002, CLIN INFECT DIS, V34, pE23, DOI 10.1086/338870; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P44; DEGELAU J, 1992, ARCH INTERN MED, V152, P390, DOI 10.1001/archinte.152.2.390; DOLIN R, 1982, NEW ENGL J MED, V307, P580, DOI 10.1056/NEJM198209023071002; Englund JA, 1998, CLIN INFECT DIS, V26, P1418, DOI 10.1086/516358; FOX JP, 1982, AM J EPIDEMIOL, V116, P228, DOI 10.1093/oxfordjournals.aje.a113408; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; HAY AJ, 1986, J ANTIMICROB CHEMOTH, V18, P19, DOI 10.1093/jac/18.Supplement_B.19; HAYDEN FG, 1991, ANTIMICROB AGENTS CH, V35, P1741, DOI 10.1128/AAC.35.9.1741; HAYDEN FG, 1992, CURR TOP MICROBIOL, V176, P119; HAYDEN FG, 1989, NEW ENGL J MED, V321, P1696, DOI 10.1056/NEJM198912213212502; HOUCK P, 1995, ARCH INTERN MED, V155, P533, DOI 10.1001/archinte.155.5.533; Hurt AC, 2004, ANTIVIR RES, V62, P37, DOI 10.1016/j.antiviral.2003.11.008; Hurt Aeron C, 2003, Commun Dis Intell Q Rep, V27, P542; Mungall BA, 2004, VIRUS RES, V103, P195, DOI 10.1016/j.virusres.2004.02.033; OXFORD JS, 1984, VIRAL CHEMOTHERAPY, V1, P169; *PUBL HLTH AG CAN, INT REC US AM INFL; REUMAN PD, 1989, ANTIVIR RES, V11, P27, DOI 10.1016/0166-3542(89)90018-1; Shiraishi K, 2003, J INFECT DIS, V188, P57, DOI 10.1086/375799; SWEET C, 1991, J INFECT DIS, V164, P969, DOI 10.1093/infdis/164.5.969; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tominack R L, 1987, Infect Dis Clin North Am, V1, P459; WANG C, 1993, J VIROL, V67, P5585, DOI 10.1128/JVI.67.9.5585-5594.1993; YOUNKIN SW, 1983, ANTIMICROB AGENTS CH, V23, P577, DOI 10.1128/AAC.23.4.577; Ziegler T, 1999, J INFECT DIS, V180, P935, DOI 10.1086/314994	27	516	580	1	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 22	2006	295	8					891	894		10.1001/jama.295.8.joc60020	http://dx.doi.org/10.1001/jama.295.8.joc60020			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014DO	16456087	Bronze			2022-12-24	WOS:000235459200021
J	Guido, NJ; Wang, X; Adalsteinsson, D; McMillen, D; Hasty, J; Cantor, CR; Elston, TC; Collins, JJ				Guido, NJ; Wang, X; Adalsteinsson, D; McMillen, D; Hasty, J; Cantor, CR; Elston, TC; Collins, JJ			A bottom-up approach to gene regulation	NATURE			English	Article							NOISE-PROPAGATION; ESCHERICHIA-COLI; TOGGLE SWITCH; NETWORKS; EXPRESSION	The ability to construct synthetic gene networks enables experimental investigations of deliberately simplified systems that can be compared to qualitative and quantitative models(1-23). If simple, well-characterized modules can be coupled together into more complex networks with behaviour that can be predicted from that of the individual components, we may begin to build an understanding of cellular regulatory processes from the 'bottom up'. Here we have engineered a promoter to allow simultaneous repression and activation of gene expression in Escherichia coli. We studied its behaviour in synthetic gene networks under increasingly complex conditions: unregulated, repressed, activated, and simultaneously repressed and activated. We develop a stochastic model that quantitatively captures the means and distributions of the expression from the engineered promoter of this modular system, and show that the model can be extended and used to accurately predict the in vivo behaviour of the network when it is expanded to include positive feedback. The model also reveals the counterintuitive prediction that noise in protein expression levels can increase upon arrest of cell growth and division, which we confirm experimentally. This work shows that the properties of regulatory subsystems can be used to predict the behaviour of larger, more complex regulatory networks, and that this bottom-up approach can provide insights into gene regulation.	Boston Univ, Ctr Biodynam, Bioinformat Program, Dept Biomed Engn, Boston, MA 02215 USA; Univ N Carolina, Dept Stat & Operat Res, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Math, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ Toronto, Inst Opt Sci, Mississauga, ON L5L 1C6, Canada; Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON L5L 1C6, Canada; Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Boston University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University Toronto Mississauga; University of Toronto; University Toronto Mississauga; University of California System; University of California San Diego	Collins, JJ (corresponding author), Boston Univ, Ctr Biodynam, Bioinformat Program, Dept Biomed Engn, 44 Cummington St, Boston, MA 02215 USA.	jcollins@bu.edu	Wang, Xiao/A-8414-2008	Wang, Xiao/0000-0002-4056-0155; McMillen, David/0000-0003-2676-5450				Adalsteinsson D, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-24; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GREENWOOD D, 1973, J INFECT DIS, V128, P211, DOI 10.1093/infdis/128.2.211; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Isalan M, 2005, PLOS BIOL, V3, P488, DOI 10.1371/journal.pbio.0030064; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Ptashne M, 1992, GENETIC SWITCH PHAGE; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Sambrook JFE, 1989, MOL CLONING LAB MANU; Weiss R., 2003, Natural Computing, V2, P47, DOI 10.1023/A:1023307812034; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	30	254	270	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2006	439	7078					856	860		10.1038/nature04473	http://dx.doi.org/10.1038/nature04473			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012JA	16482159				2022-12-24	WOS:000235333600052
J	Fisker, N; Carlsen, NLT; Kolmos, HJ; Tonning-Sorensen, L; Host, A; Christensen, PB				Fisker, N; Carlsen, NLT; Kolmos, HJ; Tonning-Sorensen, L; Host, A; Christensen, PB			Identifying a hepatitis B outbreak by molecular surveillance: a case study	BRITISH MEDICAL JOURNAL			English	Article							VIRUS-INFECTION; NOSOCOMIAL TRANSMISSION; DENMARK; DISEASE; VIALS		Odense Univ Hosp, Dept Clin Immunol, DK-5000 Odense C, Denmark; Odense Univ Hosp, Dept Paediat, DK-5000 Odense, Denmark; Odense Univ Hosp, Dept Clin Microbiol, DK-5000 Odense C, Denmark; Odense Univ Hosp, Dept Internal Med, Infect Dis Sect, DK-5000 Odense C, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Fisker, N (corresponding author), Odense Univ Hosp, Dept Clin Immunol, Sdr Blvd 29, DK-5000 Odense C, Denmark.	niels.fisker@dadlnet.dk	Christensen, Peer B./B-8042-2015	Christensen, Peer Brehm/0000-0003-1394-058X				Abulrahi HA, 1997, LANCET, V349, P23, DOI 10.1016/S0140-6736(96)03508-8; BRUGUERA M, 1990, J CLIN GASTROENTEROL, V12, P298, DOI 10.1097/00004836-199006000-00013; Christensen PB, 2001, J CLIN VIROL, V22, P133, DOI 10.1016/S1386-6532(01)00175-5; Dumpis U, 2003, J MED VIROL, V69, P331, DOI 10.1002/jmv.10293; Fisker N, 2004, J CLIN VIROL, V31, P46, DOI 10.1016/j.jcv.2004.05.004; HADLER SC, 1991, J INFECT DIS, V163, P454, DOI 10.1093/infdis/163.3.454; Katzenstein TL, 1999, AIDS, V13, P1737, DOI 10.1097/00002030-199909100-00018; Kidd-Ljunggren K, 1999, J HOSP INFECT, V43, P57, DOI 10.1053/jhin.1999.0607; Krause G, 2003, INFECT CONT HOSP EP, V24, P122, DOI 10.1086/502176; MCMAHON BJ, 1985, J INFECT DIS, V151, P599, DOI 10.1093/infdis/151.4.599; NORDER H, 1995, 9 C VIR VERS LE CHES, P39; Osterhaus ADME, 1998, J HEART LUNG TRANSPL, V17, P158; TEDDER RS, 1995, LANCET, V346, P137, DOI 10.1016/S0140-6736(95)91207-X; Widell A, 1999, ANN INTERN MED, V130, P130, DOI 10.7326/0003-4819-130-2-199901190-00007	14	12	12	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 11	2006	332	7537					343	345		10.1136/bmj.332.7537.343	http://dx.doi.org/10.1136/bmj.332.7537.343			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	012YI	16470056	Green Published			2022-12-24	WOS:000235376400020
J	Barbera, AJ; Chodaparambil, JV; Kelley-Clarke, B; Joukov, V; Walter, JC; Luger, K; Kaye, KM				Barbera, AJ; Chodaparambil, JV; Kelley-Clarke, B; Joukov, V; Walter, JC; Luger, K; Kaye, KM			The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA	SCIENCE			English	Article							EPSTEIN-BARR-VIRUS; NUCLEAR ANTIGEN; DNA-SEQUENCES; CORE PARTICLE; EPISOME-MAINTENANCE; CRYSTAL-STRUCTURE; GENE-EXPRESSION; BINDING; PROTEIN; CHROMATIN	Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen (LANA) mediates viral genome attachment to mitotic chromosomes. We find that N-terminal LANA docks onto chromosomes by binding nucleosomes through the folded region of histones H2A-H2B. The same LANA residues were required for both H2A-H2B binding and chromosome association. Further, LANA did not bind Xenopus sperm chromatin, which is deficient in H2A-H2B; chromatin binding was rescued after assembly of nucleosomes containing H2A-H2B. We also describe the 2.9-angstrom crystal structure of a nucleosome complexed with the first 23 LANA amino acids. The LANA peptide forms a hairpin that interacts exclusively with an acidic H2A-H2B region that is implicated in the formation of higher order chromatin structure. Our findings present a paradigm for how nucleosomes may serve as binding platforms for viral and cellular proteins and reveal a previously unknown mechanism for KSHV latency.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA; Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Colorado State University; Howard Hughes Medical Institute; Colorado State University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Kaye, KM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA.	kkaye@rics.bwh.harvard.edu	Chodaparambil, Jayanth V/F-3229-2015; Joukov, Vladimir/K-3525-2019	Walter, Johannes/0000-0002-4186-7570; SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331	NATIONAL CANCER INSTITUTE [R01CA082036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062267, R01GM067777] Funding Source: NIH RePORTER; NCI NIH HHS [CA82036] Funding Source: Medline; NIGMS NIH HHS [R01 GM067777, GM067777, GM62267] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Barbera AJ, 2004, J VIROL, V78, P294, DOI 10.1128/JVI.78.1.294-301.2004; BARBERA AJ, UNPUB; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Cotter MA, 1999, VIROLOGY, V264, P254, DOI 10.1006/viro.1999.9999; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Decker LL, 1996, J EXP MED, V184, P283, DOI 10.1084/jem.184.1.283; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Hung SC, 2001, P NATL ACAD SCI USA, V98, P1865, DOI 10.1073/pnas.031584698; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kapoor P, 2001, EMBO J, V20, P222, DOI 10.1093/emboj/20.1.222; Krithivas A, 2000, J VIROL, V74, P9637, DOI 10.1128/JVI.74.20.9637-9645.2000; Krithivas A, 2002, J VIROL, V76, P11596, DOI 10.1128/JVI.76.22.11596-11604.2002; Luger K, 1998, CURR OPIN STRUC BIOL, V8, P33, DOI 10.1016/S0959-440X(98)80007-9; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; MOORE PS, 1995, NEW ENGL J MED, V332, P1181, DOI 10.1056/NEJM199505043321801; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Park JH, 2002, NAT GENET, V32, P273, DOI 10.1038/ng982; Park YJ, 2005, J BIOL CHEM, V280, P1817, DOI 10.1074/jbc.M411347200; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; PHILPOTT A, 1991, CELL, V65, P569, DOI 10.1016/0092-8674(91)90089-H; Piolot T, 2001, J VIROL, V75, P3948, DOI 10.1128/JVI.75.8.3948-3959.2001; Renne R, 2001, J VIROL, V75, P458, DOI 10.1128/JVI.75.1.458-468.2001; Sears J, 2004, J VIROL, V78, P11487, DOI 10.1128/JVI.78.21.11487-11505.2004; Shinohara H, 2002, J VIROL, V76, P12917, DOI 10.1128/JVI.76.24.12917-12924.2002; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Tetsuka T, 2004, VIRUS GENES, V29, P175, DOI 10.1023/B:VIRU.0000036377.48454.d8; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Verma SC, 2003, FEMS MICROBIOL LETT, V222, P155, DOI 10.1016/S0378-1097(03)00261-1; Wong LY, 2004, J VIROL, V78, P10074, DOI 10.1128/JVI.78.18.10074-10085.2004; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7	38	384	395	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2006	311	5762					856	861		10.1126/science.1120541	http://dx.doi.org/10.1126/science.1120541			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012XT	16469929				2022-12-24	WOS:000235374900051
J	Gwack, Y; Sharma, S; Nardone, J; Tanasa, B; Iuga, A; Srikanth, S; Okamura, H; Bolton, D; Feske, S; Hogan, PG; Rao, AJ				Gwack, Yousang; Sharma, Sonia; Nardone, Julie; Tanasa, Bogdan; Iuga, Alina; Srikanth, Sonal; Okamura, Heidi; Bolton, Diana; Feske, Stefan; Hogan, Patrick G.; Rao, Anjana			A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT	NATURE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; TO-EMBRYO TRANSITION; PROTEIN-KINASES; DUAL-SPECIFICITY; ACTIVATION-LOOP; CA2+ SENSOR; CALCIUM; CELLS; STORE; GSK-3	Precise regulation of the NFAT ( nuclear factor of activated T cells) family of transcription factors (NFAT1 - 4) is essential for vertebrate development and function(1). In resting cells, NFAT proteins are heavily phosphorylated and reside in the cytoplasm; in cells exposed to stimuli that raise intracellular free Ca2+ levels, they are dephosphorylated by the calmodulin-dependent phosphatase calcineurin and translocate to the nucleus(1). NFAT dephosphorylation by calcineurin is countered by distinct NFAT kinases, among them casein kinase 1 (CK1) and glycogen synthase kinase 3 (GSK3)(1-5). Here we have used a genome-wide RNA interference ( RNAi) screen in Drosophila(6,7) to identify additional regulators of the signalling pathway leading from Ca2+- calcineurin to NFAT. This screen was successful because the pathways regulating NFAT subcellular localization (Ca2+ influx, Ca2+ - calmodulin calcineurin signalling and NFAT kinases) are conserved across species(8,9), even though Ca2+-regulated NFAT proteins are not themselves represented in invertebrates. Using the screen, we have identified DYRKs (dual-specificity tyrosine-phosphorylation regulated kinases) as novel regulators of NFAT. DYRK1A and DYRK2 counter calcineurin-mediated dephosphorylation of NFAT1 by directly phosphorylating the conserved serine-proline repeat 3 (SP-3) motif of the NFAT regulatory domain, thus priming further phosphorylation of the SP-2 and serine-rich region 1 (SRR1) motifs by GSK3 and CK1, respectively. Thus, genetic screening in Drosophila can be successfully applied to cross evolutionary boundaries and identify new regulators of a transcription factor that is expressed only in vertebrates.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Rao, AJ (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, 200 Longwood Ave, Boston, MA 02115 USA.	arao@cbr.med.harvard.edu	Feske, stefan/ABB-3554-2021	Feske, stefan/0000-0001-5431-8178				Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Armknecht S, 2005, METHOD ENZYMOL, V392, P55, DOI 10.1016/S0076-6879(04)92004-6; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Bhattacharyya A, 2003, GENES BRAIN BEHAV, V2, P179, DOI 10.1034/j.1601-183X.2003.00025.x; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Carafoli E, 2003, NAT REV MOL CELL BIO, V4, P326, DOI 10.1038/nrm1073; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Harwood AJ, 2001, CELL, V105, P821, DOI 10.1016/S0092-8674(01)00412-3; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Neal JW, 2001, J BIOL CHEM, V276, P3666, DOI 10.1074/jbc.M004888200; Nishi Y, 2005, DEV BIOL, V288, P139, DOI 10.1016/j.ydbio.2005.09.053; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Roderick HL, 2003, CURR BIOL, V13, pR976, DOI 10.1016/j.cub.2003.11.048; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Shirayama M, 2006, CURR BIOL, V16, P47, DOI 10.1016/j.cub.2005.11.070; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Wiechmann S, 2003, BIOCHEM BIOPH RES CO, V302, P403, DOI 10.1016/S0006-291X(03)00148-7; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	30	287	309	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					646	650		10.1038/nature04631	http://dx.doi.org/10.1038/nature04631			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16511445				2022-12-24	WOS:000237920800050
J	Huang, Y; Fang, J; Bedford, MT; Zhang, Y; Xu, RM				Huang, Y; Fang, J; Bedford, MT; Zhang, Y; Xu, RM			Recognition of histone H3 lysine-4 methylation by the double tudor domain of JMJD2A	SCIENCE			English	Article							BINDING; CHROMODOMAIN; BROMODOMAIN; PROTEIN; FAMILY; 53BP1; TAIL; DNA	Biological responses to histone methylation critically depend on the faithful readout and transduction of the methyl-lysine signal by "effector'' proteins, yet our understanding of methyl-lysine recognition has so far been limited to the study of histone binding by chromodomain and WD40-repeat proteins. The double tudor domain of JMJD2A, a Jmjc domain - containing histone demethylase, binds methylated histone H3-K4 and H4-K20. We found that the double tudor domain has an interdigitated structure, and the unusual fold is required for its ability to bind methylated histone tails. The cocrystal structure of the JMJD2A double tudor domain with a trimethylated H3-K4 peptide reveals that the trimethyl-K4 is bound in a cage of three aromatic residues, two of which are from the tudor-2 motif, whereas the binding specificity is determined by side-chain interactions involving amino acids from the tudor-1 motif. Our study provides mechanistic insights into recognition of methylated histone tails by tudor domains and reveals the structural intricacy of methyl-lysine recognition by two closely spaced effector domains.	Cold Spring Harbor Lab, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; Univ Texas, MD Anderson Canc Ctr, Sci Pk Res Div, Smithville, TX 78957 USA	Cold Spring Harbor Laboratory; University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; UTMD Anderson Cancer Center	Xu, RM (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Struct Biol Program, New York, NY 10016 USA.	rmxu@saturn.med.nyu.edu	Bedford, Mark T/E-7856-2011; xu, rui/GRX-5734-2022; Huang, Ying/AFM-0838-2022	Huang, Ying/0000-0002-2806-2874; Fang, Jia/0000-0001-8583-1652; Zhang, Yi/0000-0002-2789-0811	NIDDK NIH HHS [DK62248] Funding Source: Medline; NIGMS NIH HHS [GM68804, GM 63718] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062248, R01DK062248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Charier G, 2004, STRUCTURE, V12, P1551, DOI 10.1016/j.str.2004.06.014; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Gray SG, 2005, J BIOL CHEM, V280, P28507, DOI 10.1074/jbc.M413687200; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Zhang DZ, 2005, MOL CELL BIOL, V25, P6404, DOI 10.1128/MCB.25.15.6404-6414.2005	18	352	370	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					748	751		10.1126/science.1125162	http://dx.doi.org/10.1126/science.1125162			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16601153				2022-12-24	WOS:000237312100051
J	Hsieh, HH; Jewitt, D				Hsieh, HH; Jewitt, D			A population of comets in the main asteroid belt	SCIENCE			English	Article							JUPITER-FAMILY COMETS; KUIPER-BELT; WATER; EVOLUTION	Comets are icy bodies that sublimate and become active when close to the Sun. They are believed to-originate in two cold reservoirs beyond the orbit of Neptune: the Kuiper Belt (equilibrium temperatures of similar to 40 kelvin) and the Oort Cloud (similar to 10 kelvin). We present optical data showing the existence of a population of comets originating in a third reservoir: the main asteroid belt. The main-belt comets are unlike the Kuiper Belt and Oort Cloud comets in that they likely formed where they currently reside and may be collisionally activated. The existence of the mainbelt comets lends new support to the idea that main-belt objects could be a major source of terrestrial water.	Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA	University of Hawaii System	Hsieh, HH (corresponding author), Univ Hawaii, Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA.	hsieh@ifa.hawaii.edu						AGHI S, 1973, ASTRON ASTROPHYS, V24, P107; AHEARN MF, 1992, ICARUS, V98, P54, DOI 10.1016/0019-1035(92)90206-M; Carvano JM, 2003, ICARUS, V161, P356, DOI 10.1016/S0019-1035(02)00035-0; Cheng AF, 2004, ICARUS, V169, P357, DOI 10.1016/j.icarus.2004.02.002; Cohen BA, 2000, ICARUS, V145, P369, DOI 10.1006/icar.2000.6329; Cyr KE, 1998, ICARUS, V135, P537, DOI 10.1006/icar.1998.5959; DE BR, 1977, J GEOPHYS RES-SPACE, V82, P999, DOI 10.1029/JA082i007p00999; Di Sisto RP, 2005, ICARUS, V174, P81, DOI 10.1016/j.icarus.2004.10.024; EIST EW, 1996, 6456 IAU, P1; FANALE FP, 1989, ICARUS, V82, P97, DOI 10.1016/0019-1035(89)90026-2; Fernandez JA, 2002, ICARUS, V159, P358, DOI 10.1006/icar.2002.6903; Hodapp KW, 2004, ASTRON NACHR, V325, P636, DOI 10.1002/asna.200410300; Hsieh HH, 2004, ASTRON J, V127, P2997, DOI 10.1086/383208; JEWITT D, 1993, NATURE, V362, P730, DOI 10.1038/362730a0; JEWITT DC, 1990, ASTRON J, V100, P933, DOI 10.1086/115572; Jewitt DC, 2004, SPACE SCI S, P659; JONES TD, 1990, ICARUS, V88, P172, DOI 10.1016/0019-1035(90)90184-B; Keil K, 2000, PLANET SPACE SCI, V48, P887, DOI 10.1016/S0032-0633(00)00054-4; KRESAK L, 1980, MOON PLANETS, V22, P83, DOI 10.1007/BF00896869; LEBOFSKY LA, 1981, ICARUS, V48, P453, DOI 10.1016/0019-1035(81)90055-5; Levison HF, 1997, ICARUS, V127, P13, DOI 10.1006/icar.1996.5637; Levison HF, 1996, ASTR SOC P, V107, P173; Morbidelli A, 2000, METEORIT PLANET SCI, V35, P1309, DOI 10.1111/j.1945-5100.2000.tb01518.x; Oort J., 1950, BAIN, V11, P91; OWEN T, 1991, ASTROPHYS SPACE SC L, V167, P429; Pittich EA, 2004, ASTRON ASTROPHYS, V422, P369, DOI 10.1051/0004-6361:20034085; READ MT, 2005, 8624 IAU, P1; Sasselov DD, 2000, ASTROPHYS J, V528, P995, DOI 10.1086/308209; WHIPPLE FL, 1950, ASTROPHYS J, V111, P375, DOI 10.1086/145272	29	308	309	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					561	563		10.1126/science.1125150	http://dx.doi.org/10.1126/science.1125150			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16556801				2022-12-24	WOS:000237296700040
J	Van Wassenbergh, S; Herrel, A; Adriaens, D; Huysentruyt, F; Devaere, S; Aerts, P				Van Wassenbergh, S; Herrel, A; Adriaens, D; Huysentruyt, F; Devaere, S; Aerts, P			A catfish that can strike its prey on land	NATURE			English	Article							CAPTURE		Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium; Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium	University of Antwerp; Ghent University; Ghent University	Van Wassenbergh, S (corresponding author), Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium.	sam.vanwassenbergh@ua.ac.be	Herrel, Anthony/C-3712-2013; Huysentruyt, Frank/F-2809-2010; Adriaens, Dominique/G-1587-2010	Herrel, Anthony/0000-0003-0991-4434; Adriaens, Dominique/0000-0003-3610-2773; Van Wassenbergh, Sam/0000-0001-5746-4621; Aerts, Peter/0000-0002-6867-5421				Ahlberg PE, 2005, NATURE, V437, P137, DOI 10.1038/nature03893; AHLBERG PE, 1994, NATURE, V368, P507, DOI 10.1038/368507a0; Bramble D.M., 1985, P230; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Huysentruyt F, 2004, BELG J ZOOL, V134, P41; LAUDER GV, 1980, J MORPHOL, V163, P283, DOI 10.1002/jmor.1051630305; SPONDER DL, 1981, J ZOOL, V193, P517; Summers AP, 1998, J EXP ZOOL, V281, P280, DOI 10.1002/(SICI)1097-010X(19980701)281:4<280::AID-JEZ4>3.0.CO;2-K; Van Wassenbergh S, 2005, J EXP BIOL, V208, P4627, DOI 10.1242/jeb.01919	9	33	34	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					881	881		10.1038/440881a	http://dx.doi.org/10.1038/440881a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612372				2022-12-24	WOS:000236736700028
J	Monnier, L; Mas, E; Ginet, C; Michel, F; Villon, L; Cristol, JP; Colette, C				Monnier, L; Mas, E; Ginet, C; Michel, F; Villon, L; Cristol, JP; Colette, C			Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic Hyperglycemia in patients with type 2 diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IN-VIVO FORMATION; CARDIOVASCULAR-DISEASE; LIPID-PEROXIDATION; POSTPRANDIAL HYPERGLYCEMIA; MACROVASCULAR DISEASE; ISOPROSTANE FORMATION; PLATELET ACTIVATION; MASS-SPECTROMETRY; METABOLIC-CONTROL; BLOOD-GLUCOSE	Context Glycemic disorders, one of the main risk factors for cardiovascular disease, are associated with activation of oxidative stress. Objective To assess the respective contributions of sustained chronic hyperglycemia and of acute glucose fluctuations to oxidative stress in type 2 diabetes. Design, Setting, and Participants Case-control study of 21 patients with type 2 diabetes (studied 2003-2005) compared with 21 age- and sex-matched controls (studied in 2001) in Montpellier, France Main Outcome Measures Oxidative stress, estimated from 24-hour urinary excretion rates of free 8-iso prostaglandin F-2 alpha (8-iso PGF(2 alpha)). Assessment of glucose fluctuations was obtained from continuous glucose monitoring system data by calculating the mean amplitude of glycemic excursions (MAGE). Postprandial contribution to glycemic instability was assessed by determining the postprandial increment of glucose level above preprandial values (mean postprandial incremental area under the curve [AUCpp]). Long-term exposure to glucose was estimated from hemoglobin A(1c), from fasting glucose levels, and from mean glucose concentrations over a 24-hour period. Results Mean (SD) urinary 8-iso PGF(2 alpha) excretion rates were higher in the 21 patients with diabetes (482 [206] pg/mg of creatinine) compared with controls (275 [ 85] pg/mg of creatinine). In univariate analysis, only MAGE (r = 0.86; P < .001) and AUCpp (r = 0.55; P = .009) showed significant correlations with urinary 8-iso PGF(2 alpha) excretion rates. Relationships between 8-iso PGF(2 alpha) excretion rates and either MAGE or AUCpp remained significant after adjustment for the other markers of diabetic control in multiple linear regression analysis (multiple R-2 = 0.72 for the model including MAGE and multiple R-2 = 0.41 for the model including AUCpp). Standardized regression coefficients were 0.830 (P < .001) for MAGE and 0.700 (P = .003) for AUCpp. Conclusions Glucose fluctuations during postprandial periods and, more generally, during glucose swings exhibited a more specific triggering effect on oxidative stress than chronic sustained hyperglycemia. The present data suggest that interventional trials in type 2 diabetes should target not only hemoglobin A(1c) and mean glucose concentrations but also acute glucose swings.	Univ Montpellier, Lapeyronie Hosp, Dept Metab Dis, F-34295 Montpellier 5, France; Univ Montpellier, Univ Inst Clin Res, Lab Human Nutr & Atherogenesis, F-34295 Montpellier 5, France	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier	Monnier, L (corresponding author), Univ Montpellier, Lapeyronie Hosp, Dept Metab Dis, 371 Ave Doyen Giraud, F-34295 Montpellier 5, France.	l-monnier@chu-montpellier.fr						[Anonymous], 2005, DIABETES CARE, V28, pS4; [Anonymous], 1995, DIABETES, V44, P968; Basu S, 2005, ANTIOXID REDOX SIGN, V7, P221, DOI 10.1089/ars.2005.7.221; Basu S, 1998, FEBS LETT, V428, P32, DOI 10.1016/S0014-5793(98)00481-5; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Bessard J, 2001, J CHROMATOGR B, V754, P333, DOI 10.1016/S0378-4347(00)00621-6; Bonora E, 2001, DIABETOLOGIA, V44, P2107, DOI 10.1007/s001250100020; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Ceriello A, 2004, ARCH INTERN MED, V164, P2090, DOI 10.1001/archinte.164.19.2090; Ceriello A, 2003, DIABETOLOGIA, V46, pM9, DOI 10.1007/s00125-002-0931-5; Ceriello A, 2002, DIABETES CARE, V25, P1439, DOI 10.2337/diacare.25.8.1439; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Davi G, 2005, ANTIOXID REDOX SIGN, V7, P256, DOI 10.1089/ars.2005.7.256; Davi G, 2003, CIRCULATION, V107, P3199, DOI 10.1161/01.CIR.0000074205.17807.D0; Davi G, 1999, CIRCULATION, V99, P224; Davi G, 1997, ARTERIOSCL THROM VAS, V17, P3230, DOI 10.1161/01.ATV.17.11.3230; Desideri G, 2003, J CLIN ENDOCR METAB, V88, P5341, DOI 10.1210/jc.2003-030724; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; Eastman RC, 1997, DIABETES CARE, V20, P725, DOI 10.2337/diacare.20.5.725; Fava D, 2002, DIABETIC MED, V19, P752, DOI 10.1046/j.1464-5491.2002.00762.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Guerci B, 2003, DIABETES CARE, V26, P582, DOI 10.2337/diacare.26.3.582; Jokl R, 1997, DIABETES REV, V5, P316; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; Klonoff DC, 2005, DIABETES CARE, V28, P1231, DOI 10.2337/diacare.28.5.1231; Laakso M, 1997, DIABETES REV, V5, P294; Lyons TJ, 1997, DIABETES REV, V5, P365; Metzger M, 2002, DIABETES CARE, V25, P1185, DOI 10.2337/diacare.25.7.1185; Monnier L, 2003, DIABETES CARE, V26, P881, DOI 10.2337/diacare.26.3.881; Monnier L, 2004, EUR J CLIN INVEST, V34, P37, DOI 10.1111/j.1365-2362.2004.01280.x; Monnier L, 2002, DIABETES CARE, V25, P737, DOI 10.2337/diacare.25.4.737; MONNIER LH, 1984, DIABETES, V33, P907, DOI 10.2337/diabetes.33.9.907; Monsod TP, 2002, DIABETES CARE, V25, P889, DOI 10.2337/diacare.25.5.889; Montero A, 2000, KIDNEY INT, V58, P1963, DOI 10.1111/j.1523-1755.2000.00368.x; MORROW JD, 1995, NEW ENGL J MED, V332, P1198, DOI 10.1056/NEJM199505043321804; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Patrono C, 2005, CURR OPIN PHARMACOL, V5, P198, DOI 10.1016/j.coph.2004.11.003; Roberts LJ, 2000, FREE RADICAL BIO MED, V28, P505, DOI 10.1016/S0891-5849(99)00264-6; Sampson MJ, 2002, DIABETES CARE, V25, P537, DOI 10.2337/diacare.25.3.537; Schwedhelm E, 2003, CLIN CHEM LAB MED, V41, P1552, DOI 10.1515/CCLM.2003.238; SERVICE FJ, 1970, DIABETES, V19, P644, DOI 10.2337/diab.19.9.644; SERVICE FJ, 1987, DIABETES CARE, V10, P225, DOI 10.2337/diacare.10.2.225; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stojiljkovic MP, 2002, J HYPERTENS, V20, P1215, DOI 10.1097/00004872-200206000-00036; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Taskinen MR, 2003, DIABETOLOGIA, V46, P733, DOI 10.1007/s00125-003-1111-y; TROVATI M, 1991, DIABETOLOGIA, V34, P662, DOI 10.1007/BF00400996; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Zar J.H., 1996, BIOSTAT ANAL, V3rd	55	1610	1804	4	70	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2006	295	14					1681	1687		10.1001/jama.295.14.1681	http://dx.doi.org/10.1001/jama.295.14.1681			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031LY	16609090	Bronze			2022-12-24	WOS:000236707300024
J	Saaddine, JB; Cadwell, B; Gregg, EW; Engelgau, MM; Vinicor, F; Imperatore, G; Narayan, KMV				Saaddine, JB; Cadwell, B; Gregg, EW; Engelgau, MM; Vinicor, F; Imperatore, G; Narayan, KMV			Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002	ANNALS OF INTERNAL MEDICINE			English	Article						n	GLYCEMIC CONTROL; MANAGED CARE; RISK-FACTORS; EYE CARE; QUALITY; HEALTH; MELLITUS; ADULTS; REDUCTION; DISEASE	Background: Progress of diabetes care is a subject of public health concern. Objective: To assess changes in quality of diabetes care in the United States by using standardized measures. Design: National population-based, serial cross-sectional surveys. Setting: National Health and Nutrition Examination Survey (19881994 and 1999-2002) and the Behavioral Risk Factor Surveillance System (1995 and 2002). Participants: Survey participants 18 to 75 years of age who reported a diagnosis of diabetes. Measurements: Glycemic control, blood pressure, low-density lipoprotein (LDL) cholesterol level, annual cholesterol level monitoring, and annual foot and dilated eye examination, as defined by the National Diabetes Quality Improvement Alliance measures. Results: In the past decade, the proportion of persons with diabetes with poor glycemic control (hemoglobin A(1c) > 9%) showed a non statistically significant decrease of 3.9% (95% Cl, -10.4% to 2.5%), while the proportion of persons with fair or good lipid control (LDL cholesterol level < 3.4 mmol/L [< 130 mg/dL]) had a statistically significant increase of 21.9% (Cl, 12.4% to 31.3%). Mean LDL cholesterol level decreased by 0.5 mmol/L (18.8 mg/dL). Although mean hemoglobin A, did not change, the proportion of persons with hemoglobin A, of 6% to 8% increased from 34.2% to 47.0%. The blood pressure distribution did not change. Annual lipid testing, dilated eye examination, and foot examination increased by 8.3% (Cl, 4.0% to 12.7%), 4.5% (Cl, 0.5% to 8.5%), and 3.8% (Cl, -0.1% to 7.7%), respectively. The proportion of persons reporting annual influenza vaccination and aspirin use improved by 6.8 percentage points (Cl, 2.9 percentage points to 10.7 percentage points) and 13.1 percentage points (Cl, 5.4 percentage points to 20.7 percentage points), respectively. Limitations: Data are self-reported, and the surveys do not have all National Diabetes Quality Improvement Alliance indicators. Conclusion: Diabetes processes of care and intermediate outcomes have improved nationally in the past decade. But 2 in 5 persons with diabetes still have poor LDL cholesterol control, 1 in 3 persons still has poor blood pressure control, and 1 in 5 persons still has poor glycemic control.	Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Saaddine, JB (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Highway,NE MS-K10, Atlanta, GA 30341 USA.	jsaddine@cdc.gov	Narayan, K.M. Venkat/J-9819-2012	Narayan, K.M. Venkat/0000-0001-8621-5405; Gregg, Edward/0000-0003-2381-6822				*AM ASS CLIN END, 2002, ENDOCR PRACT S1, V8, P40; [Anonymous], 2005, DIABETES CARE, V28, pS4; [Anonymous], 1994, VITAL HLTH STAT, P1; Beckles GLA, 1998, DIABETES CARE, V21, P1432, DOI 10.2337/diacare.21.9.1432; Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Bowlin SJ, 1996, J CLIN EPIDEMIOL, V49, P511, DOI 10.1016/0895-4356(96)00010-8; Bridges RB, 1996, J PERIODONTOL, V67, P1185, DOI 10.1902/jop.1996.67.11.1185; Brown AF, 2005, ARCH OPHTHALMOL-CHIC, V123, P669, DOI 10.1001/archopht.123.5.669; *CDCP, 2005, NAT DIAB FACT SHEET; Early Treatment Diabetic Retinopathy Study Res Grp, 1991, OPHTHALMOLOGY, V98, P766; Engelgau MM, 1998, DIABETES CARE, V21, P2062, DOI 10.2337/diacare.21.12.2062; Fleming BB, 2001, DIABETES CARE, V24, P1815, DOI 10.2337/diacare.24.10.1815; Fowles JB, 1999, INT J QUAL HEALTH C, V11, P407, DOI 10.1093/intqhc/11.5.407; Frazier EL, 1992, USING CHRONIC DIS DA, P1; Gerstein HC, 2000, LANCET, V355, P253; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; Grant RW, 2005, DIABETES CARE, V28, P337, DOI 10.2337/diacare.28.2.337; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; Honeycutt Amanda A, 2003, Health Care Manag Sci, V6, P155, DOI 10.1023/A:1024467522972; Imperatore G, 2004, AM J EPIDEMIOL, V160, P531, DOI 10.1093/aje/kwh232; JAVITT JC, 1994, DIABETES CARE, V17, P909, DOI 10.2337/diacare.17.8.909; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; KENNY SJ, 1993, DIABETES CARE, V16, P1507, DOI 10.2337/diacare.16.11.1507; Kerr EA, 2004, ANN INTERN MED, V141, P272, DOI 10.7326/0003-4819-141-4-200408170-00007; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; KORN EL, 1999, WILEY S PRO STAT SUR, P1; LITZELMAN DK, 1993, ANN INTERN MED, V119, P36, DOI 10.7326/0003-4819-119-1-199307010-00006; McClain MR, 2003, DIABETES CARE, V26, P597, DOI 10.2337/diacare.26.3.597; Mealey B, 1999, J PERIODONTOL, V70, P935; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; National Center for Health Statistics, NHANES 1999 2000 DAT; Petersen M, 2003, DIABETES CARE, V26, P917; Roubideaux Y, 2004, AM J PUBLIC HEALTH, V94, P60, DOI 10.2105/AJPH.94.1.60; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; Sawin CT, 2004, DIABETES CARE, V27, pB90, DOI 10.2337/diacare.27.suppl_2.B90; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; SCHWARTZ JS, 1997, CIRCULATION S1, V96, P1504; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SIEGEL JE, 1992, J AM SOC NEPHROL, V3, pS111; Stearne MR, 1998, BMJ-BRIT MED J, V317, P720; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; STEIN AD, 1995, AM J EPIDEMIOL, V141, P1097, DOI 10.1093/oxfordjournals.aje.a117375; STEIN AD, 1993, AM J PUBLIC HEALTH, V83, P1768, DOI 10.2105/AJPH.83.12.1768; Taylor GW, 1996, J PERIODONTOL, V67, P1085, DOI 10.1902/jop.1996.67.10s.1085; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; U.S. Department of Health and Human Services (DHHS) National Center for Health Statistics, 1996, 3 NAT HLTH NUTR EX S; WEINBERER M, 1995, J GEN INTERN MED, V10, P59, DOI 10.1007/BF02600227; 2002, DIABETES CARE S1, V25, pS33; 2002, DIABETES CARE S1, V25, pS80	52	437	453	1	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2006	144	7					465	474		10.7326/0003-4819-144-7-200604040-00005	http://dx.doi.org/10.7326/0003-4819-144-7-200604040-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031DU	16585660				2022-12-24	WOS:000236685100001
J	Boyman, O; Kovar, M; Rubinstein, MP; Surh, CD; Sprent, J				Boyman, O; Kovar, M; Rubinstein, MP; Surh, CD; Sprent, J			Selective stimulation of T cell subsets with antibody-cytokine immune complexes	SCIENCE			English	Article							RECOMBINANT INTERLEUKIN-2; IL-2 RECEPTOR; GAMMA-CHAIN; IN-VIVO; MEMORY; PROTEINS	Interleukin-2 (IL-2), which is a growth factor for T lymphocytes, can also sometimes be inhibitory. Thus, the proliferation of CD8(+) T cells in vivo is increased after the injection of a monoclonal antibody that is specific for IL-2 (IL-2 mAb), perhaps reflecting the removal of IL-2-dependent CD4(+) T regulatory cells (T regs). Instead, we show here that IL-2 mAb augments the proliferation of CD8(+) cells in mice simply by increasing the biological activity of preexisting IL-2 through the formation of immune complexes. When coupled with recombinant IL-2, some IL-2/IL-2 mAb complexes cause massive (>100-fold) expansion of CD8(+) cells in vivo, whereas others selectively stimulate CD4(+) T regs. Thus, different cytokine-antibody complexes can be used to selectively boost or inhibit the immune response.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	Scripps Research Institute; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Sprent, J (corresponding author), Scripps Res Inst, Dept Immunol, IMM4,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	j.sprent@garvan.org.au	Kovar, Marek/H-7793-2014	Boyman, Onur/0000-0001-8279-5545				BOYMAN O, UNPUB; COURTNEY LP, 1994, IMMUNOPHARMACOLOGY, V28, P223, DOI 10.1016/0162-3109(94)90058-2; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Kamimura D, 2004, J IMMUNOL, V173, P6041, DOI 10.4049/jimmunol.173.10.6041; KLEIN B, 1995, IMMUNOL TODAY, V16, P216, DOI 10.1016/0167-5699(95)80161-8; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Murakami M, 2002, P NATL ACAD SCI USA, V99, P8832, DOI 10.1073/pnas.132254399; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; SATO J, 1993, BIOTHERAPY, V6, P225, DOI 10.1007/BF01878084; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; WALDMANN TA, 1989, ANNU REV BIOCHEM, V58, P875, DOI 10.1146/annurev.bi.58.070189.004303; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; ZURAWSKI SM, 1986, J IMMUNOL, V137, P3354	19	643	672	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2006	311	5769					1924	1927		10.1126/science.1122927	http://dx.doi.org/10.1126/science.1122927			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16484453				2022-12-24	WOS:000236387800045
J	Raymond, J; Segre, D				Raymond, J; Segre, D			The effect of oxygen on biochemical networks and the evolution of complex life	SCIENCE			English	Article							ATMOSPHERIC OXYGEN; EARTH	The evolution of oxygenic photosynthesis and ensuing oxygenation of Earth's atmosphere represent a major transition in the history of life. Although many organisms retreated to anoxic environments, others evolved to use oxygen as a. high-potential redox couple white concomitantly mitigating its toxicity. To understand the changes in biochemistry and enzymology that accompanied adaptation to O-2, we integrated network analysis with information on enzyme evolution to infer how oxygen availability changed the architecture of metabolic networks. Our analysis revealed the existence of four discrete groups of networks of increasing complexity, with transitions between groups being contingent on the presence of key metabolites, including molecular oxygen, which was required for transition into the largest networks.	Lawrence Livermore Natl Lab, Microbial Syst Div, Biosci Directorate, Livermore, CA 94550 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Boston Univ, Dept Biol, Bioinformat Program, Boston, MA 02215 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Boston University; Boston University	Raymond, J (corresponding author), Lawrence Livermore Natl Lab, Microbial Syst Div, Biosci Directorate, POB 5508, Livermore, CA 94550 USA.		Segrè, Daniel/A-1993-2009	Segrè, Daniel/0000-0003-4859-1914				Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Des Marais DJ, 2000, SCIENCE, V289, P1703; Dismukes GC, 2001, P NATL ACAD SCI USA, V98, P2170, DOI 10.1073/pnas.061514798; Ebenhoh Oliver, 2005, Genome Inform, V16, P203; Ebenhoh Oliver, 2004, Genome Inform, V15, P35; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Handorf T, 2005, J MOL EVOL, V61, P498, DOI 10.1007/s00239-005-0027-1; HAYES JM, 1994, NOBEL S, V84; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kirschvink JL, 2000, P NATL ACAD SCI USA, V97, P1400, DOI 10.1073/pnas.97.4.1400; Knoll AH, 2003, GEOBIOLOGY, V1, P3, DOI 10.1046/j.1472-4669.2003.00002.x; Morowitz Harold J., 1999, Complexity, V4, P39, DOI 10.1002/(SICI)1099-0526(199907/08)4:6<39::AID-CPLX8>3.0.CO;2-2; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Raymond J, 2004, GEOBIOLOGY, V2, P199, DOI 10.1111/j.1472-4677.2004.00037.x; Rees DC, 2003, SCIENCE, V300, P929, DOI 10.1126/science.1083075; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724	20	314	326	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1764	1767		10.1126/science.1118439	http://dx.doi.org/10.1126/science.1118439			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556842				2022-12-24	WOS:000236204300042
J	Scannell, DR; Byrne, KP; Gordon, JL; Wong, S; Wolfe, KH				Scannell, DR; Byrne, KP; Gordon, JL; Wong, S; Wolfe, KH			Multiple rounds of speciation associated with reciprocal gene loss in polyploid yeasts	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; GENOME DUPLICATION; EVOLUTION; HYBRID; DIVERGENT; STERILITY; ORDER	A whole- genome duplication occurred in a shared ancestor of the yeast species Saccharomyces cerevisiae, Saccharomyces castellii and Candida glabrata. Here we trace the subsequent losses of duplicated genes, and show that the pattern of loss differs among the three species at 20% of all loci. For example, several transcription factor genes, including STE12, TEC1, TUP1 and MCM1, are single-copy in S. cerevisiae but are retained in duplicate in S. castellii and C. glabrata. At many loci, different species have lost different members of a duplicated gene pair, so that 4 - 7% of single- copy genes compared between any two species are not orthologues. This pattern of gene loss provides strong evidence for speciation through a version of the Bateson - Dobzhansky - Muller mechanism, in which the loss of alternative copies of duplicated genes leads to reproductive isolation(1,2). We show that the lineages leading to the three species diverged shortly after the whole-genome duplication, during a period of precipitous gene loss. The set of loci at which single- copy paralogues are retained is biased towards genes involved in ribosome biogenesis and genes that evolve slowly, consistent with the hypothesis that reciprocal gene loss is more likely to occur between duplicated genes that are functionally indistinguishable. We propose a simple, unified model in which a single mechanism - passive gene loss - enabled whole- genome duplication and led to the rapid emergence of new yeast species.	Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland	Trinity College Dublin	Wolfe, KH (corresponding author), Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland.	khwolfe@tcd.ie	Wolfe, Kenneth H/B-4653-2009	Wolfe, Kenneth/0000-0003-4992-4979; Scannell, Devin/0000-0002-8188-5992; Byrne, Kevin/0000-0002-6368-154X; Gordon, Jonathan/0000-0002-1033-4368				Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Coyne J. A., 2004, SPECIATION; Delneri D, 2003, NATURE, V422, P68, DOI 10.1038/nature01418; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fischer G, 2001, GENOME RES, V11, P2009, DOI 10.1101/gr.212701; Goffeau A, 1997, NATURE, V387, P5, DOI DOI 10.1038/387005B0.PUBMED:9169864; Greig D, 2002, SCIENCE, V298, P1773, DOI 10.1126/science.1076374; Greig D, 2002, P ROY SOC B-BIOL SCI, V269, P1167, DOI 10.1098/rspb.2002.1989; Guldener U, 2005, NUCLEIC ACIDS RES, V33, pD364, DOI 10.1093/nar/gki053; Hittinger CT, 2004, P NATL ACAD SCI USA, V101, P14144, DOI 10.1073/pnas.0404319101; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Lynch M, 2000, AM NAT, V156, P590, DOI 10.1086/316992; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Taylor JS, 2001, TRENDS GENET, V17, P299, DOI 10.1016/S0168-9525(01)02318-6; WERTH CR, 1991, AM NAT, V137, P515, DOI 10.1086/285180; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648	25	302	318	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2006	440	7082					341	345		10.1038/nature04562	http://dx.doi.org/10.1038/nature04562			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541074	Green Published			2022-12-24	WOS:000235997600054
J	Wilson, KA; McBride, MF; Bode, M; Possingham, HP				Wilson, KA; McBride, MF; Bode, M; Possingham, HP			Prioritizing global conservation efforts	NATURE			English	Article							BIODIVERSITY; HOTSPOTS; COSTS	One of the most pressing issues facing the global conservation community is how to distribute limited resources between regions identified as priorities for biodiversity conservation(1-3). Approaches such as biodiversity hotspots(4), endemic bird areas(5) and ecoregions(6) are used by international organizations to prioritize conservation efforts globally(7). Although identifying priority regions is an important first step in solving this problem, it does not indicate how limited resources should be allocated between regions. Here we formulate how to allocate optimally conservation resources between regions identified as priorities for conservation - the 'conservation resource allocation problem'. Stochastic dynamic programming is used to find the optimal schedule of resource allocation for small problems but is intractable for large problems owing to the " curse of dimensionality"(8). We identify two easy- to- use and easy- to- interpret heuristics that closely approximate the optimal solution. We also show the importance of both correctly formulating the problem and using information on how investment returns change through time. Our conservation resource allocation approach can be applied at any spatial scale. We demonstrate the approach with an example of optimal resource allocation among five priority regions in Wallacea and Sundaland, the transition zone between Asia and Australasia.	Univ Queensland, Ctr Ecol, Sch Integrat Biol, Brisbane, Qld 4072, Australia; Univ Queensland, Ctr Ecol, Sch Phys Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Wilson, KA (corresponding author), Univ Queensland, Ctr Ecol, Sch Integrat Biol, Brisbane, Qld 4072, Australia.	k.wilson2@uq.edu.au	Bode, Michael/P-1333-2019; Bode, Michael/A-7116-2009; Possingham, Hugh/B-1337-2008; Wilson, Kerrie/W-4181-2019; McBride, Marissa FC/D-5573-2009; POSSINGHAM, HUGH/R-8310-2019; Wilson, Kerrie A/C-8058-2009	Bode, Michael/0000-0002-5886-4421; Bode, Michael/0000-0002-5886-4421; Possingham, Hugh/0000-0001-7755-996X; Wilson, Kerrie/0000-0002-0092-935X; POSSINGHAM, HUGH/0000-0001-7755-996X; Wilson, Kerrie A/0000-0002-0092-935X; McBride, Marissa/0000-0002-7498-292X				Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; BALMFORD A, 2000, CONSERV BIOL, V14, P1; Bellman RE., 2010, DYNAMIC PROGRAMMING; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Clark CW, 2000, OX ECOL EV; Costello C, 2004, RESOUR ENERGY ECON, V26, P157, DOI 10.1016/j.reseneeco.2003.11.005; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Dalton R, 2000, NATURE, V406, P818, DOI 10.1038/35022727; Drechsler M, 2005, BIOL CONSERV, V122, P253, DOI 10.1016/j.biocon.2004.07.015; Frazee SR, 2003, BIOL CONSERV, V112, P275, DOI 10.1016/S0006-3207(02)00400-7; Groves C., 2000, DESIGNING GEOGRAPHY; HALPERN BS, IN PRESS CONSERV BIO; Linkie M, 2004, BIODIVERS CONSERV, V13, P1809, DOI 10.1023/B:BIOC.0000035867.90891.ea; MacArthur R. H., 1967, THEORY ISLAND BIOGEO; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Moore J, 2004, BIOL CONSERV, V117, P343, DOI 10.1016/j.biocon.2003.12.013; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Odling-Smee L, 2005, NATURE, V437, P614, DOI 10.1038/437614a; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626; POSSINGHAM H, 1993, DECISION SCI TOOLS T, P536; Possingham HP, 2005, NATURE, V436, P919, DOI 10.1038/436919a; Possingham HP, 2001, CONSERVATION BIOLOGY: RESEARCH PRIORITIES FOR THE NEXT DECADE, P225; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Wilson K, 2005, ENVIRON MANAGE, V35, P527, DOI 10.1007/s00267-004-0095-9	28	428	449	2	241	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 16	2006	440	7082					337	340		10.1038/nature04366	http://dx.doi.org/10.1038/nature04366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541073				2022-12-24	WOS:000235997600053
J	Alle, H; Geiger, JRP				Alle, H; Geiger, JRP			Combined analog and action potential coding in hippocampal mossy fibers	SCIENCE			English	Article							DENTATE GRANULE CELLS; MECHANORECEPTOR NEURONS; IN-VIVO; SYNAPSES; BOUTONS; TRANSMISSION; MODULATION; ACTIVATION; PLASTICITY; CHANNELS	In the mammalian cortex, it is generally assumed that the output information of neurons is encoded in the number and the timing of action potentials. Here, we show, by using direct patch-clamp recordings from presynaptic hippocampal mossy fiber boutons, that axons transmit analog signals in addition to action potentials. Excitatory presynaptic potentials result from subthreshold dendritic synaptic inputs, which propagate several hundreds of micrometers along the axon and modulate action potential-evoked transmitter release at the mossy fiber-CA3 synapse. This combined analog and action potential coding represents an additional mechanism for information transmission in a major hippocampal pathway.	Max Planck Inst Brain Res, Independent Hertie Res Grp, D-60528 Frankfurt, Germany	Max Planck Society	Geiger, JRP (corresponding author), Max Planck Inst Brain Res, Independent Hertie Res Grp, D-60528 Frankfurt, Germany.	geiger@mpih-frankfurt.mpg.de						Acsady L, 1998, J NEUROSCI, V18, P3386; ALLE H, UNPUB; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Bischofberger J, 2002, J NEUROSCI, V22, P10593; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Gao TM, 1998, J NEUROPHYSIOL, V80, P2860, DOI 10.1152/jn.1998.80.6.2860; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; Ivanov AI, 2003, J NEUROSCI, V23, P1206, DOI 10.1523/JNEUROSCI.23-04-01206.2003; JACKSON MB, 1993, J NEUROPHYSIOL, V69, P692, DOI 10.1152/jn.1993.69.3.692; Juusola M, 1996, TRENDS NEUROSCI, V19, P292, DOI 10.1016/S0166-2236(96)10028-X; Katz PS, 2003, CURR BIOL, V13, pR554, DOI 10.1016/S0960-9822(03)00471-8; MUNOZ MD, 1990, BRAIN RES, V509, P91, DOI 10.1016/0006-8993(90)90313-Z; PASZTOR VM, 1982, SCIENCE, V215, P1635, DOI 10.1126/science.7071583; Penttonen M, 1997, HIPPOCAMPUS, V7, P437, DOI 10.1002/(SICI)1098-1063(1997)7:4<437::AID-HIPO9>3.0.CO;2-F; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Rieke F, 1998, SPIKES EXPLORING NEU; Ruiz A, 2003, NEURON, V39, P961, DOI 10.1016/S0896-6273(03)00559-2; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0	26	265	272	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2006	311	5765					1290	1293		10.1126/science.1119055	http://dx.doi.org/10.1126/science.1119055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019XB	16513983				2022-12-24	WOS:000235870400043
J	Qiao, YF; Molina, H; Pandey, A; Zhang, J; Cole, PA				Qiao, YF; Molina, H; Pandey, A; Zhang, J; Cole, PA			Chemical rescue of a mutant enzyme in living cells	SCIENCE			English	Article							SRC FAMILY KINASES; TYROSINE KINASE; V-SRC; TRANSFORMATION FINGERPRINT; ACTIVATION; PROTEIN; SPECIFICITY; ADHESIONS; INTEGRIN; ACTIN	The restoration of catalytic activity to mutant enzymes by small molecules is well established for in vitro systems. Here, we show that the protein tyrosine kinase Src arginine-388 -> alanine(R388A) mutant can be rescued in live cells with the use of the small molecule imidazole. Cellular rescue of a viral Src homolog was rapid and reversible and conferred predicted oncogenic properties. Using chemical rescue in combination with mass spectrometry, we confirmed six known Src kinase substrates and identified several new protein targets. Chemical rescue data suggest that cellular Src is active under basal conditions. Rescue of R388A cellular Src provided insights into the mitogen-activated protein kinase pathway. This chemical rescue approach will likely have many applications in cell signaling.	Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Cole, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	pcole@jhmi.edu	Pandey, Akhilesh/B-4127-2009	Pandey, Akhilesh/0000-0001-9943-6127				AMANCHY R, 2005, SCI STKE, V267; BELL JG, 1975, J GEN VIROL, V27, P127, DOI 10.1099/0022-1317-27-2-127; BELSHAW PJ, 1995, ANGEW CHEM INT EDIT, V34, P2129, DOI 10.1002/anie.199521291; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; CARTER P, 1987, SCIENCE, V237, P394, DOI 10.1126/science.3299704; CRAIK CS, 1987, SCIENCE, V237, P909, DOI 10.1126/science.3303334; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HWANG YW, 1987, J BIOL CHEM, V262, P13081; Iguchi K, 2002, APOPTOSIS, V7, P519, DOI 10.1023/A:1020691026578; Kazansky AV, 2001, CELL GROWTH DIFFER, V12, P1; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Li LM, 2003, MOL CELL BIOL, V23, P2883, DOI 10.1128/MCB.23.8.2883-2892.2003; Lowry WE, 2002, DEV CELL, V2, P733, DOI 10.1016/S1534-5807(02)00175-2; Malek RL, 2002, ONCOGENE, V21, P7256, DOI 10.1038/sj.onc.1205900; Paz K, 2004, ONCOGENE, V23, P8455, DOI 10.1038/sj.onc.1207803; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Shah K, 2002, CHEM BIOL, V9, P35, DOI 10.1016/S1074-5521(02)00086-8; Shogren-Knaak MA, 2001, ANNU REV CELL DEV BI, V17, P405, DOI 10.1146/annurev.cellbio.17.1.405; Spritz RA, 1998, AM J MED GENET, V75, P101, DOI 10.1002/(SICI)1096-8628(19980106)75:1<101::AID-AJMG20>3.0.CO;2-P; Suprynowicz FA, 2002, ONCOGENE, V21, P1695, DOI 10.1038/sj.onc.1205223; TONEY MD, 1989, SCIENCE, V243, P1485, DOI 10.1126/science.2538921; Tran NH, 2003, J BIOL CHEM, V278, P11221, DOI 10.1074/jbc.M210318200; VIHINEN M, 1994, P NATL ACAD SCI USA, V91, P12803, DOI 10.1073/pnas.91.26.12803; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Williams DM, 2000, J BIOL CHEM, V275, P38127, DOI 10.1074/jbc.C000606200; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	30	91	92	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2006	311	5765					1293	1297		10.1126/science.1122224	http://dx.doi.org/10.1126/science.1122224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019XB	16513984				2022-12-24	WOS:000235870400044
J	Banerjee, A; Santos, WL; Verdine, GL				Banerjee, A; Santos, WL; Verdine, GL			Structure of a DNA glycosylase searching for lesions	SCIENCE			English	Article							COLI FPG PROTEIN; ESCHERICHIA-COLI; DAMAGE RECOGNITION; CRYSTAL-STRUCTURE; REPAIR; BASE; 8-OXOGUANINE; SPECIFICITY; COMPLEXES; CLEAVAGE	DNA glycosylases must interrogate millions of base pairs of undamaged DNA in order to locate and then excise one damaged nucleobase. The nature of this search process remains poorly understood. Here we report the use of disulfide cross-linking (DXL) technology to obtain structures of a bacterial. DNA glycosylase, MutM, interrogating undamaged DNA. These structures, solved to 2.0 angstrom resolution, reveal the nature of the search process: The protein inserts a probe residue into the helical stack and severely buckles the target base pair, which remains intrahelical. MutM therefore actively interrogates the intact DNA helix white searching for damage.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Verdine, GL (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	gregory_verdine@harvard.edu	Banerjee, Anirban/AAC-4286-2020	Banerjee, Anirban/0000-0002-9314-2862; banerjee, anirban/0000-0003-1494-6801; Santos, Webster/0000-0002-4731-8548	NATIONAL CANCER INSTITUTE [R01CA100742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044853, F32GM067380] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA100742] Funding Source: Medline; NIGMS NIH HHS [F32 GM067380, GM044853, R01 GM044853] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATHERTON FR, 1945, J CHEM SOC, P660, DOI 10.1039/jr9450000660; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Banerjee A., UNPUB; Bhagwat M, 1996, BIOCHEMISTRY-US, V35, P659, DOI 10.1021/bi9522662; BOITEUX S, 1990, J BIOL CHEM, V265, P3916; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Cao CY, 2004, NAT STRUCT MOL BIOL, V11, P1230, DOI 10.1038/nsmb864; Coste F, 2004, J BIOL CHEM, V279, P44074, DOI 10.1074/jbc.M405928200; Fedorova OS, 2002, BIOCHEMISTRY-US, V41, P1520, DOI 10.1021/bi011524u; FROEHLER BC, 1986, TETRAHEDRON LETT, V27, P469, DOI 10.1016/S0040-4039(00)85507-0; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; Fromme JC, 2002, NAT STRUCT BIOL, V9, P544, DOI 10.1038/nsb809; GEWIRTH DT, 1995, NAT STRUCT BIOL, V2, P386, DOI 10.1038/nsb0595-386; Gilboa R, 2002, J BIOL CHEM, V277, P19811, DOI 10.1074/jbc.M202058200; He C, 2005, MOL CELL, V20, P117, DOI 10.1016/j.molcel.2005.08.013; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Ishchenko AA, 2002, BIOCHEMISTRY-US, V41, P7540, DOI 10.1021/bi0121297; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; LETSINGER RL, 1981, J AM CHEM SOC, V103, P7394, DOI 10.1021/ja00414a086; LIPSCOMB LA, 1995, P NATL ACAD SCI USA, V92, P719, DOI 10.1073/pnas.92.3.719; ODA Y, 1991, NUCLEIC ACIDS RES, V19, P1407, DOI 10.1093/nar/19.7.1407; Parikh SS, 2000, MUTAT RES-DNA REPAIR, V460, P183, DOI 10.1016/S0921-8777(00)00026-4; Plum GE, 1995, BIOCHEMISTRY-US, V34, P16148, DOI 10.1021/bi00049a030; Serre L, 2002, EMBO J, V21, P2854, DOI 10.1093/emboj/cdf304; Stivers JT, 2004, PROG NUCLEIC ACID RE, V77, P37, DOI 10.1016/S0079-6603(04)77002-6; TCHOU J, 1994, J BIOL CHEM, V269, P15318; Verdine GL, 1997, CHEM BIOL, V4, P329, DOI 10.1016/S1074-5521(97)90123-X; Viadiu H, 2000, MOL CELL, V5, P889, DOI 10.1016/S1097-2765(00)80329-9; WINKLER FK, 1993, EMBO J, V12, P1781, DOI 10.1002/j.1460-2075.1993.tb05826.x; Zharkov DO, 2005, MUTAT RES-FUND MOL M, V577, P24, DOI 10.1016/j.mrfmmm.2005.03.011; Zharkov DO, 1997, J BIOL CHEM, V272, P5335, DOI 10.1074/jbc.272.8.5335	32	168	186	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2006	311	5764					1153	1157		10.1126/science.1120288	http://dx.doi.org/10.1126/science.1120288			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017IU	16497933				2022-12-24	WOS:000235688100049
J	Servadei, F				Servadei, F			Coma scales	LANCET			English	Editorial Material							SCORE; TRAUMA; VALIDATION; INJURY; NEED		Osped Gen Provinciale M Bufalini, WHO, Neurotrauma Collaborating Ctr, I-47023 Cesena, Italy	World Health Organization	Servadei, F (corresponding author), Osped Gen Provinciale M Bufalini, WHO, Neurotrauma Collaborating Ctr, I-47023 Cesena, Italy.	francoservadei@libero.it	Servadei, Franco/ABX-4656-2022	Servadei, Franco/0000-0002-3595-3464				Bates D, 2001, J NEUROL NEUROSUR PS, V71, P20; BENZER A, 1991, LANCET, V338, P977, DOI 10.1016/0140-6736(91)91840-Q; BORN JD, 1988, ACTA NEUROCHIR, V91, P1, DOI 10.1007/BF01400520; Bouillon B, 1997, J TRAUMA, V42, P652, DOI 10.1097/00005373-199704000-00012; Chesnut RM, 2003, J TRAUMA, V54, P678; Gabbe Belinda J, 2003, Emerg Med (Fremantle), V15, P353, DOI 10.1046/j.1442-2026.2003.00474.x; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; MARRUBINI MB, 1984, INTENS CARE MED, V10, P217; MILLER JD, 1986, NEUROSURG REV, V9, P135, DOI 10.1007/BF01743065; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Norwood SH, 2002, J TRAUMA, V53, P503, DOI 10.1097/00005373-200209000-00018; Plum F, 1972, Contemp Neurol Ser, V10, P1; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; Stein SC, 2001, J TRAUMA, V50, P759, DOI 10.1097/00005373-200104000-00032; TEASDALE G, 1974, LANCET, V2, P81; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611	18	14	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 18	2006	367	9510					548	549		10.1016/S0140-6736(06)68197-X	http://dx.doi.org/10.1016/S0140-6736(06)68197-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	013GM	16488781				2022-12-24	WOS:000235397800006
J	Chekulaeva, M; Hentze, MW; Ephrussi, A				Chekulaeva, M; Hentze, MW; Ephrussi, A			Bruno acts as a dual repressor of oskar translation, promoting mRNA oligomerization and formation of silencing particles	CELL			English	Article							POLE CELL-FORMATION; BINDING-PROTEIN; DOSAGE COMPENSATION; INITIATION-FACTORS; SEX-LETHAL; DROSOPHILA; LOCALIZATION; RIBOSOMES; REQUIRE; RECRUITMENT	Prior to reaching the posterior pole of the Drosophila oocyte, oskar mRNA is translationally silenced by Bruno binding to BREs in the 3' untranslated region. The elF4E binding protein Cup interacts with Bruno and inhibits Oskar translation. Validating current models, we directly demonstrate the mechanism proposed for Cup-mediated repression: inhibition of small ribosomal subunit recruitment to Oskar mRNA. However, 43S complex recruitment remains inhibited in the absence of functional Cup, uncovering a second Bruno-dependent silencing mechanism. This mechanism involves mRNA oligomerization and formation of large (50S-80S) silencing particles that cannot be accessed by ribosomes. Bruno-dependent mRNA oligomerization into silencing particles emerges as a mode of translational control that may be particularly suited to coupling with mRNA transport.	European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; European Mol Biol Lab, Gene Express Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Chekulaeva, M (corresponding author), European Mol Biol Lab, Dev Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	hentze@embl.de; ephrussi@embl.de	Hentze, Matthias W/V-3980-2017; Ephrussi, Anne/AAG-4075-2020; Ephrussi, Anne/ABD-4393-2021; Chekulayeva, Marina/AAK-4853-2020	Hentze, Matthias W/0000-0002-4023-7876; Ephrussi, Anne/0000-0002-5061-4620; 				Baron-Benhamou Julie, 2004, Methods Mol Biol, V257, P135, DOI 10.1385/1-59259-750-5:135; Beckmann K, 2005, CELL, V122, P529, DOI 10.1016/j.cell.2005.06.011; Braat AK, 2004, DEV CELL, V7, P125, DOI 10.1016/j.devcel.2004.06.009; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Castagnetti S, 2000, DEVELOPMENT, V127, P1063; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Czaplinski K, 2005, DEV CELL, V8, P505, DOI 10.1016/j.devcel.2005.01.012; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Ferrandon D, 1997, EMBO J, V16, P1751, DOI 10.1093/emboj/16.7.1751; Gebauer F, 2003, MOL CELL, V11, P1397, DOI 10.1016/S1097-2765(03)00176-X; Gebauer F, 1999, EMBO J, V18, P6146, DOI 10.1093/emboj/18.21.6146; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; KOZAK M, 1978, CELL, V15, P1109, DOI 10.1016/0092-8674(78)90039-9; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Lee JH, 2002, P NATL ACAD SCI USA, V99, P16689, DOI 10.1073/pnas.262569399; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; Lie YS, 1999, DEVELOPMENT, V126, P4989; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Preiss T, 2003, BIOESSAYS, V25, P1201, DOI 10.1002/bies.10362; RONGO C, 1995, DEVELOPMENT, V121, P2737; SMITH JL, 1992, CELL, V70, P849, DOI 10.1016/0092-8674(92)90318-7; Spirin A. S., 1966, Current Topics in Developmental Biology, V1, P1; SPIRIN AS, 1994, MOL REPROD DEV, V38, P107, DOI 10.1002/mrd.1080380117; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; TRACHSEL H, 1977, J MOL BIOL, V116, P755, DOI 10.1016/0022-2836(77)90269-8; Wagner C, 2001, J MOL BIOL, V313, P511, DOI 10.1006/jmbi.2001.5057; Webster PJ, 1997, GENE DEV, V11, P2510, DOI 10.1101/gad.11.19.2510; Wickens M, 2000, COLD SPRING HARBOR M, V39, P295; Wilhelm JE, 2003, J CELL BIOL, V163, P1197, DOI 10.1083/jcb.200309088	37	157	159	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 10	2006	124	3					521	533		10.1016/j.cell.2006.01.031	http://dx.doi.org/10.1016/j.cell.2006.01.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	014FG	16469699	Bronze			2022-12-24	WOS:000235464000015
J	Pokidysheva, E; Zhang, Y; Battisti, AJ; Bator-Kelly, CM; Chipman, PR; Xiao, CA; Gregorio, GG; Hendrickson, WA; Kuhn, RJ; Rossmann, MG				Pokidysheva, E; Zhang, Y; Battisti, AJ; Bator-Kelly, CM; Chipman, PR; Xiao, CA; Gregorio, GG; Hendrickson, WA; Kuhn, RJ; Rossmann, MG			Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN	CELL			English	Article							LIGAND-BINDING; ENVELOPE GLYCOPROTEIN; CELLULAR RECEPTOR; STRUCTURAL BASIS; DENDRITIC CELLS; INFECTION; VISUALIZATION; POLYOMAVIRUS; ORGANIZATION; ENHANCEMENT	Dengue virus (DENV) is a significant human pathogen that causes millions of infections and results in about 24,000 deaths each year. Dendritic cell-specific ICAM3 grabbing nonintegrin (DC-SIGN), abundant in immature dendritic cells, was previously reported as being an ancillary receptor interacting with the surface of DENV. The structure of DENV in complex with the carbohydrate recognition domain (CRD) of DC-SIGN was determined by cryo-electron microscopy at 25 angstrom resolution. One CRD monomer was found to bind to two glycosylation sites at Asn67 of two neighboring glycoproteins in each icosahedral asymmetric unit, leaving the third Asn67 residue vacant. The vacancy at the third Asn67 site is a result of the nonequivalence of the glycoprotein environments, leaving space for the primary receptor binding to domain III of E. The use of carbohydrate moieties for receptor binding sites suggests a mechanism for avoiding immune surveillance.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Columbia University; Howard Hughes Medical Institute	Pokidysheva, E (corresponding author), Purdue Univ, Dept Biol Sci, Lilly Hall,915 W State St, W Lafayette, IN 47907 USA.	mr@purdue.edu	Xiao, Chuan/B-2130-2010; Kuhn, Richard/AAR-2722-2021	Xiao, Chuan/0000-0001-6599-8762; Kuhn, Richard/0000-0003-4148-1026; Chipman, Paul/0000-0003-3652-4087; Gregorio, Gabriel Glenn/0000-0001-8677-133X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055672] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 55672, AI40895] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker TS, 1999, MICROBIOL MOL BIOL R, V63, P862, DOI 10.1128/MMBR.63.4.862-922.1999; Bernhard OK, 2004, J BIOL CHEM, V279, P51828, DOI 10.1074/jbc.M402741200; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; Bhardwaj S, 2001, J VIROL, V75, P4002, DOI 10.1128/JVI.75.8.4002-4007.2001; Bhella D, 2004, J BIOL CHEM, V279, P8325, DOI 10.1074/jbc.M311334200; Burmeister WP, 2004, J VIROL, V78, P7727, DOI 10.1128/JVI.78.14.7727-7736.2004; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Conway JF, 1999, J STRUCT BIOL, V128, P106, DOI 10.1006/jsbi.1999.4168; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; He YN, 2002, P NATL ACAD SCI USA, V99, P10325, DOI 10.1073/pnas.152161599; JOHNSON AJ, 1994, VIROLOGY, V203, P241, DOI 10.1006/viro.1994.1481; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200; Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Pletnev SV, 2001, CELL, V105, P127, DOI 10.1016/S0092-8674(01)00302-6; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; ROSSMANN MG, 1994, PROTEIN SCI, V3, P1712, DOI 10.1002/pro.5560031010; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Rossmann MG, 2002, TRENDS MICROBIOL, V10, P324, DOI 10.1016/S0966-842X(02)02383-1; Snyder GA, 2005, J MOL BIOL, V347, P979, DOI 10.1016/j.jmb.2005.01.063; Stehle T, 1996, STRUCTURE, V4, P183, DOI 10.1016/S0969-2126(96)00021-4; Stehle T, 1997, EMBO J, V16, P5139, DOI 10.1093/emboj/16.16.5139; Su SV, 2004, J BIOL CHEM, V279, P19122, DOI 10.1074/jbc.M400184200; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Verdaguer N, 2004, NAT STRUCT MOL BIOL, V11, P429, DOI 10.1038/nsmb753; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553; Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270	44	229	239	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 10	2006	124	3					485	493		10.1016/j.cell.2005.11.042	http://dx.doi.org/10.1016/j.cell.2005.11.042			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	014FG	16469696	Bronze			2022-12-24	WOS:000235464000012
J	Cyranoski, D				Cyranoski, D			No end in sight for stem-cell odyssey	NATURE			English	News Item								Advanced Cell Technology was founded in 1994 and has led the field in cloning and stem cell research for more than a decade. However, following the revelation that Korean researcher Woo Suk Hwang lied about successfully cloning a human embryo, Advanced Cell Technology need to tread cautiously when it comes to future research. Funding for therapeutic cloning research has dried up as a result of the controversy, as has the supply of human eggs.										Cibelli J.B., 2001, J REGEN MED, V2, P25, DOI [10.1089/152489001753262168, DOI 10.1089/152489001753262168]; Klimanskaya I, 2004, CLONING STEM CELLS, V6, P217, DOI 10.1089/clo.2004.6.217; Weissman IL, 2006, NATURE, V439, P145, DOI 10.1038/439145a	3	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 9	2006	439	7077					658	659		10.1038/439658a	http://dx.doi.org/10.1038/439658a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	010KH	16467811				2022-12-24	WOS:000235193100019
J	Monson, RK; Lipson, DL; Burns, SP; Turnipseed, AA; Delany, AC; Williams, MW; Schmidt, SK				Monson, RK; Lipson, DL; Burns, SP; Turnipseed, AA; Delany, AC; Williams, MW; Schmidt, SK			Winter forest soil respiration controlled by climate and microbial community composition	NATURE			English	Article							TURBULENT FLUX MEASUREMENTS; TEMPERATURE-DEPENDENCE; HIGH-ELEVATION; AIR-FLOWS; CO2; N2O; CH4; SNOWPACK	Most terrestrial carbon sequestration at mid-latitudes in the Northern Hemisphere occurs in seasonal, montane forest ecosystems(1). Winter respiratory carbon dioxide losses from these ecosystems are high, and over half of the carbon assimilated by photosynthesis in the summer can be lost the following winter(2,3). The amount of winter carbon dioxide loss is potentially susceptible to changes in the depth of the snowpack; a shallower snowpack has less insulation potential, causing colder soil temperatures and potentially lower soil respiration rates. Recent climate analyses have shown widespread declines in the winter snowpack of mountain ecosystems in the western USA and Europe that are coupled to positive temperature anomalies(4-6). Here we study the effect of changes in snow cover on soil carbon cycling within the context of natural climate variation. We use a six-year record of net ecosystem carbon dioxide exchange in a subalpine forest to show that years with a reduced winter snowpack are accompanied by significantly lower rates of soil respiration. Furthermore, we show that the cause of the high sensitivity of soil respiration rate to changes in snow depth is a unique soil microbial community that exhibits exponential growth and high rates of substrate utilization at the cold temperatures that exist beneath the snow. Our observations suggest that a warmer climate may change soil carbon sequestration rates in forest ecosystems owing to changes in the depth of the insulating snow cover.	Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; Univ Colorado, Ctr Interdisciplinary Res Environm Sci, Boulder, CO 80309 USA; Univ Colorado, Dept Geog, Boulder, CO 80309 USA; Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; Natl Ctr Atmospher Res, Boulder, CO 80305 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; California State University System; San Diego State University; National Center Atmospheric Research (NCAR) - USA	Monson, RK (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	Russell.Monson@colorado.edu	Burns, Sean P/A-9352-2008; Schmidt, Steven K/G-2771-2010	Burns, Sean P/0000-0002-6258-1838; Schmidt, Steven K/0000-0002-9175-2085				[Anonymous], 2002, EOS T; Brooks PD, 2005, GLOBAL CHANGE BIOL, V11, P231, DOI 10.1111/j.1365-2486.2004.00877.x; Brooks PD, 1997, OECOLOGIA, V110, P403, DOI 10.1007/s004420050175; Burnett AW, 2003, J CLIMATE, V16, P3535, DOI [10.1175/1520-0442(2003)016<3535:IGLSDT>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;3535:IGLSDT&gt;2.0.CO;2]; Decker KLM, 2003, SOIL SCI SOC AM J, V67, P1234, DOI 10.2136/sssaj2003.1234; Fitzhugh RD, 2003, SOIL SCI SOC AM J, V67, P1897, DOI 10.2136/sssaj2003.1897; Groffman PM, 2001, BIOGEOCHEMISTRY, V56, P135, DOI 10.1023/A:1013039830323; Hubbard RM, 2005, BIOGEOCHEMISTRY, V73, P93, DOI 10.1007/s10533-004-1990-0; Katterer T, 1998, BIOL FERT SOILS, V27, P258, DOI 10.1007/s003740050430; Laternser M, 2003, INT J CLIMATOL, V23, P733, DOI 10.1002/joc.912; Lipson DA, 2004, APPL ENVIRON MICROB, V70, P2867, DOI 10.1128/AEM.70.5.2867-2879.2004; Lipson DA, 1999, ECOLOGY, V80, P1623; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Massman WJ, 1997, J GEOPHYS RES-ATMOS, V102, P18851, DOI 10.1029/97JD00844; Mast MA, 1998, GLOBAL BIOGEOCHEM CY, V12, P607, DOI 10.1029/98GB02313; Mikan CJ, 2002, SOIL BIOL BIOCHEM, V34, P1785, DOI 10.1016/S0038-0717(02)00168-2; Monson RK, 2005, OECOLOGIA, V146, P130, DOI 10.1007/s00442-005-0169-2; Monson RK, 2002, GLOBAL CHANGE BIOL, V8, P459, DOI 10.1046/j.1365-2486.2002.00480.x; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; PATTERSON DE, 1981, CAN GEOTECH J, V18, P131, DOI 10.1139/t81-012; Scherrer SC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020255; SCHMIDT SK, 1992, FEMS MICROBIOL ECOL, V101, P197, DOI 10.1016/0378-1097(92)90816-7; Scott-Denton LE, 2003, SOIL BIOL BIOCHEM, V35, P525, DOI 10.1016/S0038-0717(03)00007-5; SOMMERFELD RA, 1993, NATURE, V361, P140, DOI 10.1038/361140a0; Swanson AL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021809; Turnipseed AA, 2004, AGR FOREST METEOROL, V125, P187, DOI 10.1016/j.agrformet.2004.04.007; Turnipseed AA, 2003, AGR FOREST METEOROL, V119, P1, DOI 10.1016/S0168-1923(03)00136-9; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Williams MW, 1996, WATER RESOUR RES, V32, P3161, DOI 10.1029/96WR02240	30	395	452	15	313	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 9	2006	439	7077					711	714		10.1038/nature04555	http://dx.doi.org/10.1038/nature04555			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	010KH	16467835				2022-12-24	WOS:000235193100041
J	Steinbrook, R				Steinbrook, R			Facing the diabetes epidemic - Mandatory reporting of glycosylated hemoglobin values in New York City	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Frieden TR, 2004, AM J PUBLIC HEALTH, V94, P2059, DOI 10.2105/AJPH.94.12.2059; MacLean Charles D, 2004, Clin Trials, V1, P532, DOI 10.1191/1740774504cn051oa; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335	5	68	68	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2006	354	6					545	548		10.1056/NEJMp068008	http://dx.doi.org/10.1056/NEJMp068008			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	010HF	16467539				2022-12-24	WOS:000235177500001
J	Hallal, PC; Wells, JCK; Reichert, FF; Anselmi, L; Victora, CG				Hallal, PC; Wells, JCK; Reichert, FF; Anselmi, L; Victora, CG			Early determinants of physical activity in adolescence: prospective birth cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; FAMILIAL AGGREGATION; CHILDHOOD; OBESITY; PARTICIPATION; OVERWEIGHT; TRACKING; FITNESS; ADULTS; LIFE	Objective To examine the effects of early social, anthropometric, and behavioural variables on physical activity in adolescence. Design Prospective birth cohort study. Setting Pelotas, southern Brazil. Participants 4453 adolescents aged 10-12 years participating in the Pelotas 1993 birth cohort study (follow-up rate 87.5%). Main outcome measures Sedentary lifestyle (< 300 Minutes of physical activity per week) and median physical activity score (minutes per week). Results The prevalence Of a sedentary lifestyle at age 10-12 years was 58.2% (95% confidence interval 56.7% to 59.7%). Risk factors for a sedentary lifestyle in adolescence were female sex, high family income at birth, high maternal education at birth, and low birth order. Weight gain variables at ages 0-1, 1-4, and 4-11 years and overweight at age 1 or 4 years were not significant predictors of physical activity Levels of physical activity at age 4 years, based on maternal report, were inversely related to a sedentary lifestyle at age 10-12 years. Conclusions Physical activity in adolescence does not seem to be programmed by physiological factors in infancy A positive association between birth order and activity may be due to greater intensity of play in childhood and adolescence. Tracking of physical activity from age 4 to 10-12),cars, however, Suggests that. genetic factors or early habit formation may be important.	Univ Fed Pelotas, Postgrad Program Epidemiol, BR-96030002 Pelotas, RS, Brazil; Inst Child Hlth, MRC, Childhood Nutr Ctr, London, England; Univ Fed Rio Grande do Sul, Inst Psychol, BR-90046900 Porto Alegre, RS, Brazil	Universidade Federal de Pelotas; University of London; University College London; Universidade Federal do Rio Grande do Sul	Hallal, PC (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Duque Caxias 250 3 Piso, BR-96030002 Pelotas, RS, Brazil.	prchallal@terra.com.br	Reichert, Felipe F/E-4899-2012; Wells, Jonathan/A-4604-2009; Hallal, Pedro C/A-3249-2011; Victora, Cesar G/D-4476-2013; Victora, Cesar Gomes/Y-2455-2019	Reichert, Felipe F/0000-0002-0951-9875; Wells, Jonathan/0000-0003-0411-8025; Hallal, Pedro C/0000-0003-1470-6461; Victora, Cesar G/0000-0002-2465-2180; Victora, Cesar Gomes/0000-0002-2465-2180	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Achenbach T.M., 1983, MANUAL CHILD BEHAV C; Alfano CM, 2002, PREV MED, V34, P82, DOI 10.1006/pmed.2001.0963; [Anonymous], 2004, GLOB STRAT DIET PHYS; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Barros FC, 2005, LANCET, V365, P847, DOI 10.1016/S0140-6736(05)71042-4; Beunen GP, 2004, MED SCI SPORT EXER, V36, P1930, DOI 10.1249/01.MSS.0000145536.87255.3A; Biddle S, 1998, YOUNG ACTIVE YOUNG P; DASILVA RC, 2000, CAD SAUDE PUBLICA, V16, P1991; Dias-da-Costa Juvenal Soares, 2005, Cad. Saúde Pública, V21, P275, DOI 10.1590/S0102-311X2005000100030; EATON WO, 1989, DEV PSYCHOL, V25, P668, DOI 10.1037/0012-1649.25.4.668; Forrester T, 2004, J NUTR, V134, P211, DOI 10.1093/jn/134.1.211; FREUD S, 1962, SEXUALITY PSYCHOL LO; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hallal PC, 2003, MED SCI SPORT EXER, V35, P1894, DOI 10.1249/01.MSS.0000093615.33774.0E; Harpham T., 2003, J INT DEV, V15, P353, DOI DOI 10.1002/(ISSN)1099-1328; Horta BL, 2003, J EPIDEMIOL COMMUN H, V57, P226, DOI 10.1136/jech.57.3.226; Janz KF, 2000, MED SCI SPORT EXER, V32, P1250, DOI 10.1097/00005768-200007000-00011; Kemper HCG, 2001, EUR J APPL PHYSIOL, V84, P395, DOI 10.1007/s004210100392; KORNER AF, 1985, CHILD DEV, V56, P38, DOI 10.2307/1130171; Kraut A, 2003, MED SCI SPORT EXER, V35, P2038, DOI 10.1249/01.MSS.0000099087.96549.96; LUCAS A, 1991, CIBA F SYMP, V156, P38; MACCOBY EE, 1979, CHILD DEV, V50, P632, DOI 10.2307/1128928; Malina RM, 1996, RES Q EXERCISE SPORT, V67, pS48, DOI 10.1080/02701367.1996.10608853; MARCUS J, 1985, DEV PSYCHOBIOL, V18, P327, DOI 10.1002/dev.420180405; McMurray RG, 2003, MED SCI SPORT EXER, V35, P1914, DOI 10.1249/01.MSS.0000093612.59984.0E; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Merom D, 2004, J SCI MED SPORT, V7, P32, DOI 10.1016/S1440-2440(04)80041-0; Mitchell BD, 2003, ANN EPIDEMIOL, V13, P128, DOI 10.1016/S1047-2797(02)00255-7; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Morabia A, 2005, AM J PUBLIC HEALTH, V95, P632, DOI 10.2105/2004.047877; OEHLSCHLAEGER MH, 2000, REV SAUDE PUBL, V38, P157; Ong KK, 2004, EUR J ENDOCRINOL, V151, pU131, DOI 10.1530/eje.0.151U131; Parks SE, 2003, J EPIDEMIOL COMMUN H, V57, P29, DOI 10.1136/jech.57.1.29; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Pomerleau J, 2000, PREV MED, V31, P665, DOI 10.1006/pmed.2000.0761; Rogers I, 2003, INT J OBESITY, V27, P755, DOI 10.1038/sj.ijo.0802316; SAUDINO KJ, 1995, BRIT J DEV PSYCHOL, V13, P81, DOI 10.1111/j.2044-835X.1995.tb00666.x; Simonen RL, 2002, MED SCI SPORT EXER, V34, P1137, DOI 10.1097/00005768-200207000-00014; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Strauss RS, 2001, JAMA-J AM MED ASSOC, V286, P2845, DOI 10.1001/jama.286.22.2845; Tammelin T, 2003, AM J PREV MED, V24, P22, DOI 10.1016/S0749-3797(02)00575-5; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Victora CG, 2006, REV SAUDE PUBL, V40, P39, DOI 10.1590/S0034-89102006000100008; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wells JCK, 1996, AM J HUM BIOL, V8, P465, DOI 10.1002/(SICI)1520-6300(1996)8:4<465::AID-AJHB6>3.0.CO;2-X; WHO Expert Committee, 1995, PHYS STAT US INT ANT	48	102	114	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2006	332	7548					1002	1005		10.1136/bmj.38776.434560.7C	http://dx.doi.org/10.1136/bmj.38776.434560.7C			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040TK	16601016	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000237403100015
J	Stevens, J; Blixt, O; Tumpey, TM; Taubenberger, JK; Paulson, JC; Wilson, IA				Stevens, J; Blixt, O; Tumpey, TM; Taubenberger, JK; Paulson, JC; Wilson, IA			Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus	SCIENCE			English	Article							BINDING PROPERTIES; SIALIC-ACID; GLYCOSYLATION; DETERMINANTS; OLIGOSACCHARIDES; GLYCOPEPTIDES; EVOLUTION; SUBTYPES; HUMANS; FUSION	The hemagglutinin (HA) structure at 2.9 angstrom resolution, from a highly pathogenic Vietnamese H5N1 influenza virus, is more related to the 1918 and other human H1 HAS than to a 1997 duck H5 HA. Glycan microarray analysis of this Viet04 HA reveals an avian alpha 2-3 sialic acid receptor binding preference. Introduction of mutations that can convert H1 serotype HAS to human alpha 2-6 receptor specificity only enhanced or reduced affinity for avian-type receptors. However, mutations that can convert avian H2 and H3 HAS to human receptor specificity, when inserted onto the Viet04 H5 HA framework, permitted binding to a natural human alpha 2-6 glycan, which suggests a path for this H5N1 virus to gain a foothold in the human population.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Consortium Funct Glycom, Glycan Array Synth Core D, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Ctr Dis Control & Prevent, Influenza Branch, Div Viral & Rickettsial Dis, Atlanta, GA 30333 USA; Armed Forces Inst Pathol, Dept Mol Pathol, Washington, DC 20306 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Centers for Disease Control & Prevention - USA; United States Department of Defense	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu	Taubenberger, Jeffery/AAQ-1407-2021; Paulson, James/AAG-3565-2019	Blixt, Ola/0000-0003-4143-6276	NATIONAL CANCER INSTITUTE [R01CA055896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042266, P01AI058113, R37AI042266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060938, U54GM062116] Funding Source: NIH RePORTER; NCI NIH HHS [CA55896] Funding Source: Medline; NIAID NIH HHS [AI42266, AI058113] Funding Source: Medline; NIGMS NIH HHS [GM062116, GM060938] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; BAUM LG, 1990, ACTA HISTOCHEM, P35; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; DEBRAY H, 1981, EUR J BIOCHEM, V117, P41; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Harvey R, 2004, J VIROL, V78, P502, DOI 10.1128/JVI.78.1.502-507.2004; Hoffmann E, 2005, P NATL ACAD SCI USA, V102, P12915, DOI 10.1073/pnas.0506416102; Hulse DJ, 2004, J VIROL, V78, P9954, DOI 10.1128/JVI.78.18.9954-9964.2004; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; JOZIASSE DH, 1987, J BIOL CHEM, V262, P2025; Kaverin NV, 2004, J VIROL, V78, P240, DOI 10.1128/JVI.78.1.240-249.2004; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; KAWAOKA Y, 1989, VIROLOGY, V169, P283, DOI 10.1016/0042-6822(89)90153-0; KIDO H, 1992, J BIOL CHEM, V267, P13573; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; Klenk HD, 2002, VIRUS RES, V82, P73; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Lamblin G, 2001, GLYCOCONJUGATE J, V18, P661, DOI 10.1023/A:1020867221861; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Nobusawa E, 2000, VIROLOGY, V278, P587, DOI 10.1006/viro.2000.0679; Parrish CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/annurev.micro.59.030804.121059; Perdue ML, 2000, VET MICROBIOL, V74, P77, DOI 10.1016/S0378-1135(00)00168-1; PHILPOTT M, 1990, J VIROL, V64, P2941, DOI 10.1128/JVI.64.6.2941-2947.1990; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; ROGERS GN, 1989, VIROLOGY, V173, P317, DOI 10.1016/0042-6822(89)90249-3; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0	47	764	915	0	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					404	410		10.1126/science.1124513	http://dx.doi.org/10.1126/science.1124513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16543414				2022-12-24	WOS:000236941800041
J	Champion, L; Stern, M; Israel-Biet, D; Mamzer-Bruneel, MF; Peraldi, MN; Kreis, H; Porcher, R; Morelon, E				Champion, L; Stern, M; Israel-Biet, D; Mamzer-Bruneel, MF; Peraldi, MN; Kreis, H; Porcher, R; Morelon, E			Brief communication: Sirolimus-associated pneumonitis: 24 cases in renal transplant recipients	ANNALS OF INTERNAL MEDICINE			English	Article							INTERSTITIAL PNEUMONITIS; LIVER-TRANSPLANTATION; THERAPY; REJECTION; EFFICACY	Background: Interstitial pneumonitis is an ill-defined side effect of sirolimus, a new immunosuppressant drug recently introduced for patients having organ transplantation. Objective: To evaluate clinical and laboratory features of sirolimus-associated pneumonitis. Design: Case series. Setting: 1 transplantation center in Paris, France. Patients: 24 patients who had renal transplantation and developed sirolimus-associated pneumonitis, including 8 patients previously reported. Measurements: Symptoms; laboratory tests, including broncho alveolar fluid analysis; and computed tomography (CT) of the chest. Intervention: Withdrawal or dose reduction of sirolimus. Results: Clinical symptoms included cough (23 patients), fatigue (20 patients), fever (16 patients), and dyspnea (8 patients). Computed tomography of the chest showed reticular and ground-glass opacities (4 patients), bronchiolitis obliterans- organizing pneumonia (19 patients), and lobar consolidation (1 patient). Bronchoalveolar lavage showed lymphocytic (19 patients) or eosinophilic (3 patients) alveolitis or pulmonary hemorrhage (2 patients). A reduction in the sirolimus dose resulted in transient clinical improvement in 2 patients, but discontinuation of drug therapy was eventually necessary in all patients. All patients recovered completely within 6 months. Limitations: The sirolimus trough level in patients from this single center was higher than that usually used in patients having renal transplantation, Conclusion: Lymphocytic alveolitis and radiologic bronchiolitis obliterans- organizing pneumonia are the key findings in sirolimus-associated pneumonitis. Sirolimus withdrawal was associated with recovery within 6 months.	Hop St Louis, Paris, France; Hop Necker Enfants Malad, Paris, France; Hop Foch, Paris, France; Hop Georges Pompidou, Paris, France; Hop Edouard Herriot, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon	Morelon, E (corresponding author), Univ Lyon 1, Hop Edouard Herriot, Serv Nephrol Med, 3 Pl Arsonval, F-69437 Lyon 3, France.	emmanuel.morelon@chu-lyon.fr	Mamzer, Marie-France/V-1713-2017	Mamzer, Marie-France/0000-0001-7570-1803; Porcher, Raphael/0000-0002-5277-4679; STERN, Marc/0000-0001-5275-6959; ISRAEL-BIET, Dominique/0000-0003-4308-4411				Avitzur Y, 2003, J PEDIATR GASTR NUTR, V37, P91, DOI 10.1097/00005176-200307000-00017; Dupont P, 2003, QJM-INT J MED, V96, P401, DOI 10.1093/qjmed/hcg072; FOURNIER E, 1985, CHEST, V88, P563, DOI 10.1378/chest.88.4.563; Haydar AA, 2004, AM J TRANSPLANT, V4, P137, DOI 10.1046/j.1600-6135.2003.00292.x; Kahan BD, 2000, LANCET, V356, P194, DOI 10.1016/S0140-6736(00)02480-6; Kreis H, 2004, J AM SOC NEPHROL, V15, P809, DOI 10.1097/01.ASN.0000113248.59077.76; Lennon A, 2001, TRANSPLANTATION, V72, P1166, DOI 10.1097/00007890-200109270-00034; Lindenfeld JA, 2005, AM J TRANSPLANT, V5, P1392, DOI 10.1111/j.1600-6143.2005.00849.x; MacDonald AS, 2001, TRANSPLANTATION, V71, P271, DOI 10.1097/00007890-200101270-00019; Mahalati K, 2000, TRANSPLANTATION, V69, P1531; Mahe E, 2005, TRANSPLANTATION, V79, P476, DOI 10.1097/01.TP.0000151630.25127.3A; Manito N, 2004, J HEART LUNG TRANSPL, V23, P780, DOI 10.1016/j.healun.2003.07.008; McWilliams TJ, 2003, J HEART LUNG TRANSPL, V22, P210, DOI 10.1016/S1053-2498(02)00564-8; Morelon E, 2003, TRANSPLANT P, V35, p52S, DOI 10.1016/S0041-1345(03)00244-6; Morelon E, 2001, TRANSPLANTATION, V72, P787, DOI 10.1097/00007890-200109150-00008; Pham PTT, 2004, TRANSPLANTATION, V77, P1215, DOI 10.1097/01.TP.0000118413.92211.B6	16	142	173	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2006	144	7					505	509		10.7326/0003-4819-144-7-200604040-00009	http://dx.doi.org/10.7326/0003-4819-144-7-200604040-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031DU	16585664				2022-12-24	WOS:000236685100005
J	Bautista, DM; Jordt, SE; Nikai, T; Tsuruda, PR; Read, AJ; Poblete, J; Yamoah, EN; Basbaum, AI; Julius, D				Bautista, DM; Jordt, SE; Nikai, T; Tsuruda, PR; Read, AJ; Poblete, J; Yamoah, EN; Basbaum, AI; Julius, D			TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents	CELL			English	Article							ION-CHANNEL TRPA1; CAPSAICIN-RECEPTOR; VANILLOID RECEPTOR; CYCLOPHOSPHAMIDE CYSTITIS; NOCICEPTIVE NEURONS; GANGLION NEURONS; PULMONARY-EDEMA; AIR-POLLUTANTS; GUINEA-PIGS; ACROLEIN	TRPA1 is an excitatory ion channel targeted by pungent irritants from mustard and garlic. TRPA1 has been proposed to function in diverse sensory processes, including thermal (cold) nociception, hearing, and inflammatory pain. Using TRPA1-deficient mice, we now show that this channel is the sole target through which mustard oil and garlic activate primary afferent nociceptors to produce inflammatory pain. TRPA1 is also targeted by environmental irritants, such as acrolein, that account for toxic and inflammatory actions of tear gas, vehicle exhaust, and metabolic byproducts of chemotherapeutic agents. TRPA1-deficient mice display normal cold sensitivity and unimpaired auditory function, suggesting that this channel is not required for the initial detection of noxious cold or sound. However, TRPA1-deficient mice exhibit pronounced deficits in bradykinin-evoked nociceptor excitation and pain hypersensitivity. Thus, TRPA1 is an important component of the transduction machinery through which environmental irritants and endogenous proalgesic agents depolarize nociceptors, to elicit inflammatory pain.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Univ Calif San Francisco, Dept Anat & Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Dept Otolaryngol, Davis, CA 95616 USA	University of California System; University of California San Francisco; Yale University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; University of California System; University of California Davis	Julius, D (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	julius@cmp.ucsf.edu	Jordt, Sven-Eric/ABE-6517-2020	Jordt, Sven-Eric/0000-0001-6171-5622; Read, Andrew/0000-0001-7336-8496				AHLUWALIA A, 1994, BRIT J PHARMACOL, V111, P1017, DOI 10.1111/j.1476-5381.1994.tb14845.x; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cesare P, 1999, P NATL ACAD SCI USA, V96, P7658, DOI 10.1073/pnas.96.14.7658; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; COX PJ, 1979, BIOCHEM PHARMACOL, V28, P2045, DOI 10.1016/0006-2952(79)90222-3; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dinis P, 2004, J NEUROSCI, V24, P11253, DOI 10.1523/JNEUROSCI.2657-04.2004; Dou HV, 2004, JARO-J ASSOC RES OTO, V5, P215, DOI 10.1007/s10162-003-4020-3; DRAY A, 1993, TRENDS NEUROSCI, V16, P99, DOI 10.1016/0166-2236(93)90133-7; DUNN PM, 1990, BRIT J PHARMACOL, V100, P656, DOI 10.1111/j.1476-5381.1990.tb15863.x; FLEMING RA, 1997, PHARMACOTHERAPY, V17, P146; Ghilarducci DP, 1995, REV ENVIRON CONTAM T, V144, P95; HALES CA, 1992, J APPL PHYSIOL, V72, P555, DOI 10.1152/jappl.1992.72.2.555; HALES CA, 1988, J APPL PHYSIOL, V64, P1121, DOI 10.1152/jappl.1988.64.3.1121; Handzel Z T, 2000, Rev Environ Health, V15, P325; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Inoue T, 2005, PAIN, V117, P193, DOI 10.1016/j.pain.2005.06.012; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Kollarik M, 2004, J PHYSIOL-LONDON, V555, P115, DOI 10.1113/jphysiol.2003.054890; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; LEIKAUF GD, 1989, J APPL PHYSIOL, V66, P171, DOI 10.1152/jappl.1989.66.1.171; Leikauf GD, 2002, ENVIRON HEALTH PERSP, V110, P505, DOI 10.1289/ehp.02110s4505; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; MAGGI CA, 1992, J AUTONOM NERV SYST, V38, P201, DOI 10.1016/0165-1838(92)90031-B; Martinez-Caro L, 2000, NEUROREPORT, V11, P1213, DOI 10.1097/00001756-200004270-00014; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Morris JB, 1999, J APPL PHYSIOL, V87, P1877, DOI 10.1152/jappl.1999.87.5.1877; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Nicol D, 2002, INTERN MED J, V32, P199, DOI 10.1046/j.1445-5994.2002.00222.x; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Reid G, 2005, PFLUG ARCH EUR J PHY, V451, P250, DOI 10.1007/s00424-005-1437-z; Reid G, 2002, NEUROSCI LETT, V324, P164, DOI 10.1016/S0304-3940(02)00181-7; SPRINGALL DR, 1990, ENVIRON HEALTH PERSP, V85, P151, DOI 10.2307/3430678; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Symanowicz PT, 2004, NEUROSCI LETT, V362, P150, DOI 10.1016/j.neulet.2004.03.016; Takamoto S, 2004, J CHROMATOGR B, V806, P59, DOI 10.1016/j.jchromb.2004.02.008; TURNER CR, 1993, J APPL PHYSIOL, V75, P2456, DOI 10.1152/jappl.1993.75.6.2456; Undem BJ, 2001, RESP RES, V2, P234, DOI 10.1186/rr62; Wang HB, 2005, NEURON, V46, P9, DOI 10.1016/j.neuron.2005.03.011	51	1367	1436	3	132	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1269	1282		10.1016/j.cell.2006.02.023	http://dx.doi.org/10.1016/j.cell.2006.02.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564016	Bronze			2022-12-24	WOS:000237241400025
J	Voorhoeve, PM; le Sage, C; Schrier, M; Gillis, AJM; Stoop, H; Nagel, R; Liu, YP; van Duijse, J; Drost, J; Griekspoor, A; Zlotorynski, E; Yabuta, N; De Vita, G; Nojima, H; Looijenga, LHJ; Agami, R				Voorhoeve, PM; le Sage, C; Schrier, M; Gillis, AJM; Stoop, H; Nagel, R; Liu, YP; van Duijse, J; Drost, J; Griekspoor, A; Zlotorynski, E; Yabuta, N; De Vita, G; Nojima, H; Looijenga, LHJ; Agami, R			A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors	CELL			English	Article							MICRORNA TARGETS; DNA-DAMAGE; TREATMENT RESPONSE; LET-7 MICRORNA; CYCLE ARREST; P53; EXPRESSION; SENESCENCE; PROTEIN; RAS	Endogenous small RNAs (miRNAs) regulate gene expression by mechanisms conserved across metazoans. While the number of verified human miRNAs is still expanding, only few have been functionally annotated. To perform genetic screens for novel functions of miRNAs, we developed a library of vectors expressing the majority of cloned human miRNAs and created corresponding DNA barcode arrays. In a screen for miRNAs that cooperate with oncogenes in cellular transformation, we identified miR-372 and miR-373, each permitting proliferation and tumorigenesis of primary human cells that harbor both oncogenic RAS and active wild-type p53. These miRNAs neutralize p53-mediated CDK inhibition, possibly through direct inhibition of the expression of the tumor-suppressor LATS2. We provide evidence that these miRNAs are potential novel oncogenes participating in the development of human testicular germ cell tumors by numbing the p53 pathway, thus allowing tumorigenic growth in the presence of wild-type p53.	Netherlands Canc Inst, Div Tumour Biol, Amsterdam, Netherlands; Erasmus Univ, Med Ctr Rotterdam, Dr Daniel Denhoed Canc Ctr, Dept Pathol,Josephine Nefkens Inst, Rotterdam, Netherlands; Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, CEINGE Biotecnol Avanzate, Naples, Italy; Osaka Univ, Dept Mol Genet, Osaka, Japan	Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; CEINGE Biotecnologie Avanzate; University of Naples Federico II; Osaka University	Agami, R (corresponding author), Netherlands Canc Inst, Div Tumour Biol, Plesmanlaan 121, Amsterdam, Netherlands.	r.agami@nki.nl	De Vita, Glauco/AAH-3128-2020; Drost, Jarno/M-6964-2017; Drost, Jarno/J-9758-2012; Looijenga, Leendert/B-8145-2019; agami, reuven/GOG-8289-2022; De Vita, Gabriella/H-4422-2011	De Vita, Glauco/0000-0001-6679-9474; Drost, Jarno/0000-0002-2941-6179; Drost, Jarno/0000-0002-2941-6179; Looijenga, Leendert/0000-0002-8146-1911; De Vita, Gabriella/0000-0002-7302-1174; Griekspoor, Alexander/0000-0003-0144-4335; , Ying Poi/0000-0002-4152-9168; Liu, Ying Poi/0000-0002-9932-718X; Agami, Reuven/0000-0002-2848-2473				Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Almstrup K, 2004, CANCER RES, V64, P4736, DOI 10.1158/0008-5472.CAN-04-0679; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burger H, 1998, BRIT J CANCER, V77, P1562, DOI 10.1038/bjc.1998.257; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; De Vita G, 2005, MOL ENDOCRINOL, V19, P76, DOI 10.1210/me.2004-0172; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Duursma A, 2005, MOL CELL BIOL, V25, P6937, DOI 10.1128/MCB.25.16.6937-6947.2005; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kersemaekers AMF, 2002, J CLIN ONCOL, V20, P1551, DOI 10.1200/JCO.20.6.1551; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YY, 2003, COMMUN PUR APPL ANAL, V2, P1; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lutzker SG, 1996, NAT MED, V2, P804, DOI 10.1038/nm0796-804; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; Mayer F, 2003, CLIN CANCER RES, V9, P767; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mostert M, 2000, LAB INVEST, V80, P1055, DOI 10.1038/labinvest.3780110; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1356-9597.2004.00732.x; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; XU TA, 1995, DEVELOPMENT, V121, P1053; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	50	994	1086	0	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1169	1181		10.1016/j.cell.2006.02.037	http://dx.doi.org/10.1016/j.cell.2006.02.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564011	Bronze			2022-12-24	WOS:000237241400018
J	Walsh, T; Casadei, S; Coats, KH; Swisher, E; Stray, SM; Higgins, J; Roach, KC; Mandell, J; Lee, MK; Ciernikova, S; Foretova, L; Soucek, P; King, MC				Walsh, T; Casadei, S; Coats, KH; Swisher, E; Stray, SM; Higgins, J; Roach, KC; Mandell, J; Lee, MK; Ciernikova, S; Foretova, L; Soucek, P; King, MC			Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXONIC SPLICING ENHANCERS; POPULATION-BASED SAMPLE; LARGE GENOMIC DELETIONS; OVARIAN-CANCER; INHERITED MUTATIONS; PROSTATE-CANCER; COWDEN-SYNDROME; PROPHYLACTIC OOPHORECTOMY; FOLLOW-UP; GENE	Context Genetic testing for inherited mutations in BRCA1 and BRCA2 has become integral to the care of women with a severe family history of breast or ovarian cancer, but an unknown number of patients receive negative (ie, wild-type) results when they actually carry a pathogenic BRCA1 or BRCA2 mutation. Furthermore, other breast cancer genes generally are not evaluated. Objective To determine the frequency and types of undetected cancer-predisposing mutations in BRCA1, BRCA2, CHEK2, TP53, and PTEN among patients with breast cancer from high-risk families with negative (wild-type) genetic test results for BRCA1 and BRCA2. Design, Setting, and Participants Between 2002-2005, probands from 300 US families with 4 or more cases of breast or ovarian cancer but with negative (wild-type) commercial genetic test results for BRCA1 and BRCA2 were screened by multiple DNA-based and RNA-based methods to detect genomic rearrangements in BRCA1 and BRCA2 and germline mutations of all classes in CHEK2, TP53, and PTEN. Main Outcome Measures Previously undetected germline mutations in BRCA1, BRCA2, CHEK2, TP53, and PTEN that predispose to breast cancer; frequencies of these mutations among families with negative genetic test results. Results Of the 300 probands, 52 (17%) carried previously undetected mutations, including 35 (12%) with genomic rearrangements of BRCA1 or BRCA2, 14 (5%) with CHEK2 mutations, and 3 (1%) with TP53 mutations. At BRCA1 and BRCA2, 22 different genomic rearrangements were found, of sizes less than 1 kb to greater than 170 kb; of these, 14 were not previously described and all were individually rare. At CHEK2, a novel 5.6-kb genomic deletion was discovered in 2 families of Czechoslovakian ancestry. This deletion was found in 8 of 631 (1.3%) patients with breast cancer and in none of 367 healthy controls in the Czech and Slovak Republics. For all rearrangements, exact genomic breakpoints were determined and diagnostic primers validated. The 3 families with TP53 mutations included cases of childhood sarcoma or brain tumors in addition to multiple cases of breast cancer. Conclusions The mutational spectra of BRCA1 and BRCA2 include many high-penetrance, individually rare genomic rearrangements. Among patients with breast cancer and severe family histories of cancer who test negative ( wild type) for BRCA1 and BRCA2, approximately 12% can be expected to carry a large genomic deletion or duplication in one of these genes, and approximately 5% can be expected to carry a mutation in CHEK2 or TP53. Effective methods for identifying these mutations should be made available to women at high risk.	Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; Morgagni Pierantoni Hosp, Dept Med Oncol, Forli, Italy; Slovak Acad Sci, Canc Res Inst, Dept Canc Genet, Bratislava, Slovakia; Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; Natl Inst Publ Hlth, Ctr Occupat Dis, Prague, Czech Republic	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Slovak Academy of Sciences; Masaryk Memorial Cancer Institute; National Institute of Public Health (SZU) - Czech Republic	King, MC (corresponding author), Univ Washington, Dept Med, Box 357720, Seattle, WA 98195 USA.	mcking@u.washington.edu	Ciernikova, Sona/ABB-3569-2021; Soucek, Pavel/H-8018-2019	Soucek, Pavel/0000-0002-4294-6799; Foretova, Lenka/0000-0003-0494-2620; King, Mary-Claire/0000-0001-9426-1743; Walsh, Tom/0000-0002-8875-0310	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013160] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES13160] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Agata S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032789; Antoniou AC, 2005, J MED GENET, V42, P602, DOI 10.1136/jmg.2004.024133; Bogdanova N, 2005, INT J CANCER, V116, P263, DOI 10.1002/ijc.21022; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Campos Berta, 2003, Hum Mutat, V22, P337, DOI 10.1002/humu.9176; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Claverie-Martin F, 2005, J HUM GENET, V50, P370, DOI 10.1007/s10038-005-0265-5; Cybulski C, 2004, AM J HUM GENET, V75, P1131, DOI 10.1086/426403; Cybulski C, 2004, CANCER RES, V64, P2677, DOI 10.1158/0008-5472.CAN-04-0341; Dong XY, 2003, AM J HUM GENET, V72, P270, DOI 10.1086/346094; Dufault MR, 2004, INT J CANCER, V110, P320, DOI 10.1002/ijc.20073; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Eisen A, 2005, J CLIN ONCOL, V23, P7491, DOI 10.1200/JCO.2004.00.7138; Eng C, 2000, J MED GENET, V37, P828, DOI 10.1136/jmg.37.11.828; Fackenthal JD, 2002, AM J HUM GENET, V71, P625, DOI 10.1086/342192; FitzGerald MG, 1998, ONCOGENE, V17, P727, DOI 10.1038/sj.onc.1201984; Foretova L, 2004, HUM MUTAT, V23, DOI 10.1002/humu.9226; Fortin J, 2005, BBA-GENE STRUCT EXPR, V1731, P57, DOI 10.1016/j.bbaexp.2005.08.011; Frank TS, 1998, J CLIN ONCOL, V16, P2417, DOI 10.1200/JCO.1998.16.7.2417; Gad S, 2002, ONCOGENE, V21, P6841, DOI 10.1038/sj.onc.1205685; Gorski B, 2005, BREAST CANCER RES TR, V92, P19, DOI 10.1007/s10549-005-1409-1; Hartmann Carolin, 2004, Hum Mutat, V24, P534, DOI 10.1002/humu.9291; Hartmann LC, 2001, JNCI-J NATL CANCER I, V93, P1633, DOI 10.1093/jnci/93.21.1633; Hendrickson BC, 2005, GENE CHROMOSOME CANC, V43, P309, DOI 10.1002/gcc.20189; Hirsh-Yechezkel G, 2003, GYNECOL ONCOL, V89, P494, DOI 10.1016/S0090-8258(03)00152-5; Hogervorst FBL, 2003, CANCER RES, V63, P1449; Huzarski T, 2005, BREAST CANCER RES TR, V90, P187, DOI 10.1007/s10549-004-3778-2; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; Kilpivaara O, 2004, INT J CANCER, V111, P543, DOI 10.1002/ijc.20299; King MC, 2001, JAMA-J AM MED ASSOC, V286, P2251, DOI 10.1001/jama.286.18.2251; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Kolomietz E, 2002, GENE CHROMOSOME CANC, V35, P97, DOI 10.1002/gcc.10111; Kramer JL, 2005, J CLIN ONCOL, V23, P8629, DOI 10.1200/JCO.2005.02.9199; Langston AA, 1996, NEW ENGL J MED, V334, P137, DOI 10.1056/NEJM199601183340301; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Lynch ED, 1997, AM J HUM GENET, V61, P1254, DOI 10.1086/301639; Malone KE, 2000, CANCER, V88, P1393, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P; Mazoyer S, 2005, HUM MUTAT, V25, P415, DOI 10.1002/humu.20169; McNeil Nicole, 2004, Journal of the Association of Genetic Technologists, V30, P41; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; MELJERSHELJBOER H, 2001, NEW ENGL J MED, V345, P159; Montagna M, 2003, HUM MOL GENET, V12, P1055, DOI 10.1093/hmg/ddg120; Moslehi R, 2000, AM J HUM GENET, V66, P1259, DOI 10.1086/302853; Nelson HD, 2005, ANN INTERN MED, V143, P362, DOI 10.7326/0003-4819-143-5-200509060-00012; Newman B, 1998, JAMA-J AM MED ASSOC, V279, P915, DOI 10.1001/jama.279.12.915; Nichols KE, 2001, CANCER EPIDEM BIOMAR, V10, P83; Oldenburg RA, 2003, CANCER RES, V63, P8153; Pal T, 2005, CANCER-AM CANCER SOC, V104, P2807, DOI 10.1002/cncr.21536; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Pettigrew C, 2005, BREAST CANCER RES, V7, pR929, DOI 10.1186/bcr1324; Rapakko K, 2001, BRIT J CANCER, V84, P116, DOI 10.1054/bjoc.2000.1530; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Sarmanova J, 2004, EUR J HUM GENET, V12, P848, DOI 10.1038/sj.ejhg.5201249; Scheuer L, 2002, J CLIN ONCOL, V20, P1260, DOI 10.1200/JCO.2002.20.5.1260; Schutte M, 2003, AM J HUM GENET, V72, P1023, DOI 10.1086/373965; Seppala EH, 2003, BRIT J CANCER, V89, P1966, DOI 10.1038/sj.bjc.6601425; Shaag A, 2005, HUM MOL GENET, V14, P555, DOI 10.1093/hmg/ddi052; Sorek R, 2004, MOL CELL, V14, P221, DOI 10.1016/S1097-2765(04)00181-9; STARINK TM, 1986, CLIN GENET, V29, P222; Susani L, 2004, HUM MUTAT, V24, P225, DOI 10.1002/humu.20076; Tournier I, 2004, CANCER RES, V64, P8143, DOI 10.1158/0008-5472.CAN-04-2467; Tsou HC, 1997, AM J HUM GENET, V61, P1036, DOI 10.1086/301607; Unger MA, 2000, AM J HUM GENET, V67, P841, DOI 10.1086/303076; Warner E, 2005, LANCET, V365, P1747, DOI 10.1016/S0140-6736(05)66520-8; Woodward AM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027961; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109	68	469	508	1	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2006	295	12					1379	1388		10.1001/jama.295.12.1379	http://dx.doi.org/10.1001/jama.295.12.1379			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023WU	16551709	Bronze			2022-12-24	WOS:000236157700015
J	Raviglione, MC; Uplekar, MW				Raviglione, MC; Uplekar, MW			WHO's new Stop TB Strategy	LANCET			English	Editorial Material									WHO, Stop TB Dept, CH-1211 Geneva 27, Switzerland	World Health Organization	Raviglione, MC (corresponding author), WHO, Stop TB Dept, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	raviglionem@who.int		RAVIGLIONE, Mario/0000-0002-9331-2067				Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Hopewell PC, 2005, JAMA-J AM MED ASSOC, V293, P2790, DOI 10.1001/jama.293.22.2790; Kumaresan J, 2004, INT J TUBERC LUNG D, V8, P130; Lonnroth K, 2004, B WORLD HEALTH ORGAN, V82, P580; *STOP TB PARTN WHO, 2006, WHOHTMSTB200635; *WHO, 2004, WKLY EPIDEMIOL REC, V1, P6; *WHO, 2003, WHOCDSTB2003312; *WHO, 2004, WHOHTMSTB200428; World Health Organization, 2005, WHA582005REC1 WHO; World Health Organization, 2005, WHOHTMTB2006361; World Health Organization, 2005, WHOHTMTB2005351; 2005, LANCET, V5, P366	12	290	300	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					952	955		10.1016/S0140-6736(06)68392-X	http://dx.doi.org/10.1016/S0140-6736(06)68392-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546550				2022-12-24	WOS:000236242100038
J	Akbari, O; Faul, JL; Hoyte, EG; Berry, GJ; Wahlstrom, J; Kronenberg, M; DeKruyff, RH; Umetsu, DT				Akbari, O; Faul, JL; Hoyte, EG; Berry, GJ; Wahlstrom, J; Kronenberg, M; DeKruyff, RH; Umetsu, DT			CD4+ invariant T-cell-receptor plus natural killer T cells in bronchial asthma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							V-ALPHA-14 NKT CELLS; ANTIGEN PRESENTATION; AIRWAY INFLAMMATION; ATOPIC ASTHMA; RECOGNITION; SARCOIDOSIS; IL-13; HYPERREACTIVITY; REQUIREMENT; CYTOKINES	Background: Bronchial asthma is associated with an inflammatory process that is characterized by the presence in the airways of large numbers of CD4+ T cells producing interleukin-4 and interleukin-13. However, the CD4 antigen is expressed not only by class II major histocompatibility complex (MHC)-restricted CD4+ T cells, but also by a newly identified subgroup of T cells, CD1d-restricted natural killer T cells. These cells express a conserved (invariant) T-cell receptor and have a potent immunoregulatory function. Because mouse models of allergic asthma indicate that natural killer T cells are required for the development of allergen-induced airway hyperreactivity, we hypothesized that natural killer T cells play an important role in human asthma. Methods: We used CD1d-tetramers, antibodies specific for natural killer T cells, as well as reverse-transcriptase-polymerase-chain-reaction analysis of the invariant T-cell receptor of natural killer T cells to assess the frequency and distribution of natural killer T cells in the lungs and in the circulating blood of 14 patients with asthma. Results: About 60 percent of the pulmonary CD4+CD3+ cells in patients with moderate-to-severe persistent asthma were not class II MHC-restricted CD4+ T cells but, rather, natural killer T cells. The natural killer T cells expressed an invariant T-cell receptor and produced type 2 helper cytokines. In contrast, the CD4+ T cells found in the lungs of patients with sarcoidosis were conventional CD4+CD3+ T cells, not natural killer T cells. Conclusions: Together with studies in mice indicating a requirement for natural killer T cells in the development of allergen-induced airway hyperreactivity, our results strongly suggest that CD4+ natural killer T cells play a prominent pathogenic role in human asthma.	Harvard Univ, Sch Med, Childrens Hosp Boston, Karp Res Labs,Div Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Stanford Univ, Dept Med, Div Pulm & Crit Care, Stanford, CA 94305 USA; Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Karolinska Inst, Div Resp Med, Stockholm, Sweden; Karolinska Inst, Dept Med, Stockholm, Sweden; La Jolla Inst Allergy & Immunol, Div Dev Immunol, San Diego, CA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Stanford University; Stanford University; Stanford University; Karolinska Institutet; Karolinska Institutet; La Jolla Institute for Immunology	Umetsu, DT (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Karp Res Labs,Div Immunol, 1 Blackfan Cir,Rm 10127, Boston, MA 02115 USA.	dale.umetsu@childrens.harvard.edu		Berry, Gerald/0000-0002-6176-2629	NATIONAL CANCER INSTITUTE [R01CA052511] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000070] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026322, P01AI054456] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA52511] Funding Source: Medline; NCRR NIH HHS [M01-RR00070] Funding Source: Medline; NHLBI NIH HHS [R01 HL69507] Funding Source: Medline; NIAID NIH HHS [R01 AI26322, P01AI054456] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agea E, 2005, J EXP MED, V202, P295, DOI 10.1084/jem.20050773; Agostini C, 2002, CURR OPIN PULM MED, V8, P435, DOI 10.1097/00063198-200209000-00016; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Crowe NY, 2003, J IMMUNOL, V171, P4020, DOI 10.4049/jimmunol.171.8.4020; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; DJUKANOVIC R, 1991, AM REV RESPIR DIS, V143, P772, DOI 10.1164/ajrccm/143.4_Pt_1.772; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Faul JL, 1999, AM J RESP CRIT CARE, V160, P1457, DOI 10.1164/ajrccm.160.5.9812027; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Holt PG, 1999, NATURE, V402, pB12; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Lee PT, 2002, J CLIN INVEST, V110, P793, DOI 10.1172/JCI200215832; Lisbonne M, 2003, J IMMUNOL, V171, P1637, DOI 10.4049/jimmunol.171.4.1637; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Naidenko OV, 1999, J EXP MED, V190, P1069, DOI 10.1084/jem.190.8.1069; Nieuwenhuis EES, 2002, NAT MED, V8, P588, DOI 10.1038/nm0602-588; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Shigehara K, 2001, J IMMUNOL, V166, P642, DOI 10.4049/jimmunol.166.1.642; Sidobre S, 2002, J IMMUNOL METHODS, V268, P107, DOI 10.1016/S0022-1759(02)00204-1; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Wahlstrom J, 2001, AM J RESP CRIT CARE, V163, P115, DOI 10.1164/ajrccm.163.1.9906071; Wang B, 2001, J EXP MED, V194, P313, DOI 10.1084/jem.194.3.313; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yang S, 2005, J IMMUNOL, V175, P4914, DOI 10.4049/jimmunol.175.8.4914; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Ziegenhagen MW, 2003, J INTERN MED, V253, P18, DOI 10.1046/j.1365-2796.2003.01074.x	35	317	342	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1117	1129		10.1056/NEJMoa053614	http://dx.doi.org/10.1056/NEJMoa053614			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021KI	16540612				2022-12-24	WOS:000235981700005
J	Nakatsu, T; Ichiyama, S; Hiratake, J; Saldanha, A; Kobashi, N; Sakata, K; Kato, H				Nakatsu, T; Ichiyama, S; Hiratake, J; Saldanha, A; Kobashi, N; Sakata, K; Kato, H			Structural basis for the spectral difference in luciferase bioluminescence	NATURE			English	Article							SITE-DIRECTED MUTAGENESIS; FIREFLY LUCIFERASE; CRYSTAL-STRUCTURE; ACTIVE-SITE; LIGHT; COLOR; BIOSYNTHESIS; SUPERFAMILY; SYNTHETASES; REFINEMENT	Fireflies communicate with each other by emitting yellow- green to yellow- orange brilliant light. The bioluminescence reaction, which uses luciferin, Mg- ATP and molecular oxygen to yield an electronically excited oxyluciferin species, is carried out by the enzyme luciferase. Visible light is emitted during relaxation of excited oxyluciferin to its ground state. The high quantum yield(1) of the luciferin/ luciferase reaction and the change in bioluminescence colour caused by subtle structural differences in luciferase have attracted much research interest. In fact, a single amino acid substitution in luciferase changes the emission colour from yellow- green to red(2-5). Although the crystal structure of luciferase from the North American firefly ( Photinus pyralis) has been described(6,7), the detailed mechanism for the bioluminescence colour change is still unclear(8-11). Here we report the crystal structures of wild- type and red mutant ( S286N) luciferases from the Japanese Genji- botaru ( Luciola cruciata) in complex with a high- energy intermediate analogue, 5' - O-[ N-( dehydroluciferyl)-sulfamoyl] adenosine ( DLSA). Comparing these structures to those of the wild- type luciferase complexed with AMP plus oxyluciferin ( products) reveals a significant conformational change in the wild- type enzyme but not in the red mutant. This conformational change involves movement of the hydrophobic side chain of Ile 288 towards the benzothiazole ring of DLSA. Our results indicate that the degree of molecular rigidity of the excited state of oxyluciferin, which is controlled by a transient movement of Ile 288, determines the colour of bioluminescence during the emission reaction.	RIKEN Harima Inst SPring8, Kinet Crystallog Res Team, Membrane Dynam Res Grp, Mikazuki, Hyogo 6795148, Japan; Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Chem Res Inst, Kyoto 6110011, Japan	RIKEN; Kyoto University; Kyoto University	Kato, H (corresponding author), RIKEN Harima Inst SPring8, Kinet Crystallog Res Team, Membrane Dynam Res Grp, 1-1-1 Kouto, Mikazuki, Hyogo 6795148, Japan.	katohiro@pharm.kyoto-u.ac.jp		Kato, Hiroaki/0000-0002-5993-4532; Nakatsu, Toru/0000-0002-9582-4023				Adachi S, 2001, NUCL INSTRUM METH A, V467, P711, DOI 10.1016/S0168-9002(01)00472-7; BABBITT PC, 1992, BIOCHEMISTRY-US, V31, P5594, DOI 10.1021/bi00139a024; Branchini BR, 2005, BIOORG MED CHEM LETT, V15, P3860, DOI 10.1016/j.bmcl.2005.05.115; Branchini BR, 2004, BIOCHEMISTRY-US, V43, P7255, DOI 10.1021/bi036175d; Branchini BR, 2003, BIOCHEMISTRY-US, V42, P10429, DOI 10.1021/bi030099x; Branchini BR, 1999, BIOCHEMISTRY-US, V38, P13223, DOI 10.1021/bi991181o; Chang KH, 1997, BIOCHEMISTRY-US, V36, P15650, DOI 10.1021/bi971262p; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DELARUE M, 1995, CURR OPIN STRUC BIOL, V5, P48, DOI 10.1016/0959-440X(95)80008-O; DELUCA M, 1976, ADV ENZYMOL RAMB, V44, P37; DELUCA M, 1969, BIOCHEMISTRY-US, V8, P160, DOI 10.1021/bi00829a023; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; KAJIYAMA N, 1991, PROTEIN ENG, V4, P691, DOI 10.1093/protein/4.6.691; Kleinkauf H, 1996, EUR J BIOCHEM, V236, P335, DOI 10.1111/j.1432-1033.1996.00335.x; Kumasaka T, 2002, STRUCTURE, V10, P1205, DOI 10.1016/S0969-2126(02)00830-4; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Mamaev SV, 1996, J AM CHEM SOC, V118, P7243, DOI 10.1021/ja961053c; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; McCapra F., 1994, BIOLUMINESCENCE CHEM, P387; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; ROUSSEL A, 1996, TURBO FRODO MANUAL; SELIGER HH, 1960, ARCH BIOCHEM BIOPHYS, V88, P136, DOI 10.1016/0003-9861(60)90208-3; UEDA H, 1991, BIOCHIM BIOPHYS ACTA, V1080, P126, DOI 10.1016/0167-4838(91)90138-P; WHITE EH, 1969, J AM CHEM SOC, V91, P2178, DOI 10.1021/ja01036a093	29	429	443	6	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2006	440	7082					372	376		10.1038/nature04542	http://dx.doi.org/10.1038/nature04542			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541080				2022-12-24	WOS:000235997600060
J	Diehl, MR; Zhang, KC; Lee, HJ; Tirrell, DA				Diehl, MR; Zhang, KC; Lee, HJ; Tirrell, DA			Engineering cooperativity in biomotor-protein assemblies	SCIENCE			English	Article							KINESIN HEAD DOMAINS; MOLECULAR MOTORS; PROCESSIVITY; ELASTIN; OSCILLATIONS; CHEMISTRY; TRANSPORT; KIF1A		CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Diehl, MR (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	diehl@rice.edu						Badoual M, 2002, P NATL ACAD SCI USA, V99, P6696, DOI 10.1073/pnas.102692399; BURGESS SA, 1995, J MOL BIOL, V250, P52, DOI 10.1006/jmbi.1995.0357; Camalet S, 2000, P NATL ACAD SCI USA, V97, P3183, DOI 10.1073/pnas.97.7.3183; Camalet S, 1999, PHYS REV LETT, V82, P1590, DOI 10.1103/PhysRevLett.82.1590; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Duke T, 2000, PHILOS T ROY SOC B, V355, P529, DOI 10.1098/rstb.2000.0594; Endow SA, 2000, NATURE, V406, P913, DOI 10.1038/35022617; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Gross SP, 2003, CURR BIOL, V13, P1660, DOI 10.1016/j.cub.2003.08.032; HACKNEY DD, 1995, BIOPHYS J, V68, pS267; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; Hyun J, 2004, J AM CHEM SOC, V126, P7330, DOI 10.1021/ja049721e; Inoue Y, 2001, BIOPHYS J, V81, P2838, DOI 10.1016/S0006-3495(01)75925-5; Julicher F, 1997, REV MOD PHYS, V69, P1269, DOI 10.1103/RevModPhys.69.1269; Julicher F, 1997, PHYS REV LETT, V78, P4510, DOI 10.1103/PhysRevLett.78.4510; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; LEIBLER S, 1993, J CELL BIOL, V121, P1357, DOI 10.1083/jcb.121.6.1357; Meyer DE, 2004, BIOMACROMOLECULES, V5, P846, DOI 10.1021/bm034215n; Moll JR, 2001, PROTEIN SCI, V10, P649, DOI 10.1110/ps.39401; Okada Y, 2003, NATURE, V424, P574, DOI 10.1038/nature01804; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023; Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t; Vilfan A, 1998, EUR PHYS J B, V3, P535, DOI 10.1007/s100510050343	28	83	85	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2006	311	5766					1468	1471		10.1126/science.1122125	http://dx.doi.org/10.1126/science.1122125			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527982	Green Submitted			2022-12-24	WOS:000236029400051
J	Stemmler, K; Ammann, M; Donders, C; Kleffmann, J; George, C				Stemmler, K; Ammann, M; Donders, C; Kleffmann, J; George, C			Photosensitized reduction of nitrogen dioxide on humic acid as a source of nitrous acid	NATURE			English	Article							DIFFERENTIAL OPTICAL-ABSORPTION; PHOTOCHEMICAL OXIDANT FORMATION; SIMULATED VERTICAL PROFILES; HETEROGENEOUS HYDROLYSIS; SOUTHERN SWITZERLAND; URBAN ATMOSPHERE; BOUNDARY-LAYER; HONO; CHEMISTRY; PHOTOLYSIS	Nitrous acid is a significant photochemical precursor of the hydroxyl radical(1-13), the key oxidant in the degradation of most air pollutants in the troposphere. The sources of nitrous acid in the troposphere, however, are still poorly understood. Recent atmospheric measurements(7,10-17) revealed a strongly enhanced formation of nitrous acid during daytime via unknown mechanisms. Here we expose humic acid films to nitrogen dioxide in an irradiated tubular gas flow reactor and find that reduction of nitrogen dioxide on light-activated humic acids is an important source of gaseous nitrous acid. Our findings indicate that soil and other surfaces containing humic acid exhibit an organic surface photochemistry that produces reductive surface species, which react selectively with nitrogen dioxide. The observed rate of nitrous acid formation could explain the recently observed high daytime concentrations of nitrous acid in the boundary layer, the photolysis of which accounts for up to 60 per cent of the integrated hydroxyl radical source strengths(3,6-13). We suggest that this photoinduced nitrous acid production on humic acid could have a potentially significant impact on the chemistry of the lowermost troposphere.	Paul Scherrer Inst, Lab Radio & Environm Chem, CH-5232 Villigen, Switzerland; Berg Univ Wuppertal, D-42097 Wuppertal, Germany; Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; UCBL, CNRS, Lab Applicat Chim Environm, F-69622 Villeurbanne, France	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Wuppertal; University of Bern; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Stemmler, K (corresponding author), Paul Scherrer Inst, Lab Radio & Environm Chem, CH-5232 Villigen, Switzerland.	konrad.stemmler@psi.ch	George, Christian/F-5220-2018; Ammann, Markus/E-4576-2011	George, Christian/0000-0003-1578-7056; Ammann, Markus/0000-0001-5922-9000				Acker K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024643; Alicke B, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000075; Alicke B, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000579; Ammann M, 2005, PHYS CHEM CHEM PHYS, V7, P2513, DOI 10.1039/b501808k; Atkinson R, 2003, ATMOS ENVIRON, V37, pS197, DOI 10.1016/S1352-2310(03)00391-1; Aumont B, 2003, ATMOS ENVIRON, V37, P487, DOI 10.1016/S1352-2310(02)00920-2; Blough N. V., 1997, SEA SURFACE GLOBAL C, P383, DOI [10.1017/CBO9780511525025.014, DOI 10.1017/CBO9780511525025.014]; Finlayson-Pitts BJ, 2003, PHYS CHEM CHEM PHYS, V5, P223, DOI 10.1039/b208564j; George C, 2005, FARADAY DISCUSS, V130, P195, DOI 10.1039/b417888m; HARRIS GW, 1982, ENVIRON SCI TECHNOL, V16, P414, DOI 10.1021/es00101a009; Harrison RM, 1996, J GEOPHYS RES-ATMOS, V101, P14429, DOI 10.1029/96JD00341; Honrath RE, 2002, ATMOS ENVIRON, V36, P2629, DOI 10.1016/S1352-2310(02)00132-2; Janzen HH, 2004, AGR ECOSYST ENVIRON, V104, P399, DOI 10.1016/j.agee.2004.01.040; Kleffmann J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022524; Kleffmann J, 2003, ATMOS ENVIRON, V37, P2949, DOI 10.1016/S1352-2310(03)00242-5; Kleffmann J, 2002, ENVIRON SCI POLLUT R, P48; Krivacsy Z, 2000, ATMOS ENVIRON, V34, P4273, DOI 10.1016/S1352-2310(00)00211-9; Lammel G, 1996, CHEM SOC REV, V25, P361, DOI 10.1039/cs9962500361; PERNER D, 1979, GEOPHYS RES LETT, V6, P917, DOI 10.1029/GL006i012p00917; PLATT U, 1980, NATURE, V285, P312, DOI 10.1038/285312a0; Ramazan KA, 2004, PHYS CHEM CHEM PHYS, V6, P3836, DOI 10.1039/b402195a; Ren XR, 2003, ATMOS ENVIRON, V37, P3639, DOI 10.1016/S1352-2310(03)00459-X; Staffelbach T, 1997, J GEOPHYS RES-ATMOS, V102, P23345, DOI 10.1029/97JD00933; Staffelbach T, 1997, J GEOPHYS RES-ATMOS, V102, P23363, DOI 10.1029/97JD00932; STEVENSO.FJ, 1970, SOIL SCI SOC AM PRO, V34, P430, DOI 10.2136/sssaj1970.03615995003400030024x; Venterea RT, 2000, GLOBAL CHANGE BIOL, V6, P303, DOI 10.1046/j.1365-2486.2000.00309.x; Vogel B, 2003, ATMOS ENVIRON, V37, P2957, DOI 10.1016/S1352-2310(03)00243-7; ZEPP RG, 1992, ENVIRON SCI TECHNOL, V26, P313, DOI 10.1021/es00026a011; Zhou XL, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018620; Zhou XL, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001539	30	357	363	15	255	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2006	440	7081					195	198		10.1038/nature04603	http://dx.doi.org/10.1038/nature04603			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	16525469	Green Submitted, Bronze			2022-12-24	WOS:000235839500042
J	Shaw, GC; Cope, JJ; Li, LT; Corson, K; Hersey, C; Ackermann, GE; Gwynn, B; Lambert, AJ; Wingert, RA; Traver, D; Trede, NS; Barut, BA; Zhou, Y; Minet, E; Donovan, A; Brownlie, A; Balzan, R; Weiss, MJ; Peters, LL; Kaplan, J; Zon, LI; Paw, BH				Shaw, GC; Cope, JJ; Li, LT; Corson, K; Hersey, C; Ackermann, GE; Gwynn, B; Lambert, AJ; Wingert, RA; Traver, D; Trede, NS; Barut, BA; Zhou, Y; Minet, E; Donovan, A; Brownlie, A; Balzan, R; Weiss, MJ; Peters, LL; Kaplan, J; Zon, LI; Paw, BH			Mitoferrin is essential for erythroid iron assimilation	NATURE			English	Article							CARRIER PROTEIN; HELA-CELLS; ZEBRAFISH; YEAST; GENE; IDENTIFICATION; MITOCHONDRIA; BIOGENESIS; METABOLISM; EXPRESSION	Iron has a fundamental role in many metabolic processes, including electron transport, deoxyribonucleotide synthesis, oxygen transport and many essential redox reactions involving haemoproteins and Fe - S cluster proteins. Defective iron homeostasis results in either iron deficiency or iron overload(1). Precise regulation of iron transport in mitochondria is essential for haem biosynthesis(2), haemoglobin production and Fe - S cluster protein assembly(3,4) during red cell development. Here we describe a zebrafish mutant, frascati (frs)(5), that shows profound hypochromic anaemia and erythroid maturation arrest owing to defects in mitochondrial iron uptake. Through positional cloning, we show that the gene mutated in the frs mutant is a member of the vertebrate mitochondrial solute carrier family (SLC25)(6) that we call mitoferrin (mfrn). mfrn is highly expressed in fetal and adult haematopoietic tissues of zebrafish and mouse. Erythroblasts generated from murine embryonic stem cells null for Mfrn ( also known as Slc25a37) show maturation arrest with severely impaired incorporation of Fe-55 into haem. Disruption of the yeast mfrn orthologues, MRS3 and MRS4, causes defects in iron metabolism and mitochondrial Fe - S cluster biogenesis(7-10). Murine Mfrn rescues the defects in frs zebrafish, and zebrafish mfrn complements the yeast mutant, indicating that the function of the gene may be highly conserved. Our data show that mfrn functions as the principal mitochondrial iron importer essential for haem biosynthesis in vertebrate erythroblasts.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Hematol, Boston, MA 02115 USA; Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA; Harvard Univ, Sch Med, Childrens Hosp Boston, Howard Hughes Med Inst,Stem Cell Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp Boston, Div Hematol Oncol, Boston, MA 02115 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Univ Malta, Dept Physiol & Biochem, Msida MSD 06, Malta; Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Div Hematol, Philadelphia, PA 19104 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Utah System of Higher Education; University of Utah; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Jackson Laboratory; University of Malta; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Paw, BH (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Hematol, Boston, MA 02115 USA.	bpaw@rics.bwh.harvard.edu	Weiss, Mitchell J/W-9814-2018; Shaw, George C/AAA-2678-2022; Wingert, Rebecca A/ABE-2786-2020; Weiss, Mitchell J/A-1245-2013; Balzan, Rena //B-3215-2008	Weiss, Mitchell J/0000-0003-2460-3036; Wingert, Rebecca A/0000-0003-3133-7549; Cutts, Alison/0000-0002-4986-573X; Paw, Barry/0000-0002-0492-1419; Peters, Luanne/0000-0002-0784-0534	NHLBI NIH HHS [P01 HL032262, R01 HL075714] Funding Source: Medline; NIDDK NIH HHS [R01 DK070838] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262, R01HL075714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070838] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALZAN R, 1995, P NATL ACAD SCI USA, V92, P4219, DOI 10.1073/pnas.92.10.4219; Cantor AB, 2002, MOL CELL BIOL, V22, P4268, DOI 10.1128/MCB.22.12.4268-4279.2002; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Foury F, 2002, J BIOL CHEM, V277, P24475, DOI 10.1074/jbc.M111789200; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; IUCHI I, 1983, J EXP ZOOL, V226, P409, DOI 10.1002/jez.1402260311; Kobayashi K, 1999, NAT GENET, V22, P159, DOI 10.1038/9667; Li FY, 2002, MAMM GENOME, V13, P20, DOI 10.1007/s00335-001-2094-y; Li FY, 2001, FEBS LETT, V494, P79, DOI 10.1016/S0014-5793(01)02319-5; Li LT, 2004, J BIOL CHEM, V279, P33653, DOI 10.1074/jbc.M403146200; Li QZ, 2001, MAMM GENOME, V12, P830, DOI 10.1007/s00335001-2075-1; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Lyons SE, 2002, P NATL ACAD SCI USA, V99, P5454, DOI 10.1073/pnas.082695299; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; Napier I, 2005, BLOOD, V105, P1867, DOI 10.1182/blood-2004-10-3856; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Paw BH, 2003, NAT GENET, V34, P59, DOI 10.1038/ng1137; Ransom DG, 1996, DEVELOPMENT, V123, P311; Rosenberg MJ, 2002, NAT GENET, V32, P175, DOI 10.1038/ng948; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Roy CN, 1999, J BIOL CHEM, V274, P9022, DOI 10.1074/jbc.274.13.9022; Shafizadeh E, 2004, CURR OPIN HEMATOL, V11, P255, DOI 10.1097/01.moh.0000138686.15806.71; STURROCK A, 1990, J BIOL CHEM, V265, P3139; Surinya KH, 1997, J BIOL CHEM, V272, P26585, DOI 10.1074/jbc.272.42.26585; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Wohlrab H, 2005, BBA-BIOENERGETICS, V1709, P157, DOI 10.1016/j.bbabio.2005.07.003; Zhang Y, 2005, J BIOL CHEM, V280, P19794, DOI 10.1074/jbc.M500397200	30	425	438	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2006	440	7080					96	100		10.1038/nature04512	http://dx.doi.org/10.1038/nature04512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HW	16511496				2022-12-24	WOS:000235685700047
J	Walther, TC; Brickner, JH; Aguilar, PS; Bernales, S; Walter, P				Walther, TC; Brickner, JH; Aguilar, PS; Bernales, S; Walter, P			Eisosomes mark static sites of endocytosis	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; PLASMA-MEMBRANE; GLOBAL ANALYSIS; PROTEIN; ACTIN; LOCALIZATION; INTERNALIZATION; MAINTENANCE; METABOLISM	Endocytosis functions to recycle plasma membrane components, to regulate cell-surface expression of signalling receptors and to internalize nutrients in all eukaryotic cells. Internalization of proteins, lipids and other cargo can occur by one of several pathways that have different, but often overlapping, molecular requirements(1-5). To mediate endocytosis, effectors assemble transiently underneath the plasma membrane, carry out the mechanics of membrane deformation, cargo selection and vesicle internalization, and then disassemble. The mechanism by which endocytosis initiates at particular locations on the plasma membrane has remained unknown. Sites of endocytosis might be formed randomly, induced by stochastic protein and/or lipid clustering. Alternatively, endocytosis might initiate at specific locations. Here we describe large immobile protein assemblies at the plasma membrane in the yeast Saccharomyces cerevisiae that mark endocytic sites. These structures, termed eisosomes (from the Greek 'eis', meaning into or portal, and 'soma', meaning body), are composed primarily of two cytoplasmic proteins, Pil1 and Lsp1. A plasma membrane protein, Sur7, localizes to eisosomes. These structures colocalize with sites of protein and lipid endocytosis, and their components genetically interact with known endocytic effectors. Loss of Pil1 leads to clustering of eisosome remnants and redirects endocytosis and endocytic effector proteins to these clusters.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Walther, TC (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 600 16th St, San Francisco, CA 94143 USA.	twalther@itsa.ucsf.edu	Aguilar, Pablo/AAV-7336-2020; Aguilar, Pablo/E-4576-2010	Aguilar, Pablo/0000-0002-9312-2474; Walther, Tobias/0000-0003-1442-1327; Brickner, Jason/0000-0001-8019-3743				Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; deHart AKA, 2002, J CELL BIOL, V156, P241, DOI 10.1083/jcb.200107135; Dickson RC, 1999, BBA-MOL CELL BIOL L, V1438, P305, DOI 10.1016/S1388-1981(99)00068-2; ENGQVISTGOLDSTEIN, 2003, ANNU REV CELL DEV BI, V19, P287; Friant S, 2001, EMBO J, V20, P6783, DOI 10.1093/emboj/20.23.6783; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; Heiman MG, 2000, J CELL BIOL, V151, P719, DOI 10.1083/jcb.151.3.719; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huckaba TM, 2004, J CELL BIOL, V167, P519, DOI 10.1083/jcb.200404173; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kruckeberg AL, 1999, BIOCHEM J, V339, P299, DOI 10.1042/0264-6021:3390299; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Malinska K, 2004, J CELL SCI, V117, P6031, DOI 10.1242/jcs.01493; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; MUNN AL, 1995, MOL BIOL CELL, V6, P1721, DOI 10.1091/mbc.6.12.1721; Perret E, 2005, CURR OPIN CELL BIOL, V17, P423, DOI 10.1016/j.ceb.2005.06.008; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Sivadon P, 1997, YEAST, V13, P747, DOI 10.1002/(SICI)1097-0061(19970630)13:8<747::AID-YEA137>3.0.CO;2-L; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wendland B, 1996, J CELL BIOL, V135, P1485, DOI 10.1083/jcb.135.6.1485; Young ME, 2002, MOL CELL BIOL, V22, P927, DOI 10.1128/MCB.22.3.927-934.2002; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824; Zhang XP, 2004, J BIOL CHEM, V279, P22030, DOI 10.1074/jbc.M400299200; Zheng B, 1998, P NATL ACAD SCI USA, V95, P11721, DOI 10.1073/pnas.95.20.11721	30	247	253	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 23	2006	439	7079					998	1003		10.1038/nature04472	http://dx.doi.org/10.1038/nature04472			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014NE	16496001				2022-12-24	WOS:000235486100052
J	Lindenauer, PK; Behal, R; Murray, CK; Nsa, W; Bratzler, DW				Lindenauer, PK; Behal, R; Murray, CK; Nsa, W; Bratzler, DW			Volume, quality of care, and outcome in pneumonia	ANNALS OF INTERNAL MEDICINE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; ACUTE MYOCARDIAL-INFARCTION; IN-HOSPITAL MORTALITY; MEDICARE BENEFICIARIES; ELDERLY-PATIENTS; CONTROLLED-TRIAL; SURVIVAL; IMPLEMENTATION; ASSOCIATION; GUIDELINES	Background: The establishment of minimum volume thresholds has been proposed as a means of improving outcomes for patients with various medical and surgical conditions. Objective: To determine whether volume is associated with either quality of care or outcome in the treatment of pneumonia. Design: Retrospective cohort study. Setting: 3243 hospitals participating in the National Pneumonia Quality Improvement Project in 1998 and 1999. Patients: 13 480 patients with pneumonia cared for by 9741 physicians. Measurements: The association between the annual pneumonia caseload of physicians and hospitals and adherence to quality-of-care measures and severity-adjusted in-hospital and 30-day mortality rates. Results: Physician volume was unrelated to the timeliness of administration of antibiotics and the obtainment of blood cultures; however, physicians in the highest-volume quartile had lower rates of screening for and administration of influenza (21%, 19%, 20%, and 12% for quartiles 1 through 4, respectively; P < 0.01) and pneumococcal (16%, 13%, 13%, and 9% for quartiles 1 through 4, respectively; p < 0.01) vaccines. Among hospitals, the percentage of patients who received antibiotics within 4 hours of hospital arrival was inversely related to pneumonia volume (72%, 64%, 60%, and 56% for quartiles 1 through 4, respectively; P < 0.01), while selection of antibiotic, obtainment of blood cultures, and rates of immunization were similar. Physician volume was not associated with in-hospital or 30-day mortality rates. Odds ratios for in-hospital mortality rates rose with increasing hospital volume (1.14 [95% Cl, 0.87 to 1.491, 1.34 [Cl, 1.03 to 1.75], and 1.32 [Cl, 0.97 to 1.80] for quartiles 2 to 4, respectively); however, odds ratios for 30-day mortality rates were similar. Limitations: This study was limited to Medicare beneficiaries 65 years of age and older. Ascertainment of some measures of the quality of care and severity of illness depended on the documentation practices of the physician. Conclusion: Among both physicians and hospitals, higher pneumonia volume is associated with reduced adherence to selected guideline recommendations and no measurable improvement in patient outcomes.	Baystate Med Ctr, Div Healthcare Qual, Springfield, MA 01199 USA; Tufts Univ, Sch Med, Medford, MA 02155 USA; Univ Hlth Syst Consortium, Oak Brook, IL USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Univ Cent Oklahoma, Edmond, OK USA; Oklahoma Fdn Med Qual, Oklahoma City, OK USA; Univ Washington, Sch Publ Hlth & Community Med, Seattle, WA 98195 USA	Baystate Medical Center; Tufts University; Northwestern University; Feinberg School of Medicine; University of Central Oklahoma; University of Washington; University of Washington Seattle	Lindenauer, PK (corresponding author), Baystate Med Ctr, Div Healthcare Qual, 759 Chestnut St P-5931, Springfield, MA 01199 USA.	Peter.Lindenauer@bhs.org	Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213; Behal, Raj/0000-0001-5418-2581				Auerbach AD, 2002, ANN INTERN MED, V137, P859, DOI 10.7326/0003-4819-137-11-200212030-00006; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; BENNETT CL, 1989, JAMA-J AM MED ASSOC, V261, P2975, DOI 10.1001/jama.261.20.2975; Birkmeyer JD., 2000, LEAPFROG SAFETY STAN; Bratzler DW, 2002, ARCH INTERN MED, V162, P2349, DOI 10.1001/archinte.162.20.2349; Casale PN, 1998, J AM COLL CARDIOL, V32, P885, DOI 10.1016/S0735-1097(98)00325-8; Chu LA, 2003, ARCH INTERN MED, V163, P326, DOI 10.1001/archinte.163.3.326; Fine MJ, 2003, AM J MED, V115, P343, DOI 10.1016/S0002-9343(03)00395-4; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; HCUPnet, HEALTHC COST UT PROJ; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Kitahata MM, 1996, NEW ENGL J MED, V334, P701, DOI 10.1056/NEJM199603143341106; Mandell LA, 2003, CLIN INFECT DIS, V37, P1405, DOI 10.1086/380488; Marrie TJ, 2000, JAMA-J AM MED ASSOC, V283, P749, DOI 10.1001/jama.283.6.749; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Meehan TP, 2001, AM J MED, V111, P203, DOI 10.1016/S0002-9343(01)00803-8; *NAT PNEUM PROJ, MED QUAL IMPR COMM; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Panageas KS, 2003, ANN INTERN MED, V139, P658, DOI 10.7326/0003-4819-139-8-200310210-00009; Rifkin WD, 2002, MAYO CLIN PROC, V77, P1053, DOI 10.4065/77.10.1053; SAINSBURY R, 1995, LANCET, V345, P1265, DOI 10.1016/S0140-6736(95)90924-9; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487	25	50	51	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2006	144	4					262	269		10.7326/0003-4819-144-4-200602210-00008	http://dx.doi.org/10.7326/0003-4819-144-4-200602210-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	015HS	16490912				2022-12-24	WOS:000235543100005
J	Kato, T; Inagaki, H; Yamada, K; Kogo, H; Ohye, T; Kowa, H; Nagaoka, K; Taniguchi, M; Emanuel, BS; Kurahashi, H				Kato, T; Inagaki, H; Yamada, K; Kogo, H; Ohye, T; Kowa, H; Nagaoka, K; Taniguchi, M; Emanuel, BS; Kurahashi, H			Genetic variation affects de novo translocation frequency	SCIENCE			English	Article							AT-RICH PALINDROMES; CONSTITUTIONAL T(11/22); BREAKPOINT		Univ Penn, Sch Med, Inst Comprehens Med Sci, Div Mol Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Kurahashi, H (corresponding author), Univ Penn, Sch Med, Inst Comprehens Med Sci, Div Mol Genet, Philadelphia, PA 19104 USA.	kura@fujita-hu.ac.jp	Kogo, Hiroshi/AAB-8467-2019	Kogo, Hiroshi/0000-0003-0584-7158	NCI NIH HHS [CA39926, R01 CA039926, R01 CA039926-18] Funding Source: Medline; NIDCD NIH HHS [P01 DC002027, P01 DC002027-070006] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA039926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC002027] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Edelmann L, 2001, AM J HUM GENET, V68, P1, DOI 10.1086/316952; Gotter AL, 2004, HUM MOL GENET, V13, P103, DOI 10.1093/hmg/ddh004; Kurahashi H, 2000, HUM MOL GENET, V9, P1665, DOI 10.1093/hmg/9.11.1665; Kurahashi H, 2003, AM J HUM GENET, V72, P733, DOI 10.1086/368062; Kurahashi H, 2001, HUM MOL GENET, V10, P2605, DOI 10.1093/hmg/10.23.2605; Kurahashi H, 2001, NAT GENET, V29, P139, DOI 10.1038/ng1001-139; Nimmakayalu MA, 2003, HUM MOL GENET, V12, P2817, DOI 10.1093/hmg/ddg301; Tapia-Paez I, 2001, HUM GENET, V109, P167; ZACKAI EH, 1980, AM J MED GENET, V7, P507, DOI 10.1002/ajmg.1320070412	9	61	62	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2006	311	5763					971	971		10.1126/science.1121452	http://dx.doi.org/10.1126/science.1121452			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014CS	16484486	Green Accepted			2022-12-24	WOS:000235456900036
J	Watts, G				Watts, G			I'll scratch your back ... if you have one	LANCET			English	Editorial Material											Watts, G (corresponding author), 28 New End Sq, London NW3 1LS, England.	geoff@scileg.freeserve.co.uk						Glover AG, 2005, P ROY SOC B-BIOL SCI, V272, P2587, DOI 10.1098/rspb.2005.3275; Jackson RR, 2005, P NATL ACAD SCI USA, V102, P15155, DOI 10.1073/pnas.0507398102; Okamoto N, 2005, SCIENCE, V310, P287, DOI 10.1126/science.1116125; Sasakura Y, 2005, P NATL ACAD SCI USA, V102, P15134, DOI 10.1073/pnas.0503640102	4	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2006	367	9509					459	460		10.1016/S0140-6736(06)68159-2	http://dx.doi.org/10.1016/S0140-6736(06)68159-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	013FF	16473112				2022-12-24	WOS:000235394500010
J	Erbse, A; Schmidt, R; Bornemann, T; Schneider-Mergener, J; Mogk, A; Zahn, R; Dougan, DA; Bukau, B				Erbse, A; Schmidt, R; Bornemann, T; Schneider-Mergener, J; Mogk, A; Zahn, R; Dougan, DA; Bukau, B			ClpS is an essential component of the N-end rule pathway in Escherichia coli	NATURE			English	Article							METHIONINE AMINOPEPTIDASE; SUBSTRATE-SPECIFICITY; PEPTIDE LIBRARIES; DEGRADATION; PROTEIN; APOPTOSIS; CHAPERONE; CELLS	The N-end rule states that the half-life of a protein is determined by the nature of its amino-terminal residue(1). Eukaryotes and prokaryotes use N-terminal destabilizing residues as a signal to target proteins for degradation by the N-end rule pathway. In eukaryotes an E3 ligase, N-recognin, recognizes N-end rule substrates and mediates their ubiquitination and degradation by the proteasome(1,2). In Escherichia coli, N-end rule substrates are degraded by the AAA+ chaperone ClpA in complex with the ClpP peptidase (ClpAP)(3). Little is known of the molecular mechanism by which N-end rule substrates are initially selected for proteolysis. Here we report that the ClpAP-specific adaptor, ClpS, is essential for degradation of N-end rule substrates by ClpAP in bacteria. ClpS binds directly to N-terminal destabilizing residues through its substrate-binding site distal to the ClpS - ClpA interface(4), and targets these substrates to ClpAP for degradation. Degradation by the N-end rule pathway is more complex than anticipated and several other features are involved, including a net positive charge near the Nterminus and an unstructured region between the N-terminal signal and the folded protein substrate. Through interaction with this signal, ClpS converts the ClpAP machine into a protease with exquisitely defined specificity, ideally suited to regulatory proteolysis.	Univ Heidelberg, Zentrum Mol Biol Heidelberg, D-69120 Heidelberg, Germany; Humboldt Univ, Univ Klinikum Charite, D-10098 Berlin, Germany; La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia	Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; La Trobe University	Bukau, B (corresponding author), Univ Heidelberg, Zentrum Mol Biol Heidelberg, INF 282, D-69120 Heidelberg, Germany.	bukau@zmbh.uni-heidelberg.de	dougan, david/B-3359-2010	dougan, david/0000-0001-9313-1904; Bukau, Bernd/0000-0003-0521-7199; ERBSE, ANNETTE/0000-0003-0950-3707				BAKER RT, 1991, P NATL ACAD SCI USA, V88, P1090, DOI 10.1073/pnas.88.4.1090; BENBASSAT A, 1987, J BACTERIOL, V169, P751, DOI 10.1128/jb.169.2.751-757.1987; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P7021, DOI 10.1073/pnas.81.22.7021; Knoblauch NTM, 1999, J BIOL CHEM, V274, P34219, DOI 10.1074/jbc.274.48.34219; Kramer A, 1998, METH MOL B, V87, P25; Levy F, 1999, EUR J BIOCHEM, V259, P244, DOI 10.1046/j.1432-1327.1999.00024.x; Lupas AN, 2003, J STRUCT BIOL, V141, P77, DOI 10.1016/S1047-8477(02)00582-8; MAYER A, 1989, SCIENCE, V244, P1480, DOI 10.1126/science.2544030; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Varshavsky A, 2003, NAT CELL BIOL, V5, P373, DOI 10.1038/ncb0503-373; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Zeth K, 2002, NAT STRUCT BIOL, V9, P906, DOI 10.1038/nsb869	19	172	176	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2006	439	7077					753	756		10.1038/nature04412	http://dx.doi.org/10.1038/nature04412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	010KH	16467841				2022-12-24	WOS:000235193100051
J	O'Connor, RJ; Cummings, KM; Giovino, GA; McNeill, A; Kozlowski, LT				O'Connor, RJ; Cummings, KM; Giovino, GA; McNeill, A; Kozlowski, LT			How did UK cigarette makers reduce tar to 10 mg or less?	BRITISH MEDICAL JOURNAL			English	Letter									Roswell Pk Canc Inst, Dept Hlth Behav, Buffalo, NY 14263 USA; UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA	Roswell Park Cancer Institute; University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	O'Connor, RJ (corresponding author), Roswell Pk Canc Inst, Dept Hlth Behav, Buffalo, NY 14263 USA.	Richard.Oconnor@roswellpark.org	O'Connor, Richard/A-6961-2009	McNeill, Ann/0000-0002-6223-4000	NATIONAL CANCER INSTITUTE [P50CA111236] Funding Source: NIH RePORTER; NCI NIH HHS [1 P50 CA111236] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2001, RISKS ASS SMOK CIG L; *COMM EUR PARL COU, 2005, 1 REP APPL TOB PROD; Kozlowski LT, 1998, TOB CONTROL, V7, P369, DOI 10.1136/tc.7.4.369; KOZLOWSKI LT, 2002, TOBACCO CONTROL S1, V11, P40; *LGC TEDD, 1999, TAR NIC CARB MON YIE	5	18	19	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 4	2006	332	7536					302	302		10.1136/bmj.332.7536.302	http://dx.doi.org/10.1136/bmj.332.7536.302			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011HN	16455737	Green Published			2022-12-24	WOS:000235259000030
J	Yoshikuni, Y; Ferrin, TE; Keasling, JD				Yoshikuni, Y; Ferrin, TE; Keasling, JD			Designed divergent evolution of enzyme function	NATURE			English	Article							GAMMA-HUMULENE SYNTHASE; DELTA-SELINENE SYNTHASE; CONFORMATIONAL DIVERSITY; SESQUITERPENE SYNTHASES; CATALYTIC PROMISCUITY; BACTERIAL EXPRESSION; TRICHODIENE SYNTHASE; CRYSTAL-STRUCTURE; IN-VITRO; PROTEIN	It is generally believed that proteins with promiscuous functions divergently evolved to acquire higher specificity and activity(1-5), and that this process was highly dependent on the ability of proteins to alter their functions with a small number of amino acid substitutions (plasticity)(6). The application of this theory of divergent molecular evolution to promiscuous enzymes may allow us to design enzymes with more specificity and higher activity. Many structural and biochemical analyses have identified the active or binding site residues important for functional plasticity (plasticity residues)(6-10). To understand how these residues contribute to molecular evolution, and thereby formulate a design methodology, plasticity residues were probed in the active site of the promiscuous sesquiterpene synthase gamma-humulene synthase(11,12). Identified plasticity residues were systematically recombined based on a mathematical model in order to construct novel terpene synthases, each catalysing the synthesis of one or a few very different sesquiterpenes. Here we present the construction of seven specific and active synthases that use different reaction pathways to produce the specific and very different products. Creation of these enzymes demonstrates the feasibility of exploiting the underlying evolvability of this scaffold, and provides evidence that rational approaches based on these ideas are useful for enzyme design.	Univ Calif Berkeley, UCSF UCB Joint Grad Grp Bioengn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Calif Inst Quantitat Biomed Res QB3, Berkeley, CA 94720 USA; Lawrence Berkeley Lab, Phys Biosci Div, Synthet Biol Dept, Berkeley, CA 94710 USA; Univ Calif San Francisco, Dept Pharmaceut Chem & Biopharmaceut Sci, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California San Francisco	Keasling, JD (corresponding author), Univ Calif Berkeley, UCSF UCB Joint Grad Grp Bioengn, Berkeley, CA 94720 USA.	keasling@berkeley.edu	Keasling, Jay D/J-9162-2012; Yoshikuni, Yasuo/A-8804-2019; Ferrin, Thomas E./W-8842-2019; Yoshikuni, Yasuo/K-7741-2019	Keasling, Jay D/0000-0003-4170-6088; Ferrin, Thomas E./0000-0001-6227-0637; Yoshikuni, Yasuo/0000-0002-8372-640X				Adams R.P., 1995, IDENTIFICATION ESSEN; Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; Aubourg S, 2002, MOL GENET GENOMICS, V267, P730, DOI 10.1007/s00438-002-0709-y; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; BONE R, 1989, NATURE, V339, P191, DOI 10.1038/339191a0; Caruthers JM, 2000, J BIOL CHEM, V275, P25533, DOI 10.1074/jbc.M000433200; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Gerlt JA, 2005, ARCH BIOCHEM BIOPHYS, V433, P59, DOI 10.1016/j.abb.2004.07.034; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Joo H, 1999, NATURE, V399, P670, DOI 10.1038/21395; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Little DB, 2002, ARCH BIOCHEM BIOPHYS, V402, P120, DOI 10.1016/S0003-9861(02)00068-1; Martin DM, 2004, PLANT PHYSIOL, V135, P1908, DOI 10.1104/pp.104.042028; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Matsumura I, 2001, J MOL BIOL, V305, P331, DOI 10.1006/jmbi.2000.4259; Mildvan AS, 2004, BIOCHEMISTRY-US, V43, P14517, DOI 10.1021/bi048052e; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Rynkiewicz MJ, 2002, BIOCHEMISTRY-US, V41, P1732, DOI 10.1021/bi011960g; Rynkiewicz MJ, 2001, P NATL ACAD SCI USA, V98, P13543, DOI 10.1073/pnas.231313098; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Steele CL, 1998, J BIOL CHEM, V273, P2078, DOI 10.1074/jbc.273.4.2078; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; van den Heuvel RHH, 2000, P NATL ACAD SCI USA, V97, P9455, DOI 10.1073/pnas.160175897	30	315	336	5	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1078	1082		10.1038/nature04607	http://dx.doi.org/10.1038/nature04607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16495946				2022-12-24	WOS:000236906000042
J	Masgrau, L; Roujeinikova, A; Johannissen, LO; Hothi, P; Basran, J; Ranaghan, KE; Mulholland, AJ; Sutcliffe, MJ; Scrutton, NS; Leys, D				Masgrau, L; Roujeinikova, A; Johannissen, LO; Hothi, P; Basran, J; Ranaghan, KE; Mulholland, AJ; Sutcliffe, MJ; Scrutton, NS; Leys, D			Atomic description of an enzyme reaction dominated by proton tunneling	SCIENCE			English	Article							AROMATIC AMINE DEHYDROGENASE; THERMOPHILIC ALCOHOL-DEHYDROGENASE; HYDRIDE-TRANSFER REACTIONS; TRANSITION-STATE THEORY; HYDROGEN BOND-CLEAVAGE; METHYLAMINE DEHYDROGENASE; TEMPERATURE-DEPENDENCE; ELECTRON-TRANSFER; CATALYSIS; SIMULATIONS	We present an atomic-level description of the reaction chemistry of an enzyme-catalyzed reaction dominated by proton tunneling. By solving structures of reaction intermediates at near-atomic resolution, we have identified the reaction pathway for tryptamine oxidation by aromatic amine dehydrogenase. Combining experiment and computer simulation, we show proton transfer occurs predominantly to oxygen O2 of Asp(128)beta in a reaction dominated by tunneling over similar to 0.6 angstroms. The role of long-range coupled motions in promoting tunneling is controversial. We show that, in this enzyme system, tunneling is promoted by a short-range motion modulating proton-acceptor distance and no long-range coupled motion is required.	Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M60 1QD, Lancs, England; Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester M60 1QD, Lancs, England; Univ Manchester, Fac Life Sci, Manchester M60 1QD, Lancs, England; Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	University of Bristol; University of Manchester; University of Manchester; University of Manchester; University of Leicester	Leys, D (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	adrian.mulholland@bristol.ac.uk; michael.sutcliffe@manchester.ac.uk; nigel.scrutton@manchester.ac.uk; david.leys@manchester.ac.uk	Masgrau, Laura/ABA-9339-2020; Ranaghan, Kara/H-1190-2013; Masgrau, Laura/O-1214-2015; Ranaghan, Kara/B-3825-2015	Masgrau, Laura/0000-0003-4495-508X; Ranaghan, Kara/0000-0002-6391-6601; Masgrau, Laura/0000-0003-4495-508X; Roujeinikova, Anna/0000-0001-8478-4751; Mulholland, Adrian/0000-0003-1015-4567; Sutcliffe, Mike/0000-0003-0414-1700	BBSRC [BB/D01963X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [GR/R86119/01] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/D01963X/1, B19724/2, BB/C511305/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; Agrawal N, 2004, BIOCHEMISTRY-US, V43, P1998, DOI 10.1021/bi036124g; Alhambra C, 2002, CHEM PHYS LETT, V355, P388, DOI 10.1016/S0009-2614(02)00057-X; Alhambra C, 2001, CHEM PHYS LETT, V347, P512, DOI 10.1016/S0009-2614(01)00921-6; Alhambra C, 2000, J AM CHEM SOC, V122, P8197, DOI 10.1021/ja001476l; Antoniou D, 2001, J PHYS CHEM B, V105, P5553, DOI 10.1021/jp004547b; Ball P, 2004, NATURE, V431, P396, DOI 10.1038/431396a; Basran J, 2003, J BIOL CHEM, V278, P43973, DOI 10.1074/jbc.M305983200; Basran J, 2001, J BIOL CHEM, V276, P24581, DOI 10.1074/jbc.M101178200; Basran J, 2001, J BIOL CHEM, V276, P6234, DOI 10.1074/jbc.M008141200; Basran J, 1999, BIOCHEMISTRY-US, V38, P3218, DOI 10.1021/bi982719d; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Caratzoulas S, 2002, J AM CHEM SOC, V124, P3270, DOI 10.1021/ja017146y; Doll KM, 2003, J AM CHEM SOC, V125, P10877, DOI 10.1021/ja030120h; Doll KM, 2003, INORG CHEM, V42, P4849, DOI 10.1021/ic0300722; Faulder PF, 2001, J AM CHEM SOC, V123, P8604, DOI 10.1021/ja016219a; Francisco WA, 2002, J AM CHEM SOC, V124, P8194, DOI 10.1021/ja025758s; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; GOVINDARAJ S, 1994, J BACTERIOL, V176, P2922, DOI 10.1128/JB.176.10.2922-2929.1994; Harris RJ, 2000, BIOCHEMISTRY-US, V39, P1189, DOI 10.1021/bi991941v; Hatcher E, 2004, J AM CHEM SOC, V126, P5763, DOI 10.1021/ja039606o; Hothi P, 2005, FEBS J, V272, P5894, DOI 10.1111/j.1742-4658.2005.04990.x; HUSKEY WP, 1983, J AM CHEM SOC, V105, P5704, DOI 10.1021/ja00355a038; Hwang JK, 1996, J AM CHEM SOC, V118, P11745, DOI 10.1021/ja962007f; HWANG JK, 1991, J PHYS CHEM-US, V95, P8445, DOI 10.1021/j100175a009; HYUN YL, 1995, BBA-PROTEIN STRUCT M, V1251, P198, DOI 10.1016/0167-4838(95)00117-D; HYUN YL, 1995, BIOCHEMISTRY-US, V34, P12249, DOI 10.1021/bi00038a020; Klinman J P, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P415; Knapp MJ, 2002, J AM CHEM SOC, V124, P3865, DOI 10.1021/ja012205t; Knapp MJ, 2002, EUR J BIOCHEM, V269, P3113, DOI 10.1046/j.1432-1033.2002.03022.x; Kohen A, 1999, NATURE, V399, P496, DOI 10.1038/20981; Kuznetsov AM, 1999, CAN J CHEM, V77, P1085, DOI 10.1139/cjc-77-5-6-1085; Liang ZX, 2004, P NATL ACAD SCI USA, V101, P9556, DOI 10.1073/pnas.0403337101; Masgrau L, 2004, ARCH BIOCHEM BIOPHYS, V428, P41, DOI 10.1016/j.abb.2004.03.013; Mure M, 2002, BIOCHEMISTRY-US, V41, P9269, DOI 10.1021/bi020246b; Olsson MHM, 2004, J AM CHEM SOC, V126, P2820, DOI 10.1021/ja037233l; Pu JZ, 2005, J PHYS CHEM B, V109, P8551, DOI 10.1021/jp051184c; Ridder L, 2002, J AM CHEM SOC, V124, P9926, DOI 10.1021/ja0256360; Siebrand W, 2004, J PHYS CHEM B, V108, P4185, DOI 10.1021/jp030575t; Tresadern G, 2003, MOL PHYS, V101, P2775, DOI 10.1080/0026897031000121271; Truhlar D. G., 1985, THEORY CHEM REACTION, P65; Truhlar DG, 2004, INT J QUANTUM CHEM, V100, P1136, DOI 10.1002/qua.20205; Truhlar DG, 1996, J PHYS CHEM-US, V100, P12771, DOI 10.1021/jp953748q; Villa J, 2001, J PHYS CHEM B, V105, P7887, DOI 10.1021/jp011048h; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; WARSHEL A, 1989, SCIENCE, V246, P112, DOI 10.1126/science.2675313; WARSHEL A, 2006, ISOTOPE EFFECTS CHEM, P621	47	248	257	7	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					237	241		10.1126/science.1126002	http://dx.doi.org/10.1126/science.1126002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614214				2022-12-24	WOS:000236765300040
J	Psaty, BM; Weiss, NS; Furberg, CD				Psaty, BM; Weiss, NS; Furberg, CD			Recent trials in hypertension - Compelling science or commercial speech?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH OUTCOMES; 1ST-LINE AGENTS; CLINICAL-TRIAL; BETA-BLOCKADE; PREVENTION; METAANALYSIS; AMLODIPINE; INHIBITORS; MORTALITY; COMMITTEE		Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98101 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98101 USA; Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Wake Forest University; Wake Forest Baptist Medical Center	Psaty, BM (corresponding author), Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, 1730 Minor Ave,Suite 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068639, R01HL060739, R01HL074745, R01HL043201] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alderman MH, 2005, HYPERTENSION, V46, P1, DOI 10.1161/01.HYP.0000168924.37091.58; [Anonymous], 1991, JAMA, V265, P3255; Carlberg B, 2004, LANCET, V364, P1684, DOI 10.1016/S0140-6736(04)17355-8; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Heidenreich PA, 1997, J AM COLL CARDIOL, V30, P27, DOI 10.1016/S0735-1097(97)00104-6; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; PSATY BM, 1990, JAMA-J AM MED ASSOC, V263, P1653, DOI 10.1001/jama.263.12.1653; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P43, DOI 10.1001/jama.292.1.43-c; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Veterans Administration Cooperative Study Group on Antihypertensive Agents, 1967, JAMA-J AM MED ASSOC, V202, P116, DOI DOI 10.1001/JAMA.1967.03130150084015; Whelton PK, 2005, ARCH INTERN MED, V165, P1401, DOI 10.1001/archinte.165.12.1401; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; Yki-Jarvinen H, 2005, LANCET, V366, P1241, DOI 10.1016/S0140-6736(05)67504-6	24	35	35	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2006	295	14					1704	1706		10.1001/jama.295.14.1704	http://dx.doi.org/10.1001/jama.295.14.1704			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031LY	16609093				2022-12-24	WOS:000236707300028
J	Harnden, A				Harnden, A			Avian influenza - Preparing for the pandemic - Dealing with uncertainty: perspective from primary care	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford	Harnden, A (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	anthony.harnden@dphpc.ox.ac.uk						*DEP HLTH, 2005, UK HLTH DEP INFL PAN; World Health Organization, CUM NUMB CONF HUM CA	2	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 1	2006	332	7544					791	792		10.1136/bmj.332.7544.791	http://dx.doi.org/10.1136/bmj.332.7544.791			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	032JA	16575089	Green Published			2022-12-24	WOS:000236769500033
J	Smeeth, L; Cook, C; Thomas, S; Hall, AJ; Hubbard, R; Vallance, P				Smeeth, L; Cook, C; Thomas, S; Hall, AJ; Hubbard, R; Vallance, P			Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting	LANCET			English	Article							VENOUS THROMBOEMBOLISM; MYOCARDIAL-INFARCTION; DISEASE; VACCINATION; POPULATION; PREVENTION; MEDENOX; TRIAL	Background Acute infection increases the risk of arterial cardiovascular events, but effects on venous thromboembolic disease are less well established. Our aim was to investigate whether acute infections transiently increase the risk of venous thromboembolism. Methods We used the self-controlled case-series method to study the risk of first deep vein thrombosis (DVT) (n=7278) and first pulmonary embolism (PE) (n=3755) after acute respiratory and urinary tract infections. Data were obtained from records from general practices who had registered patients with the UK's Health Improvement Network database between 1987 and 2004. Findings The risks of DVT and PE were significantly raised, and were highest in the first two weeks, after urinary tract infection. The incidence ratio for DVT was 2.10 (95% CI 1.56-2.82), and that for PE 2.11 (1.38-3.23). The risk gradually fell over the subsequent months, returning to the baseline value after 1 year. The risk of DVT was also higher after respiratory tract infection, but possible diagnostic misclassification precluded a reliable estimate of the risk of PE after respiratory infection. Interpretation Acute infections are associated with a transient increased risk of venous thromboembolic events in a community setting. Our results confirm that infection should be added to the list of precipitants for venous thromboembolism, and suggest a causal relation.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Univ Nottingham, Div Resp Med, Nottingham NG7 2RD, England; UCL, British Heart Fdn Labs, Ctr Clin Pharmacol, London WC1E 6BT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Nottingham; University of London; University College London	Smeeth, L (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	liam.smeeth@lshtm.ac.uk	Smeeth, Liam/X-5862-2018	Smeeth, Liam/0000-0002-9168-6022	MRC [G108/492] Funding Source: UKRI; Medical Research Council [G108/492] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alikhan R, 2004, ARCH INTERN MED, V164, P963, DOI 10.1001/archinte.164.9.963; Alikhan R, 2003, BLOOD COAGUL FIBRIN, V14, P341, DOI 10.1097/00001721-200306000-00004; Bernstein CN, 2001, THROMB HAEMOSTASIS, V85, P430; Bhagat K, 1996, CARDIOVASC RES, V32, P822; Bhagat K, 1997, CIRCULATION, V96, P3042, DOI 10.1161/01.CIR.96.9.3042; Bourke Alison, 2004, Inform Prim Care, V12, P171; Farrington CP, 2004, VACCINE, V22, P2064, DOI 10.1016/j.vaccine.2004.01.017; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; Fowkes FJI, 2003, EUR J VASC ENDOVASC, V25, P1, DOI 10.1053/ejvs.2002.1778; Gardlund B, 1996, LANCET, V347, P1357; Koster T, 2000, LANCET, V355, P1694, DOI 10.1016/S0140-6736(00)02244-3; Kyrle PA, 2005, LANCET, V365, P1163, DOI 10.1016/S0140-6736(05)71880-8; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Lozinguez O, 2000, THROMB HAEMOSTASIS, V83, P887, DOI 10.1055/s-0037-1613938; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; Melbye H, 2004, BRIT J GEN PRACT, V54, P653; Samama MM, 2000, ARCH INTERN MED, V160, P3415, DOI 10.1001/archinte.160.22.3415; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Tata LJ, 2003, THORAX, V58, P835, DOI 10.1136/thorax.58.10.835; VIRCHOW RLK, 1998, THROMBOSE EMBOLIE TH	22	321	340	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 1	2006	367	9516					1075	1079		10.1016/S0140-6736(06)68474-2	http://dx.doi.org/10.1016/S0140-6736(06)68474-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZF	16581406				2022-12-24	WOS:000236673200031
J	Strauss, KA; Puffenberger, EG; Huentelman, MJ; Gottlieb, S; Dobrin, SE; Parod, JM; Stephan, DA; Morton, DH				Strauss, KA; Puffenberger, EG; Huentelman, MJ; Gottlieb, S; Dobrin, SE; Parod, JM; Stephan, DA; Morton, DH			Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TEMPORAL-LOBE EPILEPSY; GATED POTASSIUM CHANNEL; MYELINATED AXONS; BRAIN; PLASTICITY; CHILDHOOD; MUTATION; CASPR2; TAG-1; KV1.1	Contactin-associated protein-like 2 (CASPR2) is encoded by CNTNAP2 and clusters voltage-gated potassium channels (K(v)1.1) at the nodes of Ranvier. We report a homozygous mutation of CNTNAP2 in Old Order Amish children with cortical dysplasia, focal epilepsy, relative macrocephaly, and diminished deep-tendon reflexes. Intractable focal seizures began in early childhood, after which language regression, hyperactivity, impulsive and aggressive behavior, and mental retardation developed in all children. Resective surgery did not prevent the recurrence of seizures. Temporal-lobe specimens showed evidence of abnormalities of neuronal migration and structure, widespread astrogliosis, and reduced expression of CASPR2.	Clin Special Children, Strasburg, PA 17579 USA; Lancaster Gen Hosp, Lancaster, PA USA; Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA; Translat Genom Res Inst, Phoenix, AZ 85004 USA	Translational Genomics Research Institute	Strauss, KA (corresponding author), Clin Special Children, 535 Bunker Hill Rd, Strasburg, PA 17579 USA.	kstrauss@clinicforspecialchildren.org; dstephan@tgen.org		Puffenberger, Erik/0000-0002-6388-9148				Ashcroft FM, 2000, ION CHANNELS DIS; Avery RA, 1999, EUR J NUCL MED, V26, P830, DOI 10.1007/s002590050456; Bocti C, 2003, NEUROLOGY, V60, P191, DOI 10.1212/01.WNL.0000044055.73747.9F; Crino PB, 2004, ADV EXP MED BIOL, V548, P175; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; Fogarasi A, 2002, EPILEPSIA, V43, P638, DOI 10.1046/j.1528-1157.2002.46801.x; Holmes GL, 2001, PEDIATR RES, V49, P320, DOI 10.1203/00006450-200103000-00004; HONOVAR M, 2002, GREENFIELDS NEUROPAT, P899; Johnston MV, 2004, BRAIN DEV-JPN, V26, P73, DOI 10.1016/S0387-7604(03)00102-5; Kamiya K, 2004, J NEUROSCI, V24, P2690, DOI 10.1523/JNEUROSCI.3089-03.2004; Luiz DM, 2001, CHILD CARE HLTH DEV, V27, P73, DOI 10.1046/j.1365-2214.2001.00158.x; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Petersson S, 2003, EUR J NEUROSCI, V18, P3231, DOI 10.1111/j.1460-9568.2003.03044.x; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101; Robinson R, 2004, ANN MED, V36, P89, DOI 10.1080/07853890310019952; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; Wass CT, 2001, EPILEPSIA, V42, P1340, DOI 10.1046/j.1528-1157.2001.05901.x; Yamakawa K, 2005, NEUROREPORT, V16, P1, DOI 10.1097/00001756-200501190-00001; Zuberi SM, 1999, BRAIN, V122, P817, DOI 10.1093/brain/122.5.817	24	466	482	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2006	354	13					1370	1377		10.1056/NEJMoa052773	http://dx.doi.org/10.1056/NEJMoa052773			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026KO	16571880				2022-12-24	WOS:000236338000006
J	Liu, PT; Stenger, S; Li, HY; Wenzel, L; Tan, BH; Krutzik, SR; Ochoa, MT; Schauber, J; Wu, K; Meinken, C; Kamen, DL; Wagner, M; Bals, R; Steinmeyer, A; Zugel, U; Gallo, RL; Eisenberg, D; Hewison, M; Hollis, BW; Adams, JS; Bloom, BR; Modlin, RL				Liu, PT; Stenger, S; Li, HY; Wenzel, L; Tan, BH; Krutzik, SR; Ochoa, MT; Schauber, J; Wu, K; Meinken, C; Kamen, DL; Wagner, M; Bals, R; Steinmeyer, A; Zugel, U; Gallo, RL; Eisenberg, D; Hewison, M; Hollis, BW; Adams, JS; Bloom, BR; Modlin, RL			Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response	SCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; MYCOBACTERIUM-TUBERCULOSIS; SUSCEPTIBILITY; EXPRESSION; INFECTION	In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monocytes and macrophages is mediated principally by nitric oxide. We report here that TLR activation of human macrophages up-regulated expression of the vitamin D receptor and the vitamin D-1-hydroxylase genes, leading to induction of the antimicrobial peptide cathelicidin and killing of intracellular Mycobacterium tuberculosis. We also observed that sera from African-American individuals, known to have increased susceptibility to tuberculosis, had low 25-hydroxyvitamin D and were inefficient in supporting cathelicidin messenger RNA induction. These data support a link between TLRs and vitamin D-mediated innate immunity and suggest that differences in ability of human populations to produce vitamin D may contribute to susceptibility to microbial infection.	Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Chem & Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Genom & Proteom, Dept Energy, Los Angeles, CA 90095 USA; Univ Calif San Diego, Div Dermatol, La Jolla, CA 92161 USA; Univ Erlangen Nurnberg, Inst Klin Mikrobiol Immunol & Hyg, D-91054 Erlangen, Germany; Vet Affairs San Diego Healthcare Ctr, La Jolla, CA 92161 USA; Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; Klinikum Nurnberg, Med Klin 3, D-90340 Nurnberg, Germany; Univ Marburg, D-35043 Marburg, Germany; Schering AG, CRBA Dermatol, D-13342 Berlin, Germany; Cedars Sinai Med Ctr, Dept Med, Div Endocrinol, Los Angeles, CA 90048 USA; Med Univ S Carolina, Dept Pediat Biochem & Mol Biol, Charleston, SC 29425 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego; University of Erlangen Nuremberg; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Medical University of South Carolina; Klinikum Nurnberg Nord; Philipps University Marburg; Schering AG; Cedars Sinai Medical Center; Medical University of South Carolina; Harvard University; Harvard T.H. Chan School of Public Health	Modlin, RL (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	rmodlin@mednet.ucla.edu	Modlin, Robert L/M-7941-2014; Liu, Philip/C-9638-2011; Liu, Philip/C-2524-2009; Adams, John S/I-3365-2013; Gallo, Richard L/A-8931-2009	Modlin, Robert L/0000-0003-4720-031X; Adams, John S/0000-0001-9607-5020; Gallo, Richard L/0000-0002-1401-7861; Ochoa, Maria T/0000-0001-6550-5008; Liu, Philip/0000-0002-6144-0304	NCRR NIH HHS [RR00425] Funding Source: Medline; NIAID NIH HHS [AI052453, K22 AI085025, AI47868, AI48176, AI22553] Funding Source: Medline; NIAMS NIH HHS [AR50626, AR45676] Funding Source: Medline; NICHD NIH HHS [HD043921] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043921] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI085025, R22AI022553, R01AI022553, R21AI048176, R01AI052453, R37AI052453, R37AI047868, R01AI047868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045676, R01AR050626] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BARNES PF, 1989, J CLIN INVEST, V83, P1527, DOI 10.1172/JCI114048; Bornman L, 2004, J INFECT DIS, V190, P1631, DOI 10.1086/424462; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Giovannucci E, 2005, CANCER CAUSE CONTROL, V16, P83, DOI 10.1007/s10552-004-1661-4; Hertz CJ, 2003, J IMMUNOL, V171, P6820, DOI 10.4049/jimmunol.171.12.6820; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MATSUOKA LY, 1991, ARCH DERMATOL, V127, P536, DOI 10.1001/archderm.127.4.536; Modlin RL, 2004, NAT MED, V10, P1173, DOI 10.1038/nm1104-1173; Rich AR., 1944, PATHOGENESIS TUBERCU; Rockett KA, 1998, INFECT IMMUN, V66, P5314, DOI 10.1128/IAI.66.11.5314-5321.1998; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Sly LM, 2001, J BIOL CHEM, V276, P35482, DOI 10.1074/jbc.M102876200; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909	17	2690	2844	5	262	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2006	311	5768					1770	1773		10.1126/science.1123933	http://dx.doi.org/10.1126/science.1123933			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16497887				2022-12-24	WOS:000236204300044
J	Rieseberg, LH; Wood, TE; Baack, EJ				Rieseberg, LH; Wood, TE; Baack, EJ			The nature of plant species	NATURE			English	Article							POSTZYGOTIC ISOLATION; PATTERNS; EVOLUTION; DIVERSITY	Many botanists doubt the existence of plant species(1-5), viewing them as arbitrary constructs of the human mind, as opposed to discrete, objective entities that represent reproductively independent lineages or 'units of evolution'. However, the discreteness of plant species and their correspondence with reproductive communities have not been tested quantitatively, allowing zoologists to argue that botanists have been overly influenced by a few 'botanical horror stories', such as dandelions, blackberries and oaks(6,7). Here we analyse phenetic and/or crossing relationships in over 400 genera of plants and animals. We show that although discrete phenotypic clusters exist in most genera (>80%), the correspondence of taxonomic species to these clusters is poor (<60%) and no different between plants and animals. Lack of congruence is caused by polyploidy, asexual reproduction and over-differentiation by taxonomists, but not by contemporary hybridization. Nonetheless, crossability data indicate that 70% of taxonomic species and 75% of phenotypic clusters in plants correspond to reproductively independent lineages (as measured by postmating isolation), and thus represent biologically real entities. Contrary to conventional wisdom(8), plant species are more likely than animal species to represent reproductively independent lineages.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Rieseberg, LH (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	lriesebe@indiana.edu	Rieseberg, Loren H/B-3591-2013; Wood, Troy/F-7302-2010	Rieseberg, Loren H/0000-0002-2712-2417; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059065] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM059065-06] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold ML, 1997, NATURAL HYBRIDIZATIO; Bachmann K, 1998, THEOR BIOSCI, V117, P213; BAKER HG, 1953, SYM SOC EXP BIOL, V7, P114; Berlin B., 1974, PRINCIPLES TZELTAL P, DOI [10.1016/C2013-0-07678-5, DOI 10.1016/C2013-0-07678-5]; Carman JG, 1997, BIOL J LINN SOC, V61, P51, DOI 10.1006/bijl.1996.0118; Coyne JA, 1997, EVOLUTION, V51, P295, DOI 10.1111/j.1558-5646.1997.tb02412.x; DIAMOND JM, 1992, NATURE, V360, P627, DOI 10.1038/360627a0; EHRLICH PR, 1969, SCIENCE, V165, P1228, DOI 10.1126/science.165.3899.1228; Fisher R. A., 1954, P84; GRANT V, 1957, SPECIES PROBLEM, P38; Gray A.P., 1972, MAMMALIAN HYBRIDS CH; Hickman J.C., 1993, JEPSON MANUAL HIGHER; LEVIN DA, 1979, SCIENCE, V204, P381, DOI 10.1126/science.204.4391.381; Levin DA., 2000, OX ECOL EV; MAYR E, 1992, AM J BOT, V79, P222, DOI 10.2307/2445111; MAYR E, 1982, GROWTH BIOL THROUGHT; MCDADE LA, 1982, SYST BOT, V7, P13, DOI 10.2307/2418649; MCDADE LA, 1995, SYST BOT, V20, P606, DOI 10.2307/2419813; Mishler BD, 1999, SPECIES, P307; MISHLER BD, 1982, SYST ZOOL, V31, P491, DOI 10.2307/2413371; Morjan CL, 2004, MOL ECOL, V13, P1341, DOI 10.1111/j.1365-294X.2004.02164.x; Presgraves DC, 2002, EVOLUTION, V56, P1168, DOI 10.1111/j.0014-3820.2002.tb01430.x; Price TD, 2002, EVOLUTION, V56, P2083; Raven P.H., 1986, MODERN ASPECTS SPECI, P11; Ridley M., 1996, EVOLUTION; Russell ST, 2003, ANN ZOOL FENN, V40, P321; Sasa MM, 1998, EVOLUTION, V52, P1811, DOI 10.1111/j.1558-5646.1998.tb02258.x; Sokal R, 1963, PRINCIPLES NUMERICAL; Wang JX, 2004, CONSERV BIOL, V18, P1139, DOI 10.1111/j.1523-1739.2004.00075.x; Whitlock MC, 2003, GENETICS, V164, P767	30	185	201	8	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					524	527		10.1038/nature04402	http://dx.doi.org/10.1038/nature04402			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554818	Green Accepted			2022-12-24	WOS:000236176100055
J	Ross, LF				Ross, LF			Ethical considerations related to pregnancy in transplant recipients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RENAL-TRANSPLANTATION; LIVER-TRANSPLANTATION; OUTCOMES; CHILDREN; RETRANSPLANTATION; IMMUNOSUPPRESSION; EXPERIENCE; MOTHERS		Univ Chicago, Dept Pediat, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA	University of Chicago	Ross, LF (corresponding author), Univ Chicago, Dept Pediat, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA.							Armenti V T, 2000, Clin Transpl, P123; Armenti Vincent T, 2002, Clin Transpl, P121; Armenti VT, 1998, DRUG SAFETY, V19, P219, DOI 10.2165/00002018-199819030-00005; Arsan A, 1997, TRANSPLANT P, V29, P2479, DOI 10.1016/S0041-1345(97)00457-0; Bar J, 1996, ISRAEL J MED SCI, V32, P1183; BARTHOLER E, 1993, FAMILY BONDS ADOPTIO; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Dickenson D., 1995, Acta Geneticae Medicae et Gemellologiae, V44, P75; *FRENCH TRANSPL SO, 1997, TRANSPLANT P, V29, P2455; GHAHRAMANI N, 1993, TRANSPLANT P, V25, P2190; Glannon W, 1998, J MED PHILOS, V23, P31, DOI 10.1076/jmep.23.1.31.2595; Henshaw SK, 1998, FAM PLANN PERSPECT, V30, P24, DOI 10.2307/2991522; HOPE T, 1995, BRIT MED J, V310, P1455, DOI 10.1136/bmj.310.6992.1455; Huddy CLJ, 2001, ARCH DIS CHILD-FETAL, V85, pF23, DOI 10.1136/fn.85.1.F23; Jain AB, 2003, TRANSPLANTATION, V76, P827, DOI 10.1097/01.TP.0000084823.89528.89; JONES HW, 1993, NEW ENGL J MED, V329, P1710, DOI 10.1056/NEJM199312023292307; KASS NE, 1994, ACTA PAEDIATR, V83, P95, DOI 10.1111/j.1651-2227.1994.tb13344.x; Le Ray C, 2004, OBSTET GYNECOL, V103, P1091, DOI 10.1097/01.AOG.0000124986.32858.ba; Lessan-Pezeshki M, 2002, NEPHROL DIAL TRANSPL, V17, P703, DOI 10.1093/ndt/17.5.703; Mahowald Mary Briody, 1993, WOMEN CHILDREN HLTH; Miranda CTBC, 2002, TRANSPLANT P, V34, P506, DOI 10.1016/S0041-1345(02)02612-X; MOSS AH, 1991, JAMA-J AM MED ASSOC, V265, P1295, DOI 10.1001/jama.265.10.1295; MURRAY JE, 1963, NEW ENGL J MED, V269, P341, DOI 10.1056/NEJM196308152690704; Nagy S, 2003, OBSTET GYNECOL, V102, P121, DOI 10.1016/S0029-7844(03)00369-7; Ourahma S, 1998, TRANSPLANT P, V30, P2808, DOI 10.1016/S0041-1345(98)00818-5; PAHL MV, 1993, TRANSPL P, V25, P2727; Rawls J., 1971, THEORY JUSTICE, DOI DOI 10.5860/CHOICE.37-4151; Robertson JA., 1994, CHILDREN CHOICE FREE; Salooja N, 2001, LANCET, V358, P271, DOI 10.1016/S0140-6736(01)05482-4; Sano T, 2002, NEPHROL DIAL TRANSPL, V17, P50, DOI 10.1093/ndt/17.1.50; Sgro MD, 2002, TERATOLOGY, V65, P5, DOI 10.1002/tera.1092; Tendron A, 2002, PEDIATR NEPHROL, V17, P121, DOI 10.1007/s00467-001-0776-z; Thompson BC, 2003, QJM-INT J MED, V96, P837, DOI 10.1093/qjmed/hcg142; UBEL PA, 1995, HEALTH POLICY, V34, P145, DOI 10.1016/0168-8510(95)00714-4; UBEL PA, 1993, JAMA-J AM MED ASSOC, V270, P2469, DOI 10.1001/jama.270.20.2469; Veatch R. M., 2000, TRANSPLANTATION ETHI; Willis FR, 2000, J PAEDIATR CHILD H, V36, P230, DOI 10.1046/j.1440-1754.2000.00500.x	37	39	41	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2006	354	12					1313	1316		10.1056/NEJMsb041648	http://dx.doi.org/10.1056/NEJMsb041648			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023ZH	16554536				2022-12-24	WOS:000236164200014
J	Ueno, Y; Yamada, K; Yoshida, N; Maruyama, S; Isozaki, Y				Ueno, Y; Yamada, K; Yoshida, N; Maruyama, S; Isozaki, Y			Evidence from fluid inclusions for microbial methanogenesis in the early Archaean era	NATURE			English	Article							WESTERN-AUSTRALIA; ISOTOPE FRACTIONATION; WARRAWOONA GROUP; NORTH-POLE; CARBON; GEOCHEMISTRY; SIGNATURES; REDUCTION; EVOLUTION; HYDROGEN	Methanogenic microbes may be one of the most primitive organisms(1), although it is uncertain when methanogens first appeared on Earth. During the Archaean era (before 2.5 Gyr ago), methanogens may have been important in regulating climate, because they could have provided sufficient amounts of the greenhouse gas methane to mitigate a severely frozen condition that could have resulted from lower solar luminosity(2) during these times. Nevertheless, no direct geological evidence has hitherto been available in support of the existence of methanogens in the Archaean period, although circumstantial evidence is available in the form of similar to 2.8-Gyr-old carbon-isotope-depleted kerogen(3). Here we report crushing extraction and carbon isotope analysis of methane-bearing fluid inclusions in similar to 3.5-Gyr-old hydrothermal precipitates from Pilbara craton, Australia. Our results indicate that the extracted fluids contain microbial methane with carbon isotopic compositions of less than -56 parts per thousand included within original precipitates. This provides the oldest evidence of methanogen (>3.46 Gyr ago), pre-dating previous geochemical evidence by about 700 million years.	Tokyo Inst Technol, Res Ctr Evolving Earth & Planet, Meguro Ku, Tokyo 1528551, Japan; Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; Tokyo Inst Technol, Dept Environm Sci & Technol, Midori Ku, Yokohama, Kanagawa 2268503, Japan; Tokyo Inst Technol, Dept Environm Chem & Engn, Midori Ku, Yokohama, Kanagawa 2268503, Japan; Japan Sci & Technol Corp, SORST Project, Kawaguchi, Saitama 3320012, Japan; Univ Tokyo, Dept Earth Sci & Astron, Meguro Ku, Tokyo 1538902, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Tokyo Institute of Technology; Tokyo Institute of Technology; Japan Science & Technology Agency (JST); University of Tokyo	Ueno, Y (corresponding author), Tokyo Inst Technol, Res Ctr Evolving Earth & Planet, Meguro Ku, Tokyo 1528551, Japan.	yueno@depe.titech.ac.jp	Yamaichi, Takeshi/A-5595-2010; Yoshida, Naohiro/A-8335-2010; Isozaki, Yukio/A-1806-2009; Maruyama, Shigenori/C-8288-2009; Ueno, Yuichiro/A-9959-2014	Yoshida, Naohiro/0000-0003-0454-3849; Isozaki, Yukio/0000-0002-3596-581X; Ueno, Yuichiro/0000-0002-9095-4742				AWRAMIK SM, 1983, PRECAMBRIAN RES, V20, P357, DOI 10.1016/0301-9268(83)90081-5; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; BUICK R, 1990, SEDIMENTOLOGY, V37, P247, DOI 10.1111/j.1365-3091.1990.tb00958.x; BUICK R, 1990, Palaios, V5, P441, DOI 10.2307/3514837; Charlou JL, 2002, CHEM GEOL, V191, P345, DOI 10.1016/S0009-2541(02)00134-1; CLAYTON C, 1991, MAR PETROL GEOL, V8, P232, DOI 10.1016/0264-8172(91)90010-X; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; Hayes J.M., 1994, EARLY LIFE EARTH, V84, P220; Horita J, 1999, SCIENCE, V285, P1055, DOI 10.1126/science.285.5430.1055; Kasting JF, 2003, ANNU REV ASTRON ASTR, V41, P429, DOI 10.1146/annurev.astro.41.071601.170049; Kitajima K, 2001, J METAMORPH GEOL, V19, P581; Lollar BS, 2002, NATURE, V416, P522, DOI 10.1038/416522a; McCollom TM, 2001, GEOCHIM COSMOCHIM AC, V65, P3769, DOI 10.1016/S0016-7037(01)00655-X; Nijman W, 1999, PRECAMBRIAN RES, V95, P245; Pinti DL, 2001, GEOCHIM COSMOCHIM AC, V65, P2301, DOI 10.1016/S0016-7037(01)00590-7; RICHET P, 1977, ANNU REV EARTH PL SC, V5, P65, DOI 10.1146/annurev.ea.05.050177.000433; Roedder E., 1984, REV MINERALOGY, V12; SCHOELL M, 1983, AAPG BULL, V67, P2225; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; THORPE RI, 1992, U W AUSTR PUBLICATIO, V9, P395; Ueno Y, 2004, GEOCHIM COSMOCHIM AC, V68, P573, DOI 10.1016/S0016-7037(03)00462-9; Ueno Y, 2001, INT GEOL REV, V43, P196, DOI 10.1080/00206810109465008; Valentine DL, 2004, GEOCHIM COSMOCHIM AC, V68, P1571, DOI 10.1016/j.gca.2003.10.012; Van Kranendonk MJ, 2004, GEOCHEM-EXPLOR ENV A, V4, P253, DOI 10.1144/1467-7873/04-205; WELHAN JA, 1988, CHEM GEOL, V71, P183, DOI 10.1016/0009-2541(88)90114-3; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987	27	322	346	3	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					516	519		10.1038/nature04584	http://dx.doi.org/10.1038/nature04584			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554816				2022-12-24	WOS:000236176100053
J	Anderson, K; Jacobson, JS; Heitjan, DF; Zivin, JG; Hershman, D; Neugut, AI; Grann, VR				Anderson, K; Jacobson, JS; Heitjan, DF; Zivin, JG; Hershman, D; Neugut, AI; Grann, VR			Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation	ANNALS OF INTERNAL MEDICINE			English	Article							SURGICAL ADJUVANT BREAST; BILATERAL PROPHYLACTIC MASTECTOMY; ORAL-CONTRACEPTIVE USE; OVARIAN-CANCER RISKS; DECISION-ANALYSIS; INHERITED MUTATIONS; MEDICARE PAYMENTS; LIFE EXPECTANCY; TAMOXIFEN; OOPHORECTOMY	Background: For BRCA1 or BRCA2 mutation carriers, decision analysis indicates that prophylactic surgery or chemoprevention leads to better survival than surveillance alone. Objective: To evaluate the cost-effectiveness of the preventive strategies that are available to unaffected women carrying a single BRCA1 or BRCA2 mutation with high cancer penetrance. Design: Markov modeling with Monte Carlo simulations and probabilistic sensitivity analyses. Data Sources: Breast and ovarian cancer incidence and mortality rates, preference ratings, and costs derived from the literature; the Surveillance, Epidemiology, and End Results (SEER) Program; and the Health Care Financing Administration (now the Centers for Medicare & Medicaid Services). Target Population: Unaffected carriers of a single BRCA1 or BRCA2 mutation 35 to 50 years of age. Time Horizon: Lifetime. Perspective: Health policy, societal. Interventions: Tamoxifen, oral contraceptives, bilateral salpingo-oophorectomy, mastectomy, both surgeries, or surveillance. Outcome Measures: Cost-effectiveness. Results of Base-Case Analysis: For mutation carriers 35 years of age, both surgeries (prophylactic bilateral mastectomy and oophorectomy) had an incremental cost-effectiveness ratio over oophorectomy alone of $2352 per life-year for BRCA1 and $100 per life-year for BRCA2. With quality adjustment, oophorectomy dominated all other strategies for BRCA1 and had an incremental cost-effectiveness ratio of $2281 per life-year for BRCA2. Results of Sensitivity Analysis: Older age at intervention increased the cost-effectiveness of prophylactic mastectomy for BRCA1 mutation carriers to $73 755 per life-year. Varying the penetrance, mortality rates, costs, discount rates, and preferences had minimal effects on outcomes. Limitations: Results are dependent on the accuracy of model assumptions. Conclusion: On the basis of this model, the most cost-effective strategies for BRCA mutation carriers, with and without quality adjustment, were oophorectomy alone and oophorectomy and mastectomy, respectively.	Columbia Univ, Joseph L Mailman Sch Publ Hlth, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; New York Presbyterian Hosp, New York, NY USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Columbia University; NewYork-Presbyterian Hospital; University of Pennsylvania	Grann, VR (corresponding author), Columbia Univ, Joseph L Mailman Sch Publ Hlth, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Room 734,722 W 168th St, New York, NY 10032 USA.	VRG2@columbia.edu	Hershman, Dawn/AAG-2114-2020; Zivin, Joshua Graff/ABF-1697-2020		NATIONAL CANCER INSTITUTE [K05CA089155, K07CA095597] Funding Source: NIH RePORTER; NCI NIH HHS [K07 CA-95597, K05 CA89155] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antoniou AC, 2005, J MED GENET, V42, P602, DOI 10.1136/jmg.2004.024133; Armstrong K, 2004, J CLIN ONCOL, V22, P1045, DOI 10.1200/JCO.2004.06.090; Bass EB, 1997, MED DECIS MAKING, V17, P324, DOI 10.1177/0272989X9701700309; BECK JR, 1983, MED DECIS MAKING, V3, P419, DOI 10.1177/0272989X8300300403; Brown ML, 2002, MED CARE, V40, P104; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM199205073261902; Chappuis PO, 1999, ANN ONCOL, V10, P1163, DOI 10.1023/A:1008301314812; Chappuis PO, 2001, J NATL CANCER I, V93, P152, DOI 10.1093/jnci/93.2.152-a; Clement PB, 2002, ADV ANAT PATHOL, V9, P145, DOI 10.1097/00125480-200205000-00001; COUCH FJ, 1998, GENETIC BASIS HUMAN, P549; Cuzick J, 2002, LANCET, V360, P817; DeVita VT, 1997, CANC PRINCIPLES PRAC; Easton DF, 2004, SCIENCE, V306, P2187; EDDY DM, 1990, ANN INTERN MED, V113, P214, DOI 10.7326/0003-4819-113-3-214; Eisen A, 2000, J CLIN ONCOL, V18, P1980, DOI 10.1200/JCO.2000.18.9.1980; Farmer RDT, 1998, AM J OBSTET GYNECOL, V179, pS78, DOI 10.1053/ob.1998.v179.a92634; Fireman BH, 1997, HEALTH CARE FINANC R, V18, P51; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fisher B, 1999, J CLIN ONCOL, V17, P1632, DOI 10.1200/JCO.1999.17.5.1632; Gold MR, 1996, COST EFFECTIVENESS H; Grann VR, 2002, J CLIN ONCOL, V20, P2520, DOI 10.1200/JCO.2002.10.101; Grann VR, 1998, J CLIN ONCOL, V16, P979, DOI 10.1200/JCO.1998.16.3.979; Grann VR, 1999, CANCER J, V5, P283; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Hartmann LC, 2001, JNCI-J NATL CANCER I, V93, P1633, DOI 10.1093/jnci/93.21.1633; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; *HARV SCH PUBL HLT, 2005, CAT PREF SCOR COST E; Hershman D, 2002, J CLIN ONCOL, V20, P9, DOI 10.1200/JCO.20.1.9; Kaleli S, 2002, EUR J OBSTET GYN R B, V101, P204, DOI 10.1016/S0301-2115(01)00529-2; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; King MC, 2001, JAMA-J AM MED ASSOC, V286, P2251, DOI 10.1001/jama.286.18.2251; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Lawrence WF, 2001, CANCER EPIDEM BIOMAR, V10, P475; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; Matloff ET, 2000, J CLIN ONCOL, V18, P2484, DOI 10.1200/JCO.2000.18.12.2484; Meijers-Heijboer EJ, 2000, LANCET, V355, P2015, DOI 10.1016/S0140-6736(00)02347-3; Meijers-Heijboer H, 2001, NEW ENGL J MED, V345, P159, DOI 10.1056/NEJM200107193450301; Meijers-Heijboer H, 2003, J CLIN ONCOL, V21, P1675, DOI 10.1200/JCO.2003.09.052; Milne RL, 2005, CANCER EPIDEM BIOMAR, V14, P350, DOI 10.1158/1055-9965.EPI-04-0376; Narod SA, 2000, LANCET, V356, P1876, DOI 10.1016/S0140-6736(00)03258-X; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; *NAT CANC I DIV CA, 2001, SEER CANC STAT REV P; *NAT COMPR CANC NE, 2006, GEN FAM HIGH RISK AS, V1; Oestreicher N, 2005, CANCER, V104, P2054, DOI 10.1002/cncr.21464; Osin P P, 1999, Breast Cancer Res, V1, P36, DOI 10.1186/bcr11; POTOSKY AL, 1993, MED CARE, V31, P732; Powles T, 1998, LANCET, V352, P98; Rebbeck TR, 1999, J NATL CANCER I, V91, P1475, DOI 10.1093/jnci/91.17.1475; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; RILEY GF, 1995, MED CARE, V33, P828, DOI 10.1097/00005650-199508000-00007; Robson ME, 2004, BREAST CANCER RES, V6, pR8, DOI 10.1186/bcr658; Scheuer L, 2002, J CLIN ONCOL, V20, P1260, DOI 10.1200/JCO.2002.20.5.1260; Schrag D, 1997, NEW ENGL J MED, V336, P1465, DOI 10.1056/NEJM199705153362022; Schwartz PE, 2001, OBSTET GYN CLIN N AM, V28, P637, DOI 10.1016/S0889-8545(05)70226-6; Secker-Walker RH, 1999, J NATL CANCER I, V91, P702, DOI 10.1093/jnci/91.8.702; Swisher Elizabeth, 2003, Curr Treat Options Oncol, V4, P105, DOI 10.1007/s11864-003-0011-1; Tengs TO, 1998, MED DECIS MAKING, V18, P365, DOI 10.1177/0272989X9801800402; *THOMS PDR, 2004, 2004 DRUG TOP RED BO; *US BUR LAB STAT, 2004, CONS PRIC IND ALL UR; van Oostrom I, 2003, J CLIN ONCOL, V21, P3867, DOI 10.1200/JCO.2003.10.100; van Roosmalen MS, 2002, J CLIN ONCOL, V20, P2092, DOI 10.1200/jco.2002.08.035; Verhoog LC, 1998, LANCET, V351, P316, DOI 10.1016/S0140-6736(97)07065-7; Verhoog LC, 2000, J CLIN ONCOL, V18, p119S; Veronesi U, 1998, LANCET, V352, P93; Weinstein M C, 1983, Obstet Gynecol Surv, V38, P445, DOI 10.1097/00006254-198308000-00001; Whittemore AS, 2004, BRIT J CANCER, V91, P1911, DOI 10.1038/sj.bjc.6602239; Wickerham DL, 2002, J CLIN ONCOL, V20, P2758, DOI 10.1200/JCO.2002.20.11.2758; 2001, DRG GUIDEBOOK COMPRE	70	132	134	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2006	144	6					397	406		10.7326/0003-4819-144-6-200603210-00006	http://dx.doi.org/10.7326/0003-4819-144-6-200603210-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025FX	16549852				2022-12-24	WOS:000236251800003
J	Sharp, D				Sharp, D			Meloxicam to prevent rabies?	LANCET			English	Editorial Material							DICLOFENAC; VULTURES		The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							Agarwal N, 2004, TROP DOCT, V34, P76, DOI 10.1177/004947550403400205; Meteyer CU, 2005, J WILDLIFE DIS, V41, P707, DOI 10.7589/0090-3558-41.4.707; Pain DJ, 2003, CONSERV BIOL, V17, P661, DOI 10.1046/j.1523-1739.2003.01740.x; Shultz S, 2004, P ROY SOC B-BIOL SCI, V271, pS458, DOI 10.1098/rsbl.2004.0223; Sudarshan M. K., 2001, Journal of Communicable Diseases, V33, P245; Swan G, 2006, PLOS BIOL, V4, P395, DOI 10.1371/journal.pbio.0040066	6	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2006	367	9514					887	888		10.1016/S0140-6736(06)68361-X	http://dx.doi.org/10.1016/S0140-6736(06)68361-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546526				2022-12-24	WOS:000236242100010
J	Zacchigna, L; Vecchione, C; Notte, A; Cordenonsi, M; Dupont, S; Maretto, S; Cifelli, G; Ferrari, A; Maffei, A; Fabbro, C; Braghetta, P; Marino, G; Selvetella, G; Aretini, A; Colonnese, C; Bettarini, U; Russo, G; Soligo, S; Adorno, M; Bonaldo, P; Volpin, D; Piccolo, S; Lembo, G; Bressan, GM				Zacchigna, L; Vecchione, C; Notte, A; Cordenonsi, M; Dupont, S; Maretto, S; Cifelli, G; Ferrari, A; Maffei, A; Fabbro, C; Braghetta, P; Marino, G; Selvetella, G; Aretini, A; Colonnese, C; Bettarini, U; Russo, G; Soligo, S; Adorno, M; Bonaldo, P; Volpin, D; Piccolo, S; Lembo, G; Bressan, GM			Emilin1 links TGF-beta maturation to blood pressure homeostasis	CELL			English	Article							GROWTH-FACTOR-BETA; ACTIVATION; EXPRESSION; INHIBITOR	TGF-beta proteins are main regulators of blood vessel development and maintenance. Here, we report an unprecedented link between TGF-beta signaling and arterial hypertension based on the analysis of mice mutant for Emilin1, a cysteine-rich secreted glycoprotein expressed in the vascular tree. Emilin1 knockout animals display increased blood pressure, increased peripheral vascular resistance, and reduced vessel size. Mechanistically, we found that Emilin1 inhibits TGF-beta signaling by binding specifically to the proTGF-beta precursor and preventing its maturation by furin convertases; in the extracellular space. In support of these findings, genetic inactivation of Emifin1 causes increased TGF-beta signaling in the vascular wall. Strikingly, high blood pressure observed in Emilin1 mutants is rescued to normal levels upon inactivation of a single TGF-beta 1 allele. This study highlights the importance of modulation of TGF-beta availability in the pathogenesis of hypertension.	Univ Padua, Dev Signaling Lab, Dept Histol Microbiol & Med Biotechnol, I-35121 Padua, Italy; IRCCS, Neuromed Inst, Dept Angiocardioneurol, I-86077 Pozzilli, IS, Italy; Univ Roma La Sapienza, Dept Expt Med & Pathol, I-00161 Rome, Italy; Univ Padua, Mouse Genet Lab, Dept Histol Microbiol & Med Biotechnol, I-35121 Padua, Italy	University of Padua; IRCCS Neuromed; Sapienza University Rome; University of Padua	Piccolo, S (corresponding author), Univ Padua, Dev Signaling Lab, Dept Histol Microbiol & Med Biotechnol, Viale Colombo 3, I-35121 Padua, Italy.	piccolo@civ.bio.unipd.it; lembo@neuromed.it; bressan@civ.bio.unipd.it	Vecchione, Carmine/K-2175-2018; colonnese, claudio/AAB-9727-2020; Selvetella, Giulio/J-4342-2012; Lembo, Giuseppe/AAE-8096-2020; Cordenonsi, Michelangelo/K-7692-2016; maffei, angelo/AAC-2219-2020; Dupont, Sirio/AAP-8133-2021; Cifelli, Giuseppe/AAB-6938-2019; Braghetta, Paola/K-5478-2016	colonnese, claudio/0000-0003-4249-4689; Lembo, Giuseppe/0000-0002-3510-223X; Cordenonsi, Michelangelo/0000-0002-8253-5724; Cifelli, Giuseppe/0000-0002-6417-7185; Braghetta, Paola/0000-0003-2547-8679; Vecchione, Carmine/0000-0002-2473-4565; maffei, angelo/0000-0002-7491-0344; Dupont, Sirio/0000-0002-6869-1966; PICCOLO, STEFANO/0000-0002-2037-0004; Bonaldo, Paolo/0000-0002-9571-8140	Telethon [GGP04030] Funding Source: Medline	Telethon(Fondazione Telethon)		Agrotis Alex, 2005, Current Vascular Pharmacology, V3, P55, DOI 10.2174/1570161052773951; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Beck S, 2002, NAT CELL BIOL, V4, P981, DOI 10.1038/ncb890; Braghetta P, 2004, MATRIX BIOL, V22, P549, DOI 10.1016/j.matbio.2003.10.005; BRESSAN GM, 1993, J CELL BIOL, V121, P201, DOI 10.1083/jcb.121.1.201; De Acetis M, 2005, CIRC RES, V96, P1087, DOI 10.1161/01.RES.0000168028.36081.e0; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Eimon PM, 2002, DEVELOPMENT, V129, P3089; Faury G, 2003, J CLIN INVEST, V112, P1419, DOI 10.1172/JCI200319028; Hamilton PK, 2007, CLIN SCI, V113, P157, DOI 10.1042/CS20070080; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Khanna A, 2004, AM J PHYSIOL-HEART C, V286, pH1133, DOI 10.1152/ajpheart.00462.2003; Koli K, 2004, J CELL BIOL, V167, P123, DOI 10.1083/jcb.200403067; Mongiat M, 2000, J BIOL CHEM, V275, P25471, DOI 10.1074/jbc.M001426200; Mulvany MJ, 2002, NEWS PHYSIOL SCI, V17, P105, DOI 10.1152/nips.01366.2001; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Staessen JA, 2003, LANCET, V361, P1629, DOI 10.1016/S0140-6736(03)13302-8; Suthanthiran M, 2000, P NATL ACAD SCI USA, V97, P3479, DOI 10.1073/pnas.050420897; Ventura JJ, 2004, MOL CELL, V15, P269, DOI 10.1016/j.molcel.2004.06.007; Zanetti M, 2004, MOL CELL BIOL, V24, P638, DOI 10.1128/MCB.24.2.638-650.2004	22	230	247	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					929	942		10.1016/j.cell.2005.12.035	http://dx.doi.org/10.1016/j.cell.2005.12.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530041	Bronze			2022-12-24	WOS:000237241200016
J	Okie, S				Okie, S			Facial transplantation: Brave new face	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		*AM SOC PLAST SURG, 2006, FAC TRANSPL ASPS ASR; Morris PJ, 2004, TRANSPLANTATION, V77, P330, DOI 10.1097/01.TP.0000113810.54865.BE; Siemionow M, 2005, CLIN PLAST SURG, V32, P401, DOI 10.1016/j.cps.2005.02.003	3	34	35	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2006	354	9					889	894		10.1056/NEJMp068005	http://dx.doi.org/10.1056/NEJMp068005			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017FN	16510742				2022-12-24	WOS:000235679600001
J	Cappola, AR; Fried, LP; Arnold, AM; Danese, MD; Kuller, LH; Burke, GL; Tracy, RP; Ladenson, PW				Cappola, AR; Fried, LP; Arnold, AM; Danese, MD; Kuller, LH; Burke, GL; Tracy, RP; Ladenson, PW			Thyroid status, cardiovascular risk, and mortality in older adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ISCHEMIC-HEART-DISEASE; 20-YEAR FOLLOW-UP; SUBCLINICAL HYPOTHYROIDISM; ATRIAL-FIBRILLATION; ALL-CAUSE; DYSFUNCTION; HYPERTHYROIDISM; ASSOCIATION; CHOLESTEROL; POPULATION	Context Previous studies have suggested that subclinical abnormalities in thyroid-stimulating hormone levels are associated with detrimental effects on the cardiovascular system. Objective To determine the relationship between baseline thyroid status and incident atrial fibrillation, incident cardiovascular disease, and mortality in older men and women not taking thyroid medication. Design, Setting, and Participants A total of 3233 US community-dwelling individuals aged 65 years or older with baseline serum thyroid-stimulating hormone levels were enrolled in 1989-1990 in the Cardiovascular Health Study, a large, prospective cohort study. Main Outcome Measures Incident atrial fibrillation, coronary heart disease, cerebrovascular disease, cardiovascular death, and all-cause death assessed through June 2002. Analyses are reported for 4 groups defined according to thyroid function test results: subclinical hyperthyroidism, euthyroidism, subclinical hypothyroidism, and overt hypothyroidism. Results Individuals with overt thyrotoxicosis ( n = 4) were excluded because of small numbers. Eighty-two percent of participants ( n = 2639) had normal thyroid function, 15% ( n = 496) had subclinical hypothyroidism, 1.6% ( n = 51) had overt hypothyroidism, and 1.5% ( n = 47) had subclinical hyperthyroidism. After exclusion of those with prevalent atrial fibrillation, individuals with subclinical hyperthyroidism had a greater incidence of atrial fibrillation compared with those with normal thyroid function ( 67 events vs 31 events per 1000 person-years; adjusted hazard ratio, 1.98; 95% confidence interval, 1.29-3.03). No differences were seen between the subclinical hyperthyroidism group and euthyroidism group for incident coronary heart disease, cerebrovascular disease, cardiovascular death, or all-cause death. Likewise, there were no differences between the subclinical hypothyroidism or overt hypothyroidism groups and the euthyroidism group for cardiovascular outcomes or mortality. Specifically, individuals with subclinical hypothyroidism had an adjusted hazard ratio of 1.07 ( 95% confidence interval, 0.90-1.28) for incident coronary heart disease. Conclusion Our data show an association between subclinical hyperthyroidism and development of atrial fibrillation but do not support the hypothesis that unrecognized subclinical hyperthyroidism or subclinical hypothyroidism is associated with other cardiovascular disorders or mortality.	Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med,Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Div Epidemiol,Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Johns Hopkins Med Inst, Div Geriatr Med & Gerontol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Ctr Aging & Hlth, Baltimore, MD 21205 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Outcomes Insights Inc, Newbury Pk, CA USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Winston Salem, NC USA; Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; Univ Vermont, Dept Biochem, Burlington, VT 05405 USA; Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Dept Med, Baltimore, MD USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University; University of Vermont; University of Vermont; Johns Hopkins University	Cappola, AR (corresponding author), Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med,Ctr Clin Epidemiol & Biostat, 718 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	acappola@cceb.med.upenn.edu			NHLBI NIH HHS [N01 HC015103, N01-HC-85081, N01-HC-85086, N01HC85086, N01-HC-85082, N01-HC-85085, N01HC85079, N01-HC-85084, N01 HC035129, N01-HC-85083, N01-HC-85080, N01-HC-85079] Funding Source: Medline; NIA NIH HHS [K23 AG019161, K23-AG19161] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085080, N01HC085083, N01HC035129, N01HC085086, N01HC085085, N01HC085079, N01HC085082, N01HC085081, N01HC085084, N01HC015103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG019161] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Auer J, 2001, AM HEART J, V142, P838, DOI 10.1067/mhj.2001.119370; BAGCHI N, 1990, ARCH INTERN MED, V150, P785, DOI 10.1001/archinte.150.4.785; BELL GM, 1983, CLIN ENDOCRINOL, V18, P511, DOI 10.1111/j.1365-2265.1983.tb02881.x; Berg AO, 2004, ANN INTERN MED, V140, P125, DOI 10.7326/0003-4819-140-2-200401200-00014; Biondi B, 1999, J CLIN ENDOCR METAB, V84, P2064, DOI 10.1210/jc.84.6.2064; Biondi B, 2000, J CLIN ENDOCR METAB, V85, P4701, DOI 10.1210/jc.85.12.4701; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Cappola AR, 2003, J CLIN ENDOCR METAB, V88, P2438, DOI 10.1210/jc.2003-030398; Chu JW, 2001, J CLIN ENDOCR METAB, V86, P4591, DOI 10.1210/jc.86.10.4591; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Danese ND, 2000, J CLIN ENDOCR METAB, V85, P2993, DOI 10.1210/jcem.85.9.6841; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Hak AE, 2000, ANN INTERN MED, V132, P270, DOI 10.7326/0003-4819-132-4-200002150-00004; Helfand M, 1998, ANN INTERN MED, V129, P141, DOI 10.7326/0003-4819-129-2-199807150-00020; Helfand M, 2004, ANN INTERN MED, V140, P128, DOI 10.7326/0003-4819-140-2-200401200-00015; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Hoyert Donna L, 2005, Natl Vital Stat Rep, V53, P1; Imaizumi M, 2004, J CLIN ENDOCR METAB, V89, P3365, DOI 10.1210/jc.2003-031089; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Kanaya AM, 2002, ARCH INTERN MED, V162, P773, DOI 10.1001/archinte.162.7.773; KULLER LH, 1995, CIRCULATION, V92, P720, DOI 10.1161/01.CIR.92.4.720; Kvetny J, 2004, CLIN ENDOCRINOL, V61, P232, DOI 10.1111/j.1365-2265.2004.02088.x; Ladenson PW, 2000, ARCH INTERN MED, V160, P1573, DOI 10.1001/archinte.160.11.1573; Lindeman RD, 1999, J AM GERIATR SOC, V47, P703, DOI 10.1111/j.1532-5415.1999.tb01593.x; Magnus P, 2001, ARCH INTERN MED, V161, P2657, DOI 10.1001/archinte.161.22.2657; Pahor M, 1999, ARCH INTERN MED, V159, P237, DOI 10.1001/archinte.159.3.237; Parle JV, 2001, LANCET, V358, P861, DOI 10.1016/S0140-6736(01)06067-6; PARLE JV, 1991, CLIN ENDOCRINOL, V34, P77; Psaty BM, 1997, CIRCULATION, V96, P2455; Rodondi N, 2005, ARCH INTERN MED, V165, P2460, DOI 10.1001/archinte.165.21.2460; ROSENTHAL MJ, 1987, JAMA-J AM MED ASSOC, V258, P209, DOI 10.1001/jama.258.2.209; SAWIN CT, 1979, JAMA-J AM MED ASSOC, V242, P247, DOI 10.1001/jama.242.3.247; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Vanderpump MPJ, 1996, THYROID, V6, P155; Walsh JP, 2005, ARCH INTERN MED, V165, P2467, DOI 10.1001/archinte.165.21.2467	40	575	611	1	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2006	295	9					1033	1041		10.1001/jama.295.9.1033	http://dx.doi.org/10.1001/jama.295.9.1033			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	016XJ	16507804	Green Accepted, Bronze			2022-12-24	WOS:000235656600023
J	Falkow, S				Falkow, S			Is persistent bacterial infection good for your health?	CELL			English	Editorial Material							LYMPHOID-TISSUE LYMPHOMA; HELICOBACTER; DISEASE; PATHOGEN	Certain bacterial pathogens have evolved to survive in their human hosts for long periods without causing harm. Is it possible that these persistent bacterial infections provide a protective benefit to the host?.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Dept Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Falkow, S (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	falkow@stanford.edu						Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; BLASER MJ, 2006, ENDING WAR METAPHOR; Falkow S, 1997, ASM NEWS, V63, P359; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Mueller A, 2005, AM J PATHOL, V167, P797, DOI 10.1016/S0002-9440(10)62052-4; Mueller A, 2003, P NATL ACAD SCI USA, V100, P12289, DOI 10.1073/pnas.1635231100; Mueller A, 2003, P NATL ACAD SCI USA, V100, P1292, DOI 10.1073/pnas.242741699; Rosebury T, 1969, LIFE MAN; Segal S, 2005, BRIT MED BULL, V72, P65, DOI 10.1093/bmb/ldh041	11	44	50	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 24	2006	124	4					699	702		10.1016/j.cell.2006.02.004	http://dx.doi.org/10.1016/j.cell.2006.02.004			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RO	16497581	Bronze			2022-12-24	WOS:000237240900014
J	Vencovsky, J; Huizinga, TW				Vencovsky, J; Huizinga, TW			Rheumatoid arthritis: the goal rather than the health-care provider is key	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; TREATMENT STRATEGY; ONSET; PROGRESSION; DAMAGE		Inst Rheumatol, Prague 12850 2, Czech Republic; Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands	Institute of Rheumatology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Vencovsky, J (corresponding author), Inst Rheumatol, Prague 12850 2, Czech Republic.	venc@revma.cz	Vencovsky, Jiri/G-6094-2017	Vencovsky, Jiri/0000-0002-0851-0713				Clarke AE, 2001, J RHEUMATOL, V28, P2416; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI 10.1002/art.23364; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; Hulsmans HMJ, 2000, ARTHRITIS RHEUM, V43, P1927, DOI 10.1002/1529-0131(200009)43:9<1927::AID-ANR3>3.0.CO;2-B; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; McQueen FM, 1998, ANN RHEUM DIS, V57, P350, DOI 10.1136/ard.57.6.350; Smolen JS, 2005, BEST PRACT RES CL RH, V19, P163, DOI 10.1016/j.berh.2004.08.009; Symmons D, 2005, HEALTH TECHNOL ASSES, V9, pIII; van Aken J, 2004, ANN RHEUM DIS, V63, P274, DOI 10.1136/ard.2003.010298; Welsing PMJ, 2004, ARTHRITIS RHEUM-US, V50, P2082, DOI 10.1002/art.20350; Wolfe F, 1998, ARTHRITIS RHEUM, V41, P1571, DOI 10.1002/1529-0131(199809)41:9<1571::AID-ART7>3.0.CO;2-R	11	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2006	367	9509					450	452		10.1016/S0140-6736(06)68154-3	http://dx.doi.org/10.1016/S0140-6736(06)68154-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	013FF	16473107				2022-12-24	WOS:000235394500005
J	Kashikar-Zuck, S				Kashikar-Zuck, S			Treatment of children with unexplained chronic pain	LANCET			English	Editorial Material							PRIMARY FIBROMYALGIA SYNDROME; RANDOMIZED CONTROLLED-TRIALS; FUNCTIONAL DISABILITY; PEDIATRIC PAIN; INTERVENTION; METAANALYSIS; DEPRESSION; THERAPY		Childrens Hosp, Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Kashikar-Zuck, S (corresponding author), Childrens Hosp, Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA.	Susmita.Kashikar-Zuck@cchmc.org						Chambers CT, 2003, PROG PAIN RES MANAG, V26, P99; Eccleston C, 2002, PAIN, V99, P157, DOI 10.1016/S0304-3959(02)00072-6; Gatchel RJ, 1996, PSYCHOL APPROACHES P; Kashikar-Zuck S, 2005, J RHEUMATOL, V32, P1594; Kashikar-Zuck S, 2001, CLIN J PAIN, V17, P341, DOI 10.1097/00002508-200112000-00009; Kashikar-Zuck S, 2002, J PAIN, V3, P412, DOI 10.1054/jpai.2002.126786; Konijnenberg AY, 2005, ARCH DIS CHILD, V90, P680, DOI 10.1136/adc.2004.056820; Morley S, 1999, PAIN, V80, P1, DOI 10.1016/S0304-3959(98)00255-3; Perquin CW, 2001, PAIN, V94, P205, DOI 10.1016/S0304-3959(01)00355-4; Robins PM, 2005, J PEDIATR PSYCHOL, V30, P397, DOI 10.1093/jpepsy/jsi063	10	24	24	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 4	2006	367	9508					380	382		10.1016/S0140-6736(06)68118-X	http://dx.doi.org/10.1016/S0140-6736(06)68118-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	009UR	16458749				2022-12-24	WOS:000235139400010
J	Arron, JR; Winslow, MM; Polleri, A; Chang, CP; Wu, H; Gao, X; Neilson, JR; Chen, L; Heit, JJ; Kim, SK; Yamasaki, N; Miyakawa, T; Francke, U; Graef, IA; Crabtree, GR				Arron, Joseph R.; Winslow, Monte M.; Polleri, Alberto; Chang, Ching-Pin; Wu, Hai; Gao, Xin; Neilson, Joel R.; Chen, Lei; Heit, Jeremy J.; Kim, Seung K.; Yamasaki, Nobuyuki; Miyakawa, Tsuyoshi; Francke, Uta; Graef, Isabella A.; Crabtree, Gerald R.			NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21	NATURE			English	Article							DOWN-SYNDROME PHENOTYPES; TRANSCRIPTION FACTOR; REGULATORY NETWORK; CRITICAL REGION; MOUSE MODEL; CALCINEURIN; MICE; CALCIUM; SIGNALS; ATC	Trisomy 21 results in Down's syndrome, but little is known about how a 1.5-fold increase in gene dosage produces the pleiotropic phenotypes of Down's syndrome. Here we report that two genes, DSCR1 and DYRK1A, lie within the critical region of human chromosome 21 and act synergistically to prevent nuclear occupancy of NFATc transcription factors, which are regulators of vertebrate development. We use mathematical modelling to predict that autoregulation within the pathway accentuates the effects of trisomy of DSCR1 and DYRK1A, leading to failure to activate NFATc target genes under specific conditions. Our observations of calcineurin- and Nfatc-deficient mice, Dscr1- and Dyrk1a-overexpressing mice, mouse models of Down's syndrome and human trisomy 21 are consistent with these predictions. We suggest that the 1.5-fold increase in dosage of DSCR1 and DYRK1A cooperatively destabilizes a regulatory circuit, leading to reduced NFATc activity and many of the features of Down's syndrome. More generally, these observations suggest that the destabilization of regulatory circuits can underlie human disease.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Kyoto Univ, Grad Sch Med, HMRO, Genet Engn & Funct Genom Unit, Kyoto 6068501, Japan	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Kyoto University	Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	igraef@stanford.edu; crabtree@stanford.edu	Miyakawa, Tsuyoshi/A-7741-2008	Miyakawa, Tsuyoshi/0000-0003-0137-8200; Arron, Joseph/0000-0001-7677-9979; Heit, Jeremy/0000-0003-1055-8000; Neilson, Joel R./0000-0002-3408-608X; Kim, Seung/0000-0001-6135-7810	Medical Research Council [MC_U120097116] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Baxter LL, 2000, HUM MOL GENET, V9, P195, DOI 10.1093/hmg/9.2.195; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Benedito AB, 2005, J BIOL CHEM, V280, P2818, DOI 10.1074/jbc.M408741200; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Chang CP, 2004, J CLIN INVEST, V113, P1051, DOI 10.1172/JCI200420049; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Epstein C.J, 1986, CONSEQUENCES CHROMOS; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Holtzman D M, 1992, Mol Genet Med, V2, P105; Kegley KM, 2001, DEV BIOL, V232, P115, DOI 10.1006/dbio.2001.0179; Kentrup H, 1996, J BIOL CHEM, V271, P3488; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; KORENBERG JR, 1990, AM J MED GENET, P91; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Richtsmeier JT, 2002, AM J MED GENET, V107, P317, DOI 10.1002/ajmg.10175; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Torfs CP, 1998, AM J MED GENET, V77, P431, DOI 10.1002/(SICI)1096-8628(19980605)77:5<431::AID-AJMG15>3.0.CO;2-J; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	42	515	531	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					595	600		10.1038/nature04678	http://dx.doi.org/10.1038/nature04678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16554754				2022-12-24	WOS:000237920800038
J	Tunved, P; Hansson, HC; Kerminen, VM; Strom, J; Dal Maso, M; Lihavainen, H; Viisanen, Y; Aalto, PP; Komppula, M; Kulmala, M				Tunved, P; Hansson, HC; Kerminen, VM; Strom, J; Dal Maso, M; Lihavainen, H; Viisanen, Y; Aalto, PP; Komppula, M; Kulmala, M			High natural aerosol loading over boreal forests	SCIENCE			English	Article							PARTICLE FORMATION EVENTS; ATMOSPHERIC PARTICLES; SIZE DISTRIBUTION; ORGANIC AEROSOLS; BOUNDARY-LAYER; GROWTH; EMISSIONS; CLIMATE; CO2	Aerosols play a key role in the radiation balance of the atmosphere. Here, we present evidence that the European boreal region is a substantial source of both aerosol mass and aerosol number. The investigation supplies a straightforward relation between emissions of monoterpenes and gas-to-particle formation over regions substantially lacking in anthropogenic aerosol sources. Our results show that the forest provides an aerosol population of 1000 to 2000 particles of climatically active sizes per cubic centimeter during the late spring to early fall period. This has important implications for radiation budget estimates and relevancy for the evaluation of feedback loops believed to determine our future climate.	Dept Appl Environm Sci, Air Pollut Lab, SE-10691 Stockholm, Sweden; Finnish Meteorol Inst, FI-00101 Helsinki, Finland; Univ Helsinki, Dept Phys Sci, FI-00014 Helsinki, Finland	Finnish Meteorological Institute; University of Helsinki	Tunved, P (corresponding author), Dept Appl Environm Sci, Air Pollut Lab, Frescativagen 54, SE-10691 Stockholm, Sweden.	peter.tunved@itm.su.se	Komppula, Mika/AAC-2571-2021; Aalto, Pasi P/A-1539-2009; Kerminen, Veli-Matti/M-9026-2014; Dal Maso, Miikka/A-7980-2008; Lihavainen, Heikki/N-4840-2014; Viisanen, Yrjö/CAG-3818-2022; Kulmala, Markku T/I-7671-2016	Komppula, Mika/0000-0002-4550-3061; Aalto, Pasi P/0000-0001-8826-9108; Dal Maso, Miikka/0000-0003-3040-3612; Viisanen, Yrjö/0000-0002-9660-3281; Kulmala, Markku T/0000-0003-3464-7825				Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Boy M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003838; CIAIS P, 1995, J GEOPHYS RES-ATMOS, V100, P5051, DOI 10.1029/94JD02847; DRAXLER R, 1997, ARL224 ERL NOAA; Guenther A, 1997, ECOL APPL, V7, P34, DOI 10.1890/1051-0761(1997)007[0034:SASVIN]2.0.CO;2; Hakola H, 2003, ATMOS ENVIRON, V37, P1623, DOI 10.1016/S1352-2310(03)00014-1; Heintzenberg J, 2000, TELLUS B, V52, P1104, DOI 10.1034/j.1600-0889.2000.00136.x; Janson R, 2001, TELLUS B, V53, P423, DOI 10.1034/j.1600-0889.2001.d01-30.x; Kalberer M, 2004, SCIENCE, V303, P1659, DOI 10.1126/science.1092185; Kavouras IG, 1998, NATURE, V395, P683, DOI 10.1038/27179; KERMINEN VM, 2005, GEOPHYS RES LETT, V32; Komppula M, 2003, BOREAL ENVIRON RES, V8, P395; Kulmala M, 1998, TELLUS B, V50, P449, DOI 10.1034/j.1600-0889.1998.t01-4-00004.x; Kulmala M, 2004, J AEROSOL SCI, V35, P143, DOI 10.1016/j.jaerosci.2003.10.003; Kulmala M, 2001, TELLUS B, V53, P324, DOI 10.1034/j.1600-0889.2001.d01-24.x; LINDFORD V, 1999, BIOGENIC VOC EMISSIO, pCH10; Makela JM, 1997, GEOPHYS RES LETT, V24, P1219, DOI 10.1029/97GL00920; Makela Jyrki M., 2000, Boreal Environment Research, V5, P299; NOVAKOV T, 1993, NATURE, V365, P823, DOI 10.1038/365823a0; O'Dowd CD, 2002, NATURE, V416, P497, DOI 10.1038/416497a; Odum JR, 1996, ENVIRON SCI TECHNOL, V30, P2580, DOI 10.1021/es950943+; Spanke J, 2001, TELLUS B, V53, P406, DOI 10.1034/j.1600-0889.2001.d01-29.x; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; Tunved P, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005085; Tunved P, 2003, ATMOS CHEM PHYS, V3, P2183, DOI 10.5194/acp-3-2183-2003; Vehkamaki H, 2004, ATMOS CHEM PHYS, V4, P2015, DOI 10.5194/acp-4-2015-2004	27	326	330	5	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					261	263		10.1126/science.1123052	http://dx.doi.org/10.1126/science.1123052			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614221				2022-12-24	WOS:000236765300047
J	Moreau, CS; Bell, CD; Vila, R; Archibald, SB; Pierce, NE				Moreau, CS; Bell, CD; Vila, R; Archibald, SB; Pierce, NE			Phylogeny of the ants: Diversification in the age of angiosperms	SCIENCE			English	Article							HYMENOPTERA; ORIGIN; FORMICIDAE	We present a large-scale molecular phylogeny of the ants (Hymenoptera: Formicidae), based on 4.5 kilobases of sequence data from six gene regions extracted from 139 of the 288 described extant genera, representing 19 of the 20 subfamilies. All but two subfamilies are recovered as monophyletic. Divergence time estimates calibrated by minimum age constraints from 43 fossils indicate that most of the subfamilies representing extant ants arose much earlier than previously proposed but only began to diversify during the Late Cretaceous to Early Eocene. This period also witnessed the rise of angiosperms and most herbivorous insects.	Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; Florida State Univ, Sch Computat Sci, Dirac Sci Lib 150R, Tallahassee, FL 32306 USA	Harvard University; State University System of Florida; Florida State University	Moreau, CS (corresponding author), Harvard Univ, Museum Comparat Zool, 26 Oxford St, Cambridge, MA 02138 USA.	cmoreau@oeb.harvard.edu	Vila, Roger/A-1817-2012; Moreau, Corrie S/B-2889-2011	Vila, Roger/0000-0002-2447-4388; Moreau, Corrie/0000-0003-1139-5792				Astruc C, 2004, MOL PHYLOGENET EVOL, V31, P880, DOI 10.1016/j.ympev.2003.10.024; Bell CD, 2005, EVOLUTION, V59, P1245, DOI 10.1111/j.0014-3820.2005.tb01775.x; Bolton B., 2003, SYNOPSIS CLASSIFICAT; Brady SG, 2003, P NATL ACAD SCI USA, V100, P6575, DOI 10.1073/pnas.1137809100; CRANE PR, 1995, NATURE, V374, P27, DOI 10.1038/374027a0; Crozier RH, 1997, NATURWISSENSCHAFTEN, V84, P22, DOI 10.1007/s001140050341; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Davis CC, 2005, AM NAT, V165, pE36, DOI 10.1086/428296; Dlussky G.M.., 1997, PALEONTOL J+, V31, P616; Dlussky G. M., 2003, RUSS ENTOMOL J, V11, P411; Engel MS, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)485[0001:PNAICA]2.0.CO;2; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Grimaldi David, 1997, American Museum Novitates, V3208, P1; Grimaldi David, 2005, pi; Holldobler B., 1990, pi; Nel A., 2004, Geologica Acta, V2, P23; Ohnishi H, 2003, GENES GENET SYST, V78, P419, DOI 10.1266/ggs.78.419; Saux C, 2004, MOL PHYLOGENET EVOL, V33, P457, DOI 10.1016/j.ympev.2004.06.017; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; SHATTUCK SO, 1992, SYST ENTOMOL, V17, P199, DOI 10.1111/j.1365-3113.1992.tb00332.x; TAYLOR RW, 1978, SCIENCE, V201, P979, DOI 10.1126/science.201.4360.979; Tobin John E., 1994, P279; URBANI CB, 1992, SYST ENTOMOL, V17, P301, DOI 10.1111/j.1365-3113.1992.tb00553.x; Ward Philip S., 2005, Myrmecologische Nachrichten, V7, P87; WARD PS, 1994, SYST ENTOMOL, V19, P159, DOI 10.1111/j.1365-3113.1994.tb00585.x; Ward PS, 2003, INVERTEBR SYST, V17, P361, DOI 10.1071/IS02046; Wilf P, 2000, SCIENCE, V289, P291, DOI 10.1126/science.289.5477.291; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P7411, DOI 10.1073/pnas.0502264102	28	609	634	2	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2006	312	5770					101	104		10.1126/science.1124891	http://dx.doi.org/10.1126/science.1124891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601190				2022-12-24	WOS:000236584400040
J	Darios, F; Davletov, B				Darios, F; Davletov, B			Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3	NATURE			English	Article							NERVE GROWTH-FACTOR; PHOSPHOLIPASE A(2) ACTIVITY; ARACHIDONIC-ACID; DOCOSAHEXAENOIC ACID; NEURITE OUTGROWTH; SNARE COMPLEXES; PLASMA-MEMBRANE; AXONAL GROWTH; IN-VITRO; PROTEIN	Growth of neurite processes from the cell body is the critical step in neuronal development and involves a large increase in cell membrane surface area(1). Arachidonic-acid-releasing phospholipases are highly enriched in nerve growth cones and have previously been implicated in neurite outgrowth(2,3). Cell membrane expansion is achieved through the fusion of transport organelles with the plasma membrane(4); however, the identity of the molecular target of arachidonic acid has remained elusive. Here we show that syntaxin 3 (STX3), a plasma membrane protein, has an important role in the growth of neurites, and also serves as a direct target for omega-6 arachidonic acid. By using syntaxin 3 in a screening assay, we determined that the dietary omega-3 linolenic and docosahexaenoic acids can efficiently substitute for arachidonic acid in activating syntaxin 3. Our findings provide a molecular basis for the previously established action of omega-3 and omega-6 polyunsaturated fatty acids in membrane expansion at the growth cones, and represent the first identification of a single effector molecule for these essential nutrients.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Davletov, B (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	email@bazbek.com	Davletov, Bazbek/ABA-8569-2021	Darios, Frederic/0000-0001-9800-5990; Davletov, Bazbek/0000-0003-4658-3275	MRC [MC_U105178791] Funding Source: UKRI; Medical Research Council [MC_U105178791] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bajohrs M, 2005, BIOCHEM J, V392, P283, DOI 10.1042/BJ20050583; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; Farkas T, 2000, P NATL ACAD SCI USA, V97, P6362, DOI 10.1073/pnas.120157297; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Futerman AH, 1996, TRENDS NEUROSCI, V19, P144, DOI 10.1016/S0166-2236(96)80025-7; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hamilton JA, 2004, PROG LIPID RES, V43, P177, DOI 10.1016/j.plipres.2003.09.002; Hornfelt M, 1999, NEUROSCIENCE, V91, P1539, DOI 10.1016/S0306-4522(98)00684-8; Igarashi M, 1996, J CELL BIOL, V134, P205, DOI 10.1083/jcb.134.1.205; Kane CD, 1996, ANAL BIOCHEM, V233, P197, DOI 10.1006/abio.1996.0028; Kelly RB, 1999, TRENDS CELL BIOL, V9, pM29, DOI 10.1016/S0962-8924(99)01687-6; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Marszalek JR, 2005, ANNU REV CELL DEV BI, V21, P633, DOI 10.1146/annurev.cellbio.21.122303.120624; NAKAMURA S, 1993, NEUROREPORT, V4, P371, DOI 10.1097/00001756-199304000-00007; NEGREAMINOU P, 1993, J NEUROCHEM, V60, P1126, DOI 10.1111/j.1471-4159.1993.tb03263.x; NegreAminou P, 1996, J NEUROCHEM, V67, P2599; OSENSAND A, 1993, NATURE, V364, P445, DOI 10.1038/364445a0; Rickman C, 2005, CHEM BIOL, V12, P545, DOI 10.1016/j.chembiol.2005.03.004; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Rohrbough J, 2005, NAT REV NEUROSCI, V6, P139, DOI 10.1038/nrn1608; SCHIAVO G, 1995, J BIOL CHEM, V270, P10566, DOI 10.1074/jbc.270.18.10566; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Tang BL, 2001, J NEUROCHEM, V79, P923, DOI 10.1046/j.1471-4159.2001.00674.x; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Wainwright PE, 2002, P NUTR SOC, V61, P61, DOI 10.1079/PNS2001130; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Zheng WH, 1996, J NEUROCHEM, V66, P1868	30	266	283	4	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					813	817		10.1038/nature04598	http://dx.doi.org/10.1038/nature04598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598260				2022-12-24	WOS:000236548400045
J	Moffat, J; Grueneberg, DA; Yang, XP; Kim, SY; Kloepfer, AM; Hinkle, G; Piqani, B; Eisenhaure, TM; Luo, B; Grenier, JK; Carpenter, AE; Foo, SY; Stewart, SA; Stockwell, BR; Hacohen, N; Hahn, WC; Lander, ES; Sabatini, DM; Root, DE				Moffat, J; Grueneberg, DA; Yang, XP; Kim, SY; Kloepfer, AM; Hinkle, G; Piqani, B; Eisenhaure, TM; Luo, B; Grenier, JK; Carpenter, AE; Foo, SY; Stewart, SA; Stockwell, BR; Hacohen, N; Hahn, WC; Lander, ES; Sabatini, DM; Root, DE			A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen	CELL			English	Article							CULTURED-MAMMALIAN-CELLS; CAENORHABDITIS-ELEGANS; INTERFERING RNAS; HUMAN KINASES; IN-VIVO; GENOME; IDENTIFICATION; APOPTOSIS; PATHWAY; COMPONENTS	To enable arrayed or pooled loss-of-function screens in a wide range of mammalian cell types, including primary and nondividing cells, we are developing lentiviral short hairpin RNA (shRNA) libraries targeting the human and murine genomes. The libraries currently contain 104,000 vectors, targeting each of 22,000 human and mouse genes with multiple sequence-verified constructs. To test the utility of the library for arrayed screens, we developed a screen based on high-content imaging to identify genes required for mitotic progression in human cancer cells and applied it to an arrayed set of 5,000 unique shRNA-expressing lentiviruses that target 1,028 human genes. The screen identified several known and similar to 100 candidate regulators of mitotic progression and proliferation; the availability of multiple shRNAs targeting the same gene facilitated functional validation of putative hits. This work provides a widely applicable resource for loss-of-function screens, as well as a roadmap for its application to biological discovery.	MIT, Broad Inst, Cambridge, MA 02139 USA; Harvard Univ, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Columbia Univ, Dept Chem, Dept Sci Biol, New York, NY 10027 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Washington University (WUSTL); Columbia University	Root, DE (corresponding author), MIT, Broad Inst, Cambridge, MA 02139 USA.	droot@broad.mit.edu	Moffat, Jason/AAC-1110-2020; Stockwell, Brent R/AAE-7200-2019; Stewart, Sheila A/C-5213-2012; Carpenter, Anne/C-4982-2008	Moffat, Jason/0000-0002-5663-8586; Stockwell, Brent R/0000-0002-3532-3868; Carpenter, Anne/0000-0003-1555-8261; /0000-0002-1446-7256	NCI NIH HHS [CA103866, P50 CA112962, R01CA97061] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA103866, R01CA097061] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abbas-Terki T, 2002, HUM GENE THER, V13, P2197, DOI 10.1089/104303402320987888; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FEDERICO ME, 2003, LENTIVIRUS GENE ENG, V229; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gasparri F, 2004, J BIOMOL SCREEN, V9, P232, DOI 10.1177/1087057103262836; Golsteyn RM, 2005, CANCER LETT, V217, P129, DOI 10.1016/j.canlet.2004.08.005; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Harborth J, 2001, J CELL SCI, V114, P4557; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marron MB, 2000, J BIOL CHEM, V275, P39741, DOI 10.1074/jbc.M007189200; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Sandy P, 2005, BIOTECHNIQUES, V39, P215, DOI 10.2144/05392RV01; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tsiamis AC, 2002, MICROVASC RES, V63, P149, DOI 10.1006/mvre.2001.2377; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	42	1273	1344	1	94	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1283	1298		10.1016/j.cell.2006.01.040	http://dx.doi.org/10.1016/j.cell.2006.01.040			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564017	Bronze			2022-12-24	WOS:000237241400026
J	Patel, SD; Ciatto, C; Chen, CP; Bahna, F; Rajebhosale, M; Arkus, N; Schieren, I; Jessell, TM; Honig, B; Price, SR; Shapiro, L				Patel, SD; Ciatto, C; Chen, CP; Bahna, F; Rajebhosale, M; Arkus, N; Schieren, I; Jessell, TM; Honig, B; Price, SR; Shapiro, L			Type II cadherin ectodomain structures: Implications for classical cadherin specificity	CELL			English	Article							CELL-CELL ADHESION; N-CADHERIN; FUNCTIONAL-ANALYSIS; CRYSTAL-STRUCTURE; IDENTIFICATION; EXPRESSION; BINDING; LOCALIZATION; DIMERIZATION; MOLECULES	Type I and II classical cadherins help to determine the adhesive specificities of animal cells. Crystal-structure determination of ectodomain regions from three type II cadherins reveals adhesive dimers formed by exchange of N-terminal beta strands between partner extracellular cadherin-1 (EC1) domains. These interfaces have two conserved tryptophan side chains that anchor each swapped strand, compared with one in type I cadherins, and include large hydrophobic regions unique to type II interfaces. The EC1 domains of type I and type II cadherins appear to encode cell adhesive specificity in vitro. Moreover, perturbation of motor neuron segregation with chimeric cadherins depends on EC1 domain identity, suggesting that this region, which includes the structurally defined adhesive interface, encodes type II cadherin functional specificity in vivo.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Columbia Univ, Edward S Harkness Eye Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; University of London; University College London; Columbia University	Price, SR (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	ucgaspr@ucl.ac.uk; lss8@columbia.edu	Shapiro, Lawrence/AAE-7172-2019	Price, Stephen/0000-0001-7804-9849; Patel, Saurabh/0000-0002-5738-3175	NIGMS NIH HHS [GM-062270, GM-30518] Funding Source: Medline; Wellcome Trust [072914] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030518, R01GM062270, R01GM030518] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bekirov IH, 2002, NEUROSCIENCE, V115, P213, DOI 10.1016/S0306-4522(02)00375-5; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Espeseth A, 1998, DEVELOPMENT, V125, P301; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harrison OJ, 2005, J CELL SCI, V118, P711, DOI 10.1242/jcs.01665; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; Haussinger D, 2004, EMBO J, V23, P1699, DOI 10.1038/sj.emboj.7600192; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; May C, 2005, BLOOD, V105, P4337, DOI 10.1182/blood-2005-01-0010; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; NAKAGAWA S, 1995, DEVELOPMENT, V121, P1321; Niessen CM, 2002, J CELL BIOL, V156, P389, DOI 10.1083/jcb.200108040; Nishimura EK, 1999, DEV BIOL, V215, P155, DOI 10.1006/dbio.1999.9478; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; Patel SD, 2003, CURR OPIN STRUC BIOL, V13, P690, DOI 10.1016/j.sbi.2003.10.007; Perret E, 2004, P NATL ACAD SCI USA, V101, P16472, DOI 10.1073/pnas.0402085101; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Redies C, 2003, J PHYSIOL-PARIS, V97, P5, DOI 10.1016/j.jphysparis.2003.10.002; Redies C, 1996, DEV BIOL, V180, P413, DOI 10.1006/dbio.1996.0315; Shan WS, 2004, J BIOL CHEM, V279, P55914, DOI 10.1074/jbc.M407827200; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; Shan WS, 1999, BIOPHYS CHEM, V82, P157, DOI 10.1016/S0301-4622(99)00115-5; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SHAPIRO L, 1995, P NATL ACAD SCI USA, V92, P6793, DOI 10.1073/pnas.92.15.6793; Shimoyama Y, 1999, J BIOL CHEM, V274, P11987, DOI 10.1074/jbc.274.17.11987; Shimoyama Y, 2000, BIOCHEM J, V349, P159, DOI 10.1042/0264-6021:3490159; Sivasankar S, 1999, P NATL ACAD SCI USA, V96, P11820, DOI 10.1073/pnas.96.21.11820; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; TAKEICHI M, 1981, DEV BIOL, V87, P340, DOI 10.1016/0012-1606(81)90157-3; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Tanaka Y, 2003, MOL BIOL CELL, V14, P1597, DOI 10.1091/mbc.E02-10-0632; Troyanovsky RB, 2003, MOL CELL BIOL, V23, P7965, DOI 10.1128/MCB.23.22.7965-7972.2003; Troyanovsky S, 2005, EUR J CELL BIOL, V84, P225, DOI 10.1016/j.ejcb.2004.12.009; Zhu B, 2003, BIOPHYS J, V84, P4033, DOI 10.1016/S0006-3495(03)75129-7	42	213	227	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1255	1268		10.1016/j.cell.2005.12.046	http://dx.doi.org/10.1016/j.cell.2005.12.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564015	Bronze			2022-12-24	WOS:000237241400024
J	Suel, GM; Garcia-Ojalvo, J; Liberman, LM; Elowitz, MB				Suel, GM; Garcia-Ojalvo, J; Liberman, LM; Elowitz, MB			An excitable gene regulatory circuit induces transient cellular differentiation	NATURE			English	Article							COMPETENCE TRANSCRIPTION FACTOR; BACILLUS-SUBTILIS; FEEDBACK LOOP; EXPRESSION; NOISE; CELLS; SYSTEMS; MODULE; GROWTH; STATE	Certain types of cellular differentiation are probabilistic and transient(1-3). In such systems individual cells can switch to an alternative state and, after some time, switch back again. In Bacillus subtilis, competence is an example of such a transiently differentiated state associated with the capability for DNA uptake from the environment. Individual genes and proteins underlying differentiation into the competent state have been identified(4,5), but it has been unclear how these genes interact dynamically in individual cells to control both spontaneous entry into competence and return to vegetative growth. Here we show that this behaviour can be understood in terms of excitability in the underlying genetic circuit. Using quantitative fluorescence time-lapse microscopy, we directly observed the activities of multiple circuit components simultaneously in individual cells, and analysed the resulting data in terms of a mathematical model. We find that an excitable core module containing positive and negative feedback loops can explain both entry into, and exit from, the competent state. We further tested this model by analysing initiation in sister cells, and by re-engineering the gene circuit to specifically block exit. Excitable dynamics driven by noise naturally generate stochastic and transient responses(6), thereby providing an ideal mechanism for competence regulation.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; Univ Politecn Catalunya, Dept Fis & Engn Nucl, E-08222 Terrassa, Spain	California Institute of Technology; California Institute of Technology; Universitat Politecnica de Catalunya	Elowitz, MB (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	melowitz@caltech.edu	Garcia-Ojalvo, Jordi/A-4574-2009	Garcia-Ojalvo, Jordi/0000-0002-3716-7520; Liberman, Louisa/0000-0002-1315-0097				Dupin E, 2003, P NATL ACAD SCI USA, V100, P5229, DOI 10.1073/pnas.0831229100; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; HAHN J, 1991, J BACTERIOL, V173, P7275, DOI 10.1128/jb.173.22.7275-7282.1991; Hahn J, 1996, MOL MICROBIOL, V21, P763, DOI 10.1046/j.1365-2958.1996.371407.x; HAHN J, 1994, J BACTERIOL, V176, P5753, DOI 10.1128/JB.176.18.5753-5761.1994; Haijema BJ, 2001, MOL MICROBIOL, V40, P52, DOI 10.1046/j.1365-2958.2001.02363.x; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Keener J. P., 1998, MATH PHYSL; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lee EJ, 2005, MOL ENDOCRINOL, V19, P964, DOI 10.1210/me.2004-0034; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Meeks JC, 2002, ARCH MICROBIOL, V178, P395, DOI 10.1007/s00203-002-0476-5; NAKANO MM, 1991, J BACTERIOL, V173, P7269, DOI 10.1128/jb.173.22.7269-7274.1991; Ogura M, 1999, MOL MICROBIOL, V32, P799, DOI 10.1046/j.1365-2958.1999.01399.x; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Serror P, 1996, J BACTERIOL, V178, P5910, DOI 10.1128/jb.178.20.5910-5915.1996; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; Turgay K, 1998, EMBO J, V17, P6730; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	24	545	556	3	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					545	550		10.1038/nature04588	http://dx.doi.org/10.1038/nature04588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554821				2022-12-24	WOS:000236176100059
J	Whang, W; Manson, JE; Hu, FB; Chae, CU; Rexrode, KM; Willett, WC; Stampfer, MJ; Albert, CM				Whang, W; Manson, JE; Hu, FB; Chae, CU; Rexrode, KM; Willett, WC; Stampfer, MJ; Albert, CM			Physical exertion, exercise, and sudden cardiac death in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; RISK-FACTORS; MORTALITY; PREVENTION; FITNESS; MEN	Context Exercise is associated with a lower risk of cardiovascular events but may transiently increase the risk of ventricular arrhythmias. Its short-term and long-term associations with risk of sudden cardiac death among women are unclear. Objectives To compare the risk of sudden cardiac death in women during moderate to vigorous exertion with the risk of sudden cardiac death during lighter or no exertion; and to assess the long-term association between moderate to vigorous exercise and sudden cardiac death. Design, Setting, and Participants Prospective, nested case-crossover study of 288 cases of sudden cardiac death within the Nurses' Health Study (1980-2004); and a prospective cohort analysis of 69 693 participants without prior cardiovascular disease followed up from 1986-2004. Main Outcome Measure Risk of sudden cardiac death associated with moderate to vigorous exertion. Results The absolute risk of sudden cardiac death associated with moderate to vigorous exertion was exceedingly low at 1 per 36.5 million hours of exertion. In case-crossover analyses, the risk of sudden cardiac death was transiently elevated during moderate to vigorous exertion ( relative risk [RR], 2.38; 95% confidence interval [CI], 1.23-4.60; P=.01) compared with the risk during lesser or no exertion. Habitual moderate to vigorous exertion modified this transient risk (P=.005 for interaction) and the risk was no longer significantly elevated among those who exercised 2 or more hours per week. In the cohort analyses, an increasing amount of moderate to vigorous exercise was associated with a lower long-term risk of sudden cardiac death in age-adjusted and multivariable models that excluded biological intermediates (P=.006 for trend). This relationship was attenuated when biological intermediates were included (P=.06 for trend); however, the reduction in risk remained significant among women who exercised 4 or more hours per week ( adjusted RR, 0.41; 95% CI, 0.20-0.83; P=.01) compared with women who did not exercise. Conclusions These prospective data suggest that sudden cardiac death during exertion is an extremely rare event in women. Regular exercise may significantly minimize this small transient risk and may lower the overall long-term risk of sudden cardiac death.	Brigham & Womens Hosp, Div Prevent Med, Ctr Arrhythmia Prevent, Boston, MA 02215 USA; Massachusetts Gen Hosp, Div Cardiovasc, Boston, MA 02114 USA; Harvard Univ, Sch Med, Channing Lab, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Albert, CM (corresponding author), Brigham & Womens Hosp, Div Prevent Med, Ctr Arrhythmia Prevent, 900 Commonwealth Ave E, Boston, MA 02215 USA.	calbert@partners.org	Rexrode, Kathryn M/I-1177-2018	Rexrode, Kathryn/0000-0003-3387-8429; Albert, Christine/0000-0002-2081-1121	NCI NIH HHS [CA-87969] Funding Source: Medline; NHLBI NIH HHS [HL-03783, HL-34594] Funding Source: Medline; NIDDK NIH HHS [P30 DK040561-11] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albert CM, 2000, NEW ENGL J MED, V343, P1355, DOI 10.1056/NEJM200011093431902; Albert CM, 2003, CIRCULATION, V107, P2096, DOI 10.1161/01.CIR.0000065223.21530.11; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Burke AP, 1998, CIRCULATION, V97, P2110, DOI 10.1161/01.CIR.97.21.2110; COBB LA, 1986, J AM COLL CARDIOL, V7, P215, DOI 10.1016/S0735-1097(86)80284-4; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; KANNEL WB, 1982, ANN NY ACAD SCI, V382, P3, DOI 10.1111/j.1749-6632.1982.tb55203.x; Kannel WB, 1998, AM HEART J, V136, P205, DOI 10.1053/hj.1998.v136.90226; KJELSBERG MO, 1982, JAMA-J AM MED ASSOC, V248, P1465; KOHL HW, 1992, EPIDEMIOL REV, V14, P37, DOI 10.1093/oxfordjournals.epirev.a036091; Kushi LH, 1997, JAMA-J AM MED ASSOC, V277, P1287, DOI 10.1001/jama.277.16.1287; Lemaitre RN, 1999, ARCH INTERN MED, V159, P686, DOI 10.1001/archinte.159.7.686; LEON AS, 1987, JAMA-J AM MED ASSOC, V258, P2388, DOI 10.1001/jama.258.17.2388; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Rockhill B, 2001, AM J PUBLIC HEALTH, V91, P578, DOI 10.2105/AJPH.91.4.578; SCRAGG R, 1987, AM J EPIDEMIOL, V126, P77, DOI 10.1093/oxfordjournals.aje.a114664; Siscovick David S., 1997, Cardiology Clinics, V15, P467, DOI 10.1016/S0733-8651(05)70352-0; SISCOVICK DS, 1984, NEW ENGL J MED, V311, P874, DOI 10.1056/NEJM198410043111402; THOMPSON PD, 1982, JAMA-J AM MED ASSOC, V247, P2535, DOI 10.1001/jama.247.18.2535; Thompson PD, 2005, CIRCULATION, V112, P2354, DOI 10.1161/CIRCULATIONAHA.104.502591; VUORI I, 1986, ACTA MED SCAND, P205; WANNAMETHEE G, 1995, CIRCULATION, V91, P1749, DOI 10.1161/01.CIR.91.6.1749; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	28	107	109	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2006	295	12					1399	1403		10.1001/jama.295.12.1399	http://dx.doi.org/10.1001/jama.295.12.1399			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023WU	16551711	Bronze			2022-12-24	WOS:000236157700017
J	Kalish, RB; McCullough, LB; Chervenak, FA				Kalish, RB; McCullough, LB; Chervenak, FA			Decision-making about caesarean delivery	LANCET			English	Editorial Material							SECTION; WOMEN; OUTCOMES; TRIAL; LABOR		Cornell Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, New York, NY 10021 USA; Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, Dept Obstet & Gynecol, New York, NY USA	Cornell University; Baylor College of Medicine; Cornell University; NewYork-Presbyterian Hospital	Kalish, RB (corresponding author), Cornell Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, New York, NY 10021 USA.	robinkal@aol.com	Sampiev, Abdulmutalip/N-4757-2019; Chervenak, Frank/P-3555-2017	Sampiev, Abdulmutalip/0000-0002-5100-2239; Chervenak, Frank/0000-0002-4600-0853				Anderson GM, 2004, BMJ-BRIT MED J, V329, P696, DOI 10.1136/bmj.329.7468.696; Creasy RK, 2004, MATERNAL FETAL MED; CUNNINGHAM FG, 2001, WILLIIAMS OBSTET; Hannah ME, 2004, CAN MED ASSOC J, V170, P813, DOI 10.1503/cmaj.1032002; Hannah ME, 2002, JAMA-J AM MED ASSOC, V287, P1822, DOI 10.1001/jama.287.14.1822; James D.K., 2006, HIGH RISK PREGNANCY, V3rd ed.; Kalish RB, 2004, OBSTET GYNECOL, V103, P1137, DOI 10.1097/01.AOG.0000128118.37737.df; Landon MB, 2004, NEW ENGL J MED, V351, P2581, DOI 10.1056/NEJMoa040405; Minkoff H, 2003, NEW ENGL J MED, V348, P946, DOI 10.1056/NEJMsb022734; Nicolaides KH, 2005, AM J OBSTET GYNECOL, V193, P322, DOI 10.1016/j.ajog.2005.02.134; Osis MJD, 2001, INT J GYNECOL OBSTET, V75, pS59, DOI 10.1016/S0020-7292(01)00518-5; Schenker JG, 1999, INT J GYNECOL OBSTET, V64, P317; Whitney SN, 2004, ANN INTERN MED, V140, P54, DOI 10.7326/0003-4819-140-1-200401060-00012; 2006, FED REG, V71, P5346	14	20	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2006	367	9514					883	885		10.1016/S0140-6736(06)68359-1	http://dx.doi.org/10.1016/S0140-6736(06)68359-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546524				2022-12-24	WOS:000236242100008
J	Czech, MP				Czech, MP			MicroRNAs as therapeutic targets	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RNAS		Univ Massachusetts, Sch Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01605 USA.							Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Eckstein F, 2005, TRENDS BIOCHEM SCI, V30, P445, DOI 10.1016/j.tibs.2005.06.008; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Sullivan CS, 2005, MOL CELL, V20, P3, DOI 10.1016/j.molcel.2005.09.012; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	5	101	157	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1194	1195		10.1056/NEJMcibr060065	http://dx.doi.org/10.1056/NEJMcibr060065			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021KI	16540623				2022-12-24	WOS:000235981700018
J	Brown, RH; Clark, RN; Buratti, BJ; Cruikshank, DP; Barnes, JW; Mastrapa, RME; Bauer, J; Newman, S; Momary, T; Baines, KH; Bellucci, G; Capaccioni, F; Cerroni, P; Combes, M; Coradini, A; Drossart, P; Formisano, V; Jaumann, R; Langevin, Y; Matson, DL; McCord, TB; Nelson, RM; Nicholson, PD; Sicardy, B; Sotin, C				Brown, RH; Clark, RN; Buratti, BJ; Cruikshank, DP; Barnes, JW; Mastrapa, RME; Bauer, J; Newman, S; Momary, T; Baines, KH; Bellucci, G; Capaccioni, F; Cerroni, P; Combes, M; Coradini, A; Drossart, P; Formisano, V; Jaumann, R; Langevin, Y; Matson, DL; McCord, TB; Nelson, RM; Nicholson, PD; Sicardy, B; Sotin, C			Composition and physical properties of Enceladus' surface	SCIENCE			English	Article							KINETIC INHIBITION; MAGNETIC-FIELD; OUTER PLANETS; N-2 REDUCTION; H2O ICE; SATELLITES; DISCOVERY; CHEMISTRY; ION; CO		Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; US Geol Survey, Denver, CO 80225 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Inst Fis Spazio Interplanetario, I-0133 Rome, Italy; Ist Astrofis Spaziale, I-0133 Rome, Italy; Observ Paris, F-92195 Meudon, France; Deutsch Zentrum Luft & Raumfahrt, D-12489 Berlin, Germany; Univ Paris, Inst Astrophys Spatiale, F-91405 Orsay, France; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Nantes, F-44072 Nantes, France	University of Arizona; United States Department of the Interior; United States Geological Survey; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Helmholtz Association; German Aerospace Centre (DLR); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris Saclay; University of Washington; University of Washington Seattle; Cornell University; Nantes Universite	Brown, RH (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.		Bellucci, Giancarlo/ABA-9201-2020; Barnes, Jason W/B-1284-2009; Drossart, Pierre/H-8670-2013; Jaumann, Ralf/N-1001-2018	Bellucci, Giancarlo/0000-0003-0867-8679; Barnes, Jason W/0000-0002-7755-3530; Jaumann, Ralf/0000-0002-9759-6597; Capaccioni, Fabrizio/0000-0003-1631-4314; Newman, Sarah/0000-0003-3126-5717; Cerroni, Priscilla/0000-0003-0239-2741				Brown RH, 2004, SPACE SCI REV, V115, P111, DOI 10.1007/s11214-004-1453-x; Cruikshank DP, 2005, ICARUS, V175, P268, DOI 10.1016/j.icarus.2004.09.003; Dougherty MK, 2006, SCIENCE, V311, P1406, DOI 10.1126/science.1120985; Emery JP, 2005, ASTRON ASTROPHYS, V435, P353, DOI 10.1051/0004-6361:20042482; Grundy WM, 1999, ICARUS, V142, P536, DOI 10.1006/icar.1999.6216; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; Hansen GB, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002149; Kargel JS, 1996, ICARUS, V119, P385, DOI 10.1006/icar.1996.0026; KARGEL JS, 1995, EARTH MOON PLANETS, V67, P101, DOI 10.1007/BF00613296; Kivelson MG, 1996, NATURE, V384, P537, DOI 10.1038/384537a0; LEWIS JS, 1980, ASTROPHYS J, V238, P357, DOI 10.1086/157992; LEWIS JS, 1974, SCI AM, V230, P51, DOI 10.1038/scientificamerican0374-50; LEWIS JS, 1974, SCIENCE, V186, P440, DOI 10.1126/science.186.4162.440; LEWIS JS, 1973, ANNU REV PHYS CHEM, V24, P339, DOI 10.1146/annurev.pc.24.100173.002011; LEWIS JS, 1971, SCIENCE, V172, P1127, DOI 10.1126/science.172.3988.1127; LEWIS JS, 1971, ICARUS, V15, P174, DOI 10.1016/0019-1035(71)90072-8; MCKINNON WB, 1987, REV GEOPHYS, V25, P260, DOI 10.1029/RG025i002p00260; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; PRINN RG, 1981, ASTROPHYS J, V249, P308, DOI 10.1086/159289; Schubert G, 1996, NATURE, V384, P544, DOI 10.1038/384544a0; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; SQUYRES SW, 1983, ICARUS, V53, P319, DOI 10.1016/0019-1035(83)90152-5; STEVENSON DJ, 1982, NATURE, V298, P142, DOI 10.1038/298142a0; STEVENSON DJ, 1984, NASA C PUBL, V2330, P405; STRAZZULLA G, 1992, EUROPHYS LETT, V18, P517, DOI 10.1209/0295-5075/18/6/008; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290	26	159	160	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2006	311	5766					1425	1428		10.1126/science.1121031	http://dx.doi.org/10.1126/science.1121031			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527972				2022-12-24	WOS:000236029400038
J	Gidalevitz, T; Ben-Zvi, A; Ho, KH; Brignull, HR; Morimoto, RI				Gidalevitz, T; Ben-Zvi, A; Ho, KH; Brignull, HR; Morimoto, RI			Progressive disruption of cellular protein folding in models of polyglutamine diseases	SCIENCE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; CAENORHABDITIS-ELEGANS; HUNTINGTONS-DISEASE; AGGREGATION; PROTEASOME; MUTATION; LOCALIZATION; PATHOGENESIS; DEGRADATION; SUPPRESSION		Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Rice Inst Biomed Res, Evanston, IL 60208 USA	Northwestern University	Morimoto, RI (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Rice Inst Biomed Res, 2153 Sheridan Rd, Evanston, IL 60208 USA.	r-morimoto@northwestern.edu	BEN-ZVI, ANAT/F-1674-2012; Gidalevitz, Tali/C-9217-2009; Longo, Kenneth A/A-5631-2010	BEN-ZVI, ANAT/0000-0003-2477-6519; Gidalevitz, Tali/0000-0002-9178-6648; 	NHLBI NIH HHS [T32 HL076139] Funding Source: Medline; NIA NIH HHS [R37 AG026647] Funding Source: Medline; NIGMS NIH HHS [T32 GM08061, F32 GM075583-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061, F32GM075583] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BRIGNULL HR, UNPUB; Brown CR, 1997, J CLIN INVEST, V99, P1432, DOI 10.1172/JCI119302; Clark SG, 1997, P NATL ACAD SCI USA, V94, P10438, DOI 10.1073/pnas.94.19.10438; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Eisenmann DM, 1997, GENETICS, V146, P553; Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3; GENGYOANDO K, 1991, J MOL BIOL, V219, P429, DOI 10.1016/0022-2836(91)90184-8; GIDALEVITZ, UNPUB; GOFF SA, 1985, CELL, V41, P587, DOI 10.1016/S0092-8674(85)80031-3; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Li K, 1997, J NEUROPATHOL EXP NE, V56, P125; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; OLIVER CN, 1987, J BIOL CHEM, V262, P5488; Pedersen CB, 2003, J BIOL CHEM, V278, P47449, DOI 10.1074/jbc.M309514200; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; VANDYK TK, 1989, NATURE, V342, P451, DOI 10.1038/342451a0; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101	31	476	490	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2006	311	5766					1471	1474		10.1126/science.1124514	http://dx.doi.org/10.1126/science.1124514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16469881				2022-12-24	WOS:000236029400052
J	King, MD; Humphrey, BJ; Wang, YF; Kourbatova, EV; Ray, SM; Blumberg, HM				King, MD; Humphrey, BJ; Wang, YF; Kourbatova, EV; Ray, SM; Blumberg, HM			Emergence of community-acquired methicillin-resistant Staphylococchus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections	ANNALS OF INTERNAL MEDICINE			English	Article							FIELD GEL-ELECTROPHORESIS; PANTON-VALENTINE LEUKOCIDIN; CHILDREN; STRAINS	Background: Studies have shown that community-acquired methicillin-resistant Staphylococcus aureus (MRSA) causes S. aureus skin and soft-tissue infection in selected populations. Objective: To determine the proportion of infections caused by community-acquired MRSA. the clinical characteristics associated with community-acquired MRSA, and the molecular epidemiology of community-acquired MRSA among persons with community-onset S. aureus skin and soft-tissue infection. Design: Active, prospective laboratory surveillance to identify S. aureus recovered from skin and soft-tissue sources. Setting: 1000-bed urban hospital and its affiliated outpatient clinics in Atlanta, Georgia. Patients: 384 persons with microbiologically confirmed community-onset S. aureus skin and soft-tissue infection. Measurements: Proportion of infections caused by and clinical factors associated with community-acquired MRSA among persons with community-onset S. aureus skin and soft-tissue infection. Pulsed-field gel electrophoresis and antimicrobial susceptibility patterns were used to epidemiologically classify community-onset S. aureus infections. Comm unity-acquired MRSA was defined by MRSA isolates that either demonstrated a USA 300 or USA 400 pulsed-field type or had a susceptibility pattern showing resistance only to beta-lactams and erythromycin (for isolates not available for pulsed-field gel electrophoresis). Results: Community-onset skin and soft-tissue infection due to S. aureus was identified in 389 episodes, with MRSA accounting for 72% (279 of 389 episodes). Among all S. aureus isolates, 63% (244 of 389 isolates) were community-acquired MRSA. Among MRSA isolates, 87% (244 of 279 isolates) were community-acquired MRSA. When analysis was restricted only to MRSA isolates that were available for pulsed-field gel electrophoresis, 91% (159 of 175 isolates) had a pulsed-field type consistent with community-acquired MRSA; of these, 99% (157 of 159 isolates) were the MRSA USA 300 clone. Factors independently associated with community-acquired MRSA infection were black race (prevalence ratio, 1.53 [95% Cl, 1.16 to 2.02]), female sex (prevalence ratio, 1.16 [CI, 1.02 to 1.32]), and hospitalization within the previous 12 months (prevalence ratio, 0.80 [CI, 0.66 to 0.97]). Inadequate initial antibiotic therapy was statistically significantly more common among those with community-acquired MRSA (65%) than among those with methicillin-susceptible S. aureus skin and soft-tissue infection (1%). Limitations: Some MRSA isolates were not available for molecular typing. Conclusions: The community-acquired MRSA USA 300 clone was the predominant cause of community-onset S. aureus skin and soft-tissue infection. Empirical use of agents active against community-acquired MRSA is warranted for patients presenting with serious skin and soft-tissue infections.	Emory Univ, Sch Med, Atlanta, GA 30322 USA; Grady Mem Hosp, Atlanta, GA USA	Emory University	Blumberg, HM (corresponding author), Emory Univ, Sch Med, Atlanta, GA 30322 USA.	henry.m.blumberg@emory.edu	Blumberg, Henry/W-2156-2019	Blumberg, Henry/0000-0002-3110-2443; Ray, Susan/0000-0002-6327-088X	NCRR NIH HHS [K12 RR 017643] Funding Source: Medline; NIAID NIH HHS [K23 AI054371] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR017643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI054371] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baggett HC, 2004, J INFECT DIS, V189, P1565, DOI 10.1086/383247; BANNERMAN TL, 1995, J CLIN MICROBIOL, V33, P551, DOI 10.1128/JCM.33.3.551-555.1995; Begier EM, 2004, CLIN INFECT DIS, V39, P1446, DOI 10.1086/425313; *CDCP, 2006, CAMP PREV ANT RES PR; Charlebois ED, 2004, CLIN INFECT DIS, V39, P47, DOI 10.1086/421090; Diep BA, 2004, J CLIN MICROBIOL, V42, P2080, DOI 10.1128/JCM.42.5.2080-2084.2004; Dietrich DW, 2004, PEDIATRICS, V113, pE347, DOI 10.1542/peds.113.4.e347; Frank AL, 2002, PEDIATR INFECT DIS J, V21, P530, DOI 10.1097/00006454-200206000-00010; Gindler J. S., 1995, Morbidity and Mortality Weekly Report, V44, P1; Harrison LH, 2000, ARCH INTERN MED, V160, P89, DOI 10.1001/archinte.160.1.89; Healy CM, 2004, CLIN INFECT DIS, V39, P1460, DOI 10.1086/425321; Kourbatova EV, 2005, AM J INFECT CONTROL, V33, P385, DOI 10.1016/j.ajic.2005.06.006; Lee MC, 2004, PEDIATR INFECT DIS J, V23, P123, DOI 10.1097/01.inf.0000109288.06912.21; Lewis JS, 2005, CLIN INFECT DIS, V40, P280, DOI 10.1086/426894; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Marcinak JF, 2003, CURR OPIN INFECT DIS, V16, P265, DOI 10.1097/00001432-200306000-00014; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; National Committee for Clinical Laboratory Standards, 2000, METH DIL ANT SUSC TE, V20; National Committee for Clinical Laboratory Standards, 2004, M100S14 NAT COMM CLI; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Pastor P, 1998, CLIN INFECT DIS, V26, P590, DOI 10.1086/514589; ROSS JI, 1990, MOL MICROBIOL, V4, P1207, DOI 10.1111/j.1365-2958.1990.tb00696.x; Saiman L, 2003, CLIN INFECT DIS, V37, P1313, DOI 10.1086/379022; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Young DM, 2004, ARCH SURG-CHICAGO, V139, P947, DOI 10.1001/archsurg.139.9.947; Young DM, 2004, ARCH SURG-CHICAGO, V139, P51; 2003, MMWR MORB MORTAL WKL, V52, P793; 2003, MMWR MORB MORTAL WKL, V52, P992; 2003, MMWR MORB MORTAL WKL, V52, P88	31	591	609	0	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2006	144	5					309	317		10.7326/0003-4819-144-5-200603070-00005	http://dx.doi.org/10.7326/0003-4819-144-5-200603070-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021EA	16520471	Green Published			2022-12-24	WOS:000235965300001
J	Azevedo, RBR; Lohaus, R; Srinivasan, S; Dang, KK; Burch, CL				Azevedo, RBR; Lohaus, R; Srinivasan, S; Dang, KK; Burch, CL			Sexual reproduction selects for robustness and negative epistasis in artificial gene networks	NATURE			English	Article							DELETERIOUS MUTATIONS; SYNERGISTIC EPISTASIS; EVOLUTION; CANALIZATION; DROSOPHILA; FITNESS; PERSPECTIVE; LOAD	The mutational deterministic hypothesis for the origin and maintenance of sexual reproduction posits that sex enhances the ability of natural selection to purge deleterious mutations after recombination brings them together into single genomes(1). This explanation requires negative epistasis, a type of genetic interaction where mutations are more harmful in combination than expected from their separate effects. The conceptual appeal of the mutational deterministic hypothesis has been offset by our inability to identify the mechanistic and evolutionary bases of negative epistasis. Here we show that negative epistasis can evolve as a consequence of sexual reproduction itself. Using an artificial gene network model(2,3), we find that recombination between gene networks imposes selection for genetic robustness, and that negative epistasis evolves as a by-product of this selection. Our results suggest that sexual reproduction selects for conditions that favour its own maintenance, a case of evolution forging its own path.	Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of Houston System; University of Houston; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Azevedo, RBR (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	razevedo@uh.edu	Azevedo, Ricardo/AAV-3963-2021	Dang, Kristen/0000-0002-7512-4476; Burch, Christina/0000-0001-7830-0124; Azevedo, Ricardo/0000-0001-5402-7071				Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Burch CL, 2004, GENETICS, V167, P559, DOI 10.1534/genetics.103.021196; Charlesworth B, 1996, GENET RES, V67, P27, DOI 10.1017/S0016672300033450; CRAWLEY MJ, 2002, STAT COMPUTING; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; deVisser JAGM, 1997, GENETICS, V145, P815; deVisser JAGM, 1997, EVOLUTION, V51, P1499, DOI 10.1111/j.1558-5646.1997.tb01473.x; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Kawecki TJ, 2000, EVOLUTION, V54, P1, DOI 10.1111/j.0014-3820.2000.tb00001.x; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; Maynard Smith J., 1978, EVOLUTION SEX; Michalakis Y, 2004, SCIENCE, V306, P1492, DOI 10.1126/science.1106677; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MUKAI T, 1969, GENETICS, V61, P749; Nijhout HF, 2002, BIOESSAYS, V24, P553, DOI 10.1002/bies.10093; Rice SH, 1998, EVOLUTION, V52, P647, DOI 10.1111/j.1558-5646.1998.tb03690.x; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Stearns S. C., 1994, ACTA PALAEONTOL POL, V38, P215; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Wagner A, 1996, EVOLUTION, V50, P1008, DOI 10.1111/j.1558-5646.1996.tb02342.x; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]; Wagner GP, 1998, GENETICA, V102-3, P569, DOI 10.1023/A:1017088321094; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; Whitlock MC, 2000, EVOLUTION, V54, P1654, DOI 10.1111/j.0014-3820.2000.tb00709.x; Wilke CO, 2001, P ROY SOC B-BIOL SCI, V268, P1469, DOI 10.1098/rspb.2001.1690; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; You LC, 2002, GENETICS, V160, P1273	30	170	173	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2006	440	7080					87	90		10.1038/nature04488	http://dx.doi.org/10.1038/nature04488			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HW	16511495				2022-12-24	WOS:000235685700045
J	Li, WKW; Harrison, WG; Head, EJH				Li, WKW; Harrison, WG; Head, EJH			Coherent sign switching in multiyear trends of microbial plankton	SCIENCE			English	Article							CLIMATE-CHANGE; RECORDER DATA; PHYTOPLANKTON; CHLOROPHYLL; ABUNDANCE; BIOMASS; ECOLOGY; IMPACT	Since the 1990s, phytoplankton biomass on the continental shelf of Nova Scotia and in the Labrador Sea has undergone sustained changes in the spring and fait, which are accompanied by changes in bacterioplankton that are dampened in amplitude but coherent in the direction of change. A reversal of trend in biomass change, so-called sign switching, occurs both in time and in space. Thus, whenever (spring or fall) and wherever (Scotian Shelf or Labrador Sea) phytoplankton increase or decrease, so also does bacterioplankton. This tandem sign switch indicates coupling of the trophic levels at a multiyear time scale and contributes to an ecological fingerprint of systemwide forcing.	Bedford Inst Oceanog, Dartmouth, NS B2Y 4A2, Canada	Bedford Institute of Oceanography	Li, WKW (corresponding author), Bedford Inst Oceanog, POB 1006, Dartmouth, NS B2Y 4A2, Canada.	LiB@mar.dfo-mpo.gc.ca						Batten SD, 2003, J PLANKTON RES, V25, P697, DOI 10.1093/plankt/25.7.697; Chiba S, 2004, J OCEANOGR, V60, P149, DOI 10.1023/B:JOCE.0000038324.14054.cf; Cullen John J., 2002, P297; Ducklow HW, 2003, GLO CH IGBP, P3; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; FOURNIER RO, 1977, J FISH RES BOARD CAN, V34, P1004, DOI 10.1139/f77-153; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Gasol JM, 2000, FEMS MICROBIOL ECOL, V31, P99, DOI 10.1111/j.1574-6941.2000.tb00675.x; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Greenan BJW, 2004, CONT SHELF RES, V24, P603, DOI 10.1016/j.csr.2003.11.006; Gregg WW, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021808; HAYS GC, 1994, J PLANKTON RES, V16, P23, DOI 10.1093/plankt/16.1.23; Lazier J, 2002, DEEP-SEA RES PT I, V49, P1819, DOI 10.1016/S0967-0637(02)00064-X; Li WKW, 2004, DEEP-SEA RES PT I, V51, P1529, DOI 10.1016/j.dsr.2004.06.012; Li WKW, 2002, NATURE, V419, P154, DOI 10.1038/nature00994; Malmstrom RR, 2005, APPL ENVIRON MICROB, V71, P2979, DOI 10.1128/AEM.71.6.2979-2986.2005; McClain CR, 2004, DEEP-SEA RES PT II, V51, P281, DOI 10.1016/j.dsr2.2003.08.002; Nagata T., 2000, MICROBIAL ECOLOGY OC, P121; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Sameoto D, 2001, CAN J FISH AQUAT SCI, V58, P749, DOI 10.1139/cjfas-58-4-749; THERRIAULT JC, 1998, CAN TECH REP HYDROGR, V194, P1; Yokokawa T, 2004, LIMNOL OCEANOGR, V49, P1620, DOI 10.4319/lo.2004.49.5.1620	24	16	19	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2006	311	5764					1157	1160		10.1126/science.1122748	http://dx.doi.org/10.1126/science.1122748			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017IU	16497934				2022-12-24	WOS:000235688100050
J	Smith, EC; Lewicki, MS				Smith, EC; Lewicki, MS			Efficient auditory coding	NATURE			English	Article								The auditory neural code must serve a wide range of auditory tasks that require great sensitivity in time and frequency and be effective over the diverse array of sounds present in natural acoustic environments. It has been suggested(1-5) that sensory systems might have evolved highly efficient coding strategies to maximize the information conveyed to the brain while minimizing the required energy and neural resources. Here we show that, for natural sounds, the complete acoustic waveform can be represented efficiently with a nonlinear model based on a population spike code. In this model, idealized spikes encode the precise temporal positions and magnitudes of underlying acoustic features. We find that when the features are optimized for coding either natural sounds or speech, they show striking similarities to time-domain cochlear filter estimates, have a frequency-bandwidth dependence similar to that of auditory nerve fibres, and yield significantly greater coding efficiency than conventional signal representations. These results indicate that the auditory code might approach an information theoretic optimum and that the acoustic structure of speech might be adapted to the coding capacity of the mammalian auditory system.	Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Carnegie Mellon University	Lewicki, MS (corresponding author), Carnegie Mellon Univ, Ctr Neural Basis Cognit, 4400 5th Ave, Pittsburgh, PA 15213 USA.	lewicki@cnbc.cmu.edu						Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; Barlow HB, 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Carney LH, 1999, J ACOUST SOC AM, V105, P2384, DOI 10.1121/1.426843; CARNEY LH, 1990, J NEUROPHYSIOL, V64, P437, DOI 10.1152/jn.1990.64.2.437; Davis G, 1997, CONSTR APPROX, V13, P57, DOI 10.1007/BF02678430; DEBOER E, 1978, J ACOUST SOC AM, V63, P115, DOI 10.1121/1.381704; Emmons LH, 1997, SOUNDS NEOTROPICAL R; Irino T, 1997, J ACOUST SOC AM, V101, P412, DOI 10.1121/1.417975; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lewicki MS, 1999, ADV NEUR IN, V11, P730; Lewicki MS, 2002, NEURAL INF PROCESS S, P243; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; Olshausen BA, 2002, NEU INF PRO, P257; SHAMMA SA, 1985, J ACOUST SOC AM, V78, P1612, DOI 10.1121/1.392799; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Smith E, 2005, NEURAL COMPUT, V17, P19, DOI 10.1162/0899766052530839; Temchin AN, 2005, J NEUROPHYSIOL, V93, P3635, DOI 10.1152/jn.00885.2004; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; YANG XW, 1992, IEEE T INFORM THEORY, V38, P824, DOI 10.1109/18.119739	20	361	380	6	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2006	439	7079					978	982		10.1038/nature04485	http://dx.doi.org/10.1038/nature04485			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014NE	16495999				2022-12-24	WOS:000235486100048
J	Aitman, TJ; Dong, R; Vyse, TJ; Norsworthy, PJ; Johnson, MD; Smith, J; Mangion, J; Roberton-Lowe, C; Marshall, AJ; Petretto, E; Hodges, MD; Bhangal, G; Patel, SG; Sheehan-Rooney, K; Duda, M; Cook, PR; Evans, DJ; Domin, J; Flint, J; Boyle, JJ; Pusey, CD; Cook, HT				Aitman, TJ; Dong, R; Vyse, TJ; Norsworthy, PJ; Johnson, MD; Smith, J; Mangion, J; Roberton-Lowe, C; Marshall, AJ; Petretto, E; Hodges, MD; Bhangal, G; Patel, SG; Sheehan-Rooney, K; Duda, M; Cook, PR; Evans, DJ; Domin, J; Flint, J; Boyle, JJ; Pusey, CD; Cook, HT			Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans	NATURE			English	Article							INSULIN-RESISTANCE; FC-RECEPTORS; GENE; EXPRESSION; MACROPHAGES; MECHANISM; NEPHRITIS; CELLS; ACID	Identification of the genes underlying complex phenotypes and the definition of the evolutionary forces that have shaped eukaryotic genomes are among the current challenges in molecular genetics(1-3). Variation in gene copy number is increasingly recognized as a source of inter-individual differences in genome sequence and has been proposed as a driving force for genome evolution and phenotypic variation(3-5). Here we show that copy number variation of the orthologous rat and human Fcgr3 genes is a determinant of susceptibility to immunologically mediated glomerulonephritis. Positional cloning identified loss of the newly described, rat-specific Fcgr3 paralogue, Fcgr3-related sequence (Fcgr3-rs), as a determinant of macrophage overactivity and glomerulonephritis in Wistar Kyoto rats. In humans, low copy number of FCGR3B, an orthologue of rat Fcgr3, was associated with glomerulonephritis in the autoimmune disease systemic lupus erythematosus. The finding that gene copy number polymorphism predisposes to immunologically mediated renal disease in two mammalian species provides direct evidence for the importance of genome plasticity in the evolution of genetically complex phenotypes, including susceptibility to common human disease.	Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Physiol Genom & Med Grp, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Rheumatol Sect, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Sect Renal Med, London W12 0NN, England; Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, London W12 0NN, England	Imperial College London; Imperial College London; Imperial College London; University of Oxford; Wellcome Centre for Human Genetics; Imperial College London	Aitman, TJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Physiol Genom & Med Grp, London W12 0NN, England.	t.aitman@csc.mrc.ac.uk; t.h.cook@imperial.ac.uk	Hodges, Matthew/GZB-0433-2022	Aitman, Timothy/0000-0002-7875-4502; Norsworthy, Penny/0000-0002-5572-8491; Hodges, Matthew David John/0000-0002-6815-751X	Medical Research Council [G0400116, MC_U120097112, MC_U120061454] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0400116, MC_U120061454] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; BHAN AK, 1978, J EXP MED, V148, P246, DOI 10.1084/jem.148.1.246; Boyle JJ, 2004, CLIN EXP IMMUNOL, V137, P529, DOI 10.1111/j.1365-2249.2004.02565.x; CLARK MR, 1990, J CLIN INVEST, V86, P341, DOI 10.1172/JCI114706; Cook HT, 1999, KIDNEY INT, V55, P1319, DOI 10.1046/j.1523-1755.1999.00354.x; Coxon A, 2001, IMMUNITY, V14, P693, DOI 10.1016/S1074-7613(01)00150-9; Edberg JC, 2002, ARTHRITIS RHEUM, V46, P2132, DOI 10.1002/art.10438; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; FARBER DL, 1993, J IMMUNOL, V150, P4364; Ferrario F, 1997, OX CLIN NEP SER, P59; Gittinger FS, 2002, TISSUE ANTIGENS, V60, P64, DOI 10.1034/j.1399-0039.2002.600108.x; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Isome M, 2004, NEPHROL DIAL TRANSPL, V19, P2997, DOI 10.1093/ndt/gfh558; Karassa FB, 2002, ARTHRITIS RHEUM-US, V46, P1563, DOI 10.1002/art.10306; KAWASAKI K, 1992, KIDNEY INT, V41, P1517, DOI 10.1038/ki.1992.221; Kim MK, 2003, BLOOD, V101, P4479, DOI 10.1182/blood.V101.11.4479; Koene HR, 1998, BLOOD, V91, P673, DOI 10.1182/blood.V91.2.673.673_673_679; KUROSAKI T, 1989, NATURE, V342, P805, DOI 10.1038/342805a0; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Pravenec M, 2001, NAT GENET, V27, P156, DOI 10.1038/84777; RAVETCH JV, 1994, CELL, V78, P553, DOI 10.1016/0092-8674(94)90521-5; ROBERTON CA, 2003, THESIS U LONDON; Russell AI, 2004, HUM MOL GENET, V13, P137, DOI 10.1093/hmg/ddh021; SADO Y, 1986, J CLIN LAB IMMUNOL, V19, P193; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; YAMORI Y, 1984, HDB HYPERTENSION, V4, P224	30	541	628	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2006	439	7078					851	855		10.1038/nature04489	http://dx.doi.org/10.1038/nature04489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012JA	16482158				2022-12-24	WOS:000235333600051
J	Shogren-Knaak, M; Ishii, H; Sun, JM; Pazin, MJ; Davie, JR; Peterson, CL				Shogren-Knaak, M; Ishii, H; Sun, JM; Pazin, MJ; Davie, JR; Peterson, CL			Histone H4-K16 acetylation controls chromatin structure and protein interactions	SCIENCE			English	Article							AMINO-TERMINAL TAIL; DOSAGE COMPENSATION; TRANSCRIPTION; YEAST; ARRAYS; MOF	Acetylation of histone H4 on lysine 16 (H4-K16Ac) is a prevalent and reversible posttranslational chromatin modification in eukaryotes. To characterize the structural and functional role of this mark, we used a native chemical ligation strategy to generate histone H4 that was homogeneously acetylated at K16. The incorporation of this modified histone into nucleosomal arrays inhibits the formation of compact 30-nanometer-like fibers and impedes the ability of chromatin to form cross-fiber interactions. H4-K16Ac also inhibits the ability of the adenosine triphosphate-utilizing chromatin assembly and remodeling enzyme ACF to mobilize a mononucleosome, indicating that this single histone modification modulates both higher order chromatin structure and functional interactions between a nonhistone protein and the chromatin fiber.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada; NIA, Cellular & Mol Biol Lab, NIH, Baltimore, MD 21224 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Manitoba; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Peterson, CL (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	craig.peterson@umassmed.edu		Pazin, Michael/0000-0002-7561-3640; Ishii, Haruhiko/0000-0002-1593-096X; Davie, James/0000-0002-0420-6888	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000524] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [R01 GM054096, GM54096] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Corona DFV, 2002, EMBO REP, V3, P242, DOI 10.1093/embo-reports/kvf056; DAVIE JR, 1978, P NATL ACAD SCI USA, V75, P3574, DOI 10.1073/pnas.75.8.3574; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Eberharter A, 2004, METHOD ENZYMOL, V377, P344; Fry CJ, 2004, COLD SPRING HARB SYM, V69, P219, DOI 10.1101/sqb.2004.69.219; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; Hansen J., COMMUNICATION; HANSEN JC, 1992, BIOCHEMISTRY-US, V31, P7977, DOI 10.1021/bi00149a032; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; LOHR D, 1977, BIOCHEMISTRY-US, V16, P463, DOI 10.1021/bi00622a020; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Offermann CA, 1936, J GENET, V32, P103, DOI 10.1007/BF02982505; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; Shogren-Knaak MA, 2004, METHOD ENZYMOL, V375, P62; Smith CM, 2003, ANAL BIOCHEM, V316, P23, DOI 10.1016/S0003-2697(03)00032-0; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602	25	1347	1391	7	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2006	311	5762					844	847		10.1126/science.1124000	http://dx.doi.org/10.1126/science.1124000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012XT	16469925				2022-12-24	WOS:000235374900047
J	Ironside, JW; Bishop, MT; Connolly, K; Hegazy, D; Lowrie, S; Le Grice, M; Ritchie, DL; McCardle, LM; Hilton, DA				Ironside, JW; Bishop, MT; Connolly, K; Hegazy, D; Lowrie, S; Le Grice, M; Ritchie, DL; McCardle, LM; Hilton, DA			Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study	BRITISH MEDICAL JOURNAL			English	Article							ACCUMULATION; VCJD; KURU	Objective To perform prion protein gene (PRNP) codon 129 analysis in DNA extracted from appendix tissue samples that had tested positive for disease associated prion protein. Design Reanalysis of positive cases identified in a retrospective anonymised unlinked prevalence study of variant Creutzfeldt-Jakob disease (vCJD) in the United Kingdom. Study samples Three positive appendix tissue samples out of 12 674 samples of appendix and tonsil tested for disease associated prion protein. The patients from whom these samples were obtained were aged 20-29 years at the time of surgery, which took place in 1996-9. Setting Pathology departments in two tertiary centres in England and Scotland. Results Adequate DNA was available for analysis in two of the three specimens, both of which were homozygous for valine at codon 129 in the PRNP. Conclusions This is the first indication that the valine homozygous subgroup at codon 129 in the PRNP is susceptible to vCJD infection. All tested clinical cases of vCJD have so far occurred in the methionine homozygous subgroup, and a single case of probable iatrogenic vCJD infection has been identified in one patient who was a methionine/valine heterozygote at this genetic locus. People infected with vCJD with a valine homozygous codon 129 PRNP genotype may have a prolonged incubation period, during which horizontal spread of the infection could occur either from blood donations or from contaminated surgical instruments used on these individuals during the asymptomatic phase of the illness.	Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Natl Creutzfeldt Jakob Dis, Edinburgh EH4 2XU, Midlothian, Scotland; Derriford Hosp, Dept Histopathol, Plymouth PL6 8DSH, Devon, England	University of Edinburgh; Derriford Hospital	Ironside, JW (corresponding author), Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Natl Creutzfeldt Jakob Dis, Edinburgh EH4 2XU, Midlothian, Scotland.			Ironside, James/0000-0001-5869-2108	Medical Research Council [G0600953, G0900580] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bird SM, 2004, LANCET, V364, P1362, DOI 10.1016/S0140-6736(04)17194-8; Ersdal C, 2005, VET PATHOL, V42, P258, DOI 10.1354/vp.42-3-258; Goldfarb LG, 2004, CURR MOL MED, V4, P375, DOI 10.2174/1566524043360627; HAINFELLNER JA, 1997, BRAIN PATHOL, V7, P574; Hilton DA, 2002, BRIT MED J, V325, P633, DOI 10.1136/bmj.325.7365.633; Hilton DA, 2004, J CLIN PATHOL, V57, P300, DOI 10.1136/jcp.2003.012278; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; McLean CA, 1998, BRAIN PATHOL, V8, P429; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6	9	108	109	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 20	2006	332	7551					1186	1188		10.1136/bmj.38804.511644.55	http://dx.doi.org/10.1136/bmj.38804.511644.55			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048GJ	16606639	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000237935300017
J	Levitan, DR; Ferrell, DL				Levitan, DR; Ferrell, DL			Selection on gamete recognition proteins depends on sex, density, and genotype frequency	SCIENCE			English	Article							STRONGYLOCENTROTUS-FRANCISCANUS; SPERM LIMITATION; URCHINS; EVOLUTION; CONFLICT; FERTILIZATION; BINDIN; SPECIATION; TRAITS; SEQUENCE	Gamete recognition proteins can evolve at astonishing rates and lie at the heart of reproductive isolation and speciation in diverse taxa. However, the source of selection driving this evolution remains unknown. We report on how the sperm bindin genotype influences reproductive success under natural conditions. An interaction between genotype frequency and spawning density determines how sperm bindin genotype influences reproductive success. Common genotypes are selected under sperm-limited conditions, whereas rare genotypes are selected under conditions of intense sperm competition and sexual conflict. Variation in the evolutionary rates of bindin may reflect historic differences in sperm availability.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Levitan, DR (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	levitan@bio.fsu.edu; ferrell@bio.fsu.edu						Biermann CH, 1998, MOL BIOL EVOL, V15, P1761, DOI 10.1093/oxfordjournals.molbev.a025902; Debenham P, 2000, J MOL EVOL, V51, P481, DOI 10.1007/s002390010111; Doebeli M, 2005, J EVOLUTION BIOL, V18, P1587, DOI 10.1111/j.1420-9101.2005.00897.x; Ebert TA, 2003, FISH B-NOAA, V101, P915; GAO B, 1986, P NATL ACAD SCI USA, V83, P8634, DOI 10.1073/pnas.83.22.8634; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Gavrilets S, 2002, P NATL ACAD SCI USA, V99, P10533, DOI 10.1073/pnas.152011499; Haygood R, 2004, EVOLUTION, V58, P1414; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Kamei N, 2003, GENE DEV, V17, P2502, DOI 10.1101/gad.1133003; Levitan D, 1998, EVOLUTION, V52, P1043, DOI 10.2307/2411235; Levitan DR, 2002, ECOLOGY, V83, P464, DOI 10.2307/2680028; Levitan DR, 2004, AM NAT, V164, P298, DOI 10.1086/423150; LEVITAN DR, 1993, AM NAT, V141, P517, DOI 10.1086/285489; Mah SA, 2005, MOL BIOL EVOL, V22, P533, DOI 10.1093/molbev/msi037; McCartney MA, 2004, MOL BIOL EVOL, V21, P732, DOI 10.1093/molbev/msh071; Palumbi SR, 1999, P NATL ACAD SCI USA, V96, P12632, DOI 10.1073/pnas.96.22.12632; Payne RJH, 1997, EVOLUTION, V51, P1, DOI 10.1111/j.1558-5646.1997.tb02382.x; PENNINGTON JT, 1985, BIOL BULL-US, V169, P417, DOI 10.2307/1541492; ROWE L, 1994, TRENDS ECOL EVOL, V9, P289, DOI 10.1016/0169-5347(94)90032-9; Swanson WJ, 2002, ANNU REV ECOL SYST, V33, P161, DOI 10.1146/annurev.ecolsys.33.010802.150439	21	136	139	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					267	269		10.1126/science.1122183	http://dx.doi.org/10.1126/science.1122183			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614223				2022-12-24	WOS:000236765300049
J	Gostin, L				Gostin, L			Public health strategies for pandemic influenza - ethics and the law	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law & Publ Hlth, Washington, DC USA; Johns Hopkins Univ, Baltimore, MD USA	Georgetown University; Johns Hopkins University	Gostin, L (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						*APPL BOD, 2001, WTDS135ABR APPL BOD; Barbera J, 2001, JAMA-J AM MED ASSOC, V286, P2711, DOI 10.1001/jama.286.21.2711; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bell D, 2006, EMERG INFECT DIS, V12, P81; Bell D, 2006, EMERG INFECT DIS, V12, P88; Bell DM, 2004, EMERG INFECT DIS, V10, P1900, DOI 10.3201/eid1011.040729; Blendon RJ, 2006, HEALTH AFFAIR, V25, pW15, DOI 10.1377/hlthaff.25.w15; Centers for Disease Control and Prevention, PUBL HLTH GUID COMM; *DEP HLTH HUM SERV, FISC YEAR 2005 BUDG; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FIDLER DP, IN PRESS J LAW MED E; Gostin LO, 2006, JAMA-J AM MED ASSOC, V295, P554, DOI 10.1001/jama.295.5.554; Gostin LO, 2003, JAMA-J AM MED ASSOC, V290, P3229, DOI 10.1001/jama.290.24.3229; Gostin LO, 2001, AM J PUBLIC HEALTH, V91, P1388, DOI 10.2105/AJPH.91.9.1388; Gostin LO, 2002, JAMA-J AM MED ASSOC, V288, P622, DOI 10.1001/jama.288.5.622; *I MED, 2005, QUAR STAT PORTS ENTR; John RKS, 2005, EMERG INFECT DIS, V11, P6, DOI 10.3201/eid1101.040835; Kimura A. C., 2005, Morbidity and Mortality Weekly Report, V54, P196; Poland GA, 2005, VACCINE, V23, P2251, DOI 10.1016/j.vaccine.2005.01.043; *PUBL HLTH ASS, 1918, JAMA-J AM MED ASSOC, V71, P2068; *USDA, 2005, QUEST ANSW AV INFL; *WHO, 2003, HOSP INF CONTR GUID; *WHO, H5N1 AV INFL TIM; WHO World Health Organization, 2004, WHO SARS RISK ASS PR; *WORLD BANK, 2005, AV HUM INFL FIN NEED; 2005, FED REG         1130, V70, P71892	26	75	77	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2006	295	14					1700	1704		10.1001/jama.295.14.1700	http://dx.doi.org/10.1001/jama.295.14.1700			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031LY	16609092				2022-12-24	WOS:000236707300027
J	Gresham, D; Ruderfer, DM; Pratt, SC; Schacherer, J; Dunham, MJ; Botstein, D; Kruglyak, L				Gresham, D; Ruderfer, DM; Pratt, SC; Schacherer, J; Dunham, MJ; Botstein, D; Kruglyak, L			Genome-wide detection of polymorphisms at nucleotide resolution with a single DNA microarray	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; OLIGONUCLEOTIDE ARRAYS; HIGH-THROUGHPUT; YEAST; EVOLUTION; EXPRESSION; MUTATIONS; RATES	A central challenge of genomics is to detect, simply and inexpensively, all differences in sequence among the genomes of individual members of a species. We devised a system to detect all single-nucleotide differences between genomes with the use of data from a single hybridization to a whole-genome DNA microarray. This allowed us to detect a variety of spontaneous single-base pair substitutions, insertions, and deletions, and most ( >90%) of the similar to 30,000 known single-nucleotide polymorphisms between two Saccharomyces cerevisiae strains. We applied this approach to elucidate the genetic basis of phenotypic variants and to identify the small number of single-base pair changes accumulated during experimental evolution of yeast.	Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Kruglyak, L (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	dgresham@genomics.princeton.edu; leonid@genomics.princeton.edu	Ruderfer, Douglas M/M-5795-2016; Pratt, Stephen/C-5418-2011	Ruderfer, Douglas M/0000-0002-2365-386X; Dunham, Maitreya/0000-0001-9944-2666	NIGMS NIH HHS [R01 GM046406, P50 GM071508, R01 GM107466] Funding Source: Medline; NIMH NIH HHS [R37 MH059520] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508, R01GM046406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059520] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; Daran-Lapujade P, 2003, FEMS YEAST RES, V4, P259, DOI 10.1016/S1567-1356(03)00156-9; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Ellis TP, 2004, J BIOL CHEM, V279, P15728, DOI 10.1074/jbc.M314162200; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Gu ZL, 2005, P NATL ACAD SCI USA, V102, P1092, DOI 10.1073/pnas.0409159102; Hacia JG, 1996, NAT GENET, V14, P441, DOI 10.1038/ng1296-441; Hazen SP, 2005, PLANT PHYSIOL, V138, P990, DOI 10.1104/pp.105.061408; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MASKOS U, 1992, NUCLEIC ACIDS RES, V20, P1675, DOI 10.1093/nar/20.7.1675; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Racki WJ, 2000, EMBO J, V19, P4524, DOI 10.1093/emboj/19.17.4524; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Ronald J, 2005, GENOME RES, V15, P284, DOI 10.1101/gr.2850605; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Volkman SK, 2002, SCIENCE, V298, P216, DOI 10.1126/science.1075642; Winzeler EA, 2003, GENETICS, V163, P79; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Wong CW, 2004, GENOME RES, V14, P398, DOI 10.1101/gr.2141004; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	29	216	223	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2006	311	5769					1932	1936		10.1126/science.1123726	http://dx.doi.org/10.1126/science.1123726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16527929				2022-12-24	WOS:000236387800047
J	Krogan, NJ; Cagney, G; Yu, HY; Zhong, GQ; Guo, XH; Ignatchenko, A; Li, J; Pu, SY; Datta, N; Tikuisis, AP; Punna, T; Peregrin-Alvarez, JM; Shales, M; Zhang, X; Davey, M; Robinson, MD; Paccanaro, A; Bray, JE; Sheung, A; Beattie, B; Richards, DP; Canadien, V; Lalev, A; Mena, F; Wong, P; Starostine, A; Canete, MM; Vlasblom, J; Wu, S; Orsi, C; Collins, SR; Chandran, S; Haw, R; Rilstone, JJ; Gandi, K; Thompson, NJ; Musso, G; St Onge, P; Ghanny, S; Lam, MHY; Butland, G; Altaf-Ui, AM; Kanaya, S; Shilatifard, A; O'Shea, E; Weissman, JS; Ingles, CJ; Hughes, TR; Parkinson, J; Gerstein, M; Wodak, SJ; Emili, A; Greenblatt, JF				Krogan, NJ; Cagney, G; Yu, HY; Zhong, GQ; Guo, XH; Ignatchenko, A; Li, J; Pu, SY; Datta, N; Tikuisis, AP; Punna, T; Peregrin-Alvarez, JM; Shales, M; Zhang, X; Davey, M; Robinson, MD; Paccanaro, A; Bray, JE; Sheung, A; Beattie, B; Richards, DP; Canadien, V; Lalev, A; Mena, F; Wong, P; Starostine, A; Canete, MM; Vlasblom, J; Wu, S; Orsi, C; Collins, SR; Chandran, S; Haw, R; Rilstone, JJ; Gandi, K; Thompson, NJ; Musso, G; St Onge, P; Ghanny, S; Lam, MHY; Butland, G; Altaf-Ui, AM; Kanaya, S; Shilatifard, A; O'Shea, E; Weissman, JS; Ingles, CJ; Hughes, TR; Parkinson, J; Gerstein, M; Wodak, SJ; Emili, A; Greenblatt, JF			Global landscape of protein complexes in the yeast Saccharomyces cerevisiae	NATURE			English	Article							INTERACTION NETWORK; MASS-SPECTROMETRY; RNA-POLYMERASES; GENOME; SCALE; METHYLATION; EXPRESSION; GENES; IDENTIFICATION; LOCALIZATION	Identification of protein - protein interactions often provides insight into protein function, and many cellular processes are performed by stable protein complexes. We used tandem affinity purification to process 4,562 different tagged proteins of the yeast Saccharomyces cerevisiae. Each preparation was analysed by both matrix-assisted laser desorption/ ionization - time of flight mass spectrometry and liquid chromatography tandem mass spectrometry to increase coverage and accuracy. Machine learning was used to integrate the mass spectrometry scores and assign probabilities to the protein - protein interactions. Among 4,087 different proteins identified with high confidence by mass spectrometry from 2,357 successful purifications, our core data set ( median precision of 0.69) comprises 7,123 protein - protein interactions involving 2,708 proteins. A Markov clustering algorithm organized these interactions into 547 protein complexes averaging 4.9 subunits per complex, about half of them absent from the MIPS database, as well as 429 additional interactions between pairs of complexes. The data ( all of which are available online) will help future studies on individual proteins as well as functional genomics and systems biology.	Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Natl Univ Ireland Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Hosp Sick Children, Toronto, ON M4K 1X8, Canada; Affinium Pharmaceut, Toronto, ON M5J 1V6, Canada; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Nara Inst Sci & Technol, Comparat Genom Lab, Nara 6300101, Japan; St Louis Univ, Sch Med, Dept Biochem, St Louis, MO 63104 USA; Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	University of Toronto; University of Toronto; University College Dublin; Yale University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Howard Hughes Medical Institute; University of California System; University of California San Francisco; Nara Institute of Science & Technology; Saint Louis University; Harvard University; Howard Hughes Medical Institute	Greenblatt, JF (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, 160 Coll St, Toronto, ON M5S 3E1, Canada.	Andrew.emili@utoronto.ca; jack.Greenblatt@utoronto.ca	Cagney, Gerard/A-4648-2009; Parkinson, John/A-4424-2008; Robinson, Mark D/A-6432-2015; Haw, Robin/D-1393-2009; Robinson, Mark D./O-2254-2019; Paccanaro, Alberto/AAW-5625-2020	Parkinson, John/0000-0001-9815-1189; Robinson, Mark D/0000-0002-3048-5518; Haw, Robin/0000-0002-2013-7835; Robinson, Mark D./0000-0002-3048-5518; wodak, shoshana/0000-0002-0701-6545; Weissman, Jonathan/0000-0003-2445-670X; Collins, Sean/0000-0002-4276-5840; Cagney, Gerard/0000-0001-7189-9496; Musso, Gabriel/0000-0001-8778-8248; Davey, Michael/0000-0002-1172-5934; Alvarez, Jose/0000-0002-7184-832X; Tikuisis, Aaron/0000-0001-7326-382X; Ignatchenko, Alexandr/0000-0002-6083-941X; BRAY, JAMES/0000-0003-3554-4254				ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BRIGATI C, 1993, MOL CELL BIOL, V13, P1306, DOI 10.1128/MCB.13.2.1306; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Eissenberg JC, 2002, P NATL ACAD SCI USA, V99, P9894, DOI 10.1073/pnas.152193699; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fourel G, 1999, EMBO J, V18, P2522, DOI 10.1093/emboj/18.9.2522; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2004, CURR OPIN MICROBIOL, V7, P535, DOI 10.1016/j.mib.2004.08.012; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Korber P, 2004, CELL, V117, P5, DOI 10.1016/S0092-8674(04)00296-X; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Krogan NJ, 2001, MOL CELL BIOL, V21, P8203, DOI 10.1128/MCB.21.23.8203-8212.2001; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Mitchell T.M, 2003, MACH LEARN; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Sampath V, 2005, IUBMB LIFE, V57, P93, DOI 10.1080/15216540500078905; Scholes DT, 2001, GENETICS, V159, P1449; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1; Xia Y, 2004, ANNU REV BIOCHEM, V73, P1051, DOI 10.1146/annurev.biochem.73.011303.073950; Zhu H, 2003, CURR OPIN CHEM BIOL, V7, P55, DOI 10.1016/S1367-5931(02)00005-4	48	2176	2249	4	289	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					637	643		10.1038/nature04670	http://dx.doi.org/10.1038/nature04670			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16554755				2022-12-24	WOS:000236350400036
J	Zody, MC; Garber, M; Sharpe, T; Young, SK; Rowen, L; O'Neill, K; Whittaker, CA; Kamal, M; Chang, JL; Cuomo, CA; Dewar, K; FitzGerald, MG; Kodira, CD; Madan, A; Qin, SZ; Yang, XP; Abbasi, N; Abouelleil, A; Arachchi, HM; Baradarani, L; Birditt, B; Bloom, S; Bloom, T; Borowsky, ML; Burke, J; Butler, J; Cook, A; DeArellano, K; DeCaprio, D; Dorris, L; Dors, M; Eichler, EE; Engels, R; Fahey, J; Fleetwood, P; Friedman, C; Gearin, G; Hall, JL; Hensley, G; Johnson, E; Jones, C; Kamat, A; Kaur, A; Locke, DP; Madan, A; Munson, G; Jaffe, DB; Lui, A; Macdonald, P; Mauceli, E; Naylor, JW; Nesbitt, R; Nicol, R; O'Leary, SB; Ratcliffe, A; Rounsley, S; She, XW; Sneddon, KMB; Stewart, S; Sougnez, C; Stone, SM; Topham, K; Vincent, D; Wang, SG; Zimmer, AR; Birren, BW; Hood, L; Lander, ES; Nusbaum, C				Zody, MC; Garber, M; Sharpe, T; Young, SK; Rowen, L; O'Neill, K; Whittaker, CA; Kamal, M; Chang, JL; Cuomo, CA; Dewar, K; FitzGerald, MG; Kodira, CD; Madan, A; Qin, SZ; Yang, XP; Abbasi, N; Abouelleil, A; Arachchi, HM; Baradarani, L; Birditt, B; Bloom, S; Bloom, T; Borowsky, ML; Burke, J; Butler, J; Cook, A; DeArellano, K; DeCaprio, D; Dorris, L; Dors, M; Eichler, EE; Engels, R; Fahey, J; Fleetwood, P; Friedman, C; Gearin, G; Hall, JL; Hensley, G; Johnson, E; Jones, C; Kamat, A; Kaur, A; Locke, DP; Madan, A; Munson, G; Jaffe, DB; Lui, A; Macdonald, P; Mauceli, E; Naylor, JW; Nesbitt, R; Nicol, R; O'Leary, SB; Ratcliffe, A; Rounsley, S; She, XW; Sneddon, KMB; Stewart, S; Sougnez, C; Stone, SM; Topham, K; Vincent, D; Wang, SG; Zimmer, AR; Birren, BW; Hood, L; Lander, ES; Nusbaum, C			Analysis of the DNA sequence and duplication history of human chromosome 15	NATURE			English	Article							HUMAN-GENOME; SEGMENTAL DUPLICATIONS; GENERATION; DATABASE; DISEASE; MAP	Here we present a finished sequence of human chromosome 15, together with a high-quality gene catalogue. As chromosome 15 is one of seven human chromosomes with a high rate of segmental duplication(1), we have carried out a detailed analysis of the duplication structure of the chromosome. Segmental duplications in chromosome 15 are largely clustered in two regions, on proximal and distal 15q; the proximal region is notable because recombination among the segmental duplications can result in deletions causing Prader-Willi and Angelman syndromes(2,3). Sequence analysis shows that the proximal and distal regions of 15q share extensive ancient similarity(4). Using a simple approach, we have been able to reconstruct many of the events by which the current duplication structure arose. We find that most of the intrachromosomal duplications seem to share a common ancestry. Finally, we demonstrate that some remaining gaps in the genome sequence are probably due to structural polymorphisms between haplotypes; this may explain a significant fraction of the gaps remaining in the human genome.	MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Cambridge, MA 02141 USA; Inst Syst Biol, Seattle, WA 98103 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; UCL, Galton Lab, Dept Biol, London NW1 2HE, England	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of London; University College London	Nusbaum, C (corresponding author), MIT, Broad Inst, 320 Charles St, Cambridge, MA 02141 USA.	mczody@broad.mit.edu; chad@broad.mit.edu	Cuomo, Christina/L-2222-2019	Cuomo, Christina/0000-0002-5778-960X; DeCaprio, Dave/0000-0001-8931-9461; Engels, Reinhard/0000-0003-0921-0736; Locke, Devin/0000-0002-2527-0475; Nicol, Robert/0000-0003-1932-1392; Whittaker, Charles/0000-0002-2400-0094	MRC [G0000107] Funding Source: UKRI; Medical Research Council [G0000107] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bourque G, 2005, GENOME RES, V15, P98, DOI 10.1101/gr.3002305; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Deloukas P, 2004, NATURE, V429, P375, DOI 10.1038/nature02462; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Felsenstein J, 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Hillier LW, 2005, NATURE, V434, P724, DOI 10.1038/nature03466; Kehrer-Sawatzki H, 1998, CHROMOSOME RES, V6, P429, DOI 10.1023/A:1009287223826; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; Nusbaum C, 2006, NATURE, V439, P331, DOI 10.1038/nature04406; Nusbaum C, 2005, NATURE, V437, P551, DOI 10.1038/nature03983; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Pujana MA, 2001, GENOME RES, V11, P98, DOI 10.1101/gr.155601; Schmutz J, 2004, NATURE, V429, P365, DOI 10.1038/nature02390; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Soejima H, 2005, J CELL BIOCHEM, V95, P226, DOI 10.1002/jcb.20443; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	25	57	451	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					671	675		10.1038/nature04601	http://dx.doi.org/10.1038/nature04601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572171	Bronze			2022-12-24	WOS:000236350400044
J	Doma, MK; Parker, R				Doma, MK; Parker, R			Endonucleolytic cleavage of eukaryotic mRNAs with stalls in translation elongation	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; ESCHERICHIA-COLI; FACTOR ERF3; YEAST; DEGRADATION; TERMINATION; CODON; TURNOVER; DECAY	A fundamental aspect of the biogenesis and function of eukaryotic messenger RNA is the quality control systems that recognize and degrade non-functional mRNAs. Eukaryotic mRNAs where translation termination occurs too soon (nonsense-mediated decay) 1 or fails to occur (non-stop decay) 2 are rapidly degraded. We show that yeast mRNAs with stalls in translation elongation are recognized and targeted for endonucleolytic cleavage, referred to as 'no-go decay'. The cleavage triggered by no-go decay is dependent on translation and involves Dom34p and Hbs1p. Dom34p and Hbs1p are similar to the translation termination factors eRF1 and eRF3 (refs 3, 4), indicating that these proteins might function in recognizing the stalled ribosome and triggering endonucleolytic cleavage. No-go decay provides a mechanism for clearing the cell of stalled translation elongation complexes, which could occur as a result of damaged mRNAs or ribosomes, or as a mechanism of post-transcriptional control.	Univ Arizona, Dept Mol & Cellular Biol, Howard Hughes Med Inst, Tucson, AZ 85721 USA	Howard Hughes Medical Institute; University of Arizona	Parker, R (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Howard Hughes Med Inst, Tucson, AZ 85721 USA.	rrparker@u.arizona.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045443] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM045443] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Carr-Schmid A, 2002, MOL CELL BIOL, V22, P2564, DOI 10.1128/MCB.22.8.2564-2574.2002; Chiba Y, 1999, SCIENCE, V286, P1371, DOI 10.1126/science.286.5443.1371; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Davis L, 1998, GENETICS, V149, P45; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Gatfield D, 2004, NATURE, V429, P575, DOI 10.1038/nature02559; Harger JW, 2003, RNA, V9, P1019, DOI 10.1261/rna.5930803; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Hosoda N, 2003, J BIOL CHEM, V278, P38287, DOI 10.1074/jbc.C300300200; Inagaki Y, 2003, NUCLEIC ACIDS RES, V31, P4227, DOI 10.1093/nar/gkg440; Inge-Vechtomov S, 2003, BIOL CELL, V95, P195, DOI 10.1016/S0248-4900(03)00035-2; Kong CG, 2004, MOL CELL, V14, P233, DOI 10.1016/S1097-2765(04)00206-0; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; MUHLRAD D, 1994, NATURE, V370, P578, DOI 10.1038/370578a0; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Onouchi H, 2005, GENE DEV, V19, P1799, DOI 10.1101/gad.1317105; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; Sunohara T, 2004, J BIOL CHEM, V279, P15368, DOI 10.1074/jbc.M312805200; Sunohara T, 2004, RNA, V10, P378, DOI 10.1261/rna.5169404; van Hoof A, 2000, MOL CELL BIOL, V20, P8230, DOI 10.1128/MCB.20.21.8230-8243.2000; van Hoof A, 2005, GENETICS, V171, P1455, DOI 10.1534/genetics.105.044057; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Withey JH, 2003, ANNU REV MICROBIOL, V57, P101, DOI 10.1146/annurev.micro.57.030502.090945	28	480	495	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					561	564		10.1038/nature04530	http://dx.doi.org/10.1038/nature04530			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554824	Green Accepted			2022-12-24	WOS:000236176100062
J	Duke, T; Keshishiyan, E; Kuttumuratova, A; Ostergren, M; Ryumina, I; Stasii, E; Weber, MW; Tamburlini, G				Duke, T; Keshishiyan, E; Kuttumuratova, A; Ostergren, M; Ryumina, I; Stasii, E; Weber, MW; Tamburlini, G			Quality of hospital care for children in Kazakhstan, Republic of Moldova, and Russia: systematic observational assessment	LANCET			English	Article							HEALTH; COUNTRIES	Background Major concerns about the quality of basic hospital care for children have been raised in developing countries, but no formal assessment applying international standards has been done in the Commonwealth of Independent States. Methods We assessed 1.7 hospitals in Kazakhstan, the Republic of Moldova, and the Russian Federation with a generic WHO hospital assessment framework adapted for use in the WHO European region. WHO management guidelines for paediatric care in peripheral hospitals were used as standards. Findings Hospital access for children was generally good. Good health networks existed, and skilled and committed doctors cared for children. Case-fatality rates were low. However, unnecessary and lengthy hospital stays were common, and most children received excessive and ineffective treatment (in one country median number of drugs prescribed concurrently was 5, IQR 2-6). Several conditions were systematically overdiagnosed, especially neurological disease, or overinvestigated, such as acute diarrhoea. Reasons for these practices included absence of clear evidence-based clinical guidelines, regulations tying duration of admission to financial reimbursement, generalisation of disease-control methods from rare problems to common illnesses, and regulations maintaining financial and professional status of some subspecialties. Many disincentives to efficient practice existed. Interpretation To improve quality of hospital care for children in the Commonwealth of independent States, several issues must be addressed, including: adoption of international guidelines for inpatient management; complementary guidelines for outpatient management; reforms to health regulations governing admission and discharge criteria; improvement of quality of training, availability of medical information, and systems to promote and certify quality of care.	Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Ctr Int Child Hlth, Parkville, Vic 3052, Australia; Moscow Sci Res Inst Paediat & Paediat Surg, Moscow, Russia; WHO, Country Sub Off, Alma Ata, Kazakhstan; WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark; WHO, Off Russian Federat, Moscow, Russia; State Med & Pharmaceut Univ Republ Moldova, Kishinev, Moldova; WHO, CH-1211 Geneva, Switzerland; IRCCS Burlo Garofolo, Inst Child Hlth, Trieste, Italy	Royal Children's Hospital Melbourne; University of Melbourne; World Health Organization; World Health Organization; World Health Organization; Nicolae Testemitanu State University of Medicine & Pharmacy; World Health Organization; IRCCS Burlo Garofolo	Duke, T (corresponding author), Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Ctr Int Child Hlth, Parkville, Vic 3052, Australia.	trevor.duke@rch.org.au	Weber, Martin/GPW-6095-2022; Stasii, Ecaterina/EAJ-3597-2022					Balabanova D, 2004, HEALTH SERV RES, V39, P1927, DOI 10.1111/j.1475-6773.2004.00326.x; Conaboy KA, 2005, J CONTIN EDUC HEALTH, V25, P52, DOI 10.1002/chp.9; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; Ensor T, 1997, INT J HEALTH PLAN M, V12, P219, DOI 10.1002/(SICI)1099-1751(199707/09)12:3<219::AID-HPM482>3.0.CO;2-I; Freedman LP., 2005, DEVELOPMENT, V48, P19, DOI DOI 10.1057/PALGRAVE.DEVELOPMENT.1100107; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Parfitt T, 2005, LANCET, V366, P357, DOI 10.1016/S0140-6736(05)67007-9; UNICEF, STAT WORLDS CHILDR S; *WHO, IMCI GUID CHART BOOK; *WHO EUR OFF, 2002, TECHN CONS IMPR QUAL; World Health Organization, 2000, IMPR QUAL PAED CAR S; World Health Organization, 2000, MAN CHILD SER INF SE	12	39	42	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					919	925		10.1016/S0140-6736(06)68382-7	http://dx.doi.org/10.1016/S0140-6736(06)68382-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546540				2022-12-24	WOS:000236242100028
J	Leaper, DJ; Harding, KG				Leaper, DJ; Harding, KG			ABC of wound healing - Traumatic and surgical wounds	BRITISH MEDICAL JOURNAL			English	Editorial Material									Cardiff Univ, Wound Healing Res Unit, Cardiff, Wales; Cardiff & Vale NHS Trust, Cardiff, S Glam, Wales	Cardiff University; Cardiff University	Leaper, DJ (corresponding author), Cardiff Univ, Wound Healing Res Unit, Cardiff, Wales.							BALES S, 2000, INTRO WOUNDS; LEAPER DJ, 2002, RECENT ADV SURG; LEAPER DJ, 2004, CLIN SURG GEN; Leaper DJ, 2004, BAILEY LOVES SHORT P; TEOT L, 2004, SURG WOUNDS; Williams, 1998, WOUNDS BIOL MANAGEME	6	21	23	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 4	2006	332	7540					532	535		10.1136/bmj.332.7540.532	http://dx.doi.org/10.1136/bmj.332.7540.532			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023WB	16513711	Green Published			2022-12-24	WOS:000236155800019
J	Scott, EC				Scott, EC			Creationism and evolution: It's the American way	CELL			English	Editorial Material								The recent ruling in the Kitzmiller v. Dover court case that intelligent design is a form of religion and cannot be taught alongside evolution in science classes in US public schools garnered worldwide attention. But why is the antievolution movement so powerful in the United States?	Natl Ctr Sci Educ Inc, Oakland, CA 94609 USA		Scott, EC (corresponding author), Natl Ctr Sci Educ Inc, Oakland, CA 94609 USA.	scott@ncseweb.org		Scott, Eugenie Carol/0000-0003-3795-8207				Gross P. R., 2005, STATE STATE SCI STAN; HAMILTON D, 2004, DARWIN GOES BAKC SCH; National Research Council, 1996, NAT COMM SCI ED STAN; Scott EC, 2005, EVOLUTION VS CREATIO	4	6	7	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 10	2006	124	3					449	451		10.1016/j.cell.2006.01.028	http://dx.doi.org/10.1016/j.cell.2006.01.028			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	014FG	16469687	Bronze			2022-12-24	WOS:000235464000002
J	Hanson, LC; Ersek, M				Hanson, LC; Ersek, M			Meeting palliative care needs in post-acute care settings - "To help them live until they die"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE CARE; RANDOMIZED CONTROLLED-TRIAL; NURSING-HOME RESIDENTS; HOSPICE ENROLLMENT; QUALITY-IMPROVEMENT; PAIN MANAGEMENT; END; FACILITIES; HOSPITALIZATION; PREFERENCES		Univ N Carolina, Div Geriatr Med, Pain & Symptom Care Program, Chapel Hill, NC 27599 USA; Univ Washington, Sch Nursing, Swedish Med Ctr, Pain & Palliat Care Res Dept, Seattle, WA 98195 USA; Univ Washington, Sch Nursing, Biobehav Nursing & Hlth Syst, Seattle, WA 98195 USA	University of North Carolina; University of North Carolina Chapel Hill; Swedish Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hanson, LC (corresponding author), Univ N Carolina, Div Geriatr Med, Pain & Symptom Care Program, CB 7550, Chapel Hill, NC 27599 USA.	lhanson@med.unc.edu		Ersek, Mary/0000-0002-0520-311X; Hanson, Laura/0000-0001-5120-6058				Baer WM, 2000, J AM GERIATR SOC, V48, P879, DOI 10.1111/j.1532-5415.2000.tb06883.x; Baier RR, 2004, J AM GERIATR SOC, V52, P1988, DOI 10.1111/j.1532-5415.2004.52553.x; Bernabei R, 1998, JAMA-J AM MED ASSOC, V279, P1877, DOI 10.1001/jama.279.23.1877; Boockvar K, 2004, ARCH INTERN MED, V164, P545, DOI 10.1001/archinte.164.5.545; Bradley EH, 1998, J AM GERIATR SOC, V46, P1235, DOI 10.1111/j.1532-5415.1998.tb04539.x; Brock D B, 1998, Hosp J, V13, P49; Casarett D, 2005, JAMA-J AM MED ASSOC, V294, P211, DOI 10.1001/jama.294.2.211; Castle N G, 1997, Hosp J, V12, P59; Castle NG, 2005, MED CARE, V43, P616, DOI 10.1097/01.mlr.0000163661.67170.b9; Chan J, 2002, GERONTOLOGIST, V42, P301; Dixon Sharon, 2002, Am J Hosp Palliat Care, V19, P187, DOI 10.1177/104990910201900310; Ersek Mary, 2005, J Palliat Med, V8, P556, DOI 10.1089/jpm.2005.8.556; Ersek Mary, 2003, J Palliat Med, V6, P45, DOI 10.1089/10966210360510118; FERRELL BA, 1995, ANN INTERN MED, V123, P681, DOI 10.7326/0003-4819-123-9-199511010-00007; Fried TR, 1999, ANN INTERN MED, V131, P109, DOI 10.7326/0003-4819-131-2-199907200-00006; Gillick M, 1999, J AM GERIATR SOC, V47, P227, DOI 10.1111/j.1532-5415.1999.tb04582.x; Hanson Laura C, 2002, J Palliat Med, V5, P117; Hanson LC, 1997, J AM GERIATR SOC, V45, P1339, DOI 10.1111/j.1532-5415.1997.tb02933.x; Hanson LC, 2005, J PALLIAT MED, V8, P1207, DOI 10.1089/jpm.2005.8.1207; HENDERSON ML, 2003, IMPROVING NURSING HO; Hickman SE, 2004, J AM GERIATR SOC, V52, P1424, DOI 10.1111/j.1532-5415.2004.52402.x; Horner JK, 2005, J PAIN SYMPTOM MANAG, V30, P271, DOI 10.1016/j.jpainsymman.2005.03.014; Keay Timothy J, 2003, J Palliat Med, V6, P205, DOI 10.1089/109662103764978452; Kovach CR, 1996, AM J ALZHEIMERS DIS, V11, P7, DOI DOI 10.1177/153331759601100402; Levin JR, 1999, J AM GERIATR SOC, V47, P82, DOI 10.1111/j.1532-5415.1999.tb01905.x; LINN MW, 1989, INT J AGING HUM DEV, V28, P305, DOI 10.2190/JA0E-9T0Y-H2K8-QBV6; Maccabee Joyce, 1994, Palliative Medicine, V8, P211, DOI 10.1177/026921639400800304; Marcantonio ER, 2005, J AM GERIATR SOC, V53, P963, DOI 10.1111/j.1532-5415.2005.53305.x; Mattimore TJ, 1997, J AM GERIATR SOC, V45, P818, DOI 10.1111/j.1532-5415.1997.tb01508.x; Miller SC, 2004, J PAIN SYMPTOM MANAG, V28, P537, DOI 10.1016/j.jpainsymman.2004.10.007; Miller SC, 2004, J AM GERIATR SOC, V52, P1284, DOI 10.1111/j.1532-5415.2004.52357.x; Miller SC, 2003, J PAIN SYMPTOM MANAG, V26, P791, DOI 10.1016/S0885-3924(03)00284-7; Miller SC, 2001, AM J MED, V111, P38, DOI 10.1016/S0002-9343(01)00747-1; Molloy DW, 2000, JAMA-J AM MED ASSOC, V283, P1437, DOI 10.1001/jama.283.11.1437; Morrison RS, 2005, J AM GERIATR SOC, V53, P290, DOI 10.1111/j.1532-5415.2005.53116.x; Murtaugh CM, 2002, MED CARE, V40, P227; OMORI DM, 1991, ARCH INTERN MED, V151, P1562, DOI 10.1001/archinte.151.8.1562; Petrisek AC, 1999, GERONTOLOGIST, V39, P279, DOI 10.1093/geront/39.3.279; Reynolds Kimberly, 2002, J Palliat Med, V5, P895, DOI 10.1089/10966210260499087; Sloane PD, 2003, J AM GERIATR SOC, V51, P1587, DOI 10.1046/j.1532-5415.2003.51511.x; Tarzian Anita J, 2004, J Am Med Dir Assoc, V5, P82, DOI 10.1097/01.JAM.0000110648.46882.B3; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Teno JM, FACTS DYING; VOLICER L, 1986, JAMA-J AM MED ASSOC, V256, P2210, DOI 10.1001/jama.256.16.2210; VOLICER L, 1994, J AM GERIATR SOC, V42, P597, DOI 10.1111/j.1532-5415.1994.tb06856.x; Weissman DE, 2000, J PAIN SYMPTOM MANAG, V20, P35, DOI 10.1016/S0885-3924(00)00168-8; Wilson S A, 1998, J Palliat Med, V1, P21, DOI 10.1089/jpm.1998.1.21; Wilson SA, 1996, GERIATR NURS, V17, P6, DOI 10.1016/S0197-4572(96)80004-8; Zerzan J, 2000, JAMA-J AM MED ASSOC, V284, P2489, DOI 10.1001/jama.284.19.2489; Zimmerman Sheryl, 2003, J Am Med Dir Assoc, V4, P23, DOI 10.1016/S1525-8610(04)70260-1	50	30	30	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 8	2006	295	6					681	+		10.1001/jama.295.6.681	http://dx.doi.org/10.1001/jama.295.6.681			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	010DX	16467237				2022-12-24	WOS:000235168200028
J	Bacles, CFE; Lowe, AJ; Ennos, RA				Bacles, CFE; Lowe, AJ; Ennos, RA			Effective seed dispersal across a fragmented landscape	SCIENCE			English	Article									Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland; Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland; Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia	University of Edinburgh; UK Centre for Ecology & Hydrology (UKCEH); University of Queensland	Ennos, RA (corresponding author), Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland.	rennos@ed.ac.uk	Bacles, Cecile FE/D-3093-2010	Bacles, Cecile FE/0000-0002-1061-1898; Lowe, Andrew/0000-0003-1139-2516	Natural Environment Research Council [CEH010021, ceh010010] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Aldrich PR, 1998, SCIENCE, V281, P103, DOI 10.1126/science.281.5373.103; Bacles CFE, 2005, EVOLUTION, V59, P979, DOI 10.1111/j.0014-3820.2005.tb01037.x; Lowe AJ, 2005, HEREDITY, V95, P255, DOI 10.1038/sj.hdy.6800725; Nathan R, 2005, P NATL ACAD SCI USA, V102, P8251, DOI 10.1073/pnas.0503048102; Pearson RG, 2005, BIOL CONSERV, V123, P389, DOI 10.1016/j.biocon.2004.12.006; Schnabel A, 1998, MOL ECOL, V7, P819, DOI 10.1046/j.1365-294x.1998.00397.x	6	187	189	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2006	311	5761					628	628		10.1126/science.1121543	http://dx.doi.org/10.1126/science.1121543			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011GY	16456072				2022-12-24	WOS:000235257400037
J	Zhang, Q; Sun, XY; Watt, ED; Al-Hashimi, HM				Zhang, Q; Sun, XY; Watt, ED; Al-Hashimi, HM			Resolving the motional modes that code for RNA adaptation	SCIENCE			English	Article							HIV-1 TAR RNA; NMR RELAXATION; PROTEIN RECOGNITION; INDUCED FIT; CONFORMATION; DYNAMICS; REVEALS; BULGE; MACROMOLECULES; STABILIZATION	Using a domain elongation strategy, we decoupled internal motions in RNA from overall rotational diffusion. This allowed us to site-specifically resolve a manifold of motional modes in two regulatory RNAs from HIV-1 with the use of nuclear magnetic resonance spin relaxation methods. Base and sugar librations vary on a picosecond time scale and occur within helical domains that move collectively at diffusion-limited nanosecond time scales. Pivot points are short; functionally important, and highly mobile internal loops. These spontaneous changes in RNA conformation correlate quantitatively with those that follow adaptive recognition of diverse targets. Thus, ligands may stabilize existing RNA conformations rather than inducing new ones.	Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Div Biophys Res, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Al-Hashimi, HM (corresponding author), Univ Michigan, Dept Chem, 930 N Univ Ave, Ann Arbor, MI 48109 USA.	hashimi@umich.edu	Zhang, Qi/B-5869-2014; Zhang, Qi/E-1722-2011; Zhang, Qi/F-3323-2010; Watt, Eric D/K-9819-2015	Zhang, Qi/0000-0003-1754-4058; Watt, Eric D/0000-0002-1211-0229	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066975] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI066975-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AboulEla F, 1996, NUCLEIC ACIDS RES, V24, P3974, DOI 10.1093/nar/24.20.3974; ABOULELA F, 1995, J MOL BIOL, V253, P313, DOI 10.1006/jmbi.1995.0555; Baram D, 2005, FEBS LETT, V579, P948, DOI 10.1016/j.febslet.2004.11.063; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Davis B, 2004, J MOL BIOL, V336, P343, DOI 10.1016/j.jmb.2003.12.046; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; Dingley AJ, 1999, J AM CHEM SOC, V121, P6019, DOI 10.1021/ja9908321; Doudna JA, 2005, NAT STRUCT MOL BIOL, V12, P395, DOI 10.1038/nsmb932; Du ZH, 2002, CHEM BIOL, V9, P707, DOI 10.1016/S1074-5521(02)00151-5; Faber C, 2000, J BIOL CHEM, V275, P20660, DOI 10.1074/jbc.M000920200; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Ippolito JA, 1998, P NATL ACAD SCI USA, V95, P9819, DOI 10.1073/pnas.95.17.9819; Lawrence DC, 2003, J MOL BIOL, V326, P529, DOI 10.1016/S0022-2836(02)01305-0; Leulliot N, 2001, BIOCHEMISTRY-US, V40, P7947, DOI 10.1021/bi010680y; Lilley David M J, 2004, Methods Mol Biol, V252, P77; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MUESING MA, 1987, CELL, V48, P691, DOI 10.1016/0092-8674(87)90247-9; Murchie AIH, 2004, J MOL BIOL, V336, P625, DOI 10.1016/j.jmb.2003.12.028; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Pitt SW, 2004, J MOL BIOL, V338, P7, DOI 10.1016/j.jmb.2004.02.031; PUGLISI JD, 1992, SCIENCE, V257, P76, DOI 10.1126/science.1621097; Schroeder R, 2004, NAT REV MOL CELL BIO, V5, P908, DOI 10.1038/nrm1497; Tugarinov V, 2001, J AM CHEM SOC, V123, P3055, DOI 10.1021/ja003803v; Vallurupalli P, 2005, J AM CHEM SOC, V127, P6893, DOI 10.1021/ja0427799; Vugmeyster L, 2003, J AM CHEM SOC, V125, P8400, DOI 10.1021/ja029480f; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575	27	190	193	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2006	311	5761					653	656		10.1126/science.1119488	http://dx.doi.org/10.1126/science.1119488			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011GY	16456078				2022-12-24	WOS:000235257400046
J	Kitajima, TS; Sakuno, T; Ishiguro, K; Iemura, S; Natsume, T; Kawashima, SA; Watanabe, Y				Kitajima, TS; Sakuno, T; Ishiguro, K; Iemura, S; Natsume, T; Kawashima, SA; Watanabe, Y			Shugoshin collaborates with protein phosphatase 2A to protect cohesin	NATURE			English	Article							MEIOSIS-I; OKADAIC ACID; SISTER CHROMATIDS; KINASE CDC5; PHOSPHORYLATION; CENTROMERES; CHROMOSOME; MITOSIS; MAINTENANCE; SEPARATION	Sister chromatid cohesion, mediated by a complex called cohesin, is crucial-particularly at centromeres-for proper chromosome segregation in mitosis and meiosis. In animal mitotic cells, phosphorylation of cohesin promotes its dissociation from chromosomes, but centromeric cohesin is protected by shugoshin until kinetochores are properly captured by the spindle microtubules. However, the mechanism of shugoshin-dependent protection of cohesin is unknown. Here we find a specific subtype of serine/threonine protein phosphatase 2A (PP2A) associating with human shugoshin. PP2A colocalizes with shugoshin at centromeres and is required for centromeric protection. Purified shugoshin complex has an ability to reverse the phosphorylation of cohesin in vitro, suggesting that dephosphorylation of cohesin is the mechanism of protection at centromeres. Meiotic shugoshin of fission yeast also associates with PP2A, with both proteins collaboratively protecting Rec8-containing cohesin at centromeres. Thus, we have revealed a conserved mechanism of centromeric protection of eukaryotic chromosomes in mitosis and meiosis.	Univ Tokyo, Lab Chromosome Dynam, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; Univ Tokyo, Grad Program Biophys & Biochem, Tokyo 1130032, Japan; Japan Sci & Technol Agcy, SORST, Tokyo 1130032, Japan; Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tokyo 1350064, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST)	Watanabe, Y (corresponding author), Univ Tokyo, Lab Chromosome Dynam, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp	Ishiguro, Kei-ichiro/K-3340-2019; Kitajima, Tomoya/A-7049-2016; Sakuno, Takeshi/Y-9478-2019; Natsume, Tohru/M-7627-2018; Kawashima, Shigehiro/Q-6937-2017	Ishiguro, Kei-ichiro/0000-0002-7515-1511; Kitajima, Tomoya/0000-0002-6486-7143; Natsume, Tohru/0000-0002-1510-2582; Watanabe, Yoshinori/0000-0002-5488-4812				Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Clarke AS, 2005, DEV CELL, V8, P53, DOI 10.1016/j.devcel.2004.12.003; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; Hamant O, 2005, CURR BIOL, V15, P948, DOI 10.1016/j.cub.2005.04.049; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2004, CELL, V119, P317, DOI 10.1016/j.cell.2004.10.014; Hornig NCD, 2004, EMBO J, V23, P3144, DOI 10.1038/sj.emboj.7600303; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jiang W, 2000, GENETICS, V154, P1025; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; Kiburz BM, 2005, GENE DEV, V19, P3017, DOI 10.1101/gad.1373005; KINOSHITA N, 1990, CELL, V63, P405, DOI 10.1016/0092-8674(90)90173-C; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Le Goff X, 2001, FEBS LETT, V508, P136, DOI 10.1016/S0014-5793(01)03047-2; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lee JY, 2001, ANNU REV CELL DEV BI, V17, P753, DOI 10.1146/annurev.cellbio.17.1.753; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Mailhes JB, 2003, CHROMOSOME RES, V11, P619, DOI 10.1023/A:1024909119593; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Milutinovich M, 2003, SCIENCE, V300, P1101, DOI 10.1126/science.1084478; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Uhlmann F, 2003, CURR BIOL, V13, pR104, DOI 10.1016/S0960-9822(03)00039-3; VANDOLAH FM, 1992, J CELL PHYSIOL, V152, P190, DOI 10.1002/jcp.1041520124; VANDRE DD, 1992, J CELL SCI, V101, P79; Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003	36	437	458	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					46	52		10.1038/nature04663	http://dx.doi.org/10.1038/nature04663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16541025				2022-12-24	WOS:000237248600029
J	Xie, XS; Yu, J; Yang, WY				Xie, XS; Yu, J; Yang, WY			Perspective - Living cells as test tubes	SCIENCE			English	Editorial Material							STOKES-RAMAN SCATTERING; SINGLE-MOLECULE; GENE-EXPRESSION; RNA-POLYMERASE; IN-VIVO; KINESIN; MICROSCOPY; LOCALIZATION; TRANSPORT; MOVEMENT	The combination of specific probes and advanced optical microscopy now allows quantitative probing of biochemical reactions in living cells. On selected systems, one can detect and track a particular protein with single-molecule sensitivity, nanometer spatial precision, and millisecond time resolution. Metabolites, usually difficult to detect, can be imaged and monitored in living cells with coherent anti-Stokes Raman scattering microscopy. Here, we describe the application of these techniques in studying gene expression, active transport, and lipid metabolism.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Yang, Wei Yuan/B-4474-2011					ASHKIN A, 1990, NATURE, V348, P346, DOI 10.1038/348346a0; Babcock HP, 2004, BIOPHYS J, V87, P2749, DOI 10.1529/biophysj.104.042234; BETZIG E, 1995, OPT LETT, V20, P237, DOI 10.1364/OL.20.000237; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Cheng JX, 2004, J PHYS CHEM B, V108, P827, DOI 10.1021/jp035693v; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Deich J, 2004, P NATL ACAD SCI USA, V101, P15921, DOI 10.1073/pnas.0404200101; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; GANIKHANOV G, IN PRESS OPT LETT; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Nan XL, 2005, J PHYS CHEM B, V109, P24220, DOI 10.1021/jp056360w; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Schoenheimer R, 1938, SCIENCE, V87, P221, DOI 10.1126/science.87.2254.221; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; THORNETJOMSLAND G, 2003, MOL BIOL CELL, V14, pA104; Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142	31	200	213	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					228	230		10.1126/science.1127566	http://dx.doi.org/10.1126/science.1127566			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	032HK	16614211				2022-12-24	WOS:000236765300037
J	Hozumi, S; Maeda, R; Taniguchi, K; Kanai, M; Shirakabe, S; Sasamura, T; Speder, P; Noselli, S; Aigaki, T; Murakami, R; Matsuno, K				Hozumi, S; Maeda, R; Taniguchi, K; Kanai, M; Shirakabe, S; Sasamura, T; Speder, P; Noselli, S; Aigaki, T; Murakami, R; Matsuno, K			An unconventional myosin in Drosophila reverses the default handedness in visceral organs	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; DYNAMICS; EMBRYO; CYTOSKELETON; EXPRESSION; POLARITY; HINDGUT; GTPASES; TISSUE; MEMORY	The internal organs of animals often have left - right asymmetry(1,2). Although the formation of the anterior - posterior and dorsal ventral axes in Drosophila is well understood, left - right asymmetry has not been extensively studied. Here we find that the handedness of the embryonic gut and the adult gut and testes is reversed ( not randomized) in viable and fertile homozygous Myo31DF mutants. Myo31DF encodes an unconventional myosin, Drosophila MyoIA ( also referred to as MyoID in mammals; refs 3, 4), and is the first actin-based motor protein to be implicated in left - right patterning. We find that Myo31DF is required in the hindgut epithelium for normal embryonic handedness. Disruption of actin filaments in the hindgut epithelium randomizes the handedness of the embryonic gut, suggesting that Myo31DF function requires the actin cytoskeleton. Consistent with this, we find that Myo31DF colocalizes with the cytoskeleton. Overexpression of Myo61F, another myosin I ( ref. 4), reverses the handedness of the embryonic gut, and its knockdown also causes a left - right patterning defect. These two unconventional myosin I proteins may have antagonistic functions in left - right patterning. We suggest that the actin cytoskeleton and myosin I proteins may be crucial for generating left - right asymmetry in invertebrates.	Tokyo Univ Sci, Dept Biol Sci & Technol, Chiba 2788510, Japan; Tokyo Univ Sci, Genome & Drug Res Ctr, Chiba 2788510, Japan; Univ Nice, Inst Signalling Dev Biol & Canc, CNRS, UMR6543, F-06108 Nice 2, France; Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan; Yamaguchi Univ, Dept Phys Biol & Informat, Yamaguchi 7538512, Japan	Tokyo University of Science; Tokyo University of Science; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Tokyo Metropolitan University; Yamaguchi University	Matsuno, K (corresponding author), Tokyo Univ Sci, Dept Biol Sci & Technol, 2641 Yamazaki, Chiba 2788510, Japan.	matsuno@rs.noda.tus.ac.jp	Hozumi, Shunya/Q-8610-2019; Taniguchi, Kiichiro/ACL-8906-2022; Kanai, Motomu/J-6807-2016	Taniguchi, Kiichiro/0000-0003-2321-7280; Kanai, Motomu/0000-0003-1977-7648; Noselli, stephane/0000-0002-7296-324X; Speder, Pauline/0000-0002-2934-5841; Maeda, Reo/0000-0002-2727-3012				Adam G, 2003, DEVELOPMENT, V130, P2397, DOI 10.1242/dev.00460; BRAND AH, 1993, DEVELOPMENT, V118, P401; EATON S, 1995, J CELL BIOL, V131, P151, DOI 10.1083/jcb.131.1.151; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frydman HM, 2001, DEVELOPMENT, V128, P3209; GILLESPIE PG, 1993, NEURON, V11, P581, DOI 10.1016/0896-6273(93)90071-X; Gillespie PG, 2001, J CELL BIOL, V155, P703, DOI 10.1083/jcb.200110032; Hayashi M, 2005, DEV GROWTH DIFFER, V47, P457, DOI 10.1111/j.1440-169X.2005.00817.x; Hayashi T, 2001, DEV GROWTH DIFFER, V43, P239; Huber LA, 2000, TRAFFIC, V1, P494, DOI 10.1034/j.1600-0854.2000.010607.x; Iwaki DD, 2001, DEV BIOL, V240, P611, DOI 10.1006/dbio.2001.0483; Iwaki DD, 2002, MECH DEVELOP, V114, P71, DOI 10.1016/S0925-4773(02)00061-8; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; Ligoxygakis P, 2001, DEVELOPMENT, V128, P1171; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MartinBermudo MD, 1997, EMBO J, V16, P4184, DOI 10.1093/emboj/16.14.4184; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Mercola M, 2001, ANNU REV CELL DEV BI, V17, P779, DOI 10.1146/annurev.cellbio.17.1.779; MORGAN NS, 1995, DEV BIOL, V172, P51, DOI 10.1006/dbio.1995.0005; Pascual A, 2004, NATURE, V427, P605, DOI 10.1038/427605a; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Shibazaki Y, 2004, CURR BIOL, V14, P1462, DOI 10.1016/j.cub.2004.08.018; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; SULLIVAN W, 2000, PROTOCOLS; Tracey WD, 2000, GENETICS, V154, P273; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wood WB, 1997, ANNU REV CELL DEV BI, V13, P53	29	135	140	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					798	802		10.1038/nature04625	http://dx.doi.org/10.1038/nature04625			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598258				2022-12-24	WOS:000236548400042
J	Rodondi, N; Peng, T; Karter, AJ; Bauer, DC; Vittinghoff, E; Tang, S; Pettitt, D; Kerr, EA; Selby, JV				Rodondi, N; Peng, T; Karter, AJ; Bauer, DC; Vittinghoff, E; Tang, S; Pettitt, D; Kerr, EA; Selby, JV			Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus	ANNALS OF INTERNAL MEDICINE			English	Article							GLYCEMIC CONTROL; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; UNITED-STATES; PRIMARY-CARE; RISK-FACTORS; QUALITY; CHOLESTEROL; MANAGEMENT; HEALTH	Background: Poorly controlled cardiovascular risk factors are common. Evaluating whether physicians respond appropriately to poor risk factor control in patients may better reflect quality of care than measuring proportions of patients whose conditions are controlled. Objectives: To evaluate therapy modifications in response to poor control of hypertension, dyslipidemia, or diabetes in a large clinical population. Design: Retrospective cohort study within an 18-month period in 2002 to 2003. Setting: Kaiser Permanente of Northern California. Patients: 253 238 adult members with poor control of 1 or more of these conditions. Measurements: The authors assessed the proportion of patients with poor control who experienced a change in pharmacotherapy within 6 months, and they defined "appropriate care" as a therapy modification or return to control without therapy modification within 6 months. Results: A total of 64% of patients experienced modifications in therapy for poorly controlled systolic blood pressure, 71% forpoorly controlled diastolic blood pressure, 56% for poorly controlled low-density lipoprotein cholesterol level, and 66% for poorly controlled hemoglobin A, level. Most frequent modifications were increases in number of drug classes (from 70% to 84%) and increased dosage (from 15% to 40%). An additional 7% to 11% of those with poorly controlled blood pressure, but only 3% to 4% of those with elevated low-density lipoprotein cholesterol level or hemoglobin A(1c) level, returned to control without therapy modification. Patients with more than 1 of the 3 conditions, higher baseline values, and target organ damage were more likely to receive "appropriate care." Limitations: Patient preferences and suboptimal adherence to therapy were not measured and may explain some failures to act. Conclusions: As an additional measure of the quality of care, measuring therapy modifications in response to poor control in a large population is feasible. Many patients with poorly controlled hypertension, dyslipidemia, or diabetes had their therapy modified and, thus, seemed to receive clinically "appropriate care" with this new quality measure.	Univ Lausanne, Univ Outpatient Clin, CH-1011 Lausanne, Switzerland; Univ Calif San Francisco, San Francisco, CA 94143 USA; Kaiser Permanente Med Care Program, Oakland, CA 94611 USA; Pfizer Outcomes Res, New York, NY USA; Vet Affairs Healthcare Syst, Ann Arbor, MI USA; Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA	University of Lausanne; University of California System; University of California San Francisco; Kaiser Permanente; Pfizer; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Rodondi, N (corresponding author), Univ Lausanne, Univ Outpatient Clin, Bugnon 44, CH-1011 Lausanne, Switzerland.	nicolas.rodondi@hospvd.ch		Rodondi, Nicolas/0000-0001-9083-6896	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK020572] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asai Y, 2002, J HUM HYPERTENS, V16, P313, DOI 10.1038/sj.jhh.1001385; Asch Steven M, 2005, BMC Cardiovasc Disord, V5, P1, DOI 10.1186/1471-2261-5-1; Bell RA, 2001, AM J PREV MED, V21, P124, DOI 10.1016/S0749-3797(01)00328-2; Benetos A, 2002, ARCH INTERN MED, V162, P577, DOI 10.1001/archinte.162.5.577; Berlowitz DR, 1998, NEW ENGL J MED, V339, P1957, DOI 10.1056/NEJM199812313392701; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cook CB, 1999, DIABETES CARE, V22, P1494, DOI 10.2337/diacare.22.9.1494; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; Davis S, 2004, J DIABETES COMPLICAT, V18, P60, DOI 10.1016/S1056-8727(03)00058-8; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; Grant RW, 2005, DIABETES CARE, V28, P337, DOI 10.2337/diacare.28.2.337; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Harris MI, 1999, DIABETES CARE, V22, P403, DOI 10.2337/diacare.22.3.403; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; Joint National Committee on Prevention Detection evaluation and treatment of high blood pressure, 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005; KANNEL WB, 2000, AM J HYPERTENS 2, V0013; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Karter AJ, 2004, MED CARE, V42, P110, DOI 10.1097/01.mlr.0000109023.64650.73; Kerr EA, 2003, MED CARE, V41, P1173, DOI 10.1097/01.MLR.0000088453.57269.29; Kerr EA, 2001, AM J MANAG CARE, V7, P1033; Krein SL, 2002, HEALTH SERV RES, V37, P1159, DOI 10.1111/1475-6773.01102; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Lenfant C, 1999, JAMA-J AM MED ASSOC, V282, P2068, DOI 10.1001/jama.282.21.2068; *MED ED CO, 2001, PHYS DESK REF; *NAT COMM QUAL INS, HLTH PLAN EMPL DAT I; Oliveria SA, 2002, ARCH INTERN MED, V162, P413, DOI 10.1001/archinte.162.4.413; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Selby JV, 2004, AM J MANAG CARE, V10, P163; Stafford RS, 1997, J AM COLL CARDIOL, V29, P139, DOI 10.1016/S0735-1097(96)00441-X; The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Whyte J L, 2001, J Clin Hypertens (Greenwich), V3, P211, DOI 10.1111/j.1524-6175.2001.00461.x; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	43	149	150	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2006	144	7					475	484		10.7326/0003-4819-144-7-200604040-00006	http://dx.doi.org/10.7326/0003-4819-144-7-200604040-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031DU	16585661	Green Accepted, Green Submitted			2022-12-24	WOS:000236685100002
J	Shamovsky, I; Ivannikov, M; Kandel, ES; Gershon, D; Nudler, E				Shamovsky, I; Ivannikov, M; Kandel, ES; Gershon, D; Nudler, E			RNA-mediated response to heat shock in mammalian cells	NATURE			English	Article							TRANSCRIPTION FACTOR; STRESS-RESPONSE; FACTOR-I; ACTIVATION; FACTOR-1; COMPLEX; HSF; TEMPERATURE; EXPRESSION; REPRESSION	The heat-shock transcription factor 1 (HSF1) has an important role in the heat-shock response in vertebrates by inducing the expression of heat-shock proteins (HSPs) and other cytoprotective proteins(1). HSF1 is present in unstressed cells in an inactive monomeric form and becomes activated by heat and other stress stimuli. HSF1 activation involves trimerization and acquisition of a site-specific DNA-binding activity(2,3), which is negatively regulated by interaction with certain HSPs(4-6). Here we show that HSF1 activation by heat shock is an active process that is mediated by a ribonucleoprotein complex containing translation elongation factor eEF1A and a previously unknown non-coding RNA that we term HSR1 (heat shock RNA-1). HSR1 is constitutively expressed in human and rodent cells and its homologues are functionally interchangeable. Both HSR1 and eEF1A are required for HSF1 activation in vitro; antisense oligonucleotides or short interfering (si)RNA against HSR1 impair the heat-shock response in vivo, rendering cells thermosensitive. The central role of HSR1 during heat shock implies that targeting this RNA could serve as a new therapeutic model for cancer, inflammation and other conditions associated with HSF1 deregulation.	NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel; Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; Redox Pharmaceut Corp, Greenvale, NY 11548 USA	New York University; Technion Israel Institute of Technology; Cleveland Clinic Foundation	Gershon, D (corresponding author), NYU, Sch Med, Dept Biochem, New York, NY 10016 USA.	dgershon@redoxpharm.com; evgeny.nudler@med.nyu.edu		Nudler, Evgeny/0000-0002-8811-3071	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069800] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM069800] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Ali A, 1998, MOL CELL BIOL, V18, P4949, DOI 10.1128/MCB.18.9.4949; Baler R, 1996, CELL STRESS CHAPERON, V1, P33, DOI 10.1379/1466-1268(1996)001<0033:EFAROH>2.3.CO;2; Batulan Z, 2003, J NEUROSCI, V23, P5789; Bharadwaj S, 1999, MOL CELL BIOL, V19, P8033; CLOS J, 1990, CELL, V63, P1085, DOI 10.1016/0092-8674(90)90511-C; CLOS J, 1993, NATURE, V364, P252, DOI 10.1038/364252a0; Farkas T, 1998, MOL CELL BIOL, V18, P906, DOI 10.1128/MCB.18.2.906; Gothard LQ, 2003, J BIOL CHEM, V278, P9322, DOI 10.1074/jbc.M209412200; Jolly C, 1999, P NATL ACAD SCI USA, V96, P6769, DOI 10.1073/pnas.96.12.6769; Kristensen P, 1998, BIOCHEM BIOPH RES CO, V245, P810, DOI 10.1006/bbrc.1998.8510; Marchler G, 2001, EMBO J, V20, P499, DOI 10.1093/emboj/20.3.499; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; PANNIERS R, 1994, BIOCHIMIE, V76, P737, DOI 10.1016/0300-9084(94)90078-7; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SARGE KD, 1991, GENE DEV, V5, P1902, DOI 10.1101/gad.5.10.1902; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Shopland LS, 1996, CHROMOSOMA, V105, P158, DOI 10.1007/BF02509497; SHOPLAND LS, 1995, GENE DEV, V9, P2756, DOI 10.1101/gad.9.22.2756; Storz G, 1999, GENE DEV, V13, P633, DOI 10.1101/gad.13.6.633; Szymaski M, 2003, INT REV CYTOL, V231, P197, DOI 10.1016/S0074-7696(03)31005-8; Voellmy R, 2004, PROG NUCLEIC ACID RE, V78, P143, DOI 10.1016/S0079-6603(04)78004-6; WELCH WJ, 1985, J CELL BIOL, V101, P1198, DOI 10.1083/jcb.101.4.1198; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; WESTWOOD JT, 1993, MOL CELL BIOL, V13, P3481, DOI 10.1128/MCB.13.6.3481; Zhong M, 1999, J BIOL CHEM, V274, P3135, DOI 10.1074/jbc.274.5.3135; Zhong M, 1998, MOL CELL, V2, P101, DOI 10.1016/S1097-2765(00)80118-5; ZIMARINO V, 1990, MOL CELL BIOL, V10, P752, DOI 10.1128/MCB.10.2.752; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3; ZUO JR, 1995, MOL CELL BIOL, V15, P4319	30	274	297	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					556	560		10.1038/nature04518	http://dx.doi.org/10.1038/nature04518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554823				2022-12-24	WOS:000236176100061
J	Taylor, TD; Noguchi, H; Totoki, Y; Toyoda, A; Kuroki, Y; Dewar, K; Lloyd, C; Itoh, T; Takeda, T; Kim, DW; She, XW; Barlow, KF; Bloom, T; Bruford, E; Chang, JL; Cuomo, CA; Eichler, E; FitzGerald, MG; Jaffe, DB; LaButti, K; Nicol, R; Park, HS; Seaman, C; Sougnez, C; Yang, XP; Zimmer, AR; Zody, MC; Birren, BW; Nusbaum, C; Fujiyama, A; Hattori, M; Rogers, J; Lander, ES; Sakaki, Y				Taylor, TD; Noguchi, H; Totoki, Y; Toyoda, A; Kuroki, Y; Dewar, K; Lloyd, C; Itoh, T; Takeda, T; Kim, DW; She, XW; Barlow, KF; Bloom, T; Bruford, E; Chang, JL; Cuomo, CA; Eichler, E; FitzGerald, MG; Jaffe, DB; LaButti, K; Nicol, R; Park, HS; Seaman, C; Sougnez, C; Yang, XP; Zimmer, AR; Zody, MC; Birren, BW; Nusbaum, C; Fujiyama, A; Hattori, M; Rogers, J; Lander, ES; Sakaki, Y			Human chromosome 11 DNA sequence and analysis including novel gene identification	NATURE			English	Article							HUMAN GENOME; CHROMOSOME; RECOMBINATION; REGION; MAP	Chromosome 11, although average in size, is one of the most gene- and disease-rich chromosomes in the human genome. Initial gene annotation indicates an average gene density of 11.6 genes per megabase, including 1,524 protein-coding genes, some of which were identified using novel methods, and 765 pseudogenes. One-quarter of the protein-coding genes shows overlap with other genes. Of the 856 olfactory receptor genes in the human genome, more than 40% are located in 28 single- and multi-gene clusters along this chromosome. Out of the 171 disorders currently attributed to the chromosome, 86 remain for which the underlying molecular basis is not yet known, including several mendelian traits, cancer and susceptibility loci. The high-quality data presented here-nearly 134.5 million base pairs representing 99.8% coverage of the euchromatic sequence-provide scientists with a solid foundation for understanding the genetic basis of these disorders and other biological phenomena.	RIKEN Genom Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Cambridge, MA 02141 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Mitsubishi Res Inst Inc, Chiyoda Ku, Tokyo 1008141, Japan; Korea Res Inst Biosci & Biotechnol, Taejon 305333, South Korea; Univ Washington, Seattle, WA 98195 USA; UCL, Dept Biol, Galton Lab, HUGO Gene Nomenclature Comm, London NW1 2HE, England; Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; Kitasato Univ, Kitasato Inst Life Sci, Kanagawa 2288555, Japan	RIKEN; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Wellcome Trust Sanger Institute; Mitsubishi Research Institute; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Washington; University of Washington Seattle; University of London; University College London; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Kitasato University	Taylor, TD (corresponding author), RIKEN Genom Sci Ctr, Tsurumi Ku, 1-7-22 Suehiro Cho, Kanagawa 2300045, Japan.	taylor@gsc.riken.jp	Hattori, Masahira/AAD-3785-2019; Bruford, Elspeth/AAU-4961-2020; Cuomo, Christina/L-2222-2019; Itoh, Takehiko/E-8873-2014; Taylor, Todd/A-7121-2009; Hattori, Masahira/C-6958-2016	Bruford, Elspeth/0000-0002-8380-5247; Cuomo, Christina/0000-0002-5778-960X; Itoh, Takehiko/0000-0002-6113-557X; Taylor, Todd/0000-0003-4247-6253; Hattori, Masahira/0000-0001-9467-0344; Nicol, Robert/0000-0003-1932-1392	Medical Research Council [G0000107] Funding Source: researchfish; MRC [G0000107] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BRAGG L, 1952, PROC R SOC LON SER-A, V213, P425, DOI 10.1098/rspa.1952.0136; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Hillier LW, 2005, NATURE, V434, P724, DOI 10.1038/nature03466; Hubbard T, 2005, NUCLEIC ACIDS RES, V33, pD447, DOI 10.1093/nar/gki138; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Krogh A, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P179; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Olender Tsviya, 2004, Genet Mol Res, V3, P545; Park HS, 2000, FEBS LETT, V475, P167, DOI 10.1016/S0014-5793(00)01632-X; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SANGER F, 1951, BIOCHEM J, V49, P463, DOI 10.1042/bj0490463; Schmutz J, 2004, NATURE, V429, P365, DOI 10.1038/nature02390; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Suto Y, 1996, GENOMICS, V33, P321, DOI 10.1006/geno.1996.0202; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WIEDEMANN H. R., 1964, J GENET HUM, V13, P223; Yada T, 2003, Pac Symp Biocomput, P375	28	55	788	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					497	500		10.1038/nature04632	http://dx.doi.org/10.1038/nature04632			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554811	Bronze			2022-12-24	WOS:000236176100048
J	Catalona, WJ; Loeb, S; Han, M				Catalona, WJ; Loeb, S; Han, M			Viewpoint: Expanding prostate cancer screening	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RADICAL PROSTATECTOMY; PSA VELOCITY; PREOPERATIVE PSA; ANTIGEN LEVELS; 2.6 NG/ML; MEN; RISK; DISEASE; DEATH	Prostate cancer screening is controversial, and major professional associations offer differing screening guidelines. The authors address 3 key issues about prostate cancer screening: 1) the prostate-specific antigen (PSA) criteria to recommend a prostate biopsy, 2) the appropriate age to start screening, and 3) the appropriate age to stop screening. The authors argue, on the basis of evidence published since 2000, that data supporting the efficacy of PSA screening are convincing. They recommend screening for risk assessment for average-risk men beginning at age 40 years, screening selected healthy men older than age 70 years, and lowering the PSA threshold for considering biopsy to 2.5 ng/mL for all men.	Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; Georgetown Univ, Sch Med, Washington, DC USA	Northwestern University; Feinberg School of Medicine; Georgetown University	Catalona, WJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, 303 E Chicago Ave,Tarry 16-703, Chicago, IL 60611 USA.	wcatalona@nmff.org		Loeb, Stacy/0000-0003-3933-9207				Antenor JAV, 2005, UROLOGY, V66, P156, DOI 10.1016/j.urology.2005.01.008; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; CARTER HB, 1992, JAMA-J AM MED ASSOC, V267, P2215, DOI 10.1001/jama.267.16.2215; CATALONA WJ, 1994, J UROLOGY, V152, P2037, DOI 10.1016/S0022-5347(17)32300-5; CATALONA WJ, 1993, JAMA-J AM MED ASSOC, V270, P948, DOI 10.1001/jama.270.8.948; D'Amico AV, 2005, JAMA-J AM MED ASSOC, V294, P440, DOI 10.1001/jama.294.4.440; D'Amico AV, 2004, NEW ENGL J MED, V351, P125, DOI 10.1056/NEJMoa032975; Fang J, 2002, UROLOGY, V59, P889, DOI 10.1016/S0090-4295(02)01646-1; Howard DH, 2005, J HEALTH ECON, V24, P891, DOI 10.1016/j.jhealeco.2005.03.002; Krumholtz JS, 2002, UROLOGY, V60, P469, DOI 10.1016/S0090-4295(02)01875-7; Krumholtz JS, 2002, UROLOGY, V60, P474; Kundu SD, 2004, J UROLOGY, V172, P2227, DOI 10.1097/01.ju.0000145222.94455.73; KUNDU SD, 2005, AGE SPECIFIC RISK PR, P258; LOEB S, 2006, IN PRESS J UROL; LOEB S, 2005, BASELINE PROSTATE SP, P533; Nadler RB, 2005, J UROLOGY, V174, P2154, DOI 10.1097/01.ju.0000181213.07447.8f; *NAT COMPR CANC NE, 2005, PROST CANC EARL DET; OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860; Pelzer AE, 2005, UROLOGY, V66, P1029, DOI 10.1016/j.urology.2005.05.025; Punglia RS, 2003, NEW ENGL J MED, V349, P335, DOI 10.1056/NEJMoa021659; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Whittemore AS, 2005, J UROLOGY, V174, P872, DOI 10.1097/01.ju.0000169262.18000.8a	22	41	45	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2006	144	6					441	443		10.7326/0003-4819-144-6-200603210-00012	http://dx.doi.org/10.7326/0003-4819-144-6-200603210-00012			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025FX	16549857				2022-12-24	WOS:000236251800009
J	Rothemund, PWK				Rothemund, PWK			Folding DNA to create nanoscale shapes and patterns	NATURE			English	Article							NANOSTRUCTURES; MICROSCOPE; OCTAHEDRON; NANOWIRES; MOLECULE; LATTICES; SURFACE; ARRAYS; DESIGN	'Bottom- up fabrication', which exploits the intrinsic properties of atoms and molecules to direct their self- organization, is widely used to make relatively simple nanostructures. A key goal for this approach is to create nanostructures of high complexity, matching that routinely achieved by ' top- down' methods. The self- assembly of DNA molecules provides an attractive route towards this goal. Here I describe a simple method for folding long, single- stranded DNA molecules into arbitrary two- dimensional shapes. The design for a desired shape is made by raster- filling the shape with a 7- kilobase single- stranded scaffold and by choosing over 200 short oligonucleotide ' staple strands' to hold the scaffold in place. Once synthesized and mixed, the staple and scaffold strands self- assemble in a single step. The resulting DNA structures are roughly 100 nm in diameter and approximate desired shapes such as squares, disks and five- pointed stars with a spatial resolution of 6 nm. Because each oligonucleotide can serve as a 6- nm pixel, the structures can be programmed to bear complex patterns such as words and images on their surfaces. Finally, individual DNA structures can be programmed to form larger assemblies, including extended periodic lattices and a hexamer of triangles ( which constitutes a 30- megadalton molecular complex).	CALTECH, Dept Comp Sci & Computat Neural Syst, Pasadena, CA 91125 USA	California Institute of Technology	Rothemund, PWK (corresponding author), CALTECH, Dept Comp Sci & Computat Neural Syst, Pasadena, CA 91125 USA.	pwkr@dna.caltech.edu						CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Feynman R. P., 1960, ENG SCI, VXXIII, P22, DOI [10.1109/84.128057, DOI 10.1109/84.128057]; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Heinrich AJ, 2002, SCIENCE, V298, P1381, DOI 10.1126/science.1076768; JUNNO T, 1995, APPL PHYS LETT, V66, P3627, DOI 10.1063/1.113809; LABEAN TH, 1999, DIMACS SERIES DISCRE, V54, P123; Le JD, 2004, NANO LETT, V4, P2343, DOI 10.1021/nl048635+; Mao CB, 2004, SCIENCE, V303, P213, DOI 10.1126/science.1092740; Park S.H., 2006, ANGEW CHEM, V118, P749; Reif JH, 2002, LECT NOTES COMPUT SC, V2380, P1; Rothemund PWK, 2004, J AM CHEM SOC, V126, P16344, DOI 10.1021/ja044319l; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; SEEMAN NC, 1990, J BIOMOL STRUCT DYN, V8, P573, DOI 10.1080/07391102.1990.10507829; Seeman NC, 2005, REP PROG PHYS, V68, P237, DOI 10.1088/0034-4885/68/1/R05; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191; Winfree Erik, 1996, DNA BASED COMPUTERS, V27, P199; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yan H, 2003, P NATL ACAD SCI USA, V100, P8103, DOI 10.1073/pnas.1032954100; Yokoyama T, 2001, NATURE, V413, P619, DOI 10.1038/35098059; ZHANG YW, 1994, J AM CHEM SOC, V116, P1661, DOI 10.1021/ja00084a006	24	4742	4941	105	2166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2006	440	7082					297	302		10.1038/nature04586	http://dx.doi.org/10.1038/nature04586			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541064	Green Published			2022-12-24	WOS:000235997600044
J	Dawson, MR; Marivaux, L; Li, CK; Beard, KC; Metais, G				Dawson, MR; Marivaux, L; Li, CK; Beard, KC; Metais, G			Laonastes and the "Lazarus effect'' in recent mammals	SCIENCE			English	Article							RODENTS		Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA; Univ Montpellier 2, Inst Sci Evolut, Lab Paleontol, F-34095 Montpellier 05, France; Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Dawson, MR (corresponding author), Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, 4400 Forbes Ave, Pittsburgh, PA 15213 USA.	dawsonm@carnegiemnh.org	Métais, Grégoire/F-6916-2010; Beard, K. Christopher/AAQ-4438-2021	Beard, K. Christopher/0000-0002-6279-9837				Fara E, 2001, GEOL J, V36, P291, DOI 10.1002/gj.879; Flynn L.J., 1986, AM MUS NOVIT, V2841, P1; Flynn Lawrence J., 2000, Himalayan Geology, V21, P39; FLYNN LJ, 2005, PALAONT ELECT, P1; Jablonski D., 1986, P183; Jenkins P.D., 2004, SYST BIODIVERS, V2, P419, DOI DOI 10.1017/S1477200004001549; LI C-K, 1974, Vertebrata Palasiatica, V12, P43; Marivaux L, 2004, GEODIVERSITAS, V26, P493; Marivaux L, 2003, J VERTEBR PALEONTOL, V23, P420, DOI 10.1671/0272-4634(2003)023[0420:NDABRF]2.0.CO;2; Marivaux L, 2002, ZOOL SCR, V31, P225, DOI 10.1046/j.1463-6409.2002.00074.x; Marivaux L, 2004, ZOOL J LINN SOC-LOND, V142, P105, DOI 10.1111/j.1096-3642.2004.00131.x; Marshall L.G., 1982, Fieldiana Geology, V10, P1; Mein Pierre, 1997, Geodiversitas, V19, P783; NYERS N, 2000, NATURE, V403, P853; WETZEL RM, 1975, SCIENCE, V189, P379, DOI 10.1126/science.189.4200.379	15	65	76	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2006	311	5766					1456	1458		10.1126/science.1124187	http://dx.doi.org/10.1126/science.1124187			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527978				2022-12-24	WOS:000236029400047
J	Englund, JA; Boeckh, M; Kuypers, J; Nichols, WG; Hackman, RC; Morrow, RA; Fredricks, DN; Corey, L				Englund, JA; Boeckh, M; Kuypers, J; Nichols, WG; Hackman, RC; Morrow, RA; Fredricks, DN; Corey, L			Brief communication: Fatal human metapneumovirus infection in stem-cell transplant recipients	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	46th Annual Meeting of the American-Society-of-Hematology	DEC 04-07, 2004	San Diego, CA	Amer Soc Hematol			RESPIRATORY-TRACT DISEASE; TIME RT-PCR; SYNCYTIAL VIRUS; CHILDREN; ADULTS; REPLICATION; SPECIMENS; YOUNG	Background: Human metapneumovirus (hMPV), a recently discovered respiratory virus, is associated with clinical disease in young and elderly persons. Objective: To determine the importance of hMPV in hematopoietic stem-cell transplant recipients. Design: Retrospective survey of patients with consecutive residual bronchoalveolar lavage (BAL) samples. Setting: Referral cancer center. Patients: Hematopoietic stem-cell transplant recipients who underwent BAL because of lower respiratory tract disease. Measurements: Bronchoalveolar lavage specimens were assayed by quantitative real-time polymerase chain reaction methods. Results: Human metapneumovirus was detected in BAL specimens from 5 of 163 patients (3.0%). Persistent viral infection was noted in 3 patients with several samples, and hMPV was detected in 1 of 2 lung specimens tested. Infected patients became symptomatic within the first 40 days after transplantation. Initial symptoms included fever, cough, nasal congestion, and sore throat. Clinical findings included respiratory failure, pulmonary hemorrhage, and culture-negative septic shock. Four of 5 patients died with acute respiratory failure. Limitations: This retrospective study did not evaluate asymptomatic patients or those with mild disease. Conclusion: Human metapneumovirus infection in the lower respiratory tract is associated with respiratory failure in immunocompromised adults who were previously considered to have "idiopathic pneumonia." The infection may result in fulminant respiratory decompensation and shock after transplantation.	Univ Washington, Childrens Hosp & Reg Med Ctr, Seattle, WA 98105 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Englund, JA (corresponding author), Univ Washington, Childrens Hosp & Reg Med Ctr, 4800 Sand Point Way NE,Mail Stop W-8851, Seattle, WA 98105 USA.	janet.englund@seattlechildrens.org	Corey, Lawrence/AAE-1796-2020; Boeckh, Michael/AAA-1607-2022	Corey, Lawrence/0000-0002-2179-2436; Fredricks, David/0000-0003-2735-6800	NCI NIH HHS [P01 CA18029, P30 CA015704, CA 15704, CA 18029] Funding Source: Medline; NIAID NIH HHS [P01 AI 30731] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA015704, P01CA018029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; Cane PA, 2003, BONE MARROW TRANSPL, V31, P309, DOI 10.1038/sj.bmt.1703849; CORDONNIER C, 2003, TRANSPLANT INFECTION, P143; ENGLUND JA, 1988, ANN INTERN MED, V109, P203, DOI 10.7326/0003-4819-109-3-203; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; Fredricks DN, 1999, BIOTECHNIQUES, V26, P198, DOI 10.2144/99262bm04; Fredricks DN, 2000, EMERG INFECT DIS, V6, P273, DOI 10.3201/eid0603.000307; Fukuda T, 2003, BLOOD, V102, P2777, DOI 10.1182/blood-2003-05-1597; Kuiken T, 2004, AM J PATHOL, V164, P1893, DOI 10.1016/S0002-9440(10)63750-9; Kuypers J, 2005, J CLIN VIROL, V33, P299, DOI 10.1016/j.jcv.2004.11.023; Kuypers J, 2004, J CLIN VIROL, V31, P123, DOI 10.1016/j.jcv.2004.03.018; Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004; Musher B, 2004, J CLIN MICROBIOL, V42, P5517, DOI 10.1128/JCM.42.12.5517-5522.2004; Nichols WG, 2001, BLOOD, V98, P573, DOI 10.1182/blood.V98.3.573; Pelletier G, 2002, EMERG INFECT DIS, V8, P976, DOI 10.3201/eid0809.020238; Sumino KC, 2005, J INFECT DIS, V192, P1052, DOI 10.1086/432728; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Williams JV, 2005, J INFECT DIS, V192, P1061, DOI 10.1086/432732; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Zerr DM, 2002, CLIN INFECT DIS, V34, P309, DOI 10.1086/338044	20	177	183	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2006	144	5					344	349		10.7326/0003-4819-144-5-200603070-00010	http://dx.doi.org/10.7326/0003-4819-144-5-200603070-00010			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	021EA	16520475				2022-12-24	WOS:000235965300005
J	Pignone, M; Earnshaw, S; Tice, JA; Pletcher, MJ				Pignone, M; Earnshaw, S; Tice, JA; Pletcher, MJ			Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: A cost-utility analysis	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-DOSE ASPIRIN; CARDIOVASCULAR-DISEASE; SECONDARY PREVENTION; UNSTABLE ANGINA; ARTERY-DISEASE; RISK REDUCTION; STROKE; METAANALYSIS; PRAVASTATIN; MANAGEMENT	Background: Aspirin and statins are both effective for primary prevention of coronary heart disease (CHD), but their combined use has not been well studied. Objective: To perform a cost-utility analysis of the effects of aspirin therapy, statin therapy, combination therapy with both drugs, and no pharmacotherapy for the primary prevention of CHD events in men. Design: Markov model. Data Sources: Published literature. Target Population: Middle-aged men without a history of cardiovascular disease at 6 levels of 10-year risk for CHD (2.5%, 5%, 7.5%, 10%, 15%, and 25%). Time Horizon: Lifetime. Perspective: Third-party payer. Interventions: Low-dose aspirin, a statin, both drugs as combination therapy, or no therapy. Outcome Measure: Cost per quality-adjusted life-year gained. Results of Base-Case Analysis: For 45-year-old men who do not smoke, are not hypertensive, and have a 10-year risk for CHD of 7.5%, aspirin was more effective and less costly than no treatment. The addition of a statin to aspirin therapy produced an incremental cost-utility ratio of $56 200 per quality-adjusted life-year gained compared with aspirin alone. Results of Sensitivity Analysis: Excess risk for hemorrhagic stroke and gastrointestinal bleeding with aspirin, risk for CHD, the cost of statins, and the disutility of taking medication had important effects on the cost-utility ratios. Limitations: Several input parameters, particularly adverse event rates and utility values, are supported by limited empirical data. Results are applicable to middle-aged men only. Conclusions: Compared with no treatment, aspirin is less costly and more effective for preventing CHID events in middle-aged men whose 10-year risk for CHID is 7.5% or higher. The addition of a statin to aspirin therapy becomes more cost-effective when the patient's 10-year CHD risk before treatment is higher than 10%.	Univ N Carolina, RTI, Ctr Hlth Promot Econ, Chapel Hill, NC 27515 USA; RTI Hlth Solut, Res Triangle Pk, NC USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute; University of California System; University of California San Francisco	Pignone, M (corresponding author), Univ N Carolina, UNC Hosp, Div Gen Internal Med, 5039 Old Clin Bldg, Chapel Hill, NC 27599 USA.	pignone@med.unc.edu		Pignone, Michael/0000-0002-6657-7342; Earnshaw, Stephanie/0000-0003-2975-6509; Tice, Jeffrey/0000-0002-9857-2028	OFFICE OF THE DIRECTOR, CENTERS FOR DISEASE CONTROL &PREVENTION [P30CD000138] Funding Source: NIH RePORTER; ODCDC CDC HHS [1P30CD000138-01] Funding Source: Medline	OFFICE OF THE DIRECTOR, CENTERS FOR DISEASE CONTROL &PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); ODCDC CDC HHS		*AM HEART ASS, 2003, HEART DIS STROK STAT, P1; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Ashraf T, 1996, AM J CARDIOL, V78, P409, DOI 10.1016/S0002-9149(96)00328-1; Augustovski FA, 1998, J GEN INTERN MED, V13, P824, DOI 10.1046/j.1525-1497.1998.00246.x; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Berg AO, 2002, ANN INTERN MED, V136, P157, DOI 10.7326/0003-4819-136-2-200201150-00015; Briel M, 2004, AM J MED, V117, P596, DOI 10.1016/j.amjmed.2004.04.022; Briggs AH, 2002, MED DECIS MAKING, V22, P290, DOI 10.1177/027298902400448867; Chen Q, 2000, INQUIRY-J HEALTH CAR, V37, P359; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colwell John A, 2004, Diabetes Care, V27 Suppl 1, pS72; de Feyter PJ, 2002, CIRCULATION, V105, P2367, DOI 10.1161/01.CIR.0000016643.34907.17; DENNIS MS, 1993, STROKE, V24, P796, DOI 10.1161/01.STR.24.6.796; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Eisenstein EL, 2001, MED CARE, V39, P824, DOI 10.1097/00005650-200108000-00008; GAGE BF, 1995, JAMA-J AM MED ASSOC, V274, P1839, DOI 10.1001/jama.274.23.1839; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; Hart RG, 2000, ARCH NEUROL-CHICAGO, V57, P326, DOI 10.1001/archneur.57.3.326; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; He J, 1998, JAMA-J AM MED ASSOC, V280, P1930, DOI 10.1001/jama.280.22.1930; Hennekens CH, 2004, ARCH INTERN MED, V164, P40, DOI 10.1001/archinte.164.1.40; *ING, 2003, ESS RBRVS COMPR LIST; Jonsson B, 2003, J INTERN MED, V253, P472, DOI 10.1046/j.1365-2796.2003.01135.x; Kim C, 2004, AM J PREV MED, V27, P1, DOI 10.1016/j.amepre.2004.03.008; Ladabaum U, 2001, ANN INTERN MED, V135, P769, DOI 10.7326/0003-4819-135-9-200111060-00007; Lampe FC, 2000, EUR HEART J, V21, P1052, DOI 10.1053/euhj.1999.1866; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Mahoney EM, 2002, JAMA-J AM MED ASSOC, V288, P1851, DOI 10.1001/jama.288.15.1851; Marshall T, 2003, BMJ-BRIT MED J, V327, P1264, DOI 10.1136/bmj.327.7426.1264; *MED EC CO, 2003, RED BOOK WIND VERS 5; Minino A M, 2001, Natl Vital Stat Rep, V49, P1; Murphy Michael, 2002, Clin Evid, P91; NAGLIE IG, 1992, MED DECIS MAKING, V12, P239, DOI 10.1177/0272989X9201200401; NEASE RF, 1995, JAMA-J AM MED ASSOC, V273, P1185, DOI 10.1001/jama.273.15.1185; Nelson MR, 2005, BMJ-BRIT MED J, V330, P1306, DOI 10.1136/bmj.38456.676806.8F; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Pignone M, 2000, BRIT MED J, V321, P983, DOI 10.1136/bmj.321.7267.983; Pignone MP, 2001, AM J PREV MED, V20, P77, DOI 10.1016/S0749-3797(01)00255-0; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Rosenson RS, 2004, AM J MED, V116, P408, DOI 10.1016/j.amjmed.2003.10.033; Russell MW, 1998, AM J CARDIOL, V81, P1110, DOI 10.1016/S0002-9149(98)00136-2; Sanmuganathan PS, 2001, HEART, V85, P265, DOI 10.1136/heart.85.3.265; Sheridan S, 2003, J GEN INTERN MED, V18, P1039, DOI 10.1111/j.1525-1497.2003.30107.x; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; State Inpatient Database, 2015, HEALTHC COST UT PROJ; Sudlow C, 2001, Practitioner, V245, P859; Troche CJ, 1998, EUR HEART J, V19, pC59; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; White HD, 2000, NEW ENGL J MED, V343, P317, DOI 10.1056/NEJM200008033430502	50	139	144	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2006	144	5					326	336		10.7326/0003-4819-144-5-200603070-00007	http://dx.doi.org/10.7326/0003-4819-144-5-200603070-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021EA	16520473				2022-12-24	WOS:000235965300003
J	Herbig, U; Ferreira, M; Condel, L; Carey, D; Sedivy, JM				Herbig, U; Ferreira, M; Condel, L; Carey, D; Sedivy, JM			Cellular senescence in aging primates	SCIENCE			English	Article							TELOMERES		Brown Univ, Dept Biochem Mol Biol & Cell Biol, Providence, RI 02903 USA; SW Fdn Biomed Res, Dept Comparat Med, San Antonio, TX 78245 USA	Brown University; Texas Biomedical Research Institute	Sedivy, JM (corresponding author), Brown Univ, Dept Biochem Mol Biol & Cell Biol, Providence, RI 02903 USA.	john_sedivy@brown.edu			NCI NIH HHS [F32 CA099388] Funding Source: Medline; NCRR NIH HHS [P20 RR015578, P51 RR013986] Funding Source: Medline; NHLBI NIH HHS [P01 HL028972] Funding Source: Medline; NIA NIH HHS [R01 AG016694] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA099388] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015578, P51RR013986] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016694] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baerlocher GM, 2003, J LEUKOCYTE BIOL, V73, P289, DOI 10.1189/jlb.0702361; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Cristofalo VJ, 2005, EXP GERONTOL, V40, P836, DOI 10.1016/j.exger.2005.08.005; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	6	748	778	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2006	311	5765					1257	1257		10.1126/science.1122446	http://dx.doi.org/10.1126/science.1122446			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019XB	16456035				2022-12-24	WOS:000235870400032
J	Maier, T; Jenni, S; Ban, N				Maier, T; Jenni, S; Ban, N			Architecture of mammalian fatty acid synthase at 4.5 angstrom resolution	SCIENCE			English	Article							BETA-KETOACYL SYNTHASE; POLYKETIDE BIOSYNTHESIS; CHICKEN LIVER; ACTIVE-SITE; THIOESTERASE; SYNTHETASE; SUBUNIT; ORGANIZATION; FLEXIBILITY; SPECIFICITY	The homodimeric mammalian fatty acid synthase is one of the most complex cellular multienzymes, in that each 270-kilodalton polypeptide chain carries all seven functional domains required for fatty acid synthesis. We have calculated a 4.5 angstrom-resolution x-ray crystallographic map of porcine fatty acid synthase, highly homologous to the human multienzyme, and placed homologous template structures of all individual catalytic domains responsible for the cyclic elongation of fatty acid chains into the electron density. The positioning of domains reveals the complex architecture of the multienzyme forming an intertwined dimer with two lateral semicircular reaction chambers, each containing a full set of catalytic domains required for fatty acid elongation. Large distances between active sites and conformational differences between the reaction chambers demonstrate that mobility of the acyl carrier protein and general flexibility of the multienzyme must accompany handover of the reaction intermediates during the reaction cycle.	ETH, Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ban, N (corresponding author), ETH, Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	ban@mol.biol.ethz.ch	Maier, Timm/A-8835-2016	Maier, Timm/0000-0002-7459-1363				Asturias FJ, 2005, NAT STRUCT MOL BIOL, V12, P225, DOI 10.1038/nsmb899; Brink J, 2002, P NATL ACAD SCI USA, V99, P138, DOI 10.1073/pnas.012589499; Chakravarty B, 2004, P NATL ACAD SCI USA, V101, P15567, DOI 10.1073/pnas.0406901101; Chirala SS, 2001, P NATL ACAD SCI USA, V98, P3104, DOI 10.1073/pnas.051635998; DONADIO S, 1991, SCIENCE, V252, P675, DOI 10.1126/science.2024119; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Joshi AK, 2005, BIOCHEMISTRY-US, V44, P4100, DOI 10.1021/bi047856r; Joshi AK, 1998, BIOCHEMISTRY-US, V37, P2515, DOI 10.1021/bi971886v; Joshi AK, 2003, CHEM BIOL, V10, P169, DOI 10.1016/S1074-5521(03)00023-1; JOSHI AK, 1993, J BIOL CHEM, V268, P22508; Keatinge-Clay AT, 2003, STRUCTURE, V11, P147, DOI 10.1016/S0969-2126(03)00004-2; Kimber MS, 2004, J BIOL CHEM, V279, P52593, DOI 10.1074/jbc.M408105200; KITAMOTO T, 1988, J MOL BIOL, V203, P183, DOI 10.1016/0022-2836(88)90101-5; Koski MK, 2005, J MOL BIOL, V345, P1157, DOI 10.1016/j.jmb.2004.11.009; Kuhajda FP, 2005, TRENDS PHARMACOL SCI, V26, P541, DOI 10.1016/j.tips.2005.09.002; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Kumar MV, 2002, P NATL ACAD SCI USA, V99, P1921, DOI 10.1073/pnas.042683699; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; LIBERTINI LJ, 1978, J BIOL CHEM, V253, P1393; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; LYNEN F, 1967, BIOCHEM J, V102, P381, DOI 10.1042/bj1020381; MATTICK JS, 1983, J BIOL CHEM, V258, P5300; Nordling E, 2002, EUR J BIOCHEM, V269, P4267, DOI 10.1046/j.1432-1033.2002.03114.x; Olsen JG, 2001, STRUCTURE, V9, P233, DOI 10.1016/S0969-2126(01)00583-4; Persson B, 2003, CHEM-BIOL INTERACT, V143, P271, DOI 10.1016/S0009-2797(02)00223-5; Price AC, 2001, BIOCHEMISTRY-US, V40, P12772, DOI 10.1021/bi010737g; Rangan VS, 1998, J BIOL CHEM, V273, P34949, DOI 10.1074/jbc.273.52.34949; Rangan VS, 2001, BIOCHEMISTRY-US, V40, P10792, DOI 10.1021/bi015535z; Reed MAC, 2003, ORG BIOMOL CHEM, V1, P463, DOI 10.1039/b208941f; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; Shen B, 2003, CURR OPIN CHEM BIOL, V7, P285, DOI 10.1016/S1367-5931(03)00020-6; Shimomura Y, 2003, J BACTERIOL, V185, P4211, DOI 10.1128/JB.185.14.4211-4218.2003; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Staunton J, 1996, NAT STRUCT BIOL, V3, P188, DOI 10.1038/nsb0296-188; TIAN WX, 1985, J BIOL CHEM, V260, P1375; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Witkowski A, 2004, CHEM BIOL, V11, P1667, DOI 10.1016/j.chembiol.2004.09.016; Witkowski A, 2002, BIOCHEMISTRY-US, V41, P10877, DOI 10.1021/bi0259047; YUAN Z, 1986, J BIOL CHEM, V261, P3643; Zhang YM, 2003, J LIPID RES, V44, P1, DOI 10.1194/jlr.R200016-JLR200	42	298	322	4	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2006	311	5765					1258	1262		10.1126/science.1123248	http://dx.doi.org/10.1126/science.1123248			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019XB	16513975				2022-12-24	WOS:000235870400033
J	Kainosho, M; Torizawa, T; Iwashita, Y; Terauchi, T; Ono, AM; Guntert, P				Kainosho, M; Torizawa, T; Iwashita, Y; Terauchi, T; Ono, AM; Guntert, P			Optimal isotope labelling for NMR protein structure determinations	NATURE			English	Article							MALTODEXTRIN-BINDING-PROTEIN; MAGNETIC-RESONANCE SPECTRA; TORSION ANGLE DYNAMICS; CELL-FREE SYNTHESIS; CHEMICAL-SHIFT; MULTIDIMENSIONAL NMR; HETERONUCLEAR NMR; C-13; ASSIGNMENTS; RESOLUTION	Nuclear-magnetic-resonance spectroscopy can determine the three-dimensional structure of proteins in solution. However, its potential has been limited by the difficulty of interpreting NMR spectra in the presence of broadened and overlapping resonance lines and low signal-to-noise ratios. Here we present stereo-array isotope labelling ( SAIL), a technique that can overcome many of these problems by applying a complete stereospecific and regiospecific pattern of stable isotopes that is optimal with regard to the quality and information content of the resulting NMR spectra. SAIL uses exclusively chemically and enzymatically synthesized amino acids for cell-free protein expression. We demonstrate for the 17-kDa protein calmodulin and the 41-kDa maltodextrin-binding protein that SAIL offers sharpened lines, spectral simplification without loss of information, and the ability to rapidly collect the structural restraints required to solve a high-quality solution structure for proteins twice as large as commonly solved by NMR. It thus makes a large class of proteins newly accessible to detailed solution structure determination.	JST, CREST, Hachioji, Tokyo 1920397, Japan; Tokyo Metropolitan Univ, Grad Sch Sci, Hachioji, Tokyo 1920397, Japan; RIKEN Genom Sci Ctr, Tatsuo Miyazawa Mem Program, Yokohama, Kanagawa 2300045, Japan	Japan Science & Technology Agency (JST); Tokyo Metropolitan University; RIKEN	Kainosho, M (corresponding author), JST, CREST, 1-1 Minami Ohsawa, Hachioji, Tokyo 1920397, Japan.	kainosho@nmr.chem.metro-u.ac.jp	Güntert, Peter/L-5577-2013	Güntert, Peter/0000-0002-2911-7574				ARATA Y, 1994, METHOD ENZYMOL, V239, P440; Cavanagh J., 1996, PROTEIN NMR SPECTROS; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; Clore GM, 1998, CURR OPIN CHEM BIOL, V2, P564, DOI 10.1016/S1367-5931(98)80084-7; CLORE GM, 1994, PROG BIOPHYS MOL BIO, V62, P153; CORNELL WD, 1995, J AM CHEM SOC, V117, P5197; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Farmer II B. T., 1999, MOD TECHNIQUES PROTE, V16, P75; Gardner KH, 1998, ANNU REV BIOPH BIOM, V27, P357, DOI 10.1146/annurev.biophys.27.1.357; Goto NK, 2000, CURR OPIN STRUC BIOL, V10, P585, DOI 10.1016/S0959-440X(00)00135-4; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1989, J AM CHEM SOC, V111, P3997; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; IKURA M, 1991, BIOCHEMISTRY-US, V30, P9216, DOI 10.1021/bi00102a013; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; Kennedy Michael A., 2002, Journal of Structural and Functional Genomics, V2, P155, DOI 10.1023/A:1021261026670; KIGAWA T, 1995, J BIOMOL NMR, V6, P129, DOI 10.1007/BF00211776; Koradi R, 2000, COMPUT PHYS COMMUN, V124, P139, DOI 10.1016/S0010-4655(99)00436-1; LEMASTER DM, 1987, FEBS LETT, V223, P191, DOI 10.1016/0014-5793(87)80534-3; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MARKLEY JL, 1968, SCIENCE, V161, P1249, DOI 10.1126/science.161.3847.1249; MCINTOSH LP, 1990, Q REV BIOPHYS, V23, P1, DOI 10.1017/S0033583500005400; Mueller GA, 2000, J MOL BIOL, V300, P197, DOI 10.1006/jmbi.2000.3842; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; NILGES M, 1990, BIOPOLYMERS, V29, P813, DOI 10.1002/bip.360290415; Oba M, 2001, J ORG CHEM, V66, P5919, DOI 10.1021/jo010263r; Oba M, 1998, TETRAHEDRON LETT, V39, P1595, DOI 10.1016/S0040-4039(98)00037-9; Oba M, 1999, TETRAHEDRON-ASYMMETR, V10, P937, DOI 10.1016/S0957-4166(99)00083-X; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; SHARFF AJ, 1993, BIOCHEMISTRY-US, V32, P10553, DOI 10.1021/bi00091a004; Torizawa T, 2005, J AM CHEM SOC, V127, P12620, DOI 10.1021/ja051386m; Torizawa T, 2004, J BIOMOL NMR, V30, P311, DOI 10.1007/s10858-004-3534-2; VUISTER GW, 1992, J MAGN RESON, V98, P428, DOI 10.1016/0022-2364(92)90144-V; Yamazaki T, 1998, J AM CHEM SOC, V120, P5591, DOI 10.1021/ja980776o; ZUBAY G, 1973, ANNU REV GENET, V7, P267, DOI 10.1146/annurev.ge.07.120173.001411	37	368	378	2	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 2	2006	440	7080					52	57		10.1038/nature04525	http://dx.doi.org/10.1038/nature04525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HW	16511487				2022-12-24	WOS:000235685700036
J	Srivastava, R				Srivastava, R			Doctors need doctors too	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												docranjana@gmail.com							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 22	2006	295	8					866	867		10.1001/jama.295.8.866	http://dx.doi.org/10.1001/jama.295.8.866			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014DO	16493091				2022-12-24	WOS:000235459200001
J	Yin, L; Wang, J; Klein, PS; Lazar, MA				Yin, L; Wang, J; Klein, PS; Lazar, MA			Nuclear receptor Rev-erba is a critical lithium-sensitive component of the circadian clock	SCIENCE			English	Article							GENE-EXPRESSION; BIPOLAR DISORDER; VALPROIC ACID; TRANSCRIPTION; CELLS; DEACETYLASE; INHIBITORS; DROSOPHILA; MECHANISM; RHYTHMS	Lithium is commonly used to treat bipolar disorder, which is associated with altered circadian rhythm. Lithium is a potent inhibitor of glycogen synthase kinase 3 (GSK3), which regulates circadian rhythm in several organisms. In experiments with cultured cells, we show here that GSK3 beta phosphorylates and stabilizes the orphan nuclear receptor Rev-erb alpha, a negative component of the circadian clock. Lithium treatment of cells leads to rapid proteasomal degradation of Rev-erb alpha and activation of clock gene Bmal1. A form of Rev-erb alpha that is insensitive to lithium interferes with the expression of circadian genes. Control of Rev-erb alpha protein stability is thus a critical component of the peripheral clock and a biological target of lithium therapy.	Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Div Hematol & Oncol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Lazar, MA (corresponding author), Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, 415 Curie Blvd, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045586, P30DK019525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058324] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 19525, DK45586] Funding Source: Medline; NIMH NIH HHS [MH058324, R01 MH058324-07, R01 MH058324-08, R01 MH058324] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abe M, 2000, NEUROREPORT, V11, P3261, DOI 10.1097/00001756-200009280-00042; Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Benedetti F, 2004, NEUROSCI LETT, V368, P123, DOI 10.1016/j.neulet.2004.06.050; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dokucu ME, 2005, NEUROPSYCHOPHARMACOL, V30, P2216, DOI 10.1038/sj.npp.1300764; Eide EJ, 2005, METHOD ENZYMOL, V393, P408, DOI 10.1016/S0076-6879(05)93019-X; Gachon F, 2004, CHROMOSOMA, V113, P103, DOI 10.1007/s00412-004-0296-2; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GELENBERG AJ, 1989, NEW ENGL J MED, V321, P1489, DOI 10.1056/NEJM198911303212201; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Iwahana E, 2004, EUR J NEUROSCI, V19, P2281, DOI 10.1111/j.0953-816X.2004.03322.x; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lenox RH, 2002, AM J MED GENET, V114, P391, DOI 10.1002/ajmg.10360; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Mansour HA, 2005, ANN MED, V37, P196, DOI 10.1080/07853890510007377; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Nagoshi E, 2005, METHOD ENZYMOL, V393, P543, DOI 10.1016/S0076-6879(05)93028-0; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Ripperger JA, 2000, GENE DEV, V14, P679; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200	29	404	424	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2006	311	5763					1002	1005		10.1126/science.1121613	http://dx.doi.org/10.1126/science.1121613			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014CS	16484495				2022-12-24	WOS:000235456900046
J	Brent, AJ; Ahmed, I; Ndiritu, M; Lewa, P; Ngetsa, C; Lowe, B; English, M; Berkeley, JA; Scott, JAG				Brent, AJ; Ahmed, I; Ndiritu, M; Lewa, P; Ngetsa, C; Lowe, B; English, M; Berkeley, JA; Scott, JAG			Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study	LANCET			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; OCCULT BACTEREMIA; EMERGENCY-DEPARTMENT; FEBRILE CHILDREN; YOUNG-CHILDREN; DEATH; BLOOD	Background Estimates of the burden of invasive bacterial disease in sub-Saharan Africa have previously relied on selected groups of patients, such as inpatients; they are, therefore, probably underestimated, potentially hampering vaccine implementation. Our aim was to assess the incidence of bacteraemia in all children presenting to a hospital in Kenya, irrespective of clinical presentation or decision to admit. Methods We did a community-based observational study for which we cultured blood from 1093 children who visited a Kenyan hospital outpatient department. We estimated bacteraemia incidence with a Demographic Surveillance System, and investigated the clinical significance of bacteraemia and the capacity of clinical signs to identify cases. Results The yearly incidence of bacteraemia per 100 000 children aged younger than 2 years and younger than 5 years was 2440 (95% CI 1307-3573) and 1192 (692-1693), respectively. Incidence of pneumococcal bacteraemia was 597 (416-778) per 100 000 person-years of observation in children younger than age 5 years. Three-quarters of episodes had a clinical focus or required admission, or both; one in six was fatal. After exclusion of children with occult bacteraemia, the incidence of clinically significant bacteraemia per 100 000 children younger than age 2 years or 5 years fell to 1741 (790-2692) and 909 (475-1343), respectively, and the yearly incidence of clinically significant pneumococcal bacteraemia was 436 (132-739) per 100 000 children younger than 5 years old. Clinical signs identified bacteraemia poorly. Interpretation Clinically significant bacteraemia in children in Kilifil is twice as common, and pneumococcal bacteraemia four times as common, as previously estimated. Our data support the introduction of pneumococcal vaccine in sub-Saharan Africa.	Wellcome Trust KEMRI Ctr Geog Med Res, Kilifi, Kenya; Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Brent, AJ (corresponding author), John Radcliffe Hosp, Nuffield Dept Infect Dis & Microbiol, Oxford OX3 9DU, England.	andrew_brent@doctors.org.uk		Berkley, James/0000-0002-1236-849X	Wellcome Trust [061089, 050563, 083579, 081697, 081835] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alpern ER, 2000, PEDIATRICS, V106, P505, DOI 10.1542/peds.106.3.505; Bahwere P, 2001, Int J Infect Dis, V5, P180, DOI 10.1016/S1201-9712(01)90067-0; BASS JW, 1993, PEDIATR INFECT DIS J, V12, P466, DOI 10.1097/00006454-199306000-00003; Berkley JA, 2005, NEW ENGL J MED, V352, P1380; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; FLEISHER GR, 1994, J PEDIATR-US, V124, P504, DOI 10.1016/S0022-3476(05)83126-9; GHIORGHIS B, 1992, E AFR MED J, V69, P74; JAFFE DM, 1987, NEW ENGL J MED, V317, P1175, DOI 10.1056/NEJM198711053171902; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; LEPAGE P, 1987, LANCET, V1, P1458; Luck S, 2003, LANCET, V361, P1953, DOI 10.1016/S0140-6736(03)13553-2; MCGOWAN JE, 1973, NEW ENGL J MED, V288, P1309, DOI 10.1056/NEJM197306212882501; MCINTYRE P, 1983, BRIT MED J, V286, P1055, DOI 10.1136/bmj.286.6370.1055-a; MCINTYRE P, 1983, BRIT MED J, V286, P203, DOI 10.1136/bmj.286.6360.203; Molyneux CS, 2002, J BIOSOC SCI, V34, P109, DOI 10.1017/S0021932002001098; Mulholland EK, 2005, NEW ENGL J MED, V352, P75, DOI 10.1056/NEJMe048306; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; Mulholland K, 1999, PEDIATR INFECT DIS J, V18, pS17; MUNGALA VO, 1994, E AFR MED J, V71, P747; Norton EB, 2004, PEDIATR INFECT DIS J, V23, P145, DOI 10.1097/01.inf.0000109258.82988.40; SAEZLLORENS X, 1995, PEDIATR INFECT DIS J, V14, P557, DOI 10.1097/00006454-199507000-00001; Stoll ML, 2004, ARCH PEDIAT ADOL MED, V158, P671, DOI 10.1001/archpedi.158.7.671; TEELE DW, 1975, J PEDIATR-US, V87, P227, DOI 10.1016/S0022-3476(75)80584-1; TEELE DW, 1979, PEDIATR CLIN N AM, V26, P773; UNAIDS AND WHO, 2003, AIDS EP UPD 2003, p[5, 20]; Walsh AL, 2000, PEDIATR INFECT DIS J, V19, P312, DOI 10.1097/00006454-200004000-00010; *WHO, 1997, IMCI JOINT WHO UNICE; *WHO, 1997, IMCI CHART BOOKL; World Health Organization, 2000, MAN CHILD SER INF SE; 2003, KENYA DEMOGRAPHIC HL, P38	33	115	117	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2006	367	9509					482	488		10.1016/S0140-6736(06)68180-4	http://dx.doi.org/10.1016/S0140-6736(06)68180-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	013FF	16473125				2022-12-24	WOS:000235394500029
J	McGrath, PT; Iniesta, AA; Ryan, KR; Shapiro, L; McAdams, HH				McGrath, PT; Iniesta, AA; Ryan, KR; Shapiro, L; McAdams, HH			A dynamically localized protease complex and a polar specificity factor control a cell cycle master regulator	CELL			English	Article							CAULOBACTER MCPA CHEMORECEPTOR; SIGNAL-TRANSDUCTION PROTEIN; BACTERIAL CHEMORECEPTOR; RESPONSE REGULATOR; ESCHERICHIA-COLI; HISTIDINE KINASE; DNA-REPLICATION; CLPXP PROTEASE; CRESCENTUS; PROTEOLYSIS	Regulated proteolysis is essential for cell cycle progression in both prokaryotes and eukaryotes. We show here that the ClpXP protease, responsible for the degradation of multiple bacterial proteins, is dynamically localized to specific cellular positions in Caulobacter where it degrades colocalized proteins. The CtrA cell cycle master regulator, that must be cleared from the Caulobacter cell to allow the initiation of chromosome replication, interacts with the ClpXP protease at the cell pole where it is degraded. We have identified a novel, conserved protein, RcdA, that forms a complex with CtrA and ClpX in the cell. RcdA is required for CtrA polar localization and degradation by ClpXP. The localization pattern of RcdA is coincident with and dependent upon ClpX localization. Thus, a dynamically localized ClpXP proteolysis complex in concert with a cytoplasmic factor provides temporal and spatial specificity to protein degradation during a bacterial cell cycle.	Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Stanford University; Stanford University; University of California System; University of California Berkeley	McGrath, PT (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	shapiro@stanford.edu	Iniesta, Antonio A/G-7798-2015	Iniesta, Antonio A/0000-0002-7629-1057	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032506, R37GM032506] Funding Source: NIH RePORTER; NHGRI NIH HHS [T32 HG00044] Funding Source: Medline; NIGMS NIH HHS [GM32506] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ades SE, 2004, CURR BIOL, V14, pR924, DOI 10.1016/j.cub.2004.10.015; Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; Alley MRK, 2001, MOL MICROBIOL, V40, P1335, DOI 10.1046/j.1365-2958.2001.02476.x; ALLEY MRK, 1992, GENE DEV, V6, P825, DOI 10.1101/gad.6.5.825; ALLEY MRK, 1993, SCIENCE, V259, P1754, DOI 10.1126/science.8456303; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BlondeletRouault MH, 1997, GENE, V190, P315, DOI 10.1016/S0378-1119(97)00014-0; Chen JC, 2005, MOL MICROBIOL, V55, P1085, DOI 10.1111/j.1365-2958.2004.04443.x; Crosson S, 2004, CELL CYCLE, V3, P1252, DOI 10.4161/cc.3.10.1181; Din N, 1998, MOL MICROBIOL, V27, P1051, DOI 10.1046/j.1365-2958.1998.00752.x; Domian IJ, 1999, P NATL ACAD SCI USA, V96, P6648, DOI 10.1073/pnas.96.12.6648; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; EDWARDS P, 1991, J BACTERIOL, V173, P5568, DOI 10.1128/jb.173.17.5568-5572.1991; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Holtzendorff J, 2004, SCIENCE, V304, P983, DOI 10.1126/science.1095191; Hung DY, 2002, P NATL ACAD SCI USA, V99, P13160, DOI 10.1073/pnas.202495099; Jacobs C, 2003, MOL MICROBIOL, V47, P1279, DOI 10.1046/j.1365-2958.2003.03379.x; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; Judd EM, 2003, P NATL ACAD SCI USA, V100, P8235, DOI 10.1073/pnas.1433105100; Kelly AJ, 1998, GENE DEV, V12, P880, DOI 10.1101/gad.12.6.880; LANGE R, 1994, GENE DEV, V8, P1600, DOI 10.1101/gad.8.13.1600; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Martin ME, 2004, MOL MICROBIOL, V54, P60, DOI 10.1111/j.1365-2958.2004.04251.x; Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019; Msadek T, 1998, MOL MICROBIOL, V27, P899, DOI 10.1046/j.1365-2958.1998.00735.x; Osteras M, 1999, J BACTERIOL, V181, P3039; Potocka I, 2002, J BACTERIOL, V184, P6635, DOI 10.1128/JB.184.23.6635-6642.2002; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Reisenauer A, 2002, EMBO J, V21, P4969, DOI 10.1093/emboj/cdf490; Ryan KR, 2004, P NATL ACAD SCI USA, V101, P7415, DOI 10.1073/pnas.0402153101; Ryan KR, 2002, J MOL BIOL, V324, P443, DOI 10.1016/S0022-2836(02)01042-2; Skerker JM, 2004, NAT REV MICROBIOL, V2, P325, DOI 10.1038/nrmicro864; Skerker JM, 2000, EMBO J, V19, P3223, DOI 10.1093/emboj/19.13.3223; Tsai JW, 2001, J BACTERIOL, V183, P5001, DOI 10.1128/JB.183.17.5001-5007.2001; Viollier PH, 2004, CURR OPIN MICROBIOL, V7, P572, DOI 10.1016/j.mib.2004.10.005; Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999; Weart RB, 2005, MOL MICROBIOL, V57, P238, DOI 10.1111/j.1365-2958.2005.04673.x	41	135	137	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 10	2006	124	3					535	547		10.1016/j.cell.2005.12.033	http://dx.doi.org/10.1016/j.cell.2005.12.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	014FG	16469700	Bronze			2022-12-24	WOS:000235464000016
J	Lee, JB; Hite, RK; Hamdan, SM; Xie, XS; Richardson, CC; van Oijen, AM				Lee, JB; Hite, RK; Hamdan, SM; Xie, XS; Richardson, CC; van Oijen, AM			DNA primase acts as a molecular brake in DNA replication	NATURE			English	Article							LAGGING-STRAND SYNTHESIS; GENE 4 HELICASE/PRIMASE; BACTERIOPHAGE T7; SINGLE-MOLECULE; POLYMERASE; PROTEIN; MECHANISM; BINDING; PROCESSIVITY; KINETICS	A hallmark feature of DNA replication is the coordination between the continuous polymerization of nucleotides on the leading strand and the discontinuous synthesis of DNA on the lagging strand(1). This synchronization requires a precisely timed series of enzymatic steps that control the synthesis of an RNA primer, the recycling of the lagging-strand DNA polymerase, and the production of an Okazaki fragment. Primases synthesize RNA primers at a rate that is orders of magnitude lower(2-4) than the rate of DNA synthesis by the DNA polymerases at the fork. Furthermore, the recycling of the lagging-strand DNA polymerase from a finished Okazaki fragment to a new primer is inherently slower than the rate of nucleotide polymerization(5). Different models have been put forward to explain how these slow enzymatic steps can take place at the lagging strand without losing coordination with the continuous and fast leading-strand synthesis(6-8). Nonetheless, a clear picture remains elusive. Here we use single-molecule techniques to study the kinetics of a multiprotein replication complex from bacteriophage T7 and to characterize the effect of primase activity on fork progression. We observe the synthesis of primers on the lagging strand to cause transient pausing of the highly processive leading-strand synthesis. In the presence of both leading- and lagging-strand synthesis, we observe the formation and release of a replication loop on the lagging strand. Before loop formation, the primase acts as a molecular brake and transiently halts progression of the replication fork. This observation suggests a mechanism that prevents leading- strand synthesis from outpacing lagging-strand synthesis during the slow enzymatic steps on the lagging strand.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Grad Program Biol & Biomed Sci, Boston, MA 02115 USA; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	van Oijen, AM (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 250 Longwood Ave, Boston, MA 02115 USA.	antoine_van_oijen@hms.harvard.edu	Lee, Jong-Bong/AAH-4669-2020; van Oijen, Antoine/I-3167-2014	van Oijen, Antoine/0000-0002-1794-5161; Hamdan, Samir/0000-0001-5192-1852				Ahnert P, 2000, EMBO J, V19, P3418, DOI 10.1093/emboj/19.13.3418; Alberts B, 2003, NATURE, V421, P431, DOI 10.1038/nature01407; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; BERNSTEIN JA, 1988, J BIOL CHEM, V263, P14891; BERNSTEIN JA, 1988, P NATL ACAD SCI USA, V85, P396, DOI 10.1073/pnas.85.2.396; Bustamante C, 2000, CURR OPIN STRUC BIOL, V10, P279, DOI 10.1016/S0959-440X(00)00085-3; Frick DN, 1999, J BIOL CHEM, V274, P35889, DOI 10.1074/jbc.274.50.35889; Frick DN, 1998, P NATL ACAD SCI USA, V95, P7957, DOI 10.1073/pnas.95.14.7957; Frick DN, 1999, J BIOL CHEM, V274, P35899, DOI 10.1074/jbc.274.50.35899; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; He ZG, 2004, J BIOL CHEM, V279, P22190, DOI 10.1074/jbc.M401100200; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; KOLODNER R, 1978, J BIOL CHEM, V253, P574; Kusakabe T, 1998, EMBO J, V17, P1542, DOI 10.1093/emboj/17.5.1542; Lee J, 2002, J MOL BIOL, V316, P19, DOI 10.1006/jmbi.2001.5325; Maier B, 2000, P NATL ACAD SCI USA, V97, P12002, DOI 10.1073/pnas.97.22.12002; Mitkova AV, 2003, J BIOL CHEM, V278, P52253, DOI 10.1074/jbc.M308956200; Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425; Salinas F, 2000, P NATL ACAD SCI USA, V97, P7196, DOI 10.1073/pnas.97.13.7196; SHEAFF RJ, 1993, BIOCHEMISTRY-US, V32, P3027, DOI 10.1021/bi00063a014; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; Swart JR, 1995, BIOCHEMISTRY-US, V34, P16097, DOI 10.1021/bi00049a025; TABOR S, 1987, J BIOL CHEM, V262, P16212; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tougu K, 1996, J BIOL CHEM, V271, P21398, DOI 10.1074/jbc.271.35.21398; van Oijen AM, 2003, SCIENCE, V301, P1235, DOI 10.1126/science.1084387; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; Yang JS, 2005, J BIOL CHEM, V280, P25416, DOI 10.1074/jbc.M501847200	30	215	222	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2006	439	7076					621	624		10.1038/nature04317	http://dx.doi.org/10.1038/nature04317			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008IO	16452983	Green Published, Green Submitted			2022-12-24	WOS:000235033900048
J	Burton, RA; Wilson, SM; Hrmova, M; Harvey, AJ; Shirley, NJ; Stone, BA; Newbigin, EJ; Bacic, A; Fincher, GB				Burton, RA; Wilson, SM; Hrmova, M; Harvey, AJ; Shirley, NJ; Stone, BA; Newbigin, EJ; Bacic, A; Fincher, GB			Cellulose synthase-like CslF genes mediate the synthesis of cell wall (1,3;1,4)-beta-D-glucans	SCIENCE			English	Article							MONOCLONAL-ANTIBODY; HIGHER-PLANTS; BARLEY; FAMILY; ARABIDOPSIS; REVEALS	A characteristic feature of grasses and commercially important cereals is the presence of (1,3; 1,4)-beta-D-glucans in their cell walls. We have used comparative genomics to link a major quantitative trait locus for (1,3; 1,4)-beta-D-glucan content in barley grain to a cluster of cellulose synthase-like CslF genes in rice. After insertion of rice CslF genes into Arabidopsis, we detected (1,3; 1,4)-beta-D-glucan in walls of transgenic plants using specific monoclonal antibodies and enzymatic analysis. Because wild-type Arabidopsis does not contain CslF genes or have (1,3; 1,4)-beta-D-glucans in its walls, these experiments provide direct, gain-of-function evidence for the participation of rice CslF genes in (1,3; 1,4)-beta-D-glucan biosynthesis.	Univ Adelaide, Sch Agr Food & Wine, Australian Ctr Plant Funct Genom, Glen Osmond, SA 5064, Australia; Univ Melbourne, Sch Bot, Australian Ctr Plant Funct Genom, Parkville, Vic 3010, Australia; La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia	University of Adelaide; University of Melbourne; La Trobe University	Fincher, GB (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Australian Ctr Plant Funct Genom, Waite Campus, Glen Osmond, SA 5064, Australia.	geoff.fincher@adelaide.edu.au	Hrmova, Maria/AAH-3951-2020; Burton, Rachel A/C-4441-2011	Burton, Rachel A/0000-0002-0638-4709; Newbigin, Ed/0000-0002-9644-302X; Shirley, Neil/0000-0001-8114-9891; Bacic, Tony/0000-0001-7483-8605; Harvey, Andrew John/0000-0002-3488-0531; Hrmova, Maria/0000-0002-3545-0605				Bacic A., 1988, BIOCHEM PLANT, V14, P297, DOI [DOI 10.1016/B978-0-08-092615-5.50014-X, 10.1016/B978-0-08-092615-5.50014-X]; BRAATEN JT, 1994, EUR J CLIN NUTR, V48, P465; Brennan CS, 2005, J CEREAL SCI, V42, P1, DOI 10.1016/j.jcs.2005.01.002; Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; BURTON RA, UNPUB; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Coutinho PM, 1999, ROY SOC CH, P3; Dhugga KS, 2004, SCIENCE, V303, P363, DOI 10.1126/science.1090908; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; HAN F, 1995, THEOR APPL GENET, V91, P921, DOI 10.1007/BF00223901; Hazen SP, 2002, PLANT PHYSIOL, V128, P336, DOI 10.1104/pp.010875; Liepman AH, 2005, P NATL ACAD SCI USA, V102, P2221, DOI 10.1073/pnas.0409179102; McLaren JS, 2005, TRENDS BIOTECHNOL, V23, P339, DOI 10.1016/j.tibtech.2005.04.004; MEIKLE PJ, 1994, PLANT J, V5, P1, DOI 10.1046/j.1365-313X.1994.5010001.x; Pear JR, 1996, P NATL ACAD SCI USA, V93, P12637, DOI 10.1073/pnas.93.22.12637; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Saxena IM, 1997, CELLULOSE, V4, P33, DOI 10.1023/A:1018411101036; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Stewart RJ, 2001, PROTEIN ENG, V14, P245, DOI 10.1093/protein/14.4.245; Taylor NG, 2000, PLANT CELL, V12, P2529, DOI 10.1105/tpc.12.12.2529; Trethewey JAK, 2005, AM J BOT, V92, P1660, DOI 10.3732/ajb.92.10.1660; Wilson Z. E., UNPUB; ZABLACKIS E, 1995, PLANT PHYSIOL, V107, P1129, DOI 10.1104/pp.107.4.1129; [No title captured]	24	319	345	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 31	2006	311	5769					1940	1942		10.1126/science.1122975	http://dx.doi.org/10.1126/science.1122975			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16574868				2022-12-24	WOS:000236387800049
J	Downey, M; Houlsworth, R; Maringele, L; Rollie, A; Brehme, M; Galicia, S; Guillard, S; Partington, M; Zubko, MK; Krogan, NJ; Emili, A; Greenblatt, JF; Harrington, L; Lydall, D; Durocher, D				Downey, M; Houlsworth, R; Maringele, L; Rollie, A; Brehme, M; Galicia, S; Guillard, S; Partington, M; Zubko, MK; Krogan, NJ; Emili, A; Greenblatt, JF; Harrington, L; Lydall, D; Durocher, D			A genome-wide screen identifies the evolutionarily conserved KEOPS complex as a telomere regulator	CELL			English	Article							SINGLE-STRANDED-DNA; DE-NOVO TELOMERE; SACCHAROMYCES-CEREVISIAE; CHROMOSOME ENDS; CHECKPOINT PATHWAYS; YEAST PID261/BUD32; BINDING PROTEIN; CDC13-1 MUTANTS; IN-VIVO; DAMAGE	Telomere capping is the essential function of telomeres. To identify new genes involved in telomere capping, we carried out a genome-wide screen in Saccharomyces cerevisiae for suppressors of cdc13-1, an allele of the telomere-capping protein Cdc13. We report the identification of five novel suppressors, including the previously uncharacterized gene YML036W, which we name CGI121. Cgi121 is part of a conserved protein complex-the KEOPS complex-containing the protein kinase Bud32, the putative peptidase Kae1, and the uncharacterized protein Gon7. Deletion of CGI121 suppresses cdc13-1 via the dramatic reduction in ssDNA levels that accumulate in cdc13-1 cgi121 mutants. Deletion of BUD32 or other KEOPS components leads to short telomeres and at failure to add telomeres de novo to DNA double-strand breaks. Our results therefore indicate that the KEOPS complex promotes both telomere uncapping and telomere elongation.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 1A8, Canada; Univ Toronto, Grad Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Princess Margaret Hosp, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Res Ctr Mol Med, A-1090 Vienna, Austria; Inst Canc Res, Ctr Canc Therapeut, Sutton SM2 5NG, Surrey, England; Univ Newcastle, Newcastle Gen Hosp, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Univ Newcastle, Newcastle Gen Hosp, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Univ Newcastle, Newcastle Gen Hosp, Ctr Integrated Syst Biol Ageing & Nutr, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Manchester; University of London; Institute of Cancer Research - UK; Newcastle General Hospital; Newcastle University - UK; Newcastle General Hospital; Newcastle University - UK; Newcastle General Hospital; Newcastle University - UK	Lydall, D (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	d.a.lydall@ncl.ac.uk; durocher@mshri.on.ca	Brehme, Marc/G-8697-2015; Durocher, Daniel/A-7733-2010	Brehme, Marc/0000-0003-0694-331X; Durocher, Daniel/0000-0003-3863-8635	Wellcome Trust [075294, 054371] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bertuch AA, 2004, GENETICS, V166, P1651, DOI 10.1534/genetics.166.4.1651; Bianchi A, 2004, MOL CELL, V16, P139, DOI 10.1016/j.molcel.2004.09.009; Booth C, 2001, NUCLEIC ACIDS RES, V29, P4414, DOI 10.1093/nar/29.21.4414; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Cervantes RB, 2002, CURR OPIN CELL BIOL, V14, P351, DOI 10.1016/S0955-0674(02)00325-3; Chan SWL, 2003, MOL CELL, V11, P1379, DOI 10.1016/S1097-2765(03)00174-6; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chen QJ, 2001, MOL CELL BIOL, V21, P1819, DOI 10.1128/MCB.21.5.1819-1827.2001; Chiu SY, 2003, RNA, V9, P77, DOI 10.1261/rna.2137903; COHN M, 1995, SCIENCE, V269, P396, DOI 10.1126/science.7618104; Craven RJ, 1999, GENETICS, V152, P1531; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; Diede SJ, 2001, CURR BIOL, V11, P1336, DOI 10.1016/S0960-9822(01)00400-6; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; DuBois ML, 2002, GENETICS, V161, P995; Enomoto S, 2004, MOL CELL BIOL, V24, P837, DOI 10.1128/MCB.24.2.837-845.2004; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Facchin S, 2003, FEBS LETT, V549, P63, DOI 10.1016/S0014-5793(03)00770-1; Facchin S, 2002, BIOCHEM J, V364, P457, DOI 10.1042/BJ20011376; Fukuhara N, 2005, MOL CELL, V17, P537, DOI 10.1016/j.molcel.2005.01.010; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Grandin N, 2001, EMBO J, V20, P6127, DOI 10.1093/emboj/20.21.6127; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hackett JA, 2003, MOL CELL BIOL, V23, P8450, DOI 10.1128/MCB.23.23.8450-8461.2003; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; HE F, 1993, P NATL ACAD SCI USA, V90, P7034, DOI 10.1073/pnas.90.15.7034; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hughes TR, 2000, P NATL ACAD SCI USA, V97, P6457, DOI 10.1073/pnas.97.12.6457; Kanellis P, 2003, CURR BIOL, V13, P1583, DOI 10.1016/S0960-9822(03)00578-5; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; Lopreiato R, 2004, BIOCHEM J, V377, P395, DOI 10.1042/BJ20030638; Lottersberger F, 2003, GENETICS, V165, P1717; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Lydall D, 2003, J CELL SCI, V116, P4057, DOI 10.1242/jcs.00765; Mangahas JL, 2001, MOL BIOL CELL, V12, P4078, DOI 10.1091/mbc.12.12.4078; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Miyoshi A, 2003, BIOCHEM BIOPH RES CO, V303, P399, DOI 10.1016/S0006-291X(03)00333-4; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Reichenbach P, 2003, CURR BIOL, V13, P568, DOI 10.1016/S0960-9822(03)00173-8; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Seki Y, 2002, GENE, V285, P101, DOI 10.1016/S0378-1119(02)00429-8; Snow BE, 2003, CURR BIOL, V13, P698, DOI 10.1016/S0960-9822(03)00210-0; Stellwagen AE, 2003, GENE DEV, V17, P2384, DOI 10.1101/gad.1125903; Taggart AKP, 2003, CURR OPIN CELL BIOL, V15, P275, DOI 10.1016/S0955-0674(03)00040-1; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Teo SH, 2001, EMBO REP, V2, P197, DOI 10.1093/embo-reports/kve038; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Zhou JL, 2000, MOL CELL BIOL, V20, P1947, DOI 10.1128/MCB.20.6.1947-1955.2000; Zubko MK, 2004, GENETICS, V168, P103, DOI 10.1534/genetics.104.027904	60	139	149	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1155	1168		10.1016/j.cell.2005.12.044	http://dx.doi.org/10.1016/j.cell.2005.12.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564010	Bronze			2022-12-24	WOS:000237241400017
J	Leite, M				Leite, M			Stem cell research in Brazil: A difficult launch	CELL			English	Editorial Material								It has been one year since Brazil passed a law enabling scientists to work with human embryonic stem cells and to derive new stem cell lines from human embryos. But several major hurdles have put human embryonic stem cell research on hold.											0	6	6	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 24	2006	124	6					1107	1109		10.1016/j.cell.2006.03.003	http://dx.doi.org/10.1016/j.cell.2006.03.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16563999	Bronze			2022-12-24	WOS:000237241400006
J	Squire, SB; Obasi, A; Nhlema-Simwaka, B				Squire, SB; Obasi, A; Nhlema-Simwaka, B			The Global Plan to Stop TB: a unique opportunity to address poverty and the Millennium Development Goals	LANCET			English	Editorial Material									Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Res Equ & Community Hlth Trust, Lilongwe, Malawi	Liverpool School of Tropical Medicine; University of Liverpool	Squire, SB (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	sbsquire@liv.ac.uk	Obasi, Angela/AAK-4395-2021	Obasi, Angela/0000-0001-6801-8889; Squire, Stephen/0000-0001-7173-9038				Squire SB, 2005, INT J TUBERC LUNG D, V9, P25; TUDORHART J, 1971, LANCET, V1, P405; World Health Organization, 2005, WHOHTMTB2005352; 2005, LANCET, V366, P2063	4	18	20	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					955	957		10.1016/S0140-6736(06)68393-1	http://dx.doi.org/10.1016/S0140-6736(06)68393-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546551				2022-12-24	WOS:000236242100039
J	Berkes, F; Hughes, TP; Steneck, RS; Wilson, JA; Bellwood, DR; Crona, B; Folke, C; Gunderson, LH; Leslie, HM; Norberg, J; Nystrom, M; Olsson, P; Osterblom, H; Scheffer, M; Worm, B				Berkes, F; Hughes, TP; Steneck, RS; Wilson, JA; Bellwood, DR; Crona, B; Folke, C; Gunderson, LH; Leslie, HM; Norberg, J; Nystrom, M; Olsson, P; Osterblom, H; Scheffer, M; Worm, B			Ecology - Globalization, roving bandits, and marine resources	SCIENCE			English	Editorial Material							RESILIENCE; GOVERNANCE		Univ Manitoba, Nat Resources Inst, Winnipeg, MB R3T 2N2, Canada; Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; Univ Wageningen & Res Ctr, Dept Environm Sci, Aquat Ecol & Water Qual Management Grp, NL-6700 DD Wageningen, Netherlands; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA; Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden; Stockholm Univ, Ctr Transdisciplinary Environm Res, S-10691 Stockholm, Sweden; Univ Maine, Sch Marine Sci, Orono, ME 04469 USA; Univ Maine, Sch Marine Sci, Walpole, ME 04573 USA; James Cook Univ N Queensland, Sch Marine Biol, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	University of Manitoba; Dalhousie University; Wageningen University & Research; Princeton University; Emory University; Stockholm University; Stockholm University; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; James Cook University	Berkes, F (corresponding author), Univ Manitoba, Nat Resources Inst, Winnipeg, MB R3T 2N2, Canada.	berkes@cc.umanitoba.ca	Leslie, Heather/B-4980-2014; Hughes, Terry P/L-4721-2013; Folke, Carl/Z-1545-2019; Osterblom, Henrik/D-4249-2012; Leslie, Heather M./I-7812-2019; Olsson, Per/AAE-9104-2019; Bellwood, David/E-2497-2011; Scheffer, Marten/C-1852-2012	Hughes, Terry P/0000-0002-5257-5063; Leslie, Heather M./0000-0003-4512-9417; Folke, Carl/0000-0002-4050-3281; Osterblom, Henrik/0000-0002-1913-5197; Worm, Boris/0000-0002-5742-8716; Nystrom, Magnus/0000-0003-3608-2426; Olsson, Per/0000-0002-9038-4786; Berkes, Fikret/0000-0001-8402-121X; Norberg, Jon/0000-0003-1861-5030				Andrew NL, 2002, OCEANOGR MAR BIOL, V40, P343; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BERKES F, 2005, INDIGENOUS USE MANAG, P13; Castilla JC, 2005, SCIENCE, V309, P1324; Costanza R, 1999, ECOL ECON, V31, P171, DOI 10.1016/S0921-8009(99)00077-4; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Folke C, 2005, ANNU REV ENV RESOUR, V30, P441, DOI 10.1146/annurev.energy.30.050504.144511; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Huitric M, 2005, ECOL SOC, V10; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; OECD, 2004, FISH PIR COMB ILL UN; Olson M, 2000, POWER PROSPERITY; Steneck Robert S., 2005, P110; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Wilson D., 2003, FISHERIES COMANAGEME; Wilson JA, 2006, ECOL SOC, V11; Young O.R., 2002, I DIMENSIONS ENV CHA, V1st ed., DOI DOI 10.7551/MITPRESS/3807.001.0001	21	491	500	4	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1557	1558		10.1126/science.1122804	http://dx.doi.org/10.1126/science.1122804			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543444				2022-12-24	WOS:000236029500027
J	Hegreness, M; Shoresh, N; Hartl, D; Kishony, R				Hegreness, M; Shoresh, N; Hartl, D; Kishony, R			An equivalence principle for the incorporation of favorable mutations in asexual populations	SCIENCE			English	Article							ESCHERICHIA-COLI; BENEFICIAL MUTATIONS; ADAPTIVE EVOLUTION; RNA VIRUSES; ADAPTATION; COMPETITION; LANDSCAPE; SELECTION; GENETICS; SEX	Rapid evolution of asexual populations, such as that of cancer cells or of microorganisms developing drug resistance, can include the simultaneous spread of distinct beneficial mutations. We demonstrate that evolution in such cases is driven by the fitness effects and appearance times of only a small minority of favorable mutations. The complexity of the mutation-selection process is thereby greatly reduced, and much of the evolutionary dynamics can be encapsulated in two parameters - an effective selection coefficient and effective rate of beneficial mutations. We confirm this theoretical finding and estimate the effective parameters for evolving populations of fluorescently labeled Escherichia coli. The effective parameters constitute a simple description and provide a natural standard for comparing adaptation between species and across environments.	Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Harvard Medical School	Kishony, R (corresponding author), Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA.	roy_kishony@hms.harvard.edu						ATWOOD KC, 1951, P NATL ACAD SCI USA, V37, P146, DOI 10.1073/pnas.37.3.146; Bull JJ, 2005, NAT GENET, V37, P342, DOI 10.1038/ng0405-342; CHAO L, 1983, EVOLUTION, V37, P125, DOI 10.1111/j.1558-5646.1983.tb05521.x; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Gillespie J. H., 1991, CAUSES MOL EVOLUTION; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; HARTL DL, 1981, P NATL ACAD SCI-BIOL, V78, P6344, DOI 10.1073/pnas.78.10.6344; HEPPNER GH, 1984, CANCER RES, V44, P2259; Imhof M, 2001, P NATL ACAD SCI USA, V98, P1113, DOI 10.1073/pnas.98.3.1113; KIM J, 1991, ASSESSING ECOLOGICAL, P193; Kimura M, 1985, NEUTRAL THEORY MOL E; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Novelli MR, 1996, SCIENCE, V272, P1187, DOI 10.1126/science.272.5265.1187; Orr HA, 2003, GENETICS, V163, P1519; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.1111/j.1558-5646.1998.tb01823.x, 10.2307/2411226]; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; Rozen DE, 2002, CURR BIOL, V12, P1040, DOI 10.1016/S0960-9822(02)00896-5; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219	27	168	171	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1615	1617		10.1126/science.1122469	http://dx.doi.org/10.1126/science.1122469			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543462				2022-12-24	WOS:000236029500048
J	Stover, J; Bertozzi, S; Gutierrez, JP; Walker, N; Stanecki, KA; Greener, R; Gouws, E; Hankins, C; Garnett, GP; Salomon, JA; Boerma, JT; De Lay, P; Ghys, PD				Stover, J; Bertozzi, S; Gutierrez, JP; Walker, N; Stanecki, KA; Greener, R; Gouws, E; Hankins, C; Garnett, GP; Salomon, JA; Boerma, JT; De Lay, P; Ghys, PD			The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries	SCIENCE			English	Article							HIV PREVENTION; AIDS		Joint UN Programme HIV AIDS UNAIDS, CH-1211 Geneva, Switzerland; Futures Grp Constella, Glastonbury, CT 06033 USA; Natl Inst Publ Hlth, Cuernavaca 62508, Morelos, Mexico; Ctr Invest & Docencia Econ, Mexico City 01210, DF, Mexico; UN Childrens Fund UNICEF, New York, NY 10017 USA; Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; Harvard Univ, Cambridge, MA 02138 USA; WHO, CH-1211 Geneva 27, Switzerland	UNAIDS; Instituto Nacional de Salud Publica; Centro de Investigacion y Docencia Economicas A.C. (CIDE); UNICEF; Imperial College London; Harvard University; World Health Organization	Ghys, PD (corresponding author), Joint UN Programme HIV AIDS UNAIDS, CH-1211 Geneva, Switzerland.	ghysp@unaids.org	Gutierrez, Juan Pablo/A-4253-2010; Garnett, Geoffrey P/A-9312-2008; Salomon, Joshua/S-1929-2019; Salomon, Joshua A/D-3898-2009	Gutierrez, Juan Pablo/0000-0002-0557-5562; Salomon, Joshua/0000-0003-3929-5515; Salomon, Joshua A/0000-0003-3929-5515; Hankins, Catherine/0000-0002-1642-8592; Bertozzi, Stefano M/0000-0002-1723-7085				Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; BERTOZZI S, IN PRESS DIS CONTROL; Marins JRP, 2003, AIDS, V17, P1675, DOI 10.1097/00002030-200307250-00012; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6; Pisani E, 2003, BRIT MED J, V326, P1384, DOI 10.1136/bmj.326.7403.1384; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X; Stover J, 2003, ADDING FAMILY PLANNI; *UNAIDS, 2005, RES NEEDS EXP RESP A; *USAID, 2004, COV SEL SERV HIV AID	11	82	88	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2006	311	5766					1474	1476		10.1126/science.1121176	http://dx.doi.org/10.1126/science.1121176			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16456039				2022-12-24	WOS:000236029400053
J	Tildesley, MJ; Savill, NJ; Shaw, DJ; Deardon, R; Brooks, SP; Woolhouse, MEJ; Grenfell, BT; Keeling, MJ				Tildesley, MJ; Savill, NJ; Shaw, DJ; Deardon, R; Brooks, SP; Woolhouse, MEJ; Grenfell, BT; Keeling, MJ			Optimal reactive vaccination strategies for a foot-and-mouth outbreak in the UK	NATURE			English	Article							CONTROL POLICIES; GREAT-BRITAIN; EPIDEMIC; TRANSMISSION; SPREAD; DESIGN; IMPACT	Foot-and-mouth disease (FMD) in the UK provides an ideal opportunity to explore optimal control measures for an infectious disease. The presence of fine-scale spatio-temporal data for the 2001 epidemic has allowed the development of epidemiological models that are more accurate than those generally created for other epidemics(1-5) and provide the opportunity to explore a variety of alternative control measures. Vaccination was not used during the 2001 epidemic; however, the recent DEFRA ( Department for Environment Food and Rural Affairs) contingency plan(6) details how reactive vaccination would be considered in future. Here, using the data from the 2001 epidemic, we consider the optimal deployment of limited vaccination capacity in a complex heterogeneous environment. We use a model of FMD spread to investigate the optimal deployment of reactive ring vaccination of cattle constrained by logistical resources. The predicted optimal ring size is highly dependent upon logistical constraints but is more robust to epidemiological parameters. Other ways of targeting reactive vaccination can significantly reduce the epidemic size; in particular, ignoring the order in which infections are reported and vaccinating those farms closest to any previously reported case can substantially reduce the epidemic. This strategy has the advantage that it rapidly targets new foci of infection and that determining an optimal ring size is unnecessary.	Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; Univ Warwick, Math Inst, Coventry CV4 7AL, W Midlands, England; Univ Cambridge, Ctr Math Sci, Stat Lab, Cambridge CB3 0WB, England; Univ Edinburgh, Ashworth Labs, Ctr Infect Dis, Epidemiol Grp, Edinburgh EH9 3JF, Midlothian, Scotland; Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush Vet Ctr, Roslin EH25 9RG, Midlothian, Scotland; Univ Cambridge, Ctr Vet Sci, Cambridge Infect Dis Consortium, Cambridge CB3 0ES, England; Penn State Univ, Mueller Lab, Biol Dept 208, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of Warwick; University of Warwick; University of Cambridge; University of Edinburgh; University of Edinburgh; University of Cambridge; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Keeling, MJ (corresponding author), Univ Warwick, Dept Biol Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	m.j.keeling@warwick.ac.uk	Keeling, Matt J/J-9280-2012; Tildesley, Michael/B-6559-2008	Keeling, Matt J/0000-0003-4639-4765; Savill, Nicholas/0000-0002-9769-6168; Tildesley, Michael/0000-0002-6875-7232; Shaw, Darren/0000-0003-2016-1541	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anderson I., 2002, FOOT MOUTH DIS 2001; Barnett PV, 2002, VACCINE, V20, P1505, DOI 10.1016/S0264-410X(01)00503-5; *DEFRA, 2004, DEFRA FOOT MOUTH DIS; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Matthews L, 2003, P ROY SOC B-BIOL SCI, V270, P1659, DOI 10.1098/rspb.2003.2429; McLean AR, 1995, TRENDS MICROBIOL, V3, P458, DOI 10.1016/S0966-842X(00)89010-1; Morris RS, 2001, VET REC, V149, P137, DOI 10.1136/vr.149.5.137; Muller J, 2000, J MATH BIOL, V41, P143, DOI 10.1007/s002850070003; Williams JR, 1996, J EPIDEMIOL COMMUN H, V50, P667, DOI 10.1136/jech.50.6.667; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Woolhouse MEJ, 1997, VET J, V153, P41, DOI 10.1016/S1090-0233(97)80007-X; Woolhouse MEJ, 1996, EPIDEMIOL INFECT, V116, P363, DOI 10.1017/S0950268800052699	16	187	189	0	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 2	2006	440	7080					83	86		10.1038/nature04324	http://dx.doi.org/10.1038/nature04324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HW	16511494				2022-12-24	WOS:000235685700044
J	Yu, B; Edstrom, WC; Benach, J; Hamuro, Y; Weber, PC; Gibney, BR; Hunt, JF				Yu, B; Edstrom, WC; Benach, J; Hamuro, Y; Weber, PC; Gibney, BR; Hunt, JF			Crystal structures of catalytic complexes of the oxidative DNA/RNA repair enzyme AlkB	NATURE			English	Article							ESCHERICHIA-COLI; ALKYLATION DAMAGE; DNA; DIOXYGENASE; BACTERIAL; 3-METHYLTHYMINE; DEMETHYLATION; MECHANISM; PROTEINS; IRON	Nucleic acid damage by environmental and endogenous alkylation reagents creates lesions that are both mutagenic and cytotoxic, with the latter effect accounting for their widespread use in clinical cancer chemotherapy(1,2). Escherichia coli AlkB(3-9) and the homologous human proteins ABH2 and ABH3 (refs 5, 7) promiscuously repair DNA and RNA bases damaged by S(N)2 alkylation reagents, which attach hydrocarbons to endocyclic ring nitrogen atoms (N1 of adenine and guanine and N3 of thymine and cytosine)(3,4,10-15). Although the role of AlkB in DNA repair has long been established based on phenotypic studies, its exact biochemical activity was only elucidated recently after sequence profile analysis revealed it to be a member of the Fe-oxoglutarate-dependent dioxygenase superfamily. These enzymes use an Fe(II) cofactor and 2-oxoglutarate co-substrate to oxidize organic substrates. AlkB hydroxylates an alkylated nucleotide base to produce an unstable product that releases an aldehyde to regenerate the unmodified base. Here we have determined crystal structures of substrate and product complexes of E. coli AlkB at resolutions from 1.8 to 2.3 angstrom. Whereas the Fe-2-oxoglutarate dioxygenase core matches that in other superfamily members, a unique subdomain holds a methylated trinucleotide substrate into the active site through contacts to the polynucleotide backbone. Amide hydrogen exchange studies and crystallographic analyses suggest that this substrate-binding 'lid' is conformationally flexible, which may enable docking of diverse alkylated nucleotide substrates in optimal catalytic geometry. Different crystal structures show open and closed states of a tunnel putatively gating O(2) diffusion into the active site. Exposing crystals of the anaerobic Michaelis complex to air yields slow but substantial oxidation of 2-oxoglutarate that is inefficiently coupled to nucleotide oxidation. These observations suggest that protein dynamics modulate redox chemistry and that a hypothesized migration of the reactive oxy-ferryl ligand on the catalytic Fe ion may be impeded when the protein is constrained in the crystal lattice.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Columbia Univ, Fairchild Ctr 702A, NE Struct Genom Consortium, New York, NY 10027 USA; ExSAR Corp, Monmouth Jct, NJ 08852 USA; Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University	Hunt, JF (corresponding author), Columbia Univ, Dept Biol Sci, MC2434, New York, NY 10027 USA.	jfhunt@biology.columbia.edu		Gibney, Brian/0000-0002-8966-7463				Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; CHEN BRJ, 1994, J BACTERIOL, V176, P6255, DOI 10.1128/jb.176.20.6255-6261.1994; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Elkins JM, 2002, BIOCHEMISTRY-US, V41, P5185, DOI 10.1021/bi016014e; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P3456, DOI 10.1093/nar/gkh655; Hegg EL, 1999, BIOCHEMISTRY-US, V38, P16714, DOI 10.1021/bi991796l; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; Koivisto P, 2004, J BIOL CHEM, V279, P40470, DOI 10.1074/jbc.M407960200; Koivisto P, 2003, J BIOL CHEM, V278, P44348, DOI 10.1074/jbc.M307361200; Krebs C, 2005, INORG CHEM, V44, P742, DOI 10.1021/ic048523l; Mishina Y, 2003, J AM CHEM SOC, V125, P8730, DOI 10.1021/ja034636c; Muller I, 2004, BIOCHEMISTRY-US, V43, P3075, DOI 10.1021/bi035752v; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Price JC, 2005, BIOCHEMISTRY-US, V44, P8138, DOI 10.1021/bi050227c; Que L, 2004, J BIOL INORG CHEM, V9, P684, DOI 10.1007/s00775-004-0574-8; Rohde JU, 2003, SCIENCE, V299, P1037, DOI 10.1126/science.299.5609.1037; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Valegard K, 2004, NAT STRUCT MOL BIOL, V11, P95, DOI 10.1038/nsmb712; Wilmouth RC, 2002, STRUCTURE, V10, P93, DOI 10.1016/S0969-2126(01)00695-5; Zhang ZH, 2002, FEBS LETT, V517, P7, DOI 10.1016/S0014-5793(02)02520-6	28	184	191	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 16	2006	439	7078					879	884		10.1038/nature04561	http://dx.doi.org/10.1038/nature04561			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012JA	16482161				2022-12-24	WOS:000235333600057
J	Shishehbor, MH; Litaker, D; Pothier, CE; Lauer, MS				Shishehbor, MH; Litaker, D; Pothier, CE; Lauer, MS			Association of socioeconomic status with functional capacity, heart rate recovery, and all-cause mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK; TREADMILL EXERCISE; INSULIN-RESISTANCE; SOCIAL-CLASS; HEALTH; DEATH; PREDICTOR; ACCESS; CARE	Context Lower socioeconomic status (SES) confers heightened cardiovascular risk and mortality, although the mediating pathways are unclear. Objective To evaluate the extent to which exercise physiologic characteristics account for the association between lower SES and mortality. Design, Setting, and Participants Prospective cohort study of 30 043 consecutive patients living in 7 counties in northeast Ohio referred between 1990 and 2002 for symptom-limited stress testing for evaluation of known or suspected coronary artery disease. Follow-up for mortality continued through February 2004. Main Outcome Measures Estimated functional capacity in metabolic equivalents and heart rate recovery, physiologic characteristics that are determined directly from exercise; testing and all-cause mortality during a median follow-up of 6.5 years. Results Multivariable models adjusting for demographics, insurance status, smoking status, and clinical confounders demonstrated a strong association between a composite SES score based on census block data and functional capacity (adjusted odds ratio comparing 25th with 75th percentile values, 1.72; 95% confidence interval [CI], 1.56-1.89; P<.001) as well as heart rate recovery (adjusted odds ratio comparing 25th with 75th percentile values, 1.18; 95% CI, 1.07-1.30; P<.001). There were 2174 deaths, with mortality risk increasing from 5% to 10% as SES decreased by quartile (P<.001). Cox proportional hazards models that included all confounding variables except exercise physiologic characteristics demonstrated increased mortality as SES decreased (adjusted hazard ratio comparing 25th with 75th percentile values, 1.32; 95% CI, 1.22-1.42; P<.001). After further adding functional capacity and heart rate recovery, the magnitude of this relationship was reduced (comparing 25th with 75th percentile values; adjusted hazard ratio, 1.17; 95% CI, 1.08-1.26; P<.001), with these variables explaining 47% of the association. Conclusions Impaired functional capacity and abnormal heart rate recovery were strongly associated with lower SES and accounted for a major proportion of the correlation between SES and mortality. Efforts to modify these clinical features among patients with low SES may narrow disparities in mortality.	Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Louis Stokes Cleveland VA Med Ctr, Dept Med, Cleveland, OH USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University	Lauer, MS (corresponding author), Cleveland Clin, Dept Cardiovasc Med, Desk JJ-40, Cleveland, OH 44195 USA.	lauerm@ccf.org	Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177	NHLBI NIH HHS [R01 HL-072771-02, P50 HL-77107-1, R01 HL-66004-2] Funding Source: Medline; NICHD NIH HHS [K12 HD049091] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD049091] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066004, R01HL072771, P50HL077107] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140; Alter DA, 2004, JAMA-J AM MED ASSOC, V291, P1100, DOI 10.1001/jama.291.9.1100; Anderson RT, 1997, EPIDEMIOLOGY, V8, P42, DOI 10.1097/00001648-199701000-00007; Beachler M, 2003, J RURAL HEALTH, V19, P416; Berkman LF, 2005, CIRCULATION, V111, P3022, DOI 10.1161/CIRCULATIONAHA.104.509810; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; BLENDON RJ, 1989, JAMA-J AM MED ASSOC, V261, P278, DOI 10.1001/jama.261.2.278; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P143; CHEADLE A, 1991, PREV MED, V20, P250, DOI 10.1016/0091-7435(91)90024-X; Church TS, 2002, ARTERIOSCL THROM VAS, V22, P1869, DOI 10.1161/01.ATV.0000036611.77940.F8; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Eagle KA, 2002, CIRCULATION, V105, P1257, DOI 10.1161/hc1002.104956; EKELUND LG, 1988, NEW ENGL J MED, V319, P1379, DOI 10.1056/NEJM198811243192104; Fagard RH, 1999, MED SCI SPORT EXER, V31, pS624, DOI 10.1097/00005768-199911001-00022; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; GOLDSTEIN DS, 1987, BAILLIERE CLIN ENDOC, V1, P253, DOI 10.1016/S0950-351X(87)80063-0; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; HAAN M, 1987, AM J EPIDEMIOL, V125, P989, DOI 10.1093/oxfordjournals.aje.a114637; HACKBARTH DP, 1995, J PUBLIC HEALTH POL, V16, P213, DOI 10.2307/3342593; Harrell F. E., 2001, REGRESSION MODELING; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hemingway H, 2005, CIRCULATION, V111, P3071, DOI 10.1161/CIRCULATIONAHA.104.497347; *I MED COMM UND EL, 2003, UNEQ TREATM CONFR RA; IMAI K, 1994, J AM COLL CARDIOL, V24, P1529, DOI 10.1016/0735-1097(94)90150-3; Isganaitis E, 2005, ARTERIOSCL THROM VAS, V25, P2451, DOI 10.1161/01.ATV.0000186208.06964.91; Jackson L, 2005, HEART, V91, P10, DOI 10.1136/hrt.2004.045559; KRIEGER N, 1994, INT J HEALTH SERV, V24, P25, DOI 10.2190/2JG7-YMD5-WCP2-XXNT; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Lauer Michael S, 2003, J Cardiopulm Rehabil, V23, P88, DOI 10.1097/00008483-200303000-00003; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Lind L, 2002, AM HEART J, V144, P666, DOI 10.1067/mhj.2002.124836; MCEWEN BS, 1999, SOCIOECONOMIC STATUS; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392; Panzer C, 2002, DIABETES, V51, P803, DOI 10.2337/diabetes.51.3.803; Pitzalis MV, 2001, AM HEART J, V141, P765, DOI 10.1067/mhj.2001.114806; Robert SA, 1998, J HEALTH SOC BEHAV, V39, P18, DOI 10.2307/2676387; Roux AVD, 2005, CIRCULATION, V111, P3020, DOI 10.1016/CIRCULATIONAHA.105.542845; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Shishehbor MH, 2004, DIABETES CARE, V27, P936, DOI 10.2337/diacare.27.4.936; Shishehbor MH, 2002, AM J MED, V113, P643, DOI 10.1016/S0002-9343(02)01324-4; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Snader CE, 1997, J AM COLL CARDIOL, V30, P641, DOI 10.1016/S0735-1097(97)00217-9; Srivastava R, 2000, AM J MED, V109, P20, DOI 10.1016/S0002-9343(00)00441-1; Stewart MK, 2003, J RURAL HEALTH, V19, P391; Therneau T. M., 2000, STAT BIOL HEALTH; Tiukinhoy Susan, 2003, J Cardiopulm Rehabil, V23, P84, DOI 10.1097/00008483-200303000-00002; Tonne C, 2005, CIRCULATION, V111, P3063, DOI 10.1161/CIRCULATIONAHA.104.496174; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; *US DEP HHS, 1996, PUBL US DEP HLTH HUM; Waitzman NJ, 1998, AM J PUBLIC HEALTH, V88, P973, DOI 10.2105/AJPH.88.6.973; Watanabe J, 2001, CIRCULATION, V104, P1911, DOI 10.1161/circ.104.16.1911; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Yen IH, 1999, AM J EPIDEMIOL, V149, P898	60	114	116	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2006	295	7					784	792		10.1001/jama.295.7.784	http://dx.doi.org/10.1001/jama.295.7.784			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011YZ	16478901	Bronze			2022-12-24	WOS:000235306700023
J	Illes, J; Kirschen, MP; Edwards, E; Stanford, LR; Bandettini, P; Cho, MK; Ford, PJ; Glover, GH; Kulynych, J; Macklin, R; Michael, DB; Wolf, SM				Illes, J; Kirschen, MP; Edwards, E; Stanford, LR; Bandettini, P; Cho, MK; Ford, PJ; Glover, GH; Kulynych, J; Macklin, R; Michael, DB; Wolf, SM		Working Grp Incidental Findings	Ethics - Incidental findings in brain imaging research	SCIENCE			English	Editorial Material									Stanford Univ, Ctr Biomed Eth, Palo Alto, CA 94304 USA; Stanford Univ, Dept Radiol, Palo Alto, CA 94304 USA; Stanford Univ, Program Neurosci, Palo Alto, CA 94304 USA; Stanford Univ, Dept Pediat, Palo Alto, CA 94304 USA; Natl Inst Neurol Disorders & Stroke, NIH, Bethesda, MD 20892 USA; Natl Inst Drug Abuse, NIH, Bethesda, MD 20892 USA; NIMH, NIH, Bethesda, MD 20892 USA; Cleveland Clin Fdn, Dept Bioeth, Cleveland, OH 44195 USA; Johns Hopkins Hosp & Hlth Syst, Legal Dept, Washington, DC 20005 USA; Albert Einstein Coll Med, Dept Bioeth, Bronx, NY 10461 USA; Michigan Head & Spine Inst, Southfield, MI 48075 USA; Univ Minnesota, Sch Law, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Bioeth, Minneapolis, MN 55455 USA	Stanford University; Stanford University; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Cleveland Clinic Foundation; Johns Hopkins University; Johns Hopkins Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Illes, J (corresponding author), Stanford Univ, Ctr Biomed Eth, Palo Alto, CA 94304 USA.	illes@stanford.edu	Kam, Grace/F-5364-2012; Bandettini, Peter A./F-5871-2012		NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045831] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG003389-02, P50 HG003389-01, P50 HG003389] Funding Source: Medline; NINDS NIH HHS [R01 NS045831] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		*CENTR BRAIN TUM R, 1997, PRIM BRAIN TUM US 19; CLAYTON EW, 1997, GENETIC SECRETS PROT, P126; Illes J, 2004, J MAGN RESON IMAGING, V20, P743, DOI 10.1002/jmri.20180; Illes J, 2004, NEUROLOGY, V62, P888, DOI 10.1212/01.WNL.0000118531.90418.89; Illes J, 2002, BRAIN COGNITION, V50, P358, DOI 10.1016/S0278-2626(02)00532-8; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Kim BS, 2002, AM J NEURORADIOL, V23, P1674; Kirschen MP, 2006, J MAGN RESON IMAGING, V23, P205, DOI 10.1002/jmri.20499; QUAID KA, 1993, AM J CARDIOL, V72, pD64, DOI 10.1016/0002-9149(93)90013-3; Shalowitz DI, 2005, JAMA-J AM MED ASSOC, V294, P737, DOI 10.1001/jama.294.6.737; Weber F, 2006, J NEUROL SCI, V240, P81, DOI 10.1016/j.jns.2005.09.008	11	184	186	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2006	311	5762					783	784		10.1126/science.1124665	http://dx.doi.org/10.1126/science.1124665			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012XT	16469905	Green Accepted			2022-12-24	WOS:000235374900025
J	Dong, M; Yeh, F; Tepp, WH; Dean, C; Johnson, EA; Janz, R; Chapman, ER				Dong, M; Yeh, F; Tepp, WH; Dean, C; Johnson, EA; Janz, R; Chapman, ER			SV2 is the protein receptor for botulinum neurotoxin A	SCIENCE			English	Article							SYNAPTIC VESICLE PROTEIN; SYNAPTOTAGMIN-I; NEUROTRANSMITTER RELEASE; B NEUROTOXIN; GANGLIOSIDES; BINDING; CELLS; TETANUS; TOXINS; IDENTIFICATION	How the widely used botulinum neurotoxin A (BoNT/A) recognizes and enters neurons is poorly understood. We found that BoNT/A enters neurons by binding to the synaptic vesicle protein SV2 (isoforms A, B, and C). Fragments of SV2 that harbor the toxin interaction domain inhibited BoNT/A from binding to neurons. BoNT/A binding to SV2A and SV2B knockout hippocampal neurons was abolished and was restored by expressing SV2A, SV2B, or SV2C. Reduction of SV2 expression in PC12 and Neuro-2a cells also inhibited entry of BoNT/A, which could be restored by expressing SV2 isoforms. Finally, mice that lacked an SV2 isoform (SV2B) displayed reduced sensitivity to BoNT/A. Thus, SV2 acts as the protein receptor for BoNT/A.	Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; Univ Wisconsin, Dept Food Microbiol & Toxicol, Madison, WI 53706 USA; Univ Wisconsin, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA; Univ Texas, Houston Med Sch, WM Keck Ctr Learning & Memory, Houston, TX 77030 USA; Univ Texas, Houston Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Chapman, ER (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA.	chapman@physiology.wisc.edu	Taylor, Graham/A-4027-2012	Chapman, Edwin/0000-0001-9787-8140; Janz, Roger/0000-0002-9872-0596	NATIONAL EYE INSTITUTE [R01EY016452] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY016452, R01 EY016452-03] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; BAJJALIEH SM, 1994, J NEUROSCI, V14, P5223, DOI 10.1523/jneurosci.14-09-05223.1994; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; Bullens RWM, 2002, J NEUROSCI, V22, P6876; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; DOLLY JO, 1984, NATURE, V307, P457, DOI 10.1038/307457a0; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; HUGHES R, 1962, J PHYSIOL-LONDON, V160, P221, DOI 10.1113/jphysiol.1962.sp006843; Janz R, 1999, NEUROSCIENCE, V94, P1279, DOI 10.1016/S0306-4522(99)00370-X; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Johnson EA, 1999, ANNU REV MICROBIOL, V53, P551, DOI 10.1146/annurev.micro.53.1.551; Keller JE, 2004, BIOCHEMISTRY-US, V43, P526, DOI 10.1021/bi0356698; KITAMURA M, 1980, BIOCHIM BIOPHYS ACTA, V628, P328, DOI 10.1016/0304-4165(80)90382-7; Kitamura M, 1999, BBA-MOL CELL BIOL L, V1441, P1, DOI 10.1016/S1388-1981(99)00140-7; Malizio CJ, 2000, METH MOL B, V145, P27; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Montecucco C, 2004, TRENDS MICROBIOL, V12, P442, DOI 10.1016/j.tim.2004.08.002; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; Nishiki T, 1996, FEBS LETT, V378, P253, DOI 10.1016/0014-5793(95)01471-3; NISHIKI T, 1994, J BIOL CHEM, V269, P10498; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; SIMPSON LL, 1971, J NEUROCHEM, V18, P1341, DOI 10.1111/j.1471-4159.1971.tb00235.x; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Yowler BC, 2004, BIOCHEMISTRY-US, V43, P9725, DOI 10.1021/bi0494673; Yowler BC, 2002, J BIOL CHEM, V277, P32815, DOI 10.1074/jbc.M205258200	31	551	588	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					592	596		10.1126/science.1123654	http://dx.doi.org/10.1126/science.1123654			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16543415				2022-12-24	WOS:000237296700049
J	Esquivel, A; Meric-Bernstam, F; Bernstam, EV				Esquivel, A; Meric-Bernstam, F; Bernstam, EV			Accuracy and self correction of information received from an internet breast cancer list: content analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objectives To determine the prevalence of false or misleading statements in messages posted by internet cancer support groups and whether these statements were identified as false or misleading and corrected by other participants in subsequent postings. Design Analysis of content of postings. Setting Internet cancer support group Breast Cancer, Mailing List. Main outcome measures Number of false or misleading statements posted from 1 January to 23 April 2005 and whether these were identified and corrected by participants in subsequent postings. Results 10 of 4600 postings (0.22%) were found to be false or misleading. Of these, seven were identified as false or misleading by other participants and corrected within an average of four hours and 33 minutes (maximum, nine hours and nine minutes). Conclusions Most posted information on breast cancer was accurate. Most false or misleading statements were rapidly corrected by participants in subsequent postings.	Univ Texas, Hlth Sci Ctr Houston, Sch Hlth Informat Sci, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Bernstam, EV (corresponding author), Univ Texas, Hlth Sci Ctr Houston, Sch Hlth Informat Sci, 7000 Fannin St, Houston, TX 77030 USA.	elmer.v.bernstam@uth.tmc.edu		Bernstam, Elmer/0000-0001-7643-791X	NATIONAL CANCER INSTITUTE [R15CA091895] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008306] Funding Source: NIH RePORTER; NCI NIH HHS [1K08CA91895] Funding Source: Medline; NLM NIH HHS [5K22LM008306] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Biermann JS, 1999, CANCER, V86, P381, DOI 10.1002/(SICI)1097-0142(19990801)86:3<381::AID-CNCR4>3.3.CO;2-7; Culver JD, 1997, J GEN INTERN MED, V12, P466, DOI 10.1046/j.1525-1497.1997.00084.x; Eisenberg DM, 2001, ANN INTERN MED, V135, P344, DOI 10.7326/0003-4819-135-5-200109040-00011; Feenberg AL, 1996, J NEUROL SCI, V139, P129, DOI 10.1016/0022-510X(96)00093-7; Ferguson S., 2020, J ED ONLINE; FOX S, 2000, ONLINE HLTH CARE REV, P3; Hoch DB, 1999, SEIZURE-EUR J EPILEP, V8, P30, DOI 10.1053/seiz.1998.0217; Jadad AR, 1998, JAMA-J AM MED ASSOC, V279, P611, DOI 10.1001/jama.279.8.611; Mursch K, 2003, ZBL NEUROCHIR, V64, P71; Price SL, 1999, J AM MED INFORM ASSN, P911; Satterlund MJ, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.3.e15; Till James E, 2003, Health Qual Life Outcomes, V1, P16, DOI 10.1186/1477-7525-1-16; Weinberg N, 1996, HEALTH SOC WORK, V21, P24, DOI 10.1093/hsw/21.1.24; 2000, AM SOC CLIN ONC 36 A	14	128	130	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2006	332	7547					939	942		10.1136/bmj.38753.524201.7C	http://dx.doi.org/10.1136/bmj.38753.524201.7C			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037JV	16513686	Green Published, Bronze			2022-12-24	WOS:000237143900015
J	Kupfer, A; Muller, H; Antoniazzi, MM; Jared, C; Greven, H; Nussbaum, RA; Wilkinson, M				Kupfer, A; Muller, H; Antoniazzi, MM; Jared, C; Greven, H; Nussbaum, RA; Wilkinson, M			Parental investment by skin feeding in a caecilian amphibian	NATURE			English	Article							REPRODUCTIVE MODES; GYMNOPHIONA; BIOLOGY; BALANCE	Although the initial growth and development of most multicellular animals depends on the provision of yolk, there are many varied contrivances by which animals provide additional or alternative investment in their offspring(1). Providing offspring with additional nutrition should be favoured by natural selection when the consequent increased fitness of the young offsets any corresponding reduction in fecundity(2). Alternative forms of nutrition may allow parents to delay and potentially redirect their investment. Here we report a remarkable form of parental care and mechanism of parent-offspring nutrient transfer in a caecilian amphibian. Boulengerula taitanus is a direct-developing, oviparous caecilian(3), the skin of which is transformed in brooding females to provide a rich supply of nutrients for the developing offspring. Young animals are equipped with a specialized dentition, which they use to peel and eat the outer layer of their mother's modified skin. This new form of parental care provides a plausible intermediate stage in the evolution of viviparity in caecilians. At independence, offspring of viviparous and of oviparous dermatotrophic caecilians are relatively large despite being provided with relatively little yolk. The specialized dentition of skin-feeding (dermatophagous) caecilians may constitute a pre-adaptation to the fetal feeding on the oviduct lining of viviparous caecilians.	Nat Hist Museum, Dept Zool, London SW7 5BD, England; Leiden Univ, Inst Biol, NL-2311 GP Leiden, Netherlands; Inst Butantan, Lab Biol Celular, BR-05503900 Sao Paulo, Brazil; Univ Dusseldorf, Inst Zoomorphol & Zellbiol, D-40225 Dusseldorf, Germany; Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Ecol & Evolut Biol, Ann Arbor, MI 48109 USA	Natural History Museum London; Leiden University; Leiden University - Excl LUMC; Instituto Butantan; Heinrich Heine University Dusseldorf; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wilkinson, M (corresponding author), Nat Hist Museum, Dept Zool, Cromwell Rd, London SW7 5BD, England.	mw@bmnh.org	Mueller, Hendrik/B-4979-2010; Wilkinson, Mark/J-2026-2014; Kupfer, Alexander/B-5417-2010; Antoniazzi, Marta/A-3495-2017; Jared, Carlos/D-3299-2012; Antoniazzi, Marta Maria/AAF-1942-2021	Mueller, Hendrik/0000-0001-6764-7376; Wilkinson, Mark/0000-0002-9459-8976; Jared, Carlos/0000-0002-9117-6276; Antoniazzi, Marta Maria/0000-0002-0575-7921				Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Exbrayat J. M., 2000, GYMNOPHIONES CURIEUX; Gower DJ, 2005, CONSERV BIOL, V19, P45, DOI 10.1111/j.1523-1739.2005.00589.x; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; HIMSTEDT W, 1996, BLINDWUHLEN; Kupfer A, 2004, BIOL J LINN SOC, V83, P207, DOI 10.1111/j.1095-8312.2004.00382.x; Lehtinen RM, 2003, REPROD BIOL PHYLOGEN, V2, P343; Loader SP, 2003, J ZOOL, V259, P93, DOI 10.1017/S0952836902003060; Malonza PK, 2005, TROP ZOOL, V18, P49, DOI 10.1080/03946975.2005.10531214; Muller H, 2005, ZOOMORPHOLOGY, V124, P171, DOI 10.1007/s00435-005-0005-6; Muller M., 1977, ZOOL JB ANAT, V97, P532; Nussbaum RA, 2003, REPROD BIOL PHYLOGEN, V1, P527; NUSSBAUM RA, 1994, COPEIA, P750; O'Reilly J. C., 1998, American Zoologist, V38, p187A; PARKER HW, 1956, NATURE, V178, P250, DOI 10.1038/178250a0; PARKER HW, 1964, COPEIA, P75; Pennisi E, 1999, SCIENCE, V283, P623, DOI 10.1126/science.283.5402.623; Romeis B., 1989, MIKROSKOPISCHE TECHN; San Mauro D, 2005, AM NAT, V165, P590, DOI 10.1086/429523; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Taylor E. H., 1968, CAECILIANS WORLD; TOLEDO RC, 1995, COMP BIOCHEM PHYS A, V111, P1, DOI 10.1016/0300-9629(95)98515-I; TOLEDO RC, 1993, COMP BIOCHEM PHYS A, V105, P593, DOI 10.1016/0300-9629(93)90259-7; Wake MH, 1998, J EXP ZOOL, V282, P477; WELDON PJ, 1993, J HERPETOL, V27, P219, DOI 10.2307/1564942; Wilkinson M, 1998, J NAT HIST, V32, P1403, DOI 10.1080/00222939800770701; Wilkinson Mark, 2003, African Journal of Herpetology, V52, P83	28	83	91	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					926	929		10.1038/nature04403	http://dx.doi.org/10.1038/nature04403			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612382	Green Published			2022-12-24	WOS:000236736700039
J	Robins, JH; Ross, HA; Allen, MS; Matisoo-Smith, E				Robins, JH; Ross, HA; Allen, MS; Matisoo-Smith, E			Taxonomy - Sus bucculentus revisited	NATURE			English	Editorial Material							DNA		Univ Auckland, Dept Anthropol, Auckland 1, New Zealand; Univ Auckland, Allan Wilson Ctr Mol Ecol & Evolut, Auckland 1, New Zealand; Univ Auckland, Bioinformat Inst, Auckland 1, New Zealand; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Auckland; Massey University; University of Auckland; University of Auckland; University of Auckland	Robins, JH (corresponding author), Univ Auckland, Dept Anthropol, Private Bag 92019, Auckland 1, New Zealand.	j.robins@auckland.ac.nz	Ross, Howard/D-2978-2009; Allen, Melinda S/AAB-7224-2021	Allen, Melinda S/0000-0001-5041-5106; Matisoo-Smith, Elizabeth/0000-0002-3500-8307				Groves Colin P., 2000, P261; Groves CP, 1997, NATURE, V386, P335, DOI 10.1038/386335a0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HANDT O, 1994, EXPERIENTIA, V50, P524, DOI 10.1007/BF01921720; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KIRCH PV, 1982, TIKOPIA PREHISTORY E, P100; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Swofford, 2001, PAUP PHYLOGENETIC AN, DOI DOI 10.1111/J.0014-3820.2002.TB00191.X	9	14	15	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086								10.1038/nature04770	http://dx.doi.org/10.1038/nature04770			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612336				2022-12-24	WOS:000236736700029
J	Self, CH; Thompson, S				Self, CH; Thompson, S			How specific are therapeutic rnonoclonal antibodies?	LANCET			English	Editorial Material									Newcastle Univ, Sch Med, Sch Clin & Lab Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Self, CH (corresponding author), Newcastle Univ, Sch Med, Sch Clin & Lab Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	C.H.Self@ncl.ac.uk						Bodey B, 2000, CURR PHARM DESIGN, V6, P261, DOI 10.2174/1381612003401109; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Christiansen J, 2004, MOL CANCER THER, V3, P1493; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Levine MN, 2005, J CLIN ONCOL, V23, P7775, DOI 10.1200/JCO.2005.04.1558; Morrow KJ, 2005, GENET ENG NEWS, V25, P1; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; Self CH, 1996, NAT MED, V2, P817, DOI 10.1038/nm0796-817; Smith KA, 2004, J CLIN PATHOL, V57, P912, DOI 10.1136/jcp.2003.014407; Stockwin LH, 2003, EXPERT OPIN BIOL TH, V3, P1133, DOI 10.1517/14712598.3.7.1133; Thompson JF, 2001, ANN SURG ONCOL, V8, P564, DOI 10.1245/aso.2001.8.7.564	11	12	16	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2006	367	9516					1038	1039		10.1016/S0140-6736(06)68396-7	http://dx.doi.org/10.1016/S0140-6736(06)68396-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZF	16581388				2022-12-24	WOS:000236673200009
J	Jansen, VAA; van Baalen, M				Jansen, VAA; van Baalen, M			Altruism through beard chromodynamics	NATURE			English	Article							GREEN BEARD; EVOLUTION; COOPERATION; SELECTION	The evolution of altruism, a behaviour that benefits others at one's own fitness expense, poses a darwinian paradox. The paradox is resolved if many interactions are with related individuals so that the benefits of altruism are reaped by copies of the altruistic gene in other individuals(1), a mechanism called kin selection(2). However, recognition of altruists could provide an alternative route towards the evolution of altruism(1,3-5). Arguably the simplest recognition system is a conspicuous, heritable tag, such as a green beard(1,3). Despite the fact that such genes have been reported(6-8), the 'green beard effect'(3) has often been dismissed because it is unlikely that a single gene can code for altruism and a recognizable tag(1,3,9). Here we model the green beard effect and find that if recognition and altruism are always inherited together, the dynamics are highly unstable, leading to the loss of altruism. In contrast, if the effect is caused by loosely coupled separate genes, altruism is facilitated through beard chromodynamics in which many beard colours co-occur. This allows altruism to persist even in weakly structured populations and implies that the green beard effect, in the form of a fluid association of altruistic traits with a recognition tag, can be much more prevalent than hitherto assumed.	Univ London Royal Holloway & Bedford New Coll, Sch Biol Sci, Egham TW20 0EX, Surrey, England; Univ Paris 06, CNRS, UMR 7625, Lab Ecol ENS, F-75252 Paris 05, France	University of London; Royal Holloway University London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Jansen, VAA (corresponding author), Univ London Royal Holloway & Bedford New Coll, Sch Biol Sci, Egham TW20 0EX, Surrey, England.	vincent.jansen@rhul.ac.uk; minus.van.baalen@ens.fr	Jansen, Vincent A A/C-8353-2009; van Baalen, Minus/J-9285-2012	Jansen, Vincent A.A./0000-0002-6518-2090; van Baalen, Minus/0000-0002-3713-5967				Axelrod R, 2004, EVOLUTION, V58, P1833; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BLAUSTEIN AR, 1983, AM NAT, V121, P749, DOI 10.1086/284101; Dawkins R., 1982, pi; Dawkins R, 1976, SELFISH GENE; Haig D, 1996, P NATL ACAD SCI USA, V93, P6547, DOI 10.1073/pnas.93.13.6547; Haig David, 1997, P284; Hamilton W.D., 1987, P417; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Riolo RL, 2001, NATURE, V414, P441, DOI 10.1038/35106555; SMITH J. M., 1964, Nature, V201, P1145, DOI 10.1038/2011145a0; Summers K, 2005, P ROY SOC B-BIOL SCI, V272, P643, DOI 10.1098/rspb.2004.2890; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Baalen M, 1998, J THEOR BIOL, V193, P631, DOI 10.1006/jtbi.1998.0730; van Baalen M, 2003, P ROY SOC B-BIOL SCI, V270, P69, DOI 10.1098/rspb.2002.2151; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507	20	206	212	3	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					663	666		10.1038/nature04387	http://dx.doi.org/10.1038/nature04387			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572169	Green Submitted			2022-12-24	WOS:000236350400042
J	Ahmed, QA; Memish, ZA; Allegranzi, B; Pittet, D				Ahmed, QA; Memish, ZA; Allegranzi, B; Pittet, D		WHO Global Patient Safety Challeng	Muslim health-care workers and alcohol-based handrubs	LANCET			English	Editorial Material							INFECTION-CONTROL; HYGIENE		Univ Hosp Geneva, Infect Control Programme, Geneva, Switzerland; Med Univ S Carolina, Div Pulm & Crit Care Med, Charleston, SC 29425 USA; King Fahad Natl Guard Hosp, King Abdulaziz Med City, Saudi Arabian Natl Guard Hlth Affairs, Adult Infect Dis Sect,Dept Med, Riyadh, Saudi Arabia; King Fahad Natl Guard Hosp, King Abdulaziz Med City, Saudi Arabian Natl Guard Hlth Affairs, Infect Prevent & Control Programme, Riyadh, Saudi Arabia; Univ Verona, Dept Infect Dis, I-37100 Verona, Italy; WHO, Global Patient Safety Challenge, World Alliance Patient Safety, WHO Headquarters, CH-1211 Geneva, Switzerland	University of Geneva; Medical University of South Carolina; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; National Guard Health Affairs - Saudi Arabia; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; National Guard Health Affairs - Saudi Arabia; University of Verona; World Health Organization	Pittet, D (corresponding author), Univ Hosp Geneva, Infect Control Programme, Geneva, Switzerland.	didier.pittet@hcuge.ch	Memish, Ziad Ahmed/AEJ-9424-2022	Memish, Ziad Ahmed/0000-0002-5099-0714				ALBERT RK, 1981, NEW ENGL J MED, V304, P1465, DOI 10.1056/NEJM198106113042404; BINABDULAZIZALM.M, 2001, ISLAMIC VERDICTS, V2, P26; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; *COUNC AM ISL REL, ISL AM MUSL; Douglas Mary, 1966, PURITY DANGER ANAL C, p[8, 41]; DOUTHAT R, 2005, ATLANTIC MONTHLY, V295, P58; HENLEY A, 1999, CULTURE RELIG PATIEN, P92; Hugonnet S, 2002, ARCH INTERN MED, V162, P1037, DOI 10.1001/archinte.162.9.1037; Jumaa PA, 2005, INT J INFECT DIS, V9, P3, DOI 10.1016/j.ijid.2004.05.005; Katme AM, 1999, BRIT MED J, V319, P520; Kretzer EK, 1998, AM J INFECT CONTROL, V26, P245, DOI 10.1016/S0196-6553(98)80008-4; Lankford MG, 2003, EMERG INFECT DIS, V9, P217; MARECHAL B, 2002, GUIDEBOOK ISLAM MUSL; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pittet D, 2000, INFECT CONT HOSP EP, V21, P381, DOI 10.1086/501777; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 1999, ANN INTERN MED, V130, P126, DOI 10.7326/0003-4819-130-2-199901190-00006; Pittet D, 2004, J HOSP INFECT, V58, P1, DOI 10.1016/j.jhin.2004.06.002; Pittet D, 2004, ANN INTERN MED, V141, P1, DOI 10.7326/0003-4819-141-1-200407060-00008; Pittet D, 2003, LANCET INFECT DIS, V3, P269, DOI 10.1016/S1473-3099(03)00601-7; Pittet D, 2001, LANCET, P9; Pittet D, 2005, LANCET, V366, P1246, DOI 10.1016/S0140-6736(05)67506-X; ROBINSON BA, 2002, MANY MUSLIMS ARE US; Stone S, 2001, LANCET, V357, P479, DOI 10.1016/S0140-6736(05)71288-5; Teare L, 2001, BRIT MED J, V323, P411, DOI 10.1136/bmj.323.7310.411; Turner P, 2004, J HOSP INFECT, V56, P287, DOI 10.1016/j.jhin.2004.01.005; World Health Organization (WHO), WHO GUID HAND HYG HL; [No title captured]; 30 DAYS MUSLIM WORLD	29	60	62	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2006	367	9515					1025	1027		10.1016/S0140-6736(06)68431-6	http://dx.doi.org/10.1016/S0140-6736(06)68431-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028GE	16564366				2022-12-24	WOS:000236474200032
J	Craik, DJ				Craik, DJ			Chemistry - Seamless proteins tie up their loose ends	SCIENCE			English	Editorial Material							PEPTIDE; CYCLOTIDES		Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Queensland	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Craik, David/B-1695-2010	Craik, David/0000-0003-0007-6796				Clark RJ, 2005, P NATL ACAD SCI USA, V102, P13767, DOI 10.1073/pnas.0504613102; Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399; Cole AM, 2004, CURR PROTEIN PEPT SC, V5, P373, DOI 10.2174/1389203043379657; Craik DJ, 2006, CURR OPIN DRUG DISC, V9, P251; Eisenbrandt R, 1999, J BIOL CHEM, V274, P22548, DOI 10.1074/jbc.274.32.22548; GRAN L, 1973, ACTA PHARMACOL TOX, V33, P400; Gustafson KR, 2004, CURR PROTEIN PEPT SC, V5, P331, DOI 10.2174/1389203043379468; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; Simonsen SM, 2005, PLANT CELL, V17, P3176, DOI 10.1105/tpc.105.034678; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Trabi M, 2002, TRENDS BIOCHEM SCI, V27, P132, DOI 10.1016/S0968-0004(02)02057-1	13	243	254	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2006	311	5767					1563	1564		10.1126/science.1125248	http://dx.doi.org/10.1126/science.1125248			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543448				2022-12-24	WOS:000236029500031
J	Lesne, S; Koh, MT; Kotilinek, L; Kayed, R; Glabe, CG; Yang, A; Gallagher, M; Ashe, KH				Lesne, S; Koh, MT; Kotilinek, L; Kayed, R; Glabe, CG; Yang, A; Gallagher, M; Ashe, KH			A specific amyloid-beta protein assembly in the brain impairs memory	NATURE			English	Article							APP(SW) TRANSGENIC MICE; ALZHEIMERS-DISEASE; A-BETA; MOUSE MODEL; PRECURSOR PROTEIN; IN-VIVO; PLAQUES; AGE; OLIGOMERS; DEFICITS	Memory function often declines with age(1), and is believed to deteriorate initially because of changes in synaptic function rather than loss of neurons(2). Some individuals then go on to develop Alzheimer's disease with neurodegeneration. Here we use Tg2576 mice, which express a human amyloid-beta precursor protein ( APP) variant linked to Alzheimer's disease, to investigate the cause of memory decline in the absence of neurodegeneration or amyloid-beta protein amyloidosis. Young Tg2576 mice (< 6 months old) have normal memory and lack neuropathology, middle- aged mice ( 6 - 14 months old) develop memory deficits without neuronal loss, and old mice (> 14 months old) form abundant neuritic plaques containing amyloid-beta ( refs 3 - 6). We found that memory deficits in middle- aged Tg2576 mice are caused by the extracellular accumulation of a 56- kDa soluble amyloid-beta assembly, which we term A beta* 56 ( A beta star 56). A beta* 56 purified from the brains of impaired Tg2576 mice disrupts memory when administered to young rats. We propose that A beta*56 impairs memory independently of plaques or neuronal loss, and may contribute to cognitive deficits associated with Alzheimer's disease.	Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Grad Program Neurosci, Minneapolis, MN 55455 USA; Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA; Minneapolis VA Med Ctr, Ctr Geriatr Res Educ & Clin, Minneapolis, MN 55417 USA; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ So Calif, Dept Pharmaceut Sci, Los Angeles, CA 90089 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of California System; University of California Irvine; University of Southern California	Ashe, KH (corresponding author), Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA.	hsiao005@umn.edu		Lesne, Sylvain/0000-0001-9411-1868				Albert MS, 2002, ANN NEUROL, V51, P282, DOI 10.1002/ana.10156; Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Barelli HL, 1997, MOL MED, V3, P695, DOI 10.1007/BF03401708; Benzing WC, 1999, NEUROBIOL AGING, V20, P581, DOI 10.1016/S0197-4580(99)00065-2; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Craik F.I.M., 1977, HDB PSYCHOL AGING, P384; Duff K, 2005, NAT MED, V11, P826, DOI 10.1038/nm0805-826; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; GORDON JA, 1968, J BIOL CHEM, V243, P5663; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kawas CH, 2003, NEUROLOGY, V60, P1089, DOI 10.1212/01.WNL.0000055813.36504.BF; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Orr HT, 2004, NATURE, V431, P747, DOI 10.1038/431747a; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sergeant N, 2002, J NEUROCHEM, V81, P663, DOI 10.1046/j.1471-4159.2002.00901.x; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; Stern EA, 2004, J NEUROSCI, V24, P4535, DOI 10.1523/JNEUROSCI.0462-04.2004; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002	28	2285	2375	79	485	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2006	440	7082					352	357		10.1038/nature04533	http://dx.doi.org/10.1038/nature04533			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541076				2022-12-24	WOS:000235997600056
J	Helmy, KY; Katschke, KJ; Gorgani, NN; Elliott, JM; Diehl, L; Scales, SJ; Ghilardi, N; Campagne, MV				Helmy, KY; Katschke, KJ; Gorgani, NN; Elliott, JM; Diehl, L; Scales, SJ; Ghilardi, N; Campagne, MV			CRIg: A macrophage complement receptor required for phagocytosis of circulating pathogens	CELL			English	Article							IMMUNOGLOBULIN-LIKE DOMAINS; LISTERIA-MONOCYTOGENES; TRANSMEMBRANE PROTEINS; ALTERNATIVE PATHWAY; HUMAN NEUTROPHILS; DENDRITIC CELLS; KUPFFER CELLS; C3B RECEPTORS; 2 PARTS; LIVER	The complement system serves an important role in clearance of pathogens, immune complexes, and apoptotic cells present in the circulation. Complement fragments deposited on the particle surface serve as targets for complement receptors present on phagocytic cells. Although Kupffer cells, the liver resident macrophages, play a dominant role in clearing particles in circulation, complement receptors involved in this process have yet to be identified. Here we report the identification and characterization of a Complement Receptor of the Immunoglobulin superfamily, CRIg, that binds complement fragments C3b and iC3b. CRIg expression on Kupffer cells is required for efficient binding and phagocytosis of complement C3-opsonized particles. In turn, Kupffer cells from CRIg-deficient mice are unable to efficiently clear C3-opsonized pathogens in the circulation, resulting in increased infection and mortality of the host. CRIg therefore represents a dominant component of the phagocytic system responsible for rapid clearance of C3-opsonized particles from the circulation.	Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Campagne, MV (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	menno@gene.com	Gorgani, Nick/GXF-5438-2022; Scales, Suzie J./H-4507-2019	Scales, Suzie J./0000-0003-2544-0283; Ghilardi, Nico/0000-0003-4945-3097				Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Ahn JH, 2002, BLOOD, V100, P1742, DOI 10.1182/blood.V100.5.1742.h81702001742_1742_1754; ARNAOUT MA, 1981, J IMMUNOL, V127, P1348; Austin CD, 2004, MOL BIOL CELL, V15, P5268, DOI 10.1091/mbc.E04-07-0591; Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697; BENACERRAF B, 1959, J EXP MED, V110, P27, DOI 10.1084/jem.110.1.27; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Braun V, 2004, EMBO J, V23, P4166, DOI 10.1038/sj.emboj.7600427; BRIONES V, 1992, AM J VET RES, V53, P191; BROWN EJ, 1991, CURR OPIN IMMUNOL, V3, P76, DOI 10.1016/0952-7915(91)90081-B; CARPENTIER JL, 1991, CELL REGUL, V2, P41, DOI 10.1091/mbc.2.1.41; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; COLTEN HR, 1992, ANNU REV IMMUNOL, V10, P809, DOI 10.1146/annurev.iy.10.040192.004113; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; CROIZE J, 1993, INFECT IMMUN, V61, P5134, DOI 10.1128/IAI.61.12.5134-5139.1993; Cunnion KM, 2004, J LAB CLIN MED, V143, P358, DOI 10.1016/j.lab.2004.03.005; Dussurget O, 2004, ANNU REV MICROBIOL, V58, P587, DOI 10.1146/annurev.micro.57.030502.090934; Ebe Y, 1999, PATHOL INT, V49, P519, DOI 10.1046/j.1440-1827.1999.00910.x; Fang YF, 1998, J IMMUNOL, V160, P5273; FEARON DT, 1981, J EXP MED, V153, P1615, DOI 10.1084/jem.153.6.1615; GORDON DL, 1988, J INFECT DIS, V157, P697, DOI 10.1093/infdis/157.4.697; Gregory SH, 1996, J IMMUNOL, V157, P2514; Gregory SH, 2002, J IMMUNOL, V168, P308, DOI 10.4049/jimmunol.168.1.308; HAMMER CH, 1981, J BIOL CHEM, V256, P3995; HIRAKATA Y, 1991, INFECT IMMUN, V59, P289, DOI 10.1128/IAI.59.1.289-294.1991; HOLERS VM, 1992, IMMUNOL TODAY, V13, P231; HONG KS, 1991, J IMMUNOL, V146, P1868; Jelezarova E, 2003, J BIOL CHEM, V278, P51806, DOI 10.1074/jbc.M304613200; Langnaese K, 2000, BBA-GENE STRUCT EXPR, V1492, P522, DOI 10.1016/S0167-4781(00)00131-7; METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753; PANGBURN MK, 1980, J EXP MED, V152, P1102, DOI 10.1084/jem.152.4.1102; PINTO AJ, 1991, J LEUKOCYTE BIOL, V49, P579, DOI 10.1002/jlb.49.6.579; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; ROGERS HW, 1993, INFECT IMMUN, V61, P5090, DOI 10.1128/IAI.61.12.5090-5096.1993; Scott CC, 2003, J MEMBRANE BIOL, V193, P137, DOI 10.1007/s00232-002-2008-2; SENGELOV H, 1994, J IMMUNOL, V153, P804; Smith DK, 1997, J MOL BIOL, V274, P530, DOI 10.1006/jmbi.1997.1432; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Walker MG, 2002, BBA-GENE STRUCT EXPR, V1574, P387, DOI 10.1016/S0167-4781(01)00358-X; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wu HZ, 2003, INFECT IMMUN, V71, P5986, DOI 10.1128/IAI.71.10.5986-5993.2003	46	373	403	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					915	927		10.1016/j.cell.2005.12.039	http://dx.doi.org/10.1016/j.cell.2005.12.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530040	Bronze			2022-12-24	WOS:000237241200015
J	Nam, Y; Sliz, P; Song, LY; Aster, JC; Blacklow, SC				Nam, Y; Sliz, P; Song, LY; Aster, JC; Blacklow, SC			Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes	CELL			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; T-CELL LEUKEMIA; KAPPA-B COMPLEX; CRYSTAL-STRUCTURE; ANKYRIN DOMAIN; MAMMALIAN NOTCH; C-ELEGANS; ALAGILLE-SYNDROME; HUMAN HOMOLOG; HUMAN JAGGED1	Notch receptors transduce essential developmental signals between neighboring cells by forming a complex that leads to transcription of target genes upon activation. We report here the crystal structure of a Notch transcriptional activation complex containing the ankyrin domain of human Notch1 (ANK), the transcription factor CSL on cognate DNA, and a polypeptide from the coactivator Mastermind-like-1 (MAML-1). Together, CSL and ANK create a groove to bind the MAML-1 polypeptide as a kinked, 70 A helix. The composite binding surface likely restricts the recruitment of MAML proteins to promoters on which Notch:CSL complexes have been preassembled, ensuring tight transcriptional control of Notch target genes.	Harvard Univ, Sch Med, Biol & Biomed Sci Grad Program, Div Med Sci, Boston, MA 02115 USA; Howard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard University; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Blacklow, SC (corresponding author), Harvard Univ, Sch Med, Biol & Biomed Sci Grad Program, Div Med Sci, Boston, MA 02115 USA.	sblacklow@rics.bwh.harvard.edu		Sliz, Piotr/0000-0002-6522-0835; Nam, Yunsun/0000-0002-7939-8626	NATIONAL CANCER INSTITUTE [R01CA092433, R56CA092433] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NCI NIH HHS [CA119130, R01 CA119130, R01 CA092433, R01 CA092433-02S1, R01 CA092433-04, R01 CA092433-02, R01 CA092433-03, R01 CA092433-01A1, CA92433, R01 CA119130-01] Funding Source: Medline; NCRR NIH HHS [P41 RR012408-108514, P41 RR012408] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Ehebauer MT, 2005, BIOCHEM J, V392, P13, DOI 10.1042/BJ20050515; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jeffries S, 2002, MOL CELL BIOL, V22, P3927, DOI 10.1128/MCB.22.11.3927-3941.2002; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; KODOYIANNI V, 1992, MOL BIOL CELL, V3, P1199, DOI 10.1091/mbc.3.11.1199; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Lubman OY, 2005, PROTEIN SCI, V14, P1274, DOI 10.1110/ps.041184105; Lubman OY, 2004, MOL CELL, V13, P619, DOI 10.1016/S1097-2765(04)00120-0; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Nettles KW, 2005, ANNU REV PHYSIOL, V67, P309, DOI 10.1146/annurev.physiol.66.032802.154710; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Petcherski AG, 2000, NATURE, V405, P364, DOI 10.1038/35012645; Petcherski AG, 2000, CURR BIOL, V10, pR471, DOI 10.1016/S0960-9822(00)00577-7; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; Roehl H, 1996, EMBO J, V15, P7002, DOI 10.1002/j.1460-2075.1996.tb01092.x; ROEHL H, 1993, NATURE, V364, P632, DOI 10.1038/364632a0; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Tani S, 2001, NUCLEIC ACIDS RES, V29, P1373, DOI 10.1093/nar/29.6.1373; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Zweifel ME, 2003, PROTEIN SCI, V12, P2622, DOI 10.1110/ps.03279003	54	335	367	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					973	983		10.1016/j.cell.2005.12.037	http://dx.doi.org/10.1016/j.cell.2005.12.037			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530044	Bronze			2022-12-24	WOS:000237241200019
J	Jafar, TH				Jafar, TH			The growing burden of chronic kidney disease in Pakistan	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Aga Khan Univ, Clin Epidemiol Unit, Karachi, Pakistan	Aga Khan University	Jafar, TH (corresponding author), Aga Khan Univ, Clin Epidemiol Unit, Karachi, Pakistan.							Ahmad K, 2005, J HYPERTENS, V23, P1979, DOI 10.1097/01.hjh.0000187258.86824.00; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Jafar TH, 2005, J AM SOC NEPHROL, V16, P1413, DOI 10.1681/ASN.2004121100; Jafar TH, 2005, CIRCULATION, V111, P1291, DOI 10.1161/01.CIR.0000157699.87728.F1	4	69	70	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2006	354	10					995	997		10.1056/NEJMp058319	http://dx.doi.org/10.1056/NEJMp058319			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	019FY	16525135	Green Published			2022-12-24	WOS:000235822200002
J	Ghosh, A; Praefcke, GJK; Renault, L; Wittinghofer, A; Herrmann, C				Ghosh, A; Praefcke, GJK; Renault, L; Wittinghofer, A; Herrmann, C			How guanylate-binding proteins achieve assembly-stimulated processive cleavage of GTP to GMP	NATURE			English	Article							NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; MEDIATED ENDOCYTOSIS; DOMAIN; DYNAMIN; IDENTIFICATION; INHIBITION; HYDROLYSIS; ACTIVATION; RECEPTOR	Interferons are immunomodulatory cytokines that mediate antipathogenic and anti-proliferative effects in cells(1). Interferon-gamma-inducible human guanylate binding protein 1 ( hGBP1) belongs to the family of dynamin-related large GTP-binding proteins(2), which share biochemical properties not found in other families of GTP-binding proteins such as nucleotide-dependent oligomerization and fast cooperative GTPase activity(3). hGBP1 has an additional property by which it hydrolyses GTP to GMP in two consecutive cleavage reactions(4,5). Here we show that the isolated aminoterminal G domain of hGBP1 retains the main enzymatic properties of the full-length protein and can cleave GDP directly. Crystal structures of the N-terminal G domain trapped at successive steps along the reaction pathway and biochemical data reveal the molecular basis for nucleotide-dependent homodimerization and cleavage of GTP. Similar to effector binding in other GTP-binding proteins, homodimerization is regulated by structural changes in the switch regions. Homodimerization generates a conformation in which an arginine finger and a serine are oriented for efficient catalysis. Positioning of the substrate for the second hydrolysis step is achieved by a change in nucleotide conformation at the ribose that keeps the guanine base interactions intact and positions the beta-phosphates in the gamma-phosphate-binding site.	Lab Enzymol & Biochim Struct, CNRS, UPR 9063, F-91198 Gif Sur Yvette, France; Max Planck Inst Mol Physiol, Abt Strukturelle Biol, D-44227 Dortmund, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Max Planck Society	Wittinghofer, A (corresponding author), Lab Enzymol & Biochim Struct, CNRS, UPR 9063, Ave Terrasse, F-91198 Gif Sur Yvette, France.	alfred.wittinghofer@mpi-dortmund.mpg.de		Praefcke, Gerrit/0000-0001-8818-1499; RENAULT, Louis/0000-0003-1722-074X; Ghosh, Agnidipta/0000-0002-7753-0240				Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; CHENG YSE, 1991, MOL CELL BIOL, V11, P4717, DOI 10.1128/MCB.11.9.4717; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Ghosh A, 2004, MOL CELL, V15, P727, DOI 10.1016/j.molcel.2004.07.017; Guenzi E, 2003, EMBO J, V22, P3772, DOI 10.1093/emboj/cdg382; Guenzi E, 2001, EMBO J, V20, P5568, DOI 10.1093/emboj/20.20.5568; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Lavie A, 1998, BIOCHEMISTRY-US, V37, P3677, DOI 10.1021/bi9720787; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Modiano N, 2005, P NATL ACAD SCI USA, V102, P8680, DOI 10.1073/pnas.0503227102; Neun R, 1996, FEBS LETT, V390, P69, DOI 10.1016/0014-5793(96)00628-X; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; Praefcke GJK, 2004, J MOL BIOL, V344, P257, DOI 10.1016/j.jmb.2004.09.026; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Praefcke GJK, 1999, J MOL BIOL, V292, P321, DOI 10.1006/jmbi.1999.3062; Prakash B, 2000, EMBO J, V19, P4555, DOI 10.1093/emboj/19.17.4555; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; SCHWEMMLE M, 1994, J BIOL CHEM, V269, P11299; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Song BD, 2004, J BIOL CHEM, V279, P40431, DOI 10.1074/jbc.M407007200; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sun YJ, 2002, NAT STRUCT BIOL, V9, P95, DOI 10.1038/nsb744; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200; Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200	30	149	152	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2006	440	7080					101	104		10.1038/nature04510	http://dx.doi.org/10.1038/nature04510			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HW	16511497				2022-12-24	WOS:000235685700048
J	Longstreth, GF				Longstreth, GF			Functional dyspepsia - Managing the conundrum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Kaiser Permanente Med Ctr, San Diego, CA USA; Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA	Kaiser Permanente; University of California System; University of California San Diego	Longstreth, GF (corresponding author), Kaiser Permanente Med Ctr, San Diego, CA USA.							Andrews CN, 2005, GASTROENTEROLOGY, V128, pA456, DOI 10.1053/j.gastro.2005.09.020; DROSSMAN DA, IN PRESS GASTROENTER; Talley NJ, 2005, AM J GASTROENTEROL, V100, P2324, DOI 10.1111/j.1572-0241.2005.00225.x	3	7	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2006	354	8					791	793		10.1056/NEJMp058326	http://dx.doi.org/10.1056/NEJMp058326			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014CL	16495391				2022-12-24	WOS:000235456200003
J	Frigaard, NU; Martinez, A; Mincer, TJ; DeLong, EF				Frigaard, NU; Martinez, A; Mincer, TJ; DeLong, EF			Proteorhodopsin lateral gene transfer between marine planktonic Bacteria and Archaea	NATURE			English	Article							PHOTOTROPHY; LIBRARIES	Planktonic Bacteria, Archaea and Eukarya reside and compete in the ocean's photic zone under the pervasive influence of light. Bacteria in this environment were recently shown to contain photoproteins called proteorhodopsins, thought to contribute to cellular energy metabolism by catalysing light-driven proton translocation across the cell membrane(1-7). So far, proteorhodopsin genes have been well documented only in proteobacteria and a few other bacterial groups. Here we report the presence and distribution of proteorhodopsin genes in Archaea affiliated with the order Thermoplasmatales, in the ocean's upper water column. The genomic context and phylogenetic relationships of the archaeal and proteobacterial proteorhodopsins indicate its probable lateral transfer between planktonic Bacteria and Archaea. About 10% of the euryarchaeotes in the photic zone contained the proteorhodopsin gene adjacent to their small-subunit ribosomal RNA. The archaeal proteorhodopsins were also found in other genomic regions, in the same or in different microbial lineages. Although euryarchaeotes were distributed throughout the water column, their proteorhodopsins were found only in the photic zone. The cosmopolitan phylogenetic distribution of proteorhodopsins reflects their significant light-dependent fitness contributions, which drive the photoprotein's lateral acquisition and retention, but constrain its dispersal to the photic zone.	MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; MIT, Div Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	DeLong, EF (corresponding author), MIT, Dept Civil & Environm Engn, Bldg 48,15 Vassar St, Cambridge, MA 02139 USA.	delong@mit.edu	Frigaard, Niels-Ulrik/H-1277-2011; chen, qi/C-8585-2011	Frigaard, Niels-Ulrik/0000-0002-9389-8109; Mincer, Tracy/0000-0002-4644-5609				Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Beja O, 2000, ENVIRON MICROBIOL, V2, P516, DOI 10.1046/j.1462-2920.2000.00133.x; de la Torre JR, 2003, P NATL ACAD SCI USA, V100, P12830, DOI 10.1073/pnas.2133554100; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DeLong EF, 2003, ASM NEWS, V69, P503; DELONG EF, IN PRESS SCIENCE; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Giovannoni SJ, 2005, NATURE, V438, P82, DOI 10.1038/nature04032; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Giuliano G, 2003, TRENDS PLANT SCI, V8, P145, DOI 10.1016/S1360-1385(03)00053-0; Herndl GJ, 2005, APPL ENVIRON MICROB, V71, P2303, DOI 10.1128/AEM.71.5.2303-2309.2005; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; Massana R, 2000, APPL ENVIRON MICROB, V66, P1777, DOI 10.1128/AEM.66.5.1777-1787.2000; Moreira D, 2004, ENVIRON MICROBIOL, V6, P959, DOI 10.1111/j.1462-2920.2004.00644.x; Ochman H, 2005, P NATL ACAD SCI USA, V102, P6595, DOI 10.1073/pnas.0502035102; Pearson A, 2001, GEOCHIM COSMOCHIM AC, V65, P3123, DOI 10.1016/S0016-7037(01)00657-3; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P661, DOI 10.1128/AEM.68.2.661-667.2002; Ruch S, 2005, MOL MICROBIOL, V55, P1015, DOI 10.1111/j.1365-2958.2004.04460.x; Sabehi G, 2005, PLOS BIOL, V3, P1409, DOI 10.1371/journal.pbio.0030273; Sabehi G, 2004, ENVIRON MICROBIOL, V6, P903, DOI 10.1111/j.1462-2920.2004.00676.x; Suzuki MT, 2004, MICROB ECOL, V48, P473, DOI 10.1007/s00248-004-0213-5; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Woese CR, 2004, MICROBIOL MOL BIOL R, V68, P173, DOI 10.1128/MMBR.68.2.173-186.2004; Wuchter C, 2003, FEMS MICROBIOL LETT, V219, P203, DOI 10.1016/S0378-1097(03)00060-0	30	226	243	3	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2006	439	7078					847	850		10.1038/nature04435	http://dx.doi.org/10.1038/nature04435			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012JA	16482157				2022-12-24	WOS:000235333600050
J	Yellon, DM; Opie, LH				Yellon, DM; Opie, LH			Postconditioning for protection of the infarcting heart	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION; REPERFUSION; ISCHEMIA; INJURY		UCL Hosp, Hatter Cardiovasc Inst, London WC1E 6DB, England; Sch Med, London WC1E 6DB, England; Univ Cape Town, Fac Hlth Sci, Hatter Heart Res Inst, ZA-7925 Cape Town, South Africa	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Cape Town	Yellon, DM (corresponding author), UCL Hosp, Hatter Cardiovasc Inst, London WC1E 6DB, England.	hatter-institute@ucl.ac.uk	Yellon, Derek M/ABD-5110-2021	Hausenloy, Derek/0000-0003-0729-4956; Yellon, Derek/0000-0001-7791-9320				Bose AK, 2005, DIABETES, V54, P146, DOI 10.2337/diabetes.54.1.146; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Hausenloy DJ, 2005, TRENDS CARDIOVAS MED, V15, P69, DOI 10.1016/j.tcm.2005.03.001; Hausenloy DJ, 2005, AM J PHYSIOL-HEART C, V288, pH971, DOI 10.1152/ajpheart.00374.2004; Hausenloy DJ, 2003, J MOL CELL CARDIOL, V35, P339, DOI 10.1016/S0022-2828(03)00043-9; Kin H, 2005, CARDIOVASC RES, V67, P124, DOI 10.1016/j.cardiores.2005.02.015; Kloner RA, 2004, J AM COLL CARDIOL, V44, P276, DOI 10.1016/j.jacc.2004.03.068; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Staat P, 2005, CIRCULATION, V112, P2143, DOI 10.1161/CIRCULATIONAHA.105.558122; van Domburg RT, 2005, J AM COLL CARDIOL, V46, P15, DOI 10.1016/j.jacc.2005.03.047; Yellon DM, 2003, PHYSIOL REV, V83, P1113, DOI 10.1152/physrev.00009.2003; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	12	50	60	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2006	367	9509					456	458		10.1016/S0140-6736(06)68157-9	http://dx.doi.org/10.1016/S0140-6736(06)68157-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	013FF	16473110				2022-12-24	WOS:000235394500008
J	Thompson, MJ; Ninis, N; Perera, R; Mayon-White, R; Phillips, C; Bailey, L; Harnden, A; Mant, D; Levin, M				Thompson, MJ; Ninis, N; Perera, R; Mayon-White, R; Phillips, C; Bailey, L; Harnden, A; Mant, D; Levin, M			Clinical recognition of meningococcal disease in children and adolescents	LANCET			English	Article							BACTERIAL-MENINGITIS; HEALTH-CARE; MANAGEMENT; FEATURES; DELIVERY; ADULTS	Background Meningococcal disease is a rapidly progressive childhood infection of global importance. To our knowledge, no systematic quantitative research exists into the occurrence of symptoms before admission to hospital. Methods Data were obtained from questionnaires answered by parents and from primary-care records for the course of illness before admission to hospital in 448 children (103 fatal, 345 non-fatal), aged 16 years or younger, with meningococcal disease. In 373 cases, diagnosis was confirmed with microbiological techniques. The rest of the children were included because they had a purpuric rash, and either meningitis or evidence of septicaemic shock. Results were standardised to UK case-fatality rates. Findings The time-window for clinical diagnosis was narrow. Most children had only non-specific symptoms in the first 4-6 h, but were close to death by 24 h. Only 165 (51%) children were sent to hospital after the first consultation. The classic features of haemorrhagic rash, meningism, and impaired consciousness developed late (median onset 13-22 h). By contrast, 72% of children had early symptoms of sepsis (leg pains, cold hands and feet, abnormal skin colour) that first developed at a median time of 8 h, much earlier than the median time to hospital admission of 19 h. Interpretation Classic clinical features of meningococcal disease appear late in the illness. Recognising early symptoms of sepsis could increase the proportion of children identified by primary-care clinicians and shorten the time to hospital admission. The framework within which meningococcal disease is diagnosed should be changed to emphasise identification of these early symptoms by parents and clinicians.	Univ Oxford, Dept Primary Hlth Care, Oxford, England; Univ London Imperial Coll Sci & Technol, Fac Med, Dept Paediat, London, England	University of Oxford; Imperial College London	Thompson, MJ (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford, England.		Mant, David CA/C-7763-2009	Perera, Rafael/0000-0003-2418-2091; Levin, Michael/0000-0003-2767-6919	Medical Research Council [G0000340] Funding Source: Medline; MRC [G0000340] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BRANDTZAEG P, 2003, OXFORD TXB MED, P478; Davison K L, 2002, Commun Dis Public Health, V5, P205; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Goldacre MJ, 2003, BRIT MED J, V327, P596, DOI 10.1136/bmj.327.7415.596; Granier S, 1998, BRIT J GEN PRACT, V48, P1167; Harrison LH, 1999, JAMA-J AM MED ASSOC, V281, P1906, DOI 10.1001/jama.281.20.1906; *HLTH PROT AG, 2002, ENH SURV MEN DIS; Inkelis SH, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e3; Nadel S, 1998, J ACCID EMERG MED, V15, P298; Ninis N, 2005, BRIT MED J, V330, P1475, DOI 10.1136/bmj.330.7506.1475; Ragunathan L, 2000, J INFECTION, V40, P74, DOI 10.1053/jinf.1999.0595; Ramsay M, 1997, COMMUN DIS REP CDR R, V7, pR49; Riordan FAI, 1996, BRIT MED J, V313, P1255, DOI 10.1136/bmj.313.7067.1255; Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; SORENSEN HT, 1992, J CLIN EPIDEMIOL, V45, P1289; STUART JM, 1997, C D R REV, V7, P3; TARLOW MJ, 1992, LANCET, V340, P1481, DOI 10.1016/0140-6736(92)92678-9; Tikhomirov Eugene, 1997, World Health Statistics Quarterly, V50, P170; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000	21	306	315	0	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 4	2006	367	9508					397	403		10.1016/S0140-6736(06)67932-4	http://dx.doi.org/10.1016/S0140-6736(06)67932-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	009UR	16458763				2022-12-24	WOS:000235139400028
J	Huai, Q; Mazar, AP; Kuo, A; Parry, GC; Shaw, DE; Callahan, J; Li, YD; Yuan, C; Bian, CB; Chen, LQ; Furie, B; Furie, BC; Cines, DB; Huang, MD				Huai, Q; Mazar, AP; Kuo, A; Parry, GC; Shaw, DE; Callahan, J; Li, YD; Yuan, C; Bian, CB; Chen, LQ; Furie, B; Furie, BC; Cines, DB; Huang, MD			Structure of human urokinase plasminogen activator in complex with its receptor	SCIENCE			English	Article							BINDING; UPAR; METASTASIS; INHIBITION; RESIDUES; INVASION; SYSTEM; GROWTH	The urokinase plasminogen activator binds to its cellular receptor with high affinity and initiates signaling cascades that are implicated in pathological processes including tumor growth, metastasis, and inflammation. We report the crystal structure at 1.9 angstroms of the urokinase receptor complexed with the urokinase amino-terminal fragment and an antibody against the receptor. The three domains of urokinase receptor form a concave shape with a central cone-shaped cavity where the urokinase fragment inserts. The structure provides insight into the flexibility of the urokinase receptor that enables its interaction with a wide variety of ligands and a basis for the design of urokinase-urokinase receptor antagonists.	Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Div Hemostasis & Thrombosis, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Attenuon LLC, San Diego, CA 92121 USA; Univ Penn, Med Ctr, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R China; Univ Alabama, Struct Biol Lab, Dept Chem, Grad Program Biotechnol, Huntsville, AL 35899 USA; Univ Alabama, Struct Biol Lab, Dept Chem, Grad Program Chem, Huntsville, AL 35899 USA; Univ Alabama, Struct Biol Lab, Dept Chem, Grad Program Mat Sci, Huntsville, AL 35899 USA; DE Shaw Res & Dev, New York, NY 10036 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Pennsylvania; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; University of Alabama System; University of Alabama Huntsville; University of Alabama System; University of Alabama Huntsville; University of Alabama System; University of Alabama Huntsville; D. E. Shaw Research	Huang, MD (corresponding author), Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Div Hemostasis & Thrombosis, Boston, MA 02215 USA.	mhuang@fjirsm.ac.cn	Huang, Mingdong/J-4278-2017	Huang, Mingdong/0000-0003-0085-9141	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086584] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL086584-01, R01 HL086584] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Behrendt N, 2004, BIOL CHEM, V385, P103, DOI 10.1515/BC.2004.031; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Dano K, 1999, APMIS, V107, P120, DOI 10.1111/j.1699-0463.1999.tb01534.x; ESTREICHER A, 1989, J BIOL CHEM, V264, P1180; HANSEN AP, 1994, BIOCHEMISTRY-US, V33, P4847, DOI 10.1021/bi00182a013; Jo M, 2003, J BIOL CHEM, V278, P1642, DOI 10.1074/jbc.M210877200; KOOK YH, 1994, EMBO J, V13, P3983, DOI 10.1002/j.1460-2075.1994.tb06714.x; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Magdolen V, 1996, EUR J BIOCHEM, V237, P743, DOI 10.1111/j.1432-1033.1996.0743p.x; Mohanam S, 1997, ONCOGENE, V14, P1351, DOI 10.1038/sj.onc.1200963; Mondino A, 2004, TRENDS IMMUNOL, V25, P450, DOI 10.1016/j.it.2004.06.004; Myohanen H, 2004, CELL MOL LIFE SCI, V61, P2840, DOI 10.1007/s00018-004-4230-9; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; Ploug M, 2003, CURR PHARM DESIGN, V9, P1499, DOI 10.2174/1381612033454630; PLOUG M, 1995, BIOCHEMISTRY-US, V34, P12524, DOI 10.1021/bi00039a006; QUATTRONE A, 1995, ANTI-CANCER DRUG DES, V10, P97; Quax PHA, 1998, ARTERIOSCL THROM VAS, V18, P693, DOI 10.1161/01.ATV.18.5.693; Rabbani S A, 2001, Surg Oncol Clin N Am, V10, P393; Stephens RW, 1997, CLIN CHEM, V43, P1868; Yu W, 1997, J CELL BIOL, V137, P767, DOI 10.1083/jcb.137.3.767	22	244	262	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 3	2006	311	5761					656	659		10.1126/science.1121143	http://dx.doi.org/10.1126/science.1121143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011GY	16456079				2022-12-24	WOS:000235257400047
J	Wickless, SC; Shwayder, TA				Wickless, SC; Shwayder, TA			A medical mystery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Oakwood Hlth Syst, Dearborn, MI 48124 USA; Henry Ford Hlth Syst, Detroit, MI 48202 USA	Beaumont Health; Henry Ford Health System; Henry Ford Hospital	Wickless, SC (corresponding author), Oakwood Hlth Syst, Dearborn, MI 48124 USA.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2004	351	15					1547	1547		10.1056/NEJMicm040304	http://dx.doi.org/10.1056/NEJMicm040304			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859UP	16541560				2022-12-24	WOS:000224293700013
J	Yamane, K; Toumazou, C; Tsukada, Y; Erdjument-Bromage, H; Tempst, P; Wong, JM; Zhang, Y				Yamane, Kenichi; Toumazou, Charalambos; Tsukada, Yu-ichi; Erdjument-Bromage, Hediye; Tempst, Paul; Wong, Jiemin; Zhang, Yi			JHDM2A, a JmjC-containing H3K9 dernethylase, facilitates transcription activation by androgen receptor	CELL			English	Article							HISTONE LYSINE METHYLATION; OXIDATIVE DEMETHYLATION; ARGININE METHYLATION; ESCHERICHIA-COLI; HORMONE-RECEPTOR; COMPLEX; METHYLTRANSFERASE; CHROMATIN; GENES; REPRESSION	Covalent modification of histones plays an important role in regulating chromatin dynamics and transcription. Histone methylation was thought to be an irreversible modification until recently. Using a biochemical assay coupled with chromatography, we have purified a JmjC domain-containing protein, JHDM2A, which specifically demethylates mono- and dimethyl-H3K9. Similar to JHDM1, JHDM2A-mediated histone demethylation requires cofactors Fe(II) and a-ketoglutarate. Mutational studies indicate that a JmjC domain and a zinc finger present in JHDM2A are required for its enzymatic activity. Overexpression of JHDM2A greatly reduced the H3K9 methylation level in vivo. Knockdown of JHDM2A results in an increase in the dimethyl-K9 levels at the promoter region of a subset of genes concomitant with decrease in their expression. Finally, JHDM2A exhibits hormone-dependent recruitment to androgen-receptor target genes, resulting in H3K9 demethylation and transcriptional activation. Thus, our work identifies a histone demethylase and links its function to hormone-dependent transcriptional activation.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10021 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; Memorial Sloan Kettering Cancer Center	Zhang, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	Hu, Ruogu/B-2203-2008	Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987; Wong, Jiemin/0000-0002-5311-842X; Zhang, Yi/0000-0002-2789-0811	NCI NIH HHS [P30 CA08748] Funding Source: Medline; NIDDK NIH HHS [DK065264] Funding Source: Medline; NIGMS NIH HHS [GM68804] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ALLIS CD, 1980, CELL, V20, P55; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; BYVOET P, 1972, ARCH BIOCHEM BIOPHYS, V152, P887, DOI 10.1016/0003-9861(72)90286-X; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HOOG C, 1991, MOL REPROD DEV, V30, P173, DOI 10.1002/mrd.1080300302; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Siu MKY, 2004, BIOESSAYS, V26, P978, DOI 10.1002/bies.20099; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	43	612	648	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					483	495		10.1016/j.cell.2006.03.027	http://dx.doi.org/10.1016/j.cell.2006.03.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16603237	Bronze, Green Submitted			2022-12-24	WOS:000237506100015
J	Zimmermann, TS; Lee, ACH; Akinc, A; Bramlage, B; Bumcrot, D; Fedoruk, MN; Harborth, J; Heyes, JA; Jeffs, LB; John, M; Judge, AD; Lam, K; McClintock, K; Nechev, LV; Palmer, LR; Racie, T; Rohl, I; Seiffert, S; Shanmugam, S; Sood, V; Soutschek, J; Toudjarska, I; Wheat, AJ; Yaworski, E; Zedalis, W; Koteliansky, V; Manoharan, M; Vornlocher, HP; MacLachlan, I				Zimmermann, TS; Lee, ACH; Akinc, A; Bramlage, B; Bumcrot, D; Fedoruk, MN; Harborth, J; Heyes, JA; Jeffs, LB; John, M; Judge, AD; Lam, K; McClintock, K; Nechev, LV; Palmer, LR; Racie, T; Rohl, I; Seiffert, S; Shanmugam, S; Sood, V; Soutschek, J; Toudjarska, I; Wheat, AJ; Yaworski, E; Zedalis, W; Koteliansky, V; Manoharan, M; Vornlocher, HP; MacLachlan, I			RNAi-mediated gene silencing in non-human primates	NATURE			English	Article							INTERFERING RNA; MODIFIED SIRNAS; PHARMACOKINETICS; CHOLESTEROL; INHIBITION; POTENT; MICE; CELL	The opportunity to harness the RNA interference (RNAi) pathway to silence disease-causing genes holds great promise for the development of therapeutics directed against targets that are otherwise not addressable with current medicines(1,2). Although there are numerous examples of in vivo silencing of target genes after local delivery of small interfering RNAs (siRNAs)(3-5), there remain only a few reports of RNAi-mediated silencing in response to systemic delivery of siRNA(6-8), and there are no reports of systemic efficacy in non-rodent species. Here we show that siRNAs, when delivered systemically in a liposomal formulation, can silence the disease target apolipoprotein B (ApoB) in non-human primates. APOB-specific siRNAs were encapsulated in stable nucleic acid lipid particles (SNALP) and administered by intravenous injection to cynomolgus monkeys at doses of 1 or 2.5 mg kg(-1). A single siRNA injection resulted in dose-dependent silencing of APOB messenger RNA expression in the liver 48 h after administration, with maximal silencing of >90%. This silencing effect occurred as a result of APOB mRNA cleavage at precisely the site predicted for the RNAi mechanism. Significant reductions in ApoB protein, serum cholesterol and low-density lipoprotein levels were observed as early as 24 h after treatment and lasted for 11 days at the highest siRNA dose, thus demonstrating an immediate, potent and lasting biological effect of siRNA treatment. Our findings show clinically relevant RNAi-mediated gene silencing in non-human primates, supporting RNAi therapeutics as a potential new class of drugs.	Alnylam Pharmaceut Inc, Cambridge, MA 02142 USA; Protiva Biotherapeut Inc, Burnaby, BC V5G 4Y1, Canada; Alnylam Europe AG, D-95326 Kulmbach, Germany		Zimmermann, TS (corresponding author), Alnylam Pharmaceut Inc, 300 3rd St, Cambridge, MA 02142 USA.	tzimmermann@alnylam.com; ian@protivabio.com		Fedoruk, Matthew/0000-0002-9553-9476				Bartlett DW, 2006, NUCLEIC ACIDS RES, V34, P322, DOI 10.1093/nar/gkj439; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; CHONN A, 1991, J IMMUNOL, V146, P4234; Crooke RM, 2005, J LIPID RES, V46, P872, DOI 10.1194/jlr.M400492-JLR200; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Lennernas H, 1997, CLIN PHARMACOKINET, V32, P403, DOI 10.2165/00003088-199732050-00005; Levin AA, 1999, BBA-GENE STRUCT EXPR, V1489, P69, DOI 10.1016/S0167-4781(99)00140-2; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Shankar P, 2005, JAMA-J AM MED ASSOC, V293, P1367, DOI 10.1001/jama.293.11.1367; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Song EW, 2003, J VIROL, V77, P7174, DOI 10.1128/JVI.77.13.7174-7181.2003; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Thakker DR, 2004, P NATL ACAD SCI USA, V101, P17270, DOI 10.1073/pnas.0406214101	19	1094	1344	8	194	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					111	114		10.1038/nature04688	http://dx.doi.org/10.1038/nature04688			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16565705				2022-12-24	WOS:000237248600043
J	Sundstrom, J; Riserus, U; Byberg, L; Zethelius, B; Lithell, H; Lind, L				Sundstrom, J; Riserus, U; Byberg, L; Zethelius, B; Lithell, H; Lind, L			Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; INSULIN-RESISTANCE; ALL-CAUSE; PREVENTION; GLUCOSE; EVENTS; HEALTH; RISK	Objectives To find out if the presence of the metabolic syndrome increases the risk of subsequent total and cardiovascular mortality, taking into account established risk factors for cardiovascular disease. Design Prospective cohort study. Setting General population. Participants A community based sample of 2322 men followed since 1970 for a maximum of 32.7 years, investigated at ages 50 and 70. Main outcome measures The relations of die metabolic syndrome defined by the national cholesterol education programme (NCEP) of the US National Heart, Lung, and Blood Institute or criteria of the World Health Organization (WHO) to subsequent total and cardiovascular mortality. Results When adding the metabolic syndrome to models with established risk factors for cardiovascular disease (smoking, diabetes, hypertension, and serum cholesterol) at age 50, presence of the metabolic syndrome as defined in the NCEP significantly predicted total and cardiovascular mortality (Cox proportional hazard ratios 1.36, 95% confidence interval 1.17 to 1.58; and 1.59,1.29 to 1.95, respectively). The metabolic syndrome added prognostic information to that of the established risk factors for cardiovascular disease (likelihood ratio tests, P < 0.0001 for both outcomes). Similar results were obtained in a subsample without diabetes or manifest cardiovascular disease. Conclusions In a large, community based sample of middle aged men, the presence of the metabolic syndrome according to the definition of the NCEP gave long term prognostic information regarding total mid cardiovascular mortality if the status of established risk factors for cardiovascular disease was known. If confirmed this may indicate clinical value in diagnosing the metabolic syndrome.	Uppsala Univ, Dept Med Sci, SE-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Publ Hlth & Caring Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital	Sundstrom, J (corresponding author), Uppsala Univ, Dept Med Sci, SE-75185 Uppsala, Sweden.	johan.sundstrom@medsci.uu.se	Sundström, Johan/A-6286-2009; Sundstrom, Johan/R-2139-2019	Sundström, Johan/0000-0003-2247-8454; Sundstrom, Johan/0000-0003-2247-8454				[Anonymous], 1997, Diabetes Care, V20 Suppl 1, pS1; BATKAU B, 1999, DIABETIC MED, V16, P442; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Ford ES, 2004, ATHEROSCLEROSIS, V173, P309, DOI 10.1016/j.atherosclerosis.2003.12.022; Girman CJ, 2004, AM J CARDIOL, V93, P136, DOI 10.1016/j.amjcard.2003.09.028; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hedstrand H, 1975, Ups J Med Sci Suppl, V19, P1; Hunt KJ, 2004, CIRCULATION, V110, P1251, DOI 10.1161/01.CIR.0000140762.04598.F9; ILN G, 2004, ARCH INTERN MED, V164, P1066; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Katzmarzyk PT, 2004, ARCH INTERN MED, V164, P1092, DOI 10.1001/archinte.164.10.1092; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Rutter MK, 2004, CIRCULATION, V110, P380, DOI 10.1161/01.CIR.0000136581.59584.0E; Sattar N, 2003, CIRCULATION, V108, P414, DOI 10.1161/01.CIR.0000080897.52664.94; Schillaci G, 2004, J AM COLL CARDIOL, V43, P1817, DOI 10.1016/j.jacc.2003.12.049; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Zethelius B, 2005, DIABETOLOGIA, V48, P862, DOI 10.1007/s00125-005-1711-9	23	277	290	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2006	332	7546					878	881		10.1136/bmj.38766.624097.1F	http://dx.doi.org/10.1136/bmj.38766.624097.1F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037FK	16510492	Green Published, Bronze			2022-12-24	WOS:000237132100014
J	Hataye, J; Moon, JJ; Khoruts, A; Reilly, C; Jenkins, MK				Hataye, J; Moon, JJ; Khoruts, A; Reilly, C; Jenkins, MK			Naive and memory CD4(+) T cell survival controlled by clonal abundance	SCIENCE			English	Article							HOMEOSTATIC PROLIFERATION; TCR REPERTOIRE; IN-VIVO; MHC; ABSENCE; COMPETITION; INDUCTION; DIVERSITY; IMMUNITY; SIGNALS	Immunity to a plethora of microbes depends on a diverse repertoire of naive lymphocytes and the production of long-lived memory cells. We present evidence here that low clonal abundance in a polyclonal repertoire favors the survival and activation of naive CD4(+) T cells as well as the survival of their memory cell progeny. The inverse relation between clonal frequency and survival suggests that intraclonal competition could help maintain an optimally diverse repertoire of T cells and an optimal environment for the generation of long-lived memory cells.	Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Ctr Immunol, Dept Med, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hataye, J (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA.	hata0006@umn.edu	Jenkins, Marc K/G-1063-2012; moon, james/F-1031-2014	Jenkins, Marc K/0000-0001-8009-7655; moon, james/0000-0001-8071-1491	NCI NIH HHS [T32 CA009138] Funding Source: Medline; NIAID NIH HHS [AI39614, T32-AI007313, F32 AI063793-01A1, AI27998, F32 AI063793] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007313, R01AI027998, R01AI039614, R37AI027998, F32AI063793] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; Clarke SRM, 2000, J IMMUNOL, V165, P2458, DOI 10.4049/jimmunol.165.5.2458; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kassiotis G, 2002, NAT IMMUNOL, V3, P244, DOI 10.1038/ni766; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; McSorley SJ, 2002, IMMUNITY, V16, P365, DOI 10.1016/S1074-7613(02)00289-3; Min B, 2004, P NATL ACAD SCI USA, V101, P3874, DOI 10.1073/pnas.0400606101; Moses CT, 2003, P NATL ACAD SCI USA, V100, P1185, DOI 10.1073/pnas.0334572100; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Troy AE, 2003, J IMMUNOL, V170, P672, DOI 10.4049/jimmunol.170.2.672; Varga SM, 2001, J IMMUNOL, V166, P1554, DOI 10.4049/jimmunol.166.3.1554; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Witherden D, 2000, J EXP MED, V191, P355, DOI 10.1084/jem.191.2.355	22	280	284	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2006	312	5770					114	116		10.1126/science.1124228	http://dx.doi.org/10.1126/science.1124228			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16513943				2022-12-24	WOS:000236584400044
J	Friedman, RA				Friedman, RA			The changing face of teenage drug abuse - The trend toward prescription drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Weill Cornell Med Coll, Psychopharmacol Clin, New York, NY 10021 USA	Cornell University	Friedman, RA (corresponding author), Weill Cornell Med Coll, Psychopharmacol Clin, New York, NY 10021 USA.							DOE J, 2005, COUNTER DIVERSION AB; *IMS HLTH, 2004, INT PROM SERV CMR; JOHNSTON LD, 2005, IN PRESS MONITORING; *OFF APPL STUD, 2005, NSDUH SER H, V28; *PHARM RES MAN AM, 2004, PHRMA ANN MEMB SURV	5	82	82	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 6	2006	354	14					1448	1450		10.1056/NEJMp068010	http://dx.doi.org/10.1056/NEJMp068010			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	029DP	16598042				2022-12-24	WOS:000236539000002
J	Duthie, C; Gibbs, G; Burns, KC				Duthie, C; Gibbs, G; Burns, KC			Seed dispersal by weta	SCIENCE			English	Article									Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	Victoria University Wellington	Burns, KC (corresponding author), Victoria Univ Wellington, Sch Biol Sci, POB 600, Wellington, New Zealand.	kevin.burns@vuw.ac.nz		Burns, K.C./0000-0002-4938-2877				Amico G, 2000, NATURE, V408, P929, DOI 10.1038/35050170; Christian CE, 2001, NATURE, V413, P635, DOI 10.1038/35098093; Darwin Charles., 1866, ORIGIN SPECIES; Gibbs G., 2001, NZ WETA; Vulinec K, 2002, BIOTROPICA, V34, P297, DOI 10.1111/j.1744-7429.2002.tb00541.x; Williams PA, 2000, AUSTRAL ECOL, V25, P523, DOI 10.1046/j.1442-9993.2000.01078.x	6	51	54	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1575	1575		10.1126/science.1123544	http://dx.doi.org/10.1126/science.1123544			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543452				2022-12-24	WOS:000236029500035
J	Lee, JW; Helmann, JD				Lee, JW; Helmann, JD			The PerR transcription factor senses H2O2 by metal-catalysed histidine oxidation	NATURE			English	Article							BACILLUS-SUBTILIS; PEROXIDE STRESS; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; 2-OXO-HISTIDINE; INTEGRATION; REGULATOR; REPRESSOR; PROTEINS; RESIDUES	The sensing of reactive oxygen species is essential for cellular responses to oxidative stress(1). The sensing of peroxides is typically mediated by redox- active cysteines in sensors such as the bacterial OxyR, OhrR, and Hsp33 proteins(2,3). Bacillus subtilis PerR is the prototype for a widespread family of metal- dependent peroxide sensors that regulate inducible peroxide- defence genes(4). Here we show that PerR senses peroxides by metal- catalysed oxidation. PerR contains two metal- binding sites: a structural Zn2+ site and a regulatory divalent metal ion site that preferentially binds Fe2+ or Mn2+ ( ref. 5). Protein oxidation, catalysed by a bound ferrous ion, leads to the rapid and direct incorporation of one oxygen atom into histidine 37 ( H37) or H91, two of the residues that coordinate the bound Fe2+. This mechanism accounts for the ability of PerR to sense low levels of hydrogen peroxide in vivo. The reduction of hydrogen peroxide by metal ions to generate highly reactive hydroxyl radicals underlies the genotoxic effects of peroxides(1), and has been shown to contribute to enzyme inactivation, but has not previously been shown to provide a regulatory mechanism for peroxide sensing.	Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA	Cornell University	Helmann, JD (corresponding author), Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA.	jdh9@cornell.edu	LEE, JIN-WON/L-1116-2016	LEE, JIN-WON/0000-0002-1201-8254; Helmann, John/0000-0002-3832-3249				Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; Berlett BS, 2001, P NATL ACAD SCI USA, V98, P451, DOI 10.1073/pnas.021552298; CHEN L, 1995, P NATL ACAD SCI USA, V92, P8190, DOI 10.1073/pnas.92.18.8190; Fuangthong M, 2002, J BACTERIOL, V184, P3276, DOI 10.1128/JB.184.12.3276-3286.2002; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Hahn JS, 2000, J BIOL CHEM, V275, P38254, DOI 10.1074/jbc.M006079200; He C, 2005, MOL CELL, V20, P117, DOI 10.1016/j.molcel.2005.08.013; Helmann JD, 2003, J BACTERIOL, V185, P243, DOI 10.1128/JB.185.1.243-253.2003; Herbig AF, 2001, MOL MICROBIOL, V41, P849, DOI 10.1046/j.1365-2958.2001.02543.x; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Jewett SL, 1999, FREE RADICAL BIO MED, V26, P905, DOI 10.1016/S0891-5849(98)00274-3; Kaltwasser M, 2002, APPL ENVIRON MICROB, V68, P2624, DOI 10.1128/AEM.68.5.2624-2628.2002; Kiley PJ, 2004, PLOS BIOL, V2, P1714, DOI 10.1371/journal.pbio.0020400; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Lucana DOD, 2003, MOL GENET GENOMICS, V268, P618, DOI 10.1007/s00438-002-0776-0; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Mongkolsuk S, 2002, MOL MICROBIOL, V45, P9, DOI 10.1046/j.1365-2958.2002.03015.x; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Schoneich C, 2002, CHEM RES TOXICOL, V15, P717, DOI 10.1021/tx025504k; Schoneich C, 2000, J PHARMACEUT BIOMED, V21, P1093, DOI 10.1016/S0731-7085(99)00182-X; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Toledano MB, 2004, TRENDS BIOCHEM SCI, V29, P351, DOI 10.1016/j.tibs.2004.05.005; UCHIDA K, 1994, J BIOL CHEM, V269, P2405; UCHIDA K, 1993, FEBS LETT, V332, P208, DOI 10.1016/0014-5793(93)80632-5; Wright AF, 2004, NAT GENET, V36, P1153, DOI 10.1038/ng1448	27	411	422	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2006	440	7082					363	367		10.1038/nature04537	http://dx.doi.org/10.1038/nature04537			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541078				2022-12-24	WOS:000235997600058
J	Dougherty, MK; Khurana, KK; Neubauer, FM; Russell, CT; Saur, J; Leisner, JS; Burton, ME				Dougherty, MK; Khurana, KK; Neubauer, FM; Russell, CT; Saur, J; Leisner, JS; Burton, ME			Identification of a dynamic atmosphere at Enceladus with the Cassini magnetometer	SCIENCE			English	Article							IO; SYSTEM; SATELLITES; ENGINE; SPACE		Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2AZ, England; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90025 USA; Univ Cologne, Inst Geophys & Meteorol, D-50923 Cologne, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Imperial College London; University of California System; University of California Los Angeles; University of Cologne; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Dougherty, MK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Prince Consort Rd, London SW7 2AZ, England.	m.dougherty@imperial.ac.uk	Saur, Joachim/V-6780-2019; Russell, Christopher T/E-7745-2012	Saur, Joachim/0000-0003-1413-1231; Russell, Christopher T/0000-0003-1639-8298; Khurana, Krishan/0000-0002-2856-1171	STFC [PP/D000912/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D000912/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		BELCHER JW, 1987, SCIENCE, V238, P170, DOI 10.1126/science.238.4824.170; Brown RH, 2006, SCIENCE, V311, P1425, DOI 10.1126/science.1121031; Dougherty MK, 2004, SPACE SCI REV, V114, P331, DOI 10.1007/s11214-004-1432-2; DRELL SD, 1965, J GEOPHYS RES, V70, P3131, DOI 10.1029/JZ070i013p03131; Esposito LW, 2005, SCIENCE, V307, P1251, DOI 10.1126/science.1105606; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; Huddleston DE, 1998, J GEOPHYS RES-PLANET, V103, P19887, DOI 10.1029/97JE03557; Kivelson MG, 2001, J GEOPHYS RES-SPACE, V106, P26121, DOI 10.1029/2000JA002510; NEUBAUER FM, 1980, J GEOPHYS RES-SPACE, V85, P1171, DOI 10.1029/JA085iA03p01171; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Saur J, 2005, ASTROPHYS J, V620, pL115, DOI 10.1086/428665; Sittler EC, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2002JA009647; SMITH BA, 1982, SCIENCE, V215, P504, DOI 10.1126/science.215.4532.504; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290	15	285	287	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2006	311	5766					1406	1409		10.1126/science.1120985	http://dx.doi.org/10.1126/science.1120985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527966				2022-12-24	WOS:000236029400032
J	Qiu, MH; Ren, ZF; Che, L; Dai, DX; Harich, SA; Wang, XY; Yang, XM; Xu, CX; Xie, DQ; Gustafsson, M; Skodje, RT; Sun, ZG; Zhang, DH				Qiu, MH; Ren, ZF; Che, L; Dai, DX; Harich, SA; Wang, XY; Yang, XM; Xu, CX; Xie, DQ; Gustafsson, M; Skodje, RT; Sun, ZG; Zhang, DH			Observation of Feshbach resonances in the F+H-2 -> HF+H reaction	SCIENCE			English	Article							POTENTIAL-ENERGY SURFACE; EXACT QUANTUM; SEMICLASSICAL REACTION; REACTION DYNAMICS; TRANSITION-STATE; CROSS-SECTIONS; MOLECULAR-BEAM; SCATTERING; F+H2; PROBABILITIES	Reaction resonances, or transiently stabilized transition-state structures, have proven highly challenging to capture experimentally. Here, we used the highly sensitive H atom Rydberg tagging time-of-flight method to conduct a crossed molecular beam scattering study of the F + H-2 --> HF + H reaction with full quantum-state resolution. Pronounced forward-scattered HF products in the v' = 2 vibrational state were clearly observed at a collision energy of 0.52 kcal/mol; this was attributed to both the ground and the first excited Feshbach resonances trapped in the peculiar HF(v' = 3)-H' vibrationally adiabatic potential, with substantial enhancement by constructive interference between the two resonances.	Chinese Acad Sci, State Key Lab Mol React Dynam, Dalian Inst Chem Phys, Dalian 116023, Peoples R China; Chinese Acad Sci, Dalian Inst Chem Phys, Ctr Theoret Computat Chem, Dalian 116023, Peoples R China; Dalian Jiaotong Univ, Dept Phys, Dalian, Peoples R China; Nanjing Univ, Dept Chem, Inst Theoret & Computat Chem, Nanjing 210093, Jiangsu, Peoples R China; Acad Sinica, Inst Atom & Mol Sci, Taipei, Taiwan; Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; Natl Univ Singapore, Dept Computat Sci, Singapore 119260, Singapore	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Dalian Jiaotong University; Nanjing University; Academia Sinica - Taiwan; University of Colorado System; University of Colorado Boulder; National University of Singapore	Yang, XM (corresponding author), Chinese Acad Sci, State Key Lab Mol React Dynam, Dalian Inst Chem Phys, Dalian 116023, Peoples R China.	xmyang@dicp.ac.cn; dqxie@nju.edu.cn; zhangdh@dicp.ac.cn	Ren, Zefeng/T-2259-2019; Gustafsson, Magnus/A-1661-2010; Sun, Zhigang/B-5757-2011; Gustafsson, Magnus/GSD-2741-2022; Gustafsson, Magnus/GOV-3301-2022; Ren, Zefeng/B-1500-2009; Yang, Xueming/C-8764-2013	Gustafsson, Magnus/0000-0002-7629-0169; Gustafsson, Magnus/0000-0002-7629-0169; Gustafsson, Magnus/0000-0002-7629-0169; Ren, Zefeng/0000-0002-5263-9346; 				AOIZ FJ, 1994, CHEM PHYS LETT, V223, P215, DOI 10.1016/0009-2614(94)00435-8; Castillo JF, 1996, J CHEM PHYS, V104, P6531, DOI 10.1063/1.471373; Chao SD, 2000, J CHEM PHYS, V113, P3487, DOI 10.1063/1.1289526; Dai DX, 2003, SCIENCE, V300, P1730, DOI 10.1126/science.1084041; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Fernandez-Alonso F, 2002, ANNU REV PHYS CHEM, V53, P67, DOI 10.1146/annurev.physchem.53.091001.094554; Harich SA, 2002, NATURE, V419, P281, DOI 10.1038/nature01068; Hayes M, 2005, CHEM PHYS, V308, P259, DOI 10.1016/j.chemphys.2004.05.028; KNOWLES PJ, 1988, CHEM PHYS LETT, V145, P514, DOI 10.1016/0009-2614(88)87412-8; KUPPERMANN A, 1981, POTENTIAL ENERGY SUR, P375; LANGHOFF SR, 1974, INT J QUANTUM CHEM, V8, P61, DOI 10.1002/qua.560080106; LEE YT, 1987, SCIENCE, V236, P793, DOI 10.1126/science.236.4803.793; Liu KP, 2001, ANNU REV PHYS CHEM, V52, P139, DOI 10.1146/annurev.physchem.52.1.139; Liu XH, 2000, SCIENCE, V289, P1536, DOI 10.1126/science.289.5484.1536; MANOLOPOULOS DE, 1993, SCIENCE, V262, P1852, DOI 10.1126/science.262.5141.1852; NEUMARK DM, 1985, J CHEM PHYS, V82, P3045, DOI 10.1063/1.448254; NEUMARK DM, 1984, PHYS REV LETT, V53, P226, DOI 10.1103/PhysRevLett.53.226; Nizkorodov SA, 1999, J CHEM PHYS, V111, P8404, DOI 10.1063/1.480182; Rusin LY, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1873772; Russell CL, 1996, CHEM PHYS LETT, V256, P465, DOI 10.1016/0009-2614(96)00445-9; Schatz GC, 2000, SCIENCE, V288, P1599, DOI 10.1126/science.288.5471.1599; SCHATZ GC, 1973, J CHEM PHYS, V58, P4023, DOI 10.1063/1.1679760; SCHATZ GC, 1975, J CHEM PHYS, V63, P685, DOI 10.1063/1.431391; SCHATZ GC, 1975, J CHEM PHYS, V63, P674, DOI 10.1063/1.431390; Schnieder L, 1997, J CHEM PHYS, V107, P6175, DOI 10.1063/1.474283; Skodje RT, 2000, PHYS REV LETT, V85, P1206, DOI 10.1103/PhysRevLett.85.1206; Skouteris D, 2000, COMPUT PHYS COMMUN, V133, P128, DOI 10.1016/S0010-4655(00)00167-3; Stark K, 1996, J CHEM PHYS, V104, P6515, DOI 10.1063/1.471372; Strazisar BR, 2000, SCIENCE, V290, P958, DOI 10.1126/science.290.5493.958; WERNER HJ, 1988, J CHEM PHYS, V89, P5803, DOI 10.1063/1.455556; WU SF, 1973, MOL PHYS, V25, P839, DOI 10.1080/00268977300100731; Xie T, 2002, J CHEM PHYS, V116, P7461, DOI 10.1063/1.1467328	32	265	275	10	298	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2006	311	5766					1440	1443		10.1126/science.1123452	http://dx.doi.org/10.1126/science.1123452			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527975				2022-12-24	WOS:000236029400042
J	Lange, PF; Wartosch, L; Jentsch, TJ; Fuhrmann, JC				Lange, PF; Wartosch, L; Jentsch, TJ; Fuhrmann, JC			ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function	NATURE			English	Article							GREY-LETHAL MUTATION; AUTOSOMAL RECESSIVE OSTEOPETROSIS; MALIGNANT OSTEOPETROSIS; CL-CHANNELS; MOUSE; GENE; PROTEINS; DISEASE; ATPASE; LEADS	Mutations in ClC-7, a late endosomal/lysosomal member of the CLC family of chloride channels and transporters(1,2), cause osteopetrosis(3) and lysosomal storage disease(4) in humans and mice. Severe osteopetrosis is also observed with mutations in the OSTM1 gene, which encodes a membrane protein of unknown function(5). Here we show that both ClC-7 and Ostm1 proteins co-localize in late endosomes and lysosomes of various tissues, as well as in the ruffled border of bone-resorbing osteoclasts. Co-immunoprecipitations show that ClC-7 and Ostm1 form a molecular complex and suggest that Ostm1 is a beta-subunit of ClC-7. ClC-7 is required for Ostm1 to reach lysosomes, where the highly glycosylated Ostm1 luminal domain is cleaved. Protein but not RNA levels of ClC-7 are greatly reduced in grey-lethal mice, which lack Ostm1, suggesting that the ClC-7-Ostm1 interaction is important for protein stability. As ClC-7 protein levels in Ostm1-deficient tissues and cells, including osteoclasts, are decreased below 10% of normal levels, Ostm1 mutations probably cause osteopetrosis by impairing the acidification of the osteoclast resorption lacuna, which depends on ClC-7 (ref. 3). The finding that grey-lethal mice, just like ClC-7-deficient mice(4), show lysosomal storage and neurodegeneration in addition to osteopetrosis implies a more general importance for ClC-7-Ostm1 complexes.	Univ Hamburg, ZMNH, Zentrum Mol Neurobiol Hamburg, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Jentsch, TJ (corresponding author), Univ Hamburg, ZMNH, Zentrum Mol Neurobiol Hamburg, Falkenried 94, D-20246 Hamburg, Germany.	Jentsch@zmnh.uni-hamburg.de	Lange, Philipp F/E-5752-2011; Lange, Philipp F/AAB-9073-2020	Lange, Philipp F/0000-0003-1171-5864; Lange, Philipp F/0000-0003-1171-5864; Jentsch, Thomas/0000-0002-3509-2553; Fuhrmann, Jens/0000-0001-5730-381X				Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Boyce BF, 2003, NAT MED, V9, P395, DOI 10.1038/nm0403-395; Brandt S, 1995, FEBS LETT, V377, P15, DOI 10.1016/0014-5793(95)01298-2; Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; Cleiren E, 2001, HUM MOL GENET, V10, P2861, DOI 10.1093/hmg/10.25.2861; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Fischer T, 2003, P NATL ACAD SCI USA, V100, P8270, DOI 10.1073/pnas.1432965100; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Frattini A, 2003, J BONE MINER RES, V18, P1740, DOI 10.1359/jbmr.2003.18.10.1740; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; Jentsch TJ, 2005, CURR OPIN NEUROBIOL, V15, P319, DOI 10.1016/j.conb.2005.05.002; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Nishi T, 2000, J BIOL CHEM, V275, P6824, DOI 10.1074/jbc.275.10.6824; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Quarello P, 2004, J BONE MINER RES, V19, P1194, DOI 10.1359/JBMR.040407; Rajapurohitam V, 2001, BONE, V28, P513, DOI 10.1016/S8756-3282(01)00416-1; Ramirez A, 2004, HUM MUTAT, V23, P471, DOI 10.1002/humu.20028; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Vacher J, 1999, MAMM GENOME, V10, P239, DOI 10.1007/s003359900980	26	252	261	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2006	440	7081					220	223		10.1038/nature04535	http://dx.doi.org/10.1038/nature04535			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	16525474	Bronze			2022-12-24	WOS:000235839500048
J	Ciccarelli, FD; Doerks, T; von Mering, C; Creevey, CJ; Snel, B; Bork, P				Ciccarelli, FD; Doerks, T; von Mering, C; Creevey, CJ; Snel, B; Bork, P			Toward automatic reconstruction of a highly resolved tree of life	SCIENCE			English	Article							HORIZONTAL GENE-TRANSFER; ANIMAL PHYLOGENY; EVOLUTION; GENOMES; ECDYSOZOA; BACTERIA; HISTORY; VIEW	We have developed an automatable procedure for reconstructing the tree of life with branch lengths comparable across all three domains. The tree has its basis in a concatenation of 31 orthologs occurring in 191 species with sequenced genomes. It revealed interdomain discrepancies in taxonomic classification. Systematic detection and subsequent exclusion of products of horizontal gene transfer increased phylogenetic resolution, allowing us to confirm accepted relationships and resolve disputed and preliminary classifications. For example, we place the phylum Acidobacteria as a sister group of delta-Proteobacteria, support a Gram-positive origin of Bacteria, and suggest a thermophilic last universal common ancestor.	European Mol Biol Lab, D-69012 Heidelberg, Germany; European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; Fdn Italiana Ric Cancro, Inst Mol Oncol Fdn, I-20139 Milan, Italy; Radboud Univ Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; Max Delbruck Ctr, D-13092 Berlin, Germany	European Molecular Biology Laboratory (EMBL); IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; Radboud University Nijmegen; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69012 Heidelberg, Germany.	peer.bork@embl.de	von Mering, Christian/B-3300-2008; Creevey, Christopher James/A-1836-2013; Bork, Peer/F-1813-2013; Puigbò, Pere/A-2214-2008; Snel, Berend/B-8886-2011; Ciccarelli, Francesca/D-5380-2014	von Mering, Christian/0000-0001-7734-9102; Creevey, Christopher James/0000-0001-7183-1555; Bork, Peer/0000-0002-2627-833X; Snel, Berend/0000-0002-5804-8547; Ciccarelli, Francesca/0000-0002-9325-0900				Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Brochier C, 2000, TRENDS GENET, V16, P529, DOI 10.1016/S0168-9525(00)02142-9; Brochier C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r42; Brown JR, 2001, NAT GENET, V28, P281, DOI 10.1038/90129; Daubin V, 2003, SCIENCE, V301, P829, DOI 10.1126/science.1086568; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Hillis DM, 2003, SYST BIOL, V52, P124, DOI 10.1080/10635150390132911; Honda D, 1999, J MOL EVOL, V48, P723, DOI 10.1007/PL00006517; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Koch AL, 2003, TRENDS MICROBIOL, V11, P166, DOI 10.1016/S0966-842X(03)00063-5; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Koonin EV, 1996, TRENDS GENET, V12, P334, DOI 10.1016/0168-9525(96)20010-1; Kreil DP, 2001, NUCLEIC ACIDS RES, V29, P1608, DOI 10.1093/nar/29.7.1608; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; NAGELI KW, 1849, ALLG SCHWEIZ GES GES, V10, P45; Philip GK, 2005, MOL BIOL EVOL, V22, P1175, DOI 10.1093/molbev/msi102; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2003, CURR OPIN MICROBIOL, V6, P498, DOI 10.1016/j.mib.2003.09.008; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Wildman DE, 2003, P NATL ACAD SCI USA, V100, P7181, DOI 10.1073/pnas.1232172100; Wolf YI, 1999, GENOME RES, V9, P689	28	1123	1173	8	257	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2006	311	5765					1283	1287		10.1126/science.1123061	http://dx.doi.org/10.1126/science.1123061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019XB	16513982	Green Submitted			2022-12-24	WOS:000235870400041
J	Dornelas, M; Connolly, SR; Hughes, TP				Dornelas, M; Connolly, SR; Hughes, TP			Coral reef diversity refutes the neutral theory of biodiversity	NATURE			English	Article							SPECIES-ABUNDANCE DISTRIBUTION; FOREST BIODIVERSITY; LONG-TERM; COMMUNITIES; ECOLOGY; HYPOTHESIS; STABILITY; MODEL	The global decline of coral reefs(1,2) highlights the need to understand the mechanisms that regulate community structure and sustain biodiversity in these systems. The neutral theory, which assumes that individuals are demographically identical regardless of species, seeks to explain ubiquitous features of community structure and biodiversity patterns(3-5). Here we present a test of neutral-theory predictions with the use of an extensive species-level data set of Indo-Pacific coral communities. We show that coral assemblages differ markedly from neutral-model predictions for patterns of community similarity and the relative abundance of species. Within local communities, neutral models do not fit relative abundance distributions as well as the classical log-normal distribution. Relative abundances of species across local communities also differ markedly from neutral-theory predictions: coral communities exhibit community similarity values that are far more variable, and lower on average, than the neutral theory can produce. Empirical community similarities deviate from the neutral model in a direction opposite to that predicted in previous critiques of the neutral theory(6-9). Instead, our results support spatio-temporal environmental stochasticity as a major driver of diversity patterns on coral reefs(10,11).	James Cook Univ N Queensland, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; James Cook Univ N Queensland, Sch Marine Biol & Aquaculture, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Dornelas, M (corresponding author), James Cook Univ N Queensland, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	maria.dornelas@jcu.edu.au	Hughes, Terry P/L-4721-2013; Dornelas, Maria/E-3595-2010; Connolly, Sean R./E-7773-2011	Hughes, Terry P/0000-0002-5257-5063; Dornelas, Maria/0000-0003-2077-7055; Connolly, Sean R./0000-0003-1537-0859				Adler PB, 2004, ECOLOGY, V85, P1265, DOI 10.1890/03-0602; [Anonymous], 2012, NUMERICAL ECOLOGY; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; Bellwood DR, 2005, ECOL LETT, V8, P643, DOI 10.1111/j.1461-0248.2005.00763.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chave J, 2002, THEOR POPUL BIOL, V62, P153, DOI 10.1006/tpbi.2002.1597; CHESSON P, 1989, TRENDS ECOL EVOL, V4, P293, DOI 10.1016/0169-5347(89)90024-4; Clark JS, 2003, NATURE, V423, P635, DOI 10.1038/nature01632; Connell JH, 2004, ECOL MONOGR, V74, P179, DOI 10.1890/02-4043; Connolly SR, 2005, SCIENCE, V309, P1363, DOI 10.1126/science.1113281; Engen S, 1996, MATH BIOSCI, V132, P169, DOI 10.1016/0025-5564(95)00054-2; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Hubbell SP, 1997, CORAL REEFS, V16, pS9, DOI 10.1007/s003380050237; Hubbell Stephen P., 2001, V32, pi; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Karlson RH, 2004, NATURE, V429, P867, DOI 10.1038/nature02685; Maurer BA, 2004, BASIC APPL ECOL, V5, P413, DOI 10.1016/j.baae.2004.08.006; McGill B, 2003, OIKOS, V102, P679, DOI 10.1034/j.1600-0706.2003.12617.x; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; MCGILL BJ, IN PRESS ECOLOGY; Pandolfi JM, 1996, PALEOBIOLOGY, V22, P152, DOI 10.1017/S0094837300016158; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Rickfeld RE, 2003, OIKOS, V100, P185, DOI 10.1034/j.1600-0706.2003.12018.x; Terborgh J, 1996, ECOLOGY, V77, P561, DOI 10.2307/2265630; Volkov I, 2004, NATURE, V427, P696, DOI 10.1038/427696a; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Whitfield J, 2002, NATURE, V417, P480, DOI 10.1038/417480a; Williamson M, 2005, J ANIM ECOL, V74, P409, DOI 10.1111/j.1365-2656.2005.00936.x; Wootton JT, 2005, NATURE, V433, P309, DOI 10.1038/nature03211	30	185	189	2	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2006	440	7080					80	82		10.1038/nature04534	http://dx.doi.org/10.1038/nature04534			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HW	16511493				2022-12-24	WOS:000235685700043
J	Michels, KM; Hofman, KJ; Keusch, GT; Hrynkow, SH				Michels, KM; Hofman, KJ; Keusch, GT; Hrynkow, SH			Stigma and global health: looking forward	LANCET			English	Editorial Material									NIH, Fogarty Int Ctr, Div Int Training & Res, Bethesda, MD 20892 USA; NIH, Fogarty Int Ctr, Div Adv Studies & Policy Anal, Bethesda, MD 20892 USA; NIH, Fogarty Int Ctr, Off Director, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Michels, KM (corresponding author), NIH, Fogarty Int Ctr, Div Int Training & Res, Bldg 10, Bethesda, MD 20892 USA.	mischelsk@mail.nih.gov		HOFMAN, KAREN/0000-0001-9512-7220; /0000-0001-5724-2965					0	12	12	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 11	2006	367	9509					538	539		10.1016/S0140-6736(06)68190-7	http://dx.doi.org/10.1016/S0140-6736(06)68190-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	013FF	16473135				2022-12-24	WOS:000235394500039
J	Chao, XJ; Muff, TJ; Park, SY; Zhang, S; Pollard, AM; Ordal, GW; Bilwes, AM; Crane, BR				Chao, XJ; Muff, TJ; Park, SY; Zhang, S; Pollard, AM; Ordal, GW; Bilwes, AM; Crane, BR			A receptor-modifying deamidase in complex with a signaling phosphatase reveals reciprocal regulation	CELL			English	Article							BACILLUS-SUBTILIS; CHEMOTAXIS PROTEINS; CHEY-P; METHYLATION; BEHAVIOR; PROGRAM; FAMILY; DOMAIN; MCPB	Signal transduction underlying bacterial chemotaxis involves excitatory phosphorylation and feedback control through deamidation and methylation of sensory receptors. The structure of a complex between the signal-terminating phosphatase, CheC, and the receptor-modifying deamidase, CheD, reveals how CheC mimics receptor substrates to inhibit CheD and how CheD stimulates CheC phosphatase activity. CheD resembles other cysteine deamidases from bacterial pathogens that inactivate host Rho-GTPases. CheD not only deamidates receptor glutamine residues contained within a conserved structural motif but also hydrolyzes glutamyl-methyl-esters at select regulatory positions. Substituting Gln into the receptor motif of CheC turns the inhibitor into a CheD substrate. Phospho-CheY, the intracellular signal and CheC target, stabilizes the CheC: CheD complex and reduces availability of CheD. A point mutation that dissociates CheC from CheD impairs chemotaxis in vivo. Thus, CheC incorporates an element of an upstream receptor to influence both its own effect on receptor output and that of its binding partner, CheD.	Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; Proteom & Mass Spectrometry Core Facil, Ithaca, NY 14853 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	Cornell University; University of Illinois System; University of Illinois Urbana-Champaign	Chao, XJ (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	bc69@cornell.edu		Bilwes Crane, Alexandrine/0000-0001-9922-0692	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066775, R01GM054365, R56GM054365] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM066775, GM054365] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buetow L, 2001, NAT STRUCT BIOL, V8, P584, DOI 10.1038/89610; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; ESNOUSF BM, 1997, J MOL GRAPHICS, V15, P138; Falke JJ, 2001, TRENDS BIOCHEM SCI, V26, P257, DOI 10.1016/S0968-0004(00)01770-9; Flatau G, 2000, BIOCHEM BIOPH RES CO, V267, P588, DOI 10.1006/bbrc.1999.1904; Foynes S, 2000, INFECT IMMUN, V68, P2016, DOI 10.1128/IAI.68.4.2016-2023.2000; Hoffmann C, 2005, REV PHYSIOL BIOCH P, V152, P49, DOI 10.1007/s10254-004-0026-4; KEHRY MR, 1983, P NATL ACAD SCI-BIOL, V80, P3599, DOI 10.1073/pnas.80.12.3599; Kirby JR, 1999, J BIOL CHEM, V274, P11092, DOI 10.1074/jbc.274.16.11092; Kirby JR, 2001, MOL MICROBIOL, V42, P573, DOI 10.1046/j.1365-2958.2001.02581.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kristich CJ, 2004, J BACTERIOL, V186, P5950, DOI 10.1128/JB.186.17.5950-5955.2004; Kristich CJ, 2002, J BIOL CHEM, V277, P25356, DOI 10.1074/jbc.M201334200; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Park SY, 2004, MOL CELL, V16, P563, DOI 10.1016/j.molcel.2004.10.018; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Pepperkok R, 2000, J CELL BIOL, V148, P715, DOI 10.1083/jcb.148.4.715; Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7; ROSARIO MML, 1995, BIOCHEMISTRY-US, V34, P3823, DOI 10.1021/bi00011a040; Saulmon MM, 2004, MICROBIOL-SGM, V150, P581, DOI 10.1099/mic.0.26463-0; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schmidt G, 1998, J BIOL CHEM, V273, P13669, DOI 10.1074/jbc.273.22.13669; Stennicke HR, 1999, CELL DEATH DIFFER, V6, P1054, DOI 10.1038/sj.cdd.4400599; Szurmant H, 2004, J BIOL CHEM, V279, P21787, DOI 10.1074/jbc.M311497200; Szurmant H, 2003, J BIOL CHEM, V278, P48611, DOI 10.1074/jbc.M306180200; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; WEST AH, 1995, J MOL BIOL, V250, P276, DOI 10.1006/jmbi.1995.0376; Zimmer MA, 2000, J BIOL CHEM, V275, P24264, DOI 10.1074/jbc.M004001200	32	57	62	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 10	2006	124	3					561	571		10.1016/j.cell.2005.11.046	http://dx.doi.org/10.1016/j.cell.2005.11.046			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	014FG	16469702	Bronze			2022-12-24	WOS:000235464000018
J	Lakhani, SA; Masud, A; Kuida, K; Porter, GA; Booth, CJ; Mehal, WZ; Inayat, I; Flavell, RA				Lakhani, SA; Masud, A; Kuida, K; Porter, GA; Booth, CJ; Mehal, WZ; Inayat, I; Flavell, RA			Caspases 3 and 7: Key mediators of mitochondrial events of apoptosis	SCIENCE			English	Article							CELL-DEATH; ACTIVATION; DISRUPTION; CLEAVAGE; COMPLEX; CPP32; MICE	The current model of apoptosis holds that upstream signals lead to activation of downstream effector caspases. We generated mice deficient in the two effectors, caspase 3 and caspase 7, which died immediately after birth with defects in cardiac development. Fibroblasts lacking both enzymes were highly resistant to both mitochondrial and death receptor-mediated apoptosis, displayed preservation of mitochondrial membrane potential, and had defective nuclear translocation of apoptosis-inducing factor (AIF). Furthermore, the early apoptotic events of Bax translocation and cytochrome c release were also delayed. We conclude that caspases 3 and 7 are critical mediators of mitochondrial events of apoptosis.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Vertex Pharmaceut, Cambridge, MA 02139 USA	Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Vertex Pharmaceuticals	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	George A, Porter/E-7315-2013	George A, Porter/0000-0003-0726-9988; Lakhani, Saquib/0000-0003-3235-3460	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001401, K12HD000850] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD044580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002965, P30DK034989] Funding Source: NIH RePORTER; NICHD NIH HHS [1 K08 HD044580, K12 HD00850, K08 HD044580, K12 HD001401, K12 HD000850, 5 K12 HD01401] Funding Source: Medline; NIDDK NIH HHS [NIDDK P30-34989, K08 DK002965, K08 DK002965-04] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Cande C, 2004, CELL DEATH DIFFER, V11, P591, DOI 10.1038/sj.cdd.4401400; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Hausmann G, 2000, J CELL BIOL, V149, P623, DOI 10.1083/jcb.149.3.623; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Leonard JR, 2002, J NEUROPATH EXP NEUR, V61, P673, DOI 10.1093/jnen/61.8.673; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lippke JA, 1996, J BIOL CHEM, V271, P1825, DOI 10.1074/jbc.271.4.1825; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; van Loo G, 2002, CELL DEATH DIFFER, V9, P1031, DOI 10.1038/sj.cdd.4401088; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343	21	876	925	8	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2006	311	5762					847	851		10.1126/science.1115035	http://dx.doi.org/10.1126/science.1115035			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012XT	16469926	Green Accepted			2022-12-24	WOS:000235374900048
J	Derbyshire, SWG				Derbyshire, SWG			Controversy - Can fetuses feel pain?	BRITISH MEDICAL JOURNAL			English	Article							FETAL PAIN; STRESS-RESPONSE; INFANTS; ANESTHESIA; AFFERENTS; ANALGESIA; NEONATE; SURGERY; RAT		Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Derbyshire, SWG (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	s.w.derbyshire@bham.ac.uk		Derbyshire, Stuart/0000-0002-2766-3424				ANAND KJS, 1992, NEW ENGL J MED, V326, P1, DOI 10.1056/NEJM199201023260101; ANAND KJS, 1987, LANCET, V1, P243; ANAND KJS, 1987, NEW ENGL J MED, V317, P1321, DOI 10.1056/NEJM198711193172105; ANDREWS K, 1994, PAIN, V56, P95, DOI 10.1016/0304-3959(94)90154-6; BRONFENBRENNER U, 1994, PSYCHOL REV, V101, P568, DOI 10.1037/0033-295X.101.4.568; Chugani H T, 1998, Pediatrics, V102, P1225; Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; Collett Teresa Stanton, 2003, Pepperdine Law Rev, V30, P161; CRAIG KD, 1993, PAIN, V52, P287, DOI 10.1016/0304-3959(93)90162-I; Cunningham N, 1999, PAIN FORUM, V8, P93; Derbyshire SWG, 2004, NEUROIMAGE, V23, P392, DOI 10.1016/j.neuroimage.2004.04.033; Derbyshire SWG, 1999, BIOETHICS, V13, P1, DOI 10.1111/1467-8519.00129; Fisk NM, 2001, ANESTHESIOLOGY, V95, P828, DOI 10.1097/00000542-200110000-00008; FITZGERALD M, 1987, J PHYSIOL-LONDON, V383, P79; FITZGERALD M, 1987, J COMP NEUROL, V261, P98, DOI 10.1002/cne.902610108; GIANNAKOULOPOULOS X, 1994, LANCET, V344, P77, DOI 10.1016/S0140-6736(94)91279-3; Glover V, 1999, BRIT J OBSTET GYNAEC, V106, P881, DOI 10.1111/j.1471-0528.1999.tb08424.x; GOLDMANRAKIC PS, 1987, CHILD DEV, V58, P601, DOI 10.2307/1130201; Goodman MB, 2003, TRENDS NEUROSCI, V26, P643, DOI 10.1016/j.tins.2003.09.013; Herschkowitz N, 2000, BRAIN DEV-JPN, V22, P411, DOI 10.1016/S0387-7604(00)00185-6; Hevner RF, 2000, J NEUROPATH EXP NEUR, V59, P385, DOI 10.1093/jnen/59.5.385; Hobson Peter., 2002, CRADLE THOUGHT EXPLO; James D, 1998, BRIT MED J, V316, P1580, DOI 10.1136/bmj.316.7144.1580; Kostovic I, 2002, ANAT RECORD, V267, P1, DOI 10.1002/ar.10069; LARROCHE JC, 1981, ANAT EMBRYOL, V162, P301, DOI 10.1007/BF00299974; LEE E, LATE ABORTION REV EV; Lee SJ, 2005, JAMA-J AM MED ASSOC, V294, P947, DOI 10.1001/jama.294.8.947; MALIK K, 2000, MAN BEAST ZOMBIE; McGrath PJ, 2002, CLIN PERINATOL, V29, P555, DOI 10.1016/S0095-5108(02)00021-0; Mellor DJ, 2005, BRAIN RES REV, V49, P455, DOI 10.1016/j.brainresrev.2005.01.006; MERSKEY H, 1991, European Psychiatry, V6, P153; Piaget J., 1923, LANGUAGE THOUGHT CHI; ROGERS MC, 1992, NEW ENGL J MED, V326, P55, DOI 10.1056/NEJM199201023260109; Slater R, 2006, J NEUROSCI, V26, P3662, DOI 10.1523/JNEUROSCI.0348-06.2006; Ulfig N, 2000, HISTOL HISTOPATHOL, V15, P771, DOI 10.14670/HH-15.771; Vygotsky L.S., 1980, MIND SOC; 2001, REPORT MRC EXPERT GR	37	46	48	1	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 15	2006	332	7546					909	912B		10.1136/bmj.332.7546.909	http://dx.doi.org/10.1136/bmj.332.7546.909			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	037FK	16613970	Green Published			2022-12-24	WOS:000237132100026
J	Jones, N; Blasutig, IM; Eremina, V; Ruston, JM; Bladt, F; Li, HP; Huang, HM; Larose, L; Li, SSC; Takano, T; Quaggin, SE; Pawson, T				Jones, N; Blasutig, IM; Eremina, V; Ruston, JM; Bladt, F; Li, HP; Huang, HM; Larose, L; Li, SSC; Takano, T; Quaggin, SE; Pawson, T			Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes	NATURE			English	Article							CONGENITAL NEPHROTIC SYNDROME; SLIT DIAPHRAGM; MICE LACKING; FAMILY; DEFICIENT; DISEASE; KINASE; GENE; FYN; ALPHA-ACTININ-4	The glomerular filtration barrier in the kidney is formed in part by a specialized intercellular junction known as the slit diaphragm, which connects adjacent actin-based foot processes of kidney epithelial cells (podocytes)(1). Mutations affecting a number of slit diaphragm proteins, including nephrin ( encoded by NPHS1)(2), lead to renal disease owing to disruption of the filtration barrier and rearrangement of the actin cytoskeleton(3), although the molecular basis for this is unclear. Here we show that nephrin selectively binds the Src homology 2 (SH2)/SH3 domain-containing Nck adaptor proteins(4), which in turn control the podocyte cytoskeleton in vivo. The cytoplasmic tail of nephrin has multiple YDxV sites that form preferred bindingmotifs for the Nck SH2 domain once phosphorylated by Src-family kinases. We show that this Nck - nephrin interaction is required for nephrin-dependent actin reorganization. Selective deletion of Nck from podocytes of transgenic mice results in defects in the formation of foot processes and in congenital nephrotic syndrome. Together, these findings identify a physiological signalling pathway in which nephrin is linked through phosphotyrosine-based interactions to Nck adaptors, and thus to the underlying actin cytoskeleton in podocytes. Simple and widely expressed SH2/SH3 adaptor proteins can therefore direct the formation of a specialized cellular morphology in vivo.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; McGill Univ Hlth Ctr, Dept Med, Montreal, PQ H3A 2B4, Canada; Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; St Michaels Hosp, Div Nephrol, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; McGill University; Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Pawson, T (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	pawson@mshri.on.ca	Pawson, Tony J/E-4578-2013	Blasutig, Ivan/0000-0001-7310-2647				Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Chen M, 1998, J BIOL CHEM, V273, P25171, DOI 10.1074/jbc.273.39.25171; Ciani L, 2003, MOL CELL BIOL, V23, P3575, DOI 10.1128/MCB.23.10.3575-3582.2003; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Gruenheid S, 2001, NAT CELL BIOL, V3, P856, DOI 10.1038/ncb0901-856; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Lahdenpera J, 2003, KIDNEY INT, V64, P404, DOI 10.1046/j.1523-1755.2003.00097.x; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; Oh J, 2004, PEDIATR NEPHROL, V19, P130, DOI 10.1007/s00467-003-1367-y; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Putaala H, 2000, J AM SOC NEPHROL, V11, P991, DOI 10.1681/ASN.V116991; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Rantanen M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016142.29721.22; Rivera GM, 2004, CURR BIOL, V14, P11, DOI 10.1016/j.cub.2003.12.033; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Roselli S, 2004, MOL CELL BIOL, V24, P550, DOI 10.1128/MCB.24.2.550-560.2004; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Welsch T, 2001, AM J PHYSIOL-RENAL, V281, pF769, DOI 10.1152/ajprenal.2001.281.4.F769; Yu CCK, 2001, CURR BIOL, V11, P34, DOI 10.1016/S0960-9822(00)00024-5	30	357	374	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					818	823		10.1038/nature04662	http://dx.doi.org/10.1038/nature04662			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16525419	Bronze			2022-12-24	WOS:000236548400046
J	Ogden, CL; Carroll, MD; Curtin, LR; McDowell, MA; Tabak, CJ; Flegal, KM				Ogden, CL; Carroll, MD; Curtin, LR; McDowell, MA; Tabak, CJ; Flegal, KM			Prevalence of overweight and obesity in the United States, 1999-2004	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							US CHILDREN; TRENDS; ADOLESCENTS; UNDERWEIGHT; ADULTS; CHINA	Context The prevalence of overweight in children and adolescents and obesity in adults in the United States has increased over several decades. Objective To provide current estimates of the prevalence and trends of overweight in children and adolescents and obesity in adults. Design, Setting, and Participants Analysis of height and weight measurements from 3958 children and adolescents aged 2 to 19 years and 4431 adults aged 20 years or older obtained in 2003-2004 as part of the National Health and Nutrition Examination Survey ( NHANES), a nationally representative sample of the US population. Data from the NHANES obtained in 1999-2000 and in 2001-2002 were compared with data from 2003-2004. Main Outcome Measures Estimates of the prevalence of overweight in children and adolescents and obesity in adults. Overweight among children and adolescents was defined as at or above the 95th percentile of the sex-specific body mass index (BMI) for age growth charts. Obesity among adults was defined as a BMI of 30 or higher; extreme obesity was defined as a BMI of 40 or higher. Results In 2003-2004, 17.1% of US children and adolescents were overweight and 32.2% of adults were obese. Tests for trend were significant for male and female children and adolescents, indicating an increase in the prevalence of overweight in female children and adolescents from 13.8% in 1999-2000 to 16.0% in 2003-2004 and an increase in the prevalence of overweight in male children and adolescents from 14.0% to 18.2%. Among men, the prevalence of obesity increased significantly between 1999-2000 (27.5%) and 2003-2004 (31.1%). Among women, no significant increase in obesity was observed between 1999-2000 (33.4%) and 2003-2004 (33.2%). The prevalence of extreme obesity ( body mass index >= 40) in 2003-2004 was 2.8% in men and 6.9% in women. In 2003-2004, significant differences in obesity prevalence remained by race/ethnicity and by age. Approximately 30% of non-Hispanic white adults were obese as were 45.0% of non-Hispanic black adults and 36.8% of Mexican Americans. Among adults aged 20 to 39 years, 28.5% were obese while 36.8% of adults aged 40 to 59 years and 31.0% of those aged 60 years or older were obese in 2003-2004. Conclusions The prevalence of overweight among children and adolescents and obesity among men increased significantly during the 6-year period from 1999 to 2004; among women, no overall increases in the prevalence of obesity were observed. These estimates were based on a 6-year period and suggest that the increases in body weight are continuing in men and in children and adolescents while they may be leveling off in women.	Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); Centers for Disease Control & Prevention - USA	Ogden, CL (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd,Room 4414, Hyattsville, MD 20782 USA.	Cogden@cdc.gov	Flegal, Katherine M/A-4608-2013; Bannuru, Raveendhara/G-2601-2011	Bannuru, Raveendhara/0000-0002-8069-5783; Flegal, Katherine/0000-0002-0838-469X				Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; Kuczmarski RJ., 2000, VITAL HLTH STAT, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Luo J, 2002, INT J OBESITY, V26, P553, DOI 10.1038/sj.ijo.0801944; *NIH, 1998, OBES RES, V6, P464; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Rennie KL, 2005, OBES REV, V6, P11, DOI 10.1111/j.1467-789X.2005.00164.x; Silventoinen K, 2004, INT J OBESITY, V28, P710, DOI 10.1038/sj.ijo.0802614; Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971	14	6596	6752	11	777	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2006	295	13					1549	1555		10.1001/jama.295.13.1549	http://dx.doi.org/10.1001/jama.295.13.1549			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RG	16595758	Bronze			2022-12-24	WOS:000236505400022
J	Li, W; Feng, ZY; Sternberg, PW; Xu, XZS				Li, W; Feng, ZY; Sternberg, PW; Xu, XZS			A C-elegans stretch receptor neuron revealed by a mechanosensitive TRP channel homologue	NATURE			English	Article							CAENORHABDITIS-ELEGANS; GENE; MECHANOTRANSDUCTION; PROTEIN; PATHWAY; SYSTEM; FAMILY	The nematode Caenorhabditis elegans is commonly used as a genetic model organism for dissecting integration of the sensory and motor systems(1). Despite extensive genetic and behavioural analyses that have led to the identification of many genes and neural circuits involved in regulating C. elegans locomotion behaviour(1), it remains unclear whether and how somatosensory feedback modulates motor output during locomotion. In particular, no stretch receptors have been identified in C. elegans, raising the issue of whether stretch-receptor-mediated proprioception is used by C. elegans to regulate its locomotion behaviour. Here we have characterized TRP-4, the C. elegans homologue of the mechanosensitive TRPN channel. We show that trp-4 mutant worms bend their body abnormally, exhibiting a body posture distinct from that of wild-type worms during locomotion, suggesting that TRP-4 is involved in stretch-receptor-mediated proprioception. We show that TRP-4 acts in a single neuron, DVA, to mediate its function in proprioception, and that the activity of DVA can be stimulated by body stretch. DVA both positively and negatively modulates locomotion, providing a unique mechanism whereby a single neuron can fine-tune motor activity. Thus, DVA represents a stretch receptor neuron that regulates sensory - motor integration during C. elegans locomotion.	Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Xu, XZS (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	shawnxu@umich.edu		Sternberg, Paul/0000-0002-7699-0173	NIGMS NIH HHS [R01 GM078276, R01 GM078276-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078276] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cattaert D, 2001, PROG NEUROBIOL, V63, P199, DOI 10.1016/S0301-0082(00)00030-7; Chalfie M., 1988, NEMATODE CAENORHABDI, P337; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708; Goldberg CJ, 1999, STUD HEALTH TECHNOL, V59, P53; Goodman MB, 2003, ANNU REV PHYSIOL, V65, P429, DOI 10.1146/annurev.physiol.65.092101.142659; HALL WC, 2001, NEUROSCIENCE, P347; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; Lints R, 1999, DEVELOPMENT, V126, P5819; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Samuel ADT, 2005, CURR BIOL, V15, pR341, DOI 10.1016/j.cub.2005.04.021; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xu XZS, 2003, CELL, V114, P285, DOI 10.1016/S0092-8674(03)00565-8	21	207	225	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					684	687		10.1038/nature04538	http://dx.doi.org/10.1038/nature04538			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572173	Green Accepted, Green Published			2022-12-24	WOS:000236350400047
J	Gilbert, MJ; Thornton, CR; Wakley, GE; Talbot, NJ				Gilbert, MJ; Thornton, CR; Wakley, GE; Talbot, NJ			A P-type ATPase required for rice blast disease and induction of host resistance	NATURE			English	Article							GENE; PATHOGENICITY; PENETRATION; PROTEIN; IDENTIFICATION; INFECTION	To cause diseases in plants, pathogenic microorganisms have evolved mechanisms to deliver proteins directly into plant cells, where they suppress plant defences and facilitate tissue invasion(1-3). How plant pathogenic fungi, which cause many of the world's most serious plant diseases, deliver proteins during plant infection is currently unknown. Here we report the characterization of a P-type ATPase-encoding gene, MgAPT2, in the economically important rice blast pathogen Magnaporthe grisea, which is required for exocytosis during plant infection. Targeted gene replacement showed that MgAPT2 is required for both foliar and root infection by the fungus, and for the rapid induction of host defence responses in an incompatible reaction. Delta Mgapt2 mutants are impaired in the secretion of a range of extracellular enzymes and accumulate abnormal Golgi-like cisternae. However, the loss of MgAPT2 does not significantly affect hyphal growth or sporulation, indicating that the establishment of rice blast disease involves the use of MgApt2-dependent exocytotic processes that operate during plant infection.	Univ Exeter, Sch Biosci, Washington Singer Labs, Exeter EX4 4QG, Devon, England	University of Exeter	Talbot, NJ (corresponding author), Univ Exeter, Sch Biosci, Washington Singer Labs, Perry Rd, Exeter EX4 4QG, Devon, England.	n.j.talbot@exeter.ac.uk	Talbot, Nicholas J/I-9584-2014; Talbot, Nicholas J/I-5618-2019	Talbot, Nicholas J/0000-0001-6434-7757; Talbot, Nicholas J/0000-0001-6434-7757				Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Balhadere PV, 2001, PLANT CELL, V13, P1987, DOI 10.1105/tpc.13.9.1987; CARROLL AM, 1994, FUNGAL GENET NEWSLET, V41, P22, DOI DOI 10.4148/1941-4765.1367; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; CHIDA T, 1987, J PESTIC SCI, V12, P49; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Kim S, 2001, MOL CELLS, V11, P115; Lussier M, 1996, J BIOL CHEM, V271, P11001, DOI 10.1074/jbc.271.18.11001; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Mendgen K, 1996, ANNU REV PHYTOPATHOL, V34, P367, DOI 10.1146/annurev.phyto.34.1.367; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Rose MD., 1990, METHODS YEAST GENETI; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; SOUTHERN JA, 1991, J GEN VIROL, V72, P1551, DOI 10.1099/0022-1317-72-7-1551; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tucker SL, 2004, PLANT CELL, V16, P1575, DOI 10.1105/tpc.021279; VALENT B, 1991, GENETICS, V127, P87; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171	28	86	95	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					535	539		10.1038/nature04567	http://dx.doi.org/10.1038/nature04567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554820				2022-12-24	WOS:000236176100057
J	Shi, N; Ye, S; Alam, A; Chen, LP; Jiang, YX				Shi, N; Ye, S; Alam, A; Chen, LP; Jiang, YX			Atomic structure of a Na+- and K+-conducting channel	NATURE			English	Article							GMP-ACTIVATED CHANNEL; POTASSIUM CHANNELS; DIVALENT-CATIONS; EXCISED PATCHES; ION CHANNELS; SELECTIVITY; PERMEATION; BLOCKAGE	Ion selectivity is one of the basic properties that define an ion channel. Most tetrameric cation channels, which include the K+, Ca2+, Na+ and cyclic nucleotide-gated channels, probably share a similar overall architecture in their ion-conduction pore, but the structural details that determine ion selection are different. Although K+ channel selectivity has been well studied from a structural perspective(1,2), little is known about the structure of other cation channels. Here we present crystal structures of the NaK channel from Bacillus cereus, a non-selective tetrameric cation channel, in its Na+- and K+-bound states at 2.4 angstrom and 2.8 angstrom resolution, respectively. The NaK channel shares high sequence homology and a similar overall structure with the bacterial KcsA K+ channel, but its selectivity filter adopts a different architecture. Unlike a K+ channel selectivity filter, which contains four equivalent K+-binding sites, the selectivity filter of the NaK channel preserves the two cation-binding sites equivalent to sites 3 and 4 of a K+ channel, whereas the region corresponding to sites 1 and 2 of a K+ channel becomes a vestibule in which ions can diffuse but not bind specifically. Functional analysis using an Rb-86 flux assay shows that the NaK channel can conduct both Na+ and K+ ions. We conclude that the sequence of the NaK selectivity filter resembles that of a cyclic nucleotide-gated channel and its structure may represent that of a cyclic nucleotide-gated channel pore.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Jiang, YX (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA.	youxing.jiang@utsouthwestern.edu		Alam, Amer/0000-0001-9580-4949	NIGMS NIH HHS [R01 GM079179] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079179] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG CM, 1980, BIOPHYS J, V30, P473, DOI 10.1016/S0006-3495(80)85108-3; ARMSTRONG CM, 1982, J GEN PHYSIOL, V80, P663, DOI 10.1085/jgp.80.5.663; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COLAMARTINO G, 1991, J PHYSIOL-LONDON, V440, P189, DOI 10.1113/jphysiol.1991.sp018703; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; HAYNES L, 1985, NATURE, V317, P61, DOI 10.1038/317061a0; HAYNES LW, 1986, NATURE, V321, P66, DOI 10.1038/321066a0; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; STERN JH, 1987, SCIENCE, V236, P1674, DOI 10.1126/science.3037695; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; ZIMMERMAN AL, 1992, J PHYSIOL-LONDON, V449, P759, DOI 10.1113/jphysiol.1992.sp019112; ZUFALL F, 1994, ANNU REV BIOPH BIOM, V23, P577, DOI 10.1146/annurev.bb.23.060194.003045	27	190	194	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					570	574		10.1038/nature04508	http://dx.doi.org/10.1038/nature04508			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16467789				2022-12-24	WOS:000236176100064
J	Shiow, LR; Rosen, DB; Brdickova, N; Xu, Y; An, JP; Lanier, LL; Cyster, JG; Matloubian, M				Shiow, LR; Rosen, DB; Brdickova, N; Xu, Y; An, JP; Lanier, LL; Cyster, JG; Matloubian, M			CD69 acts downstream of interferon-alpha/beta to inhibit S1P(1) and lymphocyte egress from lymphoid organs	NATURE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR-1; T-CELLS; EXPRESSION; MICE; ACTIVATION; LIGAND; SEQUESTRATION; EMIGRATION; THYMOCYTES; INDUCTION	Naive lymphocytes continually enter and exit lymphoid organs in a recirculation process that is essential for immune surveillance. During immune responses, the egress process can be shut down transiently(1). When this occurs locally it increases lymphocyte numbers in the responding lymphoid organ; when it occurs systemically it can lead to immunosuppression as a result of the depletion of recirculating lymphocytes. Several mediators of the innate immune system are known to cause shutdown, including interferon alpha/beta (IFN-alpha/beta) and tumour necrosis factor(2-5), but the mechanism has been unclear. Here we show that treatment with the IFN-alpha/beta inducer polyinosine polycytidylic acid (hereafter 'poly(I:C)') inhibited egress by a mechanism that was partly lymphocyte-intrinsic. The transmembrane C-type lectin CD69 was rapidly induced and CD69(-/-) cells were poorly retained in lymphoid tissues after treatment with poly(I:C) or infection with lymphocytic choriomeningitis virus. Lymphocyte egress requires sphingosine 1-phosphate receptor-1 (S1P(1)), and IFN-alpha/beta was found to inhibit lymphocyte responsiveness to S1P. By contrast, CD69(-/-) cells retained S1P(1) function after exposure to IFN-alpha/beta. In coexpression experiments, CD69 inhibited S1P(1) chemotactic function and led to downmodulation of S1P(1). In a reporter assay, S1P(1) crosslinking led to co-crosslinking and activation of a CD69-CD3 zeta chimaera. CD69 co-immunoprecipitated with S1P(1) but not the related receptor, S1P(3). These observations indicate that CD69 forms a complex with and negatively regulates S1P(1) and that it functions downstream of IFN-alpha/beta, and possibly other activating stimuli, to promote lymphocyte retention in lymphoid organs.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu; mehrdad.matloubian@ucsf.edu	Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952				Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Bikah G, 2000, NAT IMMUNOL, V1, P402, DOI 10.1038/80841; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; CHU P, 2003, J BIOL, V2; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; DEGRE M, 1973, P SOC EXP BIOL MED, V142, P1087; Esplugues E, 2003, J EXP MED, V197, P1093, DOI 10.1084/jem.20021337; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Graeler M, 2002, FASEB J, V16, P1874, DOI 10.1096/fj.02-0548com; HALL JG, 1965, BRIT J EXP PATHOL, V46, P450; Kalaaji A N, 1988, Reg Immunol, V1, P56; KORNGOLD R, 1983, J IMMUNOL, V130, P2236; Lauzurica P, 2000, BLOOD, V95, P2312, DOI 10.1182/blood.V95.7.2312.007k16_2312_2320; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; LOPEZCABRERA M, 1995, J BIOL CHEM, V270, P21545, DOI 10.1074/jbc.270.37.21545; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Murata K, 2003, INT IMMUNOL, V15, P987, DOI 10.1093/intimm/dxg102; Nakayama T, 2002, J IMMUNOL, V168, P87, DOI 10.4049/jimmunol.168.1.87; RAMIREZ R, 1994, J EXP MED, V180, P1147, DOI 10.1084/jem.180.3.1147; RISSO A, 1991, J IMMUNOL, V146, P4105; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; Rosen H, 2003, P NATL ACAD SCI USA, V100, P10907, DOI 10.1073/pnas.1832725100; Rosen H, 2003, CURR OPIN CHEM BIOL, V7, P461, DOI 10.1016/S1367-5931(03)00085-1; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Sancho D, 2000, J IMMUNOL, V165, P3868, DOI 10.4049/jimmunol.165.7.3868; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; Young AJ, 2000, EUR J IMMUNOL, V30, P327, DOI 10.1002/1521-4141(200001)30:1<327::AID-IMMU327>3.3.CO;2-K	30	838	866	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					540	544		10.1038/nature04606	http://dx.doi.org/10.1038/nature04606			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16525420				2022-12-24	WOS:000236176100058
J	Tillie-Leblond, I; Marquette, CH; Perez, T; Scherpereel, A; Zanetti, C; Tonnel, AB; Remy-Jardin, M				Tillie-Leblond, I; Marquette, CH; Perez, T; Scherpereel, A; Zanetti, C; Tonnel, AB; Remy-Jardin, M			Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: Prevalence and risk factors	ANNALS OF INTERNAL MEDICINE			English	Article							SPIRAL CT; D-DIMER; DIAGNOSIS; ANGIOGRAPHY; THROMBOSIS; EMERGENCY; ARTERIES; BEDSIDE; TESTS; LUNG	Background: Diagnosis of pulmonary embolism (PE) is difficult in patients with chronic obstructive pulmonary disease (COPD) and exacerbation. Objective: To evaluate PE in patients with COPD and exacerbation of unknown origin and explore factors associated with PE. Design: Prospective cohort study. Setting: University-affiliated hospital in France. Patients: 211 consecutive patients, all current or former smokers with COPD, who were admitted to the hospital for severe exacerbation of unknown origin and did not require invasive mechanical ventilation. Measurements: Spiral computed tomography angiography (CTA) and ultrasonography within 48 hours of admission and assessment of the Geneva score. Patients were classified as PE positive (positive results on CTA or negative results on CTA and positive results on ultrasonography) or PE negative (negative results on CTA and negative results on ultrasonography or negative results on CTA and no recurrence of PE at follow-up 3 months later). Results: 49 of 197 patients (25% [95% Cl, 19% to 32%]) met the diagnostic criteria for PE. Clinical factors associated with PE were previous thromboembolic disease (risk ratio, 2.43 [Cl, 1.49 to 3.94]), malignant disease (risk ratio, 1.82 [Cl, 1.13 to 2.92)), and decrease in PaCO2 of at least 5 mm Hg (risk ratio, 2.10 [Cl, 1.23 to 3.58]). A total of 9.2% (Cl, 4.7% to 15.9%) of patients with a low-probability Geneva score received a diagnosis of PE. An exploratory analysis suggested that substituting malignant disease for recent surgery in the Geneva score might improve its performance in excluding PE in this sample who were more likely to have malignant disease than to have had recent surgery. However, this improvement seems insufficient to exclude PE with enough certainty to withhold therapy for low-risk patients on the basis of the modified score. Limitations: This study was done in only 1 center. Patients with COPD requiring invasive mechanical ventilation in the intensive care unit were not included. The upper bound of the 95% Cl for the low probability of PE according to the Geneva score is too high to rule out PE. The classification of COPD exacerbation of unknown origin was based on the clinician's assessment, not on a standard evaluation for all patients. Conclusion: This study showed a 25% prevalence of PE in patients with COPD hospitalized for severe exacerbation of unknown origin. Three clinical factors are associated with the increased risk for PE. The Geneva score and the modified Geneva score should be prospectively evaluated in patients with COPD.	Univ Hosp A Calmette, CHRU, Lung Dept, F-59037 Lille, France	Universite de Lille - ISITE; CHU Lille	Tillie-Leblond, I (corresponding author), Univ Hosp A Calmette, CHRU, Lung Dept, 1 Rue Leclercq, F-59037 Lille, France.		Marquette, Charles Hugo/O-4084-2016	Marquette, Charles Hugo/0000-0002-0846-9941				BAUM GL, 1960, AM J MED SCI, V240, P609; Bourriot K, 2003, CHEST, V123, P359, DOI 10.1378/chest.123.2.359; Carson JL, 1996, CHEST, V110, P1212, DOI 10.1378/chest.110.5.1212; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; Ghaye B, 2001, RADIOLOGY, V219, P629, DOI 10.1148/radiology.219.3.r01jn32629; Hartmann IJC, 2000, AM J RESP CRIT CARE, V162, P2232, DOI 10.1164/ajrccm.162.6.2006030; Hyers TM, 1999, AM J RESP CRIT CARE, V159, P1; LESSER BA, 1992, CHEST, V102, P17, DOI 10.1378/chest.102.1.17; LIPPMANN M, 1981, CHEST, V79, P39, DOI 10.1378/chest.79.1.39; LIPPMANN ML, 1993, CHEST, V104, P983, DOI 10.1378/chest.104.3.983c; Mispelaere D, 2002, REV MAL RESPIR, V19, P415; Mitchell R S, 1968, Aspen Emphysema Conf, V9, P109; Musset D, 2002, LANCET, V360, P1914, DOI 10.1016/S0140-6736(02)11914-3; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Prediletto R, 1999, CRIT CARE, V3, P111, DOI 10.1186/cc352; PRESCOTT SM, 1981, AM REV RESPIR DIS, V123, P32; Remy-Jardin M, 2002, EUR RADIOL, V12, P1971, DOI 10.1007/s00330-002-1485-0; Remy-Jardin M, 2000, EUR RADIOL, V10, P1297, DOI 10.1007/s003300000460; RemyJardin M, 1997, RADIOLOGY, V204, P157, DOI 10.1148/radiology.204.1.9205239; Rodger MA, 2001, CHEST, V120, P115, DOI 10.1378/chest.120.1.115; RYAN SF, 1963, AM J PATHOL, V43, P767; Stein PD, 1996, CHEST, V109, P78, DOI 10.1378/chest.109.1.78; Tillie-Leblond I, 2002, RADIOLOGY, V223, P461, DOI 10.1148/radiol.2232010913; van Strijen MJL, 2005, J THROMB HAEMOST, V3, P17, DOI 10.1111/j.1538-7836.2004.01064.x; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92; WINTER JH, 1983, THORAX, V38, P605, DOI 10.1136/thx.38.8.605	27	189	203	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2006	144	6					390	396		10.7326/0003-4819-144-6-200603210-00005	http://dx.doi.org/10.7326/0003-4819-144-6-200603210-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025FX	16549851				2022-12-24	WOS:000236251800002
J	Lienhardt, C; Rustomjee, R				Lienhardt, C; Rustomjee, R			Improving tuberculosis control: an interdisciplinary approach	LANCET			English	Editorial Material							COUNTRIES		Inst Rech Dev, Programme TB, UMR 145, Montpellier, France; Int Union TB & Lung Dis, Paris, France; MRC, Unit Clin & Biomed TB Res, Durban, South Africa	Institut de Recherche pour le Developpement (IRD)	Lienhardt, C (corresponding author), IUATLD, 68 Blvd St Michel, F-75006 Paris, France.	clienhardt@iuatld.org	Lienhardt, Christian/AAU-4969-2021	Lienhardt, Christian/0000-0003-0233-893X				Baltussen R, 2005, BMJ-BRIT MED J, V331, P1364, DOI 10.1136/bmj.38645.660093.68; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Harries AD, 2002, B WORLD HEALTH ORGAN, V80, P464; Jaffre Y., 2003, MED INHOSPITALIERE D; Jaiswal A, 2003, TROP MED INT HEALTH, V8, P625, DOI 10.1046/j.1365-3156.2003.01061.x; Lienhardt C, 2004, TROP MED INT HEALTH, V9, P833, DOI 10.1111/j.1365-3156.2004.01273.x; OGDEN JA, 2000, T ROY SOC TROP MED H, V94, P1; *WHO, TB EM DECL WHO REG O; *WHO, 2005, WHOHTMTB2005349; World Health Organization, 1994, WHOTB94179	10	7	8	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					949	950		10.1016/S0140-6736(06)68390-6	http://dx.doi.org/10.1016/S0140-6736(06)68390-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546548				2022-12-24	WOS:000236242100036
J	Daffonchio, D; Borin, S; Brusa, T; Brusetti, L; van der Wielen, PWJJ; Bolhuis, H; Yakimov, MM; D'Auria, G; Giuliano, L; Marty, D; Tamburini, C; McGenity, TJ; Hallsworth, JE; Sass, AM; Timmis, KN; Tselepides, A; de Lange, GJ; Hubner, A; Thomson, J; Varnavas, SP; Gasparoni, F; Gerber, HW; Malinverno, E; Corselli, C; Garcin, J; McKew, B; Golyshin, PN; Lampadariou, N; Polymenakou, P; Calore, D; Cenedese, S; Zanon, F; Hoog, S				Daffonchio, D; Borin, S; Brusa, T; Brusetti, L; van der Wielen, PWJJ; Bolhuis, H; Yakimov, MM; D'Auria, G; Giuliano, L; Marty, D; Tamburini, C; McGenity, TJ; Hallsworth, JE; Sass, AM; Timmis, KN; Tselepides, A; de Lange, GJ; Hubner, A; Thomson, J; Varnavas, SP; Gasparoni, F; Gerber, HW; Malinverno, E; Corselli, C; Garcin, J; McKew, B; Golyshin, PN; Lampadariou, N; Polymenakou, P; Calore, D; Cenedese, S; Zanon, F; Hoog, S		Biodeep Sci Party	Stratified prokaryote network in the oxic-anoxic transition of a deep-sea halocline	NATURE			English	Article							BRINE-SEAWATER INTERFACE; RNA GENE-SEQUENCES; KEBRIT DEEP; DIVERSITY; SEDIMENTS; COMMUNITY; BACTERIA; BASINS; SULFUR; TYRO	The chemical composition of the Bannock basin has been studied in some detail(1,2). We recently showed that unusual microbial populations, including a new division of Archaea (MSBL1)(3), inhabit the NaCl-rich hypersaline brine. High salinities tend to reduce biodiversity(4), but when brines come into contact with fresher water the natural haloclines formed frequently contain gradients of other chemicals, including permutations of electron donors and acceptors, that may enhance microbial diversity, activity and biogeochemical cycling(5,6). Here we report a 2.5-m-thick chemocline with a steep NaCl gradient at 3.3 km within the water column between Bannock anoxic hypersaline brine(7) and overlying sea water. The chemocline supports some of the most biomass-rich and active microbial communities in the deep sea, dominated by Bacteria rather than Archaea, and including four major new divisions of Bacteria. Significantly higher metabolic activities were measured in the chemocline than in the overlying sea water and underlying brine; functional analyses indicate that a range of biological processes is likely to occur in the chemocline. Many prokaryotic taxa, including the phylogenetically new groups, were confined to defined salinities, and collectively formed a diverse, sharply stratified, deep-sea ecosystem with sufficient biomass to potentially contribute to organic geological deposits.	Univ Milan, DiSTAM, CoNISMa, I-20133 Milan, Italy; Univ Groningen, CEES, Dept Microbial Ecol, NL-9751 NN Haren, Netherlands; CNR, Ist Ambiente Marino Costiero, I-98122 Messina, Italy; Univ Mediterranee, CNRS, UMR 6117, LMGEM, F-13288 Marseille, France; Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England; GBF, Div Microbiol, D-38122 Braunschweig, Germany; Inst Marine Biol Crete, Iraklion 71003, Greece; Univ Utrecht, Fac Geosci, NL-3584 CD Utrecht, Netherlands; Southampton Oceanog Ctr, Southampton SO14 3EE, Hants, England; Univ Patras, Dept Geol, Patras 26100, Greece; Tecnomare SpA, ENI Grp, I-30124 Venice, Italy; Univ Appl Sci, Tech Fachhsch Berlin, D-13353 Berlin, Germany; Univ Milano Bicocca, DGSG, CoNISMa, I-20126 Milan, Italy	CoNISMa; University of Milan; University of Groningen; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Essex; Helmholtz Association; Helmholtz-Center for Infection Research; Utrecht University; NERC National Oceanography Centre; University of Southampton; University of Patras; Eni SpA; Technical University of Berlin; CoNISMa; University of Milano-Bicocca	Daffonchio, D (corresponding author), Univ Milan, DiSTAM, CoNISMa, I-20133 Milan, Italy.	daniele.daffonchio@unimi.it	Bolhuis, Henk/M-6677-2019; Lampadariou, Nikolaos/H-1201-2011; Tselepides, Anastasios/AAO-3965-2021; Bolhuis, Henk/S-2986-2019; Sass, Andrea Michaela/G-6537-2014; Tamburini, Christian/AAO-8577-2020; D'Auria, Giuseppe/E-6583-2010; Daffonchio, Daniele/AAF-4922-2019; McGenity, Terry/B-8661-2011; Giuliano, Laura/P-2204-2019; Corselli, Cesare/E-9970-2011; Bolhuis, Henk/H-8535-2014; Bolhuis, Henk/A-4308-2008; Tamburini, Christian/I-7821-2012; De Lange, Gert J/B-9639-2014; Polymenakou, Paraskevi/AAW-5313-2020; Hubner, Andreas/G-1751-2016; Yakimov, Michail/H-1829-2016; Hallsworth, John E./K-7876-2013	Bolhuis, Henk/0000-0002-4772-1898; Sass, Andrea Michaela/0000-0001-9396-7648; Tamburini, Christian/0000-0003-3752-7423; Daffonchio, Daniele/0000-0003-0947-925X; Bolhuis, Henk/0000-0002-4772-1898; Tamburini, Christian/0000-0003-3752-7423; De Lange, Gert J/0000-0002-9420-3022; Tselepides, Anastasios/0000-0002-7880-9091; Borin, Sara/0000-0001-7479-8199; van der Wielen, Paul/0000-0002-4851-5762; Hubner, Andreas/0000-0001-7342-9789; D'Auria, Giuseppe/0000-0003-0672-2541; Lampadariou, Nikolaos/0000-0003-2171-7150; Golyshin, Peter/0000-0002-5433-0350; Polymenakou, Paraskevi/0000-0002-9787-7372; McKew, Boyd/0000-0001-5607-6619; Yakimov, Michail/0000-0003-1418-363X; Malinverno, Elisa/0000-0002-9124-5155; McGenity, Terence/0000-0002-1497-8822; Hallsworth, John E./0000-0001-6797-9362; Brusetti, Lorenzo/0000-0002-1773-6618	NERC [soc010003] Funding Source: UKRI; Natural Environment Research Council [soc010003] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], 1985, NATURE, V314, P152, DOI 10.1038/314152a0; Benlloch S, 2002, ENVIRON MICROBIOL, V4, P349, DOI 10.1046/j.1462-2920.2002.00306.x; CANFIELD DE, 1991, SCIENCE, V251, P1471, DOI 10.1126/science.11538266; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Coolen MJL, 2002, SCIENCE, V296, P2407, DOI 10.1126/science.1071893; Coolen MJL, 2000, APPL ENVIRON MICROB, V66, P2589, DOI 10.1128/AEM.66.6.2589-2598.2000; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; DELANGE GJ, 1990, MAR CHEM, V31, P205, DOI 10.1016/0304-4203(90)90039-F; DELANGE GJ, 1990, MAR CHEM, V31, P63, DOI 10.1016/S0304-4203(05)80005-2; Eder W, 1999, ARCH MICROBIOL, V172, P213, DOI 10.1007/s002030050762; Eder W, 2002, ENVIRON MICROBIOL, V4, P758, DOI 10.1046/j.1462-2920.2002.00351.x; Eder W, 2001, APPL ENVIRON MICROB, V67, P3077, DOI 10.1128/AEM.67.7.3077-3085.2001; Ferrer M, 2005, CHEM BIOL, V12, P895, DOI 10.1016/j.chembiol.2005.05.020; HENNEKE E, 1990, MAR CHEM, V31, P113, DOI 10.1016/0304-4203(90)90033-9; Henneke E, 1997, GEOCHIM COSMOCHIM AC, V61, P307, DOI 10.1016/S0016-7037(96)00355-9; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; LAROCK PA, 1979, APPL ENVIRON MICROB, V37, P466, DOI 10.1128/AEM.37.3.466-470.1979; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; LUTHER GW, 1990, MAR CHEM, V31, P137, DOI 10.1016/0304-4203(90)90035-B; Minz D, 1999, APPL ENVIRON MICROB, V65, P4659; Moune S, 2003, FEMS MICROBIOL ECOL, V44, P117, DOI 10.1016/S0168-6496(03)00017-5; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; PEARSON TH, 1979, MAR BIOL, V53, P371, DOI 10.1007/BF00391620; Shannon C.E., 1963, MATH THEORY COMMUNIC; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Van Cappellen P, 1998, ENVIRON SCI TECHNOL, V32, P2931, DOI 10.1021/es980307m; van der Wielen PWJJ, 2005, SCIENCE, V307, P121, DOI 10.1126/science.1103569	29	137	145	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2006	440	7081					203	207		10.1038/nature04418	http://dx.doi.org/10.1038/nature04418			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	16525471	Bronze			2022-12-24	WOS:000235839500044
J	Kubo, T; Durham, WB; Stern, LA; Kirby, SH				Kubo, T; Durham, WB; Stern, LA; Kirby, SH			Grain size-sensitive creep in ice II	SCIENCE			English	Article							PRESSURE; RHEOLOGY; SATELLITES; DEFORMATION; VISCOSITY; EVOLUTION; VI	Rheological experiments on fine-grained water ice II at low strain rates reveal a creep mechanism that dominates at conditions of low stress. Using cryogenic scanning electron microscopy, we observed that a change in stress exponent from 5 to 2.5 correlates strongly with a decrease in grain size from about 40 to 6 micrometers. The grain size-sensitive creep of ice II demonstrated here plausibly dominates plastic strain at the low-stress conditions in the interior of medium- to large-sized icy moons of the outer solar system.	Kyushu Univ, Fac Sci, Dept Earth & Planetary Sci, Fukuoka 8128581, Japan; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; US Geol Survey, Menlo Pk, CA 94025 USA	Kyushu University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of the Interior; United States Geological Survey	Kubo, T (corresponding author), Kyushu Univ, Fac Sci, Dept Earth & Planetary Sci, Fukuoka 8128581, Japan.	kubotomo@geo.kyushu-u.ac.jp	Durham, William/P-7202-2019	Kirby, Stephen/0000-0001-8324-0971				BERTIE JE, 1963, J CHEM PHYS, V38, P840, DOI 10.1063/1.1733772; CONSOLMAGNO GJ, 1978, ICARUS, V34, P280, DOI 10.1016/0019-1035(78)90168-9; Durham WB, 1997, J GEOPHYS RES-PLANET, V102, P16293, DOI 10.1029/97JE00916; Durham WB, 1996, J GEOPHYS RES-SOL EA, V101, P2989, DOI 10.1029/95JB03542; DURHAM WB, 1988, J GEOPHYS RES-SOLID, V93, P10191, DOI 10.1029/JB093iB09p10191; Durham WB, 2001, J GEOPHYS RES-SOL EA, V106, P11031, DOI 10.1029/2000JB900446; ECHELMEYER K, 1986, GEOPHYS RES LETT, V13, P693, DOI 10.1029/GL013i007p00693; Edington J. W., 1976, PROG MATER SCI, V21, P61; ELLSWORTH K, 1983, ICARUS, V54, P490, DOI 10.1016/0019-1035(83)90242-7; FLETCHER NH, 1970, CHEM PHYSICS ICE, P57; Goldsby DL, 1997, SCRIPTA MATER, V37, P1399, DOI 10.1016/S1359-6462(97)00246-7; Goldsby DL, 2001, J GEOPHYS RES-SOL EA, V106, P11017, DOI 10.1029/2000JB900336; HEARD HC, 1990, GEOPHYS MONOGR SER, V56, P225; McKinnon WB, 1998, ASTROPHYS SPACE SC L, V227, P525, DOI 10.1007/978-94-011-5252-5_22; Poirier J., 1985, CREEP CRYSTALS; POIRIER JP, 1982, NATURE, V299, P683, DOI 10.1038/299683a0; POIRIER JP, 1981, NATURE, V292, P225, DOI 10.1038/292225a0; REYNOLDS RT, 1979, GEOPHYS RES LETT, V6, P121, DOI 10.1029/GL006i002p00121; ROTHERY DA, 1999, SATELLITES OUTER PLA; SCHUBERT G, 1981, ICARUS, V47, P46, DOI 10.1016/0019-1035(81)90090-7; SCHUBERT G, 1986, SATELLITES, P242; SOTIN C, 1987, J PHYS-PARIS, V48, P233, DOI 10.1051/jphyscol:1987132; Sotin C., 1985, ICES SOLAR SYSTEM, V156, P109; Stern LA, 1997, J GEOPHYS RES-SOL EA, V102, P5313, DOI 10.1029/96JB03894	24	15	15	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 3	2006	311	5765					1267	1269		10.1126/science.1121296	http://dx.doi.org/10.1126/science.1121296			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019XB	16513977				2022-12-24	WOS:000235870400035
J	Falagas, ME; Michalopoulos, A				Falagas, ME; Michalopoulos, A			Polymyxins: old antibiotics are back	LANCET			English	Editorial Material							RESISTANT PSEUDOMONAS-AERUGINOSA; INTRAVENOUS COLISTIN; INFECTIONS; ACINETOBACTER; EFFICACY; SAFETY		Alfa Inst Biomed Sci, Athens, Greece; Henry Dunant Hosp, Dept Med, Athens, Greece; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; Henry Dunant Hosp, Intens Care Unit, Athens, Greece	Alfa Institute Of Biomedical Sciences; Henry Dunant Hospital; Tufts University; Henry Dunant Hospital	Falagas, ME (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr		Michalopoulos, Argyris/0000-0002-6904-164X				Conway SP, 2000, ANN PHARMACOTHER, V34, P1238; Falagas ME, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-24; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323; Garnacho-Montero J, 2003, CLIN INFECT DIS, V36, P1111, DOI 10.1086/374337; Hsueh PR, 2005, CLIN MICROBIOL INFEC, V11, P670, DOI 10.1111/j.1469-0691.2005.01196.x; KOCHWESER J, 1970, ANN INTERN MED, V72, P331, DOI 10.7326/0003-4819-72-3-331; Levin AS, 1999, CLIN INFECT DIS, V28, P1008, DOI 10.1086/514732; Linden PK, 2003, CLIN INFECT DIS, V37, pE154, DOI 10.1086/379611; Ouderkirk JP, 2003, ANTIMICROB AGENTS CH, V47, P2659, DOI 10.1128/AAC.47.8.2659-2662.2003; Parchuri S, 2005, HEART LUNG, V34, P360, DOI 10.1016/j.hrtlng.2004.11.001; PERKINS RL, 1964, JAMA-J AM MED ASSOC, V190, P421; Reina R, 2005, INTENS CARE MED, V31, P1058, DOI 10.1007/s00134-005-2691-4	12	42	43	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2006	367	9511					633	634		10.1016/S0140-6736(06)68241-X	http://dx.doi.org/10.1016/S0140-6736(06)68241-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	016HR	16503447				2022-12-24	WOS:000235611800008
J	Keusch, GT; Wilentz, J; Kleinman, A				Keusch, GT; Wilentz, J; Kleinman, A			Stigma and global health: developing a research agenda	LANCET			English	Editorial Material									Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Keusch, GT (corresponding author), Boston Univ Med Campus, Boston, MA 02118 USA.	keusch@bu.edu		/0000-0001-5724-2965				Goffman E., 1963, BEHAV PUBLIC PLACES; Institute of Medicine,, 2001, NEUR PSYCH DEV DIS M; KLEINMAN A, 1995, SOC SCI MED, V40, P1319, DOI 10.1016/0277-9536(94)00254-Q; Office of the Surgeon General, 2019, SURG GEN ADV MAR US; *WHO, 2001, 166 WHO; World Health Organisation, 2001, MENT DIS AFF ON 4 PE	6	108	110	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 11	2006	367	9509					525	527		10.1016/S0140-6736(06)68183-X	http://dx.doi.org/10.1016/S0140-6736(06)68183-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	013FF	16473128				2022-12-24	WOS:000235394500032
J	Harnden, A; Ninis, N; Thompson, M; Perera, R; Levin, M; Mant, D; Mayon-White, R				Harnden, A; Ninis, N; Thompson, M; Perera, R; Levin, M; Mant, D; Mayon-White, R			Parenteral penicillin for children with meningococcal disease before hospital admission: case-control study	BRITISH MEDICAL JOURNAL			English	Article							ANTIBIOTIC-TREATMENT; CASE-FATALITY; ENDOTOXIN; RELEASE	Objective To explore the impact on mortality and morbidity of parenteral penicillin given to children before admission to hospital with suspected meningococcal disease. Design Retrospective comparison of fatal and non-fatal cases. Setting England, Wales, and Northern Ireland; December 1997 to February 1999. Participants 158 children aged 0-16 years (26 died, 132 survived) in whom a general practitioner had made the diagnosis of meningococcal disease before hospital admission. Results Administration of parenteral penicillin by general practitioners was associated with increased odds ratios for death (7.4, 95% confidence interval 1.5 to 37.7) and complications in survivors (5.0,1.7 to 15.0). Children who received penicillin had more severe disease on admission (median Glasgow meningococcal septicaemia prognostic score (GMSPS) 6.5 v 4.0, P = 0.002). Severity on admission did not differ significantly with time taken to reach hospital. Conclusions Children who were given parenteral penicillin by a general practitioner had more severe disease on reaching hospital than those who were not given penicillin before admission. The association with poor outcome may be because children who arc more severely 01 are being given penicillin before admission.	Univ Oxford, Dept Primary Hlth Care, Inst Hlth Sci, Oxford OX3 7LF, England; Univ London Imperial Coll Sci Technol & Med, Dept Paediat, Fac Med, London, England; Brighton & Sussex Med Sch, Div Med, Brighton, E Sussex, England	University of Oxford; Imperial College London; University of Brighton; University of Sussex	Harnden, A (corresponding author), Univ Oxford, Dept Primary Hlth Care, Inst Hlth Sci, Oxford OX3 7LF, England.	anthony.harnden@dphpc.ox.ac.uk	Mant, David CA/C-7763-2009	Perera, Rafael/0000-0003-2418-2091; Levin, Michael/0000-0003-2767-6919	MRC [G0000340] Funding Source: UKRI; Medical Research Council [G0000340] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDERSEN BM, 1980, ACTA PATH MICRO IM B, V88, P231; Brandtzaeg P, 1988, Prog Clin Biol Res, V272, P263; BRANDTZAEG P, 1989, J INFECT DIS, V159, P195, DOI 10.1093/infdis/159.2.195; CARTWRIGHT K, 1992, BMJ-BRIT MED J, V305, P143, DOI 10.1136/bmj.305.6846.143; HURLEY JC, 1992, CLIN INFECT DIS, V15, P840, DOI 10.1093/clind/15.5.840; MELLADO MC, 1991, EPIDEMIOL INFECT, V106, P283, DOI 10.1017/S0950268800048421; Ninis N, 2005, BRIT MED J, V330, P1475, DOI 10.1136/bmj.330.7506.1475; Norgard B, 2002, J INFECTION, V45, P144, DOI 10.1053/jinf.2002.1037; Sorensen HT, 1998, J CLIN EPIDEMIOL, V51, P717, DOI 10.1016/S0895-4356(98)00064-X; STRANG JR, 1992, BRIT MED J, V305, P141, DOI 10.1136/bmj.305.6846.141	10	34	34	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 3	2006	332	7553					1295	1297		10.1136/bmj.38789.723611.55	http://dx.doi.org/10.1136/bmj.38789.723611.55			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051YG	16554335	Green Published, Bronze			2022-12-24	WOS:000238197000014
J	Wang, XH; Aliyari, R; Li, WX; Li, HW; Kim, K; Carthew, R; Atkinson, P; Ding, SW				Wang, XH; Aliyari, R; Li, WX; Li, HW; Kim, K; Carthew, R; Atkinson, P; Ding, SW			RNA interference directs innate immunity against viruses in adult Drosophila	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; ANTIVIRAL RESPONSE; DISTINCT ROLES; ANIMAL VIRUS; PATHWAY; SUPPRESSION; INDUCTION; PROTEINS	Innate immunity against bacterial. and fungal pathogens is mediated by Toll. and immune deficiency (Imd) pathways, but little is known about the antiviral response in Drosophila. Here, we demonstrate that an RNA interference pathway protects adult flies from infection by two evolutionarily diverse viruses. Our work also describes a molecular framework for the viral immunity, in which Viral double-stranded RNA produced during infection acts as the pathogen trigger whereas Drosophila Dicer-2 and Argonaute-2 act as host sensor and effector, respectively. These findings establish a Drosophila model for studying the innate immunity against viruses in animals.	Univ Calif Riverside, Grad Program Microbiol, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Plant Pathol, Riverside, CA 92521 USA; Univ Calif Riverside, Ctr Plant Cell Biol, Inst Integrat Genome Biol, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; Northwestern University	Ding, SW (corresponding author), Univ Calif Riverside, Grad Program Microbiol, Riverside, CA 92521 USA.	dingsw@ucr.edu	Ding, Shou Wei/AAC-2533-2020	Ding, SW/0000-0002-4697-8413	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068743] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI052447, AI052447] Funding Source: Medline; NIGMS NIH HHS [R01 GM068743] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ball LA, 1999, ADV VIRUS RES, V53, P229, DOI 10.1016/S0065-3527(08)60350-4; Dong XF, 1998, J VIROL, V72, P6024, DOI 10.1128/JVI.72.7.6024-6033.1998; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102	18	537	569	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					452	454		10.1126/science.1125694	http://dx.doi.org/10.1126/science.1125694			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16556799	Green Accepted			2022-12-24	WOS:000236941800054
J	Miller, PM; Gavrilets, S; Rice, WR				Miller, PM; Gavrilets, S; Rice, WR			Sexual conflict via maternal-effect genes in ZW species	SCIENCE			English	Article							EVOLUTION; CHROMOSOME; SELECTION		Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; Univ Tennessee, Dept Math, Knoxville, TN 37996 USA	University of California System; University of California Santa Barbara; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Miller, PM (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	pmiller@lifesci.ucsb.edu		Miller, Paige/0000-0002-5419-8601	NIGMS NIH HHS [GM56693] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056693] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DOMBROWSKI SM, NCBI HDB NATL LIB ME, pCH20; Gavrilets S, 1998, GENETICS, V149, P1147; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Hurst LD, 1996, Q REV BIOL, V71, P317, DOI 10.1086/419442; RICE WR, 1987, GENETICS, V116, P161; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; Spencer HG, 2003, GENETICS, V164, P1689; Spencer HG, 2000, ANNU REV GENET, V34, P457, DOI 10.1146/annurev.genet.34.1.457	8	22	22	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2006	312	5770					73	73		10.1126/science.1123727	http://dx.doi.org/10.1126/science.1123727			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601185				2022-12-24	WOS:000236584400031
J	Miller, KM; Rog, O; Cooper, JP				Miller, KM; Rog, O; Cooper, JP			Semi-conservative DNA replication through telomeres requires Taz1	NATURE			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; FORK REVERSAL; PROTEIN; RECOMBINATION; HELICASE; LENGTH; CELLS; ORIGINS	Telomere replication is achieved through the combined action of the conventional DNA replication machinery and the reverse transcriptase, telomerase. Telomere-binding proteins have crucial roles in controlling telomerase activity; however, little is known about their role in controlling semi-conservative replication, which synthesizes the bulk of telomeric DNA(1). Telomere repeats in the fission yeast Schizosaccharomyces pombe are bound by Taz1, a regulator of diverse telomere functions(2-4). It is generally assumed that telomere-binding proteins impede replication fork progression. Here we show that, on the contrary, Taz1 is crucial for efficient replication fork progression through the telomere. Using two-dimensional gel electrophoresis(5), we find that loss of Taz1 leads to stalled replication forks at telomeres and internally placed telomere sequences, regardless of whether the telomeric G-rich strand is replicated by leading-or lagging-strand synthesis. In contrast, the Taz1-interacting protein Rap1 is dispensable for efficient telomeric fork progression. Upon loss of telomerase, taz1 Delta telomeres are lost precipitously, suggesting that maintenance of taz1 Delta telomere repeats cannot be sustained through semi-conservative replication. As the human telomere proteins TRF1 and TRF2 are Taz1 orthologues, we predict that one or both of the human TRFs may orchestrate fork passage through human telomeres. Stalled forks at dysfunctional human telomeres are likely to accelerate the genomic instability that drives tumorigenesis.	Canc Res UK, Telomere Biol Lab, London WC2A 3PX, England	Cancer Research UK	Cooper, JP (corresponding author), Canc Res UK, Telomere Biol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	julie.cooper@cancer.org.uk		Miller, Kyle/0000-0002-4544-0013; cooper, julia promisel/0000-0003-2171-2587				Ahn JS, 2005, EMBO J, V24, P2011, DOI 10.1038/sj.emboj.7600670; Beernink HTH, 2003, CURR BIOL, V13, P575, DOI 10.1016/S0960-9822(03)00169-6; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; DUBEY DD, 1994, EMBO J, V13, P3638, DOI 10.1002/j.1460-2075.1994.tb06671.x; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Gasser R, 1996, J MOL BIOL, V258, P224, DOI 10.1006/jmbi.1996.0245; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Ivessa AS, 2002, GENE DEV, V16, P1383, DOI 10.1101/gad.982902; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Londono-Vallejo JA, 2004, CANCER RES, V64, P2324, DOI 10.1158/0008-5472.CAN-03-4035; Lustig AJ, 2003, NAT REV GENET, V4, P916, DOI 10.1038/nrg1207; Makovets S, 2004, MOL CELL BIOL, V24, P4019, DOI 10.1128/MCB.24.9.4019-4031.2004; Miller KM, 2005, EMBO J, V24, P3128, DOI 10.1038/sj.emboj.7600779; Miller KM, 2003, MOL CELL, V11, P303, DOI 10.1016/S1097-2765(03)00041-8; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Ohki R, 2004, NUCLEIC ACIDS RES, V32, P1627, DOI 10.1093/nar/gkh309; Segurado M, 2003, EMBO REP, V4, P1048, DOI 10.1038/sj.embor.7400008; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sugawara N., 1988, DNA SEQUENCES TELOME; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011	28	199	199	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					824	828		10.1038/nature04638	http://dx.doi.org/10.1038/nature04638			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598261				2022-12-24	WOS:000236548400047
J	Loring, JF; Campbell, C				Loring, JF; Campbell, C			Science and law - Intellectual property and human embryonic stem cell research	SCIENCE			English	Editorial Material									Burnham Inst Med Res, La Jolla, CA 92037 USA; McDermott Will & Emery LLP, Washington, DC 20005 USA	Sanford Burnham Prebys Medical Discovery Institute	Loring, JF (corresponding author), Burnham Inst Med Res, La Jolla, CA 92037 USA.	jloring@burnham.org; ccampbell@mwe.com	Loring, Jeanne F/A-1620-2011	Loring, Jeanne F/0000-0001-6226-9767				BONGSO A, 1994, HUM REPROD, V9, P2110, DOI 10.1093/oxfordjournals.humrep.a138401; RAEBURN P, 1994, MILWAUKEE J     1104; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Vogel G, 2004, SCIENCE, V305, P1887; 2003, Patent No. 10430496; 2001, Patent No. 09982637; 2005, Patent No. 11036245; 2005, Patent No. 11033335	8	23	25	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2006	311	5768					1716	1717		10.1126/science.1120953	http://dx.doi.org/10.1126/science.1120953			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	024OA	16556826				2022-12-24	WOS:000236204300024
J	Hoffman, RM				Hoffman, RM			Viewpoint: Limiting prostate cancer screening	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RADICAL PROSTATECTOMY; OLDER MEN; ANTIGEN; TRENDS; TRIAL; LUNG	Prostate cancer screening is controversial, and major professional associations offer differing screening guidelines. The author addresses 3 key issues about prostate cancer screening: 1) the prostate-specific antigen (PSA) criteria to recommend a prostate biopsy, 2) the appropriate age to start screening, and 3) the appropriate age to stop screening. The author argues, on the basis of evidence published since 2000, that data supporting the efficacy of PSA screening remain unconvincing. The author recommends that screening should not be expanded to include average-risk men younger than age 50 years or older than age 75 years and that a PSA threshold below 4.0 ng/mL should not be used to trigger biopsy referral.	New Mexico Vet Affairs Hlth Care Syst, Albuquerque, NM 87108 USA; Univ New Mexico, Sch Med, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA	University of New Mexico	Hoffman, RM (corresponding author), New Mexico Vet Affairs Hlth Care Syst, 111GIM,1501 San Pedro Dr SE, Albuquerque, NM 87108 USA.	rhoffman@unm.edu		Hoffman, Richard/0000-0002-4714-7726				Alibhai SMH, 2003, J CLIN ONCOL, V21, P3318, DOI 10.1200/JCO.2003.09.034; Berg AO, 2002, ANN INTERN MED, V137, P915, DOI 10.7326/0003-4819-137-11-200212030-00013; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Bubolz T, 2001, UROLOGY, V58, P977, DOI 10.1016/S0090-4295(01)01434-0; Carroll P, 2001, UROLOGY, V57, P225, DOI 10.1016/S0090-4295(00)00994-8; de Koning HJ, 2002, INT J CANCER, V97, P237, DOI 10.1002/ijc.1588; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Etzioni R, 2002, J NATL CANCER I, V94, P981; Fang JY, 2001, UROLOGY, V58, P411, DOI 10.1016/S0090-4295(01)01304-8; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; Gohagan JK, 2000, CONTROL CLIN TRIALS, V21, p251S, DOI 10.1016/S0197-2456(00)00097-0; Krumholtz JS, 2002, UROLOGY, V60, P469, DOI 10.1016/S0090-4295(02)01875-7; Krumholtz JS, 2002, UROLOGY, V60, P474; Lu-Yao GL, 1999, UROLOGY, V54, P301, DOI 10.1016/S0090-4295(99)00100-4; LUYAO GL, 1993, JAMA-J AM MED ASSOC, V269, P2633, DOI 10.1001/jama.269.20.2633; *NAT COMPR CANC NE, 2005, PROST CANC EARL DET; Ross KS, 2000, JAMA-J AM MED ASSOC, V284, P1399, DOI 10.1001/jama.284.11.1399; Ross LE, 2004, PREV MED, V38, P732, DOI 10.1016/j.ypmed.2004.01.005; Schroder F H, 1994, Can J Oncol, V4 Suppl 1, P102; SCHRODER FH, 1994, CAN J ONCOL S1, V4, P106; Smith RA, 2002, CA-CANCER J CLIN, V52, P8, DOI 10.3322/canjclin.52.1.8; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Welch HG, 2005, J NATL CANCER I, V97, P1132, DOI 10.1093/jnci/dji205; Welch HG, 1996, ANN INTERN MED, V124, P577, DOI 10.7326/0003-4819-124-6-199603150-00007	24	24	24	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2006	144	6					438	440		10.7326/0003-4819-144-6-200603210-00011	http://dx.doi.org/10.7326/0003-4819-144-6-200603210-00011			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025FX	16549856				2022-12-24	WOS:000236251800008
J	Dye, C				Dye, C			Global epidemiology of tuberculosis	LANCET			English	Editorial Material							PREVALENCE; TRENDS; BURDEN		WHO, HIV AIDS TB & Malaria, CH-1211 Geneva 27, Switzerland	World Health Organization	Dye, C (corresponding author), WHO, HIV AIDS TB & Malaria, CH-1211 Geneva 27, Switzerland.	dyec@who.int	Dye, Christopher/AIC-4659-2022	Dye, Christopher/0000-0002-2957-1793				Asamoah-Odei E, 2004, LANCET, V364, P35, DOI 10.1016/S0140-6736(04)16587-2; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Dye C, 2002, J INFECT DIS, V185, P1197, DOI 10.1086/339818; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; *WHO, 2006, GLOB TUB CONTR SURV, P242; *WHO IUATALD, 2004, 3 WHO IUATALD, P299; World Health Organization, 2004, WORLD HLTH REP 2004	10	528	552	0	46	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					938	940		10.1016/S0140-6736(06)68384-0	http://dx.doi.org/10.1016/S0140-6736(06)68384-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546542				2022-12-24	WOS:000236242100030
J	Blasiak, LC; Vaillancourt, FH; Walsh, CT; Drennan, CL				Blasiak, LC; Vaillancourt, FH; Walsh, CT; Drennan, CL			Crystal structure of the non-haem iron halogenase SyrB2 in syringomycin biosynthesis	NATURE			English	Article							ALPHA-KETOGLUTARATE DIOXYGENASE; ESCHERICHIA-COLI; GENE-CLUSTER; INTERMEDIATE; CHLORINATION; MECHANISM; PROGRAM; TAURINE; ENZYMES; SYSTEM	Non- haem Fe( II)/ alpha-ketoglutarate ( alpha KG)- dependent enzymes harness the reducing power of alpha KG to catalyse oxidative reactions, usually the hydroxylation of unactivated carbons, and are involved in processes such as natural product biosynthesis, the mammalian hypoxic response, and DNA repair(1,2). These enzymes couple the decarboxylation of alpha KG with the formation of a high- energy ferryl- oxo intermediate that acts as a hydrogen- abstracting species(2-4). All previously structurally characterized mononuclear iron enzymes contain a 2- His, 1- carboxylate motif that coordinates the iron(1,2). The two histidines and one carboxylate, known as the ' facial triad', form one triangular side of an octahedral iron coordination geometry. A subclass of mononuclear iron enzymes has been shown to catalyse halogenation reactions, rather than the more typical hydroxylation reaction(5,6). SyrB2, a member of this subclass, is a non- haem Fe( II)/ alpha KG-dependent halogenase that catalyses the chlorination of threonine in syringomycin E biosynthesis(5). Here we report the structure of SyrB2 with both a chloride ion and alpha KG coordinated to the iron ion at 1.6 angstrom resolution. This structure reveals a previously unknown coordination of iron, in which the carboxylate ligand of the facial triad is replaced by a chloride ion.	MIT, Dept Chem, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Drennan, CL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	cdrennan@MIT.EDU						Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang ZX, 2002, GENE, V296, P235, DOI 10.1016/S0378-1119(02)00860-0; Cowtan K., 1994, CRYSTALLOGRAPHY, V31, P34; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; Goldsmith CR, 2002, INORG CHEM, V41, P4642, DOI 10.1021/ic025616z; GRGURINA I, 1994, EXPERIENTIA, V50, P130, DOI 10.1007/BF01984950; Grzyska PK, 2005, BIOCHEMISTRY-US, V44, P3845, DOI 10.1021/bi048746n; Guenzi E, 1998, J BIOL CHEM, V273, P32857, DOI 10.1074/jbc.273.49.32857; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KLEYWEGT GJ, 1994, CCP4 ESF EACBM NEWSL, V31, P9; Koehntop KD, 2005, J BIOL INORG CHEM, V10, P87, DOI 10.1007/s00775-005-0624-x; KOJIMA T, 1993, J AM CHEM SOC, V115, P11328, DOI 10.1021/ja00077a035; LAFORTELLE E, 1997, METHOD ENZYMOL, V276, P472; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Price JC, 2005, BIOCHEMISTRY-US, V44, P8138, DOI 10.1021/bi050227c; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vaillancourt FH, 2005, NATURE, V436, P1191, DOI 10.1038/nature03797; Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102; VAILLANCOURT FH, IN PRESS CHEMBIOCHEM; Walton JD, 1996, PLANT CELL, V8, P1723, DOI 10.1105/tpc.8.10.1723	29	260	265	5	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2006	440	7082					368	371		10.1038/nature04544	http://dx.doi.org/10.1038/nature04544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541079				2022-12-24	WOS:000235997600059
J	Graham, PL; Lin, SX; Larson, EL				Graham, PL; Lin, SX; Larson, EL			A US population-based survey of Staphylococcus aureus colonization	ANNALS OF INTERNAL MEDICINE			English	Article							METHICILLIN-RESISTANT; NASAL CARRIAGE; RISK-FACTORS; COMMUNITY; PREVALENCE; EPIDEMIOLOGY; INFECTIONS; EMERGENCE; CHILDREN	Background: The epidemiology of staphylococcal colonization and community-associated methicillin-resistant Staphylococcus aureus (MRSA) is changing, and little is known from the national perspective. Objective: To describe the U.S. epidemiology of S. aureus nasal colonization, compare risk factors for colonization with methicillin-sensitive S. aureus (MSSA) versus MRSA, and compare antibiotic resistance patterns and genetic factors of colonizing strains of S. aureus. Design: Secondary analysis of data from the National Health and Nutrition Examination Survey (NHANES), a stratified, multistage probability sample. Setting: United States. Participants: 2001-2002 NHANES participants older than 1 year of age. Measurements: Colonization of MSSA and MRSA, risk factors for colonization, antimicrobial resistance, and percentage of isolates with selected genetic factors. Results: The prevalence of colonization with S. aureus and with MRSA was 31.6% and 0.84%, respectively, in the noninstitutionalized U.S. population. People younger than 65 years of age, men, persons with less education, and persons with asthma were more likely to acquire S. aureus. Persons of black race and those of Mexican birth had lower risk for S. aureus colonization. Persons 65 years of age or older, women, persons with diabetes, and those who were in long-term care in the past year were more likely to have MRSA colonization. Hispanic persons had statistically significantly less risk than white persons. Isolates of MRSA with staphylococcal chromosomal cassette mec type IV (which is often associated with community-associated MRSA) were statistically significantly more likely to be sensitive to erythromycin, clindamycin, and ciprofloxacin. Limitations: Colonizing isolates may be different from isolates associated with infection. Risk factors identified may differ from those associated with invasive disease. The 2001-2002 NHANES data are several years old and may not reflect the most recent changes in epidemiology, but they are the only national data available. Conclusions: Characteristics of persons with MSSA and MRSA seem to differ. These findings may be useful for differentiating those who may be at risk for MRSA.	Columbia Univ, Dept Pediat, New York, NY 10032 USA; New York Presbyterian Med Ctr, New York, NY USA	Columbia University	Graham, PL (corresponding author), Columbia Univ, Dept Pediat, 622 W 168th St,PH 4 W,Room 463, New York, NY 10032 USA.	pgl43@columbia.edu	Graham, Petra/V-8136-2019	Graham, Petra/0000-0003-2890-2447	NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR017648, P20RR020616] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR020616, K12-RR017648, P20 RR020616-03] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bischoff WE, 2004, INFECT CONT HOSP EP, V25, P485, DOI 10.1086/502427; Charlebois ED, 2002, CLIN INFECT DIS, V34, P425, DOI 10.1086/338069; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Dufour P, 2002, CLIN INFECT DIS, V35, P819, DOI 10.1086/342576; Frank AL, 1999, PEDIATR INFECT DIS J, V18, P993, DOI 10.1097/00006454-199911000-00012; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Gorak EJ, 1999, CLIN INFECT DIS, V29, P797, DOI 10.1086/520437; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Jernigan JA, 2003, INFECT CONT HOSP EP, V24, P445, DOI 10.1086/502223; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Larson E, 2004, J URBAN HEALTH, V81, P498, DOI 10.1093/jurban/jth133; Larson E, 2003, EMERG INFECT DIS, V9, P1096; LAYTON MC, 1995, INFECT CONT HOSP EP, V16, P12; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Ma XX, 2002, ANTIMICROB AGENTS CH, V46, P1147, DOI 10.1128/AAC.46.4.1147-1152.2002; Maguire GP, 1996, MED J AUSTRALIA, V164, P721, DOI 10.5694/j.1326-5377.1996.tb122270.x; Mainous AG, 2005, EMERG INFECT DIS, V11, P883, DOI 10.3201/EID1106.040960; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Replogle ML, 2000, CLIN INFECT DIS, V30, P515, DOI 10.1086/313715; Sattler CA, 2002, PEDIATR INFECT DIS J, V21, P910, DOI 10.1097/00006454-200210000-00005; Solomon S, 2003, AM J INFECT CONTROL, V31, P481; Taylor JP, 2000, AM J PUBLIC HEALTH, V90, P271, DOI 10.2105/AJPH.90.2.271; *US DEP HHS NAT CT, 2005, NAT HLTH NUTR EX SUR; *US DEP HHS NAT CT, 2005, NHANES GEN AN GUID; *US DEP HHS NAT CT, 2005, NHANES 2001 2002 DAT; VandenBergh MFQ, 1999, J LAB CLIN MED, V133, P525, DOI 10.1016/S0022-2143(99)90181-6; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; 1999, MMWR MORB MORTAL WKL, V48, P707	31	308	314	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2006	144	5					318	325		10.7326/0003-4819-144-5-200603070-00006	http://dx.doi.org/10.7326/0003-4819-144-5-200603070-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021EA	16520472				2022-12-24	WOS:000235965300002
J	Wilkinson, IB; McEniery, CM; Cockcroft, JR				Wilkinson, IB; McEniery, CM; Cockcroft, JR			Atenolol and cardiovascular risk: an issue close to the heart	LANCET			English	Editorial Material							BLOOD-PRESSURE; HYPERTENSION; TRIAL; METAANALYSIS; REDUCTION; MORTALITY; OUTCOMES; DISEASE		Wales Heart Res Inst, Dept Cardiol, Cardiff CF14 4XN, Wales; Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England	Cardiff University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Cockcroft, JR (corresponding author), Wales Heart Res Inst, Dept Cardiol, Cardiff CF14 4XN, Wales.	cockcroftjr@cf.ac.uk		wilkinson, ian/0000-0001-6598-9399				*CAFE INV, 2006, CIRCULATION; Carlberg B, 2004, LANCET, V364, P1684, DOI 10.1016/S0140-6736(04)17355-8; Cockcroft JR, 2002, LANCET, V359, P2202, DOI 10.1016/S0140-6736(02)09075-X; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Dhakam Z, 2006, AM J HYPERTENS, V19, P214, DOI 10.1016/j.amjhyper.2005.08.007; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; KELLY R, 1989, HYPERTENSION, V14, P14, DOI 10.1161/01.HYP.14.1.14; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; Morgan T, 2004, AM J HYPERTENS, V17, P118, DOI 10.1016/j.amjhyper.2003.09.012; REMINGTON JW, 1956, J APPL PHYSIOL, V9, P433, DOI 10.1152/jappl.1956.9.3.433; Safar ME, 2002, HYPERTENSION, V39, P735, DOI 10.1161/hy0202.098325; Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; Wilkinson IB, 2000, J PHYSIOL-LONDON, V525, P263, DOI 10.1111/j.1469-7793.2000.t01-1-00263.x; Wilkinson IB, 1998, CURR OPIN LIPIDOL, V9, P237, DOI 10.1097/00041433-199806000-00009; Williams B, 2004, J HYPERTENS, V22, P447, DOI 10.1097/00004872-200403000-00002	16	27	27	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2006	367	9511					627	629		10.1016/S0140-6736(06)68238-X	http://dx.doi.org/10.1016/S0140-6736(06)68238-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	016HR	16503444				2022-12-24	WOS:000235611800005
J	Lund, ST; Bohlmann, J				Lund, ST; Bohlmann, J			The molecular basis for wine grape quality - A volatile subject	SCIENCE			English	Editorial Material							SAUVIGNON BLANC GRAPES; FUNCTIONAL-CHARACTERIZATION; IDENTIFICATION; EXPRESSION; SYNTHASE; BERRY	Volatile organic compounds are important flavor components of finished wines. In addition to winemaking practices, which shape wine quality, cultivation of the grape berries in the vineyard each season affects the production of volatile organic compounds as well as other chemical components that ultimately contribute to our perception of flavor in finished wines. By studying how berry flavor components are determined by the interplay of vine genotypes, the environment, and cultivation practices at the molecular level, scientists will develop advanced tools and knowledge that will aid viticulturalists in consistently producing balanced, flavorful berries for wine production.	Univ British Columbia, Wine Res Ctr, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Lund, ST (corresponding author), Univ British Columbia, Wine Res Ctr, 241-2205 E Mall, Vancouver, BC V6T 1Z4, Canada.	stlund@interchange.ubc.ca						Campo E, 2005, J AGR FOOD CHEM, V53, P5682, DOI 10.1021/jf047870a; Canal- Llauberes R. M., 1993, WINE MICROBIOLOGY BI, P477; COOMBE BG, 1992, AM J ENOL VITICULT, V43, P101; des Gachons CP, 2000, J AGR FOOD CHEM, V48, P3387, DOI 10.1021/jf990979b; Girard B, 2002, AM J ENOL VITICULT, V53, P99; JACKSON DI, 1993, AM J ENOL VITICULT, V44, P409; Kotseridis Y, 1999, J CHROMATOGR A, V849, P245, DOI 10.1016/S0021-9673(99)00540-3; LACEY MJ, 1991, AM J ENOL VITICULT, V42, P103; Lucker J, 2004, PHYTOCHEMISTRY, V65, P2649, DOI 10.1016/j.phytochem.2004.08.017; Martin DM, 2004, PHYTOCHEMISTRY, V65, P1223, DOI 10.1016/j.phytochem.2004.03.018; Mathieu S, 2005, J EXP BOT, V56, P2721, DOI 10.1093/jxb/eri265; van Leeuwen C, 2004, AM J ENOL VITICULT, V55, P207; Wang J, 2005, PLANT J, V44, P606, DOI 10.1111/j.1365-313X.2005.02552.x; WATSON B, 2003, OREGON VITICULTURE, P235	14	134	143	3	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 10	2006	311	5762					804	805		10.1126/science.1118962	http://dx.doi.org/10.1126/science.1118962			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012XT	16469915				2022-12-24	WOS:000235374900034
J	Roy, PM; Meyer, G; Vielle, B; Le Gall, C; Verschuren, F; Carpentier, F; Leveau, P; Furber, A				Roy, PM; Meyer, G; Vielle, B; Le Gall, C; Verschuren, F; Carpentier, F; Leveau, P; Furber, A		EMDEPU Study Grp	Appropriateness of diagnostic management and outcomes of suspected pulmonary embolism	ANNALS OF INTERNAL MEDICINE			English	Article							VENOUS THROMBOEMBOLISM; COMPUTED-TOMOGRAPHY; PREDICTION	Background: International guidelines include several strategies for diagnosing pulmonary embolism with confidence, but little is known about how these guidelines are implemented in routine practice. Objective: To evaluate the appropriateness of diagnostic management of suspected pulmonary embolism and the relationship between diagnostic criteria and outcome. Design: Prospective cohort study with a 3-month follow-up. Setting: 116 emergency departments in France and 1 in Belgium. Patients: 1529 consecutive outpatients with suspected pulmonary embolism. Measurements: Appropriateness of diagnostic criteria according to international guidelines; incidence of thromboembolic events during follow-up. Results: Diagnostic management was inappropriate in 662 (43%) patients: 36 of 429 (8%) patients with confirmed pulmonary embolism and 626 of 1100 (57%) patients in whom pulmonary embolism was ruled out. independent risk factors for inappropriate management were age older than 75 years (adjusted odds ratio, 2.27 [95% Cl, 1.48 to 3.47]), known heart failure (odds ratio, 1.53 [Cl, 1.11 to 2.12]), chronic lung disease (odds ratio, 1.39 [Cl, 1.00 to 1.94]), current or recent pregnancy (odds ratio, 5.92 [Cl, 1.81 to 19.30]), currently receiving anticoagulant treatment (odds ratio, 4.57 [Cl, 2.51 to 8.31]), and the lack of a written diagnostic algorithm and clinical probability scoring in the emergency department (odds ratio, 2.54 [Cl, 1.51 to 4.28]). Among patients who did not receive anticoagulant treatment, 44 had a thromboembolic event during follow-up: 5 of 418 (1.2%) patients who received appropriate management and 39 of 506 (7.7%) patients who received inappropriate management (absolute risk difference, 6.5 percentage points [Cl, 4.0 to 9.1 percentage points]; P < 0.001). Inappropriateness was independently associated with thromboembolism occurrence (adjusted odds ratio, 4.29 [Cl, 1.45 to 12.70]). Limitations: This was an observational study without evaluation of the risk for overdiagnosis. Conclusions: Diagnostic management that does not adhere to guidelines is frequent and harmful in patients with suspected pulmonary embolism. Several risk factors for inappropriateness constitute useful findings for subsequent interventions.	CHU Angers, Serv Accueil & Traitement Urgences, F-49033 Angers 01, France; Hop Europeen Georges Pompidou, Paris, France; Ctr Hosp Gen, Argenteuil, France; Clin Univ St Luc, B-1200 Brussels, Belgium; CHU Grenoble, F-38043 Grenoble, France; Ctr Hosp Nord Deux Sevres, Thouars, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Roy, PM (corresponding author), CHU Angers, Serv Accueil & Traitement Urgences, 4 Rue Larrey, F-49033 Angers 01, France.	PMRoy@chu-angers.fr	Roy, Pierre-Marie/AAA-7737-2022					BARRITT DW, 1960, LANCET, V1, P1309; Campbell IA, 2003, THORAX, V58, P470; Chagnon I, 2002, AM J MED, V113, P269, DOI 10.1016/S0002-9343(02)01212-3; Chunilal SD, 2003, JAMA-J AM MED ASSOC, V290, P2849, DOI 10.1001/jama.290.21.2849; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Fedullo PF, 2003, NEW ENGL J MED, V349, P1247, DOI 10.1056/NEJMcp035442; Fesmire FM, 2003, ANN EMERG MED, V41, P257, DOI 10.1067/mem.2003.40; GRIMSHAW JM, 2001, MED CARE S, V39, P112; Kearon C, 2003, CAN MED ASSOC J, V168, P183; Kline JA, 2000, ANN EMERG MED, V35, P168, DOI 10.1016/S0196-0644(00)70137-5; Kruip MJHA, 2003, ANN INTERN MED, V138, P941, DOI 10.7326/0003-4819-138-12-200306170-00005; Linkins LA, 2003, ANN INTERN MED, V139, P893, DOI 10.7326/0003-4819-139-11-200312020-00007; Miller AC, 2003, THORAX, V58, P463, DOI 10.1136/thorax.58.6.463; Mountain David, 2003, Emerg Med (Fremantle), V15, P250, DOI 10.1046/j.1442-2026.2003.00444.x; Musset D, 2002, LANCET, V360, P1914, DOI 10.1016/S0140-6736(02)11914-3; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Perrier A, 2004, AM J MED, V116, P291, DOI 10.1016/j.amjmed.2003.09.041; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Pineda LA, 2001, CHEST, V120, P791, DOI 10.1378/chest.120.3.791; Schoepf UJ, 2004, CIRCULATION, V109, P2160, DOI 10.1161/01.CIR.0000128813.04325.08; STEIN PD, 1991, CHEST, V100, P598, DOI 10.1378/chest.100.3.598; Torbicki A, 2000, EUR HEART J, V21, P1301; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010	23	227	232	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2006	144	3					157	164		10.7326/0003-4819-144-3-200602070-00003	http://dx.doi.org/10.7326/0003-4819-144-3-200602070-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	008XS	16461959				2022-12-24	WOS:000235074800001
J	Halloran, ME; Longini, IM				Halloran, ME; Longini, IM			Public health - Community studies for vaccinating schoolchildren against influenza	SCIENCE			English	Editorial Material							CAIV-T; CHILDREN; TRIVALENT; EFFICACY; POPULATION		Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, Seattle, WA 98109 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Halloran, ME (corresponding author), Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, Seattle, WA 98109 USA.	betz@u.washington.edu						Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; Francis T, 1955, AM J PUBLIC HEALTH N, V45, P1; HALLORAN ME, 1991, EPIDEMIOLOGY, V2, P331, DOI 10.1097/00001648-199109000-00004; Halloran ME, 2003, AM J EPIDEMIOL, V158, P305, DOI 10.1093/aje/kwg163; Halloran ME, 2001, AM J EPIDEMIOL, V154, P391, DOI 10.1093/aje/154.5.391; JORDAN R, 2005, IN PRESS VACCINE, DOI DOI 10.1016/J.VACCINE.2005.09.017; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; MONTO AS, 1969, B WORLD HEALTH ORGAN, V41, P537; NEUSTADT RE, 2005, SWINE FLU AFFAIR DEC; Patel R, 2005, J THEOR BIOL, V234, P201, DOI 10.1016/j.jtbi.2004.11.032; Piedra PA, 2005, VACCINE, V23, P1540, DOI 10.1016/j.vaccine.2004.09.025; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; RUDENKO LG, 1993, J INFECT DIS, V168, P881, DOI 10.1093/infdis/168.4.881; Weycker D, 2005, VACCINE, V23, P1284, DOI 10.1016/j.vaccine.2004.08.044	14	57	59	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2006	311	5761					615	616		10.1126/science.1122143	http://dx.doi.org/10.1126/science.1122143			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	011GY	16456066				2022-12-24	WOS:000235257400031
J	WOLF, S; DEOM, CM; BEACHY, RN; LUCAS, WJ				WOLF, S; DEOM, CM; BEACHY, RN; LUCAS, WJ			MOVEMENT PROTEIN OF TOBACCO MOSAIC-VIRUS MODIFIES PLASMODESMATAL SIZE EXCLUSION LIMIT	SCIENCE			English	Article									WASHINGTON UNIV,DEPT BIOL,ST LOUIS,MO 63130	Washington University (WUSTL)	WOLF, S (corresponding author), UNIV CALIF DAVIS,DEPT BOT,DAVIS,CA 95616, USA.			Deom, C. Michael/0000-0002-7008-9720				ALLISON AV, 1974, PHYTOPATHOLOGY, V64, P784, DOI 10.1094/Phyto-64-784; ATABEKOV JG, 1984, ADV VIRUS RES, V29, P313, DOI 10.1016/S0065-3527(08)60412-1; DEOM CM, 1987, SCIENCE, V237, P389, DOI 10.1126/science.237.4813.389; ERWEE MG, 1983, PLANTA, V158, P320, DOI 10.1007/BF00397334; ERWEE MG, 1985, PLANTA, V163, P9, DOI 10.1007/BF00395891; ERWEE MG, 1984, PROTOPLASMA, V122, P162, DOI 10.1007/BF01281693; Esau, 1969, PHLOEM HDB PFLANZENA; FISHER DG, 1988, PLANT CELL ENVIRON, V11, P639, DOI 10.1111/j.1365-3040.1988.tb01806.x; FLAGGNEWTON J, 1979, SCIENCE, V205, P404, DOI 10.1126/science.377490; Gibbs A, 1976, INTERCELLULAR COMMUN, P149; Gunning B. E. S., 1976, Transport and transfer processes in plants. [Wardlaw, I.F.; Passioura, J.B. (Editors)]., P15; Gunning B. E. S., 1976, Intercellular communication in plants: studies in plasmodesmata., P1; KITAJIMA EW, 1969, VIROLOGY, V37, P681, DOI 10.1016/0042-6822(69)90288-8; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; Loewenstein W R, 1978, Ann N Y Acad Sci, V307, P285, DOI 10.1111/j.1749-6632.1978.tb41958.x; Lucas W E, 2014, UNPUB; MADORE MA, 1986, PLANT PHYSIOL, V82, P432, DOI 10.1104/pp.82.2.432; MESHI T, 1987, EMBO J, V6, P2557, DOI 10.1002/j.1460-2075.1987.tb02544.x; NISHIGUCHI M, 1978, J GEN VIROL, V39, P53, DOI 10.1099/0022-1317-39-1-53; NISHIGUCHI M, 1980, J GEN VIROL, V46, P497, DOI 10.1099/0022-1317-46-2-497; OPARKA KJ, 1988, PLANTA, V176, P533, DOI 10.1007/BF00397661; PALEVITZ BA, 1985, PLANTA, V164, P473, DOI 10.1007/BF00395962; PEARCE RH, 1978, J CHROMATOGR, V151, P548; PICK U, 1981, ARCH BIOCHEM BIOPHYS, V212, P186, DOI 10.1016/0003-9861(81)90358-1; POITEVIN E, 1988, BIOPHYS CHEM, V31, P247, DOI 10.1016/0301-4622(88)80030-9; SIMPSON I, 1978, ANAL BIOCHEM, V89, P304, DOI 10.1016/0003-2697(78)90755-8; SQUIRE PG, 1981, J CHROMATOGR, V210, P433, DOI 10.1016/S0021-9673(00)80335-0; STEWART WW, 1981, NATURE, V292, P17, DOI 10.1038/292017a0; TERRY BR, 1987, PLANTA, V171, P145, DOI 10.1007/BF00391090; TUCKER EB, 1985, PROTOPLASMA, V128, P167, DOI 10.1007/BF01276338; TUCKER EB, 1982, PROTOPLASMA, V113, P193, DOI 10.1007/BF01280907; VANBEL AJE, 1985, PLANT CELL ENVIRON, V8, P173; WEINTRAUB M, 1976, J ULTRA MOL STRUCT R, V56, P351, DOI 10.1016/S0022-5320(76)90010-1; WOLF S, UNPUB	34	518	540	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 20	1989	246	4928					377	379		10.1126/science.246.4928.377	http://dx.doi.org/10.1126/science.246.4928.377			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AV670	16552920				2022-12-24	WOS:A1989AV67000037
J	Ramsey, IS; Moran, MM; Chong, JHA; Clapham, DE				Ramsey, IS; Moran, MM; Chong, JHA; Clapham, DE			A voltage-gated proton-selective channel lacking the pore domain	NATURE			English	Article							ALVEOLAR EPITHELIAL-CELLS; NADPH OXIDASE; HUMAN-NEUTROPHILS; H+ CURRENTS; PHAGOCYTES; SENSOR; DEPENDENCE; REVEALS; PH	Voltage changes across the cell membrane control the gating of many cation-selective ion channels. Conserved from bacteria to humans(1), the voltage-gated-ligand superfamily of ion channels are encoded as polypeptide chains of six transmembrane-spanning segments (S1-S6). S1-S4 functions as a self-contained voltage-sensing domain (VSD), in essence a positively charged lever that moves in response to voltage changes. The VSD 'ligand' transmits force via a linker to the S5-S6 pore domain 'receptor'(2), thereby opening or closing the channel. The ascidian VSD protein Ci-VSP gates a phosphatase activity rather than a channel pore, indicating that VSDs function independently of ion channels(3). Here we describe a mammalian VSD protein (H(V)1) that lacks a discernible pore domain but is sufficient for expression of a voltage-sensitive proton-selective ion channel activity. H(v)1 currents are activated at depolarizing voltages, sensitive to the transmembrane pH gradient, H+-selective, and Zn2+-sensitive. Mutagenesis of H(v)1 identified three arginine residues in S4 that regulate channel gating and two histidine residues that are required for extracellular inhibition of H(v)1 by Zn2+. H(v)1 is expressed in immune tissues and manifests the characteristic properties of native proton conductances (G(vH+)). In phagocytic leukocytes(4), G(vH+) are required to support the oxidative burst that underlies microbial killing by the innate immune system(4,5). The data presented here identify H(v)1 as a long-sought voltage-gated H+ channel and establish H(v)1 as the founding member of a family of mammalian VSD proteins.	Harvard Univ, Sch Med, Dept Neurobiol, Childrens Hosp,Dept Cardiol,Howard Hughes Med Ins, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Clapham, DE (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Childrens Hosp,Dept Cardiol,Howard Hughes Med Ins, Enders 1309,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [T32 HL007572] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; Cherny V V, 1997, Membr Cell Biol, V11, P337; Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; DeCoursey TE, 2002, J GEN PHYSIOL, V120, P773, DOI 10.1085/jgp.20028704; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeCoursey TE, 2001, J PHYSIOL-LONDON, V535, P767, DOI 10.1111/j.1469-7793.2001.00767.x; DeCoursey TE, 2001, J BIOL CHEM, V276, P36063, DOI 10.1074/jbc.C100352200; DeCoursey TE, 1998, J GEN PHYSIOL, V112, P503, DOI 10.1085/jgp.112.4.503; Eder C, 2001, PROG NEUROBIOL, V64, P277, DOI 10.1016/S0301-0082(00)00062-9; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Henderson LM, 1999, J GEN PHYSIOL, V114, P771, DOI 10.1085/jgp.114.6.771; HENDERSON LM, 1988, BIOCHEM J, V255, P285; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Morgan D, 2002, J GEN PHYSIOL, V119, P571, DOI 10.1085/jgp.20018544; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Pomes R, 2002, BIOPHYS J, V82, P2304, DOI 10.1016/S0006-3495(02)75576-8; Price MO, 2002, BLOOD, V99, P2653, DOI 10.1182/blood.V99.8.2653; QU AY, 1994, AM J PHYSIOL, V266, pC1263, DOI 10.1152/ajpcell.1994.266.5.C1263; Rada BK, 2004, BLOOD, V104, P2947, DOI 10.1182/blood-2004-03-1005; SASAKI M, IN PRESS SCIENCE; Schilling T, 2002, J PHYSIOL-LONDON, V545, P93, DOI 10.1113/jphysiol.2002.028878; SMITH RM, 1991, BLOOD, V77, P673; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0; Tombola F, 2005, NEURON, V48, P719, DOI 10.1016/j.neuron.2005.11.024; YU FH, 2004, SCI STKE	30	453	461	3	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1213	1216		10.1038/nature04700	http://dx.doi.org/10.1038/nature04700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16554753	Green Accepted			2022-12-24	WOS:000237080000050
J	Huang, WD; Ma, K; Zhang, J; Qatanani, M; Cuvillier, J; Liu, J; Dong, BN; Huang, XF; Moore, DD				Huang, WD; Ma, K; Zhang, J; Qatanani, M; Cuvillier, J; Liu, J; Dong, BN; Huang, XF; Moore, DD			Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration	SCIENCE			English	Article							RAT-LIVER; GENE-EXPRESSION; HEPATOCYTES; LIGANDS; IDENTIFICATION; HEPATECTOMY; MODULATION; SECRETION; PATHWAY; PHASE	Liver mass depends on one or more unidentified humoral signals that drive regeneration when liver functional capacity is diminished. Bile acids are important liver products, and their levels are tightly regulated. Here, we identify a role for nuclear receptor - dependent bile acid signaling in normal liver regeneration. Elevated bile acid levels accelerate regeneration, and decreased levels inhibit liver regrowth, as does the absence of the primary nuclear bile acid receptor FXR. We propose that FXR activation by increased bile acid flux is a signal of decreased functional capacity of the liver. FXR, and possibly other nuclear receptors, may promote homeostasis not only by regulating expression of appropriate metabolic target genes but also by driving homeotrophic liver growth.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; City Hope Natl Med Ctr, Beckman Res Inst, Dept Gene Regulat & Drug Discovery, Duarte, CA 91010 USA	Baylor College of Medicine; City of Hope; Beckman Research Institute of City of Hope	Moore, DD (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	moore@bcm.tmc.edu			NIDDK NIH HHS [R01 DK053366, U19 DK62434] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434, R01DK053366] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barone M, 1996, HEPATOLOGY, V23, P1159, DOI 10.1053/jhep.1996.v23.pm0008621149; BUCHER NLR, 1963, INT REV CYTOL, V15, P245, DOI 10.1016/S0074-7696(08)61119-5; Chijiiwa K, 1996, BRIT J SURG, V83, P482, DOI 10.1002/bjs.1800830414; Columbano A, 2005, HEPATOLOGY, V42, P1118, DOI 10.1002/hep.20883; Columbano A, 2003, CELL DEATH DIFFER, V10, pS19, DOI 10.1038/sj.cdd.4401113; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; GARCIAMARIN JJ, 1990, CLIN SCI, V78, P55, DOI 10.1042/cs0780055; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; Gupta S, 2004, J BIOL CHEM, V279, P5821, DOI 10.1074/jbc.M310979200; Higgins GM, 1931, ARCH PATHOL, V12, P186; HUANG W, 2005, MOL ENDOCRINOL  0414; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kren BT, 2001, LIVER TRANSPLANT, V7, P321, DOI 10.1053/jlts.2001.23062; Kullak-Ublick G A, 2000, Clin Liver Dis, V4, P357, DOI 10.1016/S1089-3261(05)70114-8; LEONG GF, 1959, AM J PHYSIOL, V197, P880, DOI 10.1152/ajplegacy.1959.197.4.880; Li W, 2002, J BIOL CHEM, V277, P28411, DOI 10.1074/jbc.M202807200; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; MELCHIORRI C, 1993, CARCINOGENESIS, V14, P1825, DOI 10.1093/carcin/14.9.1825; Monte MJ, 1997, BBA-MOL BASIS DIS, V1362, P56, DOI 10.1016/S0925-4439(97)00063-X; Monte MJ, 2002, J HEPATOL, V36, P534, DOI 10.1016/S0168-8278(01)00296-3; MOOLTEN FL, 1967, SCIENCE, V158, P272, DOI 10.1126/science.158.3798.272; Oe S, 2004, HEPATOLOGY, V40, P1098, DOI 10.1002/hep.20426; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Romero-Gallo J, 2005, ONCOGENE, V24, P3028, DOI 10.1038/sj.onc.1208475; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sainz GR, 1997, INT J EXP PATHOL, V78, P109, DOI 10.1046/j.1365-2613.1997.d01-246.x; Setchell KDR, 1997, GASTROENTEROLOGY, V112, P226, DOI 10.1016/S0016-5085(97)70239-7; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; SOLOPAEV B P, 1957, Biull Eksp Biol Med, V43, P109; Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467; Su AI, 2002, P NATL ACAD SCI USA, V99, P11181, DOI 10.1073/pnas.122359899; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Ueda JJ, 2002, SURGERY, V131, P564, DOI 10.1067/msy.2002.123008; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Wiezer MJ, 2000, ANN SURG, V232, P208, DOI 10.1097/00000658-200008000-00010; Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398; Zhang J, 2004, J BIOL CHEM, V279, P49517, DOI 10.1074/jbc.M409041200	44	484	516	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2006	312	5771					233	236		10.1126/science.1121435	http://dx.doi.org/10.1126/science.1121435			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614213				2022-12-24	WOS:000236765300039
J	Weinreich, DM; Delaney, NF; DePristo, MA; Hartl, DL				Weinreich, DM; Delaney, NF; DePristo, MA; Hartl, DL			Darwinian evolution can follow only very few mutational paths to fitter proteins	SCIENCE			English	Article							TEM BETA-LACTAMASE; IN-VITRO; ANTIBIOTIC-RESISTANCE; CEPHALOSPORINS; AGGREGATION; ADAPTATION; LANDSCAPE; STABILITY; SEQUENCE	Five point mutations in a particular beta-lactamase allele jointly increase bacterial resistance to a clinically important antibiotic by a factor of similar to 100,000. In principle, evolution to this high-resistance beta-lactamase might follow any of the 120 mutational trajectories linking these alleles. However, we demonstrate that 102 trajectories are inaccessible to Darwinian selection and that many of the remaining trajectories have negligible probabilities of realization, because four of these five mutations fail to increase drug resistance in some combinations. Pervasive biophysical pleiotropy within the beta-lactamase seems to be responsible, and because such pleiotropy appears to be a general property of missense mutations, we conclude that much protein evolution will be similarly constrained. This implies that the protein tape of life may be largely reproducible and even predictable.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Weinreich, DM (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	dmw@post.harvard.edu	Weinreich, Dan/AAZ-6606-2021					AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Barlow M, 2002, GENETICS, V160, P823; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; GEORGIOU G, 1994, PROTEIN SCI, V3, P1953, DOI 10.1002/pro.5560031107; GILLESPIE JH, 1984, EVOLUTION, V38, P1116, DOI [10.2307/2408444, 10.1111/j.1558-5646.1984.tb00380.x]; Gould S.J, 1989, WONDERFUL LIFE BURGE; Hall BG, 2004, DRUG RESIST UPDATE, V7, P111, DOI 10.1016/j.drup.2004.02.003; Hall BG, 2002, ANTIMICROB AGENTS CH, V46, P3035, DOI 10.1128/AAC.46.9.3035-3038.2002; Huang WZ, 1997, P NATL ACAD SCI USA, V94, P8801, DOI 10.1073/pnas.94.16.8801; Jacoby GA, 2005, TEM EXTENDED SPECTRU; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; MALCOLM BA, 1990, NATURE, V345, P86, DOI 10.1038/345086a0; MEDEIROS AA, 1997, CLIN INFECT DIS   S1, V24, P19; Orencia MC, 2001, NAT STRUCT BIOL, V8, P238, DOI 10.1038/84981; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Orr HA, 2005, EVOLUTION, V59, P216; Orr HA, 2002, EVOLUTION, V56, P1317, DOI 10.1111/j.0014-3820.2002.tb01446.x; RAQUET X, 1994, J MOL BIOL, V244, P625, DOI 10.1006/jmbi.1994.1756; RAQUET X, 1995, PROTEINS, V23, P63, DOI 10.1002/prot.340230108; Sideraki V, 2001, P NATL ACAD SCI USA, V98, P283, DOI 10.1073/pnas.011454198; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Walsh C., 2003, ANTIBIOTICS ACTIONS; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; WATSON N, 1988, GENE, V70, P399, DOI 10.1016/0378-1119(88)90212-0; Weinreich DM, 2005, EVOLUTION, V59, P1165; WRIGHT S, 1932, P 6 INT C GEN, P356	26	897	906	2	173	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2006	312	5770					111	114		10.1126/science.1123539	http://dx.doi.org/10.1126/science.1123539			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601193				2022-12-24	WOS:000236584400043
J	Blander, JM; Medzhitov, R				Blander, JM; Medzhitov, R			Toll-dependent selection of microbial antigens for presentation by dendritic cells	NATURE			English	Article							CLASS-II COMPLEXES; APOPTOTIC CELLS; MATURATION; RECEPTOR; ALPHA; TRANSPORT; LIPOPOLYSACCHARIDE; EXPRESSION; SIGNALS	Dendritic cells constitutively sample the tissue microenvironment and phagocytose both microbial and host apoptotic cells(1-4). This leads to the induction of immunity against invading pathogens or ;tolerance to peripheral self antigens, respectively(5-9). The outcome of antigen presentation by dendritic cells depends on their activation status, such that Toll-like receptor (TLR)-induced dendritic cell activation makes them immunogenic, whereas steady-state presentation of self antigens leads to tolerance(5,6,8,10). TLR-inducible expression of co-stimulatory signals is one of the mechanisms of self/ non-self discrimination(5,11). However, it is unclear whether or how the inducible expression of co-stimulatory signals would distinguish between self antigens and microbial antigens when both are encountered by dendritic cells during infection(6,8). Here we describe a new mechanism of antigen selection in dendritic cells for presentation by major histocompatibility complex class II molecules (MHCII) that is based on the origin of the antigen. We show that the efficiency of presenting antigens from phagocytosed cargo is dependent on the presence of TLR ligands within the cargo. Furthermore, we show that the generation of peptide - MHC class II complexes is controlled by TLRs in a strictly phagosome-autonomous manner.	Yale Univ, Sch Med, Immunobiol Sect, Howard Hughes Med Inst, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, Howard Hughes Med Inst, 300 Cedar St, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu		Blander, Julie Magarian/0000-0001-9207-1700				Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Boes M, 2004, TRENDS CELL BIOL, V14, P175, DOI 10.1016/j.tcb.2004.02.004; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Henson PM, 2001, NAT REV MOL CELL BIO, V2, P627, DOI 10.1038/35085094; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Larsson M, 2001, TRENDS IMMUNOL, V22, P141, DOI 10.1016/S1471-4906(01)01860-9; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Luhrmann A, 2000, Methods Cell Sci, V22, P329, DOI 10.1023/A:1017963401560; MATHIS DJ, 1983, P NATL ACAD SCI-BIOL, V80, P273, DOI 10.1073/pnas.80.1.273; Ravichandran KS, 2003, CELL, V113, P817, DOI 10.1016/S0092-8674(03)00471-9; RUDENSKY AY, 1991, NATURE, V353, P660, DOI 10.1038/353660a0; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Thieblemont N, 1999, J EXP MED, V190, P523, DOI 10.1084/jem.190.4.523; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Viret C, 2000, J IMMUNOL, V164, P4627, DOI 10.4049/jimmunol.164.9.4627; Watts C, 2004, NAT IMMUNOL, V5, P685, DOI 10.1038/ni1088; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Zhong GM, 1997, P NATL ACAD SCI USA, V94, P13856, DOI 10.1073/pnas.94.25.13856	30	631	666	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					808	812		10.1038/nature04596	http://dx.doi.org/10.1038/nature04596			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16489357				2022-12-24	WOS:000236548400044
J	Kaleeba, JAR; Berger, EA				Kaleeba, JAR; Berger, EA			Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: Cystine transporter xCT	SCIENCE			English	Article							SURFACE HEPARAN-SULFATE; TARGET-CELLS; HUMAN-HERPESVIRUS-8; PROTEIN; TAT; INDUCTION; INFECTION; DEPLETION; CHAIN	Kaposi's sarcoma-associated herpesvirus (KSHV, human herpesvirus 8) is the causative agent of Kaposi's sarcoma and other lymphoproliferative syndromes often associated with HIV/AIDS. Functional complementary DNA selection for a receptor mediating KSHV cell fusion identified xCT, the 12-transmembrane light chain of the human cystine/glutamate exchange transporter system x(c)(-). Expression of recombinant xCT rendered otherwise not susceptible target cells permissive for both KSHV cell fusion and virion entry. Antibodies against xCT blocked KSHV fusion and entry with naturally permissive target cells. KSHV target cell permissiveness correlated closely with endogenous expression of xCT messenger RNA and protein in diverse human and nonhuman cell types.	NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Berger, EA (corresponding author), NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.	edward_berger@nih.gov	Kaleeba, Johnan/ABI-1548-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000733, ZIAAI000733] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Akula SM, 2003, J VIROL, V77, P7978, DOI 10.1128/JVI.77.14.7978-7990.2003; Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; Akula SM, 2001, VIROLOGY, V282, P245, DOI 10.1006/viro.2000.0851; Aoki Y, 2004, BLOOD, V104, P810, DOI 10.1182/blood-2003-07-2533; Bassi MT, 2001, PFLUG ARCH EUR J PHY, V442, P286, DOI 10.1007/s004240100537; Bechtel JT, 2003, J VIROL, V77, P6474, DOI 10.1128/JVI.77.11.6474-6481.2003; Birkmann A, 2001, J VIROL, V75, P11583, DOI 10.1128/JVI.75.23.11583-11593.2001; Bridges CC, 2004, INVEST OPHTH VIS SCI, V45, P2906, DOI 10.1167/iovs.03-1355; Bubman D, 2003, HEMATOL ONCOL CLIN N, V17, P717, DOI 10.1016/S0889-8588(03)00044-3; Choi J, 2000, J BIOL CHEM, V275, P3693, DOI 10.1074/jbc.275.5.3693; DEY B, 2003, CURRENT PROTOCOLS S, V54; Haque M, 2003, J VIROL, V77, P6761, DOI 10.1128/JVI.77.12.6761-6768.2003; Herzenberg LA, 1997, P NATL ACAD SCI USA, V94, P1967, DOI 10.1073/pnas.94.5.1967; KALEEBA JAR, UNPUB; Kolesnikova TV, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-10; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; Naranatt PP, 2003, J VIROL, V77, P1524, DOI 10.1128/JVI.77.2.1524-1539.2003; Opalenik SR, 1998, ARCH BIOCHEM BIOPHYS, V351, P17, DOI 10.1006/abbi.1997.0566; Pertel PE, 2002, J VIROL, V76, P4390, DOI 10.1128/JVI.76.9.4390-4400.2002; Qiang W, 2004, J VIROL, V78, P11926, DOI 10.1128/JVI.78.21.11926-11938.2004; Sasaki H, 2002, J BIOL CHEM, V277, P44765, DOI 10.1074/jbc.M208704200; Sato H, 2000, ANTIOXID REDOX SIGN, V2, P665, DOI 10.1089/ars.2000.2.4-665; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Smith Ernest S, 2004, Methods Mol Biol, V269, P65; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; Tailor CS, 2003, CURR TOP MICROBIOL, V281, P29; Triantafilou K, 2001, CRIT REV IMMUNOL, V21, P311; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; WANG JF, 2004, BLOOD, V104	30	116	123	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2006	311	5769					1921	1924		10.1126/science.1120878	http://dx.doi.org/10.1126/science.1120878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16574866				2022-12-24	WOS:000236387800044
J	Baker, J				Baker, J			Introduction - Tiger, tiger, burning bright	SCIENCE			English	Editorial Material																			0	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2006	311	5766					1388	1388		10.1126/science.311.5766.1388	http://dx.doi.org/10.1126/science.311.5766.1388			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527961				2022-12-24	WOS:000236029400027
J	Berman, JR; Kenyon, C				Berman, JR; Kenyon, C			Germ-cell loss extends C-elegans life span through regulation of DAF-16 by kri-1 and lipophilic-hormone signaling	CELL			English	Article							CAVERNOUS MALFORMATIONS CCM1; CAENORHABDITIS-ELEGANS; REPRODUCTIVE DEVELOPMENT; BINDING-PROTEIN; ENCODING KRIT1; PATHWAY; LONGEVITY; INSULIN/IGF-1; RECEPTOR; INTERFERENCE	In C. elegans, removing the germ cells extends life span by triggering the nuclear localization and activation of the DAF-16/FOXO transcription factor in the intestine. In this study, we identify and analyze genes required for germline removal to extend life span. We find that the reproductive system communicates with the intestine through lipophilic-hormone signaling and that a gene called kri-1 is likely to act in the intestine to promote DAF-16 nuclear localization in response to this signal. This lipophilic-signaling pathway and kri-1 are not required for DAF-16's nuclear localization and life-span extension in animals with decreased insulin/IGF-1 signaling. Thus, this pathway specifically enables the integration of cues from the reproductive system with central DAF-16-activation pathways to influence the aging of the animal.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Miss Bay,Genentech Hall,600 16th St,Room S312D, San Francisco, CA 94143 USA.	ckenyon@biochem.ucsf.edu		Kenyon, Cynthia/0000-0003-3446-2636	NIA NIH HHS [AG020932] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG020932] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Antebi A, 2000, GENE DEV, V14, P1512; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; BRENNER S, 1974, GENETICS, V77, P71; Cargill SL, 2003, AGING CELL, V2, P185, DOI 10.1046/j.1474-9728.2003.00049.x; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; DORMAN JB, 1995, GENETICS, V141, P1399; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gems D, 1998, GENETICS, V150, P129; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; LARSEN PL, 1995, GENETICS, V139, P1567; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Mak HY, 2004, DEVELOPMENT, V131, P1777, DOI 10.1242/dev.01069; Mello C, 1995, METHOD CELL BIOL, V48, P451; Nanji M, 2005, AGING CELL, V4, P235, DOI 10.1111/j.1474-9726.2005.00166.x; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; Riddle DL, 1997, C ELEGANS, P739; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256	38	223	231	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					1055	1068		10.1016/j.cell.2006.01.039	http://dx.doi.org/10.1016/j.cell.2006.01.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530050	Bronze			2022-12-24	WOS:000237241200025
J	Barsoum, RS				Barsoum, RS			Chronic kidney disease in the developing world	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Cairo Univ, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University	Barsoum, RS (corresponding author), Cairo Univ, Cairo, Egypt.			Barsoum, Rashad/0000-0003-1620-764X				Barsoum RS, 2002, ARTIF ORGANS, V26, P737, DOI 10.1046/j.1525-1594.2002.07061.x; BARSOUM RS, 2005, KIDNEY DIS DEV WORLD, P1; International Society of Nephrology, PROGR DET MAN CHRON; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	4	312	336	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2006	354	10					997	999		10.1056/NEJMp058318	http://dx.doi.org/10.1056/NEJMp058318			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	019FY	16525136				2022-12-24	WOS:000235822200003
J	Chidambaram, JD; Alemayehu, W; Melese, M; Lakew, T; Yi, E; House, J; Cevallos, V; Zhou, ZX; Maxey, K; Lee, DC; Shapiro, BL; Srinivasan, M; Porco, T; Whitcher, JP; Gaynor, BD; Lietman, TM				Chidambaram, JD; Alemayehu, W; Melese, M; Lakew, T; Yi, E; House, J; Cevallos, V; Zhou, ZX; Maxey, K; Lee, DC; Shapiro, BL; Srinivasan, M; Porco, T; Whitcher, JP; Gaynor, BD; Lietman, TM			Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHLAMYDIA-TRACHOMATIS; DOSE AZITHROMYCIN; COMMUNITY; DISEASE; AREAS	Context The World Health Organization recommends mass antibiotic distributions in its strategy to eliminate blinding trachoma as a public health concern. Some hypothesize that a single distribution is sufficient to control the ocular strains of chlamydia that cause trachoma. Others believe infection will inevitably return and periodic treatments or other measures are essential. Objective To determine whether ocular chlamydial infection returns to the community up to 24 months after a single mass antibiotic distribution in a hyperendemic region of Ethiopia. Design, Setting, and Participants Longitudinal cohort study conducted March 2003 to March 2005 in the Gurage Zone of Ethiopia. Eight randomly selected villages were assessed for ocular chlamydial infection. Fifteen untreated villages were randomly chosen at 12 months to allow assessment of a secular trend. Intervention A single dose of oral azithromycin was offered to all residents of the 8 selected villages who were aged 1 year or older. Main Outcome Measure Prevalence of ocular chlamydial infection in all children aged 1 to 5 years from each intervention village prior to treatment and 2, 6, 12, 18, and 24 months after mass antibiotic treatment, and also in untreated villages enrolled at 12 months. Results Five hundred fifteen children were examined for ocular chlamydial infection at baseline. For the follow-up examinations, the mean participation rate was 83%. The mean prevalence of infection in children aged 1 to 5 years decreased from 43.5% (95% confidence interval [CI], 35.0%-52.0%) to 5.1% ( 95% CI, 1.1%-9.2%) after treatment. On average, infection returned gradually over 24 months to 11.3% ( 95% CI, 4.5%-18.1%; P = .001). In 7 of 8 villages, infection was higher at 24 months than at 2 months. In the remaining village, no infection could be identified at any point after treatment. Villages enrolled at 12 months had significantly fewer infections than those enrolled 12 months earlier, suggesting a secular trend ( P < .001). Conclusions Ocular chlamydial infection was not eliminated in children aged 1 to 5 years after a single mass azithromycin distribution; it slowly returned over 24 months, although not to baseline levels. Repeated treatments or other effective measures will be necessary for elimination.	Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Global Hlth, San Francisco, CA 94143 USA; Orbis Int, Addis Ababa, Ethiopia; Aravind Eye Hosp, Madural, India; Calif Dept Hlth Serv, Berkeley, CA 94704 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; California Department of Health Care Services	Lietman, TM (corresponding author), Univ Calif San Francisco, Francis I Proctor Fdn, Box 0412,513 Parnassus Ave,Med Sci S309, San Francisco, CA 94143 USA.	tom.lietman@ucsf.edu		Chidambaram, Jaya/0000-0001-5438-2858	NATIONAL EYE INSTITUTE [U10EY016214] Funding Source: NIH RePORTER; NEI NIH HHS [U10-EY016214] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bird M, 2003, J INFECT DIS, V187, P1669, DOI 10.1086/374743; Burton MJ, 2005, LANCET, V365, P1321, DOI 10.1016/S0140-6736(05)61029-X; Chidambaram JD, 2005, LANCET INFECT DIS, V5, P194, DOI 10.1016/S1473-3099(05)70032-3; Chidambaram JD, 2004, EMERG INFECT DIS, V10, P1895; Diamant J, 2001, Ophthalmic Epidemiol, V8, P109, DOI 10.1076/opep.8.2.109.4156; Dolin PJ, 1997, LANCET, V349, P1511, DOI 10.1016/S0140-6736(97)01355-X; Gaynor BD, 2003, EMERG INFECT DIS, V9, P596, DOI 10.3201/eid0905.020577; Gaynor Bruce D., 2002, International Ophthalmology Clinics, V42, P85; Hoechsmann A, 2001, Ophthalmic Epidemiol, V8, P145, DOI 10.1076/opep.8.2.145.4169; Jha H, 2002, CLIN INFECT DIS, V35, P765, DOI 10.1086/342298; Lietman T, 1999, NAT MED, V5, P572, DOI 10.1038/8451; Lietman TM, 2005, NEW ENGL J MED, V352, P414; Mariotti SP, 2004, NEW ENGL J MED, V351, P2004, DOI 10.1056/NEJMe048205; Melese M, 2004, JAMA-J AM MED ASSOC, V292, P721, DOI 10.1001/jama.292.6.721; Peeling RW, 1998, SEX TRANSM INFECT, V74, P66, DOI 10.1136/sti.74.1.66; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; Solomon AW, 2005, NEW ENGL J MED, V352, P414; Solomon AW, 2004, NEW ENGL J MED, V351, P1962, DOI 10.1056/NEJMoa040979; VERRENGIA JB, ANTIBIOTIC DOSE MAY; Wang SA, 2005, J INFECT DIS, V191, P917, DOI 10.1086/428290; West ES, 2005, INVEST OPHTH VIS SCI, V46, P83, DOI 10.1167/iovs.04-0327; WHO, 2004, WHOPBDGET042; Zhang JZ, 2004, PEDIATR INFECT DIS J, V23, P217, DOI 10.1097/01.inf.0000115501.60397.a6	24	101	101	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2006	295	10					1142	1146		10.1001/jama.295.10.1142	http://dx.doi.org/10.1001/jama.295.10.1142			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	019GB	16522834	Bronze, Green Accepted			2022-12-24	WOS:000235822500022
J	Watts, G				Watts, G			CO2 and trees: that sinking feeling	LANCET			English	Editorial Material											Watts, G (corresponding author), 28 New End Sq, London NW3 1LS, England.	geoff@scileg.freeserve.co.uk						Betts RA, 2000, NATURE, V408, P187, DOI 10.1038/35041545; *CLIM CAR, 2005, STAMP OUT GLOB WARM; Keppler F, 2006, NATURE, V439, P187, DOI 10.1038/nature04420; Korner C, 2005, SCIENCE, V309, P1360, DOI 10.1126/science.1113977	4	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2006	367	9512					715	716		10.1016/S0140-6736(06)68282-2	http://dx.doi.org/10.1016/S0140-6736(06)68282-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	020JX	16517259				2022-12-24	WOS:000235906000009
J	Glickman, SW; Rasiel, EB; Hamilton, CD; Kubataev, A; Schulman, KA				Glickman, SW; Rasiel, EB; Hamilton, CD; Kubataev, A; Schulman, KA			A portfolio model of drug development for tuberculosis	SCIENCE			English	Editorial Material									Duke Univ, Fuqua Sch Business, Hlth Sector Management Program, Durham, NC 27708 USA; Duke Univ, Dept Econ, Durham, NC 27708 USA; Duke Univ, Sch Med, Dept Med, Div Gen Internal Med, Durham, NC 27710 USA; Amer Int Hlth Alliance, Moscow 125047, Russia; Duke Univ, Med Ctr, Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA	Duke University; Duke University; Duke University; Duke University	Schulman, KA (corresponding author), Duke Univ, Fuqua Sch Business, Hlth Sector Management Program, Durham, NC 27708 USA.	kevin.schulman@duke.edu						Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Das P, 2002, LANCET INFECT DIS, V2, P54, DOI 10.1016/S1473-3099(01)00174-8; *MAN ASS INT FED P, 2004, RES DEV NEGL DIS LES; PhRMA (Pharmaceutical Research and Manufacturers of America), 2001, PHARM IND PROF 2001; Seaworth BJ, 2002, INFECT DIS CLIN N AM, V16, P73, DOI 10.1016/S0891-5520(03)00047-3; Sharpe P, 1998, HARVARD BUS REV, V76, P45; Slutsky AS, 2004, CAN MED ASSOC J, V171, P1203, DOI 10.1503/cmaj.1041634; Stonebraker JS, 2002, INTERFACES, V32, P77, DOI 10.1287/inte.32.6.77.6475; *STOP TB PARTN WOR, STRAT PLAN PREP GLOB; Tiggemann RF, 1998, DRUG INF J, V32, P813, DOI 10.1177/009286159803200321; *WHO, 2005, 104 WHO; WIDDUS R, 2004, COMB DIS ASS POV FIN; Zumla A, 2001, Lancet Infect Dis, V1, P199, DOI 10.1016/S1473-3099(01)00096-2	13	31	32	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2006	311	5765					1246	1247		10.1126/science.1119299	http://dx.doi.org/10.1126/science.1119299			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019XB	16513969				2022-12-24	WOS:000235870400026
J	Wu, ZH; Shi, YL; Tibbetts, RS; Miyamoto, S				Wu, ZH; Shi, YL; Tibbetts, RS; Miyamoto, S			Molecular linkage between the kinase ATM and NF-kappa B signaling in response to genotoxic stimuli (Publication with Expression of Concern. See vol. 371, pg. 1002, 2021)	SCIENCE			English	Article; Publication with Expression of Concern							ACTIVATION; UBIQUITIN; PROTEIN; PATHWAY	The transcription factor NF-kappa B modulates apoptotic responses induced by genotoxic stress. We show that NF-kappa B essential modulator (NEMO), the regulatory subunit of I kappa B kinase (IKK) (which phosphorylates the NF-kappa B inhibitor I kappa B), associates with activated ataxia telangiectasia mutated (ATM) after the induction of DNA double-strand breaks. ATM phosphorylates serine-85 of NEMO to promote its ubiquitin-dependent nuclear export. ATM is also exported in a NEMO-dependent manner to the cytoplasm, where it associates with and causes the activation of IKK in a manner dependent on another IKK regulator, a protein rich in glutamate, leucine, lysine, and serine (ELKS). Thus, regulated nuclear shuttling of NEMO links two signaling kinases, ATM and IKK, to activate NF-kappa B by genotoxic signals.	Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Miyamoto, S (corresponding author), Univ Wisconsin, Dept Pharmacol, 301 SMI,1300 Univ Ave, Madison, WI 53706 USA.	smiyamot@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297	NATIONAL CANCER INSTITUTE [R01CA081065, R01CA077474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067868] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA77474, R01-CA81065] Funding Source: Medline; NIGMS NIH HHS [R01-GM067868] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Criswell T, 2003, ONCOGENE, V22, P5813, DOI 10.1038/sj.onc.1206680; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Hur GM, 2003, GENE DEV, V17, P873, DOI 10.1101/gad.1062403; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Panta GR, 2004, MOL CELL BIOL, V24, P1823, DOI 10.1128/MCB.24.5.1823-1835.2004; Piret B, 1999, ONCOGENE, V18, P2261, DOI 10.1038/sj.onc.1202541; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Yang DQ, 2000, NAT CELL BIOL, V2, P893, DOI 10.1038/35046542	22	408	425	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2006	311	5764					1141	1146		10.1126/science.1121513	http://dx.doi.org/10.1126/science.1121513			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017IU	16497931				2022-12-24	WOS:000235688100046
J	Samuelson, MH				Samuelson, MH			Breast cancer: not for women only	LANCET			English	Editorial Material											Samuelson, MH (corresponding author), 18 Overlook Dr, N Kingstown, RI 02852 USA.	michael@michael-samuelson.com							0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 18	2006	367	9510					605	605		10.1016/S0140-6736(06)68227-5	http://dx.doi.org/10.1016/S0140-6736(06)68227-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	013GM	16488804				2022-12-24	WOS:000235397800035
J	Vandermeer, J; Perfecto, I				Vandermeer, J; Perfecto, I			A keystone mutualism drives pattern in a power function	SCIENCE			English	Article							DISTURBANCE; SIGNATURES; DYNAMICS	Data that can be described by a power function are ubiquitous in nature. Although there is consensus that such data frequently emerge generally from nonlinear complex systems, a variety of specific mechanisms may be responsible for creating the pattern in particular cases. Here, we report on the distribution of a scale insect (Coccus viridis) that is a common agricultural pest. Its distribution in an organic coffee farm in southern Mexico generally follows a power function, but there are subtle deviations from that function. We offer a biological explanation for both adherence to the power functions and associated deviations, along with supporting evidence.	Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Vandermeer, J (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	jvander@umich.edu						Bak P., 2013, NATURE WORKS SCI SEL; BESS HENRY A., 1958, PROC HAWAIIAN ENT SOC, V16, P349; Guichard F, 2003, AM NAT, V161, P889, DOI 10.1086/375300; Holldobler B., 1990, pi; Levin S. A., 1997, SPATIAL ECOLOGY ROLE, P271; Pascual M, 2005, TRENDS ECOL EVOL, V20, P88, DOI 10.1016/j.tree.2004.11.012; Pascual M, 2002, PHILOS T ROY SOC B, V357, P657, DOI 10.1098/rstb.2001.0983; Pascual M, 2001, ECOLOGY, V82, P2357, DOI 10.1890/0012-9658(2001)082[2357:ODASST]2.0.CO;2; Philpott SM, 2004, OIKOS, V105, P141, DOI 10.1111/j.0030-1299.2004.12889.x; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Schroeder M, 1991, FRACTALS CHAOS POWER; Smith M. R., 1942, JOUR AGRIC UNIV PUERTO RICO, V26, P21; STERN VM, 1973, ANNU REV ENTOMOL, V18, P259, DOI 10.1146/annurev.en.18.010173.001355; VANDERMEER JR, UNPUB; YOUNG GR, 1982, TROP PEST MANAGE, V28, P107, DOI 10.1080/09670878209370686	15	44	45	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2006	311	5763					1000	1002		10.1126/science.1121432	http://dx.doi.org/10.1126/science.1121432			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014CS	16484494				2022-12-24	WOS:000235456900045
J	Kaiser, R				Kaiser, R			Flowers and fungi use scents to mimic each other	SCIENCE			English	Editorial Material							FLORAL MIMICRY; PLANT	Some flowering plants mimic the scent and appearance of mushroom fruiting bodies. Fungi' may also mimic flowers. in addition, infection of plants by certain fungi can direct the plant to develop nonfunctional floral-like structures that nonetheless primarily serve the reproductive advantage of the fungus. These various mimicries may serve to attract insects that in turn spread fungal spores or plant pollen, thus facilitating sexual reproduction of the cryptic organism.	Gicaudan Schweiz AG, Fragrance Res, CH-8600 Dubendorf, Switzerland		Kaiser, R (corresponding author), Gicaudan Schweiz AG, Fragrance Res, Ueberlandstr 138, CH-8600 Dubendorf, Switzerland.	roman.kaiser@givaudan.com						CONNICK WJ, 1991, J AGR FOOD CHEM, V39, P185, DOI 10.1021/jf00001a037; ENDRESS PK, 1994, DIVERSITY EVOLUTIONA, P127; FUNGANTI C, 1993, BIOORG MED CHEM LETT, V3, P2777; GAUMANN E, 1959, BEITR KRYPTOGAMENFL, V12, P355; Kaiser R, 2004, CHEM BIODIVERS, V1, P13, DOI 10.1002/cbdv.200490005; KAISER R, 1993, SCENT ORCHIDS, P31; Naef A, 2002, NEW PHYTOL, V154, P717, DOI 10.1046/j.1469-8137.2002.00406.x; Neinhuis C., 1994, PALMENGARTEN, V58, P15; Pfunder M, 2000, AM J BOT, V87, P48, DOI 10.2307/2656684; Raguso RA, 1998, MOL ECOL, V7, P1127, DOI 10.1046/j.1365-294x.1998.00426.x; ROY BA, 1993, NATURE, V362, P56, DOI 10.1038/362056a0; Roy BA, 1997, OECOLOGIA, V109, P414, DOI 10.1007/s004420050101; VOGEL S, 1978, FLORA, V167, P329	13	63	68	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 10	2006	311	5762					806	807		10.1126/science.1119499	http://dx.doi.org/10.1126/science.1119499			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012XT	16469916				2022-12-24	WOS:000235374900035
J	Yildiz, A				Yildiz, A			GE prizewinner - How molecular motors move	SCIENCE			English	Editorial Material							HAND-OVER-HAND; MYOSIN-V		Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94107 USA	University of California System; University of California San Francisco	Yildiz, A (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94107 USA.	yildiz@cmp.ucsf.edu	Yildiz, Ahmet/E-6167-2015	Yildiz, Ahmet/0000-0003-4792-174X				Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Kubitscheck U, 2000, BIOPHYS J, V78, P2170, DOI 10.1016/S0006-3495(00)76764-6; Spudich JA, 2001, NAT REV MOL CELL BIO, V2, P387, DOI 10.1038/35073086; Tanaka H, 2002, NATURE, V415, P192, DOI 10.1038/415192a; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2004, J BIOL CHEM, V279, P37223, DOI 10.1074/jbc.C400252200; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	7	8	8	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 10	2006	311	5762					792	793		10.1126/science.1125068	http://dx.doi.org/10.1126/science.1125068			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012XT	16469911				2022-12-24	WOS:000235374900031
J	Gillies, J; Sheehan, M				Gillies, J; Sheehan, M			Commentary: When should patients be held responsible for their lifestyle choices?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Selkirk Hlth Ctr, Selkirk TD7 4LQ, Scotland; Univ Keele, Ctr Profess Eth, Keele ST5 5BG, Staffs, England	Keele University	Gillies, J (corresponding author), Selkirk Hlth Ctr, Selkirk TD7 4LQ, Scotland.	john.gillies@selkirkhc.borders.scot.nhs.uk		Sheehan, Mark/0000-0002-7191-901X				Barendregt JJ, 1997, NEW ENGL J MED, V337, P1052, DOI 10.1056/NEJM199710093371506; BEAUCHAMP T, 2001, PRINCIPLES MED ETHIC, P247; McPherson S, 2006, BRIT MED J, V332, P276, DOI 10.1136/bmj.332.7536.276; RUSSELL LB, 1989, SCIENCE, V246, P892, DOI 10.1126/science.2510299; Wilkinson Stephen, 1999, J Appl Philos, V16, P255, DOI 10.1111/1468-5930.00128	5	2	2	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 4	2006	332	7536					279	279		10.1136/bmj.332.7536.279	http://dx.doi.org/10.1136/bmj.332.7536.279			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011HN	16455727	Green Published			2022-12-24	WOS:000235259000022
J	Shao, ZJ; Li, W; Ren, J; Liang, XF; Xu, L; Diao, BW; Li, MC; Lu, MJ; Ren, HY; Cui, ZG; Zhu, BQ; Dai, ZW; Zhang, L; Chen, X; Kan, B; Xu, JG				Shao, ZJ; Li, W; Ren, J; Liang, XF; Xu, L; Diao, BW; Li, MC; Lu, MJ; Ren, HY; Cui, ZG; Zhu, BQ; Dai, ZW; Zhang, L; Chen, X; Kan, B; Xu, JG			Identification of a new Neisseria meningitidis serogroup C clone from Anhui province, China	LANCET			English	Article							FIELD GEL-ELECTROPHORESIS; MENINGOCOCCAL DISEASE; SUBGROUP-III; GENOTYPES; VARIANTS; PATTERNS; PROTEIN	Background Outbreaks of a new serogroup C meningococcal disease emerged during 2003-04 (five outbreaks with 43 cases) and in 2004-05 (five outbreaks with 29 cases), all in Anhui province, China. We describe the molecular epidemiology and features of the causative bacterial strains. Methods We used pulsed-field gel electrophoresis (PFGE) and multi-locus sequence typing (MLST) to analyse the strains. Findings Of 34 strains of Neisseria meningitidis cultured during 2003-04 from Anhui province, 31 were group C meningococci, 28 of which were associated with three of five outbreaks; one from a patient and 27 from close contacts of eight patients. Of 30 strains isolated from Anhui province during 2004-05, 17 were identified as serogroup C meningococci, ten of which were associated with four of five outbreaks. In a nationwide survey, 542 strains were isolated during 2004-05; 58 were serogroup C meningococci interspersed among 11 other provinces where no serogroup C outbreak occurred. Of the 106 serogroup C strains analysed, 89 had identical PFGE patterns, designated AH1. Of 28 strains selected for MLST analyses, 25 were sequence type 4821 (ST-4821), which did not belong to any of the previously reported sequence types that can form a new hypervirulent lineage. Interpretation ST-4821 seems to be unique and caused the serogroup C meningitis outbreaks during the two seasons from 2003 to 2005 in Anhui province. The emergence of this sequence type has epidemiological importance that should be monitored for future spread in China and the rest of the world.	Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Communicable Dis Control & Prevent, Beijing 102206, Peoples R China; Chinese Ctr Dis Control & Prevent China CDC, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China; Chinese Ctr Dis Control & Prevent China CDC, Natl Immunizat Program Ctr, Beijing 102206, Peoples R China; China Anhui Prov Ctr Dis Control & Prevent, Hefei, Anhui, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention	Xu, JG (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Communicable Dis Control & Prevent, POB 5, Beijing 102206, Peoples R China.	xujg@public.bta.net.cn			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ACHTMAN M, 1992, J INFECT DIS, V165, P53, DOI 10.1093/infdis/165.1.53; Achtman M, 1995, MENINGOCOCCAL DIS, P159; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gautom RK, 1997, J CLIN MICROBIOL, V35, P2977, DOI 10.1128/JCM.35.11.2977-2980.1997; HU XJ, 1991, NEISSERIAE 1990, P165; Hu XJ, 1991, J CHIN EPIDEMIOL, V12, P136; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; MOORE PS, 1988, JAMA-J AM MED ASSOC, V260, P2686, DOI 10.1001/jama.260.18.2686; *NAT COMM CLIN LAB, 2003, M7A6 NAT COMM CLIN L; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Popovic T, 2001, J CLIN MICROBIOL, V39, P75, DOI 10.1128/JCM.39.1.75-85.2001; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Sacchi CT, 1998, CLIN DIAGN LAB IMMUN, V5, P845, DOI 10.1128/CDLI.5.6.845-855.1998; Takahashi H, 2004, J MED MICROBIOL, V53, P657, DOI 10.1099/jmm.0.45541-0; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Urwin R, 2004, INFECT IMMUN, V72, P5955, DOI 10.1128/IAI.72.10.5955-5962.2004; WANG JF, 1992, INFECT IMMUN, V60, P5267, DOI 10.1128/IAI.60.12.5267-5282.1992; ZHU PX, 1995, J CLIN MICROBIOL, V33, P458, DOI 10.1128/JCM.33.2.458-462.1995; Zhu PX, 2001, P NATL ACAD SCI USA, V98, P5234, DOI 10.1073/pnas.061386098	21	81	122	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2006	367	9508					419	423		10.1016/S0140-6736(06)68141-5	http://dx.doi.org/10.1016/S0140-6736(06)68141-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	009UR	16458767				2022-12-24	WOS:000235139400032
J	Girguis, PR; Lee, RW				Girguis, PR; Lee, RW			Thermal preference and tolerance of alvinellids	SCIENCE			English	Article							POMPEII WORMS; TEMPERATURE		Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	Harvard University; Washington State University	Girguis, PR (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	pgirguis@oeb.harvard.edu; rlee@mail.wsu.edu		Girguis, Peter/0000-0002-3599-8160				Cary SC, 1998, NATURE, V391, P545, DOI 10.1038/35286; Chevaldonne P, 2000, MAR ECOL PROG SER, V208, P293, DOI 10.3354/meps208293; COONEY D, 1964, THERMOPHILIC FUNGI, P63; HOCHACHKA P, 2002, BIOCH ADAPTATION MEC, P363; JOHNSON KS, 1988, DEEP-SEA RES, V35, P1711, DOI 10.1016/0198-0149(88)90045-3; Le Bris N, 2005, DEEP-SEA RES PT I, V52, P1071, DOI 10.1016/j.dsr.2005.01.003; Sarrazin J, 2002, CAH BIOL MAR, V43, P275; Shillito B, 2004, HIGH PRESSURE RES, V24, P169, DOI 10.1080/08957950310001635774; WEHNER R, 1992, NATURE, V357, P586, DOI 10.1038/357586a0; WICKSTROM CE, 1973, SCIENCE, V181, P1063, DOI 10.1126/science.181.4104.1063	10	65	66	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					231	231		10.1126/science.1125286	http://dx.doi.org/10.1126/science.1125286			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614212				2022-12-24	WOS:000236765300038
J	Parson, A				Parson, A			The long journey from stem cells to medical product	CELL			English	Editorial Material								There is much interest in developing stem cells and the cells derived from them as therapies for treating human disease and injury, but many biological, technological and regulatory hurdles have to be overcome before these cell therapies can be brought to commercial fruition.											0	23	23	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 7	2006	125	1					9	11		10.1016/j.cell.2006.03.024	http://dx.doi.org/10.1016/j.cell.2006.03.024			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615881	Bronze			2022-12-24	WOS:000237314200005
J	Suzuki, N; Suzuki, S; Millar, DG; Unno, M; Hara, H; Calzascia, T; Yamasaki, S; Yokosuka, T; Chen, NJ; Elford, AR; Suzuki, J; Takeuchi, A; Mirtsos, C; Bouchard, D; Ohashi, PS; Yeh, WC; Saito, T				Suzuki, N; Suzuki, S; Millar, DG; Unno, M; Hara, H; Calzascia, T; Yamasaki, S; Yokosuka, T; Chen, NJ; Elford, AR; Suzuki, J; Takeuchi, A; Mirtsos, C; Bouchard, D; Ohashi, PS; Yeh, WC; Saito, T			A critical role for the innate immune signaling molecule IRAK-4 in T cell activation	SCIENCE			English	Article							ANTIGEN RECEPTOR; MECHANISM; KINASE; MALT1; BCL10; MICE	IRAK-4 is a protein kinase that is pivotal in mediating signals for innate immune responses. Here, we report that IRAK-4 signaling is also essential for eliciting adaptive immune responses. Thus, in the absence of IRAK-4, in vivo T cell responses were significantly impaired. Upon T cell receptor stimulation, IRAK-4 is recruited to T cell lipid rafts, where it induces downstream signals, including protein kinase C theta activation through the association with Zap70. This signaling pathway was found to be required for optimal activation of nuclear factor kappa B. Our findings suggest that T cells use this critical regulator of innate immunity for the development of acquired immunity, suggesting that IRAK-4 may be involved in direct signal cross talk between the two systems.	RIKEN Res Ctr Allergy & Immunol, Lab Cell Signaling, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Univ Hlth Network, Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada; Univ Hlth Network, Adv Med Discovery Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Chiba Univ, Grad Sch Med, Dept Mol Genet, Chuo Ku, Chiba 2608670, Japan	RIKEN; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Chiba University	Yeh, WC (corresponding author), Amgen San Francisco, 1120 Vet Blvd, San Francisco, CA 94080 USA.	wyeh@uhnres.utoronto.ca; saito@rcai.riken.jp	Saito, Takashi/C-9684-2009	Saito, Takashi/0000-0001-9495-3547; Ohashi, Pamela S./0000-0003-2915-9317; Millar, Douglas/0000-0002-8640-7148; Takeuchi, Arata/0000-0003-0412-533X; Calzascia, Thomas/0000-0001-8225-6744				Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Habiro K, 2003, TRANSPLANTATION, V76, P854, DOI 10.1097/01.TP.0000084868.09385.83; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Ohta A, 1997, J IMMUNOL METHODS, V209, P85, DOI 10.1016/S0022-1759(97)00152-X; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Suzuki N, 2003, J IMMUNOL, V171, P6065, DOI 10.4049/jimmunol.171.11.6065; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	16	88	99	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2006	311	5769					1927	1932		10.1126/science.1124256	http://dx.doi.org/10.1126/science.1124256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16574867				2022-12-24	WOS:000236387800046
J	Park-Wyllie, LY; Juurlink, DN; Kopp, A; Shah, BR; Stukel, TA; Stumpo, C; Dresser, L; Low, DE; Mamdani, MM				Park-Wyllie, LY; Juurlink, DN; Kopp, A; Shah, BR; Stukel, TA; Stumpo, C; Dresser, L; Low, DE; Mamdani, MM			Outpatient gatifloxacin therapy and dysglycemia in older adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DRUG-INDUCED DISORDERS; SOCIOECONOMIC-STATUS; COMORBIDITY ADJUSTMENT; GLUCOSE-HOMEOSTASIS; ELDERLY-PATIENTS; HYPOGLYCEMIA; PERFORMANCE; SCORES; CIPROFLOXACIN; HYPERGLYCEMIA	BACKGROUND: Gatifloxacin has been associated with both hypoglycemia and hyperglycemia. We examined dysglycemia-related health outcomes associated with various antibiotics in a population of approximately 1.4 million Ontario, Canada, residents 66 years of age or older. METHODS: We conducted two population-based, nested case-control studies. In the first, case patients were persons treated in the hospital for hypoglycemia after outpatient treatment with a macrolide, a second-generation cephalosporin, or a respiratory fluoroquinolone (gatifloxacin, levofloxacin, moxifloxacin, or ciprofloxacin). In the second, case patients were persons who received hospital care for hyperglycemia. For each case patient, we identified up to five controls matched according to age, sex, the presence or absence of diabetes, and the timing of antibiotic therapy. RESULTS: Between April 2002 and March 2004, we identified 788 patients treated for hypoglycemia within 30 days after antibiotic therapy. As compared with macrolide antibiotics, gatifloxacin was associated with an increased risk of hypoglycemia (adjusted odds ratio, 4.3; 95 percent confidence interval, 2.9 to 6.3). Levofloxacin was also associated with a slightly increased risk (adjusted odds ratio, 1.5; 95 percent confidence interval, 1.2 to 2.0), but no such risk was seen with moxifloxacin, ciprofloxacin, or cephalosporins. We then identified 470 patients treated for hyperglycemia within 30 days after antibiotic therapy. As compared with macrolides, gatifloxacin was associated with a considerably increased risk of hyperglycemia (adjusted odds ratio, 16.7; 95 percent confidence interval, 10.4 to 26.8), but no risk was noted with the other antibiotics. Risks were similar in the two studies regardless of the presence or absence of diabetes. CONCLUSIONS: As compared with the use of other broad-spectrum oral antibiotics, including other fluoroquinolones, the use of gatifloxacin among outpatients is associated with an increased risk of in-hospital treatment for both hypoglycemia and hyperglycemia.	Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada; Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Univ Toronto, St Michaels Hosp, Dept Family & Community Med, Ctr Res Inner City Hlth, Toronto, ON M4N 3M5, Canada; Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Clin Epidemiol Unit, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Pediat, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Pharm, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Microbiol, Toronto, ON M4N 3M5, Canada; Toronto E Gen & Orthoped Hosp, Dept Pharm, Toronto, ON, Canada; Mt Sinai Hosp, Dept Pharm, Toronto, ON M5G 1X5, Canada; Mt Sinai Hosp, Univ Hlth Network, Dept Microbiol, Toronto, ON M5G 1X5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University Health Network Toronto	Juurlink, DN (corresponding author), Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Med, 2075 Bayview Ave,G Wng 106, Toronto, ON M4N 3M5, Canada.	dnj@ices.on.ca	Low, Donald/B-1726-2012	Stukel, Therese/0000-0002-2951-1360				Alter DA, 2004, JAMA-J AM MED ASSOC, V291, P1100, DOI 10.1001/jama.291.9.1100; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Alter DA, 2002, MED CARE, V40, P60, DOI 10.1097/00005650-200201000-00008; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Ambrose PG, 2003, J ANTIMICROB CHEMOTH, V52, P435, DOI 10.1093/jac/dkg370; Arce Francis Clifford A, 2004, Endocr Pract, V10, P40; ASSAN R, 1993, DIABETES METAB, V19, P262; Baker SE, 2002, ANN PHARMACOTHER, V36, P1722; Ball P, 2000, INT J ANTIMICROB AG, V16, P263, DOI 10.1016/S0924-8579(00)00254-5; Basaria S, 2005, AM J MED, V118, P706, DOI 10.1016/j.amjmed.2004.11.028; Bhatia Vishal, 2004, Endocr Pract, V10, P86; Biggs WS, 2003, J AM BOARD FAM PRACT, V16, P455, DOI 10.3122/jabfm.16.5.455; Brogan SE, 2005, ANESTH ANALG, V101, P635, DOI 10.1213/01.ANE.0000175305.08998.1B; Canadian Institute for Health Information, 2003, INT STAT CLASS DIS R; Cannon CP, 2005, NEW ENGL J MED, V352, P1646, DOI 10.1056/NEJMoa043528; Chan JCN, 1996, DRUG SAFETY, V15, P135, DOI 10.2165/00002018-199615020-00005; *CTR DRUG EV REV, MED PROD SAF INF; *CTR DRUG EV REV, 2005, 21061 NDA CTR DRUG E; *CTR DRUG EV REV, 2003, QUEST ANSW TROV PUBL; Donaldson AR, 2004, ANN PHARMACOTHER, V38, P602, DOI 10.1345/aph.1D360; *FOOD DRUG ADM, 1998, P9216 FOOD DRUG ADM; *FOOD DRUG ADM, 1999, GLAX WELLC VOL RAX; Frothingham R, 2005, CLIN INFECT DIS, V41, P1269, DOI 10.1086/496929; Frothingham R, 2004, EMERG INFECT DIS, V10, P156, DOI 10.3201/eid1001.030307; FROTHINGHAM R, 2004, 44 INT C ANT AG CHEM, P19; Gajjar DA, 2000, PHARMACOTHERAPY, V20, p76S, DOI 10.1592/phco.20.8.76S.35182; Glazier RH, 2003, CAN J PUBLIC HEALTH, V94, P140, DOI 10.1007/BF03404588; GRASELA D, 1999, 39 INT C ANT AG CHEM, P11; Graumlich JF, 2005, PHARMACOTHERAPY, V25, P1296, DOI 10.1592/phco.2005.25.10.1296; Greenberg AL, 2005, CLIN INFECT DIS, V40, P1210, DOI 10.1086/428847; Happe MR, 2004, ANN INTERN MED, V141, P968, DOI 10.7326/0003-4819-141-12-200412210-00021; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Kahn, 2001, CHEMOTHERAPY, V47, P44; Khovidhunkit W, 2004, ANN INTERN MED, V141, P969, DOI 10.7326/0003-4819-141-12-200412210-00022; LeBlanc M, 2004, PHARMACOTHERAPY, V24, P926, DOI 10.1592/phco.24.9.926.36093; LETOURNEAU G, 2003, CAN ADVERSE REACT NE, V13, P1; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Linder JA, 2005, AM J MED, V118, P259, DOI 10.1016/j.amjmed.2004.09.015; Maeda N, 1996, BRIT J PHARMACOL, V117, P372, DOI 10.1111/j.1476-5381.1996.tb15201.x; Mamdani M, 2004, LANCET, V363, P1751, DOI 10.1016/S0140-6736(04)16299-5; Mamdani MM, 2000, CAN MED ASSOC J, V162, P1421; Menzies DJ, 2002, AM J MED, V113, P232, DOI 10.1016/S0002-9343(02)01158-0; Mohr JF, 2005, PHARMACOTHERAPY, V25, P1303, DOI 10.1592/phco.2005.25.10.1303; PANDIT MK, 1993, ANN INTERN MED, V118, P529, DOI 10.7326/0003-4819-118-7-199304010-00008; Ray JG, 2001, ARCH INTERN MED, V161, P1405, DOI 10.1001/archinte.161.11.1405; Rubinstein E, 2001, CHEMOTHERAPY, V47, P3, DOI 10.1159/000057838; Saraya A, 2004, EUR J PHARMACOL, V497, P111, DOI 10.1016/j.ejphar.2004.06.032; Schneeweiss S, 2000, INT J EPIDEMIOL, V29, P891, DOI 10.1093/ije/29.5.891; Schneeweiss S, 2004, J GEN INTERN MED, V19, P444, DOI 10.1111/j.1525-1497.2004.30109.x; Schneeweiss S, 2003, HEALTH SERV RES, V38, P1103, DOI 10.1111/1475-6773.00165; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; SCHWARZBARD L, 2005, 45 INT C ANT AG CHEM, P463; *STAT CAN, 2005, POP SEX AG GROUP PRO; Tailor S.A.N., 2004, CAN J HOSP PHARM, V57, P12	55	263	272	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2006	354	13					1352	1361		10.1056/NEJMoa055191	http://dx.doi.org/10.1056/NEJMoa055191			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026KO	16510739	Green Published			2022-12-24	WOS:000236338000004
J	Shaw, P; Greenstein, D; Lerch, J; Clasen, L; Lenroot, R; Gogtay, N; Evans, A; Rapoport, J; Giedd, J				Shaw, P; Greenstein, D; Lerch, J; Clasen, L; Lenroot, R; Gogtay, N; Evans, A; Rapoport, J; Giedd, J			Intellectual ability and cortical development in children and adolescents	NATURE			English	Article							FALSE DISCOVERY RATE; GENERAL INTELLIGENCE; CEREBRAL-CORTEX; HUMAN-BRAIN; MRI DATA; THICKNESS; POPULATION; CHILDHOOD; PEOPLE; VOLUME	Children who are adept at any one of the three academic 'R's ( reading, writing and arithmetic) tend to be good at the others, and grow into adults who are similarly skilled at diverse intellectually demanding activities(1-3). Determining the neuroanatomical correlates of this relatively stable individual trait of general intelligence has proved difficult, particularly in the rapidly developing brains of children and adolescents. Here we demonstrate that the trajectory of change in the thickness of the cerebral cortex, rather than cortical thickness itself, is most closely related to level of intelligence. Using a longitudinal design, we find a marked developmental shift from a predominantly negative correlation between intelligence and cortical thickness in early childhood to a positive correlation in late childhood and beyond. Additionally, level of intelligence is associated with the trajectory of cortical development, primarily in frontal regions implicated in the maturation of intelligent activity(4,5). More intelligent children demonstrate a particularly plastic cortex, with an initial accelerated and prolonged phase of cortical increase, which yields to equally vigorous cortical thinning by early adolescence. This study indicates that the neuroanatomical expression of intelligence in children is dynamic.	NIMH, Child Psychiat Branch, Bethesda, MD 20182 USA; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); McGill University	Shaw, P (corresponding author), NIMH, Child Psychiat Branch, Bethesda, MD 20182 USA.	shawp@mail.nih.gov	Staff, Roger T/G-1826-2011; Shaw, Philip/A-1129-2008; Gogtay, Nitin/A-3035-2008; Giedd, Jay N/B-7302-2012; Kennedy, Kristen M/B-4699-2008; Gogtay, Nitin/GRR-1980-2022; Giedd, Jay N./A-3080-2008; Giedd, Jay/J-9644-2015	Staff, Roger T/0000-0003-0620-8673; Shaw, Philip/0000-0002-1313-2526; Giedd, Jay N/0000-0003-0827-3460; Kennedy, Kristen M/0000-0001-5373-9026; Giedd, Jay/0000-0003-2002-8978	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002794, ZIAMH002581, Z01MH002794, Z01MH002581, ZIAMH002240, Z01MH002240] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Booth JR, 2003, NEUROIMAGE, V20, P737, DOI 10.1016/S1053-8119(03)00404-X; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Deary IJ, 2000, INTELLIGENCE, V28, P49, DOI 10.1016/S0160-2896(99)00031-8; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Frangou S, 2004, NEUROIMAGE, V23, P800, DOI 10.1016/j.neuroimage.2004.05.027; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gottfredson LS, 1997, INTELLIGENCE, V24, P79, DOI 10.1016/S0160-2896(97)90014-3; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Kabani N, 2001, NEUROIMAGE, V13, P375, DOI 10.1006/nimg.2000.0652; Kostovic I, 2002, CEREB CORTEX, V12, P536, DOI 10.1093/cercor/12.5.536; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Kraemer HC, 2000, AM J PSYCHIAT, V157, P163, DOI 10.1176/appi.ajp.157.2.163; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; McDaniel MA, 2005, INTELLIGENCE, V33, P337, DOI 10.1016/j.intell.2004.11.005; O'Donnell S, 2005, NEUROIMAGE, V24, P948, DOI 10.1016/j.neuroimage.2004.10.014; Pinheiro Jose, 2000, MIXED EFFECTS MODELS; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Wechsler D., 2003, MANUAL WECHSLER INTE, V4th; Wilke M, 2003, NEUROIMAGE, V20, P202, DOI 10.1016/S1053-8119(03)00199-X; Yakovlev P.I., 1967, REGIONAL DEV BRAIN E; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283	30	1027	1051	15	227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2006	440	7084					676	679		10.1038/nature04513	http://dx.doi.org/10.1038/nature04513			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572172	Green Published			2022-12-24	WOS:000236350400045
J	Su, CY; Luo, DG; Terakita, A; Shichida, Y; Liao, HW; Kazmi, MA; Sakmar, TP; Yau, KW				Su, CY; Luo, DG; Terakita, A; Shichida, Y; Liao, HW; Kazmi, MA; Sakmar, TP; Yau, KW			Parietal-eye phototransduction components and their potential evolutionary implications	SCIENCE			English	Article							G-PROTEIN; CONE PHOTORECEPTORS; ALPHA-GUSTDUCIN; PINEAL; TRANSDUCIN; SUBUNIT; OPSIN; TASTE; EXPRESSION; MASTOPARAN	The parietal-eye photoreceptor is unique because it has two antagonistic light signaling pathways in the same cell - a hyperpolarizing pathway maximally sensitive to blue light and a depolarizing pathway maximally sensitive to green light. Here, we report the molecular components of these two pathways. We found two opsins in the same cell: the blue-sensitive pinopsin and a previously unidentified green-sensitive opsin, which we name parietopsin. Signaling components included gustducin-alpha and G alpha(o), but not rod or cone transducin-alpha. Single-cell recordings demonstrated that G(o) mediates the depolarizing response. Gustducin-alpha resembles transducin-alpha functionally and likely mediates the hyperpolarizing response. The parietopsin-G(o) signaling pair provides clues about how rod and cone phototransduction might have evolved.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; Core Res Evolut Sci & Technol, Kyoto 6068502, Japan; Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	Johns Hopkins University; Kyoto University; Japan Science & Technology Agency (JST); Rockefeller University	Su, CY (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	chih-ying.su@yale.edu; kwyau@mail.jhmi.edu	Luo, Donggen/D-5990-2011; Sakmar, Thomas P/D-1833-2015	Sakmar, Thomas P/0000-0002-2836-8953; Terakita, Akihisa/0000-0002-8379-8913	NEI NIH HHS [R01 EY006837-18, R01 EY014596-01, R01 EY006837-16A1, R01 EY006837-17, R01 EY014596, R01 EY006837-19, R37 EY006837-15S1, R01 EY014596-03, R37 EY006837, R01 EY014596-04, R01 EY014596-02, EY06837, R01 EY006837] Funding Source: Medline; NIDCD NIH HHS [R01 DC006904, R01 DC006904-01, R01 DC006904-02] Funding Source: Medline; NATIONAL EYE INSTITUTE [R37EY006837, R01EY014596, R01EY006837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Blackshaw S, 1997, J NEUROSCI, V17, P8083; EAKIN RM, 1973, 3 EYE; Finn JT, 1997, NATURE, V385, P815, DOI 10.1038/385815a0; Gomez MD, 2000, J NEUROSCI, V20, P5254, DOI 10.1523/JNEUROSCI.20-14-05254.2000; He W, 2000, J BIOL CHEM, V275, P37093, DOI 10.1074/jbc.M006982200; He W, 2002, CHEM SENSES, V27, P719, DOI 10.1093/chemse/27.8.719; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; HOON MA, 1995, BIOCHEM J, V309, P629, DOI 10.1042/bj3090629; Kasahara T, 2000, J NEUROCHEM, V75, P217, DOI 10.1046/j.1471-4159.2000.0750217.x; Kojima D, 1997, J BIOL CHEM, V272, P22979, DOI 10.1074/jbc.272.37.22979; LEE RH, 1992, J BIOL CHEM, V267, P24776; Max M, 1998, J BIOL CHEM, V273, P26820, DOI 10.1074/jbc.273.41.26820; MAX M, 1995, SCIENCE, V267, P1502, DOI 10.1126/science.7878470; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; OKANO T, 1994, NATURE, V372, P94, DOI 10.1038/372094a0; ONG OC, 1995, J BIOL CHEM, V270, P8495, DOI 10.1074/jbc.270.15.8495; Pichaud F, 2002, CURR OPIN GENET DEV, V12, P430, DOI 10.1016/S0959-437X(02)00321-0; PU GA, 1981, J NEUROPHYSIOL, V46, P1018, DOI 10.1152/jn.1981.46.5.1018; SOLESSIO E, 1993, NATURE, V364, P442, DOI 10.1038/364442a0; TAMOTSU S, 1986, J COMP PHYSIOL A, V159, P1, DOI 10.1007/BF00612489; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Terakita A, 2002, J BIOL CHEM, V277, P40, DOI 10.1074/jbc.M104960200; Vardi N, 1998, J COMP NEUROL, V395, P43; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Xiong WH, 1998, NAT NEUROSCI, V1, P359, DOI 10.1038/nn0998_359	28	83	83	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1617	1621		10.1126/science.1123802	http://dx.doi.org/10.1126/science.1123802			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543463				2022-12-24	WOS:000236029500049
J	Steinbrook, R				Steinbrook, R			The potential of human papillomavrius vaccines	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PREVENTION; TYPE-16											Blumenthal PD, 2005, JAMA-J AM MED ASSOC, V294, P2225, DOI 10.1001/jama.294.17.2225; GOODMAN E, 2005, BOSTON GLOBE    1112, pA11; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Schiffman M, 2005, NEW ENGL J MED, V353, P2101, DOI 10.1056/NEJMp058171	5	58	67	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1109	+		10.1056/NEJMp058305	http://dx.doi.org/10.1056/NEJMp058305			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021KI	16540608				2022-12-24	WOS:000235981700001
J	Yin, HM; Kable, SH; Zhang, X; Bowman, JM				Yin, HM; Kable, SH; Zhang, X; Bowman, JM			Signatures of H2CO photodissociation from two electronic states	SCIENCE			English	Article							UNIMOLECULAR DECOMPOSITION; FORMALDEHYDE; THRESHOLD; DYNAMICS; ENERGY	Even in small molecules, the influence of electronic state on rotational and vibrational product energies is not well understood. Here, we use experiments and theory to address this issue in photodissociation of formaldehyde, H2CO, to the radical products H + HCO. These products result from dissociation from the singlet ground electronic state or the first excited triplet state (T-1) of H2CO. Fluorescence spectra reveal a sudden decrease in the HCO rotational energy with increasing photolysis energy accompanied by substantial HCO vibrational excitation. Calculations of the rotational distribution using an ab initio potential energy surface for the T-1 state are in very good agreement with experiment and strongly support dominance of the T-1 state in the dynamics at the higher photolysis energies.	Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; Emory Univ, Dept Chem, Atlanta, GA 30322 USA; Emory Univ, Cherry L Emerson Ctr Sci Computat, Atlanta, GA 30322 USA	University of Sydney; Emory University; Emory University	Kable, SH (corresponding author), Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia.	s.kable@chem.usyd.edu.au; jmbowma@emory.edu		Kable, Scott/0000-0002-0331-6137				Bowman JM, 2006, PHYS CHEM CHEM PHYS, V8, P321, DOI 10.1039/b512847c; CHANG YT, 1992, J CHEM PHYS, V96, P4341, DOI 10.1063/1.462826; CHUANG MC, 1987, J CHEM PHYS, V87, P3855, DOI 10.1063/1.452940; Dulligan MJ, 1997, CHEM PHYS LETT, V276, P84, DOI 10.1016/S0009-2614(97)00815-4; KEMPER MJH, 1981, J CHEM PHYS, V74, P5744, DOI 10.1063/1.440940; LEE SH, 1995, J CHEM PHYS, V103, P104, DOI 10.1063/1.469648; MOORE CB, 1983, ANNU REV PHYS CHEM, V34, P525, DOI 10.1146/annurev.pc.34.100183.002521; Terentis AC, 1996, CHEM PHYS LETT, V258, P626, DOI 10.1016/0009-2614(96)00705-1; Terentis AC, 1998, J CHEM PHYS, V108, P3187, DOI 10.1063/1.475736; Townsend D, 2004, SCIENCE, V306, P1158, DOI 10.1126/science.1104386; Tyndall G.S., 1999, ATMOSPHERIC CHEM GLO; Valachovic LR, 2000, J CHEM PHYS, V112, P2752, DOI 10.1063/1.480849; Yamaguchi Y, 1998, J CHEM PHYS, V108, P5281, DOI 10.1063/1.476315; Yin HM, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1902863; Zhang XB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1872838; Zhang XB, 2004, J PHYS CHEM A, V108, P8980, DOI [10.1021/jp048339l, 10.1021/jp0483391]	16	67	69	0	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2006	311	5766					1443	1446		10.1126/science.1123397	http://dx.doi.org/10.1126/science.1123397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527976				2022-12-24	WOS:000236029400043
J	Dominici, F; Peng, RD; Bell, ML; Pham, L; McDermott, A; Zeger, SL; Samet, JM				Dominici, F; Peng, RD; Bell, ML; Pham, L; McDermott, A; Zeger, SL; Samet, JM			Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TIME-SERIES; DISTRIBUTED LAG; DAILY MORTALITY; US CITIES; RESPONSE RELATIONSHIPS; NATIONAL MORBIDITY; UNITED-STATES; CLAIMS DATA; EXPOSURE; MODELS	Context Evidence on the health risks associated with short-term exposure to fine particles (particulate matter <= 2.5 mu m in aerodynamic diameter [PM2.5]) is limited. Results from the new national monitoring network for PM2.5 make possible systematic research on health risks at national and regional scales. Objectives To estimate risks of cardiovascular and respiratory hospital admissions associated with short-term exposure to PM2.5 for Medicare enrollees and to explore heterogeneity of the variation of risks across regions. Design, Setting, and Participants A national database comprising daily time-series data daily for 1999 through 2002 on hospital admission rates (constructed from the Medicare National Claims History Files) for cardiovascular and respiratory outcomes and injuries, ambient PM2.5 levels, and temperature and dew-point temperature for 204 US urban counties (population >200 000) with 11.5 million Medicare enrollees (aged >65 years) living an average of 5.9 miles from a PM2.5 monitor. Main Outcome Measures Daily counts of county-wide hospital admissions for primary diagnosis of cerebrovascular, peripheral, and ischemic heart diseases, heart rhythm, heart failure, chronic obstructive pulmonary disease, and respiratory infection, and injuries as a control outcome. Results There was a short-term increase in hospital admission rates associated with PM2.5 for all of the health outcomes except injuries. The largest association was for heart failure, which had a 1.28% (95% confidence interval, 0.78%-1.78%) increase in risk per 10-mu g/m(3) increase in same-day PM2.5. Cardiovascular risks tended to be higher in counties located in the Eastern region of the United States, which included the Northeast, the Southeast, the Midwest, and the South. Conclusion Short-term exposure to PM2.5 increases the risk for hospital admission for cardiovascular and respiratory diseases.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yale University	Dominici, F (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, 615 N Wolfe St, Baltimore, MD 21205 USA.	fdominic@jhsph.edu	Bell, Michelle/Y-4608-2018	Bell, Michelle/0000-0002-3965-1359; Zeger, Scott/0000-0001-8907-1603	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003819, R01ES012054] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES012054-03, P30 ES 03819, P30 ES003819, R01 ES012054] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALMON S, 1965, ECONOMETRICA, V33, P178, DOI 10.2307/1911894; [Anonymous], 2005, R LANG ENV STAT COMP; BAICKER K, 2004, HLTH AFF MILLWOOD, V23; Bell ML, 2005, EPIDEMIOLOGY, V16, P436, DOI 10.1097/01.ede.0000165817.40152.85; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Burnett RT, 1997, ENVIRON HEALTH PERSP, V105, P614, DOI 10.2307/3433607; *CLEAN AIR SCI ADV, 2005, REV NAT AMB AIR QUAL; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Dominici F, 2000, J ROY STAT SOC A STA, V163, P263, DOI 10.1111/1467-985X.00170; Dominici F, 2004, J AM STAT ASSOC, V99, P938, DOI 10.1198/016214504000000656; Dominici F, 2002, J AM STAT ASSOC, V97, P100, DOI 10.1198/016214502753479266; DOMINID F, 2003, REVISED ANAL TIME SE; DUMOUCHEL WH, 1983, J AM STAT ASSOC, V78, P293, DOI 10.2307/2288631; Everson PJ, 2000, J ROY STAT SOC B, V62, P399, DOI 10.1111/1467-9868.00239; FISHER ES, 1992, AM J PUBLIC HEALTH, V82, P243, DOI 10.2105/AJPH.82.2.243; Gelman A., 2003, BAYESIAN DATA ANAL; Hartigan J. A., 1975, CLUSTERING ALGORITHM; Havranek EP, 2004, ARCH INTERN MED, V164, P1186, DOI 10.1001/archinte.164.11.1186; Ito K, 2005, EPIDEMIOLOGY, V16, P446, DOI 10.1097/01.ede.0000165821.90114.7f; Kelsall JE, 1997, AM J EPIDEMIOL, V146, P750; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Kunzli N, 2005, ENVIRON HEALTH PERSP, V113, P201, DOI 10.1289/ehp.7523; Le Tertre A, 2002, J EPIDEMIOL COMMUN H, V56, P773, DOI 10.1136/jech.56.10.773; LINDLEY DV, 1972, J ROY STAT SOC B, V34, P1; Lippmann M, 2000, Res Rep Health Eff Inst, P5; Losina E, 2003, J CLIN EPIDEMIOL, V56, P515, DOI 10.1016/S0895-4356(03)00056-8; MacQueen J., 1967, P BERK S MATH STAT P; MCCULLAGH P., 1991, GEN LINEAR MODELS; Moolgavkar SH, 2000, ENVIRON HEALTH PERSP, V108, P777, DOI 10.2307/3434732; Moolgavkar SH, 2000, INHAL TOXICOL, V12, P75, DOI 10.1080/089583700750019512; *NAT RES COUNC COM, 2004, RES PRIOR AIRB PART, V4; National Center for Environmental Assessment, 2004, AIR QUAL CRIT PART M; *OFF AIR QUAL PLAN, 2000, QUAL ASS PROJ PLAN P; Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; Peng RD, 2005, AM J EPIDEMIOL, V161, P585, DOI 10.1093/aje/kwi075; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Samoli E, 2005, ENVIRON HEALTH PERSP, V113, P88, DOI 10.1289/ehp.7387; Schwartz J, 2000, EPIDEMIOLOGY, V11, P320, DOI 10.1097/00001648-200005000-00016; Sheppard L, 1999, EPIDEMIOLOGY, V10, P23, DOI 10.1097/00001648-199901000-00006; SHEPPARD L, 2003, REVISED ANAL TIME SE, P227; Stieb DM, 2003, J AIR WASTE MANAGE, V53, P258, DOI 10.1080/10473289.2003.10466149; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Touloumi G, 1997, AM J EPIDEMIOL, V146, P177, DOI 10.1093/oxfordjournals.aje.a009249; Touloumi G, 2005, EPIDEMIOLOGY, V16, P49, DOI 10.1097/01.ede.0000142152.62400.13; *US EPA, 1997, FED REGISTER, V62, P138; *US EPA OFF RES DE, 1996, AIR QUAL CRIT PART M; Welty LJ, 2005, AM J EPIDEMIOL, V162, P80, DOI 10.1093/aje/kwi157; *WHO, 1977, INT CLASSIFICATION D, V9; Zanobetti A, 2000, Biostatistics, V1, P279, DOI 10.1093/biostatistics/1.3.279	52	1809	1908	11	630	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2006	295	10					1127	1134		10.1001/jama.295.10.1127	http://dx.doi.org/10.1001/jama.295.10.1127			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	019GB	16522832	Bronze, Green Accepted			2022-12-24	WOS:000235822500020
J	Melis, AP; Hare, B; Tomasello, M				Melis, AP; Hare, B; Tomasello, M			Chimpanzees recruit the best collaborators	SCIENCE			English	Article							RECIPROCAL ALTRUISM; EVOLUTION; MONKEYS; COOPERATION; LABOR; RANK	Humans collaborate with non-kin in special ways, but the evolutionary foundations of these collaborative skills remain unclear. We presented chimpanzees with collaboration problems in which they had to decide when to recruit a partner and which potential partner to recruit. In an initial study, individuals recruited a collaborator only when solving the problem required collaboration. In a second study, individuals recruited the more effective of two partners on the basis of their experience with each of them on a previous day. Therefore, recognizing when collaboration is necessary and determining who is the best collaborative partner are skills shared by both chimpanzees and humans, so such skills may have been present in their common ancestor before humans evolved their own complex forms of collaboration.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	Max Planck Society	Melis, AP (corresponding author), Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany.	melis@eva.mpg.de; hare@eva.mpg.de	Galantucci, Bruno/E-5770-2010					Boesch C, 2000, CHIMPANZEES TAI FORE; CHALMEAU R, 1994, PRIMATES, V35, P385, DOI 10.1007/BF02382735; Crawford M.P., 1937, COMP PSYCHOL MONOGR, V14, P1; de Waal FBM, 2000, NATURE, V404, P563, DOI 10.1038/35007138; DEWAAL FBM, 1988, ETHOL SOCIOBIOL, V9, P101, DOI 10.1016/0162-3095(88)90016-7; Engh AL, 2005, ANIM BEHAV, V69, P209, DOI 10.1016/j.anbehav.2004.04.013; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; HARCOURT A, 1992, COALLITIONS ALLIANCE; Hattori Y, 2005, J COMP PSYCHOL, V119, P335, DOI 10.1037/0735-7036.119.3.335; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P2363, DOI 10.1098/rspb.2003.2509; HEMELRIJK CK, 1991, ANIM BEHAV, V41, P923, DOI 10.1016/S0003-3472(05)80630-X; Henrich J., 2005, FDN HUMAN SOCIALITY; Hirata S., 2003, HATTATSU, V95, P103; KOYAMA NF, IN PRESS INT J PRIMA; MELIS A, IN PRESS ANIM BEHAV; Povinelli DJ, 2000, UNDERSTANDING OTHER, P459; Silk JB, 1999, ANIM BEHAV, V58, P45, DOI 10.1006/anbe.1999.1129; STAMMBACH E, 1988, BEHAVIOUR, V107, P241, DOI 10.1163/156853988X00368; Stevens JR, 2004, TRENDS COGN SCI, V8, P60, DOI 10.1016/j.tics.2003.12.003; Tomasello M, 1997, PRIMATE COGNITION; TOMASELLO M, IN PRESS BEHAV BRAIN; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; WARNEKEN F, IN PRESS CHILD DEV; WATTS D, 2002, DIVERSITY CHIMPANZEE, P244; Wilson E.O., 1975, P1; Wilson ML, 2001, ANIM BEHAV, V61, P1203, DOI 10.1006/anbe.2000.1706; Wrangham RW, 1999, YEARB PHYS ANTHROPOL, V42, P1	27	331	337	2	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2006	311	5765					1297	1300		10.1126/science.1123007	http://dx.doi.org/10.1126/science.1123007			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019XB	16513985				2022-12-24	WOS:000235870400045
J	Sulheim, S; Holme, I; Ekeland, A; Bahr, R				Sulheim, S; Holme, I; Ekeland, A; Bahr, R			Helmet use and risk of head injuries in alpine skiers and snowboarders	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SKIING INJURIES; CHILDREN; SPINE	Context Although using a helmet is assumed to reduce the risk of head injuries in alpine sports, this effect is questioned. In contrast to bicycling or inline skating, there is no policy of mandatory helmet use for recreational alpine skiers and snowboarders. Objective To determine the effect of wearing a helmet on the risk of head injury among skiers and snowboarders while correcting for other potential risk factors. Design, Setting, and Participants Case-control study at 8 major Norwegian alpine resorts during the 2002 winter season, involving 3277 injured skiers and snowboarders reported by the ski patrol and 2992 noninjured controls who were interviewed on Wednesdays and Saturdays. The controls comprised every 10th person entering the bottom main ski lift at each resort during peak hours. The number of participants interviewed corresponded with each resort's anticipated injury count based on earlier years. Main Outcome Measure Injury type, helmet use, and other risk factors (age, sex, nationality, skill level, equipment used, ski school attendance, rented or own equipment) were recorded. A multivariate logistic regression analysis was used to assess the relationship between individual risk factors (including helmet wear) and risk of head injury by comparing skiers with head injuries with uninjured controls, as well as to skiers with injuries other than head injuries. Results Head injuries accounted for 578 injuries (17.6%). Using a helmet was associated with a 60% reduction in the risk for head injury (odds ratio [OR], 0.40; 95% confidence interval [CI], 0.30-0.55; adjusted for other risk factors) when comparing skiers with head injuries with uninjured controls. The effect was slightly reduced (OR, 0.45; 95% CI, 0.34-0.59) when skiers with other injuries were used as controls. For the 147 potentially severe head injuries, those who were referred to an emergency physician or for hospital treatment, the adjusted OR was 0.43 (95% CI, 0.25-0.77). The risk for head injury was higher among snowboarders than for alpine skiers (adjusted OR, 1.53; 95% CI, 1.22-1.91). Conclusion Wearing a helmet is associated with reduced risk of head injury among snowboarders and alpine skiers.	Norwegian Sch Sport Sci, Dept Sports Med, Oslo Sports Trauma Res Ctr, N-0806 Oslo, Norway; Martina Hansens Hosp, Baerum, Norway	Norwegian School of Sport Sciences	Bahr, R (corresponding author), Norwegian Sch Sport Sci, Dept Sports Med, Oslo Sports Trauma Res Ctr, N-0806 Oslo, Norway.	roald.bahr@nih.no	Bahr, Roald/B-6964-2014	Bahr, Roald/0000-0001-5725-4237; Ekeland, Arne/0000-0001-6998-8676				*AM MED ASS, 1999, 19 AM MED ASS COUNC; Buller DB, 2003, J TRAUMA, V55, P939, DOI 10.1097/01.TA.0000078694.53320.CA; Chow TK, 1996, J TRAUMA, V41, P321, DOI 10.1097/00005373-199608000-00021; Deibert MC, 1998, J BONE JOINT SURG AM, V80A, P25, DOI 10.2106/00004623-199801000-00006; Dohjima T, 2001, ACTA ORTHOP SCAND, V72, P657, DOI 10.1080/000164701317269111; Ekeland A, 2003, AM SOC TEST MATER, V1440, P97, DOI 10.1520/STP10963S; EKELAND A, 1993, AM J SPORT MED, V21, P201, DOI 10.1177/036354659302100207; FURRER M, 1995, J TRAUMA, V39, P737, DOI 10.1097/00005373-199510000-00024; Gindler J. S., 1995, Morbidity and Mortality Weekly Report, V44, P1; Hackam DJ, 1999, J PEDIATR SURG, V34, P65, DOI 10.1016/S0022-3468(99)90230-0; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Hentschel S, 2001, CAN J NEUROL SCI, V28, P42; Hunter RE, 1999, AM J SPORT MED, V27, P381, DOI 10.1177/03635465990270032101; Jorgensen U, 1998, KNEE SURG SPORT TR A, V6, P194, DOI DOI 10.1007/S001670050098; Levy AS, 2000, SEMIN NEUROL, V20, P233, DOI 10.1055/s-2000-9833; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; MYLES ST, 1992, CAN J SURG, V35, P643; Nakaguchi H, 1999, J TRAUMA, V46, P1066, DOI 10.1097/00005373-199906000-00017; OLIVER BC, 1991, ASTM STP, V1104, P164; PRALL JA, 1995, INJURY, V26, P539, DOI 10.1016/0020-1383(95)00085-N; SACKS JJ, 1991, JAMA-J AM MED ASSOC, V266, P3016, DOI 10.1001/jama.266.21.3016; Thompson DC, 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001855, DOI 10.1002/14651858.CD001855]; TORJUSSEN J, IN PRESS BR J SPORTS	23	173	175	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 22	2006	295	8					919	924		10.1001/jama.295.8.919	http://dx.doi.org/10.1001/jama.295.8.919			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014DO	16493105	Bronze			2022-12-24	WOS:000235459200025
J	Go, AS; Iribarren, C; Chandra, M; Lathon, PV; Fortmann, SP; Quertermous, T; Hlatky, MA				Go, AS; Iribarren, C; Chandra, M; Lathon, PV; Fortmann, SP; Quertermous, T; Hlatky, MA		ADVANCE Study	Statin and beta-blocker therapy and the initial presentation of coronary heart disease	ANNALS OF INTERNAL MEDICINE			English	Article							INTIMA-MEDIA THICKNESS; NITRIC-OXIDE SYNTHASE; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; MYOCARDIAL-INFARCTION; HOSPITAL OUTCOMES; RANDOMIZED TRIAL; GLOBAL REGISTRY; ANGINA-PECTORIS; BLOOD-PRESSURE	Background: Coronary atherosclerosis develops slowly over decades but is frequently characterized clinically by sudden unstable episodes. Patients who present with unstable coronary disease, such as acute myocardial infarction, may systematically differ from patients who present with relatively stable coronary disease, such as exertional angina. Objective: To examine whether medication use or patient characteristics influence the mode of initial clinical presentation of coronary disease. Design: Case-control study Setting: Large integrated health care delivery system in northern California. Patients: Adults whose first clinical presentation of coronary disease was either acute myocardial infarction (n = 916) or stable exertional angina (n = 468). Measurements: Use of cardiac medications before the event from pharmacy databases and demographic, lifestyle, and clinical characteristics from self-report and clinical and administrative databases. Results: Compared with patients with incident stable exertional angina, patients with incident acute myocardial infarction were more likely to be men, smokers, physically inactive, and hypertensive but were less likely to have a parental history of coronary disease. Patients presenting with myocardial infarction were much less likely to have received statins (19.3% vs. 40.4%; P < 0.001) and beta-blockers (19.0% vs. 47.7%; P < 0.001) than patients presenting with exertional angina. After adjustment for potential confounders, recent use of statins (adjusted odds ratio, 0.45 [95% Cl, 0.32 to 0.62]) and beta-blockers (adjusted odds ratio, 0.26 [Cl, 0.19 to 0.35]) was associated with lower likelihoods of presenting with an acute myocardial infarction than with stable angina. Limitations: This observational study did not have information on all possible confounding factors, including use of aspirin therapy. Conclusion: Statin and beta-blocker use was associated with lower odds of presenting with an acute myocardial infarction than with stable angina. Additional studies are needed to confirm that these therapies protect against unstable, higher-risk clinical presentations of coronary disease.	Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	Kaiser Permanente; University of California System; University of California San Francisco; Stanford University	Go, AS (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway St,3rd Floor, Oakland, CA 94612 USA.	Alan.S.Go@kp.org	Go, Alan S./AAE-7745-2019	Quertermous, Thomas/0000-0002-7645-9067; Hlatky, Mark/0000-0003-4686-9441				Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Alexander M, 1999, ARCH INTERN MED, V159, P2673, DOI 10.1001/archinte.159.22.2673; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; ANDREWS TC, 1993, CIRCULATION, V88, P92, DOI 10.1161/01.CIR.88.1.92; ARELLANO MG, 1984, AM J PUBLIC HEALTH, V74, P1324, DOI 10.2105/AJPH.74.12.1324; Balk EM, 2003, ANN INTERN MED, V139, P670, DOI 10.7326/0003-4819-139-8-200310210-00011; Barua RS, 2002, CIRCULATION, V106, P905, DOI 10.1161/01.CIR.0000029091.61707.6B; Bazzano LA, 2003, ANN INTERN MED, V138, P891, DOI 10.7326/0003-4819-138-11-200306030-00010; Billinger A, 2001, J AM COLL CARDIOL, V38, P1866, DOI 10.1016/S0735-1097(01)01664-3; Black HR, 2003, JAMA-J AM MED ASSOC, V289, P2073, DOI 10.1001/jama.289.16.2073; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; CURB JD, 1983, JAMA-J AM MED ASSOC, V250, P2814; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Dunder K, 2004, AM HEART J, V147, P502, DOI 10.1016/j.ahj.2003.09.010; Fireman BH, 2000, J NATL CANCER I, V92, P136, DOI 10.1093/jnci/92.2.136; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; GERSH BJ, 2001, HEART DIS TXB CARDIO, V2, P1273; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hedblad B, 2001, CIRCULATION, V103, P1721, DOI 10.1161/01.CIR.103.13.1721; Hernandez-Perera O, 1998, J CLIN INVEST, V101, P2711, DOI 10.1172/JCI1500; Hosmer DW, 1997, STAT MED, V16, P965; Hsia J, 2004, AM J CARDIOL, V93, P673, DOI 10.1016/j.amjcard.2003.12.002; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Lee WY, 2004, AM J CARDIOL, V94, P1147, DOI 10.1016/j.amjcard.2004.07.081; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Patel H, 2004, AM HEART J, V148, P27, DOI 10.1016/j.ahj.2004.03.005; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; PETTERSSON K, 1990, CIRC RES, V67, P1027, DOI 10.1161/01.RES.67.4.1027; PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620; PSATY BM, 1989, JAMA-J AM MED ASSOC, V261, P2087, DOI 10.1001/jama.261.14.2087; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Rautaharju PM, 1998, J ELECTROCARDIOL, V31, P157, DOI 10.1016/S0022-0736(98)90132-7; Schartl M, 2001, CIRCULATION, V104, P387, DOI 10.1161/hc2901.093188; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; Shah Prediman K., 2003, Cardiology Clinics, V21, P303, DOI 10.1016/S0733-8651(03)00058-4; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Spencer FA, 2002, AM J CARDIOL, V90, P1056, DOI 10.1016/S0002-9149(02)02769-8; Steg PG, 2002, AM J CARDIOL, V90, P358, DOI 10.1016/S0002-9149(02)02489-X; Weber MA, 2004, LANCET, V363, P2049, DOI 10.1016/S0140-6736(04)16456-8; Wiklund O, 2002, STROKE, V33, P572, DOI 10.1161/hs0202.102332; WIKSTRAND J, 1988, JAMA-J AM MED ASSOC, V259, P1976, DOI 10.1001/jama.259.13.1976; Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427; Yusuf S, 2000, NEW ENGL J MED, V342, P145	51	66	67	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2006	144	4					229	238		10.7326/0003-4819-144-4-200602210-00004	http://dx.doi.org/10.7326/0003-4819-144-4-200602210-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	015HS	16490908				2022-12-24	WOS:000235543100001
J	Rein, DB; Fiore, AE; Bell, BP				Rein, DB; Fiore, AE; Bell, BP			What's next for the hepatitis A vaccine?	LANCET			English	Editorial Material							IMMUNIZATION; AREA		RTI Int, Publ Hlth Econ, Atlanta, GA 30306 USA; US Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr Infect Dis, Atlanta, GA USA	Research Triangle Institute; Centers for Disease Control & Prevention - USA	Rein, DB (corresponding author), RTI Int, Publ Hlth Econ, Atlanta, GA 30306 USA.	drein@rti.org	Fiore, Anthony/AAO-8956-2020	Rein, David/0000-0002-1271-5789				Dagan R, 2005, JAMA-J AM MED ASSOC, V294, P202, DOI 10.1001/jama.294.2.202; Fitzsimons D, 2005, SCAND J INFECT DIS, V37, P549, DOI 10.1080/00365540510043284; Ginsberg GM, 2001, J HEPATOL, V34, P92, DOI 10.1016/S0168-8278(00)00007-6; Jacobsen KH, 2004, EPIDEMIOL INFECT, V132, P1005, DOI 10.1017/S0950268804002857; Lopalco PL, 2000, VACCINE, V19, P470, DOI 10.1016/S0264-410X(00)00193-6; MacIntyre CR, 2003, J PAEDIATR CHILD H, V39, P83, DOI 10.1046/j.1440-1754.2003.00098.x; Postma MJ, 2004, VACCINE, V22, P1862, DOI 10.1016/j.vaccine.2003.11.012; *US CDCP, 2005, M ADV COMM IMM PRACT; *US CDCP, 2006, MMWR-MORBID MORTAL W, V54, pQ1; Van Damme P, 2003, LANCET, V362, P1065, DOI 10.1016/S0140-6736(03)14418-2; Victor JC, 2006, AM J EPIDEMIOL, V163, P204, DOI 10.1093/aje/kwj029; Wasley A, 2005, JAMA-J AM MED ASSOC, V294, P194, DOI 10.1001/jama.294.2.194; *WHO, 2000, MMWR WKLY EPIDEMIOL, V75, P38	13	9	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 18	2006	367	9510					546	548		10.1016/S0140-6736(06)68196-8	http://dx.doi.org/10.1016/S0140-6736(06)68196-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	013GM	16488780				2022-12-24	WOS:000235397800005
J	Terszowski, G; Muller, SM; Bleul, CC; Blum, C; Schirmbeck, R; Reimann, J; Du Pasquier, L; Amagai, T; Boehm, T; Rodewald, HR				Terszowski, G; Muller, SM; Bleul, CC; Blum, C; Schirmbeck, R; Reimann, J; Du Pasquier, L; Amagai, T; Boehm, T; Rodewald, HR			Evidence for a functional second thymus in mice	SCIENCE			English	Article							T-CELL REPERTOIRE; DIFFERENTIATION; PHENOTYPE; SELECTION; STEPS; GENE	The thymus organ supports the development of T cells and is located in the thorax. Here, we report the existence of a second thymus in the mouse neck, which develops after birth and grows to the size of a small lymph node. The cervical thymus had a typical medulla-cortex structure, was found to support T cell development, and could correct T cell deficiency in athymic nude mice upon transplantation. The identification of a regular second thymus in the mouse may provide evolutionary links to thymus organogenesis in other vertebrates and suggests a need to reconsider the effect of thoracic thymectomy on de novo T cell production.	Univ Ulm, Dept Immunol, D-89081 Ulm, Germany; Univ Ulm, Dept Internal Med 1, D-89081 Ulm, Germany; Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; Univ Basel, Inst Zool & Evolutionary Biol, CH-4051 Basel, Switzerland; Meiji Univ Oriental Med, Dept Immunol & Microbiol, Hiyoshi, Kyoto 6290392, Japan	Ulm University; Ulm University; Max Planck Society; University of Basel	Rodewald, HR (corresponding author), Univ Ulm, Dept Immunol, D-89081 Ulm, Germany.	hans-reimer.rodewald@uni-ulm.de						Anderson G, 2006, IMMUNOL REV, V209, P10, DOI 10.1111/j.0105-2896.2006.00347.x; Benoist C, 1999, FUNDAM IMMUNOL, V4th, P367; Boehm T, 2003, IMMUNOL REV, V195, P15, DOI 10.1034/j.1600-065X.2003.00070.x; BOEHM T, UNPUB; Cornu A S, 2001, Acta Otorhinolaryngol Belg, V55, P295; Eberl G, 2005, SCIENCE, V308, DOI 10.1126/science.1107558; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Itoi M, 2001, INT IMMUNOL, V13, P1203, DOI 10.1093/intimm/13.9.1203; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; LAW L. W., 1964, WISTAR INST SYMP MONOGR, V2, P105; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; Loney DA, 1998, INT J PEDIATR OTORHI, V43, P77, DOI 10.1016/S0165-5876(97)00155-9; Manley NR, 2000, SEMIN IMMUNOL, V12, P421, DOI 10.1006/smim.2000.0263; MILLER JF, 1961, LANCET, V2, P748; Muller SM, 2005, P NATL ACAD SCI USA, V102, P10587, DOI 10.1073/pnas.0502752102; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NORRIS EH, 1938, CONTRIB EMBRYOL, V166, P191; Pai L, 2005, INT J PEDIATR OTORHI, V69, P573, DOI 10.1016/j.ijporl.2004.11.022; PAPAIOANNOU V, UNPUB; PICKER LJ, 1999, FUNDAMENTAL IMMUNOLO, P486; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; Rocha B, 2005, SCIENCE, V308, DOI 10.1126/science.1107363; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Von Boehmer H, 2004, ADV IMMUNOL, V84, P201, DOI 10.1016/S0065-2776(04)84006-9; VONGAUDECKER B, 1990, HUMANEMBRYOLOGIE, V183, P340; Wu SL, 2001, ARCH PATHOL LAB MED, V125, P842	29	111	114	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2006	312	5771					284	287		10.1126/science.1123497	http://dx.doi.org/10.1126/science.1123497			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16513945				2022-12-24	WOS:000236765300054
J	Johnstone, RE				Johnstone, RE			Last words	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												JohnstoneR@rcbhsc.wvu.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2006	295	14					1624	1624		10.1001/jama.295.14.1624	http://dx.doi.org/10.1001/jama.295.14.1624			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031LY	16609075				2022-12-24	WOS:000236707300001
J	Janes, KA; Gaudet, S; Albeck, JG; Nielsen, UB; Lauffenburger, DA; Sorger, PK				Janes, KA; Gaudet, S; Albeck, JG; Nielsen, UB; Lauffenburger, DA; Sorger, PK			The response of human epithelial cells to TNF involves an inducible autocrine cascade	CELL			English	Article							TUMOR-NECROSIS-FACTOR; EPIDERMAL-GROWTH-FACTOR; NF-KAPPA-B; TYROSINE KINASE ACTIVATION; CYTOKINE-INDUCED APOPTOSIS; FACTOR-I RECEPTOR; FACTOR-ALPHA; CANCER; EGF; THERAPY	Tumor necrosis factor (TNF) is a proinflammatory cytokine that induces conflicting pro- and antiapoptotic signals whose relative strengths determine the extent of cell death. TNF receptor (TNFR) has been studied in considerable detail, but it is not known how crosstalk among antagonistic pro- and antiapoptotic signals is achieved. Here we report an experimental and computational analysis of crosstalk between prodeath TNF and prosurvival growth factors in human epithelial cells. By applying classifier-based regression to a cytokine-signaling compendium of similar to 8000 intracellular protein measurements, we demonstrate that cells respond to TNF both directly, via activated TNF receptor, and indirectly, via the sequential release of transforming growth factor-alpha (TGF-alpha), interleukin-1 alpha (IL-1 alpha), and IL-1 receptor antagonist (IL-1ra.). We refer to the contingent and time-varying series of extracellular signals induced by TNF as an "autocrine cascade." Time-dependent crosstalk of synergistic and antagonistic autocrine circuits may serve to link cellular responses to the local environment.	MIT, Ctr Cell Decis Proc, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Merrimack Pharamceut, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sorger, PK (corresponding author), MIT, Ctr Cell Decis Proc, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	psorger@mit.edu	Eckhardt, Erik/G-1567-2010	Sorger, Peter/0000-0002-3364-1838; Gaudet, Suzanne/0000-0002-5701-2825	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50-GM68762] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Anderson GM, 2004, CURR OPIN PHARMACOL, V4, P314, DOI 10.1016/j.coph.2004.04.004; ANZANO MA, 1989, CANCER RES, V49, P2898; Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Barnhart BC, 2003, CELL, V114, P148, DOI 10.1016/S0092-8674(03)00561-0; Bender K, 1998, EMBO J, V17, P5170, DOI 10.1093/emboj/17.17.5170; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Chailler Pierre, 1999, Frontiers in Bioscience, V4, pD87, DOI 10.2741/Chailler; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen WNU, 2004, J BIOL CHEM, V279, P18488, DOI 10.1074/jbc.M310874200; Dinarello CA, 2000, NEW ENGL J MED, V343, P732, DOI 10.1056/NEJM200009073431011; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Dumont JE, 2002, AM J PHYSIOL-CELL PH, V283, pC2, DOI 10.1152/ajpcell.00581.2001; Efron Bradley., 1994, INTRO BOOTSTRAP; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; FRANSEN L, 1986, EUR J CANCER CLIN ON, V22, P419, DOI 10.1016/0277-5379(86)90107-0; GarciaLloret MI, 1996, J CELL PHYSIOL, V167, P324, DOI 10.1002/(SICI)1097-4652(199605)167:2<324::AID-JCP17>3.0.CO;2-7; Gaudet S, 2005, MOL CELL PROTEOMICS, V4, P1569, DOI 10.1074/mcp.M500158-MCP200; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hambek M, 2001, CANCER RES, V61, P1045; Hofmann F, 2005, DRUG DISCOV TODAY, V10, P1041, DOI 10.1016/S1359-6446(05)03512-9; IZUMI H, 1994, EXP CELL RES, V214, P654, DOI 10.1006/excr.1994.1303; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/1066527041887258; Janes KA, 2003, MOL CELL PROTEOMICS, V2, P463, DOI 10.1074/mcp.M300045-MCP200; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; MASUI H, 1993, J CELL BIOL, V120, P85, DOI 10.1083/jcb.120.1.85; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Nielsen UB, 2003, P NATL ACAD SCI USA, V100, P9330, DOI 10.1073/pnas.1633513100; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; Panja A, 1998, J IMMUNOL, V161, P3675; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Qian H, 2001, BIOCHEM BIOPH RES CO, V284, P1176, DOI 10.1006/bbrc.2001.5100; Reinhart K, 2001, CRIT CARE MED, V29, pS121, DOI 10.1097/00003246-200107001-00037; Ruan H, 2003, CYTOKINE GROWTH F R, V14, P447, DOI 10.1016/S1359-6101(03)00052-2; Rutgeerts P, 2004, GASTROENTEROLOGY, V126, P1593, DOI 10.1053/j.gastro.2004.02.070; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Schulze A, 2001, GENE DEV, V15, P981, DOI 10.1101/gad.191101; Sfikakis PP, 2003, CURR OPIN RHEUMATOL, V15, P380, DOI 10.1097/00002281-200307000-00003; SINGH P, 1993, GASTROENTEROLOGY, V105, P1218, DOI 10.1016/0016-5085(93)90971-E; STAMPFER MR, 1993, CANCER SURV, V18, P7; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Streetz K, 2000, GASTROENTEROLOGY, V119, P446, DOI 10.1053/gast.2000.9364; Torrance CJ, 2000, NAT MED, V6, P1024, DOI 10.1038/79534; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Wu YL, 1996, J CELL PHYSIOL, V168, P499, DOI 10.1002/(SICI)1097-4652(199609)168:3<499::AID-JCP2>3.0.CO;2-K; Zwerina J, 2004, ARTHRITIS RHEUM, V50, P277, DOI 10.1002/art.11487	58	159	165	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1225	1239		10.1016/j.cell.2006.01.041	http://dx.doi.org/10.1016/j.cell.2006.01.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564013	Bronze			2022-12-24	WOS:000237241400022
J	Lien, WH; Klezovitch, O; Fernandez, TE; Delrow, J; Vasioukhin, V				Lien, WH; Klezovitch, O; Fernandez, TE; Delrow, J; Vasioukhin, V			alpha E-catenin controls cerebral cortical size by regulating the hedgehog signaling pathway	SCIENCE			English	Article							SONIC-HEDGEHOG; CELL-ADHESION; INHIBITION; GROWTH; APOPTOSIS; POLARITY	During development, cells monitor and adjust their rates of accumulation to produce organs of predetermined size. We show here that central nervous system-specific deletion of the essential adherens junction gene, alpha E-catenin, causes abnormal activation of the hedgehog pathway, resulting in shortening of the cell cycle, decreased apoptosis, and cortical hyperplasia. We propose that alpha E-catenin connects cell-density-dependent adherens junctions with the developmental hedgehog pathway and that this connection may provide a negative feedback loop controlling the size of developing cerebral cortex.	Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Vasioukhin, V (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA.	vvasiouk@fhcrc.org	Fuchs, Elaine/G-1565-2016	Lien, Wen-Hui/0000-0002-2282-3169; Vasioukhin, Valeri/0000-0002-6730-0281	NATIONAL CANCER INSTITUTE [R01CA098161] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA098161-02, R01 CA098161-03, R01 CA098161-04, R01 CA098161-01A1, R01 CA098161] Funding Source: Medline; NCRR NIH HHS [P41 RR011823-128171, P41 RR011823] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; BURGER PC, 1994, ATLAS TUMOR PATHOLOG; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Graham D. I., 2002, GREENFIELDS NEUROPAT; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Ishibashi M, 2002, DEVELOPMENT, V129, P4807; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Palma V, 2004, DEVELOPMENT, V131, P337, DOI 10.1242/dev.00930; RUIZ IAA, 2002, NAT REV NEUROSCI, V3, P24, DOI DOI 10.1038/NRN704; Saitsu H, 2005, DEV DYNAM, V232, P282, DOI 10.1002/dvdy.20236; SANGUEZA OP, 1994, J AM ACAD DERMATOL, V31, P356, DOI 10.1016/S0190-9622(94)70172-5; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X	20	205	207	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1609	1612		10.1126/science.1121449	http://dx.doi.org/10.1126/science.1121449			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543460	Green Accepted			2022-12-24	WOS:000236029500046
J	Jiang, H; Chess, L				Jiang, H; Chess, L			Mechanisms of disease - Regulation of immune responses by T cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NKT CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; NEGATIVE SELECTION; DIABETES-MELLITUS; SELF-TOLERANCE; PROTECTS MICE; TGF-BETA; ACTIVATION; KILLER; RECOGNITION		Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University	Jiang, H (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med Rheumatol, 630 W 168th St, New York, NY 10032 USA.	hj4@columbia.edu						Baxter AG, 1997, DIABETES, V46, P572, DOI 10.2337/diabetes.46.4.572; BENDELAC A, 1995, CURR OPIN IMMUNOL, V7, P367, DOI 10.1016/0952-7915(95)80112-X; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; BEVAN MJ, 1978, IMMUNOL REV, V42, P3, DOI 10.1111/j.1600-065X.1978.tb00256.x; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Boussiotis VA, 1996, IMMUNOL REV, V153, P5, DOI 10.1111/j.1600-065X.1996.tb00918.x; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Chai JG, 2005, TRANSPLANTATION, V79, P1310, DOI 10.1097/01.TP.0000159147.56408.9C; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Charlton B, 1995, CURR OPIN IMMUNOL, V7, P793, DOI 10.1016/0952-7915(95)80050-6; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; COFFMAN RL, 1991, RES IMMUNOL, V142, P7, DOI 10.1016/0923-2494(91)90002-Z; Cohn M, 2004, CELL IMMUNOL, V227, P81, DOI 10.1016/j.cellimm.2004.02.004; Cosmi L, 2003, BLOOD, V102, P4107, DOI 10.1182/blood-2003-04-1320; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; D'Orazio TJ, 1998, J IMMUNOL, V160, P2089; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; de Lafaille MAC, 2002, CURR OPIN IMMUNOL, V14, P771; Del Prete G, 1998, Int Rev Immunol, V16, P427, DOI 10.3109/08830189809043004; Falcone M, 1999, J EXP MED, V190, P963, DOI 10.1084/jem.190.7.963; FITCH FW, 1993, ANNU REV IMMUNOL, V11, P29, DOI 10.1146/annurev.immunol.11.1.29; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Frey AB, 1999, AUTOIMMUNITY, V29, P201, DOI 10.3109/08916939908998535; Furlan R, 2003, EUR J IMMUNOL, V33, P1830, DOI 10.1002/eji.200323885; Furtado GD, 2001, IMMUNOL REV, V182, P122; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hammond KJL, 1998, J EXP MED, V187, P1047, DOI 10.1084/jem.187.7.1047; Han BY, 2005, J CLIN INVEST, V115, P1879, DOI 10.1172/JCI24219; HENGARTNER H, 1988, NATURE, V336, P388, DOI 10.1038/336388a0; Horwitz DA, 2004, SEMIN IMMUNOL, V16, P135, DOI 10.1016/j.smim.2003.12.009; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; JENKINS MK, 1994, IMMUNITY, V1, P443, DOI 10.1016/1074-7613(94)90086-8; Jiang H, 1998, P NATL ACAD SCI USA, V95, P4533, DOI 10.1073/pnas.95.8.4533; Jiang H, 2000, ANNU REV IMMUNOL, V18, P185, DOI 10.1146/annurev.immunol.18.1.185; Jiang H, 2005, J CLIN INVEST, V115, P302, DOI 10.1172/JCI200523879; Jiang H, 2004, J CLIN INVEST, V114, P1198, DOI 10.1172/JCI200423411; JIANG H, 1992, SCIENCE, V256, P1213, DOI 10.1126/science.256.5060.1213; Jiang H, 2003, P NATL ACAD SCI USA, V100, P8378, DOI 10.1073/pnas.1432871100; Jiang H, 2001, P NATL ACAD SCI USA, V98, P6301, DOI 10.1073/pnas.101123098; JIANG H, 1995, IMMUNITY, V2, P185, DOI 10.1016/S1074-7613(95)80079-4; Kelsen J, 2005, CLIN EXP IMMUNOL, V141, P549, DOI 10.1111/j.1365-2249.2005.02876.x; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; KLAUS SJ, 1994, J IMMUNOL, V152, P5643; KOH DR, 1992, SCIENCE, V256, P1210, DOI 10.1126/science.256.5060.1210; Kronenberg M, 2005, IMMUNITY, V22, P657, DOI 10.1016/j.immuni.2005.06.001; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; LEDERMAN S, 1992, J EXP MED, V175, P1091, DOI 10.1084/jem.175.4.1091; Lee PT, 2002, J CLIN INVEST, V110, P793, DOI 10.1172/JCI200215832; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Levings MK, 2000, J ALLERGY CLIN IMMUN, V106, pS109, DOI 10.1067/mai.2000.106635; Li JF, 2001, J IMMUNOL, V167, P3800, DOI 10.4049/jimmunol.167.7.3800; Manavalan JS, 2004, INT IMMUNOL, V16, P1055, DOI 10.1093/intimm/dxh107; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Panoutsakopoulou V, 2004, J CLIN INVEST, V113, P1218, DOI 10.1172/JCI200420772; Piccirillo CA, 2004, TRENDS IMMUNOL, V25, P374, DOI 10.1016/j.it.2004.04.009; Roncarolo MG, 2000, CURR OPIN IMMUNOL, V12, P676, DOI 10.1016/S0952-7915(00)00162-X; Rudensky A, 2005, PHILOS T R SOC B, V360, P1645, DOI 10.1098/rstb.2005.1731; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sandberg JK, 2000, J IMMUNOL, V165, P25, DOI 10.4049/jimmunol.165.1.25; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Sharif S, 2002, ANN NY ACAD SCI, V958, P77; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shevach EM, 2001, J EXP MED, V193, pF41, DOI 10.1084/jem.193.11.F41; Shortman K, 1990, Semin Immunol, V2, P3; Singh AK, 2001, J EXP MED, V194, P1801, DOI 10.1084/jem.194.12.1801; SPRENT J, 1995, CURR OPIN IMMUNOL, V7, P196, DOI 10.1016/0952-7915(95)80004-2; VONBOEHMER H, 1990, SCIENCE, V248, P1369, DOI 10.1126/science.1972594; WALDMANN H, 1978, IMMUNOL REV, V42, P202, DOI 10.1111/j.1600-065X.1978.tb00263.x; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; WARE R, 1995, IMMUNITY, V2, P177, DOI 10.1016/S1074-7613(95)80066-2; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wilson SB, 1999, NATURE, V399, P84, DOI 10.1038/20007; Wilson SB, 1998, NATURE, V391, P177, DOI 10.1038/34419; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; ZINKERNAGEL RM, 1978, IMMUNOL REV, V42, P224, DOI 10.1111/j.1600-065X.1978.tb00264.x	97	172	218	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1166	1176		10.1056/NEJMra055446	http://dx.doi.org/10.1056/NEJMra055446			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021KI	16540617				2022-12-24	WOS:000235981700010
J	Katz, IT; Wright, AA				Katz, IT; Wright, AA			Preventing cervical cancer in the developing world	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Wright, Alexi/T-5793-2019	Katz, Ingrid/0000-0002-3014-238X				Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Lazcano-Ponce EC, 1999, ARCH MED RES, V30, P240, DOI 10.1016/S0188-0128(99)00006-8; *POP REF BUR PATH, 2004, PREV CERV CANC WORLD	3	31	33	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1110	1110		10.1056/NEJMp068031	http://dx.doi.org/10.1056/NEJMp068031			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021KI	16540609	Bronze			2022-12-24	WOS:000235981700002
J	Scherer, SE; Muzny, DM; Buhay, CJ; Chen, R; Cree, A; Ding, Y; Dugan-Rocha, S; Gill, R; Gunaratne, P; Harris, RA; Hawes, AC; Hernandez, J; Hodgson, AV; Hume, J; Jackson, A; Khan, ZM; Kovar-Smith, C; Lewis, LR; Lozado, RJ; Metzker, ML; Milosavljevic, A; Miner, GR; Montgomery, KT; Morgan, MB; Nazareth, LV; Scott, G; Sodergren, E; Song, XZ; Steffen, D; Lovering, RC; Wheeler, DA; Worley, KC; Yuan, Y; Zhang, ZD; Adams, CQ; Ansari-Lari, MA; Ayele, M; Brown, MJ; Chen, G; Chen, ZJ; Clerc-Blankenburg, KP; Davis, C; Delgado, O; Dinh, HH; Draper, H; Gonzalez-Garay, ML; Havlak, P; Jackson, LR; Jacob, LS; Kelly, SH; Li, L; Li, ZW; Liu, J; Liu, W; Lu, J; Maheshwari, M; Nguyen, BV; Okwuonu, GO; Pasternak, S; Perez, LM; Plopper, FJH; Santibanez, J; Shen, H; Tabor, PE; Verduzco, D; Waldron, L; Wang, QY; Williams, GA; Zhang, JK; Zhou, JL; Nelson, D; Kucherlapati, R; Weinstock, G; Gibbs, RA				Scherer, SE; Muzny, DM; Buhay, CJ; Chen, R; Cree, A; Ding, Y; Dugan-Rocha, S; Gill, R; Gunaratne, P; Harris, RA; Hawes, AC; Hernandez, J; Hodgson, AV; Hume, J; Jackson, A; Khan, ZM; Kovar-Smith, C; Lewis, LR; Lozado, RJ; Metzker, ML; Milosavljevic, A; Miner, GR; Montgomery, KT; Morgan, MB; Nazareth, LV; Scott, G; Sodergren, E; Song, XZ; Steffen, D; Lovering, RC; Wheeler, DA; Worley, KC; Yuan, Y; Zhang, ZD; Adams, CQ; Ansari-Lari, MA; Ayele, M; Brown, MJ; Chen, G; Chen, ZJ; Clerc-Blankenburg, KP; Davis, C; Delgado, O; Dinh, HH; Draper, H; Gonzalez-Garay, ML; Havlak, P; Jackson, LR; Jacob, LS; Kelly, SH; Li, L; Li, ZW; Liu, J; Liu, W; Lu, J; Maheshwari, M; Nguyen, BV; Okwuonu, GO; Pasternak, S; Perez, LM; Plopper, FJH; Santibanez, J; Shen, H; Tabor, PE; Verduzco, D; Waldron, L; Wang, QY; Williams, GA; Zhang, JK; Zhou, JL; Nelson, D; Kucherlapati, R; Weinstock, G; Gibbs, RA		Baylor Coll Med Human Genome Seque	The finished DNA sequence of human chromosome 12	NATURE			English	Article							HUMAN-GENOME; PERICENTRIC-INVERSION; MOLECULAR CLOCKS; PHYSICAL MAP; EVOLUTION; LINEAGES; MONKEYS; MOUSE; APES	Human chromosome 12 contains more than 1,400 coding genes(1) and 487 loci that have been directly implicated in human disease(2). The q arm of chromosome 12 contains one of the largest blocks of linkage disequilibrium found in the human genome(3). Here we present the finished sequence of human chromosome 12, which has been finished to high quality and spans approximately 132 megabases, representing similar to 4.5% of the human genome. Alignment of the human chromosome 12 sequence across vertebrates reveals the origin of individual segments in chicken, and a unique history of rearrangement through rodent and primate lineages. The rate of base substitutions in recent evolutionary history shows an overall slowing in hominids compared with primates and rodents.	Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Harvard Univ, Sch Med, Partners Healthcare Ctr Genet & Genom, Boston, MA 02115 USA; UCL, Dept Biol, Galton Lab, HUGO Gene Nomenclature Comm, London NW1 2HE, England	Baylor College of Medicine; Harvard University; Harvard Medical School; Partners Healthcare System; University of London; University College London	Scherer, SE (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, 1 Baylor Plaza, Houston, TX 77030 USA.	sscherer@bcm.tmc.edu	Wheeler, David A/M-9740-2018; Driemeier, David/H-3461-2012; Norouzi, Neil/H-2530-2012; Weinstock, George M/C-6314-2013; Kucherlapati, Raju/ABC-8807-2021	Wheeler, David A/0000-0002-9056-6299; Driemeier, David/0000-0003-3766-0654; Weinstock, George M/0000-0002-2997-4592; Lovering, Ruth/0000-0002-9791-0064; Worley, Kim/0000-0002-0282-1000; Gonzalez-Garay, Manuel/0000-0003-3412-0353; Delgado, Oliver/0000-0003-2547-5857; minja, emmanuel/0000-0001-9724-1174; /0000-0002-9833-2817	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AnsariLari MA, 1996, GENOME RES, V6, P314, DOI 10.1101/gr.6.4.314; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bourque G, 2005, GENOME RES, V15, P98, DOI 10.1101/gr.3002305; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Elango N, 2006, P NATL ACAD SCI USA, V103, P1370, DOI 10.1073/pnas.0510716103; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Hedges DJ, 2004, GENOME RES, V14, P1068, DOI 10.1101/gr.2530404; Hsu F, 2005, NUCLEIC ACIDS RES, V33, pD454, DOI 10.1093/nar/gki100; *JOHNS HOPK U MCK, ONL MEND INH MAN OMI; Kalafus KJ, 2004, GENOME RES, V14, P672, DOI 10.1101/gr.1963804; Kehrer-Sawatzki H, 2005, CYTOGENET GENOME RES, V108, P91, DOI 10.1159/000080806; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Knight SJL, 2000, AM J HUM GENET, V67, P320, DOI 10.1086/302998; LI WH, 1987, NATURE, V326, P93, DOI 10.1038/326093a0; Li Y, 2004, P NATL ACAD SCI USA, V101, P15688, DOI 10.1073/pnas.0403535101; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Montgomery KT, 2001, NATURE, V409, P945, DOI 10.1038/35057174; Nickerson E, 1998, GENOMICS, V50, P368, DOI 10.1006/geno.1998.5332; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Schmutz J, 2004, NATURE, V429, P365, DOI 10.1038/nature02390; STEGMAIER K, 1995, BLOOD, V86, P38, DOI 10.1182/blood.V86.1.38.bloodjournal86138; Steiper ME, 2004, P NATL ACAD SCI USA, V101, P17021, DOI 10.1073/pnas.0407270101; Vermeesch JR, 2003, CYTOGENET GENOME RES, V103, P63, DOI 10.1159/000076291; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wienberg J, 2005, CYTOGENET GENOME RES, V108, P139, DOI 10.1159/000080811; Yi SJ, 2002, MOL BIOL EVOL, V19, P2191, DOI 10.1093/oxfordjournals.molbev.a004043; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; Yu FL, 2005, PLOS GENET, V1, P404, DOI 10.1371/journal.pgen.0010041; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003	31	37	618	3	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2006	440	7082					346	351		10.1038/nature04569	http://dx.doi.org/10.1038/nature04569			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541075	Bronze			2022-12-24	WOS:000235997600055
J	Gosgnach, S; Lanuza, GM; Butt, SJB; Saueressig, H; Zhang, Y; Velasquez, T; Riethmacher, D; Callaway, EM; Kiehn, O; Goulding, M				Gosgnach, S; Lanuza, GM; Butt, SJB; Saueressig, H; Zhang, Y; Velasquez, T; Riethmacher, D; Callaway, EM; Kiehn, O; Goulding, M			V1 spinal neurons regulate the speed of vertebrate locomotor outputs	NATURE			English	Article							IN-VITRO; INTERNEURONS; CORD; ENGRAILED-1; NETWORKS; CIRCUITS; PAX6; IDENTIFICATION; SPECIFICATION; MOTONEURONS	The neuronal networks that generate vertebrate movements such as walking and swimming are embedded in the spinal cord(1-3). These networks, which are referred to as central pattern generators (CPGs), are ideal systems for determining how ensembles of neurons generate simple behavioural outputs. In spite of efforts to address the organization of the locomotor CPG in walking animals(2,4-6), little is known about the identity and function of the spinal interneuron cell types that contribute to these locomotor networks. Here we use four complementary genetic approaches to directly address the function of mouse V1 neurons, a class of local circuit inhibitory interneurons that selectively express the transcription factor Engrailed1. Our results show that V1 neurons shape motor outputs during locomotion and are required for generating 'fast' motor bursting. These findings outline an important role for inhibition in regulating the frequency of the locomotor CPG rhythm, and also suggest that V1 neurons may have an evolutionarily conserved role in controlling the speed of vertebrate locomotor movements.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, S-17177 Stockholm, Sweden; Univ Hamburg, Ctr Mol Neurobiol, D-20251 Hamburg, Germany	Salk Institute; Salk Institute; Karolinska Institutet; University of Hamburg	Goulding, M (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	goulding@salk.edu	Callaway, Edward/D-4336-2011; Butt, Simon/I-2689-2019; Kiehn, Ole/C-4679-2008; Riethmacher, Dieter/AAP-2227-2021; Lanuza, Guillermo/AAT-6286-2020; Riethmacher, Dieter/A-6242-2010; kiehn, ole/AAT-7881-2021; kiehn, ole/AAB-1262-2019; Riethmacher, Dieter/AAB-8690-2022	Callaway, Edward/0000-0002-6366-5267; Butt, Simon/0000-0002-2399-0102; Riethmacher, Dieter/0000-0002-4206-5529; Lanuza, Guillermo/0000-0003-3311-2263; Kiehn, Ole/0000-0002-5954-469X; Zhang, Ying/0000-0003-4363-5666	NIMH NIH HHS [R01 MH063912-06, R01 MH063912-05, R01 MH063912] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063912] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711; Angel MJ, 2005, J PHYSIOL-LONDON, V563, P597, DOI 10.1113/jphysiol.2004.076034; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Brandon EP, 2004, J NEUROSCI, V24, P5459, DOI 10.1523/JNEUROSCI.1106-04.2004; Brockschnieder D, 2004, MOL CELL BIOL, V24, P7636, DOI 10.1128/MCB.24.17.7636-7642.2004; BURKE RE, 1998, SYNAPTIC ORG BRAIN, P77; Butt SJB, 2003, NEURON, V38, P953, DOI 10.1016/S0896-6273(03)00353-2; Butt SJB, 2002, J NEUROSCI, V22, P9961; Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; FU TC, 1975, BRAIN RES, V85, P99, DOI 10.1016/0006-8993(75)91012-4; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Higashijima S, 2004, J NEUROSCI, V24, P5827, DOI 10.1523/JNEUROSCI.5342-03.2004; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jiang ZY, 1999, BRAIN RES, V816, P493, DOI 10.1016/S0006-8993(98)01199-8; Kiehn O, 1998, ANN NY ACAD SCI, V860, P110, DOI 10.1111/j.1749-6632.1998.tb09043.x; KIEHN O, 1997, NEURONS NETWORKS MOT, P47; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Kjaerulff O, 1997, J NEUROSCI, V17, P9433; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Li WC, 2004, J NEUROSCI, V24, P5840, DOI 10.1523/JNEUROSCI.1633-04.2004; Myers CP, 2005, NEURON, V46, P37, DOI 10.1016/j.neuron.2005.02.022; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Roberts A, 1998, ANN NY ACAD SCI, V860, P19, DOI 10.1111/j.1749-6632.1998.tb09036.x; Sapir T, 2004, J NEUROSCI, V24, P1255, DOI 10.1523/JNEUROSCI.3187-03.2004; Saueressig H, 1999, DEVELOPMENT, V126, P4201; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Wenner P, 2000, J NEUROPHYSIOL, V84, P2651, DOI 10.1152/jn.2000.84.5.2651	30	266	268	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2006	440	7081					215	219		10.1038/nature04545	http://dx.doi.org/10.1038/nature04545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	16525473	Bronze			2022-12-24	WOS:000235839500047
J	Urich, T; Gomes, CM; Kletzin, A; Frazao, C				Urich, T; Gomes, CM; Kletzin, A; Frazao, C			X-ray structure of a self-compartmentalizing sulfur cycle metalloenzyme	SCIENCE			English	Article							OXYGENASE-REDUCTASE; CRYSTAL-STRUCTURE; INORGANIC SULFUR; DESULFUROLOBUS-AMBIVALENS; ACIDIANUS-AMBIVALENS; DIOXYGEN ACTIVATION; ELEMENTAL SULFUR; OXIDATION; BACTERIA; ENZYMES	Numerous microorganisms oxidize sulfur for energy conservation and contribute to the global biogeochemical sulfur cycle. We have determined the 1.7 angstrom-resolution structure of the sulfur oxygenase reductase from the thermoacidophilic archaeon Acidianus ambivalens, which catalyzes an oxygen-dependent disproportionation of elemental sulfur. Twenty-four monomers form a large hollow sphere enclosing a positively charged nanocompartment. Apolar channels provide access for linear sulfur species. A cysteine persulfide and a low-potential mononuclear non-heme iron site ligated by a 2-His-1-carboxylate facial triad in a pocket of each subunit constitute the active sites, accessible from the inside of the sphere. The iron is likely the site of both sulfur oxidation and sulfur reduction.	Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal; TH Darmstadt, Inst Microbiol & Genet, D-64287 Darmstadt, Germany	Universidade Nova de Lisboa; Technical University of Darmstadt	Kletzin, A (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Ave Republ EAN, P-2781901 Oeiras, Portugal.	kletzin@bio.tu-darmstadt.de; frazao@itqb.unl.pt	Urich, Tim/C-2887-2013; Gomes, Cláudio M/A-8152-2008; Urich, Tim/J-8241-2016; Kletzin, Arnulf/AAO-7366-2020; Frazao, Carlos/C-1965-2008	Gomes, Cláudio M/0000-0003-4662-6933; Urich, Tim/0000-0002-5718-1354; Frazao, Carlos/0000-0002-7725-1671; Kletzin, Arnulf/0000-0002-4500-2232				Andersen OA, 2002, J MOL BIOL, V320, P1095, DOI 10.1016/S0022-2836(02)00560-0; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; Beinert H, 2000, EUR J BIOCHEM, V267, P5657, DOI 10.1046/j.1432-1327.2000.01637.x; Bordo D, 2000, J MOL BIOL, V298, P691, DOI 10.1006/jmbi.2000.3651; BOULEGUE J, 1978, PHOSPHORUS SULFUR, V5, P127, DOI 10.1080/03086647808069875; Chen ZW, 2005, APPL ENVIRON MICROB, V71, P621, DOI 10.1128/AEM.71.2.621-628.2005; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Ebihara Akio, 2005, Journal of Structural and Functional Genomics, V6, P21, DOI 10.1007/s10969-005-1103-x; EMMEL T, 1986, J GEN MICROBIOL, V132, P3415; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; He ZG, 2000, FEMS MICROBIOL LETT, V193, P217, DOI 10.1111/j.1574-6968.2000.tb09427.x; Kappler U, 2005, FEBS LETT, V579, P2491, DOI 10.1016/j.febslet.2005.03.060; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; KELLY DP, 1982, PHILOS T R SOC B, V298, P499, DOI 10.1098/rstb.1982.0094; Kelly DP, 1997, ANTON LEEUW INT J G, V71, P95, DOI 10.1023/A:1000135707181; KLETZIN A, 1992, J BACTERIOL, V174, P5854, DOI 10.1128/jb.174.18.5854-5859.1992; Kletzin A, 2004, J BIOENERG BIOMEMBR, V36, P77, DOI 10.1023/B:JOBB.0000019600.36757.8c; KLETZIN A, 1989, J BACTERIOL, V171, P1638, DOI 10.1128/jb.171.3.1638-1643.1989; Koehntop KD, 2005, J BIOL INORG CHEM, V10, P87, DOI 10.1007/s00775-005-0624-x; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Lin YJ, 2004, BIOCHEMISTRY-US, V43, P1418, DOI 10.1021/bi0356597; Macedo S, 2003, NAT STRUCT BIOL, V10, P285, DOI 10.1038/nsb909; Olson GJ, 2003, APPL MICROBIOL BIOT, V63, P249, DOI 10.1007/s00253-003-1404-6; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; SCHONHEIT P, 1995, WORLD J MICROB BIOT, V11, P26, DOI 10.1007/BF00339135; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; Urich T, 2005, FEMS MICROBIOL LETT, V248, P171, DOI 10.1016/j.femsle.2005.05.031; Urich T, 2004, BIOCHEM J, V381, P137, DOI 10.1042/BJ20040003; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200; Zhang C, 2000, J MOL BIOL, V299, P1075, DOI 10.1006/jmbi.2000.3678	33	67	80	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2006	311	5763					996	1000		10.1126/science.1120306	http://dx.doi.org/10.1126/science.1120306			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014CS	16484493				2022-12-24	WOS:000235456900044
J	Deaconescu, AM; Chambers, AL; Smith, AJ; Nickels, BE; Hochschild, A; Savery, NJ; Darst, SA				Deaconescu, AM; Chambers, AL; Smith, AJ; Nickels, BE; Hochschild, A; Savery, NJ; Darst, SA			Structural basis for bacterial transcription-coupled DNA repair	CELL			English	Article							RNA-POLYMERASE-II; NUCLEOTIDE EXCISION-REPAIR; ESCHERICHIA-COLI; ANGSTROM RESOLUTION; ELONGATION COMPLEX; CATABOLITE REPRESSION; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; MFD MUTANT; PROTEIN	Coupling of transcription and DNA repair in bacteria is mediated by transcription-repair coupling factor (TRCF, the product of the mfd gene), which removes transcription elongation complexes stalled at DNA lesions and recruits the nucleotide excision repair machinery to the site. Here we describe the 3.2 angstrom-resolution X-ray crystal structure of Escherichia coli TRCF. The structure consists of a compact arrangement of eight domains, including a translocation module similar to the SF2 ATPase RecG, and a region of structural similarity to UvrB. Biochemical and genetic experiments establish that another domain with structural similarity to the Tudor-like domain of the transcription elongation factor NusG plays a critical role in TRCF/RNA polymerase interactions. Comparison with the translocation module of RecG as well as other structural features indicate that TRCF function involves largescale conformational changes. These data, along with a structural model for the interaction of TRCF with the transcription elongation complex, provide mechanistic insights into TRCF function.	Rockefeller Univ, New York, NY 10021 USA; Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Univ Cambridge, Dept Biochem, Cambridge CB2 1TN, England	Rockefeller University; University of Bristol; Harvard University; Harvard Medical School; University of Cambridge	Deaconescu, AM (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	darst@rockefeller.edu	Nickels, Bryce/AAF-2549-2020	Nickels, Bryce/0000-0001-7449-8831; Savery, Nigel/0000-0002-0803-4075; Chambers, Anna/0000-0001-8133-6240; Deaconescu, Alexandra/0000-0002-2742-5493	Biotechnology and Biological Sciences Research Council [BB/C507053/1] Funding Source: Medline; NIGMS NIH HHS [GM073829, GM44025] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044025, R01GM073829] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; BOCKRATH RC, 1977, MOL GEN GENET, V156, P133, DOI 10.1007/BF00283485; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Chambers AL, 2003, NUCLEIC ACIDS RES, V31, P6409, DOI 10.1093/nar/gkg868; COWTAN K, 1994, ESF CCP4 NEWSLETTER, V31, P34; DEACONESCU A, 2005, IN PRESS ACTA CRYST; Dove Simon L, 2004, Methods Mol Biol, V261, P231; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Gelles J, 1998, CELL, V93, P13, DOI 10.1016/S0092-8674(00)81140-X; GEORGE DL, 1975, MUTAT RES, V28, P347, DOI 10.1016/0027-5107(75)90229-8; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gulick AM, 2002, ACTA CRYSTALLOGR D, V58, P306, DOI 10.1107/S0907444901018832; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; LI J, 1992, J BIOL CHEM, V267, P6012; Mahdi AA, 2003, EMBO J, V22, P724, DOI 10.1093/emboj/cdg043; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; ORREN DK, 1990, J BIOL CHEM, V265, P15796; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Pasman Z, 2000, BIOCHEMISTRY-US, V39, P5573, DOI 10.1021/bi992658z; Ponting CP, 2002, NUCLEIC ACIDS RES, V30, P3643, DOI 10.1093/nar/gkf498; RAIN JC, 2001, NATURE, V20, P8847; Roberts J, 2004, CURR OPIN MICROBIOL, V7, P120, DOI 10.1016/j.mib.2004.02.014; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1995, J BIOL CHEM, V270, P4890, DOI 10.1074/jbc.270.9.4890; SELBY CP, 1990, J BIOL CHEM, V265, P21330; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P11574, DOI 10.1073/pnas.88.24.11574; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Skorvaga M, 2002, J BIOL CHEM, V277, P1553, DOI 10.1074/jbc.M108847200; Smith AJ, 2005, NUCLEIC ACIDS RES, V33, P755, DOI 10.1093/nar/gki225; Steiner T, 2002, EMBO J, V21, P4641, DOI 10.1093/emboj/cdf455; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Theis K, 1999, EMBO J, V18, P6899, DOI 10.1093/emboj/18.24.6899; Toulokhonov I, 2003, MOL CELL, V12, P1125, DOI 10.1016/S1097-2765(03)00439-8; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Truglio JJ, 2004, EMBO J, V23, P2498, DOI 10.1038/sj.emboj.7600263; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Washburn RS, 2003, J MOL BIOL, V329, P655, DOI 10.1016/S0022-2836(03)00465-0; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; WITKIN EM, 1966, SCIENCE, V152, P1345, DOI 10.1126/science.152.3727.1345; Zalieckas JM, 1998, MOL MICROBIOL, V27, P1031, DOI 10.1046/j.1365-2958.1998.00751.x; Zeng XM, 2000, MICROBIOL-UK, V146, P2901, DOI 10.1099/00221287-146-11-2901	56	159	162	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 10	2006	124	3					507	520		10.1016/j.cell.2005.11.045	http://dx.doi.org/10.1016/j.cell.2005.11.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	014FG	16469698	Bronze			2022-12-24	WOS:000235464000014
J	Schmidt, L				Schmidt, L			Psychosocial burden of infertility and assisted reproduction	LANCET			English	Editorial Material							FERTILITY TREATMENT; SATISFACTION; COUPLES		Univ Copenhagen, Inst Publ Hlth, DK-2200 Copenhagen N, Denmark	University of Copenhagen	Schmidt, L (corresponding author), Univ Copenhagen, Inst Publ Hlth, DK-2200 Copenhagen N, Denmark.	L.Schmidt@pubhealth.ku.dk		Schmidt, Lone/0000-0002-9518-1734				Boivin J, 2003, SOC SCI MED, V57, P2325, DOI 10.1016/S0277-9536(03)00138-2; Daniluk JC, 2001, J COUNS DEV, V79, P439, DOI 10.1002/j.1556-6676.2001.tb01991.x; de Liz TM, 2005, HUM REPROD, V20, P1324, DOI 10.1093/humrep/deh743; Greil AL, 1997, SOC SCI MED, V45, P1679, DOI 10.1016/S0277-9536(97)00102-0; Jordan C, 1999, J BEHAV MED, V22, P341, DOI 10.1023/A:1018774019232; Schmidt L, 2005, HUM REPROD, V20, P3248, DOI 10.1093/humrep/dei193; Schmidt L, 2003, HUM REPROD, V18, P2638, DOI 10.1093/humrep/deg505; Slade P, 1997, HUM REPROD, V12, P183, DOI 10.1093/humrep/12.1.183; Souter VL, 1998, HUM REPROD, V13, P1831, DOI 10.1093/humrep/13.7.1831; Sundby JS, 1992, J WOMENS HEALTH, V1, P209; Sydsjo G, 2005, HUM REPROD, V20, P1952, DOI 10.1093/humrep/deh882; Verhaak CM, 2005, HUM REPROD, V20, P2253, DOI 10.1093/humrep/dei015	12	80	80	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 4	2006	367	9508					379	380		10.1016/S0140-6736(06)68117-8	http://dx.doi.org/10.1016/S0140-6736(06)68117-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	009UR	16458748				2022-12-24	WOS:000235139400009
J	Viboud, C; Bjornstad, ON; Smith, DL; Simonsen, L; Miller, MA; Grenfell, BT				Viboud, C; Bjornstad, ON; Smith, DL; Simonsen, L; Miller, MA; Grenfell, BT			Synchrony, waves, and spatial hierarchies in the spread of influenza	SCIENCE			English	Article							PANDEMIC INFLUENZA; DYNAMICS; POPULATION; MORTALITY; IMPACT; MODEL; TRANSMISSION; EPIDEMICS; EVOLUTION; PATTERNS	Quantifying long-range dissemination of infectious diseases is a key issue in their dynamics and control. Here, we use influenza-related mortality data to analyze the between-state progression of interpandemic influenza in the United States over the past 30 years. Outbreaks show hierarchical spatial spread evidenced by higher pairwise synchrony between more populous states. Seasons with higher influenza mortality are associated with higher disease transmission and more rapid spread than are mild ones. The regional spread of infection correlates more closely with rates of movement of people to and from their workplaces (workflows) than with geographical distance. Workflows are described in turn by a gravity model, with a rapid decay of commuting up to around 100 km and a long tail of rare longer range flow. A simple epidemiological model, based on the gravity formulation, captures the observed increase of influenza spatial synchrony with transmissibility; high transmission allows influenza to spread rapidly beyond local spatial constraints.	NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; NIAID, NIH, Bethesda, MD 20818 USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Viboud, C (corresponding author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.	viboudc@mail.nih.gov	Simonsen, Lone/K-4531-2014; Bjornstad, Ottar N/I-4518-2012; Smith, David L/L-8850-2013	Simonsen, Lone/0000-0003-1535-8526; Smith, David L/0000-0003-4367-3849				[Anonymous], 2012, NUMERICAL ECOLOGY; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Bonabeau E, 1998, P ROY SOC B-BIOL SCI, V265, P2421, DOI 10.1098/rspb.1998.0593; CLIFF A, 1986, SPATIAL ASPECTS INFL; CLIFF AD, 1994, SPATIAL PROCESSES; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Ferrari MJ, 2005, MATH BIOSCI, V198, P14, DOI 10.1016/j.mbs.2005.08.002; FLAHAULT A, 1988, STAT MED, V7, P1147, DOI 10.1002/sim.4780071107; Grais R F, 2004, Health Care Manag Sci, V7, P127, DOI 10.1023/B:HCMS.0000020652.38181.da; Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146; Greene SK, 2006, AM J EPIDEMIOL, V163, P316, DOI 10.1093/aje/kwj040; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; LONGINI IM, 1986, AM J EPIDEMIOL, V123, P383, DOI 10.1093/oxfordjournals.aje.a114253; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; MOLLISON D, 1991, MATH BIOSCI, V107, P255, DOI 10.1016/0025-5564(91)90009-8; MONTO AS, 1994, EPIDEMIOL REV, V16, P351, DOI 10.1093/oxfordjournals.epirev.a036158; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; SIMONSEN L, 1999, VACCINE S1, V17, P53; SMALLMANRAYNOR M, 2004, T I BR GEOGR, V27, P452, DOI DOI 10.1111/1475-5661.00065; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341; 1969, MORB MORTAL WKLY REP, V18, P217	29	559	570	8	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 21	2006	312	5772					447	451		10.1126/science.1125237	http://dx.doi.org/10.1126/science.1125237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16574822				2022-12-24	WOS:000236941800053
J	Pertz, O; Hodgson, L; Klemke, RL; Hahn, KM				Pertz, O; Hodgson, L; Klemke, RL; Hahn, KM			Spatiotemporal dynamics of RhoA activity in migrating cells	NATURE			English	Article							FLUORESCENT PROTEIN; RAC; ACTIVATION; PHOSPHORYLATION; FIBROBLASTS; CDC42	Rho family GTPases regulate the actin and adhesion dynamics that control cell migration. Current models postulate that Rac promotes membrane protrusion at the leading edge and that RhoA regulates contractility in the cell body(1,2). However, there is evidence that RhoA also regulates membrane protrusion(3,4). Here we use a fluorescent biosensor, based on a novel design preserving reversible membrane interactions, to visualize the spatiotemporal dynamics of RhoA activity during cell migration. In randomly migrating cells, RhoA activity is concentrated in a sharp band directly at the edge of protrusions. It is observed sporadically in retracting tails, and is low in the cell body. RhoA activity is also associated with peripheral ruffles and pinocytic vesicles, but not with dorsal ruffles induced by platelet-derived growth factor (PDGF). In contrast to randomly migrating cells, PDGF-induced membrane protrusions have low RhoA activity, potentially because PDGF strongly activates Rac, which has previously been shown to antagonize RhoA activity(5,6). Our data therefore show that different extracellular cues induce distinct patterns of RhoA signalling during membrane protrusion.	Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Scripps Research Institute	Pertz, O (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	pertz@ucsd.edu; khahn@med.unc.edu		Hahn, Klaus/0000-0002-1970-7562; pertz, olivier/0000-0001-8579-4919; Hodgson, Louis/0000-0001-9188-7580				Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hodgson L, 2006, METHOD ENZYMOL, V406, P140, DOI 10.1016/S0076-6879(06)06012-5; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Matsumura F, 1998, J CELL BIOL, V140, P119, DOI 10.1083/jcb.140.1.119; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Norman JC, 1998, J CELL BIOL, V143, P1981, DOI 10.1083/jcb.143.7.1981; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Shaw RJ, 1998, MOL BIOL CELL, V9, P403, DOI 10.1091/mbc.9.2.403; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048	21	601	615	5	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1069	1072		10.1038/nature04665	http://dx.doi.org/10.1038/nature04665			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16547516				2022-12-24	WOS:000236906000040
J	Giraldez, AJ; Mishima, Y; Rihel, J; Grocock, RJ; Van Dongen, S; Inoue, K; Enright, AJ; Schier, AF				Giraldez, AJ; Mishima, Y; Rihel, J; Grocock, RJ; Van Dongen, S; Inoue, K; Enright, AJ; Schier, AF			Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs	SCIENCE			English	Article							MICRORNA TARGETS; C-ELEGANS; POSTTRANSCRIPTIONAL REGULATION; CAENORHABDITIS-ELEGANS; P-BODIES; LET-7; POLYADENYLATION; MORPHOGENESIS; TRANSCRIPTION; MECHANISMS	MicroRNAs (miRNAs) comprise 1 to 3% of all vertebrate genes, but their in vivo functions and mechanisms of action remain largely unknown. Zebrafish miR-430 is expressed at the onset of zygotic transcription and regulates morphogenesis during early development. By using a microarray approach and in vivo target validation, we find that miR-430 directly regulates several hundred target messenger RNA molecules (mRNAs). Most targets are maternally expressed mRNAs that accumulate in the absence of miR-430. We also show that miR-430 accelerates the deadenylation of target mRNAs. These results suggest that miR-430 facilitates the deadenylation and clearance of maternal mRNAs during early embryogenesis.	NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Kobe Univ, Grad Sch Sci & Technol, Dept Biol, Nada Ku, Kobe, Hyogo 6578501, Japan; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	New York University; New York University; Harvard University; Kobe University; Wellcome Trust Sanger Institute	Giraldez, AJ (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA.	giraldez@mcb.harvard.edu; schier@fas.harvard.edu	Mishima, Yuichiro/I-3881-2019; Rihel, Jason/G-7106-2011; Enright, Anton/F-3094-2011	Mishima, Yuichiro/0000-0002-1075-9454; Enright, Anton/0000-0002-6090-3100; Giraldez, Antonio/0000-0002-6823-137X; Rihel, Jason/0000-0003-4067-2066; Schier, Alexander Franz/0000-0001-7645-5325				Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Ding L, 2005, MOL CELL, V19, P437, DOI 10.1016/j.molcel.2005.07.013; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Enright AJ, 2004, GENOME BIOL, V5; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lai EC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-115; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Richter JD, 1999, MICROBIOL MOL BIOL R, V63, P446, DOI 10.1128/MMBR.63.2.446-456.1999; Salles FJ, 1999, METHODS, V17, P38, DOI 10.1006/meth.1998.0705; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Vasudevan S, 2006, GENE DEV, V20, P138, DOI 10.1101/gad.1398906; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	39	1190	1248	10	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2006	312	5770					75	79		10.1126/science.1122689	http://dx.doi.org/10.1126/science.1122689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16484454				2022-12-24	WOS:000236584400032
J	Kang, YS; Do, YY; Lee, HK; Park, SH; Cheong, C; Lynch, RM; Loeffler, JM; Steinman, RM; Park, CG				Kang, YS; Do, YY; Lee, HK; Park, SH; Cheong, C; Lynch, RM; Loeffler, JM; Steinman, RM; Park, CG			A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q	CELL			English	Article							MARGINAL-ZONE MACROPHAGES; MANNOSE-BINDING LECTIN; C-TYPE LECTIN; STREPTOCOCCUS-PNEUMONIAE INFECTION; BLOOD-BORNE ANTIGENS; DC-SIGN; CAPSULAR POLYSACCHARIDE; ANTIBODY-RESPONSE; INNATE IMMUNITY; MEDIATES UPTAKE	The intricate system of serum complement proteins provides resistance to infection. A pivotal step in the complement pathway is the assembly of a C3 convertase, which digests the C3 complement component to form microbial binding C3 fragments recognized by leukocytes. The spleen and C3 provide resistance against blood-borne S. pneurnomae infection. To better understand the mechanisms involved, we studied SIGN-R1, a lectin that captures microbial polysaccharides in spleen. Surprisingly, conditional SIGN-R1 knockout mice developed deficits in C3 catabolism when given S. pneumoniae or its capsular polysaccharide intravenously. There were marked reductions in proteolysis of serum C3, deposition of C3 on organisms within SIGN-R1(+) spleen macrophages, and formation of C3 ligands. We found that SIGN-R1 directly bound the complement C1 subcomponent, C1q, and assembled a C3 convertase, but without the traditional requirement for either antibody or factor B. The transmembrane lectin SIGN-R1 therefore contributes to innate resistance by an unusual C3 activation pathway.	Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA; Rockefeller Univ, Chris Browne Ctr Immunol & Immune Dis, New York, NY 10021 USA; Rockefeller Univ, Lab Bacterial Pathogenesis, New York, NY 10021 USA	Rockefeller University; Rockefeller University; Rockefeller University	Park, CG (corresponding author), Rockefeller Univ, Cellular Physiol & Immunol Lab, 1230 York Ave, New York, NY 10021 USA.	parkc@mail.rockefeller.edu	Loeffler, Jutta M/C-2747-2008; Do, Yoonkyung/F-5231-2010; Steinman, Ralph/F-7729-2012	Do, Yoonkyung/0000-0001-7947-4767; Park, Chae Gyu/0000-0003-1906-1308	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R37AI040045, R37AI013013, R01AI013013, R56AI040045, R01AI040045] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40045, AI13013, AI057158] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMLOT PL, 1985, LANCET, V1, P1008, DOI 10.1016/S0140-6736(85)91613-7; Atkinson APM, 2004, CLIN EXP IMMUNOL, V138, P517, DOI 10.1111/j.1365-2249.2004.02634.x; Banki Z, 2005, AIDS, V19, P481, DOI 10.1097/01.aids.0000162336.20439.8d; BROWN EJ, 1982, J CLIN INVEST, V69, P85, DOI 10.1172/JCI110444; BROWN EJ, 1983, REV INFECT DIS, V5, pS797; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; CAMPBELL JR, 1991, INFECT IMMUN, V59, P1978, DOI 10.1128/IAI.59.6.1978-1983.1991; Caraher EM, 1999, J ENDOCRINOL, V162, P143, DOI 10.1677/joe.0.1620143; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; Cowell RM, 2003, J NEUROSCI, V23, P9459; FEARON DT, 1983, ANNU REV IMMUNOL, V1, P243, DOI 10.1146/annurev.iy.01.040183.001331; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Galustian C, 2004, INT IMMUNOL, V16, P853, DOI 10.1093/intimm/dxh089; Garau J, 2002, LANCET INFECT DIS, V2, P404, DOI 10.1016/S1473-3099(02)00316-X; Geijtenbeek TBH, 2002, BLOOD, V100, P2908, DOI 10.1182/blood-2002-04-1044; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Harms G, 1996, INFECT IMMUN, V64, P4220, DOI 10.1128/IAI.64.10.4220-4225.1996; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; HUMPHREY JH, 1981, EUR J IMMUNOL, V11, P221, DOI 10.1002/eji.1830110311; HUMPHREY JH, 1985, IMMUNOL LETT, V11, P149, DOI 10.1016/0165-2478(85)90161-0; Kang YS, 2003, INT IMMUNOL, V15, P177, DOI 10.1093/intimm/dxg019; Kang YS, 2004, P NATL ACAD SCI USA, V101, P215, DOI 10.1073/pnas.0307124101; Kars M, 2005, EUR J CLIN INVEST, V35, P531, DOI 10.1111/j.1365-2362.2005.01521.x; Koppel EA, 2005, EUR J IMMUNOL, V35, P2962, DOI 10.1002/eji.200526216; KRAAL G, 1986, IMMUNOLOGY, V58, P665; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Kronborg G, 2002, J INFECT DIS, V185, P1517, DOI 10.1086/340216; Lanoue A, 2004, J EXP MED, V200, P1383, DOI 10.1084/jem.20040795; Law SKA, 1997, PROTEIN SCI, V6, P263; Mabbott NA, 2001, J GEN VIROL, V82, P2307, DOI 10.1099/0022-1317-82-10-2307; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.78.21.12090-12095.2004; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Park CG, 2001, INT IMMUNOL, V13, P1283, DOI 10.1093/intimm/13.10.1283; Picard C, 2003, CURR OPIN ALLERGY CL, V3, P451, DOI 10.1097/01.all.0000104457.09202.c0; Pozdnyakova O, 2003, J IMMUNOL, V170, P84, DOI 10.4049/jimmunol.170.1.84; SawantMane S, 1996, J NEUROIMMUNOL, V69, P63; Schutze GE, 2002, PEDIATR INFECT DIS J, V21, P278, DOI 10.1097/00006454-200204000-00004; SCHWAEBLE W, 1995, J IMMUNOL, V155, P4971; Stoiber H, 2001, IMMUNOL REV, V180, P168, DOI 10.1034/j.1600-065X.2001.1800115.x; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WINKELSTEIN JA, 1977, J IMMUNOL, V118, P451; Zandvoort A, 2002, CLIN EXP IMMUNOL, V130, P4, DOI 10.1046/j.1365-2249.2002.01953.x	47	156	163	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					47	58		10.1016/j.cell.2006.01.046	http://dx.doi.org/10.1016/j.cell.2006.01.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615889	Bronze, Green Submitted			2022-12-24	WOS:000237314200013
J	Wei, W; Lu, Q; Chaudry, GJ; Leppla, SH; Cohen, SN				Wei, W; Lu, Q; Chaudry, GJ; Leppla, SH; Cohen, SN			The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin	CELL			English	Article							PSEUDOMONAS EXOTOXIN-A; WNT SIGNALING PATHWAY; MAMMALIAN-CELLS; PROTECTIVE ANTIGEN; BETA-CATENIN; GENE FAMILY; ENDOCYTOSIS; MICE; AXIN; INACTIVATION	Toxins, produced by Bacillus anthracis and other microbial pathogens require functions of host cell genes to yield toxic effects. Here we show that low density lipoprotein receptor-related protein 6 (LRP6), previously known to be a coreceptor for the Wnt signaling pathway, is required for anthrax toxin lethality in mammalian cells. Downregulation of LRP6 or coexpression of a truncated LRP6 dominant-negative peptide inhibited cellular uptake of complexes containing the protective antigen (PA) carrier of anthrax toxin moieties and protected targeted cells from death, as did antibodies against epitopes; in the LRP6 extracellular domain. Fluorescence microscopy and biochemical analyses showed that LRP6 enables toxin internalization by interacting at the cell surface with PA receptors TEM8/ATR and/or CMG2 to form a multicomponent complex that enters cells upon PA binding. Our results, which reveal a previously unsuspected biological role for LRP6, identify LRP6 as a potential target for countermeasures against anthrax toxin lethality.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; NIAID, Div Intramural Res, Microbial Pathogenesis Sect, NIH, Bethesda, MD 20892 USA	Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Cohen, SN (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	sncohen@stanford.edu	Wei, Wensheng/AAF-1325-2020; Chaudry, Ghulam/F-9761-2011	Wei, Wensheng/0000-0002-8053-2423	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000929, ZIAAI000929] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARORA N, 1992, J BIOL CHEM, V267, P15542; Bhatnagar R, 2001, CRIT REV MICROBIOL, V27, P167, DOI 10.1080/20014091096738; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Harlow E, 1999, USING ANTIBODIES LAB; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; HOOVER DL, 1994, INFECT IMMUN, V62, P4432, DOI 10.1128/IAI.62.10.4432-4439.1994; Howard GC, 1996, J CLIN INVEST, V97, P1193, DOI 10.1172/JCI118533; Howell BW, 2001, CURR OPIN NEUROBIOL, V11, P74, DOI 10.1016/S0959-4388(00)00176-8; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Leppla SH, 2000, HANDB EXP PHARM, V145, P445; LEPPLA SH, 1995, HANDB NAT T, V8, P543; LEPPLA SH, 1988, METHOD ENZYMOL, V165, P103; Li YH, 2001, J BIOL CHEM, V276, P18000, DOI 10.1074/jbc.M101589200; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Liu SH, 2003, EXPERT OPIN BIOL TH, V3, P843, DOI 10.1517/14712598.3.5.843; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Lu Q, 2004, P NATL ACAD SCI USA, V101, P17246, DOI 10.1073/pnas.0407794101; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; MILNE JC, 1994, J BIOL CHEM, V269, P20607; OBRIEN J, 1985, INFECT IMMUN, V47, P306, DOI 10.1128/IAI.47.1.306-310.1985; ORTH K, 1992, P NATL ACAD SCI USA, V89, P7422, DOI 10.1073/pnas.89.16.7422; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Schneider WJ, 2003, CELL MOL LIFE SCI, V60, P892, DOI 10.1007/s00018-003-2183-z; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; SINGH Y, 1989, J BIOL CHEM, V264, P19103; STEFANSSON S, 1995, J BIOL CHEM, V270, P19417, DOI 10.1074/jbc.270.33.19417; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tucker AE, 2003, CELL MICROBIOL, V5, P523, DOI 10.1046/j.1462-5822.2003.00298.x; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Willert K, 1999, DEVELOPMENT, V126, P4165; WILLNOW TE, 1994, J CELL SCI, V107, P719; Yu KCW, 2001, J CLIN INVEST, V107, P1387, DOI 10.1172/JCI11750; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zilberberg A, 2004, J BIOL CHEM, V279, P17535, DOI 10.1074/jbc.M311292200	51	102	118	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1141	1154		10.1016/j.cell.2005.12.045	http://dx.doi.org/10.1016/j.cell.2005.12.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564009	Bronze			2022-12-24	WOS:000237241400016
J	Li, B; Yu, JPJ; Brunzelle, JS; Moll, GN; van der Donk, WA; Nair, SK				Li, B; Yu, JPJ; Brunzelle, JS; Moll, GN; van der Donk, WA; Nair, SK			Structure and mechanism of the lantibiotic cyclase involved in nisin biosynthesis	SCIENCE			English	Article							CRYSTAL-STRUCTURE; PROTEIN FARNESYLTRANSFERASE; METHIONINE SYNTHASE; ANGSTROM RESOLUTION; LIPID-II; PEPTIDE; ZINC; COMPLEX; LACTICIN-481; SUBSTRATE		Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; Argonne Natl Labs, Life Sci Collaborat Access Team, Argonne, IL 60439 USA; BiOMaDe Technol Fdn, Groningen, Netherlands	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Argonne National Laboratory	van der Donk, WA (corresponding author), Univ Illinois, Dept Biochem, 600 S Mathews Ave, Urbana, IL 61801 USA.	vddonk@uiuc.edu; s-nair@life.uiuc.edu	van der Donk, Wilfred/K-2961-2015; Li, Bo/H-8516-2013; Nair, Satish/AAY-2510-2021	van der Donk, Wilfred/0000-0002-5467-7071; Li, Bo/0000-0002-8019-8891; Yu, John-Paul/0000-0003-1878-052X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM058822, R01GM058822, R01GM079038] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM079038, GM58822] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALESHIN A, 1992, J BIOL CHEM, V267, P19291; Alzari PM, 1996, STRUCTURE, V4, P265, DOI 10.1016/S0969-2126(96)00031-7; Bauer H, 2000, BIOCHEM BIOPH RES CO, V275, P69, DOI 10.1006/bbrc.2000.3260; Blisnick T, 2005, MOL BIOCHEM PARASIT, V141, P39, DOI 10.1016/j.molbiopara.2005.01.013; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; CARSON M, 1997, METHOD ENZYMOL, V277, P646; Chan WC, 1996, APPL ENVIRON MICROB, V62, P2966, DOI 10.1128/AEM.62.8.2966-2969.1996; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Chatterjee C, 2005, J AM CHEM SOC, V127, P15332, DOI 10.1021/ja0543043; DelvesBroughton J, 1996, ANTON LEEUW INT J G, V69, P193, DOI 10.1007/BF00399424; Evans JC, 2004, P NATL ACAD SCI USA, V101, P3729, DOI 10.1073/pnas.0308082100; Ferrer JL, 2004, J BIOL CHEM, V279, P44235, DOI 10.1074/jbc.C400325200; Hightower KE, 1999, CURR OPIN CHEM BIOL, V3, P176, DOI 10.1016/S1367-5931(99)80030-1; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; KALETTA C, 1989, J BACTERIOL, V171, P1597, DOI 10.1128/jb.171.3.1597-1601.1989; Kuipers A, 2004, J BIOL CHEM, V279, P22176, DOI 10.1074/jbc.M312789200; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; Long SB, 2000, STRUCTURE, V8, P209, DOI 10.1016/S0969-2126(00)00096-4; Long SB, 1998, BIOCHEMISTRY-US, V37, P9612, DOI 10.1021/bi980708e; MYERS LC, 1993, SCIENCE, V261, P1164, DOI 10.1126/science.8395079; Okeley NM, 2003, BIOCHEMISTRY-US, V42, P13613, DOI 10.1021/bi0354942; Park HW, 1997, SCIENCE, V275, P1800, DOI 10.1126/science.275.5307.1800; Pejchal R, 2005, PLOS BIOL, V3, P254, DOI 10.1371/journal.pbio.0030031; Pitts KE, 2002, BIOCHEMISTRY-US, V41, P10287, DOI 10.1021/bi0259148; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Siegers K, 1996, J BIOL CHEM, V271, P12294, DOI 10.1074/jbc.271.21.12294; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; vandenHooven HW, 1996, EUR J BIOCHEM, V235, P382, DOI 10.1111/j.1432-1033.1996.00382.x; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; WILKER JJ, 1995, J AM CHEM SOC, V117, P8682, DOI 10.1021/ja00138a031; Xie LL, 2004, SCIENCE, V303, P679, DOI 10.1126/science.1092600; Zhu YT, 2003, ORG BIOMOL CHEM, V1, P3304, DOI 10.1039/b304945k	33	240	247	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2006	311	5766					1464	1467		10.1126/science.1121422	http://dx.doi.org/10.1126/science.1121422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527981				2022-12-24	WOS:000236029400050
J	Wernet, MF; Mazzoni, EO; Celik, A; Duncan, DM; Duncan, I; Desplan, C				Wernet, MF; Mazzoni, EO; Celik, A; Duncan, DM; Duncan, I; Desplan, C			Stochastic spineless expression creates the retinal mosaic for colour vision	NATURE			English	Article							PHOTORECEPTOR CELLS; TARSAL DEVELOPMENT; ANTENNAL IDENTITY; OPSIN GENE; DROSOPHILA; RHODOPSIN; R7; RECEPTOR; ARISTAPEDIA; RH3	Drosophila colour vision is achieved by R7 and R8 photoreceptor cells present in every ommatidium. The fly retina contains two types of ommatidia, called 'pale' and 'yellow', defined by different rhodopsin pairs expressed in R7 and R8 cells. Similar to the human cone photoreceptors, these ommatidial subtypes are distributed stochastically in the retina. The choice between pale versus yellow ommatidia is made in R7 cells, which then impose their fate onto R8. Here we report that the Drosophila dioxin receptor Spineless is both necessary and sufficient for the formation of the ommatidial mosaic. A short burst of spineless expression at mid-pupation in a large subset of R7 cells precedes rhodopsin expression. In spineless mutants, all R7 and most R8 cells adopt the pale fate, whereas overexpression of spineless is sufficient to induce the yellow R7 fate. Therefore, this study suggests that the entire retinal mosaic required for colour vision is defined by the stochastic expression of a single transcription factor, Spineless.	NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA; Washington Univ, Dept Biol, St Louis, MO 63130 USA	New York University; Washington University (WUSTL)	Desplan, C (corresponding author), NYU, Dept Biol, Ctr Dev Genet, 100 Washington Pl, New York, NY 10003 USA.	claude.desplan@nyu.edu	Fuss, ARZU Celik/AAD-2870-2020	Fuss, ARZU Celik/0000-0001-9889-6957; mazzoni, esteban/0000-0001-8994-681X; Desplan, Claude/0000-0002-6914-1413	NEI NIH HHS [R01 EY013010-10, R01 EY013010] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013010] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BURGESS EA, 1990, MOL GEN GENET, V221, P347, DOI 10.1007/BF00259398; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; Chou WH, 1999, DEVELOPMENT, V126, P607; Duncan DM, 1998, GENE DEV, V12, P1290, DOI 10.1101/gad.12.9.1290; Emmons RB, 1999, DEVELOPMENT, V126, P3937; FEILER R, 1992, J NEUROSCI, V12, P3862; FORTINI ME, 1990, GENE DEV, V4, P444, DOI 10.1101/gad.4.3.444; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; FRYXELL KJ, 1987, EMBO J, V6, P443, DOI 10.1002/j.1460-2075.1987.tb04774.x; Gegenfurtner KR, 2003, ANNU REV NEUROSCI, V26, P181, DOI 10.1146/annurev.neuro.26.041002.131116; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; HEISENBERG M, 1977, J COMP PHYSIOL, V117, P127, DOI 10.1007/BF00612784; Huber A, 1997, FEBS LETT, V406, P6, DOI 10.1016/S0014-5793(97)00210-X; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Mazzoni EO, 2004, DEV NEUROSCI-BASEL, V26, P388, DOI 10.1159/000082281; Mikeladze-Dvali T, 2005, CELL, V122, P775, DOI 10.1016/j.cell.2005.07.026; MILLER GV, 1981, J INSECT PHYSIOL, V27, P813, DOI 10.1016/0022-1910(81)90073-1; MONTELL C, 1987, J NEUROSCI, V7, P1558; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Papatsenko D, 1997, DEVELOPMENT, V124, P1665; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; Schmitt A, 2005, J EXP BIOL, V208, P1247, DOI 10.1242/jeb.01527; Sherry DM, 1998, VISUAL NEUROSCI, V15, P1175, DOI 10.1017/S0952523898156201; Stowers RS, 1999, GENETICS, V152, P1631; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; Tomlinson A, 2003, DEV CELL, V5, P799, DOI 10.1016/S1534-5807(03)00326-5; VONPHILIPSBORN A, 1990, J COMP PHYSIOL A, V167, P737, DOI 10.1007/BF00189764; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; WADA S, 1974, Z MORPHOL TIERE, V77, P87, DOI 10.1007/BF00374212; Wakakuwa M, 2005, NATURWISSENSCHAFTEN, V92, P464, DOI 10.1007/s00114-005-0018-5; Wernet MF, 2004, TRENDS CELL BIOL, V14, P576, DOI 10.1016/j.tcb.2004.09.007; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; White RH, 2003, J EXP BIOL, V206, P3337, DOI 10.1242/jeb.00571; WOLF R, 1980, J COMP PHYSIOL, V139, P177, DOI 10.1007/BF00657080; Wolff Tanya, 1993, P1277; XU T, 1993, DEVELOPMENT, V117, P1223; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	42	264	266	2	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 9	2006	440	7081					174	180		10.1038/nature04615	http://dx.doi.org/10.1038/nature04615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	16525464	Green Accepted, Bronze			2022-12-24	WOS:000235839500037
J	Imaizumi, M; Usa, T; Tominaga, T; Neriishi, K; Akahoshi, M; Nakashima, E; Ashizawa, K; Hida, A; Soda, M; Fujiwara, S; Yamada, M; Ejima, E; Yokoyama, N; Okubo, M; Sugino, K; Suzuki, G; Maeda, R; Nagataki, S; Eguchi, K				Imaizumi, M; Usa, T; Tominaga, T; Neriishi, K; Akahoshi, M; Nakashima, E; Ashizawa, K; Hida, A; Soda, M; Fujiwara, S; Yamada, M; Ejima, E; Yokoyama, N; Okubo, M; Sugino, K; Suzuki, G; Maeda, R; Nagataki, S; Eguchi, K			Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki Atomic Bomb survivors 55-58 years after radiation exposure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							X-RAY TREATMENT; GRAVES-DISEASE; FOLLOW-UP; RECEPTOR ANTIBODIES; RADIOACTIVE FALLOUT; MARSHALL-ISLANDS; HIGH PREVALENCE; I-131 THERAPY; SERUM TSH; CANCER	Context Effects of irradiation on thyroid diseases such as thyroid nodules and autoimmune thyroid diseases have not been evaluated among people exposed to radiation more than 50 years in the past. Objective To evaluate the prevalence of thyroid diseases and their radiation-dose responses in atomic bomb survivors. Design, Setting, and Participants Survey study comprising 4091 cohort members ( mean age, 70 [SD, 9] years; 1352 men and 2739 women) who participated in the thyroid study at the Radiation Effects Research Foundation. Thyroid examinations were conducted between March 2000 and February 2003. Main Outcome Measures Prevalence of thyroid diseases, including thyroid nodules ( malignant and benign) and autoimmune thyroid diseases, and the dose-response relationship of atomic bomb radiation in each thyroid disease. Results Thyroid diseases were identified in 1833 ( 44.8%) of the total participants ( 436 men [32.2% of men] and 1397 women [51.0% of women]) ( P <. 001). In 3185 participants, excluding persons exposed in utero, not in the city at the time of the atomic bombings, or with unknown radiation dose, the prevalence of all solid nodules, malignant tumors, benign nodules, and cysts was 14.6%, 2.2%, 4.9%, and 7.7%, respectively. The prevalence of positive thyroid antibodies, antithyroid antibody - positive hypothyroidism, and Graves disease was 28.2%, 3.2%, and 1.2%, respectively. A significant linear dose-response relationship was observed for the prevalence of all solid nodules, malignant tumors, benign nodules, and cysts ( P <. 001). We estimate that about 28% of all solid nodules, 37% of malignant tumors, 31% of benign nodules, and 25% of cysts are associated with radiation exposure at a mean and median thyroid radiation dose of 0.449 Sv and 0.087 Sv, respectively. No significant dose- response relationship was observed for positive antithyroid antibodies (P=. 20), antithyroid antibody - positive hypothyroidism ( P=. 92), or Graves disease ( P=. 10). Conclusions A significant linear radiation dose response for thyroid nodules, including malignant tumors and benign nodules, exists in atomic bomb survivors. However, there is no significant dose response for autoimmune thyroid diseases.	Radiat Effects Res Fdn, Dept Clin Studies, Nagasaki 8500013, Japan; Radiat Effects Res Fdn, Dept Stat, Nagasaki 8500013, Japan; Radiat Effects Res Fdn, Dept Stat, Hiroshima, Japan; Radiat Effects Res Fdn, Dept Clin Studies, Hiroshima, Japan; Nagasaki Univ, Dept Internal Med 1, Grad Sch Biochem Sci, Nagasaki 852, Japan; Sasebo Chuo Hosp, Nagasaki, Japan; Nagasaki Saiseikai Hosp, Hiroshima, Japan; Hisayasu Clin, Hiroshima, Japan; Tsuchiya Gen Hosp, Hiroshima, Japan; Japan Radioisotope Assoc, Tokyo, Japan	Radiation Effects Research Foundation - Japan; Radiation Effects Research Foundation - Japan; Radiation Effects Research Foundation - Japan; Radiation Effects Research Foundation - Japan; Nagasaki University	Imaizumi, M (corresponding author), Radiat Effects Res Fdn, Dept Clin Studies, 1-8-6 Nakagawa, Nagasaki 8500013, Japan.	misaima@rerf.or.jp		nagataki, shigenobu/0000-0002-9974-3554				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H., 1998, P 2 INT S INF THEOR, DOI DOI 10.1007/978-1-4612-1694-0_15; AKIBA S, 1992, 591 RAD EFF RES FDN; *AT BOMB CAS COMM, 1962, 1162 ABCC; CHIOVATO L, 1994, CLIN ENDOCRINOL, V40, P803, DOI 10.1111/j.1365-2265.1994.tb02516.x; Cologne JB, 2000, LANCET, V356, P303, DOI 10.1016/S0140-6736(00)02506-X; Cox D. R., 1974, THEORETICAL STAT; Davis S, 2004, JAMA-J AM MED ASSOC, V292, P2600, DOI 10.1001/jama.292.21.2600; Davis S., 2002, HANFORD THYROID DIS; DEGROOT LJ, 1983, AM J MED, V74, P852, DOI 10.1016/0002-9343(83)91077-X; DEMIDCHIK E, 1998, RAD THYR CANC C JUL; DOBYNS BM, 1974, J CLIN ENDOCR METAB, V38, P976, DOI 10.1210/jcem-38-6-976; Eheman CR, 2003, THYROID, V13, P453, DOI 10.1089/105072503322021115; FUGAZZOLA L, 1995, CANCER RES, V55, P5617; FUJIWARA S, 1994, RADIAT RES, V137, P89, DOI 10.2307/3578795; Hedinger, 2012, HISTOLOGICAL TYPING; HEDINGER C, 1989, CANCER-AM CANCER SOC, V63, P908, DOI 10.1002/1097-0142(19890301)63:5<908::AID-CNCR2820630520>3.0.CO;2-I; *HLTH EXP GROUP, 2005, HLTH EFF CHERN ACC S; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; ITO M, 1995, THYROID, V5, P365, DOI 10.1089/thy.1995.5.365; KAZAKOV VS, 1992, NATURE, V359, P21, DOI 10.1038/359021a0; KERBER RA, 1993, JAMA-J AM MED ASSOC, V270, P2076; Klugbauer S, 1995, ONCOGENE, V11, P2459; MORIMOTO I, 1987, J NUCL MED, V28, P1115; NAGATAKI S, 1989, LANCET, V2, P385; NAGATAKI S, 1994, JAMA-J AM MED ASSOC, V272, P364, DOI 10.1001/jama.272.5.364; Nikiforov YE, 1997, CANCER RES, V57, P1690; Nygaard B, 1997, J CLIN ENDOCR METAB, V82, P2926, DOI 10.1210/jc.82.9.2926; Nygaard B, 1999, THYROID, V9, P477, DOI 10.1089/thy.1999.9.477; OKAMURA K, 1989, J AM GERIATR SOC, V37, P317, DOI 10.1111/j.1532-5415.1989.tb05497.x; Pacini F, 1998, LANCET, V352, P763, DOI 10.1016/S0140-6736(97)11397-6; PARLE JV, 1991, CLIN ENDOCRINOL, V34, P77; PIERCE DA, 1990, RADIAT RES, V123, P275, DOI 10.2307/3577733; Pierce DA, 1996, RADIAT RES, V146, P1, DOI 10.2307/3579391; POTTERN LM, 1990, J CLIN EPIDEMIOL, V43, P449, DOI 10.1016/0895-4356(90)90133-A; PRESTON D. L., 1993, EPICURE USERS GUIDE; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Preston DL, 2004, RADIAT RES, V162, P377, DOI 10.1667/RR3232; Roesch WC, 1987, US JAPAN JOINT REASS; RON E, 1989, RADIAT RES, V120, P516, DOI 10.2307/3577801; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; SCHNEIDER AB, 1993, J CLIN ENDOCR METAB, V77, P362, DOI 10.1210/jc.77.2.362; Shibata Y, 2001, LANCET, V358, P1965, DOI 10.1016/S0140-6736(01)06971-9; Shimizu Y, 1999, RADIAT RES, V152, P374, DOI 10.2307/3580222; SHORE RE, 1993, AM J EPIDEMIOL, V137, P1068, DOI 10.1093/oxfordjournals.aje.a116610; Shore RE, 2003, HEALTH PHYS, V85, P404, DOI 10.1097/00004032-200310000-00003; SHORE RE, 1985, J NATL CANCER I, V74, P1177; SHORE RE, 1993, RADIAT RES, V134, P217, DOI 10.2307/3578462; SODA M, 2003, CANC INCIDENCE 5 CON, V8, P390; Soule J, 2001, THYROID, V11, P91, DOI 10.1089/10507250150500720; Takahashi T, 2003, J EPIDEMIOL, V13, P99, DOI 10.2188/jea.13.99; Takahashi T, 1999, INT J EPIDEMIOL, V28, P742, DOI 10.1093/ije/28.4.742; Tan GH, 1997, ANN INTERN MED, V126, P226, DOI 10.7326/0003-4819-126-3-199702010-00009; THOMPSON DE, 1994, RAD RES S, V137, P17; VANDERPUMP MPJ, 2000, WERNER INGBARS THYRO, P467; Wallaschofski H, 2001, HORM METAB RES, V33, P504, DOI 10.1055/s-2001-16945; Williams ED, 2004, BRIT J CANCER, V90, P2219, DOI 10.1038/sj.bjc.6601860; Yamada M, 2004, RADIAT RES, V161, P622, DOI 10.1667/RR3183; YOSHIMOTO Y, 1995, RADIAT RES, V141, P278, DOI 10.2307/3579004; Young RW, 2005, REASSESSMENT ATOMIC	60	130	136	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2006	295	9					1011	1022		10.1001/jama.295.9.1011	http://dx.doi.org/10.1001/jama.295.9.1011			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	016XJ	16507802	Bronze			2022-12-24	WOS:000235656600021
J	Fidler, H; Thompson, C; Freeman, A; Hogan, D; Walker, G; Weinman, J				Fidler, H; Thompson, C; Freeman, A; Hogan, D; Walker, G; Weinman, J			Barriers to implementing a policy not to attempt resuscitation in acute medical admissions: prospective, cross sectional study of a successive cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To establish whether acutely unwell patients admitted to hospital wish to participate in discussions about resuscitation. Design Prospective, cross sectional study of a successive cohort of patients. Setting Admission through the emergency department. Participants 374 adult patients. Main outcome measure Whether acutely unwell patients wished to participate in discussions about resuscitation. Results Of the total sample, 74 patients consented to take part in the Study and provide full data. Of the remaining patients, 189 could not be approached for practical reasons and 111 did not wish to participate. Of the 74 patients who read the leallet, 65 (88%) reported having little or no prior knowledge, 70 (95%) understood it, 56 (76%) preferred for resuscitation decisions to be discussed with them, and 55 (74%) did not mind discussing resuscitation within 24 hours of admission and overall showed a decline in their anxiety score. Conclusion Many patients admitted through the emergency department for medical reasons cannot participate in their decision not to attempt resuscitation within 24 hours of admission. Patients who were willing to participate rated the information leaflet that was provided positively.	Inst Psychiat, Dept Psychol, Hlth Psychol Sect, London SE5 8AH, England; Univ Hosp Lewisham, Dept Gastroenterol, London SE13 6LH, England; Univ Hosp Lewisham, Emergency Dept, London SE13 6LH, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Weinman, J (corresponding author), Inst Psychiat, Dept Psychol, Hlth Psychol Sect, London SE5 8AH, England.	john.weinman@kcl.ac.uk		Weinman, John Alfred/0000-0002-6786-0166				*BMA RES COUNC UK, 2002, DEC REL CARD RES JOI; Cauchi L, 2004, RESUSCITATION, V63, P157, DOI 10.1016/j.resuscitation.2004.05.017; KIRK P, 2004, BRIT MED J, V328, P1344; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Vedula KC, 2004, ANN EMERG MED, V44, pS68, DOI 10.1016/j.annemergmed.2004.07.226	5	12	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2006	332	7539					461	462		10.1136/bmj.38740.855914.BE	http://dx.doi.org/10.1136/bmj.38740.855914.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018VM	16473857	Green Published, Bronze			2022-12-24	WOS:000235792900018
J	Chen, M; Wang, YH; Wang, YH; Huang, L; Sandoval, H; Liu, YJ; Wang, J				Chen, M; Wang, YH; Wang, YH; Huang, L; Sandoval, H; Liu, YJ; Wang, J			Dendritic cell apoptosis in the maintenance of immune tolerance	SCIENCE			English	Article							TRANSGENIC MICE; AUTOIMMUNE-DISEASE; T-LYMPHOCYTES; FAS LIGAND; IN-VIVO; ACTIVATION; EXPRESSION; PROLIFERATION; THYMOCYTES; MUTATIONS	Apoptosis in the immune system is critical for maintaining self-tolerance and preventing autoimmunity. Nevertheless, inhibiting apoptosis in lymphocytes is not alone sufficient to break self-tolerance, suggesting the involvement of other cell types. We investigated whether apoptosis in dendritic cells (DCs) helps regulate self-tolerance by generating transgenic mice expressing the baculoviral caspase inhibitor, p35, in DCs (DC-p35). DC-p35 mice displayed defective DC apoptosis, resulting in their accumulation and, in turn, chronic lymphocyte activation and systemic autoimmune manifestations. The observation that a defect in DC apoptosis can independently lead to autoimmunity is consistent with a central rote for these cells in maintaining immune self-tolerance.	Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Chen, M (corresponding author), Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA.	minc@bcm.edu; jinwang@bcm.edu		Sandoval, Hector/0000-0002-9186-7384; Chen, Min/0000-0002-0093-9056; Wang, Jin/0000-0002-3116-0838				Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; Chen M., UNPUB; Doerfler P, 2000, J IMMUNOL, V164, P4071, DOI 10.4049/jimmunol.164.8.4071; Fields ML, 2001, J IMMUNOL, V167, P2370, DOI 10.4049/jimmunol.167.4.2370; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; Izquierdo M, 1999, EMBO J, V18, P156, DOI 10.1093/emboj/18.1.156; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Ludewig B, 1998, J EXP MED, V188, P1493, DOI 10.1084/jem.188.8.1493; Maas A, 1999, J IMMUNOL, V162, P6526; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Nopora A, 2002, J IMMUNOL, V169, P3006, DOI 10.4049/jimmunol.169.6.3006; RATHMELL JC, 2002, CELL S, V109, P97; Roskrow MA, 1999, LEUKEMIA RES, V23, P549, DOI 10.1016/S0145-2126(99)00045-4; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Smith KGC, 1996, EMBO J, V15, P5167, DOI 10.1002/j.1460-2075.1996.tb00901.x; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Wu ZQ, 2004, J IMMUNOL, V172, P6313, DOI 10.4049/jimmunol.172.10.6313; Xu GZ, 2001, NATURE, V410, P494, DOI 10.1038/35068604; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S; Zornig M, 1998, CURR BIOL, V8, P467, DOI 10.1016/S0960-9822(98)70182-4	29	248	260	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2006	311	5764					1160	1164		10.1126/science.1122545	http://dx.doi.org/10.1126/science.1122545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017IU	16497935				2022-12-24	WOS:000235688100051
J	Griffiths, S; Sharp, R; Foote, TN; Bertin, I; Wanous, M; Reader, S; Colas, I; Moore, G				Griffiths, S; Sharp, R; Foote, TN; Bertin, I; Wanous, M; Reader, S; Colas, I; Moore, G			Molecular characterization of Ph1 as a major chromosome pairing locus in polyploid wheat	NATURE			English	Article							TRITICUM-AESTIVUM; HEXAPLOID WHEAT; GENETIC CONTROL; COMMON WHEAT; BAC LIBRARY; CONSTRUCTION; TURGIDUM; HOMOLOG; GENOMES	The foundation of western civilization owes much to the high fertility of bread wheat, which results from the stability of its polyploid genome. Despite possessing multiple sets of related chromosomes, hexaploid ( bread) and tetraploid ( pasta) wheat both behave as diploids at meiosis. Correct pairing of homologous chromosomes is controlled by the Ph1 locus(1). In wheat hybrids, Ph1 prevents pairing between related chromosomes(2). Lack of Ph1 activity in diploid relatives of wheat suggests that Ph1 arose on polyploidization(3). Absence of phenotypic variation, apart from dosage effects, and the failure of ethylmethane sulphonate treatment to yield mutants, indicates that Ph1 has a complex structure(4,5). Here we have localized Ph1 to a 2.5-megabase interstitial region of wheat chromosome 5B containing a structure consisting of a segment of subtelomeric heterochromatin that inserted into a cluster of cdc2-related genes after polyploidization. The correlation of the presence of this structure with Ph1 activity in related species, and the involvement of heterochromatin with Ph1 (ref. 6) and cdc2 genes with meiosis, makes the structure a good candidate for the Ph1 locus.	Augustana Coll, Sioux Falls, SD 57197 USA; John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Moore, G (corresponding author), John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England.	graham.moore@bbsrc.ac.uk	Colas, Isabelle/AAG-1908-2021	Colas, Isabelle/0000-0001-6980-9906				Allouis S, 2003, CEREAL RES COMMUN, V31, P331; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bass HW, 2000, J CELL SCI, V113, P1033; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; Cenci A, 2003, THEOR APPL GENET, V107, P931, DOI 10.1007/s00122-003-1331-z; CHAPMAN V, 1970, NATURE, V226, P376, DOI 10.1038/226376a0; DOVER GA, 1972, NATURE, V240, P159, DOI 10.1038/240159a0; Dunford RP, 2005, THEOR APPL GENET, V110, P925, DOI 10.1007/s00122-004-1912-5; Endo TR, 1996, J HERED, V87, P295, DOI 10.1093/oxfordjournals.jhered.a023003; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Foote T, 1997, GENETICS, V147, P801; Foote Trade N., 2004, Functional & Integrative Genomics, V4, P26, DOI 10.1007/s10142-003-0101-y; Giorgi B., 1978, Mutation Breeding Newsletter, P4; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; KURATA N, 1994, BIO-TECHNOL, V12, P276, DOI 10.1038/nbt0394-276; Martinez M, 2001, THEOR APPL GENET, V102, P751, DOI 10.1007/s001220051706; Martinez-Perez E, 2001, NATURE, V411, P204, DOI 10.1038/35075597; MOORE G, 1993, BIO-TECHNOL, V11, P584, DOI 10.1038/nbt0593-584; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Prieto P, 2004, NAT CELL BIOL, V6, P906, DOI 10.1038/ncb1168; Rao P. S., 1968, WHEAT INFORM SERV, V26, P6; RILEY R, 1959, NATURE, V183, P1244, DOI 10.1038/1831244a0; RILEY R, 1958, NATURE, V182, P713, DOI 10.1038/182713a0; Roberts MA, 1999, GENETICS, V153, P1909; Sasaki T, 2005, PLANT CELL PHYSIOL, V46, P3, DOI 10.1093/pcp/pci503; Schlueter SD, 2003, NUCLEIC ACIDS RES, V31, P3597, DOI 10.1093/nar/gkg533; SEARS ER, 1977, CAN J GENET CYTOL, V19, P585, DOI 10.1139/g77-063; WALL AM, 1971, GENET RES, V18, P329, DOI 10.1017/S0016672300012726	29	333	368	3	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 9	2006	439	7077					749	752		10.1038/nature04434	http://dx.doi.org/10.1038/nature04434			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	010KH	16467840				2022-12-24	WOS:000235193100050
J	Ling, JQ; Li, T; Hu, JF; Vu, TH; Chen, HL; Qiu, XW; Cherry, AM; Hoffman, AR				Ling, JQ; Li, T; Hu, JF; Vu, TH; Chen, HL; Qiu, XW; Cherry, AM; Hoffman, AR			CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1	SCIENCE			English	Article							IMPRINTING CONTROL REGION; BETA-GLOBIN LOCUS; ENHANCER-BLOCKING ACTIVITY; CHROMOSOME TERRITORIES; GENE-REGULATION; H19 GENE; CHROMATIN; METHYLATION; SITES; TRANSCRIPTION	Gene transcription may be regulated by remote enhancer or insulator regions through chromosome looping. Using a modification of chromosome conformation capture (3C) and fluorescence in situ hybridization, we found that one allele of the insulin-like growth factor 2 (Igf2)/H19 imprinting control region (ICR) on chromosome 7 colocalized with one allele of Wsb1/Nf1 on chromosome 11. Omission of CCCTC-binding factor ( CTCF) or deletion of the maternal ICR abrogated this association and altered Wsb1/Nf1 gene expression. These findings demonstrate that CTCF mediates an interchromosomal association, perhaps by directing distant DNA segments to a common transcription factory, and the data provide a model for long-range allele-specific associations between gene regions on different chromosomes that suggest a framework for DNA recombination and RNA trans-splicing.	Palo Alto Hlth Care Syst, Dept Vet Affairs, Med Serv, Palo Alto, CA 94304 USA; Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Stanford University	Hoffman, AR (corresponding author), Palo Alto Hlth Care Syst, Dept Vet Affairs, Med Serv, Palo Alto, CA 94304 USA.	arhoffman@stanford.edu	Hu, Jifan/Q-3003-2019	HU, Jifan/0000-0002-2174-0361; Hoffman, Andrew/0000-0002-0145-1917	NICHD NIH HHS [HD047013] Funding Source: Medline; NIDDK NIH HHS [DK036054, DK065283] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036054, R21DK065283] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Grande MA, 1997, J CELL SCI, V110, P1781; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim A, 2004, P NATL ACAD SCI USA, V101, P7028, DOI 10.1073/pnas.0307985101; Lestou VS, 2002, CANCER GENET CYTOGEN, V138, P153, DOI 10.1016/S0165-4608(02)00583-6; Lopes S, 2003, HUM MOL GENET, V12, P295, DOI 10.1093/hmg/ddg022; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pant V, 2004, MOL CELL BIOL, V24, P3497, DOI 10.1128/MCB.24.8.3497-3504.2004; Puttaraju M, 1999, NAT BIOTECHNOL, V17, P246, DOI 10.1038/6986; Ragoczy T, 2003, CHROMOSOME RES, V11, P513, DOI 10.1023/A:1024939130361; Sasaki H, 2000, J BIOCHEM, V127, P711, DOI 10.1093/oxfordjournals.jbchem.a022661; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Szabo PE, 2004, MOL CELL BIOL, V24, P4791, DOI 10.1128/MCB.24.11.4791-4800.2004; Thorvaldsen JL, 2002, MOL CELL BIOL, V22, P2450, DOI 10.1128/MCB.22.8.2450-2462.2002; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Verschure PJ, 1999, J CELL BIOL, V147, P13, DOI 10.1083/jcb.147.1.13; Walter J, 2003, HUM MOL GENET, V12, pR215, DOI 10.1093/hmg/ddg296; Weber M, 2003, MOL CELL BIOL, V23, P8953, DOI 10.1128/MCB.23.24.8953-8959.2003; Yang L, 2004, J BIOL CHEM, V279, P46253, DOI 10.1074/jbc.M408155200; Zaidi SK, 2005, EMBO REP, V6, P128, DOI 10.1038/sj.embor.7400337	29	381	392	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					269	272		10.1126/science.1123191	http://dx.doi.org/10.1126/science.1123191			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614224				2022-12-24	WOS:000236765300050
J	Brown, MJ				Brown, MJ			Hypertension and ethnic group	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-PRESSURE FALL; UK HIGHER; RENIN; MANAGEMENT; AFRICAN; BLACKS; WHITES; AGE; POPULATIONS; SLAVERY		Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Brown, MJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England.	mjb14@cam.ac.uk						ABSON CP, 1981, S AFR MED J, V60, P47; Agyemang C, 2005, J HYPERTENS, V23, P913, DOI 10.1097/01.hjh.0000166827.94699.f9; Agyemang C, 2003, J HUM HYPERTENS, V17, P523, DOI 10.1038/sj.jhh.1001586; Agyemang C, 2002, J HUM HYPERTENS, V16, P739, DOI 10.1038/sj.jhh.1001488; [Anonymous], 1987, J Chronic Dis, V40, P839; [Anonymous], [No title captured]; Baker EH, 1998, LANCET, V351, P1388, DOI 10.1016/S0140-6736(97)07306-6; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; BUHLER FR, 1975, AM J CARDIOL, V36, P653, DOI 10.1016/0002-9149(75)90168-X; Campese VM, 1997, NEPHROL DIAL TRANSPL, V12, P399, DOI 10.1093/ndt/12.3.399; Cappuccio FP, 2002, BRIT MED J, V325, P1271, DOI 10.1136/bmj.325.7375.1271; Cappuccio FP, 1997, HEART, V78, P555, DOI 10.1136/hrt.78.6.555; Caulfield M, 2003, LANCET, V361, P2118, DOI 10.1016/S0140-6736(03)13722-1; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P456; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; CRUICKSHANK JK, 1980, BRIT MED J, V281, P1108, DOI 10.1136/bmj.281.6248.1108; CURTIN PD, 1992, AM J PUBLIC HEALTH, V82, P1681, DOI 10.2105/AJPH.82.12.1681; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Dickerson JEC, 1999, LANCET, V353, P2008, DOI 10.1016/S0140-6736(98)07614-4; FALKNER B, 1990, HYPERTENSION, V15, P681, DOI 10.1161/01.HYP.15.6.681; Ferdinand KC, 2003, AM J HYPERTENS, V16, p50S, DOI 10.1016/S0895-7061(03)01069-0; FISHER NDL, 1994, HYPERTENSION, V23, P179, DOI 10.1161/01.HYP.23.2.179; Gibbs CR, 1999, QJM-INT J MED, V92, P187, DOI 10.1093/qjmed/92.4.187; GUYTON AC, 1972, AM J MED, V52, P584, DOI 10.1016/0002-9343(72)90050-2; GUYTON AC, 1992, HYPERTENSION, V19, pI2, DOI 10.1161/01.HYP.19.1_Suppl.I2; He FJ, 1998, HYPERTENSION, V32, P820, DOI 10.1161/01.HYP.32.5.820; JAMES GD, 1986, J HYPERTENS, V4, pS387; JULIUS S, 1988, AM HEART J, V116, P600, DOI 10.1016/0002-8703(88)90557-1; Kaufman JS, 2003, EPIDEMIOLOGY, V14, P111, DOI 10.1097/00001648-200301000-00027; Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549; Khan JM, 2005, HEART, V91, P1105, DOI 10.1136/hrt.2004.044560; Kizer JR, 2004, HYPERTENSION, V43, P1182, DOI 10.1161/01.HYP.0000128738.94190.9f; Klag MJ, 1997, JAMA-J AM MED ASSOC, V277, P1293, DOI 10.1001/jama.277.16.1293; Lane DA, 2005, J HYPERTENS, V23, P1347, DOI 10.1097/01.hjh.0000173516.60610.b5; Laragh JH, 2001, AM J HYPERTENS, V14, P1173, DOI 10.1016/S0895-7061(01)02261-0; LARAGH JH, 1979, JAMA-J AM MED ASSOC, V241, P151, DOI 10.1001/jama.241.2.151; LUFT FC, 1979, CIRCULATION, V59, P643, DOI 10.1161/01.CIR.59.4.643; LUNDJOHANSEN P, 1991, HYPERTENSION, V18, pS54; MACGREGOR GA, 1981, NATURE, V291, P329, DOI 10.1038/291329a0; Mackenzie IS, 2002, CLIN MED, V2, P465, DOI 10.7861/clinmedicine.2-5-465; MANATUNGA AK, 1993, HYPERTENSION, V22, P84, DOI 10.1161/01.HYP.22.1.84; MATERSON BJ, 1993, NEW ENGL J MED, V328, P914, DOI 10.1056/NEJM199304013281303; NYENGAARD JR, 1992, ANAT REC, V232, P194, DOI 10.1002/ar.1092320205; Padmanabhan S, 2006, HYPERTENSION, V47, P603, DOI 10.1161/01.HYP.0000197947.62601.9d; PRATT JH, 1989, NEW ENGL J MED, V321, P1152, DOI 10.1056/NEJM198910263211703; Preston RA, 1998, JAMA-J AM MED ASSOC, V280, P1168, DOI 10.1001/jama.280.13.1168; Raleigh VS, 1997, BMJ-BRIT MED J, V314, P209, DOI 10.1136/bmj.314.7075.209; Sehgal AR, 2004, HYPERTENSION, V43, P566, DOI 10.1161/01.HYP.0000118019.28487.9c; The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; WEIR MR, 1995, HYPERTENSION, V26, P124, DOI 10.1161/01.HYP.26.1.124; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634; WILSON TW, 1991, HYPERTENSION, V17, pI122, DOI 10.1161/01.HYP.17.1_Suppl.I122; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988	53	89	91	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2006	332	7545					833	836B		10.1136/bmj.332.7545.833	http://dx.doi.org/10.1136/bmj.332.7545.833			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032ZQ	16601044	Green Published			2022-12-24	WOS:000236815900022
J	Speder, P; Adam, G; Noselli, S				Speder, P; Adam, G; Noselli, S			Type ID unconventional myosin controls left-right asymmetry in Drosophila	NATURE			English	Article							RIGHT DETERMINANT INVERSIN; COMPARTMENTAL ORGANIZATION; GENITAL DISC; N-CADHERIN; MELANOGASTER; CALMODULIN; ESTABLISHMENT; ROTATION; PATHWAY; EMBRYO	Breaking left - right symmetry in Bilateria embryos is a major event in body plan organization that leads to polarized adult morphology, directional organ looping, and heart and brain function(1-4). However, the molecular nature of the determinant(s) responsible for the invariant orientation of the left - right axis ( situs choice) remains largely unknown. Mutations producing a complete reversal of left - right asymmetry ( situs inversus) are instrumental for identifying mechanisms controlling handedness, yet only one such mutation has been found in mice ( inversin)(5) and snails(6,7). Here we identify the conserved type ID unconventional myosin 31DF gene (Myo31DF) as a unique situs inversus locus in Drosophila. Myo31DF mutations reverse the dextral looping of genitalia, a prominent left - right marker in adult flies. Genetic mosaic analysis pinpoints the A8 segment of the genital disc as a left - right organizer and reveals an anterior - posterior compartmentalization of Myo31DF function that directs dextral development and represses a sinistral default state. As expected of a determinant, Myo31DF has a trigger-like function and is expressed symmetrically in the organizer, and its symmetrical overexpression does not impair left - right asymmetry. Thus Myo31DF is a dextral gene with actin-based motor activity controlling situs choice. Like mouse inversin(8), Myo31DF interacts and colocalizes with beta-catenin, suggesting that situs inversus genes can direct left - right development through the adherens junction.	Univ Nice, Inst Signalling Dev Biol & Canc, CNRS, UMR6543, F-06108 Nice 2, France; Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Noselli, S (corresponding author), Univ Nice, Inst Signalling Dev Biol & Canc, CNRS, UMR6543, F-06108 Nice 2, France.	noselli@unice.fr		Noselli, stephane/0000-0002-7296-324X; Speder, Pauline/0000-0002-2934-5841				Adam G, 2003, DEVELOPMENT, V130, P2397, DOI 10.1242/dev.00460; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Bisgrove BW, 2003, ANNU REV GENOM HUM G, V4, P1, DOI 10.1146/annurev.genom.4.070802.110428; Bobinnec Y, 1999, EUR J CELL BIOL, V78, P671, DOI 10.1016/S0171-9335(99)80053-3; Bonnafe E, 2004, MOL CELL BIOL, V24, P4417, DOI 10.1128/MCB.24.10.4417-4427.2004; Casares F, 1997, DEV GENES EVOL, V207, P216, DOI 10.1007/s004270050110; Chen EH, 1997, DEVELOPMENT, V124, P205; Dubruille R, 2002, DEVELOPMENT, V129, P5487, DOI 10.1242/dev.00148; Eley L, 2004, CELL BIOL INT, V28, P119, DOI 10.1016/j.cellbi.2003.11.009; Freeland DE, 1996, MECH DEVELOP, V56, P61, DOI 10.1016/0925-4773(96)00511-4; FREEMAN G, 1982, ROUX ARCH DEV BIOL, V191, P69, DOI 10.1007/BF00848443; Garcia-Castro MI, 2000, SCIENCE, V288, P1047, DOI 10.1126/science.288.5468.1047; Gleichauf R, 1936, Z WISS ZOOL ABT A, V148, P1; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Huber LA, 2000, TRAFFIC, V1, P494, DOI 10.1034/j.1600-0854.2000.010607.x; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Macias A, 2004, INT J DEV BIOL, V48, P1087, DOI 10.1387/ijdb.041859am; Morgan D, 1998, NAT GENET, V20, P149, DOI 10.1038/2450; Morgan D, 2002, HUM GENET, V110, P377, DOI 10.1007/s00439-002-0696-4; MORGAN NS, 1995, DEV BIOL, V172, P51, DOI 10.1006/dbio.1995.0005; Nurnberger J, 2002, MOL BIOL CELL, V13, P3096, DOI 10.1091/mbc.E02-04-0195; Raya A, 2004, CURR OPIN GENET DEV, V14, P575, DOI 10.1016/j.gde.2004.07.011; Sanchez L, 1997, DEV GENES EVOL, V207, P229, DOI 10.1007/s004270050111; Shibazaki Y, 2004, CURR BIOL, V14, P1462, DOI 10.1016/j.cub.2004.08.018; Strutt H, 2003, CURR BIOL, V13, P1451, DOI 10.1016/S0960-9822(03)00545-1; Ueshima R, 2003, NATURE, V425, P679, DOI 10.1038/425679a; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407	28	144	149	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					803	807		10.1038/nature04623	http://dx.doi.org/10.1038/nature04623			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598259				2022-12-24	WOS:000236548400043
J	Li, CB; Zhou, AL; Sang, T				Li, CB; Zhou, AL; Sang, T			Rice domestication by reducing shattering	SCIENCE			English	Article							ORYZA-SATIVA; EVOLUTION; TRAITS	Crop domestication frequently began with the selection of plants that did not naturally shed ripe fruits or seeds. The reduction in grain shattering that led to cereal domestication involved genetic loci of large effect. The molecular basis of this key domestication transition, however, remains unknown. Here we show that human selection of an amino acid substitution in the predicted DNA binding domain encoded by a gene of previously unknown function was primarily responsible for the reduction of grain shattering in rice domestication. The substitution undermined the gene function necessary for the normal development of an abscission layer that controls the separation of a grain from the pedicel.	Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University	Sang, T (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	sang@msu.edu						Cai HW, 2000, THEOR APPL GENET, V100, P840, DOI 10.1007/s001220051360; Chang TT, 2002, W CROP SCI, P3; Choi DS, 2003, PLANT CELL, V15, P1386, DOI 10.1105/tpc.011965; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Hancock J.F., 2004, PLANT EVOLUTION ORIG; Harlan J.R., 1975, CROPS MAN; Li CB, 2006, NEW PHYTOL, V170, P185, DOI 10.1111/j.1469-8137.2005.01647.x; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; Nagai YS, 2002, RICE GENET NEWSL, V19, P74; Oka H. I., 1988, Origin of cultivated rice.; Paterson AH, 2002, NEW PHYTOL, V154, P591, DOI 10.1046/j.1469-8137.2002.00420.x; Patterson SE, 2001, PLANT PHYSIOL, V126, P494, DOI 10.1104/pp.126.2.494; Poncet V, 2000, THEOR APPL GENET, V100, P147, DOI 10.1007/s001220050020; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Sharma SD, 2000, RICE BREEDING AND GENETICS, P349; SOBRIZAL K, 1999, RICE GENET NEWSLETT, V16, P74; Vaughan D.A., 1994, GENETIC HDB; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Xiong LX, 1999, THEOR APPL GENET, V98, P243, DOI 10.1007/s001220051064; Yamasaki K, 2005, PLANT CELL, V17, P944, DOI 10.1105/tpc.104.026435	23	553	629	7	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2006	311	5769					1936	1939		10.1126/science.1123604	http://dx.doi.org/10.1126/science.1123604			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16527928				2022-12-24	WOS:000236387800048
J	Chong, AS; Shen, JK; Tao, J; Yin, DP; Kuznetsov, A; Hara, M; Philipson, LH				Chong, AS; Shen, JK; Tao, J; Yin, DP; Kuznetsov, A; Hara, M; Philipson, LH			Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration	SCIENCE			English	Article							NOD; MACROPHAGES; PANCREAS	Autoimmune destruction of beta cells is the predominant cause of type 1 diabetes mellitus (T1DM) in humans and is modeled in non-obese diabetic (NOD) mice. Many therapeutic interventions prevent the development of T1DM in NOD mice, but few can induce its reversal once established. Intervention with Freund's complete adjuvant, semi-allogeneic splenocytes, and temporary islet transplantation has been reported to cure NOD mice of established T1DM. Using the same approach, we report here that this treatment cured 32% of NOD mice of established diabetes (>340 milligrams per deciliter blood glucose), although beta cells in these mice were not derived from donor splenocytes.	Univ Chicago, Dept Surg, Sect Transplantat, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Endocrinol Sect, Chicago, IL 60637 USA; Univ Illinois, Dept Surg, Chicago, IL 60612 USA	University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chong, AS (corresponding author), Univ Chicago, Dept Surg, Sect Transplantat, 5841 S Maryland Ave, Chicago, IL 60637 USA.	achong@uchicago.edu						Bock T, 2005, DIABETES, V54, P133, DOI 10.2337/diabetes.54.1.133; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Jansen A, 1996, J AUTOIMMUN, V9, P341, DOI 10.1006/jaut.1996.0046; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Molano RD, 2003, TRANSPLANTATION, V75, P1812, DOI 10.1097/01.TP.0000064622.54799.0E; Rosmalen JGM, 2000, LAB INVEST, V80, P769, DOI 10.1038/labinvest.3780080; Rother KI, 2004, J CLIN INVEST, V114, P877, DOI 10.1172/JC1200423235; Ryu S, 2001, J CLIN INVEST, V108, P63, DOI 10.1172/JCI200112335; Suri A, 2006, SCIENCE, V311, P1778, DOI 10.1126/science.1123500	10	103	117	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2006	311	5768					1774	1775		10.1126/science.1123510	http://dx.doi.org/10.1126/science.1123510			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556844				2022-12-24	WOS:000236204300045
J	Motola, DL; Cummins, CL; Rottiers, V; Sharma, KK; Li, TT; Li, Y; Suino-Powell, K; Xu, HE; Auchus, RJ; Antebi, A; Mangelsdorf, DJ				Motola, DL; Cummins, CL; Rottiers, V; Sharma, KK; Li, TT; Li, Y; Suino-Powell, K; Xu, HE; Auchus, RJ; Antebi, A; Mangelsdorf, DJ			Identification of ligands for DAF-12 that govern Dauer formation and reproduction in C. elegans	CELL			English	Article							NUCLEAR RECEPTOR; CAENORHABDITIS-ELEGANS; LARVAL DEVELOPMENT; BILE-ACID; DEVELOPMENTAL AGE; RESPONSE ELEMENTS; LONGEVITY; DIAPAUSE; HORMONE; METABOLISM	In response to environmental and dietary cues, the C. elegans orphan nuclear receptor, DAF-12, regulates dauer diapause, reproductive development, fat metabolism, and life span. Despite strong evidence for hormonal control, the identification of the DAF-12 ligand has remained elusive. In this work, we identified two distinct 3-keto-cholestenoic acid metabolites of DAF-9, a cytochrome P450 involved in hormone production, that function as ligands for DAF-12. At nanomolar concentrations, these steroidal ligands (called dafachronic acids) bind and transactivate DAF-12 and rescue the hormone deficiency of daf-9 mutants. Interestingly, DAF-9 has a biochemical activity similar to mammalian CYP27A1 catalyzing addition of a terminal acid to the side chain of sterol metabolites. Together, these results define the first steroid hormones in nematodes as ligands for an invertebrate orphan nuclear receptor and demonstrate that steroidal regulation of reproduction, from biology to molecular mechanism, is conserved from worms to humans.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Huffington Ctr Aging, Houston, TX 77030 USA; Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Baylor College of Medicine; Van Andel Institute	Mangelsdorf, DJ (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA.	davo.mango@utsouthwestern.edu	Xu, H. Eric/ABD-7487-2021	Mangelsdorf, David/0000-0002-4355-0796; Cummins, Carolyn/0000-0001-7603-6577; Xu, H. Eric/0000-0002-6829-8144	NIA NIH HHS [AG027498] Funding Source: Medline; NIDDK NIH HHS [DK59942, DK62434, DK0716620] Funding Source: Medline; NIGMS NIH HHS [GM07062, GM069338] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK059942, U19DK062434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027498] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALBERT PS, 1988, DEV BIOL, V126, P270, DOI 10.1016/0012-1606(88)90138-8; Antebi A, 2000, GENE DEV, V14, P1512; Antebi A, 1998, DEVELOPMENT, V125, P1191; BRENNER S, 1974, GENETICS, V77, P71; CALI JJ, 1991, J BIOL CHEM, V266, P7774; Chitwood DJ, 1999, CRIT REV BIOCHEM MOL, V34, P273, DOI 10.1080/10409239991209309; CHITWOOD DJ, 1983, STEROIDS, V42, P311, DOI 10.1016/0039-128X(83)90042-9; Gems D, 1998, GENETICS, V150, P129; Gerisch B, 2004, DEVELOPMENT, V131, P1765, DOI 10.1242/dev.01068; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Gill MS, 2004, AGING CELL, V3, P413, DOI 10.1111/j.1474-9728.2004.00126.x; Gissendanner CR, 2004, DEV BIOL, V266, P399, DOI 10.1016/j.ydbio.2003.10.014; HOOD SR, 1996, METHOD MOL BIOL, P203; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Jia KL, 2002, DEVELOPMENT, V129, P221; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; LARSEN PL, 1995, GENETICS, V139, P1567; Li J, 2004, DEVELOPMENT, V131, P5741, DOI 10.1242/dev.01408; Ludewig AH, 2004, GENE DEV, V18, P2120, DOI 10.1101/gad.312604; Mak HY, 2004, DEVELOPMENT, V131, P1777, DOI 10.1242/dev.01069; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Matyash V, 2004, PLOS BIOL, V2, P1561, DOI 10.1371/journal.pbio.0020280; Merris M, 2003, J LIPID RES, V44, P172, DOI 10.1194/jlr.M200323-JLR200; Mooijaart SP, 2005, AGEING RES REV, V4, P351, DOI 10.1016/j.arr.2005.03.006; Norlin M, 2003, J LIPID RES, V44, P1515, DOI 10.1194/jlr.M300047-JLR200; Ohkura K, 2003, DEVELOPMENT, V130, P3237, DOI 10.1242/dev.00540; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; ROTTIERS V, 2006, IN PRESS DEV CELL; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Shostak Y, 2004, GENE DEV, V18, P2529, DOI 10.1101/gad.1218504; Sluder AE, 2001, TRENDS GENET, V17, P206, DOI 10.1016/S0168-9525(01)02242-9; Stiernagle T, 1999, PRACT APPROACH SER, V213, P51; THOMAS JH, 1993, GENETICS, V134, P1105; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; UOMORI A, 1987, J CHEM SOC PERK T 1, P1713, DOI 10.1039/p19870001713; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; VOWELS JJ, 1992, GENETICS, V130, P105; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Zhang Z, 2001, J LIPID RES, V42, P649	42	353	373	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1209	1223		10.1016/j.cell.2006.01.037	http://dx.doi.org/10.1016/j.cell.2006.01.037			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16529801	Bronze			2022-12-24	WOS:000237241400021
J	Penengo, L; Mapelli, M; Murachelli, AG; Confalonieri, S; Magri, L; Musacchio, A; Di Fiore, PP; Polo, S; Schneider, TR				Penengo, L; Mapelli, M; Murachelli, AG; Confalonieri, S; Magri, L; Musacchio, A; Di Fiore, PP; Polo, S; Schneider, TR			Crystal structure of the ubiquitin binding domains of rabex-5 reveals two modes of interaction with ubiquitin	CELL			English	Article							GROWTH-FACTOR RECEPTOR; NUCLEOTIDE EXCHANGE; CUE DOMAIN; PROTEIN-TRANSPORT; ZINC FINGERS; RECOGNITION; ENDOCYTOSIS; MECHANISM; COMPLEX; VPS9P	The interaction between ubiquitinated proteins and intracellular proteins harboring ubiquitin binding domains (UBDs) is critical to a multitude of cellular processes. Here, we report that Rabex-5, a guanine nucleotide exchange factor for Rab5, binds to Ub through two independent UBDs. These UBDs determine a number of properties of Rabex-5, including its coupled monoubiquitination and interaction in vivo with ubiquitinated EGFRs. Structural and biochemical characterization of the UBDs of Rabex-5 revealed that one of them (MIU, motif interacting with ubiquitin) binds to Ub with modes superimposable to those of the UIM (ubiquitin-interacting motif):Ub interaction, although in the opposite orientation, The other UBD, RUZ (Rabex-5 ubiquitin binding zinc finger) binds to a surface of Ub centered on Asp58(Ub) and distinct from the "canonical" Ile44(Ub)-based surface. The two binding surfaces allow Ub to interact simultaneously with different UBDs, thus opening new perspectives in Ub-mediated signaling.	IFOM, I-20139 Milan, Italy; Euopean Inst Oncol, I-20141 Milan, Italy; Univ Milan, I-20122 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan	Di Fiore, PP (corresponding author), IFOM, Via Adamello 16, I-20139 Milan, Italy.	pierpaolo.difiore@ifom-ieo-campus.it; simona.polo@ifom-ieo-campus.it; thomas.schneider@ifom-ieo-campus.it	Schneider, Thomas/B-7442-2011; Di Fiore, Pier Paolo/K-2130-2012; Polo, Simona/P-3509-2014; Confalonieri, Stefano/AAQ-6786-2020; Mapelli, Marina/AAC-7346-2022	Schneider, Thomas/0000-0001-6955-7374; Di Fiore, Pier Paolo/0000-0002-2252-0950; Confalonieri, Stefano/0000-0001-6886-9851; Mapelli, Marina/0000-0001-8502-0649; Polo, Simona/0000-0001-5536-9399; Musacchio, Andrea/0000-0003-2362-8784; Murachelli, Andrea Giovanni/0000-0003-2968-8972				Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Barbieri MA, 2003, J BIOL CHEM, V278, P32027, DOI 10.1074/jbc.M304324200; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Davies BA, 2003, J BIOL CHEM, V278, P19826, DOI 10.1074/jbc.M301059200; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; FAZIOLI F, 1992, J BIOL CHEM, V267, P5155; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Frank DJ, 2004, CURR OPIN CELL BIOL, V16, P189, DOI 10.1016/j.ceb.2004.02.001; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Kawasaki M, 2005, GENES CELLS, V10, P639, DOI 10.1111/j.1365-2443.2005.00865.x; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE S, 2006, IN PRESS NAT STRUCT; MATTERA R, 2006, IN PRESS J BIOL CHEM; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miller SLH, 2004, J BIOL CHEM, V279, P33528, DOI 10.1074/jbc.M313097200; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; POLO S, 2003, SCI STKE, pRE17, DOI DOI 10.1126/STKE.2132003RE17; POMILLOS O, 2002, EMBO J, V21, P2397; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Prag G, 2005, P NATL ACAD SCI USA, V102, P2334, DOI 10.1073/pnas.0500118102; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707	52	225	232	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1183	1195		10.1016/j.cell.2006.02.020	http://dx.doi.org/10.1016/j.cell.2006.02.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16499958	Green Accepted, Bronze			2022-12-24	WOS:000237241400019
J	Suri, A; Calderon, B; Esparza, TJ; Frederick, K; Bittner, P; Unanue, ER				Suri, A; Calderon, B; Esparza, TJ; Frederick, K; Bittner, P; Unanue, ER			Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells	SCIENCE			English	Article							COMPLETE FREUND ADJUVANT; NOD MICE; T-CELLS; INSULIN; PREVENTION; ONSET	Type 1 diabetes mellitus results from the autoimmune destruction of the beta cells of the pancreatic islets of Langerhans and is recapitulated in the nonobese diabetic strain of mice. In an attempt to rescue islet loss, diabetic mice were made normoglycemic by islet transplantation and immunization with Freund's complete adjuvant along with multiple injections of allogeneic mate splenocytes. This treatment allowed for survival of transplanted islets and recovery of endogenous beta cell function in a proportion of mice, but with no evidence for allogeneic splenocyte-derived differentiation of new islet beta cells. Control of the autoimmune disease at a crucial time in diabetogenesis can result in recovery of beta cell function.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Suri, A (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	anish@pathology.wustl.edu; unanue@pathbox.wustl.edu		Calderon, Boris/0000-0003-1575-0739				CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; Chong AS, 2006, SCIENCE, V311, P1774, DOI 10.1126/science.1123510; Johnson KL, 2000, BIOTECHNIQUES, V29, P1220, DOI 10.2144/00296st01; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Makhlouf L, 2004, TRANSPLANTATION, V77, P990, DOI 10.1097/01.TP.0000118410.61419.59; MCINERNEY MF, 1991, DIABETES, V40, P715, DOI 10.2337/diabetes.40.6.715; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; Nishio J, 2006, SCIENCE, V311, P1775, DOI 10.1126/science.1124004; Ryu S, 2001, J CLIN INVEST, V108, P63, DOI 10.1172/JCI200112335; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Suri A, 2004, EUR J IMMUNOL, V34, P447, DOI 10.1002/eji.200324599; SURI AK, UNPUB; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; ULAETO D, 1992, P NATL ACAD SCI USA, V89, P3927, DOI 10.1073/pnas.89.9.3927; WEGMANN DR, 1993, J AUTOIMMUN, V6, P517, DOI 10.1006/jaut.1993.1043; WEGMANN DR, 1994, J AUTOIMMUN, V7, P833, DOI 10.1006/jaut.1994.1066; WEGMANN DR, 1994, EUR J IMMUNOL, V24, P1853, DOI 10.1002/eji.1830240820	17	87	98	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1778	1780		10.1126/science.1123500	http://dx.doi.org/10.1126/science.1123500			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556846				2022-12-24	WOS:000236204300047
J	Perkins, MD; Roscigno, G; Zumla, A				Perkins, MD; Roscigno, G; Zumla, A			Progress towards improved tuberculosis diagnostics for developing countries	LANCET			English	Editorial Material							PULMONARY TUBERCULOSIS		Fdn Innovat New Diagnost, CH-1216 Geneva, Switzerland; UCL, Ctr Infect Dis & Int Hlth, Windeyer Inst Med Sci, London, England	Foundation For Innovative New Diagnostics; University of London; University College London	Perkins, MD (corresponding author), Fdn Innovat New Diagnost, 71 Ave Louis Casai, CH-1216 Geneva, Switzerland.	mark.perkins@finddiagnostics.org	ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735				Aderaye G, 2004, INFECTION, V32, P333, DOI 10.1007/s15010-004-3089-x; Brodie D, 2005, CLIN CHEST MED, V26, P247, DOI 10.1016/j.ccm.2005.02.012; Bruchfeld J, 2002, SCAND J INFECT DIS, V34, P331, DOI 10.1080/00365540110080025; Chintu C, 2005, INT J TUBERC LUNG D, V9, P477; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Perkins MD, 2000, INT J TUBERC LUNG D, V4, pS182; Squire SB, 2005, INT J TUBERC LUNG D, V9, P25; Talbot EA, 2004, CLIN INFECT DIS, V39, pE1, DOI 10.1086/421388; *WHO, 2004, GLOB TUB REP 2004	9	82	88	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2006	367	9514					942	943		10.1016/S0140-6736(06)68386-4	http://dx.doi.org/10.1016/S0140-6736(06)68386-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546544				2022-12-24	WOS:000236242100032
J	Fong, LG; Frost, D; Meta, M; Qiao, X; Yang, SH; Coffinier, C; Young, SG				Fong, LG; Frost, D; Meta, M; Qiao, X; Yang, SH; Coffinier, C; Young, SG			A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria	SCIENCE			English	Article							PHASE-I TRIAL; LAMIN-A; TRANSFERASE INHIBITOR; PRELAMIN-A; ZMPSTE24; FARNESYLATION; FIBROBLASTS; COMBINATION; DEFICIENCY; TIPIFARNIB	Progerias are rare genetic diseases characterized by premature aging. Several progeroid disorders are caused by mutations that lead to the accumulation of a lipid-modified (farnesylated) form of prelamin A, a protein that contributes to the structural scaffolding for the cell nucleus. In progeria, the accumulation of farnesyl-prelamin A disrupts this scaffolding, leading to misshapen nuclei. Previous studies have shown that farnesyltransferase inhibitors (FTIs) reverse this cellular abnormality. We tested the efficacy of an FTI (ABT-100) in Zmpste24-deficient mice, a mouse model of progeria. The FTI-treated mice exhibited improved body weight, grip strength, bone integrity, and percent survival at 20 weeks of age. These results suggest that FTIs may have beneficial effects in humans with progeria.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA; Abbott Labs, Abbott Pk, IL 60064 USA; Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94107 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Abbott Laboratories; University of California System; University of California San Francisco	Fong, LG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA.	lfong@mednet.ucla.edu; sgyoung@mednet.ucla.edu		Young, Stephen/0000-0001-7270-3176	NHLBI NIH HHS [HL76839] Funding Source: Medline; NIAMS NIH HHS [AR050200] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050200] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adjei AA, 2000, CLIN CANCER RES, V6, P2318; Adjei AA, 2003, CLIN CANCER RES, V9, P2520; Agarwal AK, 2003, HUM MOL GENET, V12, P1995, DOI 10.1093/hmg/ddg213; Alsina M, 2004, BLOOD, V103, P3271, DOI 10.1182/blood-2003-08-2764; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; Dy GK, 2005, CLIN CANCER RES, V11, P1877, DOI 10.1158/1078-0432.CCR-04-1769; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Ferguson D, 2005, CLIN CANCER RES, V11, P3045, DOI 10.1158/1078-0432.CCR-04-2041; Fong LG, 2004, P NATL ACAD SCI USA, V101, P18111, DOI 10.1073/pnas.0408558102; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; HENNEKES H, 1994, J CELL SCI, V107, P1019; Izbicka E, 2005, ANTICANCER RES, V25, P3215; Kim ES, 2005, CANCER, V104, P561, DOI 10.1002/cncr.21188; LIN F, 1993, J BIOL CHEM, V268, P16321; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Moulson CL, 2005, J INVEST DERMATOL, V125, P913, DOI 10.1111/j.0022-202X.2005.23846.x; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Shackleton S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029751; Sun JZ, 2003, CANCER RES, V63, P8922; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Young SG, 2005, J LIPID RES, V46, P2531, DOI 10.1194/jlr.R500011-JLR200	24	243	264	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1621	1623		10.1126/science.1124875	http://dx.doi.org/10.1126/science.1124875			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16484451				2022-12-24	WOS:000236029500050
J	Shekhawat, G; Tark, SH; Dravid, VP				Shekhawat, G; Tark, SH; Dravid, VP			MOSFET-embedded microcantilevers for measuring deflection in biomolecular sensors	SCIENCE			English	Article							THERMAL BIMORPH ACTUATOR; CANTILEVERS; BIOSENSOR; PROBE; ARRAY	A promising approach for detecting biomolecules follows their binding to immobilized probe molecules on microfabricated cantilevers; binding causes surface stresses that bend the cantilever. We measured this deflection, which is on the order of tens of nanometers, by embedding a metal-oxide semiconductor field-effect transistor (MOSFET) into the base of the cantilever and recording decreases in drain current with deflections as small as 5 nanometers. The gate region of the MOSFET responds to surface stresses and thus is embedded in silicon nitride so as to avoid direct contact with the sample solution. This approach, which offers low noise, high sensitivity, and direct readout, was used to detect specific binding events with biotin and antibodies.	Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA; Northwestern Univ, NUANCE Ctr, Evanston, IL 60208 USA; Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Shekhawat, G (corresponding author), Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA.	g-shekhawat@northwestern.edu; v-dravid@northwestern.edu	Dravid, Vinayak/B-6688-2009					Akiyama T, 2002, REV SCI INSTRUM, V73, P2643, DOI 10.1063/1.1488148; Akiyama T, 2000, J VAC SCI TECHNOL B, V18, P2669, DOI 10.1116/1.1327299; Baselt DR, 1997, P IEEE, V85, P672, DOI 10.1109/5.573755; Baselt DR, 1996, J VAC SCI TECHNOL B, V14, P789, DOI 10.1116/1.588714; Bashir R, 2000, J MICROMECH MICROENG, V10, P483, DOI 10.1088/0960-1317/10/4/301; Blaum A, 2001, ICMTS 2001: PROCEEDINGS OF THE 2001 INTERNATIONAL CONFERENCE ON MICROELECTRONIC TEST STRUCTURES, P125, DOI 10.1109/ICMTS.2001.928650; Boisen A, 2000, ULTRAMICROSCOPY, V82, P11, DOI 10.1016/S0304-3991(99)00148-5; Britton CL, 2000, ULTRAMICROSCOPY, V82, P17, DOI 10.1016/S0304-3991(99)00155-2; Dessard V, 2002, IEEE T ELECTRON DEV, V49, P1289, DOI 10.1109/TED.2002.1013288; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; HAMADA A, 1991, IEEE T ELECTRON DEV, V38, P895, DOI 10.1109/16.75220; Jaeger RC, 2000, IEEE J SOLID-ST CIRC, V35, P85, DOI 10.1109/4.818923; Jensenius H, 2000, APPL PHYS LETT, V76, P2615, DOI 10.1063/1.126426; Lange D, 2003, SENSOR ACTUAT A-PHYS, V103, P150, DOI 10.1016/S0924-4247(02)00307-2; Lavrik NV, 2004, REV SCI INSTRUM, V75, P2229, DOI 10.1063/1.1763252; Liu C., 2005, FDN MEMS; Marie R, 2002, ULTRAMICROSCOPY, V91, P29, DOI 10.1016/S0304-3991(02)00079-7; Minne SC, 1995, APPL PHYS LETT, V67, P3918, DOI 10.1063/1.115317; Minne SC, 1998, APPL PHYS LETT, V72, P2340, DOI 10.1063/1.121353; Raiteri R, 2001, SENSOR ACTUAT B-CHEM, V79, P115, DOI 10.1016/S0925-4005(01)00856-5; Rasmussen PA, 2003, ULTRAMICROSCOPY, V97, P371, DOI 10.1016/S0304-3991(03)00063-9; Wu GH, 2001, NAT BIOTECHNOL, V19, P856, DOI 10.1038/nbt0901-856; Wu GH, 2001, P NATL ACAD SCI USA, V98, P1560, DOI 10.1073/pnas.031362498; Yee YJ, 2000, J MICROMECH MICROENG, V10, P350, DOI 10.1088/0960-1317/10/3/308; Yue M, 2004, J MICROELECTROMECH S, V13, P290, DOI 10.1109/JMEMS.2003.823216	25	223	226	2	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1592	1595		10.1126/science.1122588	http://dx.doi.org/10.1126/science.1122588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16456038				2022-12-24	WOS:000236029500041
J	Kivelson, MG				Kivelson, MG			Perspective - Does Enceladus govern magnetospheric dynamics at Saturn?	SCIENCE			English	Editorial Material							MAGNETIC-FIELD; PLASMA; IO; INTERCHANGE; INSERTION; ORBIT		Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kivelson, MG (corresponding author), Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA.	mkivelson@igpp.ucla.edu	Kivelson, Margaret G/I-9019-2012	Kivelson, Margaret G/0000-0003-3859-8581				ACUNA MH, 1983, J GEOPHYS RES-SPACE, V88, P8771, DOI 10.1029/JA088iA11p08771; Brown RH, 2006, SCIENCE, V311, P1425, DOI 10.1126/science.1121031; CONNERNEY JEP, 1983, J GEOPHYS RES-SPACE, V88, P8779, DOI 10.1029/JA088iA11p08779; de Pater I., 2015, PLANETARY SCI; Dougherty MK, 2006, SCIENCE, V311, P1406, DOI 10.1126/science.1120985; Dougherty MK, 2005, SCIENCE, V307, P1266, DOI 10.1126/science.1106098; Espinosa SA, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2001JA005084; EVIATAR A, 1992, ANN GEOPHYS, V10, P511; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; Hill T. W., 1983, PHYSICS JOVIAN MAGNE, P353, DOI DOI 10.1017/CBO9780511564574.012; HILL TW, 1976, PLANET SPACE SCI, V24, P1151, DOI 10.1016/0032-0633(76)90152-5; Jones GH, 2006, SCIENCE, V311, P1412, DOI 10.1126/science.1121011; Jurac S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015855; Kaiser M. L., 1984, SATURN, P378; Kargel JS, 2006, SCIENCE, V311, P1389, DOI 10.1126/science.1124495; Kivelson MG, 1997, GEOPHYS RES LETT, V24, P2127, DOI 10.1029/97GL02202; Krimigis SM, 2005, SCIENCE, V307, P1270, DOI 10.1126/science.1105978; LECACHEUX A, 1997, PLANETARY RADIO EMIS, V4, P313; LEISNER, 2005, GEOPHYS RES LETT, V32, DOI DOI 10.1029/2005GL022652; NEUBAUER FM, 1980, J GEOPHYS RES-SPACE, V85, P1171, DOI 10.1029/JA085iA03p01171; Paranicas C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023656; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; SHEMANSKY DE, 1993, NATURE, V363, P329, DOI 10.1038/363329a0; SOUTHWOOD DJ, 1980, J GEOPHYS RES-SPACE, V85, P5959, DOI 10.1029/JA085iA11p05959; Southwood DJ, 2001, J GEOPHYS RES-SPACE, V106, P30109, DOI 10.1029/2001JA900110; SOUTHWOOD DJ, 2005, AM GEOPH UN FALL M S; Spahn F, 2006, SCIENCE, V311, P1416, DOI 10.1126/science.1121375; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Tokar RL, 2006, SCIENCE, V311, P1409, DOI 10.1126/science.1121061; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290; Young DT, 2005, SCIENCE, V307, P1262, DOI 10.1126/science.1106151	32	26	26	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2006	311	5766					1391	1392		10.1126/science.1124494	http://dx.doi.org/10.1126/science.1124494			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527963				2022-12-24	WOS:000236029400029
J	Chitty, LS; Kagan, KO; Molina, FS; Waters, JJ; Nicolaides, KH				Chitty, LS; Kagan, KO; Molina, FS; Waters, JJ; Nicolaides, KH			Fetal nuchal translucency scan and early prenatal diagnosis of chromosomal abnormalities by rapid aneuploidy screening: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DOWNS-SYNDROME; AMNIO-PCR	Objective To investigate an approach for the analysis of samples obtained in screening for trisomy 21 that retains the advantages of quantitative fluorescent polymerase chain reaction (qf-PCR) over full karyotyping and maximises the detection of clinically significant abnormalities. Design Observational study. Setting Tertiary referral centre. Subjects 17 446 pregnancies, from which chorionic villous samples had been taken after assessment of risk for trisomy 21 by measurement of fetal nuchal translucency (NT) thickness at 11 to 13(+6) weeks of gestation. Interventions Analysis of chorionic villous samples by full karyotyping and by qf-PCR for chromosomes 13, 18, 2 1, X, and Y. Main outcome measure Detection of clinically significant chromosomal abnormalities. Results The fetal karyotype was normal in 15 548 (89.1%) cases and abnormal in 1898 (10.9%) cases, including 1722 with a likely clinically significant adverse outcome. Karyotyping all cases would lead to the diagnosis of all clinically significant abnormalities, and a policy of relying entirely on qf-PCR would lead to the diagnosis of 97.9% of abnormalities. An alternative strategy whereby qf-PCR is the main method of analysis and full karyotyping is reserved for those cases with a minimum fetal NT thickness of 4 mm would require full karyotyping in 10.1% of the cases, would identify 99.0% of the significant abnormalities, and would cost 60% less than full karyotyping for all. Conclusions In the diagnosis of chromosomal abnormalities after first trimester screening for trisomy 2 1, a policy of qf-PCR for all samples and karyotyping only if the fetal NT thickness is increased would reduce the economic costs, provide rapid delivery of results, and identify 99% of the clinically significant chromosomal abnormalities.	Kings Coll Hosp London, Sch Med, Harris Birthright Res Ctr Fetal Med, London SE5 9RS, England; Inst Child Hlth, London WC1N 1EH, England; UCLH, London WC1N 1EH, England; Great Ormond St Hosp Sick Children, N E Thames Genet Serv, Cytogenet Lab, London WC1N 3BG, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Nicolaides, KH (corresponding author), Kings Coll Hosp London, Sch Med, Harris Birthright Res Ctr Fetal Med, Denmark Hill, London SE5 9RS, England.	kypros@fetalmedicine.com		Molina, Francisca/0000-0001-9190-5654; Nicolaides, Kypros/0000-0003-1266-0711; chitty, lyn/0000-0002-4857-7138				Adinolfi M, 2001, LANCET, V358, P1030, DOI 10.1016/S0140-6736(01)06229-8; DANIEL A, 1988, CYTOGENETICS MAMMALI, P73; Department of Health, 2003, OUR INH OUR FUT REAL; Evans MI, 1999, HUM REPROD, V14, P1213, DOI 10.1093/humrep/14.5.1213; Grimshaw G M, 2003, Health Technol Assess, V7, P1; Leung WC, 2002, PRENATAL DIAG, V22, P256, DOI 10.1002/pd.314; Levett LJ, 2001, ULTRASOUND OBST GYN, V17, P115, DOI 10.1046/j.1469-0705.2001.00340.x; Mann K, 2001, LANCET, V358, P1057, DOI 10.1016/S0140-6736(01)06183-9; PERTL B, 1994, LANCET, V343, P1197, DOI 10.1016/S0140-6736(94)92404-X; Snijders RJM, 1998, LANCET, V352, P343, DOI 10.1016/S0140-6736(97)11280-6; Souka AP, 2005, AM J OBSTET GYNECOL, V192, P1005, DOI 10.1016/j.ajog.2004.12.093; Verma L, 1998, LANCET, V352, P9, DOI 10.1016/S0140-6736(97)11090-X	12	49	55	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2006	332	7539					452	454		10.1136/bmj.38730.655197.AE	http://dx.doi.org/10.1136/bmj.38730.655197.AE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018VM	16476673	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000235792900015
J	Armakolas, A; Klar, AJS				Armakolas, A; Klar, AJS			Cell type regulates selective segregation of mouse chromosome 7 DNA strands in mitosis	SCIENCE			English	Article							STEM-CELLS; MITOTIC RECOMBINATION; COSEGREGATION; CHROMATIDS; DROSOPHILA	After chromosome replication, sister chromatid copies are generally thought to segregate randomly to daughter cells. However, sister chromatids differ in their DNA strands, with each chromatid inheriting one older strand that is paired to a newly synthesized strand. Genetic analysis with a homologous chromosome pair indicated nonrandom chromatid distribution in embryonic stem cells. Biased segregation pattern was also found in all 100 endoderm cells examined, but not in any of the 165 neuroectoderm cells. In contrast, the mesoderm, cardiomyocyte, and pancreatic cells exhibited a random mode of segregation. Strand distribution mechanisms regulated by cell, type may have consequences for cellular differentiation and for evolving strategies for developmental mechanisms.	NCI, Ctr Canc Res, Gene Regulat & Chromosome Biol Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Klar, AJS (corresponding author), NCI, Ctr Canc Res, Gene Regulat & Chromosome Biol Lab, Frederick, MD 21702 USA.	klar@ncifcrf.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010386, Z01BC010386] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARMAKOLAS A, UNPUB; Beumer KJ, 1998, GENETICS, V150, P173; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; ITO K, 1987, CELL, V49, P329, DOI 10.1016/0092-8674(87)90285-6; ITO K, 1988, GENE DEV, V2, P929, DOI 10.1101/gad.2.8.929; Karpowicz P, 2005, J CELL BIOL, V170, P721, DOI 10.1083/jcb.200502073; Klar AJS, 2004, GENETICS, V167, P1833, DOI 10.1534/genetics.104.028217; KLAR AJS, 1994, TRENDS GENET, V10, P392, DOI 10.1016/0168-9525(94)90055-8; LARK KG, 1966, SCIENCE, V154, P1202, DOI 10.1126/science.154.3753.1202; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; Merok JR, 2002, CANCER RES, V62, P6791; Nelson K, 2003, CELL BIOL INT, V27, P567, DOI 10.1016/S1065-6995(03)00097-0; PIMPINELLI S, 1986, P NATL ACAD SCI USA, V83, P3900, DOI 10.1073/pnas.83.11.3900; Potten CS, 2004, J INVEST DERM SYMP P, V9, P183, DOI 10.1111/j.1087-0024.2004.09305.x; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; Rambhatla L, 2005, CANCER RES, V65, P3155, DOI 10.1158/0008-5472.CAN-04-3161; ROSENBERGER RF, 1968, J BACTERIOL, V96, P1208, DOI 10.1128/JB.96.4.1208-1213.1968; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0	19	79	81	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2006	311	5764					1146	1149		10.1126/science.1120519	http://dx.doi.org/10.1126/science.1120519			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017IU	16497932				2022-12-24	WOS:000235688100047
J	Neher, JO				Neher, JO			First response	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Valley Family Med, Renton, WA 98055 USA; Univ Washington, Renton, WA 98055 USA	University of Washington	Neher, JO (corresponding author), Valley Family Med, 3915 Talbot Rd S,Suite 401, Renton, WA 98055 USA.								0	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2006	144	4					301	302		10.7326/0003-4819-144-4-200602210-00014	http://dx.doi.org/10.7326/0003-4819-144-4-200602210-00014			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	015HS	16490918				2022-12-24	WOS:000235543100011
J	Zhu, P; Baek, SH; Bourk, EM; Ohgi, KA; Garcia-Bassets, I; Sanjo, H; Akira, S; Kotol, PF; Glass, CK; Rosenfeld, MG; Rose, DW				Zhu, P; Baek, SH; Bourk, EM; Ohgi, KA; Garcia-Bassets, I; Sanjo, H; Akira, S; Kotol, PF; Glass, CK; Rosenfeld, MG; Rose, DW			Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway	CELL			English	Article							BREAST-CANCER CELLS; N-COR; ESTROGEN-RECEPTOR; HISTONE DEACETYLASE; PROSTATE-CANCER; COREPRESSOR COMPLEX; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; REGULATED TRANSCRIPTION; MOLECULAR DETERMINANTS	Defining the precise molecular strategies that coordinate patterns of transcriptional responses to specific signals is central for understanding normal development and homeostasis as well as the pathogenesis of hormone-dependent cancers. Here we report specific prostate cancer cell/macrophage interactions that mediate a switch in function of selective androgen receptor antagonists/modulators (SARMs) from repression to activation in vivo. This is based on an evolutionarily conserved receptor N-terminal L/HX7LL motif, selectively present in sex steroid receptors, that causes recruitment of TAB2 as a component of an N-CoR corepressor complex. TAB2 acts as a sensor for inflammatory signals by serving as a molecular beacon for recruitment of MEKK1, which in turn mediates dismissal of the N-CoR/HDAC complex and permits derepression of androgen and estrogen receptor target genes. Surprisingly, this conserved sensor strategy may have arisen to mediate reversal of sex steroid-dependent repression of a limited cohort of target genes in response to inflammatory signals, linking inflammatory and nuclear receptor ligand responses to essential reproductive functions.	Univ Calif San Diego, Sch Med, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, Mol Pathol Grad Program, La Jolla, CA 92093 USA; Seoul Natl Univ, Res Ctr Funct Cellulom, Dept Biol Sci, Seoul 151742, South Korea; Osaka Univ, Dept Host Def, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Seoul National University (SNU); Osaka University	Zhu, P (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu; dwrose@ucsd.edu	Sroka, Isis C/A-2949-2009; Akira, Shizuo/C-3134-2009; Glass, Christopher/AAI-3933-2021; Garcia-Bassets, Ivan/F-5075-2010	Glass, Christopher/0000-0003-4344-3592; Garcia-Bassets, Ivan/0000-0002-6941-9585				Alen P, 1999, MOL CELL BIOL, V19, P6085; Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chung TDK, 1999, PROSTATE, V38, P199; Cicatiello L, 2004, J MOL ENDOCRINOL, V32, P719, DOI 10.1677/jme.0.0320719; Cleutjens KBJM, 1996, J BIOL CHEM, V271, P6379, DOI 10.1074/jbc.271.11.6379; Cohen PE, 1999, J LEUKOCYTE BIOL, V66, P765, DOI 10.1002/jlb.66.5.765; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; DelosSantos MJ, 1996, BIOL REPROD, V54, P563, DOI 10.1095/biolreprod54.3.563; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Glass CK, 2000, GENE DEV, V14, P121; Gouon-Evans V, 2000, DEVELOPMENT, V127, P2269; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Guenther MG, 2000, GENE DEV, V14, P1048; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Jepsen K, 2002, J CELL SCI, V115, P689; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kusumegi T, 2004, J BIOCHEM MOL TOXIC, V18, P1, DOI 10.1002/jbt.20004; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Leek RD, 1996, CANCER RES, V56, P4625; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Monroe DG, 2000, MOL CELL BIOL, V20, P4626, DOI 10.1128/MCB.20.13.4626-4634.2000; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; PANA BC, 2001, P NATL ACAD SCI USA, V98, P1047; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Reid J, 2002, J BIOL CHEM, V277, P20079, DOI 10.1074/jbc.M201003200; Sande S, 1996, MOL ENDOCRINOL, V10, P813, DOI 10.1210/me.10.7.813; Sanjo H, 2003, MOL CELL BIOL, V23, P1231, DOI 10.1128/MCB.23.4.1231-1238.2003; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shimura S, 2000, CANCER RES, V60, P5857; Smith WL, 1997, ACAD RADIOL, V4, P657, DOI 10.1016/S1076-6332(05)80273-9; Suzuki M, 2003, J BIOL CHEM, V278, P22644, DOI 10.1074/jbc.M212399200; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Tremblay A, 1999, MOL CELL, V3, P513, DOI 10.1016/S1097-2765(00)80479-7; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X	65	218	221	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 10	2006	124	3					615	629		10.1016/j.cell.2005.12.032	http://dx.doi.org/10.1016/j.cell.2005.12.032			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	014FG	16469706	Bronze			2022-12-24	WOS:000235464000022
J	Makris, NC; Ratilal, P; Symonds, DT; Jagannathan, S; Lee, S; Nero, RW				Makris, NC; Ratilal, P; Symonds, DT; Jagannathan, S; Lee, S; Nero, RW			Fish population and behavior revealed by instantaneous continental shelf-scale imaging	SCIENCE			English	Article							REVERBERATION; ENVIRONMENT; SCATTERING; MIGRATION	Until now, continental shelf environments have been monitored with highly localized line-transect methods from slow-moving research vessels. These methods significantly undersample fish populations in time and space, leaving an incomplete and ambiguous record of abundance and behavior. We show that fish populations in continental shelf environments can be instantaneously imaged over thousands of square kilometers and continuously monitored by a remote sensing technique in which the ocean acts as an acoustic waveguide. The technique has revealed the instantaneous horizontal structural characteristics and volatile short-term behavior of very large fish shoals, containing tens of millions of fish and stretching for many kilometers.	MIT, Ctr Ocean Sci & Engn, Dept Mech Engn, Cambridge, MA 02139 USA; Northeastern Univ, Dept Elect & Comp Engn, Boston, MA 02115 USA; USN, Res Lab, Stennis Space Ctr, MS 39529 USA	Massachusetts Institute of Technology (MIT); Northeastern University; United States Department of Defense; United States Navy; Naval Research Laboratory	Makris, NC (corresponding author), MIT, Ctr Ocean Sci & Engn, Dept Mech Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	makris@mit.edu		Lee, Sunwoong/0000-0002-0485-0585				ANDRESON VC, 1967, J ACOUST SOC AM, V41, P6; Balls R., 1948, Journal du Conseil Copenhague, V15, P193; BARHAM EG, 1966, SCIENCE, V151, P1399, DOI 10.1126/science.151.3716.1399; Croft DP, 2003, FISH FISH, V4, P138, DOI 10.1046/j.1467-2979.2003.00113.x; Farmer DM, 1999, J ACOUST SOC AM, V106, P2481, DOI 10.1121/1.428082; FreuEn P., 1999, DYNAMICS PELAGIC FIS; Gerlotto F, 1999, CAN J FISH AQUAT SCI, V56, P6, DOI 10.1139/cjfas-56-1-6; Goodman J. W., 1985, STAT OPTICS; Huse I, 1996, ICES J MAR SCI, V53, P863, DOI 10.1006/jmsc.1996.9999; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; LEGGETT WC, 1977, ANNU REV ECOL SYST, V8, P285, DOI 10.1146/annurev.es.08.110177.001441; Mackinson S, 1997, FISH RES, V31, P11, DOI 10.1016/S0165-7836(97)00020-9; MacLennan D.N., 1992, SPRINGER SCI BUS MED; MAKRIS NC, 1995, J ACOUST SOC AM, V97, P3547, DOI 10.1121/1.412440; Makris NC, 1996, J ACOUST SOC AM, V100, P769, DOI 10.1121/1.416239; Makris NC, 2001, J ACOUST SOC AM, V109, P909, DOI 10.1121/1.1339826; Medwin H., 1998, FUNDAMENTALS ACOUSTI; Misund OA, 1998, ICES J MAR SCI, V55, P58, DOI 10.1006/jmsc.1997.0228; Misund OA, 1997, REV FISH BIOL FISHER, V7, P1, DOI 10.1023/A:1018476523423; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; PITCHER TJ, 1997, DEV SUSTAINING WORLD, P143; Pitcher TJ., 1993, Behaviour of teleost fishes, P363, DOI 10.1007/978-94-011-1578-0_12; POTTS GW, 1970, J ZOOL, V161, P223; Ratilal P, 2005, J ACOUST SOC AM, V117, P1977, DOI 10.1121/1.1799252; RATILAL P, 2002, THESIS MIT CAMBRIDGE; ROSE GA, 1993, NATURE, V366, P458, DOI 10.1038/366458a0; Shaw E, 1970, DEV EVOLUTION BEHAVI, P452; Siebert W., 1986, CIRCUITS SIGNALS SYS; Sund O, 1935, NATURE, V135, P953, DOI 10.1038/135953a0	29	157	171	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2006	311	5761					660	663		10.1126/science.1121756	http://dx.doi.org/10.1126/science.1121756			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011GY	16456080				2022-12-24	WOS:000235257400048
J	Nam, KT; Kim, DW; Yoo, PJ; Chiang, CY; Meethong, N; Hammond, PT; Chiang, YM; Belcher, AM				Nam, KT; Kim, DW; Yoo, PJ; Chiang, CY; Meethong, N; Hammond, PT; Chiang, YM; Belcher, AM			Virus-enabled synthesis and assembly of nanowires for lithium ion battery electrodes	SCIENCE			English	Article							GENETICALLY-ENGINEERED VIRUSES; PARTICLES; PEPTIDES; PHASE; CO3O4	The selection and assembly of materials are central issues in the development of smaller, more flexible batteries. Cobalt oxide has shown excellent electrochemical cycling properties and is thus under consideration as an electrode for advanced lithium batteries. We used viruses to synthesize and assemble nanowires of cobalt oxide at room temperature. By incorporating gold-binding peptides into the filament coat, we formed hybrid gold - cobalt oxide wires that improved battery capacity. Combining virus-templated synthesis at the peptide level and methods for controlling two-dimensional assembly of viruses on polyelectrolyte multilayers provides a systematic platform for integrating these nanomaterials to form thin, flexible lithium ion batteries.	MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; MIT, Dept Chem Engn, Cambridge, MA 02139 USA; MIT, Biol Engn Div, Cambridge, MA 02139 USA; MIT, Inst Soldier Nanotechnol, Cambridge, MA 02139 USA; MIT, Inst Collaborat Biotechnol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Belcher, AM (corresponding author), MIT, Dept Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	belcher@mit.edu	Kim, Dong-Wan/E-5310-2010; Yoo, Pil J./A-1069-2012; Ibrahim, Essam Hassan/G-1960-2018; Nam, Ki Tae/A-1866-2011; Yoo, Pil J./T-2367-2019	Kim, Dong-Wan/0000-0002-1635-6082; Yoo, Pil J./0000-0002-5499-6566; Ibrahim, Essam Hassan/0000-0003-0130-2257; Nam, Ki Tae/0000-0001-6353-8877; Yoo, Pil J./0000-0002-5499-6566; Chiang, Yet-Ming/0000-0002-0833-7674				Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; Armstrong AR, 2005, ADV MATER, V17, P862, DOI 10.1002/adma.200400795; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Brown S, 1997, NAT BIOTECHNOL, V15, P269, DOI 10.1038/nbt0397-269; Cassagneau T, 1998, ADV MATER, V10, P877, DOI 10.1002/(SICI)1521-4095(199808)10:11<877::AID-ADMA877>3.0.CO;2-1; Claye AS, 2000, J ELECTROCHEM SOC, V147, P2845, DOI 10.1149/1.1393615; DeLongchamp DM, 2003, CHEM MATER, V15, P1165, DOI 10.1021/cm020945a; Dogic Z, 1997, PHYS REV LETT, V78, P2417, DOI 10.1103/PhysRevLett.78.2417; Douglas T, 1998, NATURE, V393, P152, DOI 10.1038/30211; Guo ZP, 2005, J ELECTROCHEM SOC, V152, pA2211, DOI 10.1149/1.2051847; GYU D, 2004, ADV MATER, V16, P533; Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760; Huang Y, 2005, NANO LETT, V5, P1429, DOI 10.1021/nl050795d; Joly S, 2000, LANGMUIR, V16, P1354, DOI 10.1021/la991089t; Larcher D, 2002, J ELECTROCHEM SOC, V149, pA234, DOI 10.1149/1.1435358; Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054; Long JW, 2004, CHEM REV, V104, P4463, DOI 10.1021/cr020740l; Mann S., 2001, BIOMINERALLIZATION P; Mao CB, 2004, SCIENCE, V303, P213, DOI 10.1126/science.1092740; Mao CB, 2003, P NATL ACAD SCI USA, V100, P6946, DOI 10.1073/pnas.0832310100; Massalski T.B., 1990, BINARY ALLOY PHASE D; Mui SC, 2002, J ELECTROCHEM SOC, V149, pA1610, DOI 10.1149/1.1518482; Murr MM, 2005, P NATL ACAD SCI USA, V102, P11657, DOI 10.1073/pnas.0503968102; Nam KT, 2004, NANO LETT, V4, P23, DOI 10.1021/nl0347536; Peelle BR, 2005, LANGMUIR, V21, P6929, DOI 10.1021/la050261s; Poizot P, 2000, NATURE, V407, P496, DOI 10.1038/35035045; Sakamoto JS, 2002, J ELECTROCHEM SOC, V149, pA26, DOI 10.1149/1.1425791; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; TARASCON JM, 2004, CR CHIM, V8, P9; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Yoo PJ, 2006, NAT MATER, V5, P234, DOI 10.1038/nmat1596; Yuan ZY, 2003, MATER CHEM PHYS, V79, P1, DOI 10.1016/S0254-0584(02)00442-X; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	33	1612	1700	19	1171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					885	888		10.1126/science.1122716	http://dx.doi.org/10.1126/science.1122716			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16601154	Green Submitted			2022-12-24	WOS:000237452900039
J	Potapova, TA; Daum, JR; Pittman, BD; Hudson, JR; Jones, TN; Satinover, DL; Stukenberg, PT; Gorbsky, GJ				Potapova, TA; Daum, JR; Pittman, BD; Hudson, JR; Jones, TN; Satinover, DL; Stukenberg, PT; Gorbsky, GJ			The reversibility of mitotic exit in vertebrate cells	NATURE			English	Article							CYCLIN-A; MITOSIS; DESTRUCTION; ANAPHASE; PHOSPHORYLATION; CYTOKINESIS; HYSTERESIS; DRIVES; CDC2	A guiding hypothesis for cell-cycle regulation asserts that regulated proteolysis constrains the directionality of certain cell-cycle transitions(1,2). Here we test this hypothesis for mitotic exit, which is regulated by degradation of the cyclin-dependent kinase 1 (Cdk1) activator, cyclin B3-5. Application of chemical Cdk1 inhibitors to cells in mitosis induces cytokinesis and other normal aspects of mitotic exit, including cyclin B degradation. However, chromatid segregation fails, resulting in entrapment of chromatin in the midbody. If cyclin B degradation is blocked with a proteasome inhibitor or by expression of non-degradable cyclin B, Cdk inhibitors will nonetheless induce mitotic exit and cytokinesis. However, if after mitotic exit, the Cdk1 inhibitor is washed free from cells in which cyclin B degradation is blocked, the cells can revert back to M phase. This reversal is characterized by chromosome recondensation, nuclear envelope breakdown, assembly of microtubules into a mitotic spindle, and in most cases, dissolution of the midbody, reopening of the cleavage furrow, and realignment of chromosomes at the metaphase plate. These findings demonstrate that proteasome-dependent degradation of cyclin B provides directionality for the M phase to G1 transition.	Oklahoma Med Res Fdn, Program Mol Cell & Dev Biol, Oklahoma City, OK 73104 USA; Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Oklahoma Medical Research Foundation; University of Virginia	Gorbsky, GJ (corresponding author), Oklahoma Med Res Fdn, Program Mol Cell & Dev Biol, 825 NE 13th St, Oklahoma City, OK 73104 USA.	GJG@omrf.ouhsc.edu		Potapova, Tamara/0000-0003-2761-1795; Gorbsky, Gary/0000-0003-3076-4725; Stukenberg, Todd/0000-0002-6788-2111	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050412] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM050412] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chang DC, 2003, J BIOL CHEM, V278, P37865, DOI 10.1074/jbc.M306376200; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Cross FR, 2005, MOL BIOL CELL, V16, P2129, DOI 10.1091/mbc.E04-10-0897; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Dranovsky A, 2001, NEUROBIOL AGING, V22, P517, DOI 10.1016/S0197-4580(00)00248-7; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; LOSIEWICZ MD, 1994, BIOCHEM BIOPH RES CO, V201, P589, DOI 10.1006/bbrc.1994.1742; MINSHULL J, 1989, J CELL SCI, P77; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Niiya F, 2005, J BIOL CHEM, V280, P36502, DOI 10.1074/jbc.M508007200; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5	22	148	149	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					954	958		10.1038/nature04652	http://dx.doi.org/10.1038/nature04652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612388	Green Accepted			2022-12-24	WOS:000236736700045
J	Foster, DJ; Wilson, MA				Foster, DJ; Wilson, MA			Reverse replay of behavioural sequences in hippocampal place cells during the awake state	NATURE			English	Article							SLOW-WAVE SLEEP; MEMORY; MODEL; IMPAIRMENT; EXPERIENCE; NAVIGATION; LESIONS; TASK; RATS	The hippocampus has long been known to be involved in spatial navigational learning in rodents(1,2), and in memory for events in rodents(3,4), primates(5) and humans(6). A unifying property of both navigation and event memory is a requirement for dealing with temporally sequenced information. Reactivation of temporally sequenced memories for previous behavioural experiences has been reported in sleep in rats(7,8). Here we report that sequential replay occurs in the rat hippocampus during awake periods immediately after spatial experience. This replay has a unique form, in which recent episodes of spatial experience are replayed in a temporally reversed order. This replay is suggestive of a role in the evaluation of event sequences in the manner of reinforcement learning models. We propose that such replay might constitute a general mechanism of learning and memory.	MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health	Foster, DJ (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, 77 Massachusetts Ave,46-5223, Cambridge, MA 02139 USA.	djfoster@mit.edu						BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cichosz P, 1999, CYBERNET SYST, V30, P341, DOI 10.1080/019697299125127; Foster DJ, 2000, HIPPOCAMPUS, V10, P1, DOI 10.1002/(SICI)1098-1063(2000)10:1<1::AID-HIPO1>3.0.CO;2-1; GAFFAN D, 1994, J COGNITIVE NEUROSCI, V6, P305, DOI 10.1162/jocn.1994.6.4.305; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; LIN LJ, 1992, MACH LEARN, V8, P293, DOI 10.1007/BF00992699; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; Press WH., 1992, NUMERICAL RECIPES C; RANCK FB, 1973, EXP NEUROL, V42, P461; REYNOLDS S, 2002, CSRP021 BIRM U; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1023/A:1022633531479; SUTTON RS, 1994, P 8 YAL WORKSH AD LE, P31; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	24	973	1000	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2006	440	7084					680	683		10.1038/nature04587	http://dx.doi.org/10.1038/nature04587			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16474382				2022-12-24	WOS:000236350400046
J	Kyle, RA; Therneau, TM; Rajkumar, SV; Larson, DR; Plevak, MF; Offord, JR; Dispenzieri, A; Katzmann, JA; Melton, LJ				Kyle, RA; Therneau, TM; Rajkumar, SV; Larson, DR; Plevak, MF; Offord, JR; Dispenzieri, A; Katzmann, JA; Melton, LJ			Prevalence of monoclonal gammopathy of undetermined significance	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIPLE-MYELOMA; LONG-TERM; ADULT-POPULATION; M-COMPONENTS; PROTEINS; SERUM; FREQUENCY; COMMUNITY; HISTORY	BACKGROUND: The prevalence of monoclonal gammopathy of undetermined significance (MGUS), a premalignant plasma-cell disorder, among persons 50 years of age or older has not been accurately determined. We used sensitive laboratory techniques to ascertain the prevalence of MGUS in a large population in a well-defined geographic area. METHODS: We identified all living residents of Olmsted County, Minnesota, as of January 1, 1995. We obtained serum that remained after the performance of routine clinical tests at Mayo Clinic or asked subjects for whom such serum was unavailable to provide a sample. Agarose-gel electrophoresis was performed on all serum samples, and any serum sample with a discrete band of monoclonal protein or thought to have a localized band was subjected to immunofixation. RESULTS: Serum samples were obtained from 21,463 of the 28,038 enumerated residents 50 years of age or older (76.6 percent). MGUS was identified in 694 (3.2 percent) of these persons. Age-adjusted rates were higher in men than in women (4.0 percent vs. 2.7 percent, P<0.001). The prevalence of MGUS was 5.3 percent among persons 70 years of age or older and 7.5 percent among those 85 years of age or older. The concentration of monoclonal immunoglobulin was less than 1.0 g per deciliter in 63.5 percent and at least 2.0 g per deciliter in only 4.5 percent of 694 persons. The concentration of uninvolved immunoglobulins was reduced in 27.7 percent of 447 persons tested, and 21.5 percent of 79 tested had a monoclonal urinary light chain. CONCLUSIONS: Among residents of Olmsted County, Minnesota, MGUS was found in 3.2 percent of persons 50 years of age or older and 5.3 percent of persons 70 years of age or older.	Mayo Clin, Div Hematol, Rochester, MN 55905 USA; Mayo Clin, Div Biostat, Rochester, MN 55905 USA; Mayo Clin, Div Clin Biochem & Immunol, Rochester, MN 55905 USA; Mayo Clin, Div Epidemiol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Kyle, RA (corresponding author), Mayo Clin, Div Hematol, 200 1st St SW, Rochester, MN 55905 USA.	kyle.robert@mayo.edu	Rajkumar, S. Vincent/AAV-1834-2021	Rajkumar, S. Vincent/0000-0002-5862-1833; Dispenzieri, Angela/0000-0001-8780-9512	NCI NIH HHS [CA 62242, CA 107476] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA107476, P01CA062242] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGUZZI F, 1992, EUR J HAEMATOL, V48, P192; AXELSSON U, 1966, ACTA MED SCAND, V179, P235; CARRELL RW, 1971, AUST NZ J MED, V1, P398, DOI 10.1111/j.1445-5994.1971.tb02551.x; Cohen HJ, 1998, AM J MED, V105, P362; Cohen HJ, 1998, AM J MED, V104, P439, DOI 10.1016/S0002-9343(98)00080-1; HALLEN J, 1963, ACTA MED SCAND, V173, P737; HASTIE TJ, 1990, EN ADDITIVE MODELS; KYLE RA, 1972, BLOOD-J HEMATOL, V40, P719, DOI 10.1182/blood.V40.5.719.719; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; KYLE RA, 1978, AM J MED, V64, P814, DOI 10.1016/0002-9343(78)90522-3; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Kyle RA, 2004, MAYO CLIN PROC, V79, P859, DOI 10.4065/79.7.859; KYLE RA, 2002, MANUAL CLIN LAB IMMU, P71; LUST JA, 2005, CANC DRUG DISC DEV, P519; MALACRIDA V, 1987, J CLIN PATHOL, V40, P793, DOI 10.1136/jcp.40.7.793; Melton LJ, 1998, OSTEOPOROSIS INT, V8, P68; Melton LJ, 1997, NEW ENGL J MED, V337, P1466, DOI 10.1056/NEJM199711133372012; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Rajkumar SV, 2005, BLOOD, V106, P812, DOI 10.1182/blood-2005-03-1038; SALEUN JP, 1982, J CLIN PATHOL, V35, P63, DOI 10.1136/jcp.35.1.63; VLADUTIU AO, 1987, ANN CLIN LAB SCI, V17, P157	22	850	874	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2006	354	13					1362	1369		10.1056/NEJMoa054494	http://dx.doi.org/10.1056/NEJMoa054494			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026KO	16571879	Bronze			2022-12-24	WOS:000236338000005
J	Wolff, EW; Fischer, H; Fundel, F; Ruth, U; Twarloh, B; Littot, GC; Mulvaney, R; Rothlisberger, R; de Angelis, M; Boutron, CF; Hansson, M; Jonsell, U; Hutterli, MA; Lambert, F; Kaufmann, P; Stauffer, B; Stocker, TF; Steffensen, JP; Bigler, M; Siggaard-Andersen, ML; Udisti, R; Becagli, S; Castellano, E; Severi, M; Wagenbach, D; Barbante, C; Gabrielli, P; Gaspari, V				Wolff, EW; Fischer, H; Fundel, F; Ruth, U; Twarloh, B; Littot, GC; Mulvaney, R; Rothlisberger, R; de Angelis, M; Boutron, CF; Hansson, M; Jonsell, U; Hutterli, MA; Lambert, F; Kaufmann, P; Stauffer, B; Stocker, TF; Steffensen, JP; Bigler, M; Siggaard-Andersen, ML; Udisti, R; Becagli, S; Castellano, E; Severi, M; Wagenbach, D; Barbante, C; Gabrielli, P; Gaspari, V			Southern Ocean sea-ice extent, productivity and iron flux over the past eight glacial cycles	NATURE			English	Article							DOME-C; EAST ANTARCTICA; SALT AEROSOL; DUST; EPICA; CORE; CLIMATE; MAXIMUM; VOSTOK; CO2	Sea ice and dust flux increased greatly in the Southern Ocean during the last glacial period. Palaeorecords provide contradictory evidence about marine productivity in this region, but beyond one glacial cycle, data were sparse. Here we present continuous chemical proxy data spanning the last eight glacial cycles (740,000 years) from the Dome C Antarctic ice core. These data constrain winter sea-ice extent in the Indian Ocean, Southern Ocean biogenic productivity and Patagonian climatic conditions. We found that maximum sea-ice extent is closely tied to Antarctic temperature on multi-millennial timescales, but less so on shorter timescales. Biological dimethylsulphide emissions south of the polar front seem to have changed little with climate, suggesting that sulphur compounds were not active in climate regulation. We observe large glacial-interglacial contrasts in iron deposition, which we infer reflects strongly changing Patagonian conditions. During glacial terminations, changes in Patagonia apparently preceded sea-ice reduction, indicating that multiple mechanisms may be responsible for different phases of CO2 increase during glacial terminations. We observe no changes in internal climatic feedbacks that could have caused the change in amplitude of Antarctic temperature variations observed 440,000 years ago.	British Antarctic Survey, Cambridge CB3 0ET, England; Alfred Wegener Inst Polar & Marine Res, D-27568 Bremerhaven, Germany; Lab Glaciol & Geophys Environm, F-38402 St Martin Dheres, France; Stockholm Univ, Dept Phys Geog & Quaternary Geol, S-10691 Stockholm, Sweden; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; Univ Copenhagen, Dept Geophys, DK-2100 Copenhagen O, Denmark; Univ Florence, Dept Chem, Analyt Chem Sect, I-50019 Florence, Italy; Heidelberg Univ, Inst Umweltphys, D-69120 Heidelberg, Germany; Univ Venice, Dept Environm Sci, I-30123 Venice, Italy; Univ Venice, CNR, Inst Dynam Environm Proc, I-30123 Venice, Italy	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Stockholm University; University of Bern; University of Copenhagen; University of Florence; Ruprecht Karls University Heidelberg; Universita Ca Foscari Venezia; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Dinamica dei Processi Ambientali (IDPA-CNR); Universita Ca Foscari Venezia	Wolff, EW (corresponding author), British Antarctic Survey, High Cross,Madingley Rd, Cambridge CB3 0ET, England.	ewwo@bas.ac.uk	Fischer, Hubertus/A-1211-2014; Jonsell, Ulf/F-3116-2015; Udisti, Roberto/M-7966-2015; Wolff, Eric/AAB-1097-2021; Mulvaney, Robert/K-3929-2012; Stocker, Thomas/B-1273-2013; Fundel, Felix/C-5469-2009; Barbante, Carlo/B-3195-2011; Lambert, Fabrice/M-2003-2014; Severi, Mirko/J-2508-2012	Fischer, Hubertus/0000-0002-2787-4221; Jonsell, Ulf/0000-0001-6532-8590; Udisti, Roberto/0000-0003-4440-8238; Wolff, Eric/0000-0002-5914-8531; Mulvaney, Robert/0000-0002-5372-8148; Barbante, Carlo/0000-0003-4177-2288; Lambert, Fabrice/0000-0002-2192-024X; Steffensen, Jorgen Peder/0000-0002-5516-1093; Severi, Mirko/0000-0003-1511-6762; Becagli, Silvia/0000-0003-3633-4849	NERC [bas010016] Funding Source: UKRI; Natural Environment Research Council [bas010016] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Basile I, 1997, EARTH PLANET SC LETT, V146, P573, DOI 10.1016/S0012-821X(96)00255-5; Bopp L, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000810; Bowen H. J. M, 1979, ENV CHEM ELEMENTS; Castellano E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005259; Castellano E, 2004, GLOBAL PLANET CHANGE, V42, P195, DOI 10.1016/j.gloplacha.2003.11.007; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Cosme E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004881; Delmas RJ, 2003, TELLUS B, V55, P71, DOI 10.1034/j.1600-0889.2003.00032.x; Delmonte B, 2004, EARTH-SCI REV, V66, P63, DOI 10.1016/j.earscirev.2003.10.004; Delmonte B, 2002, CLIM DYNAM, V18, P647, DOI 10.1007/s00382-001-0193-9; Gersonde R, 2005, QUATERNARY SCI REV, V24, P869, DOI 10.1016/j.quascirev.2004.07.015; Guilderson TP, 2000, GEOCHEM GEOPHY GEOSY, V1; Hara K, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004713; Kaplan MR, 2005, QUATERNARY RES, V63, P301, DOI 10.1016/j.yqres.2004.12.003; Kirchner JW, 2003, CLIMATIC CHANGE, V58, P21, DOI 10.1023/A:1023494111532; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI 10.1126/science.11053 75; Krinner G, 2003, TELLUS B, V55, P54, DOI 10.1034/j.1600-0889.2003.00004.x; Legrand M, 1995, NATO ASI SER SER I, V30, P91; LEGRAND M, 1987, J PHYS-PARIS, V48, P77, DOI 10.1051/jphyscol:1987111; LEGRAND M, 1991, NATURE, V350, P144, DOI 10.1038/350144a0; Legrand M, 1998, J GEOPHYS RES-ATMOS, V103, P10991, DOI 10.1029/98JD00929; Legrand M. R., 1988, ANN GLACIOL, V10, P116; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Littot GC, 2002, ANN GLACIOL-SER, V35, P299, DOI 10.3189/172756402781817022; Lovelock J, 1997, PHILOS T ROY SOC B, V352, P143, DOI 10.1098/rstb.1997.0009; Lunt DJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015656; Lunt DJ, 2001, GEOPHYS RES LETT, V28, P295, DOI 10.1029/2000GL012170; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Planchon FAM, 2001, ANAL CHIM ACTA, V450, P193, DOI 10.1016/S0003-2670(01)01379-4; Rankin AM, 2004, ANN GLACIOL-SER, V39, P276, DOI 10.3189/172756404781814681; Rankin AM, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002492; Reader MC, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002063; Rothlisberger R, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020338; Rothlisberger R, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015186; Rothlisberger R, 2000, ENVIRON SCI TECHNOL, V34, P338, DOI 10.1021/es9907055; Rothlisberger R, 2000, J GEOPHYS RES-ATMOS, V105, P20565, DOI 10.1029/2000JD900264; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Traversi R, 2002, ANN GLACIOL-SER, V35, P291, DOI 10.3189/172756402781816564; Udisti R, 2004, ANN GLACIOL-SER, V39, P457, DOI 10.3189/172756404781814096; *US DEP COMM NAT O, 2001, ETOPO2 2 MIN GRIDD G; Wagenbach D, 1998, J GEOPHYS RES-ATMOS, V103, P10961, DOI 10.1029/97JD01804; Wagnon P, 1999, J GEOPHYS RES-ATMOS, V104, P3423, DOI 10.1029/98JD02855; Wainer I, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021244; Watanabe O., 2003, MEM NATL I POLAR RES, V57, P1; Weller R, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004189; Wolff EW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018454	50	392	410	0	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					491	496		10.1038/nature04614	http://dx.doi.org/10.1038/nature04614			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554810	Green Published, Bronze			2022-12-24	WOS:000236176100047
J	Spigelman, M; Gillespie, S				Spigelman, M; Gillespie, S			Tuberculosis drug development pipeline: progress and hope	LANCET			English	Editorial Material									UCL Royal Free Hosp, Royal Free & Univ Coll Med Sch, Ctr Med Microbiol, London NW3 2PF, England; Global Alliance TB Drug Dev, New York, NY USA	University of London; University College London	Gillespie, S (corresponding author), UCL Royal Free Hosp, Royal Free & Univ Coll Med Sch, Ctr Med Microbiol, London NW3 2PF, England.	s.gillespie@medsch.ucl.ac.uk						Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; GINSBERG A, IN PRESS TUBERCULOSI; MATUSMOTO M, 45 ANN INT C ANT AG; Moore-Gillon J, 2001, ANN NY ACAD SCI, V953, P233, DOI 10.1111/j.1749-6632.2001.tb11382.x; O'Brien RJ, 2005, CLIN CHEST MED, V26, P327, DOI 10.1016/j.ccm.2005.02.013; Schatz A, 1944, P SOC EXP BIOL MED, V55, P66, DOI 10.3181/00379727-55-14461; SINHA RK, 44 ANN INT C ANT AG; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; *WHO GLO TUB PROGR, 1997, WHOGTB97225	10	42	45	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					945	947		10.1016/S0140-6736(06)68388-8	http://dx.doi.org/10.1016/S0140-6736(06)68388-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546546				2022-12-24	WOS:000236242100034
J	Broadhead, R; Dawe, HR; Farr, H; Griffiths, S; Hart, SR; Portman, N; Shaw, MK; Ginger, ML; Gaskell, SJ; McKean, PG; Gull, K				Broadhead, R; Dawe, HR; Farr, H; Griffiths, S; Hart, SR; Portman, N; Shaw, MK; Ginger, ML; Gaskell, SJ; McKean, PG; Gull, K			Flagellar motility is required for the viability of the bloodstream trypanosome	NATURE			English	Article							PROTEOMIC ANALYSIS; PARAFLAGELLAR ROD; BRUCEI; GENE; PROTEIN; CILIA; IDENTIFICATION; EXPRESSION; GENOMICS; PROTOZOA	The 9+2 microtubule axoneme of flagella and cilia represents one of the most iconic structures built by eukaryotic cells and organisms. Both unity and diversity are present among cilia and flagella on the evolutionary as well as the developmental scale. Some cilia are motile, whereas others function as sensory organelles and can variously possess 9+2 and 9+0 axonemes and other associated structures(1). How such unity and diversity are reflected in molecular repertoires is unclear. The flagellated protozoan parasite Trypanosoma brucei is endemic in sub-Saharan Africa, causing devastating disease in humans and other animals(2). There is little hope of a vaccine for African sleeping sickness and a desperate need for modern drug therapies(3). Here we present a detailed proteomic analysis of the trypanosome flagellum. RNA interference (RNAi)-based interrogation of this proteome provides functional insights into human ciliary diseases and establishes that flagellar function is essential to the bloodstream-form trypanosome. We show that RNAi-mediated ablation of various proteins identified in the trypanosome flagellar proteome leads to a rapid and marked failure of cytokinesis in bloodstream-form ( but not procyclic insect-form) trypanosomes, suggesting that impairment of flagellar function may provide a method of disease control. A postgenomic meta-analysis, comparing the evolutionarily ancient trypanosome with other eukaryotes including humans, identifies numerous trypanosome-specific flagellar proteins, suggesting new avenues for selective intervention.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Lancaster, Dept Biol Sci, Lancaster LA1 4YQ, England; Univ Manchester, Sch Chem, Michael Barber Ctr Mass Spectrometry, Manchester M60 1QD, Lancs, England	University of Oxford; Lancaster University; University of Manchester	Gull, K (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	keith.gull@path.ox.ac.uk		Ginger, Michael/0000-0002-9643-8482; McKean, Paul Gerard/0000-0002-0445-0741; Portman, Neil/0000-0003-0248-0258; Hart, Sarah/0000-0003-0521-6284	Biotechnology and Biological Sciences Research Council [EGH17741] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Bastin P, 2000, J CELL SCI, V113, P3321; Briggs LJ, 2004, CURR BIOL, V14, pR611, DOI 10.1016/j.cub.2004.07.041; Chodhari R, 2004, Paediatr Respir Rev, V5, P69, DOI 10.1016/j.prrv.2003.09.005; Davy BE, 2003, HUM MOL GENET, V12, P1163, DOI 10.1093/hmg/ddg122; Field MC, 2004, TRAFFIC, V5, P905, DOI 10.1111/j.1600-0854.2004.00234.x; Gadelha C, 2005, EUKARYOT CELL, V4, P516, DOI 10.1128/EC.4.3.516-525.2005; Hill KL, 2003, EUKARYOT CELL, V2, P200, DOI 10.1128/EC.2.2.200-208.2003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Liska F, 2003, FOLIA BIOL-PRAGUE, V49, P129; Lorenzetti D, 2004, P NATL ACAD SCI USA, V101, P8402, DOI 10.1073/pnas.0401832101; Moreira-Leite FF, 2001, SCIENCE, V294, P610, DOI 10.1126/science.1063775; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Padma P, 2003, MOL BIOL CELL, V14, P774, DOI 10.1091/mbc.02-06-0089; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; ROBINSON D, 1991, METHOD ENZYMOL, V196, P285; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Smith JC, 2005, J PROTEOME RES, V4, P909, DOI 10.1021/pr050013h; Sternberg JM, 2004, PARASITE IMMUNOL, V26, P469, DOI 10.1111/j.0141-9838.2004.00731.x; Steverding D, 2005, EXPERT OPIN INV DRUG, V14, P939, DOI 10.1517/13543784.14.8.939; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Tam LW, 2002, CELL MOTIL CYTOSKEL, V51, P197, DOI 10.1002/cm.10023; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; WIRTZ E, 1995, SCIENCE, V268, P1179, DOI 10.1126/science.7761835; WOODWARD R, 1990, J CELL SCI, V95, P49	29	368	371	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2006	440	7081					224	227		10.1038/nature04541	http://dx.doi.org/10.1038/nature04541			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	16525475	Bronze			2022-12-24	WOS:000235839500049
J	Sharp, D				Sharp, D			Bovine tuberculosis and badger blame	LANCET			English	Editorial Material							MYCOBACTERIUM-BOVIS; MELES-MELES; CATTLE; INFECTION; DISEASE; IMPACT		The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; CLIFTONHADLEY RS, 1995, EPIDEMIOL INFECT, V114, P179, DOI 10.1017/S0950268800052031; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Delahay RJ, 2002, VET J, V164, P90, DOI 10.1053/tvjl.2001.0667; DELARUADOMENECH R, 2005, TUBERCULOSIS EDINB, DOI DOI 10.1016/J.TUBE.2005.05; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Esteban J, 2005, CLIN MICROBIOL INFEC, V11, P840, DOI 10.1111/j.1469-0691.2005.01225.x; Garnett BT, 2005, APPL ANIM BEHAV SCI, V94, P331, DOI 10.1016/j.applanim.2005.02.013; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; HANCOX M, 2002, MICROBIOL TODAY, V29, P166; Hope JC, 2005, EXPERT REV VACCINES, V4, P891, DOI 10.1586/14760584.4.6.891; Krebs J., 1997, PB3423 HMSO; LEFEVRE AM, IMPACT LOCALISED REA; O Mairtin D, 1998, PREV VET MED, V34, P47, DOI 10.1016/S0167-5877(97)00067-6; Prasad HK, 2005, TUBERCULOSIS, V85, P421, DOI 10.1016/j.tube.2005.08.005; Reynolds D, 2006, VET MICROBIOL, V112, P119, DOI 10.1016/j.vetmic.2005.11.042; Roper TJ, 2003, NATURE, V426, P782, DOI 10.1038/nature02219; Smith GC, 2007, VET J, V173, P302, DOI 10.1016/j.tvjl.2005.11.017; White PCL, 2004, PREV VET MED, V63, P1, DOI 10.1016/j.prevetmed.2004.02.003; WILSMORE T, 2005, REV INT EVIDENCE INT; Winters A., 2005, Morbidity and Mortality Weekly Report, V54, P605	22	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2006	367	9511					631	633		10.1016/S0140-6736(06)68240-8	http://dx.doi.org/10.1016/S0140-6736(06)68240-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	016HR	16503446				2022-12-24	WOS:000235611800007
J	Sharpee, TO; Sugihara, H; Kurgansky, AV; Rebrik, SP; Stryker, MP; Miller, KD				Sharpee, TO; Sugihara, H; Kurgansky, AV; Rebrik, SP; Stryker, MP; Miller, KD			Adaptive filtering enhances information transmission in visual cortex	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; CONTRAST GAIN-CONTROL; RECEPTIVE-FIELDS; NATURAL SCENES; SPATIAL SCALE; V1 NEURONS; ADAPTATION; STATISTICS; RETINA; CELLS	Sensory neuroscience seeks to understand how the brain encodes natural environments. However, neural coding has largely been studied using simplified stimuli. In order to assess whether the brain's coding strategy depends on the stimulus ensemble, we apply a new information-theoretic method that allows unbiased calculation of neural filters (receptive fields) from responses to natural scenes or other complex signals with strong multipoint correlations. In the cat primary visual cortex we compare responses to natural inputs with those to noise inputs matched for luminance and contrast. We find that neural filters adaptively change with the input ensemble so as to increase the information carried by the neural response about the filtered stimulus. Adaptation affects the spatial frequency composition of the filter, enhancing sensitivity to under-represented frequencies in agreement with optimal encoding arguments. Adaptation occurs over 40 s to many minutes, longer than most previously reported forms of adaptation.	Univ Calif San Francisco, Sloan Swartz Ctr Theoret Neurobiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Columbia Univ, Sch Med, Ctr Theoret Neurosci, Ctr Neurobiol & Behav, New York, NY 10032 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University	Sharpee, TO (corresponding author), Univ Calif San Francisco, Sloan Swartz Ctr Theoret Neurobiol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	sharpee@phy.ucsf.edu	Sharpee, Tatyana/E-8663-2010; Kurgansky, Andrei V/X-6695-2018	Sharpee, Tatyana/0000-0002-7483-5081; Sugihara, Hiroki/0000-0002-0637-3700; Stryker, Michael/0000-0003-1546-5831	NEI NIH HHS [R01 EY013595, R01 EY013595-04] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013595] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; ATICK JJ, 1992, NEURAL COMPUT, V4, P196, DOI 10.1162/neco.1992.4.2.196; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Baddeley R, 1997, P ROY SOC B-BIOL SCI, V264, P1775, DOI 10.1098/rspb.1997.0246; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V200, pP11; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Brenner N, 2000, NEURAL COMPUT, V12, P1531, DOI 10.1162/089976600300015259; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; Dan Y, 1996, J NEUROSCI, V16, P3351; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Emondi AA, 2004, J NEUROSCI METH, V135, P95, DOI 10.1016/j.jneumeth.2003.12.022; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; Kvale MN, 2004, J NEUROPHYSIOL, V91, P604, DOI 10.1152/jn.00484.2003; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Nolt MJ, 2004, J NEUROPHYSIOL, V92, P1708, DOI 10.1152/jn.00176.2004; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; Rieke F., 1997, SPIKES EXPLORING NEU; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; SAUL AB, 1989, VISUAL NEUROSCI, V2, P593, DOI 10.1017/S0952523800003527; Sceniak MP, 2002, J NEUROPHYSIOL, V88, P1363, DOI 10.1152/jn.2002.88.3.1363; SHAPLEY R, 1979, VISION RES, V19, P431, DOI 10.1016/0042-6989(79)90109-3; SHAPLEY R, 1984, PROGR RETINAL RES, P263; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; Smyth D, 2003, J NEUROSCI, V23, P4746; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; VICTOR JD, 1987, J PHYSIOL-LONDON, V386, P219, DOI 10.1113/jphysiol.1987.sp016531; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7	44	227	232	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 23	2006	439	7079					936	942		10.1038/nature04519	http://dx.doi.org/10.1038/nature04519			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014NE	16495990	Green Accepted			2022-12-24	WOS:000235486100038
J	Roman, MJ; Moeller, E; Davis, A; Paget, SA; Crow, MK; Lockshin, MD; Sammaritano, L; Devereux, RB; Schwartz, JE; Levine, DM; Salmon, JE				Roman, MJ; Moeller, E; Davis, A; Paget, SA; Crow, MK; Lockshin, MD; Sammaritano, L; Devereux, RB; Schwartz, JE; Levine, DM; Salmon, JE			Preclinical carotid atherosclerosis in patients with rheumatoid arthritis	ANNALS OF INTERNAL MEDICINE			English	Article							ARTERIAL-WALL THICKNESS; CARDIOVASCULAR MORBIDITY; RISK-FACTORS; MORTALITY; ASSOCIATION; PREVALENCE; DISEASE; PLAQUE; WOMEN; REPRODUCIBILITY	Background: Rheumatoid arthritis is associated with increased morbidity and mortality because of cardiovascular disease, independent of traditional risk factors. Objective: To determine the prevalence of preclinical atherosclerosis in patients with rheumatoid arthritis and to identify clinical and biological markers for atherosclerotic disease in this patient population. Design: Matched, cross-sectional study. Setting: Hospital for Special Surgery in New York City Patients: 98 consecutive outpatients with rheumatoid arthritis who were followed by rheumatologists and 98 controls matched on age, sex, and ethnicity. Measurements: Cardiovascular risk factor ascertainment and carotid ultrasonography in all participants; disease severity, disease treatment, and inflammatory markers in patients with rheumatoid arthritis. Results: Despite a more favorable risk factor profile, patients with rheumatoid arthritis had a 3-fold increase in carotid atherosclerotic plaque (44% vs. 15%; p < 0.001). The relationship between rheumatoid arthritis and carotid atherosclerotic plaque remained after accounting for age, serum cholesterol levels, smoking history, and hypertensive status; adjusted predicted prevalence was 7.4% (95% Cl, 3.4% to 15.2%) for the control group and 38.5% (Cl, 25.4% to 53.5%) for patients with rheumatoid arthritis. Age (P < 0.001) and current cigarette use (P < 0.014) were also significantly associated with carotid atherosclerotic plaque. Among patients with rheumatoid arthritis, atherosclerosis was related to age, hypertension status, and use of tumor necrosis factor-a inhibitors (a possible marker of disease severity). Limitations: The study had a cross-sectional design, and inflammatory markers were determined only once. Conclusions: Patients with rheumatoid arthritis have a high prevalence of preclinical atherosclerosis independent of traditional risk factors, suggesting that chronic inflammation and, possibly, disease severity are atherogenic in this population.	Cornell Univ, Hosp Special Surg, Weill Med Coll, New York, NY 10021 USA; SUNY Stony Brook, Stony Brook, NY 11794 USA	Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Roman, MJ (corresponding author), Cornell Univ, Weill Med Coll, Div Cardiol, 525 E 68th St, New York, NY 10021 USA.	mroman@med.cornell.edu	Crow, Mary/R-8480-2019	Schwartz, Joseph/0000-0002-8944-3566	NCRR NIH HHS [M10RR0047] Funding Source: Medline; NHLBI NIH HHS [P01 HL047540] Funding Source: Medline; NIAMS NIH HHS [AR 45591] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000047] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL047540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045591] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Belcaro G, 1996, ARTERIOSCL THROM VAS, V16, P851, DOI 10.1161/01.ATV.16.7.851; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Choi HK, 2002, LANCET, V359, P1173, DOI 10.1016/S0140-6736(02)08213-2; del Rincon I, 2003, ARTHRITIS RHEUM, V48, P1833, DOI 10.1002/art.11078; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; del Sol AI, 2001, STROKE, V32, P1532, DOI 10.1161/01.STR.32.7.1532; Fischer LM, 2004, AM J CARDIOL, V93, P198, DOI 10.1016/j.amjcard.2003.09.037; Gerli R, 2004, CIRCULATION, V109, P2744, DOI 10.1161/01.CIR.0000131450.66017.B3; Joakimsen O, 1997, STROKE, V28, P2201, DOI 10.1161/01.STR.28.11.2201; Jonsson SW, 2001, J RHEUMATOL, V28, P2597; Krishnan E, 2004, CIRCULATION, V110, P1774, DOI 10.1161/01.CIR.0000142864.83780.81; Kumeda Y, 2002, ARTHRITIS RHEUM-US, V46, P1489, DOI 10.1002/art.10269; Manzi S, 1999, ARTHRITIS RHEUM-US, V42, P51, DOI 10.1002/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D; McCarey DW, 2004, LANCET, V363, P2015, DOI 10.1016/S0140-6736(04)16449-0; MYLLYKANGASLUOSUJARVI R, 1995, J RHEUMATOL, V22, P1065; Orces CH, 2002, ARTHRIT RHEUM-ARTHR, V47, P67, DOI 10.1002/art1.10160; Park YB, 2002, ARTHRITIS RHEUM, V46, P1714, DOI 10.1002/art.10359; PERSSON J, 1992, ARTERIOSCLER THROMB, V12, P261, DOI 10.1161/01.ATV.12.2.261; Pincus T, 1999, ARTHRITIS RHEUM-US, V42, P2220, DOI 10.1002/1529-0131(199910)42:10<2220::AID-ANR26>3.0.CO;2-5; Roman MJ, 1996, J AM COLL CARDIOL, V28, P751, DOI 10.1016/0735-1097(96)00225-2; ROMAN MJ, 1995, HYPERTENSION, V26, P369, DOI 10.1161/01.HYP.26.2.369; ROMAN MJ, 1992, CIRCULATION, V86, P1909, DOI 10.1161/01.CIR.86.6.1909; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Salonen JT, 1997, INTIMA-MEDIA THICKNESS AN ATHEROSCLEROSIS, P97; SALONEN JT, 1993, CIRCULATION, V87, P56; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Turesson C, 2004, ANN RHEUM DIS, V63, P952, DOI 10.1136/ard.2003.018101; WallbergJonsson S, 1997, J RHEUMATOL, V24, P445; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408	30	222	229	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2006	144	4					249	256		10.7326/0003-4819-144-4-200602210-00006	http://dx.doi.org/10.7326/0003-4819-144-4-200602210-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	015HS	16490910				2022-12-24	WOS:000235543100003
J	Zhang, KZ; Shen, XH; Wu, J; Sakaki, K; Saunders, T; Rutkowski, DT; Back, SH; Kaufman, RJ				Zhang, KZ; Shen, XH; Wu, J; Sakaki, K; Saunders, T; Rutkowski, DT; Back, SH; Kaufman, RJ			Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response	CELL			English	Article							C-REACTIVE PROTEIN; ELEMENT-BINDING PROTEINS; CREB/ATF-FAMILY; SITE-1 PROTEASE; CHOLESTEROL; PROTEOLYSIS; SREBP; ATF6; ATHEROSCLEROSIS; IDENTIFICATION	Regulated intramembrane proteolysis (RIP) of endoplasmic reticulum (ER) membrane-anchored transcription factors is known to maintain sterol homeostasis and to mediate the unfolded protein response (UPR). Here, we identified CREBH as a RIP-regulated liver-specific transcription factor that is cleaved upon ER stress and required to activate expression of acute phase response (APR) genes. Proinflammatory cytokines increase expression of ER membrane-anchored CREBH. In response to ER stress, CREBH is cleaved by site-1 and site-2 proteases to liberate an amino-terminal fragment that transits to the nucleus to activate transcription of the genes encoding serum amyloid P-component (SAP) and C-reactive protein (CRP). Proinflammatory cytokines and lipopolysaccharide activate the UPR and induce cleavage of CREBH in the liver in vivo. Together, our studies delineate a molecular mechanism for activation of an ER-localized transcription factor, CREBH, and reveal an unprecedented link by which ER stress initiates an acute inflammatory response.	Univ Michigan, Ctr Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Med, Transgen Anim Model Core, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zhang, KZ (corresponding author), Univ Michigan, Ctr Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	kaufmanr@umich.edu		Saunders, Thom/0000-0003-2015-101X; Zhang, Kezhong/0000-0002-6062-235X; Rutkowski, Thomas/0000-0001-6586-4449	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042394, R37DK042394] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL52173, R01 HL052173] Funding Source: Medline; NIDDK NIH HHS [DK42394, R01 DK042394] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cheng D, 1999, J BIOL CHEM, V274, P22805, DOI 10.1074/jbc.274.32.22805; Chin KT, 2005, NUCLEIC ACIDS RES, V33, P1859, DOI 10.1093/nar/gki332; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Feramisco JD, 2005, P NATL ACAD SCI USA, V102, P3242, DOI 10.1073/pnas.0500206102; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Khovidhunkit W, 2000, J INFECT DIS, V181, pS462, DOI 10.1086/315611; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Miao HZ, 2004, BLOOD, V103, P3412, DOI 10.1182/blood-2003-10-3591; Nadanaka S, 2004, MOL BIOL CELL, V15, P2537, DOI 10.1091/mbc.E03-09-0693; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Ochrietor JD, 2000, CYTOKINE, V12, P888, DOI 10.1006/cyto.2000.0668; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Paul A, 2004, CIRCULATION, V109, P647, DOI 10.1161/01.CIR.0000114526.50618.24; Raggo C, 2002, MOL CELL BIOL, V22, P5639, DOI 10.1128/MCB.22.16.5639-5649.2002; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rawson RB, 1998, J BIOL CHEM, V273, P28261, DOI 10.1074/jbc.273.43.28261; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sattar N, 2004, CIRCULATION, V110, P2687, DOI 10.1161/01.CIR.0000145660.60487.94; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shen XH, 2005, PLOS GENET, V1, P355, DOI 10.1371/journal.pgen.0010037; Toure BB, 2000, J BIOL CHEM, V275, P2349, DOI 10.1074/jbc.275.4.2349; Wang Y, 2000, J BIOL CHEM, V275, P27013; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoo JY, 2003, P NATL ACAD SCI USA, V100, P1157, DOI 10.1073/pnas.0336385100; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhu Y, 2002, J BIOL CHEM, V277, P6923, DOI 10.1074/jbc.M108075200	42	606	654	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 10	2006	124	3					587	599		10.1016/j.cell.2005.11.040	http://dx.doi.org/10.1016/j.cell.2005.11.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	014FG	16469704	Bronze			2022-12-24	WOS:000235464000020
J	Tsai, MY; Wang, SS; Heidinger, JM; Shumaker, DK; Adam, SA; Goldman, RD; Zheng, YX				Tsai, MY; Wang, SS; Heidinger, JM; Shumaker, DK; Adam, SA; Goldman, RD; Zheng, YX			A mitotic lamin B matrix induced by RanGTP required for spindle assembly	SCIENCE			English	Article							NUCLEAR-ENVELOPE BREAKDOWN; SMALL GTPASE RAN; CELL-CYCLE; BUILDING-BLOCKS; XENOPUS OOCYTES; IMPORTIN-BETA; AURORA-A; PROTEIN; ORGANIZATION; COMPLEX	Mitotic spindle morphogenesis is a series of highly coordinated movements that lead to chromosome segregation and cytokinesis. We report that the intermediate filament protein lamin B, a component of the interphase nuclear lamina, functions in spindle assembly. Lamin B assembled into a matrix-like network in mitosis through a process that depended on the presence of the guanosine triphosphate-bound form of the small guanosine triphosphatase Ran. Depletion of lamin B resulted in defects in spindle assembly. Dominant negative mutant lamin B proteins that disrupt lamin B assembly in interphase nuclei also disrupted spindle assembly in mitosis. Furthermore, lamin B was essential for the formation of the mitotic matrix that tethers a number of spindle assembly factors. We propose that lamin B is a structural component of the long-sought-after spindle matrix that promotes microtubule assembly and organization in mitosis.	Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21218 USA; Howard Hughes Med Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Carnegie Institution for Science; Howard Hughes Medical Institute; Johns Hopkins University; Northwestern University; Feinberg School of Medicine	Zheng, YX (corresponding author), Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21218 USA.	zheng@ciwemb.edu		Adam, Stephen/0000-0003-3444-7655	NATIONAL CANCER INSTITUTE [R01CA031760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312] Funding Source: NIH RePORTER; NCI NIH HHS [CA31760-24] Funding Source: Medline; NIGMS NIH HHS [GM56312] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; FIRMBACHKRAFT I, 1995, J CELL BIOL, V129, P17, DOI 10.1083/jcb.129.1.17; Georgatos SD, 1997, J CELL SCI, V110, P2129; Gindullis F, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-9; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Jekely G, 2003, BIOESSAYS, V25, P1129, DOI 10.1002/bies.10353; Johansen KM, 2002, CELL CYCLE, V1, P312, DOI 10.4161/cc.1.5.144; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Kapoor TM, 2001, J CELL BIOL, V154, P1125, DOI 10.1083/jcb.200106011; KIRKPATRICK D, 1994, GENETICS, V137, P381; Kisurina-Evgenieva O, 2004, J CELL SCI, V117, P6391, DOI 10.1242/jcs.01568; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Lopez-Soler RI, 2001, J CELL BIOL, V154, P61, DOI 10.1083/jcb.200101025; Lourim D, 1996, J CELL SCI, V109, P1775; LUSCHER B, 1991, EMBO J, V10, P865, DOI 10.1002/j.1460-2075.1991.tb08019.x; Maison C, 1997, EMBO J, V16, P4839, DOI 10.1093/emboj/16.16.4839; Mans BJ, 2004, CELL CYCLE, V3, P1612; Masuda K, 1997, EXP CELL RES, V232, P173, DOI 10.1006/excr.1997.3531; MIRZAYAN C, 1992, J CELL BIOL, V116, P1319, DOI 10.1083/jcb.116.6.1319; Moir RD, 2000, J CELL BIOL, V149, P1179, DOI 10.1083/jcb.149.6.1179; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; OUSPENSKI II, 1995, J BIOL CHEM, V270, P1975, DOI 10.1074/jbc.270.5.1975; Ouspenski II, 1998, EXP CELL RES, V244, P171, DOI 10.1006/excr.1998.4174; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Scholey JM, 2001, J CELL BIOL, V154, P261, DOI 10.1083/jcb.200101097; Shumaker DK, 2005, P NATL ACAD SCI USA, V102, P15494, DOI 10.1073/pnas.0507612102; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; STICK R, 1988, EMBO J, V7, P3189, DOI 10.1002/j.1460-2075.1988.tb03186.x; TSAI ML, UNPUB; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Tsai MY, 2005, CURR BIOL, V15, P2156, DOI 10.1016/j.cub.2005.10.054; van Hemert MJ, 2002, P NATL ACAD SCI USA, V99, P5390, DOI 10.1073/pnas.072556099; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Zheng YX, 2004, ANNU REV CELL DEV BI, V20, P867, DOI 10.1146/annurev.cellbio.20.012103.094648	47	228	233	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2006	311	5769					1887	1893		10.1126/science.1122771	http://dx.doi.org/10.1126/science.1122771			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16543417				2022-12-24	WOS:000236387800035
J	Yu, J; Xiao, J; Ren, XJ; Lao, KQ; Xie, XS				Yu, J; Xiao, J; Ren, XJ; Lao, KQ; Xie, XS			Probing gene expression in live cells, one protein molecule at a time	SCIENCE			English	Article							GREEN FLUORESCENT PROTEIN; MESSENGER-RNA DEGRADATION; ESCHERICHIA-COLI; SINGLE-CELL; NOISE; DNA; TRANSCRIPTION; TRANSLATION; REPRESSOR; OPERATOR	We directly observed real-time production of single protein molecules in individual Escherichia coli cells. A fusion protein of a fast-maturing yellow fluorescent protein (YFP) and a membrane-targeting peptide was expressed under a repressed condition. The membrane-localized YFP can be detected with single-molecule sensitivity. We found that the protein molecules are produced in bursts, with each burst originating from a stochastically transcribed single messenger RNA molecule, and that protein copy numbers in the bursts follow a geometric distribution. The quantitative study of low-level gene expression demonstrates the potential of single-molecule experiments in elucidating the workings of fundamental biological processes in living cells.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Appl Biosyst Inc, Foster City, CA 94404 USA	Harvard University; Thermo Fisher Scientific; Applied Biosystems	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu		Xiao, Jie/0000-0003-1433-5437				Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; BECKWITH JR, 1967, SCIENCE, V156, P597, DOI 10.1126/science.156.3775.597; BERG OG, 1978, J THEOR BIOL, V71, P587, DOI 10.1016/0022-5193(78)90326-0; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; BONDESON K, 1993, ANAL BIOCHEM, V214, P245, DOI 10.1006/abio.1993.1484; Bongaerts RJM, 2002, METHOD ENZYMOL, V358, P43; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Deich J, 2004, P NATL ACAD SCI USA, V101, P15921, DOI 10.1073/pnas.0404200101; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GILBERT W, 1967, P NATL ACAD SCI USA, V58, P2415, DOI 10.1073/pnas.58.6.2415; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; GUPTASARMA P, 1995, BIOESSAYS, V17, P987, DOI 10.1002/bies.950171112; HSIEH WT, 1987, J BIOL CHEM, V262, P14583; Ishijima A, 2001, TRENDS BIOCHEM SCI, V26, P438, DOI 10.1016/S0968-0004(01)01860-6; JACOB F, 1961, COLD SPRING HARB SYM, V26, P193, DOI 10.1101/SQB.1961.026.01.024; Lommerse PHM, 2004, BIOPHYS J, V86, P609, DOI 10.1016/S0006-3495(04)74139-9; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mowbray SL, 1998, J STRUCT BIOL, V124, P257, DOI 10.1006/jsbi.1998.4043; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Ptashne M., 2002, GENES SIGNALS; RIGNEY DR, 1979, J THEOR BIOL, V79, P247, DOI 10.1016/0022-5193(79)90250-9; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Xie XS, 1999, J BIOL CHEM, V274, P15967, DOI 10.1074/jbc.274.23.15967; YARCHUK O, 1992, J MOL BIOL, V226, P581, DOI 10.1016/0022-2836(92)90617-S	34	682	702	4	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1600	1603		10.1126/science.1119623	http://dx.doi.org/10.1126/science.1119623			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543458				2022-12-24	WOS:000236029500043
J	Becker, D; Selbach, M; Rollenhagen, C; Ballmaier, M; Meyer, TF; Mann, M; Bumann, D				Becker, D; Selbach, M; Rollenhagen, C; Ballmaier, M; Meyer, TF; Mann, M; Bumann, D			Robust Salmonella metabolism limits possibilities for new antimicrobials	NATURE			English	Article							COMPLETE GENOME SEQUENCE; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; ENTERICA; IDENTIFICATION; INFECTION; NETWORKS; BACTERIA	New antibiotics are urgently needed to control infectious diseases. Metabolic enzymes could represent attractive targets for such antibiotics, but in vivo target validation is largely lacking. Here we have obtained in vivo information about over 700 Salmonella enterica enzymes from network analysis of mutant phenotypes, genome comparisons and Salmonella proteomes from infected mice. Over 400 of these enzymes are non- essential for Salmonella virulence, reflecting extensive metabolic redundancies and access to surprisingly diverse host nutrients. The essential enzymes identified were almost exclusively associated with a small subgroup of pathways, enabling us to perform a nearly exhaustive screen. Sixty- four enzymes identified as essential in Salmonella are conserved in other important human pathogens, but almost all belong to metabolic pathways that are inhibited by current antibiotics or that have previously been considered for antimicrobial development. Our comprehensive in vivo analysis thus suggests a shortage of new metabolic targets for broad- spectrum antibiotics, and draws attention to some previously known but unexploited targets.	Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany; Max Planck Inst Biochem, Dept Proteom & Signal Transduct, D-82152 Martinsried, Germany; Hannover Med Sch, Flow Cytometry Core Facil, D-30625 Hannover, Germany; Hannover Med Sch, Inst Immunol, Mucosal Infect Jr Res Grp, D-30625 Hannover, Germany	Max Planck Society; Max Planck Society; Hannover Medical School; Hannover Medical School	Bumann, D (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany.	bumann.dirk@mh-hannover.de	Ballmaier, Matthias/J-4175-2014; Selbach, Matthias/C-5988-2008; Meyer, Thomas F. F/J-2485-2013; Mann, Matthias/A-3454-2013	Ballmaier, Matthias/0000-0002-1352-5995; Meyer, Thomas F. F/0000-0002-6120-8679; Mann, Matthias/0000-0003-1292-4799				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Badarinarayana V, 2001, NAT BIOTECHNOL, V19, P1060, DOI 10.1038/nbt1101-1060; BAUMLER AJ, 1994, INFECT IMMUN, V62, P1623; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Black MT, 2005, ADV DRUG DELIVER REV, V57, P1528, DOI 10.1016/j.addr.2005.04.006; Bumann D, 2002, MOL MICROBIOL, V43, P1269, DOI 10.1046/j.1365-2958.2002.02821.x; CURTISS R, 1989, IMMUNOL INVEST, V18, P583, DOI 10.3109/08820138909112265; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Freiberg C, 2001, J MOL MICROB BIOTECH, V3, P483; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Heath RJ, 2001, PROG LIPID RES, V40, P467, DOI 10.1016/S0163-7827(01)00012-1; Henry T, 2005, MOL MICROBIOL, V56, P252, DOI 10.1111/j.1365-2958.2005.04540.x; Hughes D, 2003, NAT REV GENET, V4, P432, DOI 10.1038/nrg1084; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Knuth K, 2004, MOL MICROBIOL, V51, P1729, DOI 10.1046/j.1365-2958.2003.03944.x; Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1; O'Ryan Miguel, 2005, Semin Pediatr Infect Dis, V16, P125, DOI 10.1053/j.spid.2005.12.008; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Porwollik S, 2005, J BACTERIOL, V187, P6545, DOI 10.1128/JB.187.18.6545-6555.2005; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Rollenhagen C, 2006, INFECT IMMUN, V74, P1649, DOI 10.1128/IAI.74.3.1649-1660.2006; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Thomson CJ, 2004, CURR OPIN MICROBIOL, V7, P445, DOI 10.1016/j.mib.2004.08.009; Wendland M, 2002, FEBS LETT, V521, P105, DOI 10.1016/S0014-5793(02)02834-X	33	278	286	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2006	440	7082					303	307		10.1038/nature04616	http://dx.doi.org/10.1038/nature04616			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541065				2022-12-24	WOS:000235997600045
J	Porco, CC; Helfenstein, P; Thomas, PC; Ingersoll, AP; Wisdom, J; West, R; Neukum, G; Denk, T; Wagner, R; Roatsch, T; Kieffer, S; Turtle, E; McEwen, A; Johnson, TV; Rathbun, J; Veverka, J; Wilson, D; Perry, J; Spitale, J; Brahic, A; Burns, JA; DelGenio, AD; Dones, L; Murray, CD; Squyres, S				Porco, CC; Helfenstein, P; Thomas, PC; Ingersoll, AP; Wisdom, J; West, R; Neukum, G; Denk, T; Wagner, R; Roatsch, T; Kieffer, S; Turtle, E; McEwen, A; Johnson, TV; Rathbun, J; Veverka, J; Wilson, D; Perry, J; Spitale, J; Brahic, A; Burns, JA; DelGenio, AD; Dones, L; Murray, CD; Squyres, S			Cassini observes the active South Pole of Enceladus	SCIENCE			English	Article							IMAGING SCIENCE; SOLAR-SYSTEM; E-RING; SATELLITES; SATURN; TECTONICS; EVOLUTION; EUROPA; WATER		Space Sci Inst, Cassini Imaging Cent Lab Operat, Boulder, CO 80301 USA; Univ London, Queen Mary, Astron Unit, London E1 4NS, England; SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Univ Paris 07, Ctr Etud Saclay, F-91191 Gif Sur Yvette, France; Univ Redlands, Dept Phys, Redlands, CA 92373 USA; Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; Univ Illinois, Dept Geol, Urbana, IL 61801 USA; German Aerosp Res Estab, Inst Planetary Res, D-12489 Berlin, Germany; Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA	University of London; Queen Mary University London; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; UDICE-French Research Universities; Universite Paris Cite; University of Arizona; University of Illinois System; University of Illinois Urbana-Champaign; Helmholtz Association; German Aerospace Centre (DLR); Free University of Berlin; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Massachusetts Institute of Technology (MIT); California Institute of Technology; Cornell University	Porco, CC (corresponding author), Space Sci Inst, Cassini Imaging Cent Lab Operat, 4750 Walnut St,Suite 205, Boulder, CO 80301 USA.	carolyn@ciclops.org	Del Genio, Anthony/D-4663-2012; Turtle, Elizabeth/K-8673-2012	Del Genio, Anthony/0000-0001-7450-1359; Turtle, Elizabeth/0000-0003-1423-5751				Brown RH, 2006, SCIENCE, V311, P1425, DOI 10.1126/science.1121031; CRUIKSHANK DP, 1980, ICARUS, V41, P246, DOI 10.1016/0019-1035(80)90008-1; DERMOTT SF, 1994, ICARUS, V109, P241, DOI 10.1006/icar.1994.1090; DERMOTT SF, 1979, ICARUS, V37, P575, DOI 10.1016/0019-1035(79)90015-0; Dougherty MK, 2006, SCIENCE, V311, P1406, DOI 10.1126/science.1120985; Eluszkiewicz J, 2003, ICARUS, V166, P375, DOI 10.1016/j.icarus.2003.08.013; Gaidos EJ, 2000, NATURE, V405, P637, DOI 10.1038/35015170; Goldsby DL, 2001, J GEOPHYS RES-SOL EA, V106, P11017, DOI 10.1029/2000JB900336; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; HANSEN GJ, COMMUNICATION; HANSEN JE, 1971, J ATMOS SCI, V28, P1400, DOI 10.1175/1520-0469(1971)028<1400:MSOPLI>2.0.CO;2; HEDMAN M, COMMUNICATION; HELFENSTEIN P, 1983, ICARUS, V53, P415, DOI 10.1016/0019-1035(83)90206-3; HOREDT GP, 1984, J GEOPHYS RES, V89, P405, DOI 10.1029/JB089iB12p10405; IONASESCU R, 2005, 343J05017 IOM JET PR; JACOBSON RA, COMMUNICATION; Jones GH, 2006, SCIENCE, V311, P1412, DOI 10.1126/science.1121011; Juhasz A, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000182; Kargel JS, 1996, ICARUS, V119, P385, DOI 10.1006/icar.1996.0026; KIEFFER SW, 1982, SATELLITES JUPITER, P647; LEWIS JS, 1971, ICARUS, V15, P174, DOI 10.1016/0019-1035(71)90072-8; MELOSH HJ, 1977, ICARUS, V31, P221, DOI 10.1016/0019-1035(77)90035-5; Neukum G., 1985, Advances in Space Research, V5, P107, DOI 10.1016/0273-1177(85)90247-9; Neukum G, 2001, SPACE SCI REV, V96, P55, DOI 10.1023/A:1011989004263; Neukum G., 2005, LUN PLAN SCI C; NEUKUM G, 1983, THESIS L MAXIMILIANS; PANG KD, 1984, J GEOPHYS RES, V89, P9459, DOI 10.1029/JB089iB11p09459; Peale SJ, 1999, ANNU REV ASTRON ASTR, V37, P533, DOI 10.1146/annurev.astro.37.1.533; Porco CC, 2004, SPACE SCI REV, V115, P363, DOI 10.1007/s11214-004-1456-7; Porco CC, 2005, SCIENCE, V307, P1237, DOI 10.1126/science.1107981; ROSS MN, 1989, ICARUS, V78, P90, DOI 10.1016/0019-1035(89)90071-7; Schubert G., 1986, SATELLITES, P224; SMITH BA, 1981, SCIENCE, V212, P163, DOI 10.1126/science.212.4491.163; Spahn F, 2006, SCIENCE, V311, P1416, DOI 10.1126/science.1121375; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; SQUYRES SW, 1983, ICARUS, V53, P319, DOI 10.1016/0019-1035(83)90152-5; Verbiscer AJ, 2005, ICARUS, V173, P66, DOI 10.1016/j.icarus.2004.05.001; WAGNER R, 2005, B AM ASTRON SOC, V37, P701; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290; Wisdom J, 2004, ASTRON J, V128, P484, DOI 10.1086/421360; YODER CF, 1979, NATURE, V279, P767, DOI 10.1038/279767a0; Zahnle K, 2003, ICARUS, V163, P263, DOI 10.1016/S0019-1035(03)00048-4	42	778	787	3	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2006	311	5766					1393	1401		10.1126/science.1123013	http://dx.doi.org/10.1126/science.1123013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527964				2022-12-24	WOS:000236029400030
J	Spencer, JR; Pearl, JC; Segura, M; Flasar, FM; Mamoutkine, A; Romani, P; Buratti, BJ; Hendrix, AR; Spilker, LJ; Lopes, RMC				Spencer, JR; Pearl, JC; Segura, M; Flasar, FM; Mamoutkine, A; Romani, P; Buratti, BJ; Hendrix, AR; Spilker, LJ; Lopes, RMC			Cassini encounters Enceladus: Background and the discovery of a south polar hot spot	SCIENCE			English	Article							SATURNS E-RING; MASS; ATMOSPHERE; EVOLUTION; DYNAMICS; TETHYS; ORIGIN; SYSTEM		SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Spencer, JR (corresponding author), SW Res Inst, Dept Space Studies, 1050 Walnut St,Suite 400, Boulder, CO 80302 USA.	spencer@boulder.swri.edu	Lopes, Rosaly M.C./D-1608-2016; Flasar, F Michael/C-8509-2012; Romani, Paul N/D-2729-2012	Lopes, Rosaly M.C./0000-0002-7928-3167; 				Brown RH, 2006, SCIENCE, V311, P1425, DOI 10.1126/science.1121031; BROWN RH, 1990, SCIENCE, V250, P431, DOI 10.1126/science.250.4979.431; BRYSON CE, 1974, J CHEM ENG DATA, V19, P107, DOI 10.1021/je60061a021; BURATTI B, 1984, ICARUS, V58, P254, DOI 10.1016/0019-1035(84)90042-3; BURATTI BJ, 1988, ICARUS, V75, P113, DOI 10.1016/0019-1035(88)90130-3; CRUIKSHANK DP, 1980, ICARUS, V41, P246, DOI 10.1016/0019-1035(80)90008-1; Czechowski L, 2005, PLANET SPACE SCI, V53, P749, DOI 10.1016/j.pss.2005.01.004; CZECHOWSKI L, 2004, 35 COMM SPAC RES COS; DERMOTT SF, 1994, ICARUS, V109, P241, DOI 10.1006/icar.1994.1090; Dougherty MK, 2006, SCIENCE, V311, P1406, DOI 10.1126/science.1120985; Emery JP, 2005, ASTRON ASTROPHYS, V435, P353, DOI 10.1051/0004-6361:20042482; Flasar FM, 2004, SPACE SCI REV, V115, P169, DOI 10.1007/s11214-004-1454-9; HAFF PK, 1983, ICARUS, V56, P426, DOI 10.1016/0019-1035(83)90164-1; HAMILTON DP, 1994, SCIENCE, V264, P550, DOI 10.1126/science.264.5158.550; HANEL R, 1982, SCIENCE, V215, P544, DOI 10.1126/science.215.4532.544; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; HORANYI M, 1992, ICARUS, V97, P248, DOI 10.1016/0019-1035(92)90131-P; Hussmann H, 2004, ICARUS, V171, P391, DOI 10.1016/j.icarus.2004.05.020; Jurac S, 2001, ICARUS, V149, P384, DOI 10.1006/icar.2000.6528; Kargel JS, 1996, ICARUS, V119, P385, DOI 10.1006/icar.1996.0026; KLINGER J, 1980, SCIENCE, V209, P271, DOI 10.1126/science.209.4453.271; MATSON DL, 1989, ICARUS, V77, P67, DOI 10.1016/0019-1035(89)90007-9; McEwen AS, 2004, CAMB PLANET, P307; MCKINNON WB, 1983, LUNAR PLANET SCI, V14, P487; PANG KD, 1984, J GEOPHYS RES, V89, P9459, DOI 10.1029/JB089iB11p09459; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; ROSS MN, 1989, ICARUS, V78, P90, DOI 10.1016/0019-1035(89)90071-7; Schubert G., 1986, SATELLITES, P224; SMITH BA, 1982, SCIENCE, V215, P504, DOI 10.1126/science.215.4532.504; Spahn F, 2006, SCIENCE, V311, P1416, DOI 10.1126/science.1121375; Spencer J.R., 1997, PLUTO CHARON, P435; SQUYRES SW, 1983, ICARUS, V53, P319, DOI 10.1016/0019-1035(83)90152-5; Tokar RL, 2006, SCIENCE, V311, P1409, DOI 10.1126/science.1121061; Verbiscer AJ, 2005, ICARUS, V173, P66, DOI 10.1016/j.icarus.2004.05.001; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290; Wisdom J, 2004, ASTRON J, V128, P484, DOI 10.1086/421360	36	374	377	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2006	311	5766					1401	1405		10.1126/science.1121661	http://dx.doi.org/10.1126/science.1121661			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527965				2022-12-24	WOS:000236029400031
J	Wilson, JJ; Kovall, RA				Wilson, JJ; Kovall, RA			Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA	CELL			English	Article							TRANSCRIPTIONAL ACTIVATION; SECONDARY STRUCTURE; ANKYRIN REPEATS; MOUSE NOTCH1; RBP-J; PROTEIN; DOMAIN; REPLACEMENT; RECEPTOR; GENES	Notch signaling mediates communication between cells and is essential for proper embryonic patterning and development. CSL is a DNA binding transcription factor that regulates transcription of Notch target genes by interacting with coregulators. Transcriptional activation requires the displacement of corepressors; from CSL by the intracellular portion of the receptor Notch (NotchIC) and the recruitment of the coactivator protein Mastermind to the complex. Here we report the 3.1 angstrom. structure of the ternary complex formed by CSL, NotchIC, and Mastermind bound to DNA. As expected, the RAM domain of Notch interacts with the beta trefoil domain of CSL; however, the C-terminal domain of CSL has an unanticipated central role in the interface formed with the Notch ankyrin repeats and Mastermind. Ternary complex formation induces a substantial conformational change within CSL, suggesting a molecular mechanism for the conversion of CSL from a repressor to an activator.	Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Kovall, RA (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.	kovallra@ucmail.uc.edu	Kovall, Rhett/A-3106-2008					Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Axelson H, 2004, SEMIN CANCER BIOL, V14, P317, DOI 10.1016/j.semcancer.2004.04.010; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bonde J, 2004, CURR OPIN HEMATOL, V11, P392, DOI 10.1097/01.moh.0000145672.42503.70; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Doyle TG, 2000, P NATL ACAD SCI USA, V97, P7877, DOI 10.1073/pnas.97.14.7877; Ehebauer MT, 2005, BIOCHEM J, V392, P13, DOI 10.1042/BJ20050515; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Fuchs KP, 2001, EUR J BIOCHEM, V268, P4639, DOI 10.1046/j.1432-1327.2001.02387.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jeffries S, 2002, MOL CELL BIOL, V22, P3927, DOI 10.1128/MCB.22.11.3927-3941.2002; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kato H, 1997, DEVELOPMENT, V124, P4133; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petcherski AG, 2000, NATURE, V405, P364, DOI 10.1038/35012645; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shaye DD, 2002, NATURE, V420, P686, DOI 10.1038/nature01234; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000; Zweifel ME, 2003, PROTEIN SCI, V12, P2622, DOI 10.1110/ps.03279003; Zweifel ME, 2001, BIOCHEMISTRY-US, V40, P14344, DOI 10.1021/bi011435h	50	261	287	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					985	996		10.1016/j.cell.2006.01.035	http://dx.doi.org/10.1016/j.cell.2006.01.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530045	Bronze			2022-12-24	WOS:000237241200020
J	Saviane, C; Silver, RA				Saviane, C; Silver, RA			Fast vesicle reloading and a large pool sustain high bandwidth transmission at a central synapse	NATURE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; CEREBELLAR MOSSY FIBER; GRANULE CELL SYNAPSES; SHORT-TERM PLASTICITY; NEUROTRANSMITTER RELEASE; EXCITATORY SYNAPSES; TRANSMITTER RELEASE; RAT; CALYX; PROBABILITY	What limits the rate at which sensory information can be transmitted across synaptic connections in the brain? High-frequency signalling is restricted to brief bursts at many central excitatory synapses(1,2), whereas graded ribbon-type synapses can sustain release(3) and transmit information(4) at high rates. Here we investigate transmission at the cerebellar mossy fibre terminal, which can fire at over 200 Hz for sustained periods in vivo(5), yet makes few synaptic contacts onto individual granule cells(6). We show that connections between mossy fibres and granule cells can sustain high-frequency signalling at physiological temperature. We use fluctuation analysis(7) and pharmacological block of desensitization to identify the quantal determinants of short-term plasticity and combine these with a short-term plasticity model and cumulative excitatory postsynaptic current analysis to quantify the determinants of sustained high-frequency transmission. We show that release is maintained at each release site by rapid reloading of release-ready vesicles from an unusually large releasable pool of vesicles(8) (similar to 300 per site). Our results establish that sustained vesicular release at high rates is not restricted to graded ribbon-type synapses and that mossy fibres are well suited for transmitting broad-bandwidth rate-coded information to the input layer of the cerebellar cortex.	UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Silver, RA (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	a.silver@ucl.ac.uk		Silver, Robin/0000-0002-5480-6638	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BETZ WJ, 1970, J PHYSIOL-LONDON, V206, P629, DOI 10.1113/jphysiol.1970.sp009034; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Griesinger CB, 2005, NATURE, V435, P212, DOI 10.1038/nature03567; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; HAMORI J, 1983, J COMP NEUROL, V220, P365, DOI 10.1002/cne.902200402; Hempel CM, 2000, J NEUROPHYSIOL, V83, P3031, DOI 10.1152/jn.2000.83.5.3031; Iwasaki S, 2001, J PHYSIOL-LONDON, V534, P861, DOI 10.1111/j.1469-7793.2001.00861.x; JAKAB RL, 1988, ANAT EMBRYOL, V179, P81, DOI 10.1007/BF00305102; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Mercer A, 2005, CEREB CORTEX, V15, P1485, DOI 10.1093/cercor/bhi027; Palay SL, 1974, CEREBELLAR CORTEX CO; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Sargent PB, 2005, J NEUROSCI, V25, P8173, DOI 10.1523/JNEUROSCI.2051-05.2005; Scheuss V, 2002, J NEUROSCI, V22, P728, DOI 10.1523/JNEUROSCI.22-03-00728.2002; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Silver RA, 2003, J NEUROSCI METH, V130, P127, DOI 10.1016/j.jneumeth.2003.09.030; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Sola E, 2004, J PHYSIOL-LONDON, V557, P843, DOI 10.1113/jphysiol.2003.060285; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Xu-Friedman MA, 2004, PHYSIOL REV, V84, P69, DOI 10.1152/physrev.00016.2003; Xu-Friedman MA, 2003, J NEUROSCI, V23, P2182; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	30	172	174	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 23	2006	439	7079					983	987		10.1038/nature04509	http://dx.doi.org/10.1038/nature04509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014NE	16496000				2022-12-24	WOS:000235486100049
J	Shalizi, A; Gaudilliere, B; Yuan, ZQ; Stegmuller, J; Shirogane, T; Ge, QY; Tan, Y; Schulman, B; Harper, JW; Bonni, A				Shalizi, A; Gaudilliere, B; Yuan, ZQ; Stegmuller, J; Shirogane, T; Ge, QY; Tan, Y; Schulman, B; Harper, JW; Bonni, A			A calcium-regulated MEF2 surnoylation switch controls postsynaptic differentiation	SCIENCE			English	Article							TRANSCRIPTION FACTOR MEF2; HISTONE DEACETYLASES; DENDRITE DEVELOPMENT; NERVOUS-SYSTEM; SUMO; ACTIVATION; APOPTOSIS; SYNAPSES; SURVIVAL	Postsynaptic differentiation of dendrites is an essential step in synapse formation. We report here a requirement for the transcription factor myocyte enhancer factor 2A (MEF2A) in the morphogenesis of postsynaptic granule neuron dendritic claws in the cerebellar cortex. A transcriptional repressor form of MEF2A that is sumoylated at lysine-403 promoted dendritic claw differentiation. Activity-dependent calcium signaling induced a calcineurin-mediated dephosphorytation of MEF2A at serine-408 and, thereby, promoted a switch from sumoylation to acetylation at lysine-403, which led to inhibition of dendritic claw differentiation. Our findings define a mechanism underlying postsynaptic differentiation that may modulate activity-dependent synapse development and plasticity in the brain.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; Cell Signaling Technol Inc, Beverly, MA 01915 USA; St Jude Childrens Hosp, Howard Hughes Med Inst, Dept Biol Struct, Memphis, TN 38105 USA; St Jude Childrens Hosp, Howard Hughes Med Inst, Dept Genet, Memphis, TN 38105 USA; St Jude Childrens Hosp, Howard Hughes Med Inst, Dept Tumor Cell Biol, Memphis, TN 38105 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; St Jude Children's Research Hospital; Howard Hughes Medical Institute; St Jude Children's Research Hospital; Howard Hughes Medical Institute; St Jude Children's Research Hospital	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Louis Pasteur Ave, Boston, MA 02115 USA.	azad_bonni@hms.harvard.edu	Yuan, Zengqiang/G-5245-2017	Yuan, Zengqiang/0000-0001-5739-2867; Harper, Jeffrey/0000-0002-6944-7236; Shalizi, Aryaman/0000-0001-9226-0800	NIA NIH HHS [AG11085] Funding Source: Medline; NINDS NIH HHS [NS41021] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Altman J., 1997, DEV CEREBELLAR SYSTE; Cajal SRY., 1995, HISTOLOGY NERVOUS SY, V1; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; HAMORI J, 1983, J COMP NEUROL, V220, P365, DOI 10.1002/cne.902200402; Heidenreich KA, 2004, MOL NEUROBIOL, V29, P155, DOI 10.1385/MN:29:2:155; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Palay S. L., 1974, CEREBELLAR CORTEX CY; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shalizi AK, 2005, CURR TOP DEV BIOL, V69, P239, DOI 10.1016/S0070-2153(05)69009-6; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zhu BM, 2004, MOL CELL BIOL, V24, P8264, DOI 10.1128/MCB.24.18.8264-8275.2004	23	354	367	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2006	311	5763					1012	1017		10.1126/science.1122513	http://dx.doi.org/10.1126/science.1122513			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014CS	16484498				2022-12-24	WOS:000235456900049
J	Bangser, M				Bangser, M			Obstetric fistula and stigma	LANCET			English	Editorial Material									Womens Dign Project, Dar Es Salaam, Tanzania		Bangser, M (corresponding author), Womens Dign Project, POB 79402, Dar Es Salaam, Tanzania.	mbangser@womensdignity.org						ABOUZAHR C, 1998, HLTH DIMENSIONS SEX, P243	1	61	62	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 11	2006	367	9509					535	536		10.1016/S0140-6736(06)68188-9	http://dx.doi.org/10.1016/S0140-6736(06)68188-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	013FF	16473133				2022-12-24	WOS:000235394500037
J	Ellermeier, CD; Hobbs, EC; Gonzalez-Pastor, JE; Losick, R				Ellermeier, CD; Hobbs, EC; Gonzalez-Pastor, JE; Losick, R			A three-protein signaling pathway governing immunity to a bacterial cannibalism toxin	CELL			English	Article							GLOBAL REPRESSOR MLC; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; GENE-EXPRESSION; TRANSCRIPTION FACTOR; SPO0A REGULON; DNA-BINDING; SPORULATION; MEMBRANE; PROTEIN	We describe a three-protein signal-transduction pathway that governs immunity to a protein toxin involved in cannibalism by the spore-forming bacterium Baciflus subtilis. Cells of B. subtilis enter the pathway to sporulate under conditions of nutrient limitation but delay becoming committed to spore formation by killing nonsporulating siblings and feeding on the dead cells. Killing is mediated by the exported toxic protein SdpC. We report that extracellular SdpC induces the synthesis of an immunity protein, SdpI, that protects toxin-producing cells from being killed. SdpI, a polytopic membrane protein, is encoded by a two-gene operon under sporulation control that contains the gene for an autorepressor, SdpR. The autorepressor binds to and blocks the promoter for the operon. Evidence indicates that SdpI is also a signal-transduction protein that responds to the SdpC toxin by sequestering the SdpR autorepressor at the membrane. Sequestration relieves repression and stimulates synthesis of immunity protein.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Ellermeier, CD (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	losick@mcb.harvard.edu	González-Pastor, José/I-2118-2015	González-Pastor, José/0000-0002-7615-7042; Ellermeier, Craig/0000-0002-8953-5081	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018568, R37GM018568] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM18568] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bohm A, 2004, CURR OPIN MICROBIOL, V7, P151, DOI 10.1016/j.mib.2004.02.009; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; CHUNG JD, 1994, J BACTERIOL, V176, P1977, DOI 10.1128/jb.176.7.1977-1984.1994; DESPICER PO, 1993, P NATL ACAD SCI USA, V90, P4295, DOI 10.1073/pnas.90.9.4295; DESPICER PO, 1991, J BACTERIOL, V173, P211, DOI 10.1128/jb.173.1.211-219.1991; Dworkin J, 2005, CELL, V121, P401, DOI 10.1016/j.cell.2005.02.032; EICHENBERGER P, 2004, PLOS BIOL, V10, P1371; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Fujita M, 2002, MOL MICROBIOL, V43, P27, DOI 10.1046/j.1365-2958.2002.02732.x; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; HAHN DR, 1988, MOL GEN GENET, V213, P125, DOI 10.1007/BF00333408; Harwood C. R., 1990, MOL BIOL METHODS BAC; Lee SJ, 2000, EMBO J, V19, P5353, DOI 10.1093/emboj/19.20.5353; Lehane MJ, 1997, P NATL ACAD SCI USA, V94, P11502, DOI 10.1073/pnas.94.21.11502; Miller JH, 1972, EXPT MOL BIOL; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; MuroPastor AM, 1997, J BACTERIOL, V179, P2788, DOI 10.1128/jb.179.8.2788-2791.1997; Parker GF, 1996, MICROBIOL-UK, V142, P3445, DOI 10.1099/13500872-142-12-3445; Steil L, 2003, J BACTERIOL, V185, P6358, DOI 10.1128/JB.185.21.6358-6370.2003; STRAUCH M, 1990, P NATL ACAD SCI USA, V87, P1801, DOI 10.1073/pnas.87.5.1801; STRAUCH MA, 1989, EMBO J, V8, P1615, DOI 10.1002/j.1460-2075.1989.tb03546.x; Tanaka Y, 2000, EMBO J, V19, P5344, DOI 10.1093/emboj/19.20.5344; Tanaka Y, 2004, MOL MICROBIOL, V53, P941, DOI 10.1111/j.1365-2958.2004.04179.x; Veening JW, 2005, MOL MICROBIOL, V56, P1481, DOI 10.1111/j.1365-2958.2005.04659.x; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; WILSON GA, 1968, J BACTERIOL, V95, P1439, DOI 10.1128/JB.95.4.1439-1449.1968; YOUNGMAN P, 1984, PLASMID, V12, P1, DOI 10.1016/0147-619X(84)90061-1	31	135	146	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 10	2006	124	3					549	559		10.1016/j.cell.2005.11.041	http://dx.doi.org/10.1016/j.cell.2005.11.041			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	014FG	16469701	Bronze			2022-12-24	WOS:000235464000017
J	Chambers, CD; Hernandez-Diaz, S; Van Marter, LJ; Werler, MM; Louik, C; Jones, KL; Mitchell, AA				Chambers, CD; Hernandez-Diaz, S; Van Marter, LJ; Werler, MM; Louik, C; Jones, KL; Mitchell, AA			Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEONATAL WITHDRAWAL SYNDROME; NITRIC-OXIDE; PREGNANT-WOMEN; EXPOSURE; FLUOXETINE; PAROXETINE; ANTIDEPRESSANTS; DEPRESSION; OUTCOMES; DEFECTS	BACKGROUND: Persistent pulmonary hypertension of the newborn (PPHN) is associated with substantial infant mortality and morbidity. A previous cohort study suggested a possible association between maternal use of the selective serotonin-reuptake inhibitor (SSRI) fluoxetine late in the third trimester of pregnancy and the risk of PPHN in the infant. We performed a case-control study to assess whether PPHN is associated with exposure to SSRIs during late pregnancy. METHODS: Between 1998 and 2003, we enrolled 377 women whose infants had PPHN and 836 matched control women and their infants. Maternal interviews were conducted by nurses, who were blinded to the study hypothesis, regarding medication use in pregnancy and potential confounders, including demographic variables and health history. RESULTS: Fourteen infants with PPHN had been exposed to an SSRI after the completion of the 20th week of gestation, as compared with six control infants (adjusted odds ratio, 6.1; 95 percent confidence interval, 2.2 to 16.8). In contrast, neither the use of SSRIs before the 20th week of gestation nor the use of non-SSRI antidepressant drugs at any time during pregnancy was associated with an increased risk of PPHN. CONCLUSIONS: These data support an association between the maternal use of SSRIs in late pregnancy and PPHN in the offspring; further study of this association is warranted. These findings should be taken into account in decisions as to whether to continue the use of SSRIs during pregnancy.	Univ Calif San Diego, Med Ctr, Dept Pediat, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA; Boston Univ, Sch Publ Hlth, Slone Epidemiol Ctr, Boston, MA USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA; Harvard Univ, Sch Med, Childrens Hosp, Boston, MA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Chambers, CD (corresponding author), Univ Calif San Diego, Med Ctr, Dept Pediat, 200 W Arbor Dr,Mail Code 8446, San Diego, CA 92103 USA.	chchambers@ucsd.edu		Louik, Carol/0000-0001-5429-5084; Chambers, Christina D/0000-0003-4675-7722; Mitchell, Allen/0000-0003-0950-6799; Werler, Martha/0000-0003-3392-6814	NHLBI NIH HHS [HL50763] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abman SH, 1999, PEDIATR PULM, P201; Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; Bearer C, 1997, ENVIRON HEALTH PERSP, V105, P202; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Chambers CD, 1996, NEW ENGL J MED, V335, P1010, DOI 10.1056/NEJM199610033351402; Costei AM, 2002, ARCH PEDIAT ADOL MED, V156, P1129, DOI 10.1001/archpedi.156.11.1129; Dakshinamurti S, 2005, PEDIATR PULM, V39, P492, DOI 10.1002/ppul.20201; Eddahibi S, 2002, J LAB CLIN MED, V139, P194, DOI 10.1067/mlc.2002.122181; Farrow KN, 2005, SEMIN PERINATOL, V29, P8, DOI 10.1053/j.semperi.2005.02.003; Finkel MS, 1996, PSYCHOPHARMACOL BULL, V32, P653; Fricker J, 1996, LANCET, V347, P1397, DOI 10.1016/S0140-6736(96)91029-6; HAGEMAN JR, 1984, AM J DIS CHILD, V138, P592, DOI 10.1001/archpedi.1984.02140440076021; Hasler G, 2004, PSYCHOL MED, V34, P1047, DOI 10.1017/S0033291703001697; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; JOHN E, 1988, AUST PAEDIATR J, V24, P357; Kallen B, 2004, ARCH PEDIAT ADOL MED, V158, P312, DOI 10.1001/archpedi.158.4.312; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Laine K, 2004, THER DRUG MONIT, V26, P685, DOI 10.1097/00007691-200412000-00016; LEMBERGER L, 1985, J CLIN PSYCHIAT, V46, P14; MCMAHON TJ, 1993, J APPL PHYSIOL, V75, P93, DOI 10.1152/jappl.1993.75.1.93; MITCHELL AA, 1981, JAMA-J AM MED ASSOC, V245, P2311; MITCHELL AA, 1986, AM J EPIDEMIOL, V123, P670, DOI 10.1093/oxfordjournals.aje.a114286; MORSESKOLKO EL, 2005, JAMA-J AM MED ASSOC, V293, P2372; Moses-Kolko Eydie L, 2004, J Am Med Womens Assoc (1972), V59, P181; Nordeng H, 2001, ACTA PAEDIATR, V90, P288, DOI 10.1080/080352501300067596; REECE EA, 1987, OBSTET GYNECOL, V70, P696; Runo JR, 2003, LANCET, V361, P1533, DOI 10.1016/S0140-6736(03)13167-4; Sanz EJ, 2005, LANCET, V365, P482, DOI 10.1016/S0140-6736(05)17865-9; Suhara T, 1998, LANCET, V351, P332, DOI 10.1016/S0140-6736(97)07336-4; VanMarter LJ, 1996, PEDIATRICS, V97, P658; Walsh-Sukys MC, 2000, PEDIATRICS, V105, P14, DOI 10.1542/peds.105.1.14; Wisner KL, 1999, JAMA-J AM MED ASSOC, V282, P1264, DOI 10.1001/jama.282.13.1264; Yaron I, 1999, ARTHRITIS RHEUM, V42, P2561, DOI 10.1002/1529-0131(199912)42:12<2561::AID-ANR8>3.0.CO;2-U; Zeskind PS, 2004, PEDIATRICS, V113, P368, DOI 10.1542/peds.113.2.368	34	556	570	0	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2006	354	6					579	587		10.1056/NEJMoa052744	http://dx.doi.org/10.1056/NEJMoa052744			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	010HF	16467545				2022-12-24	WOS:000235177500007
J	Gregson, S; Garnett, GP; Nyamukapa, CA; Hallett, TB; Lewis, JJC; Mason, PR; Chandiwana, SK; Anderson, RM				Gregson, S; Garnett, GP; Nyamukapa, CA; Hallett, TB; Lewis, JJC; Mason, PR; Chandiwana, SK; Anderson, RM			HIV decline associated with behavior change in Eastern Zimbabwe	SCIENCE			English	Article							SUB-SAHARAN AFRICA; SEXUAL-BEHAVIOR; RISK BEHAVIOR; POPULATION; TRANSMISSION; PREVALENCE; SURVEILLANCE; INFECTION; MORTALITY; DYNAMICS	Few sub-Saharan African countries have witnessed declines in HIV prevalence, and only Uganda has compelling evidence for a decline founded on sexual behavior change. We report a decline in HIV prevalence in eastern Zimbabwe between 1998 and 2003 associated with sexual behavior change in four distinct socioeconomic strata. HIV prevalence fell most steeply at young ages-by 23 and 49%, respectively, among men aged 17 to 29 years and women aged 15 to 24 years-and in more educated groups. Sexually experienced men and women reported reductions in casual sex of 49 and 22%, respectively, whereas recent cohorts reported delayed sexual debut. Selective AIDS-induced mortality contributed to the decline in HIV prevalence.	Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London SW7 2AZ, England; Biomed Res & Training Inst, Harare, Zimbabwe; Univ Witwatersrand, Fac Hlth Sci Res & Postgrad Studies, Johannesburg, South Africa	Imperial College London; Biomedical Research Training Institute; University of Witwatersrand	Gregson, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London SW7 2AZ, England.	Sajgregson@aol.com	Garnett, Geoffrey P/A-9312-2008; Lewis, James/F-6333-2013	Lewis, James/0000-0002-8603-2761; Nyamukapa, Constance/0000-0001-6779-4069; Gregson, Simon/0000-0003-2707-0714; Anderson, Roy/0000-0002-9528-3175; Hallett, Timothy/0000-0002-9681-0424	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON R M, 1991; Asamoah-Odei E, 2004, LANCET, V364, P35, DOI 10.1016/S0140-6736(04)16587-2; AsiimweOkiror G, 1997, AIDS, V11, P1757, DOI 10.1097/00002030-199714000-00013; Boily MC, 2002, AIDS, V16, P2101, DOI 10.1097/00002030-200210180-00025; Catania JA, 1999, J SEX RES, V36, P25, DOI 10.1080/00224499909551964; Decosas J, 2002, SEX TRANSM INFECT, V78, pI40, DOI 10.1136/sti.78.suppl_1.i40; Fylkesnes K, 1998, AIDS, V12, P1227, DOI 10.1097/00002030-199810000-00015; GARNETT GP, 1994, IMA J MATH APPL MED, V11, P161; Gisselquist D, 2002, INT J STD AIDS, V13, P657, DOI 10.1258/095646202760326390; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gregson S, 2004, SEX TRANSM INFECT, V80, P36, DOI 10.1136/sti.2004.012088; Gregson S., 2001, Journal of International Development, V13, P467, DOI 10.1002/jid.798; Gregson S, 2002, AIDS, V16, P643, DOI 10.1097/00002030-200203080-00017; Gregson S, 2000, AIDS, V14, pS85; Kilian AHD, 1999, AIDS, V13, P391, DOI 10.1097/00002030-199902250-00012; Lopman BA, 2005, PLOS MED, V2, P142, DOI 10.1371/journal.pmed.0020037; MAHOMVA A, IN PRESS SEX TRANSM; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; MULDER DW, 1994, LANCET, V343, P1021, DOI 10.1016/S0140-6736(94)90133-3; MUNDANDI C, IN PRESS TROP MED IN; Mwaluko G, 2003, AIDS, V17, P2645, DOI 10.1097/00002030-200312050-00012; Parkhurst JO, 2002, LANCET, V360, P78, DOI 10.1016/S0140-6736(02)09340-6; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; UNAIDS, 1999, TRENDS HIV INC PREV; WAWER MJ, 2005, 12 ANN RETR C BOST U; World Bank, 2002, REP BUILD I MARK; *ZIMB MIN HLTH CHI, 2003, ZIMB NAT HIV AIDS ES	27	253	256	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2006	311	5761					664	666		10.1126/science.1121054	http://dx.doi.org/10.1126/science.1121054			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011GY	16456081				2022-12-24	WOS:000235257400049
J	Bowles, J; Knight, D; Smith, C; Wilhelm, D; Richman, J; Mamiya, S; Yashiro, K; Chawengsaksophak, K; Wilson, MJ; Rossant, J; Hamada, H; Koopman, P				Bowles, J; Knight, D; Smith, C; Wilhelm, D; Richman, J; Mamiya, S; Yashiro, K; Chawengsaksophak, K; Wilson, MJ; Rossant, J; Hamada, H; Koopman, P			Retinoid signaling determines germ cell fate in mice	SCIENCE			English	Article							ACID; FETAL; EXPRESSION; MEIOSIS; TESTIS; INHIBITION; MIGRATION; PROTEIN; GONADS; NUMBER	Germ cells in the mouse embryo can develop as oocytes or spermatogonia, depending on molecular cues that have not been identified. We found that retinoic acid, produced by mesonephroi of both sexes, causes germ cells in the ovary to enter meiosis and inititate oogenesis. Meiosis is retarded in the fetal testis by the action of the retinoid-degrading enzyme CYP26B1, ultimately leading to spermatogenesis. In testes of Cyp26b1-knockout mouse embryos, germ cells enter meiosis precociously, as if in a normal ovary. Thus, precise regulation of retinoid levels during fetal gonad development provides the molecular control mechanism that specifies germ cell fate.	Univ Queensland, Div Genet & Dev Biol, Brisbane, Qld 4072, Australia; Univ Queensland, Australian Res Council Ctr Excellence Biotechnol, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Univ British Columbia, Fac Dent, Dept Oral Hlth Sci, Vancouver, BC V6T 1Z3, Canada; Osaka Univ, Inst Mol & Cellular Biol, Div Mol Biol, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Suita, Osaka 5650871, Japan; Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Queensland; University of Queensland; University of British Columbia; Osaka University; Japan Science & Technology Agency (JST); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Koopman, P (corresponding author), Univ Queensland, Div Genet & Dev Biol, Brisbane, Qld 4072, Australia.	p.koopman@imb.uq.edu.au	Chawengsaksophak, Kallayanee/G-4427-2014; Richman, Joy/AAD-9445-2020; Bowles, Josephine/AAG-4903-2020; Koopman, Peter A/C-9416-2009; Knight, Deon/F-1237-2010; Richman, Joy M./C-3111-2018; Bowles, Josephine/B-6583-2013; Holt, Janet E/B-2415-2013; Wilhelm, Dagmar/B-6915-2009; Hamada, Hiroshi/N-6374-2015	Chawengsaksophak, Kallayanee/0000-0001-9401-2122; Richman, Joy/0000-0002-1409-8163; Bowles, Josephine/0000-0003-2867-7438; Koopman, Peter A/0000-0001-6939-0914; Richman, Joy M./0000-0002-1409-8163; Bowles, Josephine/0000-0003-2867-7438; Wilhelm, Dagmar/0000-0002-7757-4075; Hamada, Hiroshi/0000-0002-7196-5948; Wilson, Megan/0000-0003-3425-5071				Agarwal C, 1996, J BIOL CHEM, V271, P12209, DOI 10.1074/jbc.271.21.12209; Boulogne B, 1999, BIOL REPROD, V61, P1548, DOI 10.1095/biolreprod61.6.1548; Bowles J, 2000, GENESIS, V27, P124, DOI 10.1002/1526-968X(200007)27:3<124::AID-GENE50>3.0.CO;2-E; BOWLES J, UNPUB; BUEHR M, 1993, DEV DYNAM, V198, P182, DOI 10.1002/aja.1001980304; Bullejos M, 2004, MOL REPROD DEV, V68, P422, DOI 10.1002/mrd.20105; BYSKOV AG, 1976, DEV BIOL, V52, P193, DOI 10.1016/0012-1606(76)90239-6; BYSKOV AGS, 1974, NATURE, V252, P396, DOI 10.1038/252396a0; Chuma S, 2001, DEV BIOL, V229, P468, DOI 10.1006/dbio.2000.9989; Di Carlo A, 2000, INT J DEV BIOL, V44, P241; Haselbeck RJ, 1999, DEV GENET, V25, P353, DOI 10.1002/(SICI)1520-6408(1999)25:4<353::AID-DVG9>3.0.CO;2-G; Karl J, 1995, PHILOS T ROY SOC B, V350, P235, DOI 10.1098/rstb.1995.0157; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kikonyogo A, 1999, EUR J BIOCHEM, V262, P704, DOI 10.1046/j.1432-1327.1999.00415.x; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Li H, 2004, BIOL REPROD, V70, P687, DOI 10.1095/biolreprod.103.023135; Livera G, 2000, MOL CELL ENDOCRINOL, V165, P225, DOI 10.1016/S0303-7207(00)00271-9; McCaffery P, 1999, MECH DEVELOP, V82, P119, DOI 10.1016/S0925-4773(99)00022-2; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Morita Y, 1999, ENDOCRINOLOGY, V140, P2696, DOI 10.1210/en.140.6.2696; Reijntjes S, 2005, DEV BIOL, V285, P224, DOI 10.1016/j.ydbio.2005.06.019; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; WHITTEN WK, 1979, J EMBRYOL EXP MORPH, V52, P63; Yao HHC, 2003, DEVELOPMENT, V130, P5895, DOI 10.1242/dev.00836; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0	29	699	741	3	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					596	600		10.1126/science.1125691	http://dx.doi.org/10.1126/science.1125691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16574820				2022-12-24	WOS:000237296700050
J	Poehling, KA; Talbot, TR; Griffin, MR; Craig, AS; Whitney, CG; Zell, E; Lexau, CA; Thomas, AR; Harrison, LH; Reingold, AL; Hadler, JL; Farley, MM; Anderson, BJ; Schaffner, W				Poehling, KA; Talbot, TR; Griffin, MR; Craig, AS; Whitney, CG; Zell, E; Lexau, CA; Thomas, AR; Harrison, LH; Reingold, AL; Hadler, JL; Farley, MM; Anderson, BJ; Schaffner, W			Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STREPTOCOCCUS-PNEUMONIAE INFECTIONS; CHILDREN; IMMUNIZATION; EPIDEMIOLOGY; SURVEILLANCE; RESISTANCE; PROGRAM; IMPACT	Context Streptococcus pneumoniae is a serious infection in young infants. A heptavalent pneumococcal conjugate vaccine (PCV7) was licensed in 2000 and recommended for all children aged 2 to 23 months. Objective To determine the rates of invasive pneumococcal disease (IPD) in young infants before and after PCV7 was incorporated into the childhood immunization schedule in June 2000. Design, Setting, and Participants A prospective, population-based study of infants aged 0 to 90 days who resided in areas in 8 US states with active laboratory surveillance for invasive S pneumoniae infections from July 1, 1997, to June 30, 2004. Main Outcome Measures Rates of laboratory-confirmed IPD before (July 1, 1997-June 30, 2000) and after (July 1, 2001-June 30, 2004) PCV7 introduction, excluding a transition year (July 1, 2000-June 30, 2001). Results There were 146 cases of IPD, 89 before and 57 after PCV7 introduction. Isolated bacteremia occurred in 94 cases (64%), pneumonia in 27 (18%), meningitis in 22 (15%), and septic arthritis and/or osteomyelitis in 3 (2%). Mean rates of IPD for infants aged 0 to 90 days decreased 40% from 11.8 (95% confidence interval [CI], 9.6-14.5) to 7.2 (95% CI, 5.6-9.4; P = .004) per 100 000 live births following PCV7 introduction. Among black infants, mean rates of IPD decreased significantly from 17.1 (95% CI, 11.9-24.6) to 5.3 (95% CI, 2.8-10.1; P = .001) per 100 000 live births, with a nonsignificant decrease from 9.6 (95% CI, 7.3-12.7) to 6.8 (95% CI, 4.9-9.4) per 100 000 live births for white infants. Rates of PCV7-serotype isolates decreased significantly from 7.3 (95% CI, 5.3-10.1) to 2.4 (95% CI, 1.6-3.8; P < .001) per 100 000 live births, while rates of non-PCV7 serotypes remained stable (P = .55). Conclusions Since PCV7 introduction, rates of IPD in young infants have decreased significantly, providing evidence that vaccinating children aged 2 to 23 months has led to changes in pneumococcal carriage in infants too young to receive PCV7. With a significant decrease in rates of IPD among black infants, the previous racial difference has been eliminated.	Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Educ & Res Therapeut, Nashville, TN 37232 USA; Tennessee Dept Hlth, Nashville, TN USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA USA; Minnesota Dept Hlth, Minneapolis, MN USA; Oregon Dept Human Serv, Off Dis Prevent & Epidemiol, Portland, OR USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Connecticut Dept Hlth, Infect Dis Sect, Hartford, CT USA; Emory Univ, Sch Med, Atlanta, GA USA; Atlanta Vet Affairs Med Ctr, Atlanta, GA USA; New York State Dept Hlth, Emerging Infect Program, Albany, NY USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Tennessee Department Health; Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Berkeley; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; State University of New York (SUNY) System	Poehling, KA (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat, AA-0216 Med Ctr N, Nashville, TN 37232 USA.	katherine.poehling@vanderbilt.edu		Talbot, Thomas/0000-0002-6139-212X	PHS HHS [U50/CCU416123] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abramson JS, 2000, PEDIATRICS, V106, P362; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Bradley JS, 1998, PEDIATRICS, V102, P1376, DOI 10.1542/peds.102.6.1376; *CDCP, 2001, NAT IMM SURV; Centers for Disease Control and Prevention, ACT BACT COR SURV RE; *CT DEP PUBL HLTH, 1997, CONN LIV BIRTH DAT; *CTR HLTH STAT OFF, 1997, CAL LIV BIRTH DAT; Dagan R, 2005, J INFECT DIS, V192, P367, DOI 10.1086/431679; Dagan R, 1999, VACCINE, V17, P134, DOI 10.1016/S0264-410X(98)00165-0; Flannery B, 2004, JAMA-J AM MED ASSOC, V291, P2197, DOI 10.1001/jama.291.18.2197; Freed GL, 2002, PEDIATRICS, V110, P399, DOI 10.1542/peds.110.2.399; *GA DIV PUBL HLTH, 1997, GEORG LIV BIRTH DAT; Gomez M, 1999, PEDIATR INFECT DIS J, V18, P1014, DOI 10.1097/00006454-199911000-00016; Hausdorff WP, 2002, EUR J PEDIATR, V161, pS135, DOI 10.1007/s00431-002-1066-x; Hoffman JA, 2003, PEDIATRICS, V112, P1095, DOI 10.1542/peds.112.5.1095; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Hyde TB, 2002, PEDIATRICS, V110, P690, DOI 10.1542/peds.110.4.690; McDonald LC, 2003, J CLIN MICROBIOL, V41, P2258, DOI 10.1128/JCM.41.5.2258-2260.2003; McEllistrem MC, 2005, EMERG INFECT DIS, V11, P969; *MN DEP HLTH, 1997, MINN LIV BIRTH DAT; *NAT COMM CLIN LAB, 2002, PERF STAND ANT SUSC, V22; O'Brien KL, 2004, AM J EPIDEMIOL, V159, P634, DOI 10.1093/aje/kwh082; PAVIS A, 1995, EUR J CLIN MICROBIOL, V14, P68, DOI 10.1007/BF02112625; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Rubin DB., 1987, SOCIOL METHODOL, V17, P131, DOI DOI 10.2307/271031; Sadow KB, 1999, ARCH PEDIAT ADOL MED, V153, P611, DOI 10.1001/archpedi.153.6.611; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; SIMPSON JM, 1995, EUR J PEDIATR, V154, P563, DOI 10.1007/s004310050343; *STAT OR PUBL HLTH, 1997, OR LIV BIRTH DAT; Talbot TR, 2004, PEDIATR INFECT DIS J, V23, P726, DOI 10.1097/01.inf.0000133046.60555.de; Talbot TR, 2004, CLIN INFECT DIS, V39, P641, DOI 10.1086/422653; *TN DEP HLTH, 1997, TENN LIV BIRTH DAT; *VIT STAT ADM, 1997, MAR LIV BIRTH DAT; *VIT STAT NY STAT, 1997, NEW YORK LIV BIRTH D; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; 2002, NAT VITAL STAT REPOR	36	322	341	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2006	295	14					1668	1674		10.1001/jama.295.14.1668	http://dx.doi.org/10.1001/jama.295.14.1668			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031LY	16609088	Bronze			2022-12-24	WOS:000236707300022
J	Belevich, I; Verkhovsky, MI; Wikstrom, M				Belevich, I; Verkhovsky, MI; Wikstrom, M			Proton-coupled electron transfer drives the proton pump of cytochrome c oxidase	NATURE			English	Article							CATALYTIC CYCLE; SUBUNIT-I; TRANSLOCATION; REDUCTION; OXYGEN; HEME; BACTERIORHODOPSIN; RESPIRATION; MECHANISM; DIOXYGEN	Electron transfer in cell respiration is coupled to proton translocation across mitochondrial and bacterial membranes, which is a primary event of biological energy transduction. The resulting electrochemical proton gradient is used to power energy-requiring reactions, such as ATP synthesis. Cytochrome c oxidase is a key component of the respiratory chain, which harnesses dioxygen as a sink for electrons and links O-2 reduction to proton pumping(1). Electrons from cytochrome c are transferred sequentially to the O-2 reduction site of cytochrome c oxidase via two other metal centres, Cu-A and haem a, and this is coupled to vectorial proton transfer across the membrane by a hitherto unknown mechanism. On the basis of the kinetics of proton uptake and release on the two aqueous sides of the membrane, it was recently suggested that proton pumping by cytochrome c oxidase is not mechanistically coupled to internal electron transfer(2). Here we have monitored translocation of electrical charge equivalents as well as electron transfer within cytochrome c oxidase in real time. The results show that electron transfer from haem a to the O-2 reduction site initiates the proton pump mechanism by being kinetically linked to an internal vectorial proton transfer. This reaction drives the proton pump and occurs before relaxation steps in which protons are taken up from the aqueous space on one side of the membrane and released on the other(2).	Univ Helsinki, Helsinki Bioenerget Grp, Inst Biotechnol, FIN-00014 Helsinki, Finland	University of Helsinki	Wikstrom, M (corresponding author), Univ Helsinki, Helsinki Bioenerget Grp, Inst Biotechnol, FIN-00014 Helsinki, Finland.	marten.wikstrom@helsinki.fi	Wikstrom, Marten KF/A-4403-2008	Wikstrom, Marten/0000-0002-7527-4415; Belevich, Ilya/0000-0003-2190-4909				Adelroth P, 1997, BIOCHEMISTRY-US, V36, P13824, DOI 10.1021/bi9629079; Babcock GT, 1999, P NATL ACAD SCI USA, V96, P12971, DOI 10.1073/pnas.96.23.12971; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; Bloch D, 2004, P NATL ACAD SCI USA, V101, P529, DOI 10.1073/pnas.0306036101; Branden G, 2005, BIOCHEMISTRY-US, V44, P10466, DOI 10.1021/bi0502745; Buse G, 1999, PROTEIN SCI, V8, P985, DOI 10.1110/ps.8.5.985; Faxen K, 2005, NATURE, V437, P286, DOI 10.1038/nature03921; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; Flock D, 2002, PROTEINS, V47, P75, DOI 10.1002/prot.10066; Gennis RB, 2004, FRONT BIOSCI, V9, P581, DOI 10.2741/1237; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Jasaitis A, 1999, BIOCHEMISTRY-US, V38, P2697, DOI 10.1021/bi982275l; Lanyi JK, 2001, CURR OPIN STRUC BIOL, V11, P415, DOI 10.1016/S0959-440X(00)00226-8; Michel H, 1999, BIOCHEMISTRY-US, V38, P15129, DOI 10.1021/bi9910934; MITCHELL R, 1994, BBA-BIOENERGETICS, V1186, P19, DOI 10.1016/0005-2728(94)90130-9; Morgan JE, 2001, BIOCHEMISTRY-US, V40, P6882, DOI 10.1021/bi010246w; Namslauer A, 2003, BIOCHEMISTRY-US, V42, P1488, DOI 10.1021/bi026524o; Popovic DM, 2004, FEBS LETT, V566, P126, DOI 10.1016/j.febslet.2004.04.016; Ruitenberg M, 2002, NATURE, V417, P99, DOI 10.1038/417099a; Siegbahn PEM, 2003, J PHYS CHEM B, V107, P10946, DOI 10.1021/jp035486v; THOMAS JW, 1993, BIOCHEMISTRY-US, V32, P10923, DOI 10.1021/bi00091a048; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; Verkhovskaya ML, 1997, P NATL ACAD SCI USA, V94, P10128, DOI 10.1073/pnas.94.19.10128; Verkhovsky MI, 1999, NATURE, V400, P480, DOI 10.1038/22813; Wikstrom M, 1998, CURR OPIN STRUC BIOL, V8, P480, DOI 10.1016/S0959-440X(98)80127-9; Wikstrom M, 2003, BBA-BIOENERGETICS, V1604, P61, DOI 10.1016/S0005-2728(03)00041-0; WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	29	217	236	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					829	832		10.1038/nature04619	http://dx.doi.org/10.1038/nature04619			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598262				2022-12-24	WOS:000236548400048
J	Pastorino, L; Sun, A; Lu, PJ; Zhou, XZ; Balastik, M; Finn, G; Wulf, G; Lim, J; Li, SH; Li, XJ; Xia, WM; Nicholson, LK; Lu, KP				Pastorino, L; Sun, A; Lu, PJ; Zhou, XZ; Balastik, M; Finn, G; Wulf, G; Lim, J; Li, SH; Li, XJ; Xia, WM; Nicholson, LK; Lu, KP			The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production	NATURE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; IN-VIVO; TRANSGENIC MICE; PHOSPHORYLATION; ISOMERIZATION; PRESENILIN-1; BINDING; PLAQUES; CANCER	Neuropathological hallmarks of Alzheimer's disease are neurofibrillary tangles composed of tau and neuritic plaques comprising amyloid-beta peptides (A beta) derived from amyloid precursor protein (APP), but their exact relationship remains elusive(1-3). Phosphorylation of tau and APP on certain serine or threonine residues preceding proline affects tangle formation and A beta production in vitro(3-5). Phosphorylated Ser/Thr-Pro motifs in peptides can exist in cis or trans conformations, the conversion of which is catalysed by the Pin1 prolyl isomerase(6,7). Pin1 has been proposed to regulate protein function by accelerating conformational changes(7-10), but such activity has never been visualized and the biological and pathological significance of Pin1 substrate conformations is unknown(7). Notably, Pin1 is downregulated and/or inhibited by oxidation in Alzheimer's disease neurons, Pin1 knockout causes tauopathy and neurodegeneration(8,9,11,12), and Pin1 promoter polymorphisms appear to associate with reduced Pin1 levels and increased risk for late-onset Alzheimer's disease(13,14). However, the role of Pin1 in APP processing and A beta production is unknown. Here we show that Pin1 has profound effects on APP processing and A beta production. We find that Pin1 binds to the phosphorylated Thr 668-Pro motif in APP and accelerates its isomerization by over 1,000-fold, regulating the APP intracellular domain between two conformations, as visualized by NMR. Whereas Pin1 overexpression reduces A beta secretion from cell cultures, knockout of Pin1 increases its secretion. Pin1 knockout alone or in combination with overexpression of mutant APP in mice increases amyloidogenic APP processing and selectively elevates insoluble A beta 42 (a major toxic species) in brains in an age-dependent manner, with A beta 42 being prominently localized to multivesicular bodies of neurons, as shown in Alzheimer's disease before plaque pathology(15). Thus, Pin1-catalysed prolyl isomerization is a novel mechanism to regulate APP processing and A beta production, and its deregulation may link both tangle and plaque pathologies. These findings provide new insight into the pathogenesis and treatment of Alzheimer's disease.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Canc Biol Program, Boston, MA 02215 USA; Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung 804, Taiwan; Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Kaohsiung Veterans General Hospital; Emory University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cornell University	Lu, KP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Canc Biol Program, Boston, MA 02215 USA.	klu@bidmc.harvard.edu	Balastik, Martin/C-4410-2014; xia, weiming/E-5465-2016; Wulf, Gerburg/AAS-6713-2021; Lim, Jormay/A-7257-2011	Balastik, Martin/0000-0001-5833-9996; xia, weiming/0000-0002-7463-3295; Lim, Jormay/0000-0001-7191-545X	NIA NIH HHS [R01 AG029385] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG029385] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Lu KP, 2004, TRENDS BIOCHEM SCI, V29, P200, DOI 10.1016/j.tibs.2004.02.002; Lu KP, 2003, BIOESSAYS, V25, P174, DOI 10.1002/bies.10223; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Pastorino L, 2004, MOL CELL NEUROSCI, V25, P642, DOI 10.1016/j.mcn.2003.12.013; Ramelot TA, 2001, J MOL BIOL, V307, P871, DOI 10.1006/jmbi.2001.4535; Ramelot TA, 2000, BIOCHEMISTRY-US, V39, P2714, DOI 10.1021/bi992580m; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schutkowski M, 1998, BIOCHEMISTRY-US, V37, P5566, DOI 10.1021/bi973060z; SEGAT L, 2005, IN PRESS NEUROB 1226; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; Suizu F, 2006, MOL CELL BIOL, V26, P1463, DOI 10.1128/MCB.26.4.1463-1479.2006; SULTANA R, IN PRESS NEUROB 0609; SUZUKI T, 1994, EMBO J, V13, P1114, DOI 10.1002/j.1460-2075.1994.tb06360.x; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Wijsman EM, 2004, AM J HUM GENET, V75, P398, DOI 10.1086/423393; Wintjens R, 2001, J BIOL CHEM, V276, P25150, DOI 10.1074/jbc.M010327200; Wulf G, 2004, EMBO J, V23, P3397, DOI 10.1038/sj.emboj.7600323; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	30	390	404	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					528	534		10.1038/nature04543	http://dx.doi.org/10.1038/nature04543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554819				2022-12-24	WOS:000236176100056
J	Hemingway, H; McCallum, A; Shipley, M; Manderbacka, K; Martikainen, P; Keskimaki, I				Hemingway, H; McCallum, A; Shipley, M; Manderbacka, K; Martikainen, P; Keskimaki, I			Incidence and prognostic implications of stable angina pectoris among women and men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; GENDER-DIFFERENCES; ARTERY-DISEASE; SEX BIAS; PREVALENCE; MORTALITY; VALIDITY; RISK; ONSET	Context Stable angina pectoris in women has often been considered a "soft" diagnosis, with less-severe prognostic implications than in men, but large-scale population studies are lacking. Objective To determine sex differences in the incidence and prognosis of stable angina in a large ambulatory population. Design Prospective cohort study using linked national registers. Setting All municipal primary health care centers, hospital outpatient clinics, occupational health care services, and the private sector in Finland. Participants Among ambulatory patients aged 45 to 89 years who had no history of coronary disease, we defined new cases of "nitrate angina" based on nitrate prescription ( 56 441 women and 34 885 men) or "test-positive angina" based on abnormal invasive or noninvasive test results ( 11 391 women and 15 806 men). Potentially eligible patients were evaluated between January 1, 1996, and December 31, 1998. Follow-up ended in December 2001. Main Outcome Measures Coronary mortality at 4 years (n= 7906 deaths) and fatal and nonfatal myocardial infarction at 1 year ( n= 3129 events). Results The age-standardized annual incidence per 100 population of all cases of angina was 2.03 in men and 1.89 in women, with a sex ratio of 1.07 (95% confidence interval [CI], 1.06-1.09). At every age, nitrate angina in women and men was associated with a similar increase in risk of coronary mortality relative to the general population. Women with test-positive angina who were younger than 75 years had higher coronary-standardized mortality ratios than men; for example, among those aged 55 to 64 years, it was 4.69 ( 95% CI, 3.60-6.11) in women compared with 2.40 ( 95% CI, 2.11-2.73) in men ( P <. 001 for interaction). There was a strong, graded relationship between amount of nitrates used and event rates; women using higher doses of nitrates had prognoses comparable with those of men. Among patients with diabetes and test-positive angina, age-standardized coronary event rates were 9.9 per 100 person-years in women vs 9.3 in men (P=. 69), and the fully adjusted male-female sex ratio was 1.07 ( 95% CI, 0.81-1.41). Conclusions Women have a similarly high incidence of stable angina compared with men. Furthermore, stable angina in women is associated with increased coronary mortality relative to women in the general population and, among easily identifiable clinical subgroups, has similarly high absolute rates of prognostic outcomes compared with men.	UCL, Sch Med, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; Univ Helsinki, Natl Res & Dev Ctr Welf & Hlth, Helsinki, Finland; Univ Helsinki, Dept Sociol, Populat Res Unit, Helsinki, Finland	University of London; University College London; UCL Medical School; University of Helsinki; University of Helsinki	Hemingway, H (corresponding author), UCL, Sch Med, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.	h.hemingway@ucl.ac.uk	Hemingway, Harry/C-1219-2009	Hemingway, Harry/0000-0003-2279-0624; McCallum, Alison Katherine/0000-0002-8113-2130; Martikainen, Pekka/0000-0001-9374-1438				BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627; Bottomley A, 1997, J EPIDEMIOL COMMUN H, V51, P87, DOI 10.1136/jech.51.1.87; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Britton A, 2004, BMJ-BRIT MED J, V329, P318, DOI 10.1136/bmj.38156.690150.AE; Bugiardini R, 2005, JAMA-J AM MED ASSOC, V293, P477, DOI 10.1001/jama.293.4.477; CANNON PJ, 1988, LANCET, V1, P979; Carlisle DM, 1999, AM J MED, V106, P391, DOI 10.1016/S0002-9343(99)00051-0; CASPER ML, 2000, WOMEN HEART DIS ATLA; *COLL STUD COORD C, ATH RISK COMM STUD D; Daly CA, 2005, EUR HEART J, V26, P1011, DOI 10.1093/eurheartj/ehi109; *FINL NAT PUBL HLT, STAT DAT 1 B 04 COR; Ford ES, 2003, ETHNIC DIS, V13, P85; Hemingway H, 2004, CAN J CARDIOL, V20, P305; Hemingway H, 2003, BRIT MED J, V327, P895, DOI 10.1136/bmj.327.7420.895; Hemingway H, 2001, NEW ENGL J MED, V344, P645, DOI 10.1056/NEJM200103013440906; Hetemaa T, 2004, J CLIN EPIDEMIOL, V57, P301, DOI 10.1016/j.jclinepi.2003.07.010; Hsia J, 2004, AM J CARDIOL, V93, P673, DOI 10.1016/j.amjcard.2003.12.002; JAGLAL SB, 1995, CAN MED ASSOC J, V152, P873; Javitz HS, 2004, AM J MANAG CARE, V10, pS358; Johnson BD, 2004, CIRCULATION, V109, P2993, DOI 10.1161/01.CIR.0000130642.79868.B2; Karjalainen A, 2001, AM J RESP CRIT CARE, V164, P565, DOI 10.1164/ajrccm.164.4.2012146; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lee PY, 2001, JAMA-J AM MED ASSOC, V286, P708, DOI 10.1001/jama.286.6.708; Linfante A, 2004, CIRCULATION, V110, P664; Mackay J, 2004, ATLAS HEART DIS STRO; Mieres JH, 2005, CIRCULATION, V111, P682, DOI 10.1161/01.CIR.0000155233.67287.60; MURABITO JM, 1993, CIRCULATION, V88, P2548, DOI 10.1161/01.CIR.88.6.2548; Nilsson S, 2003, BRIT J GEN PRACT, V53, P378; ORENCIA A, 1993, JAMA-J AM MED ASSOC, V269, P2392, DOI 10.1001/jama.269.18.2392; Owen-Smith V, 2003, BRIT J GEN PRACT, V53, P784; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; Philpott S, 2001, SOC SCI MED, V52, P1565, DOI 10.1016/S0277-9536(00)00269-0; Poole-Wilson PA, 2004, LANCET, V364, P849, DOI 10.1016/S0140-6736(04)16980-8; REUNANEN A, 1983, ACTA MED SCAND, P1; RICHEDWARDS JW, 1995, AM J EPIDEMIOL, V142, P909, DOI 10.1093/oxfordjournals.aje.a117738; Roger VL, 1998, J AM COLL CARDIOL, V32, P345, DOI 10.1016/S0735-1097(98)00229-0; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; SHAW LJ, 1994, ANN INTERN MED, V120, P559, DOI 10.7326/0003-4819-120-7-199404010-00005; Sorlie PD, 1996, J CLIN EPIDEMIOL, V49, P719, DOI 10.1016/0895-4356(96)00022-4; Spertus JA, 2002, CIRCULATION, V106, P43, DOI 10.1161/01.CIR.0000020688.24874.90; Sutcliffe SJ, 2003, BRIT MED J, V326, P20, DOI 10.1136/bmj.326.7379.20; TOBIN JN, 1987, ANN INTERN MED, V107, P19, DOI 10.7326/0003-4819-107-1-19; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; TUNSTALLPEDOE H, 1985, EUR HEART J, V6, P1; Warren J., 1812, N ENGL J MED SURG, V1, P1; *WHO COLL CTR DRUG, 2005, GUID AN CHEM THER AT; World Health Organization, 2022, INT CLASS DIS, V11th; Zaher C, 2004, AM J MANAG CARE, V10, pS339	48	175	178	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2006	295	12					1404	1411		10.1001/jama.295.12.1404	http://dx.doi.org/10.1001/jama.295.12.1404			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023WU	16551712				2022-12-24	WOS:000236157700018
J	Pan, XW; Ye, P; Yuan, DS; Wang, XL; Bader, JS; Boeke, JD				Pan, XW; Ye, P; Yuan, DS; Wang, XL; Bader, JS; Boeke, JD			A DNA integrity network in the yeast Saccharomyces cerevisiae	CELL			English	Article							SISTER-CHROMATID COHESION; S-PHASE; DAMAGE CHECKPOINT; CELL-CYCLE; REPLICATION STRESS; PROTEIN COMPLEXES; GENES; IDENTIFICATION; REPAIR; MRC1	A network governing DNA integrity was identified in yeast by a global genetic analysis of synthetic fitness or lethality defect (SFL) interactions. Within this network, 16 functional modules or minipathways were defined based on patterns of global SFL interactions. Modules or genes involved in DNA replication, DNA-replication checkpoint (DRC) signaling, and oxidative stress response were identified as the major guardians against lethal spontaneous DNA damage, efficient repair of which requires the functions of the DNA-damage checkpoint signaling and multiple DNA-repair pathways. This genome-wide genetic interaction network also identified novel components (DIA2, NPT1, HST3, HST4, and the CSM1 module) that potentially contribute to mitotic DNA replication and genomic stability and revealed novel functions of well-studied genes (the CTF18 module) in DRC signaling. This network will guide more detailed characterization of mechanisms governing DNA integrity in yeast and other organisms.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 733 N Broadway, Baltimore, MD 21205 USA.	jboeke@jhmi.edu	Bader, Joel/A-1818-2009	Bader, Joel/0000-0002-6020-4625; Boeke, Jef/0000-0001-5322-4946	NCRR NIH HHS [RR020839] Funding Source: Medline; NHGRI NIH HHS [HG02432] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002432] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Amon A, 1998, P NATL ACAD SCI USA, V95, P85, DOI 10.1073/pnas.95.1.85; Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bassett DE, 1997, NAT GENET, V15, P339, DOI 10.1038/ng0497-339; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Birrell GW, 2001, P NATL ACAD SCI USA, V98, P12608, DOI 10.1073/pnas.231366398; Brachmann CB, 1998, YEAST, V14, P115; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Enyenihi AH, 2003, GENETICS, V163, P47; Foss EJ, 2001, GENETICS, V157, P567; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Grunweller A, 2002, GENETICS, V162, P59; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huang ME, 2005, MOL CELL, V17, P709, DOI 10.1016/j.molcel.2005.02.008; Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Kus BM, 2004, PROTEINS, V54, P455, DOI 10.1002/prot.10620; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Merrill BJ, 1998, GENETICS, V148, P611; Morrison AJ, 2005, CELL CYCLE, V4, P568; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Naiki T, 2001, MOL CELL BIOL, V21, P5838, DOI 10.1128/MCB.21.17.5838-5845.2001; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Rajavel M, 1998, BIOCHEMISTRY-US, V37, P4181, DOI 10.1021/bi9720134; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Sutton A, 2001, MOL CELL BIOL, V21, P3514, DOI 10.1128/MCB.21.10.3514-3522.2001; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Wysocka M, 2004, EXP CELL RES, V294, P592, DOI 10.1016/j.yexcr.2003.12.008; Xu H, 2004, MOL CELL BIOL, V24, P7082, DOI 10.1128/MCB.24.16.7082-7090.2004; Ye P, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100034; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	60	433	450	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					1069	1081		10.1016/j.cell.2005.12.036	http://dx.doi.org/10.1016/j.cell.2005.12.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16487579	Bronze			2022-12-24	WOS:000237241200026
J	Zhong, WW; Sternberg, PW				Zhong, WW; Sternberg, PW			Genome-wide prediction of C-elegans genetic interactions	SCIENCE			English	Article							PROTEIN; NETWORKS; KINASE; TOOL; MAP		CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Sternberg, PW (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	pws@caltech.edu						Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baudot A, 2006, BIOINFORMATICS, V22, P248, DOI 10.1093/bioinformatics/bti757; BEITEL GJ, 1990, NATURE, V348, P503, DOI 10.1038/348503a0; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; IWASAKI K, 1995, P NATL ACAD SCI USA, V92, P10317, DOI 10.1073/pnas.92.22.10317; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee J, 2004, J MOL BIOL, V344, P585, DOI 10.1016/j.jmb.2004.09.050; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Moghal N, 2003, DEVELOPMENT, V130, P4553, DOI 10.1242/dev.00670; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Schwarz EM, 2006, NUCLEIC ACIDS RES, V34, pD475, DOI 10.1093/nar/gkj061; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Walker DS, 2002, MOL BIOL CELL, V13, P1329, DOI 10.1091/mbc.01-08-0422; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101; WU Y, 1994, GENE DEV, V8, P147, DOI 10.1101/gad.8.2.147	20	205	229	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2006	311	5766					1481	1484		10.1126/science.1123287	http://dx.doi.org/10.1126/science.1123287			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527984				2022-12-24	WOS:000236029400055
J	Deeks, SG				Deeks, SG			Challenges of developing R5 inhibitors in antiretroviral naive HIV-infected patients	LANCET			English	Editorial Material							SHORT-TERM MONOTHERAPY; CCR5 ANTAGONIST; EFFICACY; THERAPY; SAFETY		Univ Calif San Francisco, San Francisco Gen Hosp, San Francisco, CA 94110 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Deeks, SG (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, San Francisco, CA 94110 USA.	sdeeks@php.ucsf.edu						AJEUBOR MN, 2005, J IMMUNOL, V174, P8207; Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; GREAVES W, 2006, 13 C RETR OPP INF; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Lalezari J, 2005, AIDS, V19, P1443, DOI 10.1097/01.aids.0000183633.06580.8a; Mocroft A, 2004, J INFECT DIS, V190, P1947, DOI 10.1086/425424; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Moreno C, 2005, HEPATOLOGY, V42, P854, DOI 10.1002/hep.20865; Spudich SS, 2005, J INFECT DIS, V191, P890, DOI 10.1086/428095; Wolinsky SM, 2004, VIROLOGY, V328, P19, DOI 10.1016/j.virol.2004.07.021	13	17	17	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 4	2006	367	9512					711	713		10.1016/S0140-6736(06)68280-9	http://dx.doi.org/10.1016/S0140-6736(06)68280-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	020JX	16517257				2022-12-24	WOS:000235906000007
J	Jenni, S; Leibundgut, M; Maier, T; Ban, N				Jenni, S; Leibundgut, M; Maier, T; Ban, N			Architecture of a fungal fatty acid synthase at 5 angstrom resolution	SCIENCE			English	Article							ACYL CARRIER PROTEIN; COENZYME-A CARBOXYLASE; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; SACCHAROMYCES-CEREVISIAE; MULTIENZYME COMPLEX; SUBSTRATE-BINDING; YEAST; SYNTHETASE; BIOSYNTHESIS	All steps of fatty acid synthesis in fungi are catalyzed by the fatty acid synthase, which forms a 2.6-megadalton alpha(6)beta(6) complex. We have determined the molecular architecture of this multienzyme by fitting the structures of homologous enzymes that catalyze the individual steps of the reaction pathway into a 5 angstrom x-ray crystallographic electron density map. The huge assembly contains two separated reaction chambers, each equipped with three sets of active sites separated by distances up to similar to 130 angstroms, across which acyl carrier protein shuttles substrates during the reaction cycle. Regions of the electron density arising from well-defined structural features outside the catalytic domains separate the two reaction chambers and serve as a matrix in which domains carrying the various active sites are embedded. The structure rationalizes the compartmentalization of fatty acid synthesis, and the spatial arrangement of the active sites has specific implications for our understanding of the reaction cycle mechanism and of the architecture of multienzymes in general.	Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Jenni, S (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	ban@mol.biol.ethz.ch	Maier, Timm/A-8835-2016	Maier, Timm/0000-0002-7459-1363				Brown DW, 1996, P NATL ACAD SCI USA, V93, P14873, DOI 10.1073/pnas.93.25.14873; Davis MS, 2001, J BACTERIOL, V183, P1499, DOI 10.1128/JB.183.4.1499-1503.2001; Dover LG, 2004, FEMS MICROBIOL REV, V28, P225, DOI 10.1016/j.femsre.2003.10.001; Fichtlscherer F, 2000, EUR J BIOCHEM, V267, P2666, DOI 10.1046/j.1432-1327.2000.01282.x; Fisher M, 2000, STRUCTURE, V8, P339, DOI 10.1016/S0969-2126(00)00115-5; FOX JL, 1980, EUR J BIOCHEM, V109, P417, DOI 10.1111/j.1432-1033.1980.tb04810.x; HACKENJOS WA, 1987, BIOL CHEM H-S, V368, P19, DOI 10.1515/bchm3.1987.368.1.19; HORI T, 1987, J BIOCHEM-TOKYO, V101, P949, DOI 10.1093/oxfordjournals.jbchem.a121964; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Keatinge-Clay AT, 2003, STRUCTURE, V11, P147, DOI 10.1016/S0969-2126(03)00004-2; Kimber MS, 2004, J BIOL CHEM, V279, P52593, DOI 10.1074/jbc.M408105200; Kolodziej SJ, 1996, J BIOL CHEM, V271, P28422, DOI 10.1074/jbc.271.45.28422; Kolodziej SJ, 1997, J STRUCT BIOL, V120, P158, DOI 10.1006/jsbi.1997.3911; Koski MK, 2005, J MOL BIOL, V345, P1157, DOI 10.1016/j.jmb.2004.11.009; Kostrewa D, 2005, PROTEIN SCI, V14, P1570, DOI 10.1110/ps.051373005; LINDQVIST Y, 1991, J BIOL CHEM, V266, P3198; LYNEN F, 1980, EUR J BIOCHEM, V112, P431; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Olsen JG, 1999, FEBS LETT, V460, P46, DOI 10.1016/S0014-5793(99)01303-4; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; STOOPS JK, 1980, P NATL ACAD SCI-BIOL, V77, P4544, DOI 10.1073/pnas.77.8.4544; STOOPS JK, 1992, P NATL ACAD SCI USA, V89, P6585, DOI 10.1073/pnas.89.14.6585; STOOPS JK, 1978, J BIOL CHEM, V253, P4464; SUMPER M, 1969, EUR J BIOCHEM, V10, P377, DOI 10.1111/j.1432-1033.1969.tb00701.x; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Tang LJ, 1997, J BACTERIOL, V179, P3697, DOI 10.1128/jb.179.11.3697-3705.1997; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Watanabe CMH, 2002, CHEM BIOL, V9, P981, DOI 10.1016/S1074-5521(02)00213-2; WERKMEISTER K, 1981, EUR J BIOCHEM, V116, P303, DOI 10.1111/j.1432-1033.1981.tb05334.x; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; WIELAND F, 1978, P NATL ACAD SCI USA, V75, P5792, DOI 10.1073/pnas.75.12.5792; Woloshuk CP, 1998, FEMS MICROBIOL LETT, V160, P169, DOI [10.1111/j.1574-6968.1998.tb12907.x, 10.1016/S0378-1097(97)00588-0]	37	120	125	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2006	311	5765					1263	1267		10.1126/science.1123251	http://dx.doi.org/10.1126/science.1123251			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019XB	16513976				2022-12-24	WOS:000235870400034
J	Martin, W; Koonin, EV				Martin, W; Koonin, EV			Introns and the origin of nucleus-cytosol compartmentalization	NATURE			English	Article							EXON THEORY; RNA DECAY; EVOLUTION; TRANSLATION; GENES; EUKARYOTES; CLASSIFICATION; PHYLOGENY; CONTAIN; NETWORK	The origin of the eukaryotic nucleus marked a seminal evolutionary transition. We propose that the nuclear envelope's incipient function was to allow mRNA splicing, which is slow, to go to completion so that translation, which is fast, would occur only on mRNA with intact reading frames. The rapid, fortuitous spread of introns following the origin of mitochondria is adduced as the selective pressure that forged nucleus - cytosol compartmentalization.	Univ Dusseldorf, Inst Bot 3, D-40225 Dusseldorf, Germany; Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA	Heinrich Heine University Dusseldorf; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Martin, W (corresponding author), Univ Dusseldorf, Inst Bot 3, D-40225 Dusseldorf, Germany.	w.martin@uni-duesseldorf.de	Martin, William F./O-5446-2015; Martin, William/C-5680-2008	Martin, William F./0000-0003-1478-6449; 	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Audibert A, 2002, MOL CELL BIOL, V22, P6706, DOI 10.1128/MCB.22.19.6706-6718.2002; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; CAVALIERSMITH T, 1991, TRENDS GENET, V7, P145, DOI 10.1016/0168-9525(91)90102-V; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; CECH TR, 1981, CELL, V27, P487, DOI 10.1016/0092-8674(81)90390-1; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Cosson B, 2003, BIOL CELL, V95, P321, DOI 10.1016/S0248-4900(03)00059-5; Cousineau B, 2001, NATURE, V414, P84, DOI 10.1038/35102087; Dahlberg JE, 2004, CURR OPIN CELL BIOL, V16, P335, DOI 10.1016/j.ceb.2004.03.006; DARNELL JE, 1978, SCIENCE, V202, P1257, DOI 10.1126/science.364651; DARNELL JE, 1986, P NATL ACAD SCI USA, V83, P1271, DOI 10.1073/pnas.83.5.1271; DOOLITTLE W F, 1991, Current Biology, V1, P145, DOI 10.1016/0960-9822(91)90214-H; Doolittle WE, 1998, TRENDS GENET, V14, P307; DOOLITTLE WF, 1980, TRENDS BIOCHEM SCI, V5, P146; DOOLITTLE WF, 1978, NATURE, V272, P581, DOI 10.1038/272581a0; Fasken MB, 2005, NAT STRUCT MOL BIOL, V12, P482, DOI 10.1038/nsmb945; FERAT JL, 1993, NATURE, V364, P358, DOI 10.1038/364358a0; FINLAY BJ, 1992, EUR J PROTISTOL, V28, P127, DOI 10.1016/S0932-4739(11)80041-6; Forterre P, 1999, BIOESSAYS, V21, P871, DOI 10.1002/(SICI)1521-1878(199910)21:10<871::AID-BIES10>3.0.CO;2-Q; Gabaldon T, 2003, SCIENCE, V301, P609, DOI 10.1126/science.1085463; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; GILBERT W, 1987, COLD SPRING HARB SYM, V52, P901, DOI 10.1101/SQB.1987.052.01.098; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; HEATH IB, 1980, INT REV CYTOL, V64, P1, DOI 10.1016/S0074-7696(08)60235-1; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Iborra FJ, 2001, SCIENCE, V293, P1139, DOI 10.1126/science.1061216; Jeffares DC, 1998, J MOL EVOL, V46, P18, DOI 10.1007/PL00006280; Khusial P, 2005, TRENDS BIOCHEM SCI, V30, P522, DOI 10.1016/j.tibs.2005.07.006; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Levine T, 2005, CURR OPIN CELL BIOL, V17, P362, DOI 10.1016/j.ceb.2005.06.005; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2002, CURR OPIN GENET DEV, V12, P701, DOI 10.1016/S0959-437X(02)00360-X; Makarova KS, 2005, NUCLEIC ACIDS RES, V33, P4626, DOI 10.1093/nar/gki775; Mans BJ, 2004, CELL CYCLE, V3, P1612; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Nixon JEJ, 2002, P NATL ACAD SCI USA, V99, P3701, DOI 10.1073/pnas.042700299; PALMITER RD, 1975, CELL, V4, P189, DOI 10.1016/0092-8674(75)90167-1; Poole A, 1999, BIOESSAYS, V21, P880, DOI 10.1002/(SICI)1521-1878(199910)21:10<880::AID-BIES11>3.0.CO;2-P; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Rivera MC, 2004, NATURE, V431, P152, DOI 10.1038/nature02848; ROGER AJ, 1993, NATURE, V364, P289, DOI 10.1038/364289a0; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Roy SW, 2005, P NATL ACAD SCI USA, V102, P5773, DOI 10.1073/pnas.0500383102; Simpson AGB, 2002, NATURE, V419, P270, DOI 10.1038/419270a; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; Staub E, 2004, BIOESSAYS, V26, P567, DOI 10.1002/bies.20032; STOLTZFUS A, 1994, SCIENCE, V265, P202, DOI 10.1126/science.8023140; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440; Vanacova S, 2005, P NATL ACAD SCI USA, V102, P4430, DOI 10.1073/pnas.0407500102; Vellai T, 1998, J MOL EVOL, V46, P499, DOI 10.1007/PL00006331; von Dohlen CD, 2001, NATURE, V412, P433, DOI 10.1038/35086563; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102	57	357	368	0	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2006	440	7080					41	45		10.1038/nature04531	http://dx.doi.org/10.1038/nature04531			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HW	16511485				2022-12-24	WOS:000235685700034
J	Goldraij, A; Kondo, K; Lee, CB; Hancock, CN; Sivaguru, M; Vazquez-Santana, S; Kim, S; Phillips, TE; Cruz-Garcia, F; McClure, B				Goldraij, A; Kondo, K; Lee, CB; Hancock, CN; Sivaguru, M; Vazquez-Santana, S; Kim, S; Phillips, TE; Cruz-Garcia, F; McClure, B			Compartmentalization of S-RNase and HT-B degradation in self-incompatible Nicotiana	NATURE			English	Article							F-BOX PROTEIN; POLLEN-REJECTION; 120-KDA GLYCOPROTEIN; NATURAL-POPULATION; PRUNUS-AVIUM; GENE; ALATA; IDENTIFICATION; LYCOPERSICON; ALLELES	Pollen - pistil interactions are crucial for controlling plant mating. For example, S-RNase-based self-incompatibility prevents inbreeding in diverse angiosperm species. S-RNases are thought to function as specific cytotoxins that inhibit pollen that has an S-haplotype that matches one of those in the pistil. Thus, pollen and pistil factors interact to prevent mating between closely related individuals. Other pistil factors, such as HT-B, 4936-factor and the 120 kDa glycoprotein, are also required for pollen rejection but do not contribute to S-haplotype-specificity per se. Here we show that S-RNase is taken up and sorted to a vacuolar compartment in the pollen tubes. Antibodies to the 120 kDa glycoprotein label the compartment membrane. When the pistil does not express HT-B or 4936-factor, S-RNase remains sequestered, unable to cause rejection. Similarly, in wild-type pistils, compatible pollen tubes degrade HT-B and sequester S-RNase. We suggest that S-RNase trafficking and the stability of HT-B are central to S-specific pollen rejection.	Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, CIQUIBIC, RA-5000 Cordoba, Argentina; 105 Life Sci Ctr, Div Biochem, Columbia, MO 65211 USA; Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; Dept Plant Biol, Athens, GA 30602 USA; Univ Nacl Autonoma Mexico, Fac Quim, Dept Bioquim, Mexico City 04510, DF, Mexico; Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Biol, Mexico City 04510, DF, Mexico	National University of Cordoba; University of Missouri System; University of Missouri Columbia; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	McClure, B (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, CIQUIBIC, Ciudad Univ, RA-5000 Cordoba, Argentina.	mcclureb@missouri.edu	Cruz-Garcia, Felipe/A-5817-2008; Sivaguru, Mayandi/M-3393-2019; Hancock, Charles/AAA-5249-2020; Sivaguru, Mayandi/L-7845-2019	Sivaguru, Mayandi/0000-0001-5532-4393; Phillips, Thomas/0000-0002-9709-0684; Hancock, Charles Nathan/0000-0002-0875-8495				AI YJ, 1991, MOL GEN GENET, V230, P353, DOI 10.1007/BF00280291; ANDERSON MA, 1989, PLANT CELL, V1, P483, DOI 10.1105/tpc.1.5.483; Beecher B, 2001, SEX PLANT REPROD, V14, P69, DOI 10.1007/s004970100078; BERNATZKY R, 1995, BIOCHEM GENET, V33, P215, DOI 10.1007/BF02401852; CORNISH EC, 1987, NATURE, V326, P99, DOI 10.1038/326099a0; Cruz-Garcia F, 2005, PLANT J, V42, P295, DOI 10.1111/j.1365-313X.2005.02375.x; Entani T, 2003, GENES CELLS, V8, P203, DOI 10.1046/j.1365-2443.2003.00626.x; Geitmann A., 1999, FERTILIZATION HIGHER, V41, P283; Hancock CN, 2005, PLANT J, V43, P716, DOI 10.1111/j.1365-313X.2005.02490.x; Hicks GR, 2004, PLANT PHYSIOL, V134, P1227, DOI 10.1104/pp.103.037382; Ikeda K, 2004, SEX PLANT REPROD, V16, P235, DOI 10.1007/s00497-003-0200-x; Jauh GY, 1999, PLANT CELL, V11, P1867, DOI 10.1105/tpc.11.10.1867; Kao TH, 2004, PLANT CELL, V16, pS72, DOI 10.1105/tpc.016154; KHO YO, 1968, EUPHYTICA, V17, P299; Kondo K, 2002, PLANT J, V30, P143, DOI 10.1046/j.1365-313X.2002.01275.x; Kondo K, 2002, PLANT J, V29, P627, DOI 10.1046/j.0960-7412.2001.01245.x; LEE HS, 1994, NATURE, V367, P560, DOI 10.1038/367560a0; Lind JL, 1996, SEX PLANT REPROD, V9, P75, DOI 10.1007/BF02153054; LIND JL, 1994, PLANT J, V6, P491, DOI 10.1046/j.1365-313X.1994.6040491.x; Luu DT, 2000, NATURE, V407, P649, DOI 10.1038/35036623; MacIntosh GC, 2001, P NATL ACAD SCI USA, V98, P1018, DOI 10.1073/pnas.98.3.1018; MARTIN FW, 1968, GENETICS, V60, P101; McClure B, 2004, PLANT CELL, V16, P2840, DOI 10.1105/tpc.104.161130; McClure B, 1999, P NATL ACAD SCI USA, V96, P13548, DOI 10.1073/pnas.96.23.13548; MCCLURE BA, 1990, NATURE, V347, P757, DOI 10.1038/347757a0; McClure BA, 2000, ANN BOT-LONDON, V85, P113, DOI 10.1006/anbo.1999.1061; Murfett J, 1996, PLANT CELL, V8, P943, DOI 10.1105/tpc.8.6.943; MURFETT J, 1994, NATURE, V367, P563, DOI 10.1038/367563a0; Nettancourt, 2001, INCOMPATIBILITY INCO; O'Brien K, 2002, HASTINGS CENT REP, V32, P12; Paris N, 1996, PLANT PHYSIOL BIOCH, V34, P223; Qiao H, 2004, PLANT CELL, V16, P2307, DOI 10.1105/tpc.104.024919; Qiao H, 2004, PLANT CELL, V16, P582, DOI 10.1105/tpc.017673; Rogers SW, 1997, PLANT J, V11, P1359, DOI 10.1046/j.1365-313X.1997.11061359.x; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Sonneveld T, 2005, PLANT CELL, V17, P37, DOI 10.1105/tpc.104.026963; Tanner VA, 1996, J HISTOCHEM CYTOCHEM, V44, P1481, DOI 10.1177/44.12.8985140; Tsukamoto T, 1999, SEX PLANT REPROD, V12, P6, DOI 10.1007/s004970050166; Tsukamoto T, 2003, SEX PLANT REPROD, V15, P255, DOI 10.1007/s00497-002-0161-5; Ushijima K, 2004, PLANT J, V39, P573, DOI 10.1111/j.1365-313X.2004.02154.x; Ushijima K, 2003, PLANT CELL, V15, P771, DOI 10.1105/tpc.009290; VANDEURS B, 1988, J CELL BIOL, V106, P253, DOI 10.1083/jcb.106.2.253; Wesche J, 1999, J BIOL CHEM, V274, P34443, DOI 10.1074/jbc.274.48.34443	43	187	207	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2006	439	7078					805	810		10.1038/nature04491	http://dx.doi.org/10.1038/nature04491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012JA	16482149				2022-12-24	WOS:000235333600040
J	Perez-Moreno, M; Davis, MA; Wong, E; Pasolli, HA; Reynolds, AB; Fuchs, E				Perez-Moreno, M; Davis, MA; Wong, E; Pasolli, HA; Reynolds, AB; Fuchs, E			p120-Catenin mediates inflammatory responses in the skin	CELL			English	Article							NF-KAPPA-B; E-CADHERIN FUNCTION; RHO-FAMILY GTPASES; P120 CATENIN; CELL-ADHESION; BETA-CATENIN; EPIDERMAL MORPHOGENESIS; JUXTAMEMBRANE REGION; ADHERENS JUNCTION; ALPHA-CATENIN	Although p120-catenin regulates adherens junction (AJ) stability in cultured cells, genetic studies in lower eukaryotes have not revealed a role for this protein in vivo. Using conditional targeting in mice, we show that p120 null neonatal epidermis exhibits reduced intercellular AJ components but no overt disruption in barrier function or intercellular adhesion. As the mice age, however, they display epidermal hyperplasia and chronic inflammation, typified by hair degeneration and loss of body fat. Using skin engraftments and anti-inflammatory drugs, we show that these features are not attributable to reductions in junctional cadherins and catenins, but rather NFkB activation. Both in vivo and in vitro, p120 null epidermal cells activate nuclear NFkB, triggering a cascade of proinflammatory NFkB targets. Although the underlying mechanism is likely complex, we show that p120 affects NFkB activation and immune homeostasis in part through regulation of Rho GTPases. These findings provide important new insights into p120 function.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA; Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA	Howard Hughes Medical Institute; Rockefeller University; Vanderbilt University	Perez-Moreno, M (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA.	al.reynolds@vanderbilt.edu; fuchslb@rockefeller.edu	Perez-Moreno, Mirna/I-3687-2015; Fuchs, Elaine/G-1565-2016	Perez-Moreno, Mirna/0000-0002-0170-6406; Pasolli, Hilda Amalia/0000-0003-3899-3530; Davis, Michael/0000-0002-5406-4128	NATIONAL CANCER INSTITUTE [R29CA055724, P50CA095103, R01CA055724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883, R37AR027883] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA95103, P50 CA095103, CA55724, R01 CA055724] Funding Source: Medline; NIAMS NIH HHS [R01 AR027883-29, R01 AR027883, R37 AR027883] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; CHENG J, 1992, GENE DEV, V6, P1444, DOI 10.1101/gad.6.8.1444; Ciesiolka M, 2004, J CELL SCI, V117, P4325, DOI 10.1242/jcs.01298; Clevers H, 2004, CANCER CELL, V5, P5, DOI 10.1016/S1535-6108(03)00339-8; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fang X, 2004, J CELL BIOL, V165, P87, DOI 10.1083/jcb.200307109; Franz CM, 2004, J BIOL CHEM, V279, P6588, DOI 10.1074/jbc.M312812200; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Grosheva I, 2001, J CELL SCI, V114, P695; Hatzfeld M, 2005, EUR J CELL BIOL, V84, P205, DOI 10.1016/j.ejcb.2004.12.016; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; Mariner DJ, 2000, J CELL SCI, V113, P1481; Myster SH, 2003, J CELL BIOL, V160, P433, DOI 10.1083/jcb.200211083; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Pacquelet A, 2003, J CELL BIOL, V160, P313, DOI 10.1083/jcb.200207160; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Paulson AF, 2000, J BIOL CHEM, V275, P30124, DOI 10.1074/jbc.M003048200; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Pettitt J, 2003, J CELL BIOL, V162, P15, DOI 10.1083/jcb.200212136; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; Robert C, 1999, NEW ENGL J MED, V341, P1817, DOI 10.1056/NEJM199912093412407; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Werner S, 2001, TRENDS CELL BIOL, V11, P143, DOI 10.1016/S0962-8924(01)01955-9; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Zhang JY, 2005, J CELL BIOL, V168, P561, DOI 10.1083/jcb.200411060	50	217	223	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 10	2006	124	3					631	644		10.1016/j.cell.2005.11.043	http://dx.doi.org/10.1016/j.cell.2005.11.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	014FG	16469707	Bronze, Green Accepted			2022-12-24	WOS:000235464000023
J	Suzuki, Y; Nijhout, HF				Suzuki, Y; Nijhout, HF			Evolution of a polyphenism by genetic accommodation	SCIENCE			English	Article							THRESHOLD EVOLUTION; TOBACCO HORNWORM; LEPIDOPTERA; TEMPERATURE; MECHANISMS; ECOLOGY	Polyphenisms are adaptations in which a genome is associated with discrete alternative phenotypes in different environments. Little is known about the mechanism by which polyphenisms originate. We show that a mutation in the juvenile hormone-regulatory pathway in Manduca sexta enables heat stress to reveal a hidden reaction norm of larval coloration. Selection for increased color change in response to heat stress resulted in the evolution of a larval color polyphenism and a corresponding change in hormonal titers through genetic accommodation. Evidently, mechanisms that regulate developmental hormones can mask genetic variation and act as evolutionary capacitors, facilitating the origin of novel adaptive phenotypes.	Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Suzuki, Y (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	ys16@duke.edu		Suzuki, Yuichiro/0000-0002-0957-3564				Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; CASEY TM, 1976, ECOLOGY, V57, P485, DOI 10.2307/1936433; Emlen DJ, 1996, EVOLUTION, V50, P1219, DOI [10.1111/j.1558-5646.1996.tb02362.x, 10.2307/2410662]; FAIN MJ, 1975, BIOL BULL-US, V149, P506, DOI 10.2307/1540383; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; HIRUMA K, 1993, INT J INSECT MORPHOL, V22, P103, DOI 10.1016/0020-7322(93)90003-J; HUDSON A, 1966, CAN J ZOOLOG, V44, P541, DOI 10.1139/z66-058; Kitching IJ, 2002, ZOOL J LINN SOC-LOND, V135, P471, DOI 10.1046/j.1096-3642.2002.00021.x; Moczek AP, 2003, EVOL DEV, V5, P259, DOI 10.1046/j.1525-142X.2003.03033.x; Moczek AP, 2003, BEHAV ECOL, V14, P841, DOI 10.1093/beheco/arg062; Moczek AP, 2002, EVOL DEV, V4, P252, DOI 10.1046/j.1525-142X.2002.02014.x; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Nijhout H.F., 1994, INSECT HORMONES; Petersen C, 2000, PHYSIOL ENTOMOL, V25, P35, DOI 10.1046/j.1365-3032.2000.00163.x; Rendel J. M, 1967, CANALIZATION GENE CO; ROFF DA, 1994, GENETICS, V136, P395; ROUNTREE DB, 1995, J INSECT PHYSIOL, V41, P1141, DOI 10.1016/0022-1910(95)00051-U; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; SAFRANEK L, 1975, J INSECT PHYSIOL, V21, P1931, DOI 10.1016/0022-1910(75)90225-5; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Shapiro A. M., 1976, EVOL BIOL, P259, DOI DOI 10.1007/978-1-4615-6950-3_6; Tomkins JL, 2004, NATURE, V431, P1099, DOI 10.1038/nature02918; West-Eberhard Mary Jane, 2003, pi	25	279	290	1	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2006	311	5761					650	652		10.1126/science.1118888	http://dx.doi.org/10.1126/science.1118888			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011GY	16456077				2022-12-24	WOS:000235257400045
J	Sasaki, M; Takagi, M; Okamura, Y				Sasaki, M; Takagi, M; Okamura, Y			A voltage sensor-domain protein is a voltage-gated proton channel	SCIENCE			English	Article							ALVEOLAR EPITHELIAL-CELLS; HYDROGEN-ION CURRENTS; INTRACELLULAR PH; LYMNAEA-STAGNALIS; NEURONS; SNAIL; CONDUCTANCE; REVEALS; PORE	Voltage-gated proton channels have been widely observed but have not been identified at a molecular level. Here we report that a four-transmembrane protein similar to the voltage-sensor domain of voltage-gated ion channels is a voltage-gated proton channel. Cells overexpressing this protein showed depolarization-induced outward currents accompanied by tail currents. Current reversal occured at equilibrium potentials for protons. The currents exhibited pH-dependent gating and zinc ion sensitivity, two features which are characteristic of voltage-gated proton channels. Responses of voltage dependence to sequence changes suggest that mouse voltage-sensor domain-only protein is itself a channel, rather than a regulator of another channel protein.	Okazaki Inst Integrat Biosci, Sect Dev Neurophysiol, Aichi 4448787, Japan; Grad Univ Adv Studies, Aichi 4448787, Japan; Natl Inst Nat Sci, Natl Inst Physiol Sci, Aichi 4448787, Japan; Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058566, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Institute of Advanced Industrial Science & Technology (AIST)	Okamura, Y (corresponding author), Okazaki Inst Integrat Biosci, Sect Dev Neurophysiol, Higashiyama 5-1, Aichi 4448787, Japan.	yokamura@nips.ac.jp						Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BYERLY L, 1989, J PHYSIOL-LONDON, V413, P75, DOI 10.1113/jphysiol.1989.sp017642; BYERLY L, 1984, J PHYSIOL-LONDON, V351, P199, DOI 10.1113/jphysiol.1984.sp015241; Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; Cherny VV, 2003, J GEN PHYSIOL, V121, P615, DOI 10.1085/jgp.200308813; CHERNY VV, 1995, J GEN PHYSIOL, V105, P861, DOI 10.1085/jgp.105.6.861; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeCoursey TE, 1996, J MEMBRANE BIOL, V152, P131, DOI 10.1007/s002329900092; Eder C, 2001, PROG NEUROBIOL, V64, P277, DOI 10.1016/S0301-0082(00)00062-9; KAPUS A, 1993, J GEN PHYSIOL, V102, P729, DOI 10.1085/jgp.102.4.729; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; MEECH RW, 1987, J PHYSIOL-LONDON, V390, P433, DOI 10.1113/jphysiol.1987.sp016710; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; RAMSEY IS, 2000, NATURE; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Sokolov S, 2005, NEURON, V47, P183, DOI 10.1016/j.neuron.2005.06.012; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047	22	417	424	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					589	592		10.1126/science.1122352	http://dx.doi.org/10.1126/science.1122352			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16556803				2022-12-24	WOS:000237296700048
J	Langhoff-Roos, J; Kesmodel, U; Jacobsson, B; Rasmussen, S; Vogel, I				Langhoff-Roos, J; Kesmodel, U; Jacobsson, B; Rasmussen, S; Vogel, I			Spontaneous preterm delivery in primiparous women at low risk in Denmark: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GESTATIONAL-AGE; BIRTH; RATES	Objectives To analyse trends in preterm delivery and the factors contributing to preterm delivery in Denmark. To construct a standard population at low risk (white European, 20-40 years of age, with a Singleton spontaneous pregnancy) and describe the changes in this population so that time trends can be compared internationally Design population based study Participants 99.8% of all deliveries in Denmark, 1995-2004. Main outcome measures Proportion of babies born at less than 37 weeks completed gestation for each year in the overall population and in a standard population at low risk. Results Overall, the proportion of preterm deliveries increased by 22% from 1995 to 2004. During the same period, known risk factors for preterm delivery such as in vitro fertilisation, multiple pregnancies, and elective deliveries also increased, and logistic regression analyses showed that these factors were associated with all increased risk of preterm delivery Spontaneous preterm deliveries in primiparous women at low risk rose 51% (from 3.8% to 5.7%) during this time compared with 20% (2.7% to 3.2%) in multiparous women at low risk. Conclusions The overall proportion of preterm deliveries increased significantly from 1995 to 2004 and primiparity and multiple birth were the most important contributing factors. The rise in spontaneous preterm deliveries in the standard population of primiparous women at low risk was greater than in the total population.	Rigshosp, Juliane Marie Ctr, Dept Obstet, DK-2100 Copenhagen, Denmark; Aarhus Univ, Inst Publ Hlth, Dept Epidemiol, NANEA, DK-8000 Aarhus, Denmark; Sahlgrenska Univ Hosp Ostra, Perinatal Ctr, Dept Obstet & Gynecol, SE-41345 Gothenburg, Sweden; Natl Board Hlth, Hlth Stat, DK-2300 Copenhagen, Denmark; Aarhus Univ, Dept Clin Genet, DK-8000 Aarhus C, Denmark	Rigshospitalet; University of Copenhagen; Aarhus University; Sahlgrenska University Hospital; Aarhus University	Langhoff-Roos, J (corresponding author), Rigshosp, Juliane Marie Ctr, Dept Obstet, DK-2100 Copenhagen, Denmark.	jlr@dadlnet.dk	Jacobsson, Bo/O-8007-2014; Vogel, Ida/AAD-1087-2019	Jacobsson, Bo/0000-0001-5079-2374; Vogel, Ida/0000-0002-1125-0393; Langhoff-Roos, Jens/0000-0003-2838-2533				Balchin I, 2004, BJOG-INT J OBSTET GY, V111, P160, DOI 10.1046/j.1471-0528.2003.00026.x; Hedegaard M, 1996, ACTA OBSTET GYN SCAN, V75, P32, DOI 10.3109/00016349609033280; Mancuso RA, 2004, PSYCHOSOM MED, V66, P762, DOI 10.1097/01.psy.0000138284.70670.d5; *MED BIRTH REG NOR, PRET BIRTHS NORW 199; *NAT CTR HLTH STAT, PRET BIRTH US 1992 2; Yang H, 2002, AM J OBSTET GYNECOL, V186, P433, DOI 10.1067/mob.2002.120487	6	154	160	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2006	332	7547					937	939		10.1136/bmj.38751.524132.2F	http://dx.doi.org/10.1136/bmj.38751.524132.2F			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037JV	16497733	Green Published, Bronze			2022-12-24	WOS:000237143900014
J	de Pater, I; Hammel, HB; Gibbard, SG; Showalter, MR				de Pater, I; Hammel, HB; Gibbard, SG; Showalter, MR			New dust belts of Uranus: One ring, two ring, red ring, blue ring	SCIENCE			English	Article							SATURNS E-RING; PHOTOMETRY; SATELLITES	We compared near-infrared observations of the recently discovered outer rings of Uranus with Hubble Space Telescope results. We find that the inner ring, R/2003 U 2, is red, whereas the outer ring, R/2003 U 1, is very blue. Blue is an unusual color for rings; Saturn's enigmatic E ring is the only other known example. By analogy to the E ring, R/2003 U 1 is probably produced by impacts into the embedded moon Mab, which apparently orbits at a location where nongravitational perturbations favor the survival and spreading of submicron-sized dust. R/2003 U 2 more closely resembles Saturn's G ring, which is red, a typical color for dusty rings.	Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; Space Sci Inst, Boulder, CO 80301 USA; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; SETI Inst, Mountain View, CA 94043 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	de Pater, I (corresponding author), Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA.	imke@astron.berkeley.edu						Burns JA, 2001, ASTR AST LI, P641; de Pater I, 2006, ICARUS, V180, P186, DOI 10.1016/j.icarus.2005.08.011; de Pater I, 2004, ICARUS, V172, P446, DOI 10.1016/j.icarus.2004.07.012; French R. G., 1991, URANUS, P327; Gibbard SG, 2005, ICARUS, V174, P253, DOI 10.1016/j.icarus.2004.09.008; HEDMAN MM, 2005, BAAS, V37; HORANYI M, 1992, ICARUS, V97, P248, DOI 10.1016/0019-1035(92)90131-P; JOHNSON T, 2005, AM GEOPH UN FALL M S; JUHASZ A, 2002, J GEOPHYS RES, V107, P1, DOI DOI 10.1029/2001JA000182; Karkoschka E, 2001, ICARUS, V151, P51, DOI 10.1006/icar.2001.6596; SHOWALTER MR, 1993, ICARUS, V103, P124, DOI 10.1006/icar.1993.1062; Showalter MR, 2006, SCIENCE, V311, P973, DOI 10.1126/science.1122882; SHOWALTER MR, 1991, ICARUS, V94, P451, DOI 10.1016/0019-1035(91)90241-K; Throop HB, 1998, ICARUS, V131, P152, DOI 10.1006/icar.1997.5851; VANALLEN JA, 1980, SCIENCE, V207, P415, DOI 10.1126/science.207.4429.415	15	33	33	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2006	312	5770					92	94		10.1126/science.1125110	http://dx.doi.org/10.1126/science.1125110			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601188	Green Submitted			2022-12-24	WOS:000236584400037
J	Gould, DB; Phalan, FC; van Mil, SE; Sundberg, JP; Vahedi, K; Massin, P; Bousser, MG; Heutink, P; Miner, JH; Tournier-Lasserve, E; John, SWM				Gould, DB; Phalan, FC; van Mil, SE; Sundberg, JP; Vahedi, K; Massin, P; Bousser, MG; Heutink, P; Miner, JH; Tournier-Lasserve, E; John, SWM			Role of COL4A1 in small-vessel disease and hemorrhagic stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RETINAL ARTERIOLAR TORTUOSITY; HEREDITARY ENDOTHELIOPATHY; RETINOPATHY; NEPHROPATHY; MUTATIONS	Small-vessel diseases of the brain underlie 20 to 30 percent of ischemic strokes and a larger proportion of intracerebral hemorrhages. In this report, we show that a mutation in the mouse Col4a1 gene, encoding procollagen type IV alpha l, predisposes both newborn and adult mice to intracerebral hemorrhage. Surgical delivery of mutant mice alleviated birth-associated trauma and hemorrhage. We identified a COL4A1 mutation in a human family with small-vessel disease. We concluded that mutation of COL4A1 may cause a spectrum of cerebrovascular phenotypes and that persons with COL4A1 mutations may be predisposed to hemorrhage, especially after environmental stress.	Jackson Lab, Bar Harbor, ME 04609 USA; Howard Hughes Med Inst, Bar Harbor, ME USA; VU Univ Med Ctr, Dept Human Genet, Sect Med Genom, Amsterdam, Netherlands; VU Univ, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands; Hop Lariboisiere, Assistance Publ Hop Paris, Serv Neurol, F-75475 Paris, France; Hop Lariboisiere, Assistance Publ Hop Paris, Serv Ophtalmol, F-75475 Paris, France; Assistance Publ Hop Paris, INSERM, U740, Paris, France; Assistance Publ Hop Paris, Genet Lab, Paris, France; Washington Univ, Sch Med, Div Renal, St Louis, MO 63130 USA; Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Jackson Laboratory; Howard Hughes Medical Institute; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Washington University (WUSTL); Tufts University	John, SWM (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	swmj@jax.org	Tournier-Lasserve, Elisabeth/N-7134-2017	Tournier-Lasserve, Elisabeth/0000-0002-3039-1677; Heutink, Peter/0000-0001-5218-1737; Dichgans, Martin/0000-0002-0654-387X	NCI NIH HHS [CA34196] Funding Source: Medline; NEI NIH HHS [EY117211] Funding Source: Medline; NIDDK NIH HHS [DK064687] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064687] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		American Heart Association, 2005, HEART DIS STROKE STA; BREEDVELD G, IN PRESS J MED GENET; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Gupta MC, 1997, J CELL BIOL, V137, P1185, DOI 10.1083/jcb.137.5.1185; Hawes N L, 1999, Mol Vis, V5, P22; Jen J, 1997, NEUROLOGY, V49, P1322, DOI 10.1212/WNL.49.5.1322; Kase CS, 1998, STROKE PATHOPHYSIOLO, P649; Mancini GMS, 2004, EUR J PAEDIATR NEURO, V8, P45, DOI 10.1016/j.ejpn.2003.10.002; Ophoff RA, 2001, AM J HUM GENET, V69, P447, DOI 10.1086/321975; Plaisier E, 2005, KIDNEY INT, V67, P2354, DOI 10.1111/j.1523-1755.2005.00341.x; Sugiyama F, 2002, PHYSIOL GENOMICS, V10, P5, DOI 10.1152/physiolgenomics.00002.2002; Vahedi K, 2003, NEUROLOGY, V60, P57, DOI 10.1212/WNL.60.1.57	12	363	374	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 6	2006	354	14					1489	1496		10.1056/NEJMoa053727	http://dx.doi.org/10.1056/NEJMoa053727			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	029DP	16598045	Bronze			2022-12-24	WOS:000236539000007
J	Koch, C; Hepp, K				Koch, C; Hepp, K			Quantum mechanics in the brain	NATURE			English	Editorial Material									CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; ETH, Zurich, Switzerland	California Institute of Technology; California Institute of Technology; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Koch, C (corresponding author), CALTECH, Div Biol, 216-76, Pasadena, CA 91125 USA.			Koch, Christof/0000-0001-6482-8067				Hepp K, 1998, LECT NOTE PHYS, V517, P92; Koch Christof, 1999, P1; Koch Christof, 2004, QUEST CONSCIOUSNESS; Nielsen M.A., 2002, QUANTUM COMPUTATION; Penrose R., 1989, EMPERORS NEW MIND	5	84	91	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					611	612		10.1038/440611a	http://dx.doi.org/10.1038/440611a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572152	Green Accepted, Bronze			2022-12-24	WOS:000236350400025
J	Teebi, AS; El-Shanti, HI				Teebi, AS; El-Shanti, HI			Consanguinity: implications for practice, research, and policy	LANCET			English	Editorial Material							POPULATIONS; MARRIAGES; BEHAVIOR		Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; Univ Toronto, Toronto, ON M5G 1X8, Canada; Childrens Hosp Iowa, Div Med Genet, Iowa City, IA USA; Univ Iowa, Iowa City, IA USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Iowa	Teebi, AS (corresponding author), Hosp Sick Children, Div Clin & Metab Genet, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	ahmad.teebi@sickkids.ca	El-Shanti, Hatem/O-5990-2014; EL-SHANTI, HATEM/Q-4932-2016	El-Shanti, Hatem/0000-0001-6230-8316; EL-SHANTI, HATEM/0000-0001-6230-8316				AFZAL M, 1988, BEHAV GENET, V18, P583, DOI 10.1007/BF01082310; Bittles AH, 2001, CLIN GENET, V60, P89, DOI 10.1034/j.1399-0004.2001.600201.x; BITTLES AH, 1991, SCIENCE, V252, P789, DOI 10.1126/science.2028254; Hamamy H, 2005, CLIN GENET, V67, P511, DOI 10.1111/j.1399-0004.2005.00426.x; Hoodfar E, 1996, J MED GENET, V33, P212, DOI 10.1136/jmg.33.3.212; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; MORTON NE, 1978, P NATL ACAD SCI USA, V75, P3906, DOI 10.1073/pnas.75.8.3906; SHAMI SA, 1989, J MED GENET, V26, P267, DOI 10.1136/jmg.26.4.267; Sheffield VC, 2004, PEDIATR RES, V55, P908, DOI 10.1203/01.pdr.0000127013.14444.9c; Teebi AS, 2005, COMMUNITY GENET, V8, P21, DOI 10.1159/000083333; Teebi AS, 1997, GENETIC DISORDERS AR; Zlotogora J, 2002, AM J HUM BIOL, V14, P680, DOI 10.1002/ajhb.10082	12	27	28	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2006	367	9515					970	971		10.1016/S0140-6736(06)68406-7	http://dx.doi.org/10.1016/S0140-6736(06)68406-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028GE	16564347				2022-12-24	WOS:000236474200009
J	Ford, N; Darder, M				Ford, N; Darder, M			Registration problems for antiretrovirals in Africa	LANCET			English	Editorial Material									Med Sans Frontieres, ZA-7784 Khayelitsha, South Africa		Ford, N (corresponding author), Med Sans Frontieres, ZA-7784 Khayelitsha, South Africa.	Nathan.FORD@london.msf.org						BOULLE A, 2005, ANTIRETROVIRAL DRUGS; *GIL, 2005, GIL EXP GLOB ACC PRO; *GIL, 2002, GIL SCI PROV ACC ANT; *GUID DEV GROUP, 2005, ANT DRUGS TREATM HIV	4	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2006	367	9513					794	795		10.1016/S0140-6736(06)68313-X	http://dx.doi.org/10.1016/S0140-6736(06)68313-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021WL	16530559				2022-12-24	WOS:000236016500006
J	Newcomb, PA; Egan, KM				Newcomb, PA; Egan, KM			Dairy food and ovarian cancer risk	LANCET			English	Editorial Material							VITAMIN-D; MORTALITY-RATES; BREAST-CANCER; CALCIUM; EPIDEMIOLOGY; CONSUMPTION; INHIBITION; CARCINOMA; PRODUCTS; SUNLIGHT		Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98109 USA	Vanderbilt University; Fred Hutchinson Cancer Center	Newcomb, PA (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	pnewcomb@fhcrc.org						Cramer DW, 2000, CANCER EPIDEM BIOMAR, V9, P95; Freedman DM, 2002, OCCUP ENVIRON MED, V59, P257, DOI 10.1136/oem.59.4.257; Friedrich M, 2003, RECENT RES CANCER, V164, P239; Giovannucci E, 2005, CANCER CAUSE CONTROL, V16, P83, DOI 10.1007/s10552-004-1661-4; Goodman MT, 2002, AM J EPIDEMIOL, V156, P148, DOI 10.1093/aje/kwf022; Grant WB, 2003, RECENT RESULTS CANC, V164, P371; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; Larsson SC, 2006, INT J CANCER, V118, P431, DOI 10.1002/ijc.21305; LEFKOWITZ ES, 1994, INT J EPIDEMIOL, V23, P1133, DOI 10.1093/ije/23.6.1133; Lipkin M, 1999, J AM COLL NUTR, V18, p392S, DOI 10.1080/07315724.1999.10718903; Lukanova A, 2005, CANCER EPIDEM BIOMAR, V14, P98; Martinez ME, 1998, CANCER EPIDEM BIOMAR, V7, P163; Mommers M, 2006, BRIT J CANCER, V94, P165, DOI 10.1038/sj.bjc.6602890; SAUNDERS DE, 1992, GYNECOL ONCOL, V44, P131, DOI 10.1016/0090-8258(92)90028-H; SAUNDERS DE, 1995, ANTI-CANCER DRUG, V6, P562, DOI 10.1097/00001813-199508000-00009; Seidman JD, 2003, HEMATOL ONCOL CLIN N, V17, P909, DOI 10.1016/S0889-8588(03)00061-3; SWARTZ WJ, 1988, FERTIL STERIL, V49, P522	17	0	0	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2006	367	9513					797	799		10.1016/S0140-6736(06)68315-3	http://dx.doi.org/10.1016/S0140-6736(06)68315-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021WL	16530561				2022-12-24	WOS:000236016500008
J	Huitema, E; Pritchard, S; Matteson, D; Radhakrishnan, SK; Viollier, PH				Huitema, E; Pritchard, S; Matteson, D; Radhakrishnan, SK; Viollier, PH			Bacterial birth scar proteins mark future flagellum assembly site	CELL			English	Article							CELL-CYCLE PROGRESSION; BACILLUS-SUBTILIS; CAULOBACTER-CRESCENTUS; DI-GMP; POLAR LOCALIZATION; DIVISION SITES; EAL DOMAINS; FTSZ; PHOSPHODIESTERASE; IDENTIFICATION	Many prokaryotic protein complexes underlie polar asymmetry. In Caulobacter crescentus, a flagellum is built exclusively at the pole that arose from the previous cell division. The basis for this pole specificity is unclear but could involve a cytokinetic birth scar that marks the newborn pole as the flagellum assembly site. We identified two developmental proteins, TipN and TipF, which localize to the division septum and the newborn pole after division. We show that septal localization of TipN/F depends on cytokinesis. Moreover, TipF, a c-di-GMP phosphodiesterase homolog, is a flagellum assembly factor that relies on TipN for proper positioning. In the absence of TipN, flagella are assembled at ectopic locations, and TipF is mislocalized to such sites. Thus TipN and TipF establish a link between bacterial cytokinesis and polar asymmetry, demonstrating that division does indeed leave a positional mark in its wake to direct the biogenesis of a polar organelle.	Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Case Western Reserve University	Viollier, PH (corresponding author), Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	patrick.viollier@case.edu	Viollier, Patrick/AAD-9405-2021; Huitema, Edgar/G-3760-2011	Huitema, Edgar/0000-0002-5766-0830; Radhakrishnan, Sunish/0000-0001-8729-263X; Viollier, Patrick/0000-0002-5249-9910				ALLEY MRK, 1992, GENE DEV, V6, P825, DOI 10.1101/gad.6.5.825; Ben-Yehuda S, 2003, SCIENCE, V299, P532, DOI 10.1126/science.1079914; Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036; Charles M, 2001, P NATL ACAD SCI USA, V98, P9871, DOI 10.1073/pnas.171310498; Chen JC, 2005, MOL MICROBIOL, V55, P1085, DOI 10.1111/j.1365-2958.2004.04443.x; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Din N, 1998, MOL MICROBIOL, V27, P1051, DOI 10.1046/j.1365-2958.1998.00752.x; Edwards DH, 2000, EMBO J, V19, P2719, DOI 10.1093/emboj/19.11.2719; ELY B, 1991, METHOD ENZYMOL, V204, P372; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Figge RM, 2003, MOL MICROBIOL, V47, P1225, DOI 10.1046/j.1365-2958.2003.03367.x; FRANCIS NR, 1994, J MOL BIOL, V235, P1261, DOI 10.1006/jmbi.1994.1079; Gober JW, 2000, PROKARYOTIC DEVELOPMENT, P319; Hamoen LW, 2003, J BACTERIOL, V185, P693, DOI 10.1128/JB.185.2.693-697.2003; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; Howard M, 2004, J MOL BIOL, V335, P655, DOI 10.1016/j.jmb.2003.10.058; Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003; Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007; Kelly AJ, 1998, GENE DEV, V12, P880, DOI 10.1101/gad.12.6.880; Levin PA, 1997, MOL MICROBIOL, V25, P839; Losick R, 1999, GENE DEV, V13, P377, DOI 10.1101/gad.13.4.377; Lucet I, 2000, EMBO J, V19, P1467, DOI 10.1093/emboj/19.7.1467; MACALISTER TJ, 1987, J BACTERIOL, V169, P3945, DOI 10.1128/jb.169.9.3945-3951.1987; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019; McGrath PT, 2004, CURR OPIN MICROBIOL, V7, P192, DOI 10.1016/j.mib.2004.02.012; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Perry SE, 2004, MOL MICROBIOL, V54, P1237, DOI 10.1111/j.1365-2958.2004.04363.x; Pogliano J, 1997, P NATL ACAD SCI USA, V94, P559, DOI 10.1073/pnas.94.2.559; Rafelski SM, 2005, BIOPHYS J, V89, P2146, DOI 10.1529/biophysj.105.061168; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Scott ME, 2001, P NATL ACAD SCI USA, V98, P13978, DOI 10.1073/pnas.241411198; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Skerker JM, 2004, NAT REV MICROBIOL, V2, P325, DOI 10.1038/nrmicro864; Skerker JM, 2000, EMBO J, V19, P3223, DOI 10.1093/emboj/19.13.3223; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Thanbichler M, 2005, CURR OPIN GENET DEV, V15, P153, DOI 10.1016/j.gde.2005.01.001; Viollier PH, 2003, MOL MICROBIOL, V49, P331, DOI 10.1046/j.1365-2958.2003.03576.x; Viollier PH, 2002, EMBO J, V21, P4420, DOI 10.1093/emboj/cdf454; Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999; West L, 2002, J BACTERIOL, V184, P2155, DOI 10.1128/JB.184.8.2155-2166.2002; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; Wu LJ, 2003, MOL MICROBIOL, V49, P1463, DOI 10.1046/j.1365-2958.2003.03643.x	47	161	162	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					1025	1037		10.1016/j.cell.2006.01.019	http://dx.doi.org/10.1016/j.cell.2006.01.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530048	Bronze			2022-12-24	WOS:000237241200023
J	Li, B; Zhao, J; Onda, K; Jordan, KD; Yang, JL; Petek, H				Li, B; Zhao, J; Onda, K; Jordan, KD; Yang, JL; Petek, H			Ultrafast interfacial proton-coupled electron transfer	SCIENCE			English	Article							METHANOL; DYNAMICS; SURFACES; TIO2(110); SOLVATION; ALCOHOLS; WATER	The coupling of electron and nuclear motions in ultrafast charge transfer at molecule-semiconductor interfaces is central to many phenomena, including catalysis, photocatalysis, and molecular electronics. By using femtosecond laser excitation, we transferred electrons from a rutile titanium dioxide (110) surface into a CH3OH overlayer state that is 2.3 +/- 0.2 electron volts above the Fermi level. The redistributed charge was stabilized within 30 femtoseconds by the inertial motion of substrate ions ( polaron formation) and, more slowly, by adsorbate molecules ( solvation). According to a pronounced deuterium isotope effect (CH3OD), this motion of heavy atoms transforms the reverse charge transfer from a purely electronic process (nonadiabatic) to a correlated response of electrons and protons.	Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Anhua 230026, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Petek, H (corresponding author), Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA.	petek@pitt.edu	Zhao, Jin/E-2735-2016; Onda, Ken/H-3389-2014; Yang, Jinlong/D-3465-2009; Petek, Hrvoje/A-3912-2009	Zhao, Jin/0000-0003-1346-5280; Onda, Ken/0000-0003-1724-2009; Petek, Hrvoje/0000-0001-9605-2590				Bates SP, 1998, J PHYS CHEM B, V102, P2017, DOI 10.1021/jp9804998; Cukier RI, 1998, ANNU REV PHYS CHEM, V49, P337, DOI 10.1146/annurev.physchem.49.1.337; Decornez H, 2000, J PHYS CHEM A, V104, P9370, DOI 10.1021/jp001967s; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; FOX MA, 1993, CHEM REV, V93, P341, DOI 10.1021/cr00017a016; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Hammes-Schiffer S, 2001, ACCOUNTS CHEM RES, V34, P273, DOI 10.1021/ar9901117; Henderson MA, 1999, FARADAY DISCUSS, V114, P313, DOI 10.1039/a902070e; Hendry E, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.081101; JONES RO, 1989, REV MOD PHYS, V61, P689, DOI 10.1103/RevModPhys.61.689; KAMAT PV, 1993, CHEM REV, V93, P267, DOI 10.1021/cr00017a013; KAWAI T, 1980, J CHEM SOC CHEM COMM, P694, DOI 10.1039/c39800000694; Lin JP, 2005, SCIENCE, V310, P1311, DOI 10.1126/science.1118316; Liu SH, 2002, J PHYS CHEM B, V106, P12908, DOI 10.1021/jp025772r; Lu QB, 1999, PHYS REV LETT, V82, P4122, DOI 10.1103/PhysRevLett.82.4122; Minary P, 1999, J CHEM PHYS, V110, P10953, DOI 10.1063/1.479032; MONNIER R, 1978, PHYS REV B, V18, P656, DOI 10.1103/PhysRevB.18.656; Onda K, 2005, SURF SCI, V593, P32, DOI 10.1016/j.susc.2005.06.044; Onda K, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.045415; Onda K, 2005, SCIENCE, V308, P1154, DOI 10.1126/science.1109366; Perdew JP, 1997, PHYS REV LETT, V78, P1396, DOI 10.1103/PhysRevLett.78.1396; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Petek H, 1997, PROG SURF SCI, V56, P239, DOI 10.1016/S0079-6816(98)00002-1; Pshenichnikov MS, 2004, CHEM PHYS LETT, V389, P171, DOI 10.1016/j.cplett.2004.03.107; Rego LGC, 2003, J AM CHEM SOC, V125, P7989, DOI 10.1021/ja0346330; SHI XL, 1995, J PHYS CHEM-US, V99, P6917, DOI 10.1021/j100018a024; Shirota H, 1997, CHEM PHYS LETT, V281, P27, DOI 10.1016/S0009-2614(97)01230-X; Stier W, 2002, J PHYS CHEM B, V106, P8047, DOI 10.1021/jp014267b; Tanner C, 2003, SCIENCE, V302, P1736, DOI 10.1126/science.1091708; Tauber MJ, 2004, J AM CHEM SOC, V126, P3414, DOI 10.1021/ja031816d; Tributsch H, 1998, SCIENCE, V279, P1891, DOI 10.1126/science.279.5358.1891; Turi L, 1999, J CHEM PHYS, V110, P10364, DOI 10.1063/1.478969; Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233; Weida MJ, 2000, J OPT SOC AM B, V17, P1443, DOI 10.1364/JOSAB.17.001443; Zhao J.Z., UNPUB	36	188	191	5	266	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2006	311	5766					1436	1440		10.1126/science.1122190	http://dx.doi.org/10.1126/science.1122190			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527974				2022-12-24	WOS:000236029400041
J	Plasterk, RHA				Plasterk, RHA			Micro RNAs in animal development	CELL			English	Editorial Material							C-ELEGANS; CAENORHABDITIS-ELEGANS; LET-7 MICRORNA; EXPRESSION; ZEBRAFISH; GENES; IDENTIFICATION; EVOLUTION; SEQUENCE; IMPACT	Micro RNAs (miRNAs) are similar to 22 nucleotide single-stranded noncoding RNA molecules that bind to target messenger RNAs (mRNAs) and silence their expression. This Essay explores the importance of miRNAs in animal development and their possible roles in disease and evolution.	Univ Utrecht, Hubrecht Lab, KNAW, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University	Plasterk, RHA (corresponding author), Univ Utrecht, Hubrecht Lab, KNAW, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.knaw.nl						Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yoo AS, 2005, SCIENCE, V310, P1330, DOI 10.1126/science.1119481	22	358	386	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 10	2006	124	5					877	881		10.1016/j.cell.2006.02.030	http://dx.doi.org/10.1016/j.cell.2006.02.030			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530032	Bronze			2022-12-24	WOS:000237241200007
J	Cornelis, MC; El-Sohemy, A; Kabagambe, EK; Campos, H				Cornelis, MC; El-Sohemy, A; Kabagambe, EK; Campos, H			Coffee, CYP1A2 genotype, and risk of myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; GENETIC-POLYMORPHISM; CAFFEINE INTAKE; HUMAN HEALTH; FOLLOW-UP; CONSUMPTION; DEATH; METAANALYSIS; ASSOCIATION; CHOLESTEROL	Context The association between coffee intake and risk of myocardial infarction (MI) remains controversial. Coffee is a major source of caffeine, which is metabolized by the polymorphic cytochrome P450 1A2 (CYP1A2) enzyme. Individuals who are homozygous for the CYP1A2*1A allele are "rapid" caffeine metabolizers, whereas carriers of the variant CYP1A2*1F are "slow" caffeine metabolizers. Objective To determine whether CYP1A2 genotype modifies the association between coffee consumption and risk of acute nonfatal MI. Design, Setting, and Participants Cases (n = 2014) with a first acute nonfatal MI and population-based controls (n = 2014) living in Costa Rica between 1994 and 2004, matched for age, sex, and area of residence, were genotyped by restriction fragment length polymorphism polymerase chain reaction. A food frequency questionnaire was used to assess the intake of caffeinated coffee. Main Outcome Measure Relative risk of nonfatal MI associated with coffee intake, calculated using unconditional logistic regression. Results Fifty-five percent of cases (n = 1114) and 54% of controls (n = 1082) were carriers of the slow *1F allele. For carriers of the slow *1F allele, the multivariate-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) of nonfatal MI associated with consuming less than 1, 1, 2 to 3, and 4 or more cups of coffee per day were 1.00 ( reference), 0.99 (0.69-1.44), 1.36 (1.01-1.83), and 1.64 (1.14-2.34), respectively. Corresponding ORs ( 95% CIs) for individuals with the rapid *1A/*1A genotype were 1.00, 0.75 (0.51-1.12), 0.78 (0.56-1.09), and 0.99 (0.66-1.48) (P = .04 for gene X coffee interaction). For individuals younger than the median age of 59 years, the ORs ( 95% CIs) associated with consuming less than 1, 1, 2 to 3, or 4 or more cups of coffee per day were 1.00, 1.24 (0.71-2.18), 1.67 (1.08-2.60), and 2.33 (1.39-3.89), respectively, among carriers of the *1F allele. The corresponding ORs ( 95% CIs) for those with the *1A/*1A genotype were 1.00, 0.48 (0.26-0.87), 0.57 (0.35-0.95), and 0.83 (0.46-1.51). Conclusion Intake of coffee was associated with an increased risk of nonfatal MI only among individuals with slow caffeine metabolism, suggesting that caffeine plays a role in this association.	Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 3E2, Canada; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Univ Costa Rica, Ctr Centroamer Poblac, San Pedro Montes de Oca, Costa Rica	University of Toronto; Harvard University; Harvard T.H. Chan School of Public Health; Universidad Costa Rica	El-Sohemy, A (corresponding author), Univ Toronto, Dept Nutr Sci, 150 Coll St, Toronto, ON M5S 3E2, Canada.	a.el.sohemy@utoronto.ca	Kabagambe, Edmond/A-3147-2008	El-Sohemy, Ahmed/0000-0002-8877-6414; Kabagambe, Edmond/0000-0002-8993-3186	NHLBI NIH HHS [HL 071888, HL 60692] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060692, R01HL071888] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAK AAA, 1989, NEW ENGL J MED, V321, P1432, DOI 10.1056/NEJM198911233212103; BUTLER MA, 1989, P NATL ACAD SCI USA, V86, P7696, DOI 10.1073/pnas.86.20.7696; Castorena-Torres F, 2005, TOXICOL LETT, V156, P331, DOI 10.1016/j.toxlet.2004.12.005; Cornelis MC, 2004, J MED GENET, V41, P758, DOI 10.1136/jmg.2004.022012; Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3; Goodman MT, 2003, NUTR CANCER, V46, P23, DOI 10.1207/S15327914NC4601_03; GREENLAND S, 1993, EPIDEMIOLOGY, V4, P366, DOI 10.1097/00001648-199307000-00013; GU L, 1992, PHARMACOGENETICS, V2, P73, DOI 10.1097/00008571-199204000-00004; HALL C, 1985, DELLPLAIN LATIN AM S, V17; Hamdy SI, 2003, BRIT J CLIN PHARMACO, V55, P321, DOI 10.1046/j.1365-2125.2003.01787.x; Hammar N, 2003, J INTERN MED, V253, P653, DOI 10.1046/j.1365-2796.2003.01142.x; Han XM, 2001, PHARMACOGENETICS, V11, P429, DOI 10.1097/00008571-200107000-00006; Happonen P, 2004, J NUTR, V134, P2381, DOI 10.1093/jn/134.9.2381; HORI M, 1991, HYPERTENSION, V18, P565, DOI 10.1161/01.HYP.18.5.565; Jee SH, 2001, AM J EPIDEMIOL, V153, P353, DOI 10.1093/aje/153.4.353; Kabagambe EK, 2001, AM J EPIDEMIOL, V154, P1126, DOI 10.1093/aje/154.12.1126; KALOW W, 1993, CLIN PHARMACOL THER, V53, P503, DOI 10.1038/clpt.1993.63; KALOW W, 1991, CLIN PHARMACOL THER, V49, P44, DOI 10.1038/clpt.1991.8; KAWACHI I, 1994, BRIT HEART J, V72, P269; Kleemola P, 2000, ARCH INTERN MED, V160, P3393, DOI 10.1001/archinte.160.22.3393; LACROIX AZ, 1986, NEW ENGL J MED, V315, P977, DOI 10.1056/NEJM198610163151601; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; LUNDSBERG LS, 1998, CAFFEINE, P199; MYERS MG, 1992, ARCH INTERN MED, V152, P1767, DOI 10.1001/archinte.152.9.1767; Nakajima M, 1999, J BIOCHEM-TOKYO, V125, P803, DOI 10.1093/oxfordjournals.jbchem.a022352; Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840; PALMER JR, 1995, AM J EPIDEMIOL, V141, P724, DOI 10.1093/oxfordjournals.aje.a117494; Panagiotakos DB, 2003, J NUTR, V133, P3228, DOI 10.1093/jn/133.10.3228; Ranheim T, 2005, MOL NUTR FOOD RES, V49, P274, DOI 10.1002/mnfr.200400109; Rasmussen BB, 2002, PHARMACOGENETICS, V12, P473, DOI 10.1097/00008571-200208000-00008; ROSENBERG L, 1988, AM J EPIDEMIOL, V128, P570, DOI 10.1093/oxfordjournals.aje.a115004; Sachse C, 1999, BRIT J CLIN PHARMACO, V47, P445, DOI 10.1046/j.1365-2125.1999.00898.x; SCHREIBER GB, 1988, PREV MED, V17, P280, DOI 10.1016/0091-7435(88)90004-7; SCHREIBER GB, 1988, PREV MED, V17, P295, DOI 10.1016/0091-7435(88)90005-9; SHYROCK JC, 1997, AM J CARDIOL, V79, P2; SMITS P, 1987, J CARDIOVASC PHARM, V10, P136, DOI 10.1097/00005344-198708000-00002; Spiller M. A., 1998, CAFFEINE, P97; Stensvold I, 1996, BRIT MED J, V312, P544, DOI 10.1136/bmj.312.7030.544; Tavani A, 2001, EUR J EPIDEMIOL, V17, P1131, DOI 10.1023/A:1021276932160; THELLE DS, 1987, ATHEROSCLEROSIS, V67, P97, DOI 10.1016/0021-9150(87)90270-X; Tiwari AK, 2005, PHARMACOGENOMICS J, V5, P60, DOI 10.1038/sj.tpj.6500282; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; TVERDAL A, 1990, BRIT MED J, V300, P566, DOI 10.1136/bmj.300.6724.566; VANDUSSELDORP M, 1991, ARTERIOSCLER THROMB, V11, P586, DOI 10.1161/01.ATV.11.3.586; Willet W, 1998, NUTR EPIDEMIOLOGY; Willett WC, 1996, JAMA-J AM MED ASSOC, V275, P458, DOI 10.1001/jama.275.6.458; Woodward M, 1999, J EPIDEMIOL COMMUN H, V53, P481, DOI 10.1136/jech.53.8.481	47	313	324	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2006	295	10					1135	1141		10.1001/jama.295.10.1135	http://dx.doi.org/10.1001/jama.295.10.1135			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	019GB	16522833	Bronze			2022-12-24	WOS:000235822500021
J	Ciosk, R; DePalma, M; Priess, JR				Ciosk, R; DePalma, M; Priess, JR			Translational regulators maintain totipotency in the Caenorhabditis elegans germline	SCIENCE			English	Article							KH DOMAIN PROTEIN; C-ELEGANS; OVARIAN TERATOMAS; GLD-1; RNA; EMBRYOS; PAL-1; PROLIFERATION; ACTIVATION; FERTILITY	The molecular mechanisms that maintain totipotency of the germline are not well understood. Here, we show that two conserved translational regulators, MEX-3 and GLD-1, are essential for maintaining totipotency in the Cenorhabditis elegans germline. In mex-3 gld-1 mutants, germ cells transdifferentiate into various somatic cell types such as muscles or neurons. Our findings implicate RNA regulation in the maintenance of totipotency, suggest that multiple mechanisms maintain totipotency at different stages of germline development, and establish a genetically tractable model for studying the development of teratomas.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Howard Hughes Med Inst, Seattle, WA 98109 USA; Univ Washington, Dept Biol, Seattle, WA 98195 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ciosk, R (corresponding author), Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.	rafal.ciosk@fmi.ch	Ciosk, Rafal/L-7327-2013	Ciosk, Rafal/0000-0003-2234-6216				Baugh LR, 2005, DEVELOPMENT, V132, P1843, DOI 10.1242/dev.01782; Berry LW, 1997, DEVELOPMENT, V124, P925; Ciosk R, 2004, DEVELOPMENT, V131, P4831, DOI 10.1242/dev.01352; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Detwiler MR, 2001, DEV CELL, V1, P187, DOI 10.1016/S1534-5807(01)00026-0; Donnini M, 2004, J BIOL CHEM, V279, P20154, DOI 10.1074/jbc.M314071200; Donovan PJ, 2003, CURR OPIN GENET DEV, V13, P463, DOI 10.1016/j.gde.2003.08.010; Draper BW, 1996, CELL, V87, P205, DOI 10.1016/S0092-8674(00)81339-2; EPPIG JJ, 1977, NATURE, V269, P517, DOI 10.1038/269517a0; Fong YY, 2002, SCIENCE, V296, P2235, DOI 10.1126/science.1070790; FRANCIS R, 1995, GENETICS, V139, P579; FRANCIS R, 1995, GENETICS, V139, P607; Fukushige T, 2005, DEVELOPMENT, V132, P1795, DOI 10.1242/dev.01774; Hansen D, 2004, DEVELOPMENT, V131, P93, DOI 10.1242/dev.00916; Hunter CP, 1996, CELL, V87, P217, DOI 10.1016/S0092-8674(00)81340-9; Jan E, 1999, EMBO J, V18, P258, DOI 10.1093/emboj/18.1.258; Jones AR, 1996, DEV BIOL, V180, P165, DOI 10.1006/dbio.1996.0293; Kadyk LC, 1998, DEVELOPMENT, V125, P1803; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kuznicki KA, 2000, DEVELOPMENT, V127, P2907; LAUFER JS, 1980, CELL, V19, P569, DOI 10.1016/S0092-8674(80)80033-X; LINDER D, 1975, NEW ENGL J MED, V292, P63, DOI 10.1056/NEJM197501092920202; Mootz D, 2004, DEVELOPMENT, V131, P3263, DOI 10.1242/dev.01196; Saffman EE, 1999, CELL MOL LIFE SCI, V55, P1141, DOI 10.1007/s000180050363; Seydoux G, 2001, INT REV CYTOL, V203, P139; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Ulbright TM, 2005, MODERN PATHOL, V18, pS61, DOI 10.1038/modpathol.3800310; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; Xu L, 2001, GENETICS, V159, P1007	30	130	136	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 10	2006	311	5762					851	853		10.1126/science.1122491	http://dx.doi.org/10.1126/science.1122491			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012XT	16469927				2022-12-24	WOS:000235374900049
J	Kirichok, Y; Navarro, B; Clapham, DE				Kirichok, Y; Navarro, B; Clapham, DE			Whole-cell patch-clamp measurements of spermatozoa reveal an alkaline-activated Ca2+ channel	NATURE			English	Article							ION CHANNELS; MOUSE SPERM; CALCIUM-CHANNELS; MOTILITY; PH; DEPOLARIZATION; FERTILIZATION; PERMEATION; PHYSIOLOGY; CATSPER1	In mammals, sperm cells become motile during ejaculation and swim up the female reproductive tract. Before fertilization and to overcome various barriers, their motility must be hyperactivated, a motion that is characterized by vigorous asymmetric tail beating(1). Hyperactivation requires an increase in calcium in the flagella, a process that probably involves plasmalemmal ion channels(2-8). Numerous attempts in the past two decades to understand sperm cell channels have been frustrated by the difficulty of measuring spermatozoan transmembrane ion currents(2,3,9 - 16). Here, by using a simple approach to patch-clamp spermatozoa and to characterize whole-spermatozoan currents, we describe a constitutively active flagellar calcium channel that is strongly potentiated by intracellular alkalinization. This current is not present in spermatozoa lacking the sperm-specific putative ion channel protein, CatSper1. This plasma membrane protein of the six transmembrane-spanning ion channel superfamily is specifically localized to the principal piece of the sperm tail and is required for sperm cell hyperactivation and male fertility(4,5). Our results identify CatSper1 as a component of the key flagellar calcium channel, and suggest that intracellular alkalinization potentiates CatSper current to increase intraflagellar calcium and induce sperm hyperactivation.	Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst,Dept Cardiol, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School	Clapham, DE (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst,Dept Cardiol, Enders 1309,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019; Oka, Yoshitaka/C-9670-2010	Clapham, David/0000-0002-4459-9428; Oka, Yoshitaka/0000-0002-3482-3051				BABCOCK DF, 1992, P NATL ACAD SCI USA, V89, P6001, DOI 10.1073/pnas.89.13.6001; BABCOCK DF, 1983, J BIOL CHEM, V258, P6380; Carlson AE, 2005, J BIOL CHEM, V280, P32238, DOI 10.1074/jbc.M501430200; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Cooper TG, 2005, HUM REPROD, V20, P9, DOI 10.1093/humrep/deh555; Darszon A, 2005, INT REV CYTOL, V243, P79, DOI 10.1016/S0074-7696(05)43002-8; Darszon A, 1999, PHYSIOL REV, V79, P481, DOI 10.1152/physrev.1999.79.2.481; ESPINOSA F, 1995, FEBS LETT, V372, P119, DOI 10.1016/0014-5793(95)00962-9; Espinosa F, 1998, FEBS LETT, V426, P47, DOI 10.1016/S0014-5793(98)00305-6; Florman HM, 1998, BIOL REPROD, V59, P12, DOI 10.1095/biolreprod59.1.12; Fraire-Zamora JJ, 2004, AM J PHYSIOL-CELL PH, V287, pC1688, DOI 10.1152/ajpcell.00141.2004; Gonzalez-Martinez MT, 2003, J BIOL CHEM, V278, P36304, DOI 10.1074/jbc.M304479200; Gorelik J, 2002, BIOPHYS J, V83, P3296, DOI 10.1016/S0006-3495(02)75330-7; Gu Y, 2004, DEV BIOL, V274, P308, DOI 10.1016/j.ydbio.2004.06.025; GUERRERO A, 1987, FEBS LETT, V220, P295, DOI 10.1016/0014-5793(87)80833-5; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Ho HC, 2002, DEV BIOL, V250, P208, DOI 10.1006/dbio.2002.0797; Ho HC, 2001, REPRODUCTION, V122, P519, DOI 10.1530/rep.0.1220519; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Lobley Anna, 2003, Reprod Biol Endocrinol, V1, P53, DOI 10.1186/1477-7827-1-53; Quill TA, 2003, P NATL ACAD SCI USA, V100, P14869, DOI 10.1073/pnas.2136654100; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Sanchez D, 2001, FEBS LETT, V503, P111, DOI 10.1016/S0014-5793(01)02713-2; Santi CM, 1998, J GEN PHYSIOL, V112, P33, DOI 10.1085/jgp.112.1.33; Sather WA, 2003, ANNU REV PHYSIOL, V65, P133, DOI 10.1146/annurev.physiol.65.092101.142345; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044	28	321	345	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2006	439	7077					737	740		10.1038/nature04417	http://dx.doi.org/10.1038/nature04417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	010KH	16467839				2022-12-24	WOS:000235193100047
J	Wisniewska, J; Xu, J; Seifertova, D; Brewer, PB; Ruzicka, K; Blilou, I; Rouquie, D; Benkova, E; Scheres, B; Friml, J				Wisniewska, J; Xu, J; Seifertova, D; Brewer, PB; Ruzicka, K; Blilou, I; Rouquie, D; Benkova, E; Scheres, B; Friml, J			Polar PIN localization directs auxin flow in plants	SCIENCE			English	Article							ARABIDOPSIS; GRAVITROPISM; GRADIENTS; TRANSPORT		Univ Tubingen, Ctr Plant Mol Biol, D-72076 Tubingen, Germany; Univ Utrecht, Dept Mol Genet, NL-3584 CH Utrecht, Netherlands; Inst Gen & Mol Biol, Dept Biotechnol, PL-87100 Torun, Poland	Eberhard Karls University of Tubingen; Utrecht University; Nicolaus Copernicus University	Friml, J (corresponding author), Univ Tubingen, Ctr Plant Mol Biol, D-72076 Tubingen, Germany.	jiri.friml@zmbp.uni-tuebingen.de	Ruzicka, Kamil/E-3727-2012; Xu, Jian/I-2921-2012; Ruzicka, Kamil/AAT-1798-2020; Brewer, Philip B/C-6562-2008; Benkova, Eva/E-2910-2012; Friml, Jiri/D-9511-2012; Wisniewska, Justyna/D-4351-2009	Ruzicka, Kamil/0000-0002-0602-2046; Xu, Jian/0000-0001-6194-6316; Ruzicka, Kamil/0000-0002-0602-2046; Brewer, Philip B/0000-0003-4871-9260; Friml, Jiri/0000-0002-8302-7596; Scheres, Ben/0000-0001-5400-9578				Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Kepinski S, 2005, CURR BIOL, V15, pR208, DOI 10.1016/j.cub.2005.03.012; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Swarup R, 2003, DEV CELL, V5, P824, DOI 10.1016/S1534-5807(03)00370-8	7	640	677	4	216	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2006	312	5775					883	883		10.1126/science.1121356	http://dx.doi.org/10.1126/science.1121356			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16601151				2022-12-24	WOS:000237452900038
J	Guan, K; Nayernia, K; Maier, LS; Wagner, S; Dressel, R; Lee, JH; Nolte, J; Wolf, F; Li, MY; Engel, W; Hasenfuss, G				Guan, K; Nayernia, K; Maier, LS; Wagner, S; Dressel, R; Lee, JH; Nolte, J; Wolf, F; Li, MY; Engel, W; Hasenfuss, G			Pluripotency of spermatogonial stem cells from adult mouse testis	NATURE			English	Article							IN-VITRO; GERM-CELLS; GENE; EXPRESSION; EMBRYO; DIFFERENTIATION; MAINTENANCE; GENERATION; MYOGENESIS; CULTURE	Embryonic germ cells as well as germline stem cells from neonatal mouse testis are pluripotent and have differentiation potential similar to embryonic stem cells(1,2), suggesting that the germline lineage may retain the ability to generate pluripotent cells. However, until now there has been no evidence for the pluripotency and plasticity of adult spermatogonial stem cells (SSCs), which are responsible for maintaining spermatogenesis throughout life in the male(3). Here we show the isolation of SSCs from adult mouse testis using genetic selection, with a success rate of 27%. These isolated SSCs respond to culture conditions and acquire embryonic stem cell properties. We name these cells multipotent adult germline stem cells (maGSCs). They are able to spontaneously differentiate into derivatives of the three embryonic germ layers in vitro and generate teratomas in immunodeficient mice. When injected into an early blastocyst, SSCs contribute to the development of various organs and show germline transmission. Thus, the capacity to form multipotent cells persists in adult mouse testis. Establishment of human maGSCs from testicular biopsies may allow individual cell-based therapy without the ethical and immunological problems associated with human embryonic stem cells. Furthermore, these cells may provide new opportunities to study genetic diseases in various cell lineages.	Univ Gottingen, Ctr Heart, Dept Cardiol & Pneumol, D-37075 Gottingen, Germany; Univ Gottingen, Inst Human Genet, D-37073 Gottingen, Germany; Univ Gottingen, Dept Cellular & Mol Immunol, D-37073 Gottingen, Germany	University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gottingen; University of Gottingen	Hasenfuss, G (corresponding author), Univ Gottingen, Ctr Heart, Dept Cardiol & Pneumol, Robert Koch Str 40, D-37075 Gottingen, Germany.	wengel@gwdg.de; hasenfus@med.uni-goettingen.de	Dressel, Ralf/R-7065-2016; Guan, Kaomei/G-8882-2018; Wagner, Stefan/AAE-3721-2021; Maier, Lars/AAQ-8313-2021	Dressel, Ralf/0000-0002-1651-1214; Guan, Kaomei/0000-0002-0753-3083; Wagner, Stefan/0000-0002-9471-1166; Maier, Lars/0000-0001-9915-4429				Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; Bonner AE, 2004, NEOPLASIA, V6, P490, DOI 10.1593/neo.04124; DAMJANOV I, 1982, AM J PATHOL, V108, P225; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; DONEHOWER LA, 1995, MOL CARCINOGEN, V14, P16, DOI 10.1002/mc.2940140105; FURST DO, 1989, J CELL BIOL, V109, P517, DOI 10.1083/jcb.109.2.517; Giuili G, 2002, EMBO REP, V3, P753, DOI 10.1093/embo-reports/kvf149; Guan K, 1999, CYTOTECHNOLOGY, V30, P211, DOI 10.1023/A:1008041420166; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; King T, 1998, MECH DEVELOP, V79, P29, DOI 10.1016/S0925-4773(98)00166-X; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Ling V, 1997, J CELL PHYSIOL, V171, P104, DOI 10.1002/(SICI)1097-4652(199704)171:1<104::AID-JCP12>3.0.CO;2-G; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagano M, 2003, BIOL REPROD, V68, P2207, DOI 10.1095/biolreprod.102.014050; Nayernia K, 2004, HUM MOL GENET, V13, P1451, DOI 10.1093/hmg/ddh166; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469; Rossi P, 2000, J ENDOCRINOL INVEST, V23, P609, DOI 10.1007/BF03343784; Schoonjans L, 2003, STEM CELLS, V21, P90, DOI 10.1634/stemcells.21-1-90; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; STEVENS LC, 1957, J NATL CANCER I, V18, P719; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	30	650	751	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1199	1203		10.1038/nature04697	http://dx.doi.org/10.1038/nature04697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16565704				2022-12-24	WOS:000237080000047
J	Fisher, S; Grice, EA; Vinton, RM; Bessling, SL; McCallion, AS				Fisher, S; Grice, EA; Vinton, RM; Bessling, SL; McCallion, AS			Conservation of RET regulatory function from human to zebrafish without sequence similarity	SCIENCE			English	Article							HIRSCHSPRUNG-DISEASE; COMPARATIVE GENOMICS; C-RET; EXPRESSION; ELEMENTS; REVEALS; REGIONS; PATTERN; LOCI	Evolutionary sequence conservation is an accepted criterion to identify noncoding regulatory sequences. We have used a transposon-based transgenic assay in zebrafish to evaluate noncoding sequences at the zebrafish ret locus, conserved among teleosts, and at the human RET locus, conserved among mammals. Most teleost sequences directed ret-specific reporter gene expression, with many displaying overlapping regulatory control. The majority of human RET noncoding sequences also directed ret-specific expression in zebrafish. Thus, vast amounts of functional sequence information may exist that would not be detected by sequence similarity approaches.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Comparat Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Fisher, S (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	sfisher@jhmi.edu; amccalli@jhmi.edu	Fisher, Shannon/K-7351-2012	Grice, Elizabeth/0000-0003-3939-2200	NIAMS NIH HHS [AR048101] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048101] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bagheri-Fam S, 2001, GENOMICS, V78, P73, DOI 10.1006/geno.2001.6648; Baroukh N, 2005, MAMM GENOME, V16, P91, DOI 10.1007/s00335-004-2442-9; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Bisgrove BW, 1997, J NEUROBIOL, V33, P749; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Ellingsen S, 2005, DEVELOPMENT, V132, P3799, DOI 10.1242/dev.01951; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; FISHER S, UNPUB; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gottgens B, 2000, NAT BIOTECHNOL, V18, P181, DOI 10.1038/72635; Grice EA, 2005, HUM MOL GENET, V14, P3837, DOI 10.1093/hmg/ddi408; Hahn M, 2001, P NATL ACAD SCI USA, V98, P1053, DOI 10.1073/pnas.021558598; Kashuk CS, 2005, P NATL ACAD SCI USA, V102, P8949, DOI 10.1073/pnas.0503259102; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; MarcosGutierrez CV, 1997, ONCOGENE, V14, P879, DOI 10.1038/sj.onc.1201048; McCallion AS, 2003, COLD SPRING HARB SYM, V68, P373, DOI 10.1101/sqb.2003.68.373; MCCALLION AS, 2004, INBORN ERRORS DEV; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Veeramachaneni V, 2005, NUCLEIC ACIDS RES, V33, pD442, DOI 10.1093/nar/gki094; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	28	251	262	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2006	312	5771					276	279		10.1126/science.1124070	http://dx.doi.org/10.1126/science.1124070			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16556802				2022-12-24	WOS:000236765300052
J	Bridgham, JT; Carroll, SM; Thornton, JW				Bridgham, JT; Carroll, SM; Thornton, JW			Evolution of hormone-receptor complexity by molecular exploitation	SCIENCE			English	Article							MINERALOCORTICOID RECEPTOR; INTERRENAL GLAND; ORIGIN; GENE; ADAPTATION; SELECTION; PATTERNS; FISH; EYE	According to Darwinian theory, complexity evolves by a stepwise process of elaboration and optimization under natural selection. Biological systems composed of tightly integrated parts seem to challenge this view, because it is not obvious how any element's function can be selected for unless the partners with which it interacts are already present. Here we demonstrate how an integrated molecular system-the specific functional interaction between the steroid hormone aldosterone and its partner the mineralocorticoid receptor-evolved by a stepwise Darwinian process. Using ancestral gene resurrection, we show that, long before the hormone evolved, the receptor's affinity for aldosterone was present as a structural by-product of its partnership with chemically similar, more ancient ligands. Introducing two amino acid changes into the ancestral sequence recapitulates the evolution of present-day receptor specificity. Our results indicate that tight interactions can evolve by molecular exploitation-recruitment of an older molecule, previously constrained for a different role, into a new functional complex.	Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA	University of Oregon	Thornton, JW (corresponding author), Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA.	joet@uoregon.edu	Thornton, Joseph/GSN-4190-2022		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074398] Funding Source: NIH RePORTER; NICHD NIH HHS [T32 HD007348] Funding Source: Medline; NIGMS NIH HHS [F32-GM074398] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bentley P., 1998, COMP VERTEBRATE ENDO; Bulow HE, 2002, EUR J BIOCHEM, V269, P3838, DOI 10.1046/j.1432-1033.2002.03076.x; Darwin C., 1859, ORIGIN SPECIES FACSI; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Fagart J, 2005, NAT STRUCT MOL BIOL, V12, P554, DOI 10.1038/nsmb939; Farman N, 2001, AM J PHYSIOL-RENAL, V280, pF181, DOI 10.1152/ajprenal.2001.280.2.F181; FISHER RA, 1930, GENETICAL HIST NATUR; Force A, 2005, GENETICS, V170, P433, DOI 10.1534/genetics.104.027607; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Greenwood AK, 2003, ENDOCRINOLOGY, V144, P4226, DOI 10.1210/en.2003-0566; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Hellal-Levy C, 1999, FEBS LETT, V464, P9, DOI 10.1016/S0014-5793(99)01667-1; Jiang JQ, 1998, MOL CELL ENDOCRINOL, V146, P207, DOI 10.1016/S0303-7207(98)00147-6; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; NILSSON DE, 1994, P ROY SOC B-BIOL SCI, V256, P53, DOI 10.1098/rspb.1994.0048; NONAKA Y, 1995, EUR J BIOCHEM, V229, P249, DOI 10.1111/j.1432-1033.1995.tb20462.x; Nunez S, 1999, J EXP ZOOL, V284, P517, DOI 10.1002/(SICI)1097-010X(19991001)284:5<517::AID-JEZ7>3.0.CO;2-S; Piatigorsky J, 1998, ANN NY ACAD SCI, V842, P7, DOI 10.1111/j.1749-6632.1998.tb09626.x; Ryan MJ, 1998, SCIENCE, V281, P1999, DOI 10.1126/science.281.5385.1999; SIMPSON TH, 1970, J ENDOCRINOL, V46, P261, DOI 10.1677/joe.0.0460261; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Sturm A, 2005, ENDOCRINOLOGY, V146, P47, DOI 10.1210/en.2004-0128; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; WEISBART M, 1977, J STEROID BIOCHEM, V8, P1249, DOI 10.1016/0022-4731(77)90109-1; Zhu GP, 2005, SCIENCE, V307, P1279, DOI 10.1126/science.1106974	29	410	417	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2006	312	5770					97	101		10.1126/science.1123348	http://dx.doi.org/10.1126/science.1123348			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601189				2022-12-24	WOS:000236584400039
J	Johnson, ZI; Zinser, ER; Coe, A; McNulty, NP; Woodward, EMS; Chisholm, SW				Johnson, ZI; Zinser, ER; Coe, A; McNulty, NP; Woodward, EMS; Chisholm, SW			Niche partitioning among Prochlorococcus ecotypes along ocean-scale environmental gradients	SCIENCE			English	Article							NORTH-ATLANTIC OCEAN; MICROBIAL COMMUNITY STRUCTURE; SARGASSO SEA; CYANOBACTERIUM PROCHLOROCOCCUS; PHOTOSYNTHETIC PROKARYOTE; MERIDIONAL TRANSECT; PACIFIC-OCEAN; TIME-SERIES; SYNECHOCOCCUS; PICOPLANKTON	Prochlorococcus is the numerically dominant phytoplankter in the oligotrophic oceans, accounting for up to half of the photosynthetic biomass and production in some regions. Here, we describe how the abundance of six known ecotypes, which have small subunit ribosomal RNA sequences that differ by less than 3%, changed along local and basin-wide environmental gradients in the Atlantic Ocean. Temperature was significantly correlated with shifts in ecotype abundance, and laboratory experiments confirmed different temperature optima and tolerance ranges for cultured strains. Light, nutrients, and competitor abundances also appeared to play a role in shaping different distributions.	MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England	Massachusetts Institute of Technology (MIT); University of Hawaii System; University of Tennessee System; University of Tennessee Knoxville; Plymouth Marine Laboratory	Chisholm, SW (corresponding author), MIT, Dept Civil & Environm Engn, 15 Vasser St 48-119, Cambridge, MA 02139 USA.	chisholm@mit.edu	Woodward, Ernest M S/D-5755-2016; Johnson, Zackary I/E-4601-2011	Woodward, Ernest M S/0000-0002-7187-6689; Johnson, Zackary I/0000-0003-0793-8512; Chisholm, Sallie/0000-0003-1480-2445	Natural Environment Research Council [NER/O/S/2001/00680] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Ahlgren NA, 2006, ENVIRON MICROBIOL, V8, P441, DOI 10.1111/j.1462-2920.2005.00910.x; Aiken J, 2000, PROG OCEANOGR, V45, P257, DOI 10.1016/S0079-6611(00)00005-7; Campbell L, 1997, DEEP-SEA RES PT I, V44, P167, DOI 10.1016/S0967-0637(96)00102-1; Campbell L, 1998, DEEP-SEA RES PT II, V45, P2301, DOI 10.1016/S0967-0645(98)00072-1; Cavender-Bares KK, 2001, DEEP-SEA RES PT I, V48, P2373, DOI 10.1016/S0967-0637(01)00027-9; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; DuRand MD, 2001, DEEP-SEA RES PT II, V48, P1983, DOI 10.1016/S0967-0645(00)00166-1; Hooker SB, 2000, PROG OCEANOGR, V45, P313, DOI 10.1016/S0079-6611(00)00006-9; Johnson Z, 2000, DEEP-SEA RES PT I, V47, P1485, DOI 10.1016/S0967-0637(99)00111-9; Mann EL, 2002, LIMNOL OCEANOGR, V47, P976, DOI 10.4319/lo.2002.47.4.0976; Monger BC, 1999, LIMNOL OCEANOGR, V44, P1917, DOI 10.4319/lo.1999.44.8.1917; Moore LR, 2005, AQUAT MICROB ECOL, V39, P257, DOI 10.3354/ame039257; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; OLSON RJ, 1990, DEEP-SEA RES, V37, P1033, DOI 10.1016/0198-0149(90)90109-9; PALENIK B, 1992, NATURE, V355, P265, DOI 10.1038/355265a0; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Urbach E, 1998, LIMNOL OCEANOGR, V43, P1615, DOI 10.4319/lo.1998.43.7.1615; Urbach E, 1998, J MOL EVOL, V46, P188, DOI 10.1007/PL00006294; VAULOT D, 1995, SCIENCE, V268, P1480, DOI 10.1126/science.268.5216.1480; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; West NJ, 1999, APPL ENVIRON MICROB, V65, P2585; Zinser ER, 2006, APPL ENVIRON MICROB, V72, P723, DOI 10.1128/AEM.72.1.723-732.2006; Zubkov MV, 2000, PROG OCEANOGR, V45, P369, DOI 10.1016/S0079-6611(00)00008-2	29	670	690	8	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1737	1740		10.1126/science.1118052	http://dx.doi.org/10.1126/science.1118052			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556835				2022-12-24	WOS:000236204300033
J	Berkowitz, RL; Roberts, J; Minkoff, H				Berkowitz, RL; Roberts, J; Minkoff, H			Challenging the strategy of maternal age-based prenatal genetic counseling	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AMNIOCENTESIS		Columbia Univ, Med Ctr, Dept Obstet & Gynecol, New York, NY 10032 USA; SUNY Hlth Sci Ctr, SUNY Downstate, Brooklyn, NY 11203 USA; Maimonides Hosp, Brooklyn, NY 11219 USA	Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Maimonides Medical Center	Berkowitz, RL (corresponding author), Columbia Univ, Med Ctr, Dept Obstet & Gynecol, PH 16-66,622 W 168th St, New York, NY 10032 USA.	rb2212@columbia.edu						*AM COLL OBST GYN, 2001, ACOG PRACT B, V27; *AM COLL OBST GYN, 2004, COMM OP 108 INF CONS; *AM COLL OBST GYN, 1972, ACOG TECHN B, V19; American College of Obstetricians and Gynecologists, 1976, ACOG TECHN B, V39; BERKOWITZ RL, IN PRESS OBSTET GYNE; CRANDALL BF, 1980, OBSTET GYNECOL, V56, P625; Eddleman K, 2003, AM J OBSTET GYNECOL, V189, pS111, DOI 10.1016/j.ajog.2003.10.174; HOOK EB, 1983, JAMA-J AM MED ASSOC, V249, P2034, DOI 10.1001/jama.249.15.2034; HOOK EB, 1992, PRENATAL DIAGNOSIS S; Kuppermann M, 1999, AM J PUBLIC HEALTH, V89, P160, DOI 10.2105/AJPH.89.2.160; KUPPERMANN M, 1996, MED DECIS MAKING, V16, P466; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; NICOLAIDES KH, 1994, ULTRASOUND OBST GYN, V4, P353, DOI 10.1046/j.1469-0705.1994.04050353.x; *NIH, 1979, REP CONS DEV C SPONS; Resta Robert G, 2002, Med Secoli, V14, P793; TABOR A, 1986, LANCET, V1, P1287	16	14	14	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2006	295	12					1446	1448		10.1001/jama.295.12.1446	http://dx.doi.org/10.1001/jama.295.12.1446			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023WU	16551717				2022-12-24	WOS:000236157700024
J	Noble, SIR; Nelson, A; Turner, C; Finlay, IG				Noble, SIR; Nelson, A; Turner, C; Finlay, IG			Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VENOUS THROMBOEMBOLISM; CANCER-PATIENTS	Objective To find out what inpatients with advanced cancer who are receiving palliative care think about the effect of thromboprophylaxis on overall quality of life. Design Qualitative study using audiotaping of semistructured interviews. Setting Regional cancer centre in Wales. Participants 28 inpatients with advanced metastatic cancer receiving palliative care and low molecular weight heparin. Main outcome measures Recurring themes on the effect of thromboprophylaxis on overall quality of life. Results Major emerging themes showed that patients knew about the risks of venous thromboembolism and die purpose of treatment with heparin. Media coverage had raised awareness about venous thromboembolism, and many had previous experience of thromboprophylaxis. All found low molecular weight heparin an acceptable intervention, and many said that it improved their quality of life by giving them a feeling of safety and reassurance. Antiembolic stockings were considered uncomfortable and had a negative impact on quality of life. Patients were concerned that because they had advanced disease they might not be eligible for thromboprophylaxis. Conclusion Low molecular weight heparin is acceptable to inpatients With advanced cancer receiving palliative care and has a positive impact on overall quality of life. Antiembolic stockings are an unacceptable intervention in this patient group. Guidelines on thromboprophylaxis are urgently needed for palliative care inpatient units and hospices.	Cardiff Univ, Cardiff CF10 3XQ, S Glam, Wales; Holme Tower Marie Curie Ctr, Penarth, S Glam, Wales; Velindre Hosp, Cardiff, S Glam, Wales	Cardiff University; Velindre Hospital	Noble, SIR (corresponding author), Gwent Hosp, Newport NP20 2UB, Gwent, Wales.	simon.noble@velindre-tr.wales.nhs.uk	Nelson, Annmarie/B-4893-2009; Nelson, Annmarie/AAD-2193-2020	Nelson, Annmarie/0000-0002-6075-8425; Nelson, Annmarie/0000-0002-6075-8425; Noble, Simon/0000-0001-5425-2383				AMBRUS JL, 1975, J MED, V6, P61; BICK RL, 1978, SEMIN THROMB HEMOST, V5, P1; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; *HOSP DIR, 2004, DIR HOSP CAR SERV UK; *HOUS COMM HLTH CO, 2004, 2 HOUS COMM HLTH COM; Johnson MJ, 1999, CLIN ONCOL-UK, V11, P105, DOI 10.1053/clon.1999.9023; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; MISHLER E, 1984, DISCOURSE MED DIELEC; Noble SIR, 2005, PALLIATIVE MED, V19, P197, DOI 10.1191/0269216305pm1008oa; NOBLE SIR, IN PRESS J PAIN SYMP; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; SHEN VS, 1980, SOUTHERN MED J, V73, P841, DOI 10.1097/00007611-198007000-00005; SHEN VS, 1980, SOUTH MED J, V73, P811; SPROUL E. E., 1938, AMER JOUR CANCER, V34, P566	14	77	79	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2006	332	7541					577	580		10.1136/bmj.38733.616065.802	http://dx.doi.org/10.1136/bmj.38733.616065.802			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026CN	16459340	Green Published, Bronze			2022-12-24	WOS:000236314400015
J	Kennedy, M; Droser, M; Mayer, LM; Pevear, D; Mrofka, D				Kennedy, M; Droser, M; Mayer, LM; Pevear, D; Mrofka, D			Late Precambrian oxygenation; Inception of the clay mineral factory	SCIENCE			English	Article							ORGANIC-MATTER PRESERVATION; EVOLUTION; LAND; CARBON; SEDIMENTS; CHEMISTRY; BIOLOGY; LIFE; RISE	An enigmatic stepwise increase in oxygen in the late Precambrian is widely considered a prerequisite for the expansion of animal life. Accumulation of oxygen requires organic matter burial in sediments, which is largely controlled by the sheltering or preservational effects of detrital clay minerals in modern marine continental margin depocenters. Here, we show mineralogical and geochemical evidence for an increase in clay mineral deposition in the Neoproterozoic that immediately predated the first metazoans. Today most clay minerals originate in biologically active soils, so initial expansion of a primitive land biota would greatly enhance production of pedogenic clay minerals ( the "clay mineral factory''), leading to increased marine burial of organic carbon via mineral surface preservation.	Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; Univ Maine, Darling Marine Ctr, Walpole, ME 04573 USA	University of California System; University of California Riverside; University of Maine System; University of Maine Orono	Kennedy, M (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.	martink@mail.ucr.edu	Mayer, Lawrence M./A-1337-2009	Kennedy, Martin/0000-0002-1330-6864				[Anonymous], 1971, EVOLUTION SEDIMENTAR, DOI DOI 10.4319/LO.1972.17.1.0165; Banfield JF, 1999, P NATL ACAD SCI USA, V96, P3404, DOI 10.1073/pnas.96.7.3404; Brennan ST, 2004, GEOLOGY, V32, P473, DOI 10.1130/g20251.1; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; CAMPBELL SE, 1979, ORIGINS LIFE EVOL B, V9, P335, DOI 10.1007/BF00926826; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; Chamley H, 1989, CLAY SEDIMENTOLOGY; CLOUD P, 1976, Paleobiology, V2, P351; COX R, 1995, GEOCHIM COSMOCHIM AC, V59, P2919, DOI 10.1016/0016-7037(95)00185-9; DERRY LA, 1992, GEOCHIM COSMOCHIM AC, V56, P1317, DOI 10.1016/0016-7037(92)90064-P; Dott RH, 2003, J GEOL, V111, P387, DOI 10.1086/375286; FranceLanord C, 1997, NATURE, V390, P65, DOI 10.1038/36324; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; HORODYSKI RJ, 1994, SCIENCE, V263, P494, DOI 10.1126/science.263.5146.494; Kah LC, 2004, NATURE, V431, P834, DOI 10.1038/nature02974; KEIL RG, 1994, GEOCHIM COSMOCHIM AC, V58, P879, DOI 10.1016/0016-7037(94)90512-6; KEIL RG, 1994, NATURE, V370, P549, DOI 10.1038/370549a0; Kennedy MJ, 2002, SCIENCE, V295, P657, DOI 10.1126/science.1066611; KNOLL AH, 2003, LIFE YOUNG PLANET, P247; KNOLL AH, 1999, SCIENCE, V284, P2129, DOI DOI 10.1126/SCIENCE.284.5423.2129; Lynch FL, 1997, CLAY CLAY MINER, V45, P618, DOI 10.1346/CCMN.1997.0450502; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; Mayer LM, 2004, GEOCHIM COSMOCHIM AC, V68, P3863, DOI 10.1016/j.gca.2004.03.019; MAYER LM, 1994, GEOCHIM COSMOCHIM AC, V58, P1271, DOI 10.1016/0016-7037(94)90381-6; Neaman A, 2005, AM J SCI, V305, P147, DOI 10.2475/ajs.305.2.147; Prave AR, 2002, GEOLOGY, V30, P811, DOI 10.1130/0091-7613(2002)030<0811:LOLITP>2.0.CO;2; Preiss W.V., 1987, GEOLOGICAL SURVEY S, V53, P438; Ransom B, 1998, GEOCHIM COSMOCHIM AC, V62, P1329, DOI 10.1016/S0016-7037(98)00050-7; Raven JA, 2001, J EXP BOT, V52, P381, DOI 10.1093/jexbot/52.suppl_1.381; Retallack G.J., 2001, SOILS INTRO PALEOPED, V2nd, DOI [10.1002/9780470698716, DOI 10.1002/9780470698716]; RONOV AB, 1964, GEOCHEM INT, P713; RUNNEGAR B, 1982, ALCHERINGA, V6, P223, DOI 10.1080/03115518208565415; Schultz L.G., 1964, 391C US GEOL SURV, V391, P1; Shields G, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000266; Weaver C. E., 1989, CLAYS MUDS SHALES, P819; Yuan XL, 2005, SCIENCE, V308, P1017, DOI 10.1126/science.1111347	37	197	212	3	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2006	311	5766					1446	1449		10.1126/science.1118929	http://dx.doi.org/10.1126/science.1118929			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16456036				2022-12-24	WOS:000236029400044
J	Sunshine, JM; A'Hearn, MF; Groussin, O; Li, JY; Belton, MJS; Delamere, WA; Kissel, J; Klaasen, KP; McFadden, LA; Meech, KJ; Melosh, HJ; Schultz, PH; Thomas, PC; Veverka, J; Yeomans, DK; Busko, IC; Desnoyer, M; Farnham, TL; Feaga, LM; Hampton, DL; Lindler, DJ; Lisse, CM; Wellnitz, DD				Sunshine, JM; A'Hearn, MF; Groussin, O; Li, JY; Belton, MJS; Delamere, WA; Kissel, J; Klaasen, KP; McFadden, LA; Meech, KJ; Melosh, HJ; Schultz, PH; Thomas, PC; Veverka, J; Yeomans, DK; Busko, IC; Desnoyer, M; Farnham, TL; Feaga, LM; Hampton, DL; Lindler, DJ; Lisse, CM; Wellnitz, DD			Exposed water ice deposits on the surface of comet 9P/Tempel 1	SCIENCE			English	Article							SATURNS MOON PHOEBE; INFRARED-SPECTROSCOPY; DEEP IMPACT; NUCLEUS; GRAINS	We report the direct detection of solid water ice deposits exposed on the surface of comet 9P/Tempel 1, as observed by the Deep Impact mission. Three anomalously colored areas are shown to include water ice on the basis of their near-infrared spectra, which include diagnostic water ice absorptions at wavelengths of 1.5 and 2.0 micrometers. These absorptions are well modeled as a mixture of nearby non-ice regions and 3 to 6% water ice particles 10 to 50 micrometers in diameter. These particle sizes are larger than those ejected during the impact experiment, which suggests that the surface deposits are loose aggregates. The total area of exposed water ice is substantially less than that required to support the observed ambient outgassing from the comet, which likely has additional source regions below the surface.	Sci Applicat Int Corp, Chantilly, VA 20151 USA; Univ Maryland, College Pk, MD 20742 USA; Belton Space Explorat Initiat, Tucson, AZ 85716 USA; Delamere Support Serv, Boulder, CO 80301 USA; Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Hawaii, Honolulu, HI 96822 USA; Univ Arizona, Tucson, AZ 85721 USA; Brown Univ, Providence, RI USA; Cornell Univ, Ithaca, NY 14853 USA; Space Telescope Sci Inst, Baltimore, MD 21218 USA; Ball Aerosp & Technol Corp, Boulder, CO 80301 USA; Sigma Sci, Greenbelt, MD 20771 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA	Science Applications International Corporation (SAIC); University System of Maryland; University of Maryland College Park; Max Planck Society; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Hawaii System; University of Arizona; Brown University; Cornell University; Space Telescope Science Institute; Ball Aerospace & Technologies; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Sunshine, JM (corresponding author), Sci Applicat Int Corp, Chantilly, VA 20151 USA.	sunshinej@saic.com	Wellnitz, Dennis/B-4080-2012; Lisse, Carey M/B-7772-2016; Meech, Karen/CAH-1412-2022; McFadden, Lucy-Ann/I-4902-2013	Lisse, Carey M/0000-0002-9548-1526; McFadden, Lucy-Ann/0000-0002-0537-9975; Sunshine, Jessica/0000-0002-9413-8785; Meech, Karen/0000-0002-2058-5670; Feaga, Lori/0000-0002-4230-6759; Li, Jian-Yang/0000-0003-3841-9977				A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; Abell PA, 2005, ICARUS, V179, P174, DOI 10.1016/j.icarus.2005.06.012; AHearn MF, 1995, ICARUS, V118, P223, DOI 10.1006/icar.1995.1190; Barucci M. A., 2002, ASTEROIDS, P273; Barucci MA, 2004, SPACE SCI S, P647; Brown RH, 2004, SPACE SCI REV, V115, P111, DOI 10.1007/s11214-004-1453-x; CAMPINS H, 2003, B AM ASTRON SOC, V35, P10111; CLARK RN, 1981, J GEOPHYS RES, V86, P3087, DOI 10.1029/JB086iB04p03087; Clark RN, 2005, NATURE, V435, P66, DOI 10.1038/nature03558; COWAN JJ, 1979, MOON PLANETS, V21, P155, DOI 10.1007/BF00897085; Davies JK, 1997, ICARUS, V127, P238, DOI 10.1006/icar.1996.5673; DELAHODDE C, 2002, ASTEORIDS COMETS MET; Duncan MJ, 1997, SCIENCE, V276, P1670, DOI 10.1126/science.276.5319.1670; FANALE FP, 1984, ICARUS, V60, P476, DOI 10.1016/0019-1035(84)90157-X; Greenberg J., 1982, COMETS, P131; Hampton DL, 2005, SPACE SCI REV, V117, P43, DOI 10.1007/s11214-005-3390-8; HANNER MS, 1981, ICARUS, V47, P342, DOI 10.1016/0019-1035(81)90182-2; HAPKE BW, 1993, REFLECTANCE EMITTANC; Johnson TV, 2005, NATURE, V435, P69, DOI 10.1038/nature03384; Kawakita H, 2004, ASTROPHYS J, V601, pL191, DOI 10.1086/382073; Licandro J, 2002, EARTH MOON PLANETS, V90, P495, DOI 10.1023/A:1021567324530; Licandro J, 2003, ASTRON ASTROPHYS, V398, pL45, DOI 10.1051/0004-6361:20030009; Lisse CM, 2005, SPACE SCI REV, V117, P161, DOI 10.1007/s11214-005-3384-6; Nelson RM, 2004, ICARUS, V167, P1, DOI 10.1016/j.icarus.2003.10.008; Owen TC, 1999, ICARUS, V139, P379, DOI 10.1006/icar.1999.6116; Schleicher DG, 2006, ASTRON J, V131, P1130, DOI 10.1086/499301; Soderblom LA, 2004, ICARUS, V167, P100, DOI 10.1016/j.icarus.2003.08.019; Sugita S, 2005, SCIENCE, V310, P274, DOI 10.1126/science.1119091; Sunshine JM, 2005, SPACE SCI REV, V117, P269, DOI 10.1007/s11214-005-3388-2; WARREN SG, 1984, APPL OPTICS, V23, P1206, DOI 10.1364/AO.23.001206	30	184	186	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2006	311	5766					1453	1455		10.1126/science.1123632	http://dx.doi.org/10.1126/science.1123632			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16456037				2022-12-24	WOS:000236029400046
J	Tokar, RL; Johnson, RE; Hill, TW; Pontius, DH; Kurth, WS; Crary, FJ; Young, DT; Thomsen, MF; Reisenfeld, DB; Coates, AJ; Lewis, GR; Sittler, EC; Gurnett, DA				Tokar, RL; Johnson, RE; Hill, TW; Pontius, DH; Kurth, WS; Crary, FJ; Young, DT; Thomsen, MF; Reisenfeld, DB; Coates, AJ; Lewis, GR; Sittler, EC; Gurnett, DA			The interaction of the atmosphere of Enceladus with Saturn's plasma	SCIENCE			English	Article							CASSINI; SPECTROMETER; ION		Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Univ Virginia, Charlottesville, VA 22904 USA; Rice Univ, Houston, TX 77251 USA; Birmingham So Coll, Birmingham, AL 35254 USA; Univ Iowa, Iowa City, IA 52242 USA; SW Res Inst, San Antonio, TX 78228 USA; Univ Montana, Missoula, MT 59812 USA; UCL, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Virginia; Rice University; University of Iowa; Southwest Research Institute; University of Montana System; University of Montana; University of London; University College London; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Tokar, RL (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	rlt@lanl.gov	Kurth, William/AAA-7334-2019; Reisenfeld, Daniel/F-7614-2015; Coates, Andrew/C-2396-2008	Kurth, William/0000-0002-5471-6202; Coates, Andrew/0000-0002-6185-3125	UK Space Agency [PP/D00084X/1] Funding Source: researchfish	UK Space Agency		Dougherty MK, 2006, SCIENCE, V311, P1406, DOI 10.1126/science.1120985; Gurnett DA, 2004, SPACE SCI REV, V114, P395, DOI 10.1007/s11214-004-1434-0; Hill TW, 1998, J GEOPHYS RES-PLANET, V103, P19879, DOI 10.1029/98JE00945; JOHNSON RE, IN PRESS GEOPHYS RES; Jurac S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015855; Moore LE, 2004, ICARUS, V172, P503, DOI 10.1016/j.icarus.2004.07.007; Richardson JD, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020959; SHEMANSKY DE, 1993, NATURE, V363, P329, DOI 10.1038/363329a0; Sittler EC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022653; Strobel D. F., 1983, PHYSICS JOVIAN MAGNE, P51, DOI [10.1017/CBO9780511564574.004, DOI 10.1017/CB09780511564574.004]; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290; Young DT, 2004, SPACE SCI REV, V114, P1, DOI 10.1007/s11214-004-1406-4	12	163	163	3	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2006	311	5766					1409	1412		10.1126/science.1121061	http://dx.doi.org/10.1126/science.1121061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527967				2022-12-24	WOS:000236029400033
J	Marks, DJB; Harbord, MWN; MacAllister, R; Rahman, FZ; Young, J; Al-Lazikani, B; Lees, W; Novelli, M; Bloom, S; Segal, AW				Marks, DJB; Harbord, MWN; MacAllister, R; Rahman, FZ; Young, J; Al-Lazikani, B; Lees, W; Novelli, M; Bloom, S; Segal, AW			Defective acute inflammation in Crohn's disease: a clinical investigation	LANCET			English	Article							CHRONIC GRANULOMATOUS-DISEASE; NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; BOWEL-DISEASE; MURAMYL DIPEPTIDE; ASP299GLY POLYMORPHISM; VASCULAR-RESPONSES; CIGARETTE-SMOKING; NOD2 GENE; MUTATION	Background The cause of Crohn's disease has not been mechanistically proven. We tested the hypothesis that the disease is a form of immunodeficiency caused by impaired innate immunity. Methods We investigated inflammatory responses in patients and controls by quantifying neutrophil recruitment and cytokine production after acute trauma, interleukin 8 secretion by cultured monocyte-derived macrophages after exposure to inflammatory mediators, and local inflammatory and vascular changes in response to subcutaneous injection of heat-killed Escherichia coli. Findings In patients with Crohn's disease, trauma to rectum, ileum, or skin led to abnormally low neutrophil accumulation (differences from healthy individuals of 79%, n=8, p=0.0003; 57%, n=3, p=0.05; 50%, n=13, P<0.0001, respectively) and lower production of proinflammatory interleukin 8 (63%, n=7, p=0.003; 63%, n=3, p=0.05; 45%, n=8, p<0.0001) and interleukin 10 (50%, n=8, p=0.0005). Interleukin 8 secretion by cultured macrophages was reduced after exposure to acute wound fluid (38%, n=50, p<0.0001), C5a (48%, n=41, p=0.0005), or tumour necrosis factor alpha (52%, n=27, p<0.0001). Local inflammatory reaction to inoculation with E coli was attenuated, as quantified by changes in bloodflow (ileal disease 50%, n=6, p=0.01; colonic disease 77%, n=6, p=0.0003). This response was mediated by nitric oxide in controls, was increased by sildenafil in patients, and was not related to CARD15 genotype. Interpretation in Crohn's disease, a constitutionally weak immune response predisposes to accumulation of intestinal contents that breach the mucosal barrier of the bowel wall, resulting in granuloma formation and chronic inflammation. Polymorphisms in CARD15 do not underlie this phenotype, but incapacitate the NOD2 pathway that can compensate for impairment of innate inflammation. Current treatment of secondary chronic inflammation might exaggerate the underlying lesion and promote chronic disease.	UCL, Dept Med, London WC1E 6JJ, England; Inpharmatica, London, England; UCL Hosp NHS Fdn Trust, Dept Imaging, London, England; UCL Hosp NHS Fdn Trust, Dept Histopathol, London, England; UCL Hosp NHS Fdn Trust, Dept Gastroenterol, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Segal, AW (corresponding author), UCL, Dept Med, London WC1E 6JJ, England.	t.segal@ucl.ac.uk	Al-Lazikani, Bissan/AAG-4723-2022; Eckhardt, Erik/G-1567-2010; Al-Lazikani, Bissan/AFK-6457-2022	Al-Lazikani, Bissan/0000-0003-3367-2519; Segal, Anthony/0000-0001-7602-9043	Wellcome Trust [067287] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anton P A, 1999, Semin Gastrointest Dis, V10, P14; Bonen DK, 2003, GASTROENTEROLOGY, V124, P140, DOI 10.1053/gast.2003.50019; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brant SR, 2004, INFLAMM BOWEL DIS, V10, P300, DOI 10.1097/00054725-200405000-00019; BURMAN JH, 1969, GUT, V10, P1054; Clapp BR, 2005, CIRCULATION, V111, P1530, DOI 10.1161/01.CIR.0000159336.31613.31; Cobrin GM, 2005, IMMUNOL REV, V206, P277, DOI 10.1111/j.0105-2896.2005.00293.x; Connelly L, 2005, J BIOL CHEM, V280, P10040, DOI 10.1074/jbc.M411991200; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Don BR, 2000, J NEPHROL, V13, P249; Farrar MD, 2005, J APPL MICROBIOL, V98, P1191, DOI 10.1111/j.1365-2672.2005.02565.x; Farthing MJG, 2004, BEST PRACT RES CL GA, V18, P233, DOI 10.1016/j.bpg.2003.11.001; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Glossmann H, 1999, EXP GERONTOL, V34, P305, DOI 10.1016/S0531-5565(99)00003-0; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; HARVEY RF, 1980, LANCET, V1, P514; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Hugot JP, 2003, LANCET, V362, P2012, DOI 10.1016/S0140-6736(03)15024-6; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hunter MM, 2004, ALIMENT PHARM THER, V19, P167, DOI 10.1111/j.0269-2813.2004.01803.x; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Ishiyama M, 1996, BIOL PHARM BULL, V19, P1518; ISSEKUTZ AC, 1981, LAB INVEST, V45, P435; James DG, 2000, POSTGRAD MED J, V76, P457, DOI 10.1136/pmj.76.898.457; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Klein W, 2002, SCAND J GASTROENTERO, V37, P189, DOI 10.1080/003655202753416867; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Korzenik JR, 2005, J CLIN GASTROENTEROL, V39, pS59, DOI 10.1097/01.mcg.0000155553.28348.fc; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Li YM, 2004, J EXP MED, V200, P613, DOI 10.1084/jem.20040725; Lucey DR, 1996, CLIN MICROBIOL REV, V9, P532, DOI 10.1128/CMR.9.4.532; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Marciano BE, 2004, PEDIATRICS, V114, P462, DOI 10.1542/peds.114.2.462; MARIN J, 1990, GEN PHARMACOL-VASC S, V21, P575, DOI 10.1016/0306-3623(90)91002-9; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ouburg S, 2005, GUT, V54, P439; Pauleau AL, 2003, MOL CELL BIOL, V23, P7531, DOI 10.1128/MCB.23.21.7531-7539.2003; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Ryan P, 2004, AM J GASTROENTEROL, V99, P1539, DOI 10.1111/j.1572-0241.2004.40103.x; Seftel AD, 2004, CLIN CARDIOL, V27, pI14; SEGAL AW, 1976, LANCET, V2, P219; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Shanahan F, 2002, LANCET, V359, P62, DOI 10.1016/S0140-6736(02)07284-7; Sher ME, 1999, INFLAMM BOWEL DIS, V5, P73, DOI 10.1097/00054725-199905000-00001; SHIMIZU S, 1979, BIOCHEM BIOPH RES CO, V91, P108, DOI 10.1016/0006-291X(79)90589-8; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Stallmach Andreas, 2004, Int J Colorectal Dis, V19, P308, DOI 10.1007/s00384-003-0554-4; SUTHERLAND LR, 1990, GASTROENTEROLOGY, V98, P1123, DOI 10.1016/0016-5085(90)90324-T; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Watanabe T, 2005, GUT, V54, P1515, DOI 10.1136/gut.2005.071795; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233; Zimmerman DDE, 2005, DIS COLON RECTUM, V48, P1228, DOI 10.1007/s10350-004-0943-y; ZWAHLEN R, 1993, INT REV EXP PATHOL, V34, P27	58	309	322	1	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2006	367	9511					668	678		10.1016/S0140-6736(06)68265-2	http://dx.doi.org/10.1016/S0140-6736(06)68265-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	016HR	16503465				2022-12-24	WOS:000235611800031
J	Kellam, P; Weiss, RA				Kellam, P; Weiss, RA			Infectogenomics: Insights from the host genome into infectious diseases	CELL			English	Editorial Material							HIV-1 INFECTION; PATHOGENS; RESPONSES; RISK; AIDS; SUSCEPTIBILITY; PROGRESSION	Five years into the human postgenomic era, we are gaining considerable knowledge about host-pathogen interactions through host genomes. This "infectogenomics" approach should yield further insights into both diagnostic and therapeutic advances, as well as normal cellular function.	UCL, Div Infect & Immun, MRC, UCL,Ctr Med Mol Virol, London W1T 4JF, England	University of London; University College London	Weiss, RA (corresponding author), UCL, Div Infect & Immun, MRC, UCL,Ctr Med Mol Virol, London W1T 4JF, England.	r.weiss@ucl.ac.uk		Kellam, Paul/0000-0003-3166-4734				An P, 2004, J VIROL, V78, P11070, DOI 10.1128/JVI.78.20.11070-11076.2004; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Griffiths MJ, 2005, J INFECT DIS, V191, P1599, DOI 10.1086/429297; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Jenner RG, 2003, P NATL ACAD SCI USA, V100, P10399, DOI 10.1073/pnas.1630810100; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kellam P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-201; Sawyer SL, 2006, CURR BIOL, V16, P95, DOI 10.1016/j.cub.2005.11.045; Scherer A, 2004, P NATL ACAD SCI USA, V101, P12266, DOI 10.1073/pnas.0404091101; Shrestha S, 2006, J INFECT DIS, V193, P16, DOI 10.1086/498532; van Opijnen T, 2005, REV MED VIROL, V15, P219, DOI 10.1002/rmv.472; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499	17	34	37	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 24	2006	124	4					695	697		10.1016/j.cell.2006.02.003	http://dx.doi.org/10.1016/j.cell.2006.02.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RO	16497580	Green Published, Bronze			2022-12-24	WOS:000237240900013
J	Bardgett, RD; Smith, RS; Shiel, RS; Peacock, S; Simkin, JM; Quirk, H; Hobbs, PJ				Bardgett, RD; Smith, RS; Shiel, RS; Peacock, S; Simkin, JM; Quirk, H; Hobbs, PJ			Parasitic plants indirectly regulate below-ground properties in grassland ecosystems	NATURE			English	Article							FUNCTIONAL-ROLE; BARTSIA-ALPINA; COMMUNITY; IMPACT; DECOMPOSITION; RESTORATION; MANAGEMENT; DYNAMICS	Parasitic plants are one of the most ubiquitous groups of generalist parasites in both natural and managed ecosystems, with over 3,000 known species worldwide(1-3). Although much is known about how parasitic plants influence host peformance(1-4), their role as drivers of community- and ecosystem-level properties remains largely unexplored(5). Parasitic plants have the potential to influence directly the productivity and structure of plant communities because they cause harm to particular host plants, indirectly increasing the competitive status of non-host species(6-10). Such parasite-driven above-ground effects might also have important indirect consequences through altering the quantity and quality of resources that enter soil, thereby affecting the activity of decomposer organisms(3,11-13). Here we show in model grassland communities that the parasitic plant Rhinanthus minor, which occurs widely throughout Europe and North America(14), has strong direct effects on above-ground community properties, increasing plant diversity and reducing productivity. We also show that these direct effects of R. minor on the plant community have marked indirect effects on below-ground properties, ultimately increasing rates of nitrogen cycling. Our study provides evidence that parasitic plants act as a major driver of both above-ground and below-ground properties of grassland ecosystems.	Univ Lancaster, Inst Environm & Nat Sci, Soil & Ecosyst Ecol Lab, Lancaster LA1 4YQ, England; Newcastle Univ, Sch Biol & Psychol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Newcastle Univ, Sch Agr Food & Rural Dev, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Inst Grassland & Environm Res, N Wyke Res Stn, Okehampton EX20 2SB, Devon, England	Lancaster University; Newcastle University - UK; Newcastle University - UK	Bardgett, RD (corresponding author), Univ Lancaster, Inst Environm & Nat Sci, Soil & Ecosyst Ecol Lab, Lancaster LA1 4YQ, England.	r.bardgett@lancaster.ac.uk						[Anonymous], 1969, BIOL PARASITIC FLOWE; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; Bardgett RD, 2003, ECOLOGY, V84, P1277, DOI 10.1890/0012-9658(2003)084[1277:SMCEWP]2.0.CO;2; Bardgett RD, 1996, BIOL FERT SOILS, V22, P261, DOI 10.1007/BF00382522; Bardgett RD., 2005, THE BIOL OF SOIL, DOI [10.1093/acprof:oso/9780198525035.001.0001, DOI 10.1093/ACPROF:OSO/9780198525035.001.0001]; Davies DM, 1997, BIOL CONSERV, V82, P87, DOI 10.1016/S0006-3207(97)00010-4; GIBSON CC, 1992, OECOLOGIA, V89, P62, DOI 10.1007/BF00319016; GIBSON CC, 1991, OECOLOGIA, V86, P81, DOI 10.1007/BF00317393; GRIME JP, 1990, ABRIDGE COMP PLANT E; Marvier MA, 1998, ECOLOGY, V79, P2616, DOI 10.1890/0012-9658(1998)079[2616:PIOHCP]2.0.CO;2; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; McNaughton SJ, 1997, SCIENCE, V278, P1798, DOI 10.1126/science.278.5344.1798; Parker C., 1993, PARASITIC WEEDS WORL; Pennings SC, 1996, ECOLOGY, V77, P1410, DOI 10.2307/2265538; Press M.C., 1995, PARASITIC PLANTS; Press MC, 1998, OIKOS, V82, P609, DOI 10.2307/3546383; Pywell RF, 2004, J APPL ECOL, V41, P880, DOI 10.1111/j.0021-8901.2004.00940.x; Quested HM, 2003, ECOLOGY, V84, P3209, DOI 10.1890/02-0426; Quested HM, 2003, OECOLOGIA, V135, P606, DOI 10.1007/s00442-003-1225-4; Quested HM, 2002, OECOLOGIA, V130, P88, DOI 10.1007/s004420100780; RODWELL JS, 1992, GRASSLANDS MONTANE C; Smith D, 2000, AM NAT, V155, P13, DOI 10.1086/303294; Smith RS, 2003, J APPL ECOL, V40, P51, DOI 10.1046/j.1365-2664.2003.00780.x; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; TERBRAAK CJF, 2002, CANOCO REFERENCE MAN, P265; THOMAS F, 2005, PARASITES GRAND SCHE; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; WESTBURY DB, 2004, J ECOL, V63, P335	29	136	149	4	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2006	439	7079					969	972		10.1038/nature04197	http://dx.doi.org/10.1038/nature04197			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014NE	16495998				2022-12-24	WOS:000235486100046
J	Chang, LF; Kamata, H; Solinas, G; Luo, JL; Maeda, S; Venuprasad, K; Liu, YC; Karin, M				Chang, LF; Kamata, H; Solinas, G; Luo, JL; Maeda, S; Venuprasad, K; Liu, YC; Karin, M			The E3 ubiquitin ligase itch couples JNK activation to TNF alpha-induced cell death by inducing c-FLIPL turnover	CELL			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; RECEPTOR-INDUCED APOPTOSIS; UP-REGULATION; CASPASE-8 ACTIVATION; MEDIATED APOPTOSIS; SIGNALING COMPLEX; JUN KINASE; PHOSPHORYLATION; PROTEIN	The proinflammatory cytokine tumor necrosis factor (TNF) alpha signals both cell survival and death. The biological outcome of TNF alpha treatment is determined by the balance between NF-kappa B and Jun kinase(JNK) signaling; NF-kappa B promotes survival, whereas JNK enhances cell death. Critically, identity of a JNK substrate that promotes TNF alpha-induced apoptosis has been outstanding. Here we show that TNF alpha-mediated JNK activation accelerates turnover of the NF-kappa B-induced antiapoptotic protein c-FLIP, an inhibitor of caspase-8. This is not due to direct c-FLIP phosphorylation but depends on JNK-mediated phosphorylation and activation of the E3 ubiquitin ligase Itch, which specifically ubiquitinates c-FLIP and induces its proteasomal degradation. JNK1 or Itch deficiency or treatment with a JNK in hi bitor renders mice resistant in three distinct models of TNFa-induced acute liver failure, and cells from these mice do not display inducible c-FLIPL ubiquitination and degradation. Thus, JNK antagonizes NF-kappa B during TNF alpha signaling by promoting the proteasomal elimination of c-FLIPL.	Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; City Hope Natl Med Ctr, Beckman Res Inst, Div Canc Immunotherapeut & Tumor Immunol, Duarte, CA 91010 USA; La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA	University of California System; University of California San Diego; City of Hope; Beckman Research Institute of City of Hope; La Jolla Institute for Immunology	Chang, LF (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Solinas, Giovanni/P-6596-2017; Kamata, Hideaki/N-3907-2017; Solinas, Giovanni/R-4777-2019	Solinas, Giovanni/0000-0002-0140-2621; Solinas, Giovanni/0000-0002-0140-2621; poojary, venuprasd/0000-0001-8986-9092; LIU, YUN-CAI/0000-0002-0996-7109				Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Bai YL, 2004, MOL CELL, V15, P825, DOI 10.1016/j.molcel.2004.07.021; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Ciechanover A, 2004, BBA-MOL CELL RES, V1695, P3, DOI 10.1016/j.bbamcr.2004.09.018; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; DECKER K, 1974, REV PHYSIOL BIOCH P, V71, P77, DOI 10.1007/BFb0027661; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kirchhoff S, 2000, EUR J IMMUNOL, V30, P2765, DOI 10.1002/1521-4141(200010)30:10<2765::AID-IMMU2765>3.0.CO;2-W; Kirchhoff S, 2000, J IMMUNOL, V165, P6293, DOI 10.4049/jimmunol.165.11.6293; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Papa S, 2004, J CELL SCI, V117, P5197, DOI 10.1242/jcs.01483; Park KS, 2002, EUR J IMMUNOGENET, V29, P7, DOI 10.1046/j.0960-7420.2001.00260.x; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; THORNE M, 2001, NATURE REV IMMUNOL, V1, P50; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	42	570	595	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 10	2006	124	3					601	613		10.1016/j.cell.2006.01.021	http://dx.doi.org/10.1016/j.cell.2006.01.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	014FG	16469705	Bronze			2022-12-24	WOS:000235464000021
J	Tsao, DY; Freiwald, WA; Tootell, RBH; Livingstone, MS				Tsao, DY; Freiwald, WA; Tootell, RBH; Livingstone, MS			A cortical region consisting entirely of face-selective cells	SCIENCE			English	Article							TEMPORAL CORTEX; INFEROTEMPORAL CORTEX; NEURONS; MONKEY; PERCEPTION; MACAQUE; ORGANIZATION; OBJECTS; AREAS; REPRESENTATIONS	Face perception is a skill crucial to primates. In both humans and macaque monkeys, functional magnetic resonance imaging (fMRI) reveals a system of cortical regions that show increased blood flow when the subject views images of faces, compared with images of objects. However, the stimulus selectivity of single neurons within these fMRI-identified regions has not been studied. We used fMRI to identify and target the largest face-selective region in two macaques for single-unit recording. Almost all (97%) of the visually responsive neurons in this region were strongly face selective, indicating that a dedicated cortical area exists to support face processing in the macaque.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Univ Bremen, Ctr Adv Imaging, Brain Res Inst, D-28334 Bremen, Germany; Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Bremen; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Tsao, DY (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	doris@nmr.mgh.harvard.edu	Tudusciuc, Oana/C-1339-2011	Livingstone, Margaret/0000-0002-1950-0123	NCRR NIH HHS [P41:RR14075] Funding Source: Medline; NEI NIH HHS [EY13025, R01 EY016187, R01 EY016187-01A2, EY13135] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016187, R01EY013025, R01EY013135] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAYLIS GC, 1987, J NEUROSCI, V7, P330; BAYLIS GC, 1985, BRAIN RES, V342, P91, DOI 10.1016/0006-8993(85)91356-3; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Eifuku S, 2004, J NEUROPHYSIOL, V91, P358, DOI 10.1152/jn.00198.2003; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gross C. G., 1973, HDB SENSORY PHYSIOLO, P451; HARRIES MH, 1991, J COGNITIVE NEUROSCI, V3, P9, DOI 10.1162/jocn.1991.3.1.9; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2003, CURR OPIN NEUROBIOL, V13, P630, DOI 10.1016/j.conb.2003.09.017; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; PERRETT DI, 1984, HUM NEUROBIOL, V3, P197; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Pinsk MA, 2005, P NATL ACAD SCI USA, V102, P6996, DOI 10.1073/pnas.0502605102; ROLLS ET, 1992, PHILOS T R SOC B, V335, P11, DOI 10.1098/rstb.1992.0002; ROSCH E, 1978, COGN PSYCHOL, V8; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; Wang G, 1998, NEUROSCI RES, V32, P33, DOI 10.1016/S0168-0102(98)00062-5; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7	28	730	744	4	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2006	311	5761					670	674		10.1126/science.1119983	http://dx.doi.org/10.1126/science.1119983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011GY	16456083	Green Accepted			2022-12-24	WOS:000235257400051
J	Mishra, G; Zhang, WH; Deng, F; Zhao, J; Wang, XM				Mishra, G; Zhang, WH; Deng, F; Zhao, J; Wang, XM			A bifurcating pathway directs abscisic acid effects on stomatal closure and opening in Arabidopsis	SCIENCE			English	Article							PROTEIN PHOSPHATASE 2C; CELL SIGNAL-TRANSDUCTION; GUARD-CELLS; PHOSPHOLIPASE-D; ALPHA-SUBUNIT; CA2+ SIGNALS; INTERACTS; PLANTS; ABA; CHANNELS	Terrestrial plants lose water primarily through stomata, pores on the leaves. The hormone abscisic acid (ABA) decreases water loss by regulating opening and closing of stomata. Here, we show that phospholipase D alpha 1 (PLD alpha 1) mediates the ABA effects on stomata through interaction with a protein phosphatase 2C (PP2C) and a heterotrimeric GTP-binding protein ( G protein) in Arabidopsis. PLD alpha 1-produced phosphatidic acid (PA) binds to the ABI1 PP2C to signal ABA-promoted stomatal closure, whereas PLD alpha 1 and PA interact with the G alpha subunit of heterotrimeric G protein to mediate ABA inhibition of stomatal opening. The results reveal a bifurcating signaling pathway that regulates plant water loss.	Univ Missouri, Dept Biol, St Louis, MO 63121 USA; Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	University of Missouri System; University of Missouri Saint Louis; Donald Danforth Plant Science Center	Wang, XM (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	wangxue@umsl.edu	Zhao, Jian/Q-8591-2019; Wang, Xuemin/M-2853-2013; Zhao, Jian/A-2336-2008	Zhao, Jian/0000-0002-4416-7334; wang, xuemin/0000-0002-6251-6745				Assmann SM, 2005, SCIENCE, V310, P71, DOI 10.1126/science.1118580; Coursol S, 2003, NATURE, V423, P651, DOI 10.1038/nature01643; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Desikan R, 2004, J EXP BOT, V55, P205, DOI 10.1093/jxb/erh033; Fan LM, 2004, CURR OPIN PLANT BIOL, V7, P537, DOI 10.1016/j.pbi.2004.07.009; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Hetherington AM, 2004, ANNU REV PLANT BIOL, V55, P401, DOI 10.1146/annurev.arplant.55.031903.141624; Hunt L, 2003, PLANT J, V34, P47, DOI 10.1046/j.1365-313X.2003.01698.x; Jacob T, 1999, P NATL ACAD SCI USA, V96, P12192, DOI 10.1073/pnas.96.21.12192; Lein W, 2001, BBA-MOL CELL BIOL L, V1530, P172, DOI 10.1016/S1388-1981(00)00182-7; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Levchenko V, 2005, P NATL ACAD SCI USA, V102, P4203, DOI 10.1073/pnas.0500146102; McDermott M, 2004, BIOCHEM CELL BIOL, V82, P225, DOI 10.1139/o03-079; Ng CKY, 2001, NATURE, V410, P596, DOI 10.1038/35069092; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Sanchez JP, 2004, PLANT J, V38, P381, DOI 10.1111/j.1365-313X.2004.02055.x; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Sheen J, 1998, P NATL ACAD SCI USA, V95, P975, DOI 10.1073/pnas.95.3.975; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Wang XM, 2005, PLANT PHYSIOL, V139, P566, DOI 10.1104/pp.105.068809; Wang XM, 2004, CURR OPIN PLANT BIOL, V7, P329, DOI 10.1016/j.pbi.2004.03.012; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101; Zhao J, 2004, J BIOL CHEM, V279, P1794, DOI 10.1074/jbc.M309529200	24	302	342	6	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					264	266		10.1126/science.1123769	http://dx.doi.org/10.1126/science.1123769			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614222				2022-12-24	WOS:000236765300048
J	Castellino, F; Huang, AY; Altan-Bonnet, G; Stoll, S; Scheinecker, C; Germain, RN				Castellino, F; Huang, AY; Altan-Bonnet, G; Stoll, S; Scheinecker, C; Germain, RN			Chemokines enhance immunity by guiding naive CD8(+) T cells to sites of CD4 T cell-dendritic cell interaction	NATURE			English	Article							LYMPH-NODES; IN-VIVO; CD8-T-CELL MEMORY; CD4-T-CELL HELP; LYMPHOCYTES; EXPRESSION; ANTIGEN; MIGRATION; GENERATION; MOTILITY	CD8(+) T cells have a crucial role in resistance to pathogens and can kill malignant cells; however, some critical functions of these lymphocytes depend on helper activity provided by a distinct population of CD4(+) T cells. Cooperation between these lymphocyte subsets involves recognition of antigens co-presented by the same dendritic cell, but the frequencies of such antigen-bearing cells early in an infection and of the relevant naive T cells are both low. This suggests that an active mechanism facilitates the necessary cell-cell associations. Here we demonstrate that after immunization but before antigen recognition, naive CD8(+) T cells in immunogen-draining lymph nodes upregulate the chemokine receptor CCR5, permitting these cells to be attracted to sites of antigen-specific dendritic cell-CD4(+) T cell interaction where the cognate chemokines CCL3 and CCL4 (also known as MIP-1 alpha and MIP-1 beta) are produced. Interference with this actively guided recruitment markedly reduces the ability of CD4(+) T cells to promote memory CD8(+) T-cell generation, indicating that an orchestrated series of differentiation events drives nonrandom cell-cell interactions within lymph nodes, optimizing CD8(+) T-cell immune responses involving the few antigen-specific precursors present in the naive repertoire.	NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Johannes Gutenberg Univ Mainz, Dept Dermatol, D-55131 Mainz, Germany; Med Univ Vienna, Dept Rheumatol, Gen Hosp Vienna, A-1090 Vienna, Austria	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Memorial Sloan Kettering Cancer Center; Johannes Gutenberg University of Mainz; Medical University of Vienna	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rgermain@nih.gov	Huang, Alex Y./ABG-8182-2021; Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019	Huang, Alex Y./0000-0002-5701-4521; Altan-Bonnet, Gregoire/0000-0002-7283-3162	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000758, ZIAAI000758] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; CAHILL RNP, 1976, J EXP MED, V143, P870, DOI 10.1084/jem.143.4.870; Catron DM, 2004, IMMUNITY, V21, P341, DOI 10.1016/j.immuni.2004.08.007; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Cyster JG, 2003, IMMUNOL REV, V195, P5, DOI 10.1034/j.1600-065X.2003.00075.x; GERMAIN RN, IN PRESS ANN REV IMM; Guan E, 2001, J BIOL CHEM, V276, P12404, DOI 10.1074/jbc.M006327200; GUERDER S, 1992, J EXP MED, V176, P553, DOI 10.1084/jem.176.2.553; HALL JG, 1965, BRIT J EXP PATHOL, V46, P450; Hommel M, 2003, J EXP MED, V197, P269, DOI 10.1084/jem.20021512; Huang AYC, 2004, IMMUNITY, V21, P331, DOI 10.1016/S1074-7613(04)00235-3; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Nagorsen D, 2004, CYTOKINE, V25, P31, DOI 10.1016/j.cyto.2003.08.012; Proietto AI, 2004, IMMUNOBIOLOGY, V209, P163, DOI 10.1016/j.imbio.2004.03.002; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; SHERRY B, 1988, J EXP MED, V168, P2251, DOI 10.1084/jem.168.6.2251; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160	38	577	596	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					890	895		10.1038/nature04651	http://dx.doi.org/10.1038/nature04651			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612374				2022-12-24	WOS:000236736700031
J	Thorens, B				Thorens, B			A toggle for type 2 diabetes?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INSULIN-SECRETION; MICE		Univ Lausanne, Dept Physiol, Lausanne, Switzerland; Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland	University of Lausanne; University of Lausanne	Thorens, B (corresponding author), Univ Lausanne, Dept Physiol, Lausanne, Switzerland.							Guillam MT, 1997, NAT GENET, V17, P503, DOI 10.1038/ng1297-503b; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Thorens B, 2000, J BIOL CHEM, V275, P23751, DOI 10.1074/jbc.M002908200	4	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 13	2006	354	15					1636	1638		10.1056/NEJMcibr060422	http://dx.doi.org/10.1056/NEJMcibr060422			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031WW	16611957	Green Published			2022-12-24	WOS:000236736900017
J	Kyaw, MH; Lynfield, R; Schaffner, W; Craig, AS; Hadler, J; Reingold, A; Thomas, AR; Harrison, LH; Bennett, NM; Farley, MM; Facklam, RR; Jorgensen, JH; Besser, J; Zell, ER; Schuchat, A; Whitney, CG				Kyaw, MH; Lynfield, R; Schaffner, W; Craig, AS; Hadler, J; Reingold, A; Thomas, AR; Harrison, LH; Bennett, NM; Farley, MM; Facklam, RR; Jorgensen, JH; Besser, J; Zell, ER; Schuchat, A; Whitney, CG		Active Bacterial Core Surveillance	Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	43rd Interscience Conference on Antimicrobial Agents and Chemotherapy	SEP 14-17, 2003	CHICAGO, IL				ACUTE OTITIS-MEDIA; PRACTICE GUIDELINES; CARRIAGE; EFFICACY; MANAGEMENT; SEROTYPES; CHILDREN; DISEASE; SPREAD; TRIAL	Background: Five of seven serotypes in the pneumococcal conjugate vaccine, introduced for infants in the United States in 2000, are responsible for most penicillin-resistant infections. We examined the effect of this vaccine on invasive disease caused by resistant strains. Methods: We used laboratory-based data from Active Bacterial Core surveillance to measure disease caused by antibiotic-nonsusceptible pneumococci from 1996 through 2004. Cases of invasive disease, defined as disease caused by pneumococci isolated from a normally sterile site, were identified in eight surveillance areas. Isolates underwent serotyping and susceptibility testing. Results: Rates of invasive disease caused by penicillin-nonsusceptible strains and strains not susceptible to multiple antibiotics peaked in 1999 and decreased by 2004, from 6.3 to 2.7 cases per 100,000 (a decline of 57 percent; 95 percent confidence interval, 55 to 58 percent) and from 4.1 to 1.7 cases per 100,000 (a decline of 59 percent; 95 percent confidence interval, 58 to 60 percent), respectively. Among children under two years of age, disease caused by penicillin-nonsusceptible strains decreased from 70.3 to 13.1 cases per 100,000 (a decline of 81 percent; 95 percent confidence interval, 80 to 82 percent). Among persons 65 years of age or older, disease caused by penicillin-nonsusceptible strains decreased from 16.4 to 8.4 cases per 100,000 (a decline of 49 percent). Rates of resistant disease caused by vaccine serotypes fell 87 percent.An increase was seen in disease caused by serotype 19A, a serotype not included in the vaccine (from 2.0 to 8.3 per 100,000 among children under two years of age). Conclusions: The rate of antibiotic-resistant invasive pneumococcal infections decreased in young children and older persons after the introduction of the conjugate vaccine. There was an increase in infections caused by serotypes not included in the vaccine.	Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Minnesota Dept Hlth, Minneapolis, MN USA; Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; Tennessee Dept Hlth, Nashville, TN USA; Connecticut Dept Publ Hlth, Hartford, CT USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Oregon Dept Human Serv, Emerging Infect Programs, Hlth Div, Portland, OR USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; Monroe Cty Dept Hlth, Rochester, NY USA; Univ Rochester, Rochester, NY USA; Emory Univ, Sch Med, Atlanta, GA USA; Vet Affairs Med Ctr, Atlanta, GA 30033 USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA	Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Vanderbilt University; Tennessee Department Health; University of California System; University of California Berkeley; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Rochester; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; University of Texas System; University of Texas Health San Antonio	Whitney, CG (corresponding author), CDC Mailstop C-23,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	cwhitney@cdc.gov						[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P717; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1007; Dagan R, 2003, PEDIATR INFECT DIS J, V22, P532, DOI 10.1097/00006454-200306000-00009; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Givon-Lavi N, 2003, PEDIATR INFECT DIS J, V22, P524, DOI 10.1097/00006454-200306000-00008; Hausdorff WP, 2002, PEDIATR INFECT DIS J, V21, P1008, DOI 10.1097/00006454-200211000-00007; HENDLEY JO, 1975, J INFECT DIS, V132, P55, DOI 10.1093/infdis/132.1.55; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Kilpi T, 2003, CLIN INFECT DIS, V37, P1155, DOI 10.1086/378744; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Mandell LA, 2003, CLIN INFECT DIS, V37, P1405, DOI 10.1086/380488; McCormick AW, 2003, NAT MED, V9, P424, DOI 10.1038/nm839; National Committee for Clinical Laboratory Stardards, 2004, M100S14 NAT COMM CLI; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; Pelton SI, 2004, PEDIATR INFECT DIS J, V23, P1015, DOI 10.1097/01.inf.0000143645.58215.f0; PICKERING LK, 2003, RED BOOK 2003 REPORT, P490; Schrag SJ, 2000, CLIN MICROBIOL REV, V13, P588, DOI 10.1128/CMR.13.4.588-601.2000; Talbot TR, 2004, CLIN INFECT DIS, V39, P641, DOI 10.1086/422653; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; 2001, MMWR MORB MORTAL WKL, V50, P532; 2005, MMWR MORB MORTAL WKL, V54, P935	26	613	643	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 6	2006	354	14					1455	1463		10.1056/NEJMoa051642	http://dx.doi.org/10.1056/NEJMoa051642			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	029DP	16598044	Bronze			2022-12-24	WOS:000236539000004
J	Brown, MS; Goldstein, JL				Brown, MS; Goldstein, JL			Biomedicine - Lowering LDL - Not only how low, but how long?	SCIENCE			English	Editorial Material							HEART-DISEASE; CHOLESTEROL; PCSK9; STATINS; MUTATIONS; PROGRAM; SREBP; GENE		Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Brown, MS (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	mike.brown@utsouthwestern.edu; joe.goldstein@utsouthwestern.edu						Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bansal N, 2005, CURR OPIN LIPIDOL, V16, P400, DOI 10.1097/01.mol.0000174154.61307.16; Brown MS, 2004, ATHEROSCLEROSIS SUPP, V5, P13, DOI 10.1016/j.atherosclerosissup.2004.08.007; CHEN ZM, 1991, BRIT MED J, V303, P276, DOI 10.1136/bmj.303.6797.276; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; ENOS WF, 1953, JAMA-J AM MED ASSOC, V152, P1090, DOI 10.1001/jama.1953.03690120006002; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Keys A., 1980, SCIENCE, DOI DOI 10.1126/SCIENCE.208.4448.1138; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Vaughan CJ, 2004, CIRCULATION, V110, P886, DOI 10.1161/01.CIR.0000139312.10076.BA; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	23	157	187	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1721	1723		10.1126/science.1125884	http://dx.doi.org/10.1126/science.1125884			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556829				2022-12-24	WOS:000236204300027
J	Chang, CI; Chelliah, Y; Borek, D; Mengin-Lecreulx, D; Deisenhofer, J				Chang, CI; Chelliah, Y; Borek, D; Mengin-Lecreulx, D; Deisenhofer, J			Structure of tracheal cytotoxin in complex with a heterodimeric pattern-recognition receptor	SCIENCE			English	Article							PEPTIDOGLYCAN-RECOGNITION; CRYSTAL-STRUCTURE; DROSOPHILA-MELANOGASTER; ANGSTROM RESOLUTION; IMMUNE-SYSTEM; PROTEINS; PATHWAY	Tracheal cytotoxin (TCT), a naturally occurring fragment of Gram-negative peptidoglycan, is a potent elicitor of innate immune responses in Drosophila. It induces the heterodimerization of its recognition receptors, the peptidoglycan recognition proteins (PGRPs) LCa and LCx, which activates the immune deficiency pathway. The crystal structure at 2.1 angstrom resolution of TCT in complex with the ectodomains of PGRP-LCa and PGRP-LCx shows that TCT is bound to and presented by the LCx ectodomain for recognition by the LCa ectodomain; the latter lacks a canonical peptidoglycan-docking groove conserved in other PGRPs. The interface, revealed in atomic detail, between TCT and the receptor complex highlights the importance of the anhydro-containing disaccharide in bridging the two ectodomains together and the critical role of diaminopimelic acid as the specificity determinant for PGRP interaction.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; CNRS, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Centre National de la Recherche Scientifique (CNRS); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Deisenhofer, J (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	johann.deisenhofer@utsouthwestern.edu	Borek, Dominika M/D-2943-2011	Borek, Dominika M/0000-0002-4321-6253; Chang, Chung-I/0000-0003-0989-1228; MENGIN-LECREULX, Dominique/0000-0003-3205-0275				Chang CI, 2004, PLOS BIOL, V2, P1293, DOI 10.1371/journal.pbio.0020277; Chang CI, 2005, P NATL ACAD SCI USA, V102, P10279, DOI 10.1073/pnas.0504547102; Choe KM, 2005, P NATL ACAD SCI USA, V102, P1122, DOI 10.1073/pnas.0404952102; GOLDMAN WE, 1982, INFECT IMMUN, V36, P782, DOI 10.1128/IAI.36.2.782-794.1982; Guan RJ, 2004, P NATL ACAD SCI USA, V101, P17168, DOI 10.1073/pnas.0407856101; Guan RJ, 2005, J MOL BIOL, V347, P683, DOI 10.1016/j.jmb.2005.01.070; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Lim JH, 2006, J BIOL CHEM, V281, P8286, DOI 10.1074/jbc.M513030200; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mellroth P, 2005, P NATL ACAD SCI USA, V102, P6455, DOI 10.1073/pnas.0407559102; Mengin-Lecreulx D, 2005, J ENDOTOXIN RES, V11, P105, DOI 10.1179/096805105X35233; Reiser JB, 2004, J MOL BIOL, V340, P909, DOI 10.1016/j.jmb.2004.04.077; Stenbak CR, 2004, J IMMUNOL, V173, P7339, DOI 10.4049/jimmunol.173.12.7339; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772	18	113	118	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1761	1764		10.1126/science.1123056	http://dx.doi.org/10.1126/science.1123056			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556841				2022-12-24	WOS:000236204300041
J	Reyes-Turcu, FE; Horton, JR; Mullally, JE; Heroux, A; Cheng, XD; Wilkinson, KD				Reyes-Turcu, FE; Horton, JR; Mullally, JE; Heroux, A; Cheng, XD; Wilkinson, KD			The ubiquitin binding domain ZnFUBP recognizes the C-terminal diglycine motif of unanchored ubiquitin	CELL			English	Article							FREE POLYUBIQUITIN CHAINS; DEUBIQUITINATING ENZYMES; ISOPEPTIDASE-T; SACCHAROMYCES-CEREVISIAE; UBA DOMAIN; CUE DOMAIN; PROTEIN; MECHANISM; COMPLEX; SYSTEM	Ubiquitin binding proteins regulate the stability, function, and/or localization of ubiquitinated proteins. Here we report the crystal structures of the zinc-finger ubiquitin binding domain (ZnF UBP) from the deubiquitinating enzyme isopeptidase T (IsoT, or USP5) alone and in complex with ubiquitin. Unlike other ubiquitin binding domains, this domain contains a deep binding pocket where the C-terminal diglycine motif of ubiquitin is inserted, thus explaining the specificity of IsoT for an unmodified C terminus on the proximal subunit of polyubiquitin. Mutations in the domain demonstrate that it is required for optimal catalytic activation of IsoT. This domain is present in several other protein families, and the ZnF UBP domain from an E3 ligase also requires the C terminus of ubiquitin for binding. These data suggest that binding the ubiquitin C terminus may be necessary for the function of other proteins.	Brookhaven Natl Lab, Dept Biol, Upton, NY 11794 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Wilkinson, KD (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	genekdw@emory.edu	Hu, Ruogu/B-2203-2008; Horton, John/F-2375-2010; Horton, John R/ABB-4770-2020	Horton, John/0000-0001-9749-8068	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068680, F31GM075426, R01GM030308, T32GM008367] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM068680, 5T32GM008367, GM30308, 1F31GM075426-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 1997, EMBO J, V16, P4826; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COOK WJ, 1994, J MOL BIOL, V236, P601, DOI 10.1006/jmbi.1994.1169; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Davies BA, 2003, J BIOL CHEM, V278, P19826, DOI 10.1074/jbc.M301059200; Doelling JH, 2001, PLANT J, V27, P393, DOI 10.1046/j.1365-313X.2001.01106.x; Gabriel JM, 2002, BIOCHEMISTRY-US, V41, P13755, DOI 10.1021/bi026096m; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HERMANSON GT, 1992, IMMOBILIZED AFFINITY, P80; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Ingvarsdottir K, 2005, MOL CELL BIOL, V25, P1162, DOI 10.1128/MCB.25.3.1162-1172.2005; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897; LEE S, 2006, IN PRESS NAT STRUCT; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Lindsey DF, 1998, J BIOL CHEM, V273, P29178, DOI 10.1074/jbc.273.44.29178; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips CL, 2001, ACTA CRYSTALLOGR D, V57, P341, DOI 10.1107/S090744490001800X; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Prag G, 2005, P NATL ACAD SCI USA, V102, P2334, DOI 10.1073/pnas.0500118102; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Russell Nathaniel S., 2005, V301, P207; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; STEIN RL, 1995, BIOCHEMISTRY-US, V34, P12616, DOI 10.1021/bi00039a017; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Tong L, 1997, METHOD ENZYMOL, V276, P594, DOI 10.1016/S0076-6879(97)76080-4; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Wilkinson Keith D, 2004, Methods Mol Biol, V261, P15; Yin LM, 2000, BIOCHEMISTRY-US, V39, P10001, DOI 10.1021/bi0007019	52	231	240	4	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1197	1208		10.1016/j.cell.2006.02.038	http://dx.doi.org/10.1016/j.cell.2006.02.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564012	Bronze			2022-12-24	WOS:000237241400020
J	Wilson, JF				Wilson, JF			The pain divide between men and women	ANNALS OF INTERNAL MEDICINE			English	News Item												jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136					0	14	16	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2006	144	6					461	464		10.7326/0003-4819-144-6-200603210-00031	http://dx.doi.org/10.7326/0003-4819-144-6-200603210-00031			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025FX	16549870				2022-12-24	WOS:000236251800026
J	Onyebujoh, P; Rodriguez, W; Mwaba, P				Onyebujoh, P; Rodriguez, W; Mwaba, P			Priorities in tuberculosis research	LANCET			English	Editorial Material									Ctr Casai, UNICEF,UNDP,World Bank, WHO Special Programme Res & Training Trop Dis, Implementat Res & Methods, CH-1216 Geneva, Switzerland; Harvard Univ, Sch Med, Div AIDS, Landmark Ctr, Boston, MA USA; Univ Zambia, Sch Med, Dept Med, Lusaka, Zambia	The World Bank; World Health Organization; Harvard University; Harvard Medical School; University of Zambia	Onyebujoh, P (corresponding author), Ctr Casai, UNICEF,UNDP,World Bank, WHO Special Programme Res & Training Trop Dis, Implementat Res & Methods, CH-1216 Geneva, Switzerland.	onyebujohp@who.int	Mwaba, Peter/V-6017-2019					Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; [Anonymous], STOP TB PARTNERSHIP; CAMP R, WHATS PIPELINE HIV D; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; *GLOB ALL TB DRUG, 2001, EC TB DRUG DEV; *WHO, 1991, WHA448 WHO; WHO, 2004, INT POL COLL TB HIV; *WHO, 2000, SCI WORK GROUP TUB	8	23	23	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					940	942		10.1016/S0140-6736(06)68385-2	http://dx.doi.org/10.1016/S0140-6736(06)68385-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546543				2022-12-24	WOS:000236242100031
J	Shuler, MG; Bear, MF				Shuler, MG; Bear, MF			Reward timing in the primary visual cortex	SCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; SHORT-TERM-MEMORY; PREFRONTAL CORTEX; WORKING-MEMORY; NEURAL MECHANISMS; NEURONAL-ACTIVITY; ATTENTION; CORRELATE; THALAMUS; MONKEYS	We discovered that when adult rats experience an association between visual stimuli and subsequent rewards, the responses of a substantial fraction of neurons in the primary visual cortex evolve from those that relate solely to the physical attributes of the stimuli to those that accurately predict the timing of reward. In addition to revealing a remarkable type of response plasticity in adult V1, these data demonstrate that reward-timing activity - a "higher" brain function - can occur very early in sensory-processing paths. These findings challenge the traditional interpretation of activity in the primary visual cortex.	MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health	Bear, MF (corresponding author), MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.	mbear@mit.edu		Bear, Mark/0000-0002-9903-2541				Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; FUSTER JM, 1981, SCIENCE, V212, P952, DOI 10.1126/science.7233192; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; GAFFAN EA, 1988, J NEUROSCI, V8, P3144; Gilbert C, 2000, VISION RES, V40, P1217, DOI 10.1016/S0042-6989(99)00234-5; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; HUBEL D, 1959, J PHYSL, V150, P91; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Komura Y, 2001, NATURE, V412, P546, DOI 10.1038/35087595; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Liu Z, 2000, NAT NEUROSCI, V3, P1307, DOI 10.1038/81841; Miller EK, 1996, J NEUROSCI, V16, P5154; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; Purves D, 2001, PHILOS T ROY SOC B, V356, P285, DOI 10.1098/rstb.2000.0772; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Salazar RF, 2004, EUR J NEUROSCI, V20, P1391, DOI 10.1111/j.1460-9568.2004.03579.x; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Watanabe Y, 2004, J NEUROPHYSIOL, V92, P1738, DOI 10.1152/jn.00994.2003	26	396	399	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1606	1609		10.1126/science.1123513	http://dx.doi.org/10.1126/science.1123513			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543459				2022-12-24	WOS:000236029500045
J	Hansen, CJ; Esposito, L; Stewart, AIF; Colwell, J; Hendrix, A; Pryor, W; Shemansky, D; West, R				Hansen, CJ; Esposito, L; Stewart, AIF; Colwell, J; Hendrix, A; Pryor, W; Shemansky, D; West, R			Enceladus' water vapor plume	SCIENCE			English	Article							SATURNS E-RING; OSCILLATOR-STRENGTHS; SYSTEM; ATMOSPHERES; PLASMA		CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Colorado, Lab Air & Space Phys, Boulder, CO 80303 USA; Space Environm Technol, Pasadena, CA 91107 USA; Cent Arizona Coll, Coolidge, AZ 85228 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Colorado System; University of Colorado Boulder	Hansen, CJ (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	Candice.j.Hansen@jpl.nasa.gov	ESPOSITO, LARRY W/AAB-3673-2021; Colwell, Joshua/AAP-2692-2020	ESPOSITO, LARRY W/0000-0003-3381-2016; Colwell, Joshua/0000-0001-8269-6408				BURATTI BJ, 1988, ICARUS, V75, P113, DOI 10.1016/0019-1035(88)90130-3; CHAN WF, 1993, CHEM PHYS, V178, P387, DOI 10.1016/0301-0104(93)85078-M; Dougherty MK, 2006, SCIENCE, V311, P1406, DOI 10.1126/science.1120985; EIDELSBERG M, 1992, J CHEM PHYS, V96, P5585, DOI 10.1063/1.462700; Esposito LW, 2004, SPACE SCI REV, V115, P299, DOI 10.1007/s11214-004-1455-8; Esposito LW, 2005, SCIENCE, V307, P1251, DOI 10.1126/science.1105606; HARREVELT RV, 2001, J CHEM PHYS, V114, P9453; HORANYI M, 1992, ICARUS, V97, P248, DOI 10.1016/0019-1035(92)90131-P; Juhasz A, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000182; Jurac S, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010635; Jurac S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015855; Jurac S, 2001, ICARUS, V149, P384, DOI 10.1006/icar.2000.6528; Nicholson PD, 1996, SCIENCE, V272, P509, DOI 10.1126/science.272.5261.509; Saur J, 2005, ASTROPHYS J, V620, pL115, DOI 10.1086/428665; SHEMANSKY D, 2004, M COMM SPAC RES PAR; SHEMANSKY DE, 1993, NATURE, V363, P329, DOI 10.1038/363329a0; SHOWALTER MR, 1991, ICARUS, V94, P451, DOI 10.1016/0019-1035(91)90241-K; SMITH BA, 1982, SCIENCE, V215, P504, DOI 10.1126/science.215.4532.504; SMITH GR, 1990, REV GEOPHYS, V28, P117, DOI 10.1029/RG028i002p00117; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Terrile R.J., 1981, LUNAR PLANET SCI SA, V428, P10; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290	22	389	392	5	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2006	311	5766					1422	1425		10.1126/science.1121254	http://dx.doi.org/10.1126/science.1121254			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527971				2022-12-24	WOS:000236029400037
J	Jones, GH; Roussos, E; Krupp, N; Paranicas, C; Woch, J; Lagg, A; Mitchell, DG; Krimigis, SM; Dougherty, MK				Jones, GH; Roussos, E; Krupp, N; Paranicas, C; Woch, J; Lagg, A; Mitchell, DG; Krimigis, SM; Dougherty, MK			Enceladus' varying imprint on the magnetosphere of Saturn	SCIENCE			English	Article							E-RING; MICROSIGNATURES; ORBIT; ABSORPTION; PARTICLES; PROTONS; TETHYS; MODEL; MIMI		Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2BW, England	Max Planck Society; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Imperial College London	Jones, GH (corresponding author), Max Planck Inst Sonnensyst Forsch, Max Planck Str 2, D-37191 Katlenburg Lindau, Germany.	jones@mps.mpg.de	Roussos, Elias/H-2249-2011; Paranicas, Christopher/B-1470-2016; Jones, Geraint H./C-1682-2008; Krimigis, Stamatios/G-4591-2019; Mitchell, Donald G/H-4601-2016; Korpi-Lagg, Andreas/W-8166-2019	Paranicas, Christopher/0000-0002-4391-8255; Jones, Geraint H./0000-0002-5859-1136; Krimigis, Stamatios/0000-0003-2781-2386; Mitchell, Donald G/0000-0003-1960-2119; Korpi-Lagg, Andreas/0000-0003-1459-7074; Roussos, Elias/0000-0002-5699-0678	STFC [PP/D000912/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D000912/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		BRIDGE HS, 1981, SCIENCE, V212, P217, DOI 10.1126/science.212.4491.217; Brown RH, 2006, SCIENCE, V311, P1425, DOI 10.1126/science.1121031; CARBARY JF, 1983, J GEOPHYS RES-SPACE, V88, P8947, DOI 10.1029/JA088iA11p08947; Dougherty MK, 2006, SCIENCE, V311, P1406, DOI 10.1126/science.1120985; Esposito LW, 2005, SCIENCE, V307, P1251, DOI 10.1126/science.1105606; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; Jurac S, 2001, ICARUS, V149, P384, DOI 10.1006/icar.2000.6528; Krimigis SM, 2004, SPACE SCI REV, V114, P233, DOI 10.1007/s11214-004-1410-8; Krimigis SM, 2005, SCIENCE, V307, P1270, DOI 10.1126/science.1105978; Mauk BH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022485; Paranicas C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024072; Paranicas C, 2000, J GEOPHYS RES-SPACE, V105, P16005, DOI 10.1029/1999JA000350; Paranicas C, 1997, ICARUS, V125, P380, DOI 10.1006/icar.1996.5635; Roddier C, 1998, ICARUS, V136, P50, DOI 10.1006/icar.1998.6014; Roussos E, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024084; Saur J, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010207; Spahn F, 2006, SCIENCE, V311, P1416, DOI 10.1126/science.1121375; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; THOMSEN MF, 1979, GEOPHYS RES LETT, V6, P893, DOI 10.1029/GL006i011p00893; THOMSEN MF, 1980, J GEOPHYS RES-SPACE, V85, P5831, DOI 10.1029/JA085iA11p05831; Tokar RL, 2006, SCIENCE, V311, P1409, DOI 10.1126/science.1121061; VANALLEN JA, 1980, J GEOPHYS RES-SPACE, V85, P5709, DOI 10.1029/JA085iA11p05709; VANALLEN JA, 1983, J GEOPHYS RES-SPACE, V88, P6911, DOI 10.1029/JA088iA09p06911	23	53	53	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2006	311	5766					1412	1415		10.1126/science.1121011	http://dx.doi.org/10.1126/science.1121011			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527968				2022-12-24	WOS:000236029400034
J	Kumagai, A; Lee, J; Yoo, HY; Dunphy, WG				Kumagai, A; Lee, J; Yoo, HY; Dunphy, WG			TopBP1 activates the ATR-ATRIP complex	CELL			English	Article							DNA-REPLICATION CHECKPOINT; XENOPUS EGG EXTRACTS; CELL-CYCLE CHECKPOINT; II-BINDING-PROTEIN; SINGLE-STRANDED-DNA; DEPENDENT CHECKPOINT; DAMAGE CHECKPOINT; KINASE-ACTIVITIES; POLYMERASE-ALPHA; HUMAN CLASPIN	ATR is a key regulator of checkpoint responses to incompletely replicated and damaged DNA, but the mechanisms underlying control of its kinase activity are unknown. TopBP1, the vertebrate homolog of yeast Cut5/Dbp11, has dual roles in initiation of DNA replication and regulation of checkpoint responses. We show that recombinant TopBP1 induces a large increase in the kinase activity of both Xenopus and human ATR. The ATR-activating domain resides in a conserved segment of TopBP1 that is distinct from its numerous BRCT repeats. The isolated ATR-activating domain from TopBP1 induces ectopic activation of ATR-dependent signaling in both Xenopus egg extracts and human cells. Furthermore, Xenopus egg extracts containing a version of TopBP1 with an inactivating point mutation in the ATR-activating domain are defective in checkpoint regulation. These studies establish that activation of ATR by TopBP1 is a crucial step in the initiation of ATR-dependent signaling processes.	CALTECH, Div Biol 21 76, Pasadena, CA 91125 USA	California Institute of Technology	Dunphy, WG (corresponding author), CALTECH, Div Biol 21 76, Pasadena, CA 91125 USA.	dunphy@cco.caltech.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043974, R01GM043974, R01GM070891] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM070891, GM043974] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Ball HL, 2005, J BIOL CHEM, V280, P31390, DOI 10.1074/jbc.M504961200; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Canman CE, 2003, CURR BIOL, V13, pR488, DOI 10.1016/S0960-9822(03)00410-X; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; CONSTANZO V, 2003, MOL CELL, V11, P203; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Hashimoto Y, 2003, EMBO J, V22, P2526, DOI 10.1093/emboj/cdg238; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; Holway AH, 2005, GENETICS, V169, P1451, DOI 10.1534/genetics.104.036137; Honda Y, 2002, J BIOL CHEM, V277, P3599, DOI 10.1074/jbc.M104347200; Itakura E, 2005, MOL BIOL CELL, V16, P5551, DOI 10.1091/mbc.E05-05-0427; Kim SM, 2005, J BIOL CHEM, V280, P38355, DOI 10.1074/jbc.M508673200; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2004, J BIOL CHEM, V279, P49599, DOI 10.1074/jbc.M408353200; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; Lee J, 2005, MOL BIOL CELL, V16, P5269, DOI 10.1091/mbc.E05-07-0671; Lee J, 2003, MOL CELL, V11, P329, DOI 10.1016/S1097-2765(03)00045-5; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Liu QH, 2000, GENE DEV, V14, P1448; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Parrilla-Castellar E, 2003, J BIOL CHEM, V278, P45507, DOI 10.1074/jbc.C300418200; Perera D, 2004, MOL BIOL CELL, V15, P1568, DOI 10.1091/mbc.E03-06-0444; SAKA Y, 1993, CELL, V74, P383, DOI 10.1016/0092-8674(93)90428-S; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarkaria JN, 1999, CANCER RES, V59, P4375; Stokes MP, 2002, J CELL BIOL, V158, P863, DOI 10.1083/jcb.200204127; Unsal-Kacmaz K, 2004, MOL CELL BIOL, V24, P1292, DOI 10.1128/MCB.24.3.1292-1300.2003; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; Van Hatten RA, 2002, J CELL BIOL, V159, P541, DOI 10.1083/jcb.200207090; Yamane K, 1997, EUR J BIOCHEM, V250, P794, DOI 10.1111/j.1432-1033.1997.00794.x; Yamane K, 1999, ONCOGENE, V18, P5194, DOI 10.1038/sj.onc.1202922; Yamane K, 2003, CANCER RES, V63, P3049; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; Yoo HY, 2004, J BIOL CHEM, V279, P53353, DOI 10.1074/jbc.M408026200; You ZZ, 2002, J BIOL CHEM, V277, P27088, DOI 10.1074/jbc.M204120200; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	53	554	565	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					943	955		10.1016/j.cell.2005.12.041	http://dx.doi.org/10.1016/j.cell.2005.12.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530042	Bronze			2022-12-24	WOS:000237241200017
J	Johnson, DC				Johnson, DC			Clinical implications of basic research: Silencing herpes simplex virus with a vaginal microbicide	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Oregon Hlth Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	Oregon Health & Science University	Johnson, DC (corresponding author), Oregon Hlth Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.							Leung RKM, 2005, PHARMACOL THERAPEUT, V107, P222, DOI 10.1016/j.pharmthera.2005.03.004; Lu PY, 2005, ADV GENET, V54, P117, DOI 10.1016/S0065-2660(05)54006-9; Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263	3	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2006	354	9					970	971		10.1056/NEJMcibr055613	http://dx.doi.org/10.1056/NEJMcibr055613			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017FN	16510753				2022-12-24	WOS:000235679600013
J	Waters, A				Waters, A			Malaria: New vaccines for old?	CELL			English	Editorial Material							PLASMODIUM-FALCIPARUM; LIFE-CYCLE; PROTEINS; SURFACE; SPOROZOITES; ANTIGEN	Detailed analyses of the 5500 genes revealed by the complete Plasmodium genome sequence are yielding new candidate parasite antigens and strategies that may contribute to a successful vaccine against malaria in the coming decade.	Leiden Univ, Ctr Med, Dept Parasitol, NL-2333 ZA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Waters, A (corresponding author), Leiden Univ, Ctr Med, Dept Parasitol, NL-2333 ZA Leiden, Netherlands.	waters@lumc.nl	Waters, Andy P/C-9377-2009	Waters, Andy P/0000-0001-8900-2982				Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; CHOEN S, 1970, NATURE, V225, P732, DOI 10.1038/225732a0; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Graves P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000129.pub2; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Kariu T, 2002, J EXP MED, V195, P1317, DOI 10.1084/jem.20011876; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Sam-Yellowe TY, 2004, GENOME RES, V14, P1052, DOI 10.1101/gr.2126104; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Targett GA, 2005, TRENDS PARASITOL, V21, P499, DOI 10.1016/j.pt.2005.08.018; Tomas AM, 2001, EMBO J, V20, P3975, DOI 10.1093/emboj/20.15.3975; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; Vincensini L, 2005, MOL CELL PROTEOMICS, V4, P582, DOI 10.1074/mcp.M400176-MCP200	21	15	21	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 24	2006	124	4					689	693		10.1016/j.cell.2006.02.011	http://dx.doi.org/10.1016/j.cell.2006.02.011			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RO	16497579	Bronze			2022-12-24	WOS:000237240900012
J	Delsuc, F; Brinkmann, H; Chourrout, D; Philippe, H				Delsuc, F; Brinkmann, H; Chourrout, D; Philippe, H			Tunicates and not cephalochordates are the closest living relatives of vertebrates	NATURE			English	Article							PHYLOGENETIC ANALYSIS; MITOCHONDRIAL GENOME; MAXIMUM-LIKELIHOOD; OIKOPLEURA-DIOICA; NEURAL CREST; DEUTEROSTOME; TREE; AMPHIOXUS; EVOLUTION; ANIMALS	Tunicates or urochordates (appendicularians, salps and sea squirts), cephalochordates (lancelets) and vertebrates (including lamprey and hagfish) constitute the three extant groups of chordate animals. Traditionally, cephalochordates are considered as the closest living relatives of vertebrates, with tunicates representing the earliest chordate lineage(1,2). This view is mainly justified by overall morphological similarities and an apparently increased complexity in cephalochordates and vertebrates relative to tunicates(2). Despite their critical importance for understanding the origins of vertebrates(3), phylogenetic studies of chordate relationships have provided equivocal results(4-7). Taking advantage of the genome sequencing of the appendicularian Oikopleura dioica, we assembled a phylogenomic data set of 146 nuclear genes (33,800 unambiguously aligned amino acids) from 14 deuterostomes and 24 other slowly evolving species as an outgroup. Here we show that phylogenetic analyses of this data set provide compelling evidence that tunicates, and not cephalochordates, represent the closest living relatives of vertebrates. Chordate monophyly remains uncertain because cephalochordates, albeit with a non-significant statistical support, surprisingly grouped with echinoderms, a hypothesis that needs to be tested with additional data. This new phylogenetic scheme prompts a reappraisal of both morphological and palaeontological data and has important implications for the interpretation of developmental and genomic studies in which tunicates and cephalochordates are used as model animals.	Univ Montreal, Ctr Robert Cedergren, Dept Biochim, Montreal, PQ H3C 3J7, Canada; Univ Bergen, Bergen High Technol Ctr, Sars Ctr Marine Mol Biol, N-5008 Bergen, Norway	Universite de Montreal; University of Bergen	Philippe, H (corresponding author), Univ Montreal, Ctr Robert Cedergren, Dept Biochim, Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	herve.philippe@umontreal.ca	Delsuc, Frederic/B-4381-2009	Delsuc, Frederic/0000-0002-6501-6287				Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Bourlat SJ, 2003, NATURE, V424, P925, DOI 10.1038/nature01851; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Edvardsen RB, 2005, CURR BIOL, V15, pR12, DOI 10.1016/j.cub.2004.12.010; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Felsenstein J., 2004, INFERRING PHYLOGENIE; Gee H, 2001, SYST ASSOC SPEC VOL, V61, P1; Gee H., 1996, BACKBONE VIEWS ORIGI; Holland LZ, 2004, CELL MOL LIFE SCI, V61, P2290, DOI 10.1007/s00018-004-4075-2; Jefferies R.P.S., 1986, ANCESTRY VERTEBRATES; JEFFERIES RPS, 1991, CIBA F SYMP, V162, P94; Jefferies RPS, 1997, LETHAIA, V30, P1; Jeffery WR, 2004, NATURE, V431, P696, DOI 10.1038/nature02975; Morris SC, 2000, P NATL ACAD SCI USA, V97, P4426, DOI 10.1073/pnas.97.9.4426; Oda H, 2004, J CELL SCI, V117, P2757, DOI 10.1242/jcs.01045; PETERSON KJ, 1995, LETHAIA, V28, P25, DOI 10.1111/j.1502-3931.1995.tb01591.x; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Rowe T, 2004, ASSEMBLING THE TREE OF LIFE, P384; Ruiz-Trillo I, 2004, MOL PHYLOGENET EVOL, V33, P321, DOI 10.1016/j.ympev.2004.06.002; Ruppert EE, 2005, CAN J ZOOL, V83, P8, DOI 10.1139/Z04-158; SCHAEFFER B, 1987, EVOL BIOL, V21, P179; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Stone JR, 2004, EVOL DEV, V6, P123, DOI 10.1111/j.1525-142X.2004.04014.x; Swofford D. L., 2000, PAUP PHYLOGENETIC AN; Winchell CJ, 2002, MOL BIOL EVOL, V19, P762, DOI 10.1093/oxfordjournals.molbev.a004134; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yokobori S, 2005, MOL PHYLOGENET EVOL, V34, P273, DOI 10.1016/j.ympev.2004.10.002; Zrzavy J, 1998, CLADISTICS, V14, P249, DOI 10.1111/j.1096-0031.1998.tb00338.x	30	1168	1207	1	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2006	439	7079					965	968		10.1038/nature04336	http://dx.doi.org/10.1038/nature04336			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014NE	16495997	Green Submitted			2022-12-24	WOS:000235486100045
J	Hayden, FG				Hayden, FG			Antiviral resistance in influenza viruses - Implications for management and pandemic response	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Virginia, Sch Med, Dept Internal Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA	University of Virginia	Hayden, FG (corresponding author), Univ Virginia, Sch Med, Dept Internal Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA.							Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; BRIGHT RA, IN PRESS JAMA; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Hayden F, 2005, ANTIVIR THER, V10, P873; Ziegler T, 1999, J INFECT DIS, V180, P935, DOI 10.1086/314994	5	139	159	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2006	354	8					785	788		10.1056/NEJMp068030	http://dx.doi.org/10.1056/NEJMp068030			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014CL	16495389				2022-12-24	WOS:000235456200001
J	van Weel, C; Schellevis, FG				van Weel, C; Schellevis, FG			Comorbidity and guidelines: conflicting interests	LANCET			English	Editorial Material							GENERAL-PRACTICE; CARE; DEPRESSION; MORBIDITY; DISEASES; QUALITY		Radboud Univ Nijmegen Med Ctr, Dept Gen Practice, NL-6500 HB Nijmegen, Netherlands; Netherlands Inst Hlth Serv Res, Utrecht, Netherlands	Radboud University Nijmegen; Netherlands Institute for Health Services Research	van Weel, C (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Gen Practice, NL-6500 HB Nijmegen, Netherlands.	c.vanweel@hag.umcn.nl	van Weel, Chris/D-4375-2009	van Weel, Chris/0000-0003-3653-4701				Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Campbell SM, 2005, BMJ-BRIT MED J, V331, P1121, DOI 10.1136/bmj.38632.611123.AE; FEINSTEIN AR, 1970, J CHRON DIS, V23, P455, DOI 10.1016/0021-9681(70)90054-8; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; GURWITZ JH, 1992, JAMA-J AM MED ASSOC, V268, P1417, DOI 10.1001/jama.1992.03490110055029; Nuyen J, 2005, PSYCHOL MED, V35, P1185, DOI 10.1017/S0033291705004812; OLSHANSKY SJ, 1986, MILBANK Q, V64, P355, DOI 10.2307/3350025; SCHELLEVIS FG, 1993, J CLIN EPIDEMIOL, V46, P469, DOI 10.1016/0895-4356(93)90024-U; SCHELLEVIS FG, 1994, BRIT J GEN PRACT, V44, P259; Starfield Barbara, 2003, Ann Fam Med, V1, P8, DOI 10.1370/afm.1; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; van Os TWDP, 2005, J AFFECT DISORDERS, V84, P43, DOI 10.1016/j.jad.2004.09.005; VANWEEL C, 1996, EUR J GEN PRACT, V2, P17; WESTERT GP, IN PRESS MORBIDITY P	14	136	150	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 18	2006	367	9510					550	551		10.1016/S0140-6736(06)68198-1	http://dx.doi.org/10.1016/S0140-6736(06)68198-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	013GM	16488782	Green Submitted			2022-12-24	WOS:000235397800007
J	Flavell, SW; Cowan, CW; Kim, TK; Greer, PL; Lin, YX; Paradis, S; Griffith, EC; Hu, LS; Chen, CF; Greenberg, ME				Flavell, SW; Cowan, CW; Kim, TK; Greer, PL; Lin, YX; Paradis, S; Griffith, EC; Hu, LS; Chen, CF; Greenberg, ME			Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number	SCIENCE			English	Article							NEURONAL-ACTIVITY; PLASTICITY; SURVIVAL	In the mammalian nervous system, neuronal activity regulates the strength and number of synapses formed. The genetic program that coordinates this process is poorly understood. We show that myocyte enhancer factor 2 (MEF2) transcription factors suppressed excitatory synapse number in a neuronal activity- and calcineurin-dependent manner as hippocampal neurons formed synapses. In response to increased neuronal activity, calcium influx into neurons induced the activation of the calcium/calmodulin-regulated phosphatase calcineurin, which dephosphorylated and activated MEF2. When activated, MEF2 promoted the transcription of a set of genes, including arc and synGAP, that restrict synapse number. These findings define an activity-dependent transcriptional program that may control synapse number during development.	Harvard Univ, Sch Med, Childrens Hosp, Neurobiol Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Neurobiol Program, 300 Longwood Ave, Boston, MA 02115 USA.	michael.greenberg@childrens.harvard.edu	Cowan, Christopher W/I-2497-2014; Kim, Tae-Kyung/AAX-4230-2020	Kim, Tae-Kyung/0000-0001-5161-9864; /0000-0002-7002-1275; Griffith, Eric/0000-0003-0428-3215; Flavell, Steven/0000-0001-9464-1877	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028829, R01NS028829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG005870] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY013613] Funding Source: Medline; NIA NIH HHS [AG05870] Funding Source: Medline; NICHD NIH HHS [HD18655] Funding Source: Medline; NINDS NIH HHS [NS28829] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Shalizi A, 2003, J NEUROSCI, V23, P7326; SHEPHERD JD, 2004, 2004 ABSTRACT VIEWER; Vazquez LE, 2004, J NEUROSCI, V24, P8862, DOI 10.1523/JNEUROSCI.3213-04.2004; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	17	423	439	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2006	311	5763					1008	1012		10.1126/science.1122511	http://dx.doi.org/10.1126/science.1122511			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014CS	16484497				2022-12-24	WOS:000235456900048
J	Gehring, M; Huh, JH; Hsieh, TF; Penterman, J; Choi, Y; Harada, JJ; Goldberg, RB; Fischer, RL				Gehring, M; Huh, JH; Hsieh, TF; Penterman, J; Choi, Y; Harada, JJ; Goldberg, RB; Fischer, RL			DEMETER DNA glycosylase establishes MEDEA polycomb gene self-imprinting by allele-specific demethylation	CELL			English	Article							REPRESSIVE HISTONE METHYLATION; SEED DEVELOPMENT; ARABIDOPSIS-THALIANA; ESCHERICHIA-COLI; METHYLTRANSFERASE ACTIVITY; ENDOSPERM DEVELOPMENT; PROTEIN; FERTILIZATION; EXPRESSION; COMPLEX	MEDEA (MEA) is an Arabidopsis Polycomb group gene that is imprinted in the endosperm. The maternal allele is expressed and the paternal allele is silent. MEA is controlled by DEMETER (DME), a DNA glycosylase required to activate MEA expression, and METHYLTRANSFERASE I (MET1), which maintains CG methylation at the MEA locus. Here we show that DME is responsible for endosperm maternal-allele-specific hypomethylation at the MEA gene. DME can excise 5-methylcytosine in vitro and when expressed in E coli. Abasic sites opposite 5-methylcytosine inhibit DME activity and might prevent DME from generating double-stranded DNA breaks. Unexpectedly, paternal-allele silencing is not controlled by DNA methylation. Rather, Polycomb group proteins that are expressed from the maternal genome, including MEA, control paternal MEA silencing. Thus, DME establishes MEA imprinting by removing 5-methylcytosine to activate the maternal allele. MEA imprinting is subsequently maintained in the endosperm by maternal MEA silencing the paternal allele.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Calif Davis, Div Biol Sci, Plant Biol Sect, Davis, CA 95616 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California Los Angeles	Gehring, M (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	rfischer@berkeley.edu		Hsieh, Tzung-Fu/0000-0001-7584-3721	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069415] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM069415, R01 GM069415] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; Bhagwat M, 1996, BIOCHEMISTRY-US, V35, P659, DOI 10.1021/bi9522662; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Choi Y, 2004, P NATL ACAD SCI USA, V101, P7481, DOI 10.1073/pnas.0402328101; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Constancia M, 2004, NATURE, V432, P53, DOI 10.1038/432053a; CUNNINGHAM RP, 1986, J BACTERIOL, V168, P1120, DOI 10.1128/jb.168.3.1120-1127.1986; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; David-Cordonnier MH, 2001, BIOCHEMISTRY-US, V40, P11811, DOI 10.1021/bi0112356; Delaval K, 2004, CURR OPIN GENET DEV, V14, P188, DOI 10.1016/j.gde.2004.01.005; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Gehring M, 2004, PLANT CELL, V16, pS203, DOI 10.1105/tpc.017988; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Hanai R, 1998, INT J RADIAT BIOL, V73, P475, DOI 10.1080/095530098142013; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kapitonov VV, 2001, P NATL ACAD SCI USA, V98, P8714, DOI 10.1073/pnas.151269298; Kinoshita T, 1999, PLANT CELL, V11, P1945, DOI 10.1105/tpc.11.10.1945; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Kiyosue T, 1999, P NATL ACAD SCI USA, V96, P4186, DOI 10.1073/pnas.96.7.4186; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; Kohler C, 2003, GENE DEV, V17, P1540, DOI 10.1101/gad.257403; Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Luo M, 1999, P NATL ACAD SCI USA, V96, P296, DOI 10.1073/pnas.96.1.296; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Norman DPG, 2003, BIOCHEMISTRY-US, V42, P1564, DOI 10.1021/bi026823d; O'Neill MJ, 2005, HUM MOL GENET, V14, pR113, DOI 10.1093/hmg/ddi108; Ohad N, 1999, PLANT CELL, V11, P407, DOI 10.1105/tpc.11.3.407; PALMER BR, 1994, GENE, V143, P1, DOI 10.1016/0378-1119(94)90597-5; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Scharer OD, 2001, BIOESSAYS, V23, P270, DOI 10.1002/1521-1878(200103)23:3<270::AID-BIES1037>3.0.CO;2-J; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Weinfeld M, 2001, RADIAT RES, V156, P584, DOI 10.1667/0033-7587(2001)156[0584:ROBERE]2.0.CO;2; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7	43	502	537	3	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 10	2006	124	3					495	506		10.1016/j.cell.2005.12.034	http://dx.doi.org/10.1016/j.cell.2005.12.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	014FG	16469697	Green Accepted, Bronze			2022-12-24	WOS:000235464000013
J	Lynch, JA; Brent, AE; Leaf, DS; Pultz, MA; Desplan, C				Lynch, JA; Brent, AE; Leaf, DS; Pultz, MA; Desplan, C			Localized maternal orthodenticle patterns anterior and posterior in the long germ wasp Nasonia	NATURE			English	Article							SEGMENTATION GENE HUNCHBACK; DROSOPHILA EMBRYOS; BEETLE TRIBOLIUM; EXPRESSION; VITRIPENNIS; PROTEINS; GRADIENT; AXIS	The Bicoid (Bcd) gradient in Drosophila has long been a model for the action of a morphogen in establishing embryonic polarity(1). However, it is now clear that bcd is a unique feature of higher Diptera(2,3). An evolutionarily ancient gene, orthodenticle (otd), has a bcd-like role in the beetle Tribolium(4). Unlike the Bcd gradient, which arises by diffusion of protein from an anteriorly localized messenger RNA(1,5), the Tribolium Otd gradient forms by translational repression of otd mRNA by a posteriorly localized factor. These differences in gradient formation are correlated with differences in modes of embryonic patterning. Drosophila uses long germ embryogenesis, where the embryo derives from the entire anterior - posterior axis, and all segments are patterned at the blastoderm stage, before gastrulation. In contrast, Tribolium undergoes short germ embryogenesis: the embryo arises from cells in the posterior of the egg, and only anterior segments are patterned at the blastoderm stage, with the remaining segments arising after gastrulation from a growth zone. Here we describe the role of otd in the long germband embryo of the wasp Nasonia vitripennis. We show that Nasonia otd maternal mRNA is localized at both poles of the embryo, and resulting protein gradients pattern both poles. Thus, localized Nasonia otd has two major roles that allow long germ development. It activates anterior targets at the anterior of the egg in a manner reminiscent of the Bcd gradient, and it is required for pre-gastrulation expression of posterior gap genes.	NYU Biol, Ctr Dev Genet, New York, NY 10003 USA; Western Washington Univ, Bellingham, WA 98225 USA	New York University; Western Washington University	Desplan, C (corresponding author), NYU Biol, Ctr Dev Genet, 100 Washington Sq E, New York, NY 10003 USA.	cd38@nyu.edu		Desplan, Claude/0000-0002-6914-1413				BENDER M, 1988, DEV GENET, V9, P715, DOI 10.1002/dvg.1020090604; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; DALTON D, 1989, GENE DEV, V3, P1940, DOI 10.1101/gad.3.12a.1940; Dearden P, 1999, CURR BIOL, V9, pR591, DOI 10.1016/S0960-9822(99)80381-9; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; Goltsev Y, 2004, DEV BIOL, V275, P435, DOI 10.1016/j.ydbio.2004.08.021; KRAFT R, 1994, P NATL ACAD SCI USA, V91, P6634, DOI 10.1073/pnas.91.14.6634; LaRosee A, 1997, EMBO J, V16, P4403, DOI 10.1093/emboj/16.14.4403; Li YB, 1996, DEV GENES EVOL, V206, P35, DOI 10.1007/s004270050028; MARGOLIS JS, 1995, DEVELOPMENT, V121, P3067; PATEL NH, 1994, NATURE, V367, P429, DOI 10.1038/367429a0; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Pultz MA, 1999, DEVELOPMENT, V126, P701; Pultz MA, 2005, DEVELOPMENT, V132, P3705, DOI 10.1242/dev.01939; Pultz MA, 2000, GENETICS, V154, P1213; RIVERAPOMAR R, 1995, NATURE, V376, P253, DOI 10.1038/376253a0; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; Schroder R, 2003, NATURE, V422, P621, DOI 10.1038/nature01536; SIMPSONBROSE M, 1994, CELL, V78, P855, DOI 10.1016/S0092-8674(94)90622-X; Stauber M, 2002, P NATL ACAD SCI USA, V99, P274, DOI 10.1073/pnas.012292899; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; TAUTZ D, 1988, NATURE, V332, P281, DOI 10.1038/332281a0; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TREISMAN J, 1989, CELL, V59, P553; van der Zee M, 2005, CURR BIOL, V15, P624, DOI 10.1016/j.cub.2005.02.057; Wimmer EA, 2000, SCIENCE, V287, P2476, DOI 10.1126/science.287.5462.2476; Wolff C, 1995, DEVELOPMENT, V121, P4227	27	137	141	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2006	439	7077					728	732		10.1038/nature04445	http://dx.doi.org/10.1038/nature04445			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	010KH	16467838				2022-12-24	WOS:000235193100045
J	Hackam, DG; Mamdani, M; Li, P; Redelmeier, DA				Hackam, DG; Mamdani, M; Li, P; Redelmeier, DA			Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis	LANCET			English	Article							HEALTH-CARE PROFESSIONALS; ENDOTHELIAL-CELLS; IMPROVES SURVIVAL; ELDERLY-PATIENTS; CODING ACCURACY; INSULIN THERAPY; UNITED-STATES; MURINE MODEL; SIMVASTATIN; EPIDEMIOLOGY	Background Atherosclerosis and sepsis share several pathophysiological similarities, including immune dysregulation, increased thrombogenesis, and systemic inflammation. The relation between statins and risk of sepsis in patients with atherosclerosis is unknown. Methods We did a population-based cohort analysis through linked administrative databases in Ontario, Canada, with accrual from 1997 to 2002. We identified 141487 patients older than 65 years who had been hospitalised for an acute coronary syndrome, ischaemic stroke, or revascularisation, who survived for at least 3 months after discharge. 46 662 (33%) were prescribed a statin within 90 days of discharge, 94 825 (67%) were not. Propensity-based matching, which accounted for each individual's likelihood of receiving a statin, yielded a cohort of 69 168 patients, of whom half (34 584) received a statin and half (34 584) did not. Findings Incidence of sepsis was lower in patients receiving statins than in controls (71.2 vs 88.0 events per 10 000 person-years; hazard ratio [HR] 0.81; 95% CI 0.72-0.91). Adjustment for demographic characteristics, sepsis risk factors, comorbidities, and health-care use gave similar results (HR 0.81; 95% CI 0.72-0.90). The protective association between statins and sepsis persisted in high-risk subgroups, including patients with diabetes mellitus, chronic renal failure, or a history of infections. Significant reductions in severe sepsis (HR 0.83; 95% CI 0.70-0.97) and fatal sepsis (0.75; 0.61-0.93) were also observed. No benefit was noted with non-statin lipid-lowering agents (0.95; 0.75-1.22). Implications Use of stating in patients with atherosclerosis is associated with a reduced risk of subsequent sepsis. Randomised trials of statins for prevention of sepsis are warranted.	Sunnybrook & Womens Coll Hlth Sci Ctr, Div Gen Internal Med, Toronto, ON M4N 3M5, Canada; Sunnybrook & Womens Coll Hlth Sci Ctr, Div Clin Pharmacol & Toxicol, Toronto, ON M4N 3M5, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada; Univ Toronto, Clin Epidemiol & Hlth Care Res Program, Toronto, ON, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Fac Med, Toronto, ON, Canada; Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Hospital for Sick Children (SickKids); Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Redelmeier, DA (corresponding author), Sunnybrook & Womens Coll Hlth Sci Ctr, Div Gen Internal Med, G-151,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	clar@ices.on.ca	Hackam, Dan G/A-1143-2009					Al-Omran M, 2003, J VASC SURG, V38, P279, DOI 10.1016/S0741-5214(03)00274-X; Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Ando H, 2000, J PHARMACOL EXP THER, V294, P1043; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chan B., 1999, SUPPLY PHYS SERVICES; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061; Durant R, 2004, SHOCK, V22, P34, DOI 10.1097/01.shk.0000129197.46212.7e; Eaton S, 2002, AM J RESP CRIT CARE, V165, pA471; Ely EW, 2003, CRIT CARE MED, V31, P12, DOI 10.1097/00003246-200301000-00002; Fodor JG, 2000, CAN MED ASSOC J, V162, P1441; Giusti-Paiva A, 2004, SHOCK, V21, P271, DOI 10.1097/10.shk.0000115756.74059.ce; Halcox JPJ, 2004, CIRCULATION, V109, P42, DOI 10.1161/01.CIR.0000129500.29229.92; Humphries KH, 2000, J CLIN EPIDEMIOL, V53, P343, DOI 10.1016/S0895-4356(99)00188-2; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Kothe H, 2000, CIRCULATION, V101, P1760, DOI 10.1161/01.CIR.101.15.1760; Landmesser U, 2005, CIRCULATION, V111, P2356, DOI 10.1161/01.CIR.0000164260.82417.3F; LATIES AM, 1991, AM J CARDIOL, V67, P447, DOI 10.1016/0002-9149(91)90002-3; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Levy AR, 1999, CAN J CARDIOL, V15, P1277; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Mamdani M, 2004, LANCET, V363, P1751, DOI 10.1016/S0140-6736(04)16299-5; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mayo N E, 1994, Health Rep, V6, P62; McCarey DW, 2004, LANCET, V363, P2015, DOI 10.1016/S0140-6736(04)16449-0; Merx MW, 2005, CIRCULATION, V112, P117, DOI 10.1161/CIRCULATIONAHA.104.502195; Merx MW, 2004, CIRCULATION, V109, P2560, DOI 10.1161/01.CIR.0000129774.09737.5B; Naylor CD, 1999, CARDIOVASCULAR HLTH; Ollendorf DA, 2002, VALUE HEALTH, V5, P79, DOI 10.1046/j.1524-4733.2002.52013.x; Pittas AG, 2004, ARCH INTERN MED, V164, P2005, DOI 10.1001/archinte.164.18.2005; Pleiner J, 2004, CIRCULATION, V110, P3349, DOI 10.1161/01.CIR.0000147774.90396.ED; Pruefer D, 2002, CIRCULATION, V106, P2104, DOI 10.1161/01.CIR.0000034048.38910.91; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Sakabe K, 2004, AM J CARDIOL, V94, P497, DOI 10.1016/j.amjcard.2004.04.067; Schlienger RG, 2001, ARCH INTERN MED, V161, P2021, DOI 10.1001/archinte.161.16.2021; Shi JM, 2003, BLOOD COAGUL FIBRIN, V14, P575, DOI 10.1097/00001721-200309000-00010; Smith SC, 2001, CIRCULATION, V104, P1577, DOI 10.1161/hc3801.097475; Song JL, 2003, MED MYCOL, V41, P417, DOI 10.1080/1369378031000137233; Steiner S, 2005, CIRCULATION, V111, P1841, DOI 10.1161/01.CIR.0000158665.27783.0C; Sundararajan V, 2005, CRIT CARE MED, V33, P71, DOI 10.1097/01.CCM.0000150027.98160.80; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vollmer T, 2004, LANCET, V363, P1607, DOI 10.1016/S0140-6736(04)16205-3; Wolf PA, 1999, STROKE, V30, P1991, DOI 10.1161/01.STR.30.9.1991	49	222	238	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2006	367	9508					413	418		10.1016/S0140-6736(06)68041-0	http://dx.doi.org/10.1016/S0140-6736(06)68041-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	009UR	16458766				2022-12-24	WOS:000235139400031
J	Hoshino, K; Sugiyama, T; Matsumoto, M; Tanaka, T; Saito, M; Hemmi, H; Ohara, O; Akira, S; Kaisho, T				Hoshino, K; Sugiyama, T; Matsumoto, M; Tanaka, T; Saito, M; Hemmi, H; Ohara, O; Akira, S; Kaisho, T			I kappa B kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9	NATURE			English	Article							TOLL-LIKE RECEPTORS; PLASMACYTOID DENDRITIC CELLS; IKK-ALPHA; ANTIVIRAL RESPONSE; VIRAL-INFECTION; MICE LACKING; IFN-ALPHA; ACTIVATION; INDUCTION; IMMUNITY	The Toll-like receptor (TLR) family has important roles in microbial recognition and dendritic cell activation(1,2). TLRs 7 and 9 can recognize nucleic acids(3-6) and trigger signalling cascades that activate plasmacytoid dendritic cells to produce interferon-alpha (IFN-alpha) (refs 7, 8). TLR7/9-mediated dendritic cell activation is critical for antiviral immunity but also contributes to the pathogenesis of systemic lupus erythematosus, a disease in which serum IFN-alpha levels are elevated owing to plasmacytoid dendritic cell activation(8,9). TLR7/9-induced IFN-alpha induction depends on a molecular complex that contains a TLR adaptor, MyD88, and IFN regulatory factor 7 (IRF-7) (refs 10-14), but the underlying molecular mechanisms are as yet unknown. Here we show that I kappa B kinase-alpha (IKK-alpha) is critically involved in TLR7/9-induced IFN-alpha production. TLR7/9-induced IFN-alpha production was severely impaired in IKK-alpha-deficient plasmacytoid dendritic cells, whereas inflammatory cytokine induction was decreased but still occurred. Kinase-deficient IKK-alpha inhibited the ability of MyD88 to activate the Ifna promoter in synergy with IRF-7. Furthermore, IKK-alpha associated with and phosphorylated IRF-7. Our results identify a role for IKK-alpha in TLR7/9 signalling, and highlight IKK-alpha as a potential target for manipulating TLR-induced IFN-alpha production.	RIKEN, Res Ctr Allergy & Immunol, Host Def Lab, Tsurumi Ku, Kanagawa 2300045, Japan; RIKEN, Res Ctr Allergy & Immunol, Lab Immunogenom, Tsurumi Ku, Kanagawa 2300045, Japan; Univ Tokushima, Div Mol Immunol, Inst Enzyme Res, Tokushima 7708503, Japan; Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan; ERATO, Japan Sci & Technol Agcy, Suita, Osaka 5650871, Japan; Kazusa DNA Res Inst, Chiba 2920818, Japan	RIKEN; RIKEN; Tokushima University; Japan Science & Technology Agency (JST); Kazusa DNA Research Institute	Kaisho, T (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Host Def Lab, Tsurumi Ku, Suehirocho 1-7-22, Kanagawa 2300045, Japan.	tkaisho@rcai.riken.jp	Tanaka, Takashi/O-8254-2015; Kaisho, Tsuneyasu/B-4130-2012; Ohara, Osamu/G-5448-2015; Hoshino, Katsuaki/AAE-2830-2022; Ohara, Osamu/A-9119-2012; Akira, Shizuo/C-3134-2009; Hoshino, Katsuaki/L-9162-2014	Ohara, Osamu/0000-0002-3328-9571; Hoshino, Katsuaki/0000-0003-0493-4815; Hoshino, Katsuaki/0000-0003-0493-4815				Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Verthelyi D, 2001, J IMMUNOL, V166, P2372, DOI 10.4049/jimmunol.166.4.2372; Wagner H, 2004, TRENDS IMMUNOL, V25, P381, DOI 10.1016/j.it.2004.04.011	30	277	296	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					949	953		10.1038/nature04641	http://dx.doi.org/10.1038/nature04641			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612387				2022-12-24	WOS:000236736700044
J	Houstis, N; Rosen, ED; Lander, ES				Houstis, N; Rosen, ED; Lander, ES			Reactive oxygen species have a causal role in multiple forms of insulin resistance	NATURE			English	Article							NECROSIS-FACTOR-ALPHA; OXIDATIVE STRESS; TNF-ALPHA; GLUT4 TRANSLOCATION; METABOLIC SYNDROME; 3T3-L1 ADIPOCYTES; OBESITY; JNK; EXPRESSION; PREGNANCY	Insulin resistance is a cardinal feature of type 2 diabetes and is characteristic of a wide range of other clinical and experimental settings. Little is known about why insulin resistance occurs in so many contexts. Do the various insults that trigger insulin resistance act through a common mechanism? Or, as has been suggested(1), do they use distinct cellular pathways? Here we report a genomic analysis of two cellular models of insulin resistance, one induced by treatment with the cytokine tumour-necrosis factor-alpha and the other with the glucocorticoid dexamethasone. Gene expression analysis suggests that reactive oxygen species (ROS) levels are increased in both models, and we confirmed this through measures of cellular redox state. ROS have previously been proposed to be involved in insulin resistance, although evidence for a causal role has been scant. We tested this hypothesis in cell culture using six treatments designed to alter ROS levels, including two small molecules and four transgenes; all ameliorated insulin resistance to varying degrees. One of these treatments was tested in obese, insulin-resistant mice and was shown to improve insulin sensitivity and glucose homeostasis. Together, our findings suggest that increased ROS levels are an important trigger for insulin resistance in numerous settings.	MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Beth Israel Deaconess Med Ctr, Div Endocrinol, Dept Med, Boston, MA 02214 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Rosen, ED (corresponding author), MIT, Broad Inst, Cambridge, MA 02141 USA.	erosen@bidmc.harvard.edu; lander@broad.mit.edu						BALM PH, 2000, STREE PHYSL ANIMALS; Bujalska IJ, 1997, LANCET, V349, P1210, DOI 10.1016/S0140-6736(96)11222-8; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; HORNNES PJ, 1985, DIABETES METAB, V11, P310; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Kirwan JP, 2002, DIABETES, V51, P2207, DOI 10.2337/diabetes.51.7.2207; Kroder G, 1996, J CLIN INVEST, V97, P1471, DOI 10.1172/JCI118569; KUSUNOKI M, 1995, DIABETES, V44, P718, DOI 10.2337/diabetes.44.6.718; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; MCCALL JL, 1992, BRIT J SURG, V79, P1361, DOI 10.1002/bjs.1800791240; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; Moini H, 2002, ARCH BIOCHEM BIOPHYS, V397, P384, DOI 10.1006/abbi.2001.2680; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; STONER HB, 1983, BRIT J SURG, V70, P32, DOI 10.1002/bjs.1800700113; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Summers SA, 2005, DIABETES, V54, P591, DOI 10.2337/diabetes.54.3.591; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Urakawa H, 2003, J CLIN ENDOCR METAB, V88, P4673, DOI 10.1210/jc.2003-030202; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; VANPUTTEN JPM, 1985, DIABETOLOGIA, V28, P445, DOI 10.1007/BF00280889; VAUGHAN GM, 1982, J TRAUMA, V22, P263, DOI 10.1097/00005373-198204000-00001; Wang Minghan, 2005, Nutr Metab (Lond), V2, P3, DOI 10.1186/1743-7075-2-3; Yang SQ, 2000, ARCH BIOCHEM BIOPHYS, V378, P259, DOI 10.1006/abbi.2000.1829	30	1819	1913	3	328	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					944	948		10.1038/nature04634	http://dx.doi.org/10.1038/nature04634			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612386				2022-12-24	WOS:000236736700043
J	Ro, DK; Paradise, EM; Ouellet, M; Fisher, KJ; Newman, KL; Ndungu, JM; Ho, KA; Eachus, RA; Ham, TS; Kirby, J; Chang, MCY; Withers, ST; Shiba, Y; Sarpong, R; Keasling, JD				Ro, DK; Paradise, EM; Ouellet, M; Fisher, KJ; Newman, KL; Ndungu, JM; Ho, KA; Eachus, RA; Ham, TS; Kirby, J; Chang, MCY; Withers, ST; Shiba, Y; Sarpong, R; Keasling, JD			Production of the antimalarial drug precursor artemisinic acid in engineered yeast	NATURE			English	Article							CATALYZES 3 STEPS; GIBBERELLIN BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; EXPRESSION; MALARIA; PATHWAY; CYTOCHROME-P450; IDENTIFICATION; REDUCTASE; OXIDASE	Malaria is a global health problem that threatens 300-500 million people and kills more than one million people annually(1). Disease control is hampered by the occurrence of multi-drug-resistant strains of the malaria parasite Plasmodium falciparum(2,3). Synthetic antimalarial drugs and malarial vaccines are currently being developed, but their efficacy against malaria awaits rigorous clinical testing(4,5). Artemisinin, a sesquiterpene lactone endoperoxide extracted from Artemisia annua L (family Asteraceae; commonly known as sweet wormwood), is highly effective against multi-drug-resistant Plasmodium spp., but is in short supply and unaffordable to most malaria sufferers(6). Although total synthesis of artemisinin is difficult and costly(7), the semi-synthesis of artemisinin or any derivative from microbially sourced artemisinic acid, its immediate precursor, could be a cost-effective, environmentally friendly, high-quality and reliable source of artemisinin(8,9). Here we report the engineering of Saccharomyces cerevisiae to produce high titres (up to 100 mg l(-1)) of artemisinic acid using an engineered mevalonate pathway, amorphadiene synthase, and a novel cytochrome P450 monooxygenase (CYP71AV1) from A. annua that performs a three-step oxidation of amorpha-4,11-diene to artemisinic acid. The synthesized artemisinic acid is transported out and retained on the outside of the engineered yeast, meaning that a simple and inexpensive purification process can be used to obtain the desired product. Although the engineered yeast is already capable of producing artemisinic acid at a significantly higher specific productivity than A. annua, yield optimization and industrial scale-up will be required to raise artemisinic acid production to a level high enough to reduce artemisinin combination therapies to significantly below their current prices.	Univ Calif Berkeley, Lawrence Berkeley Lab, Calif Inst Quantitat Biomed Res, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Chem Engn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Bioengn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Ctr Synth Biol, Berkeley, CA 94720 USA; Amyris Biotechnol Inc, Emeryville, CA 94608 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Keasling, JD (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Calif Inst Quantitat Biomed Res, Berkeley, CA 94720 USA.	keasling@berkeley.edu	Ro, Dae-Kyun/G-9289-2012; Keasling, Jay D/J-9162-2012	Ro, Dae-Kyun/0000-0003-1288-5347; Keasling, Jay D/0000-0003-4170-6088; Sarpong, Richmond/0000-0002-0028-6323				ACTON N, 1992, J ORG CHEM, V57, P3610, DOI 10.1021/jo00039a020; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bertea CM, 2005, PLANTA MED, V71, P40, DOI 10.1055/s-2005-837749; Davies BSJ, 2005, MOL CELL BIOL, V25, P7375, DOI 10.1128/MCB.25.16.7375-7385.2005; Donald KAG, 1997, APPL ENVIRON MICROB, V63, P3341, DOI 10.1128/AEM.63.9.3341-3344.1997; ELMARAKBY SA, 1988, PHYTOCHEMISTRY, V27, P3089, DOI 10.1016/0031-9422(88)80006-2; Enserink M, 2005, SCIENCE, V307, P33, DOI 10.1126/science.307.5706.33; Gardner RG, 1999, J BIOL CHEM, V274, P31671, DOI 10.1074/jbc.274.44.31671; Haynes R. K., 1994, U.S. Patent, Patent No. 5310946; Helliwell CA, 1999, PLANT PHYSIOL, V119, P507, DOI 10.1104/pp.119.2.507; Helliwell CA, 2001, P NATL ACAD SCI USA, V98, P2065, DOI 10.1073/pnas.041588998; Hoffman S, 2004, NATURE, V430, P940, DOI 10.1038/430940a; Jackson BE, 2003, ORG LETT, V5, P1629, DOI 10.1021/ol034231x; Kim SU, 1996, PLANTA MED, V62, P480, DOI 10.1055/s-2006-957948; Korenromp EL, 2003, LANCET INFECT DIS, V3, P349, DOI 10.1016/S1473-3099(03)00657-1; Lupien S, 1999, ARCH BIOCHEM BIOPHYS, V368, P181, DOI 10.1006/abbi.1999.1298; Marsh K, 1998, LANCET, V352, P924, DOI 10.1016/S0140-6736(05)61510-3; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Mercke P, 2000, ARCH BIOCHEM BIOPHYS, V381, P173, DOI 10.1006/abbi.2000.1962; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Ralston L, 2001, ARCH BIOCHEM BIOPHYS, V393, P222, DOI 10.1006/abbi.2001.2483; SCHMID G, 1983, J AM CHEM SOC, V105, P624, DOI 10.1021/ja00341a054; SEAMAN FC, 1982, BOT REV, V48, P121, DOI 10.1007/BF02919190; Vennerstrom JL, 2004, NATURE, V430, P900, DOI 10.1038/nature02779; Wang EM, 2001, NAT BIOTECHNOL, V19, P371, DOI 10.1038/86770; WHO UNICEF, 2005, WORLD MALARIA REPORT	26	1802	2120	74	1388	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					940	943		10.1038/nature04640	http://dx.doi.org/10.1038/nature04640			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	031WU	16612385				2022-12-24	WOS:000236736700042
J	Walker, DH				Walker, DH			Targetting rickettsia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CONORII; PROTEIN		Univ Texas, Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston	Walker, DH (corresponding author), Univ Texas, Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77550 USA.							Feng HM, 2004, INFECT IMMUN, V72, P2222, DOI 10.1128/IAI.72.4.2222-2228.2004; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Martinez JJ, 2005, CELL, V123, P1013, DOI 10.1016/j.cell.2005.08.046; Martinez JJ, 2004, J CELL SCI, V117, P5097, DOI 10.1242/jcs.01382; Whitworth T, 2005, INFECT IMMUN, V73, P6668, DOI 10.1128/IAI.73.10.6668-6673.2005	5	10	12	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2006	354	13					1418	1420		10.1056/NEJMcibr055756	http://dx.doi.org/10.1056/NEJMcibr055756			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026KO	16571887				2022-12-24	WOS:000236338000015
J	Belmaker, I; Dukhan, L; Elgrici, M; Yosef, Y; Shahar-Rotberg, L				Belmaker, I; Dukhan, L; Elgrici, M; Yosef, Y; Shahar-Rotberg, L			Reduction of vaccine-preventable communicable diseases in a Bedouin population: summary of a community-based intervention programme	LANCET			English	Article							CHILDREN; INFANTS	Background The Bedouin Arab population of southern Israel is in transition from a semi-nomadic lifestyle to permanent settlement, with many characteristics of a third-world population. A major outbreak of measles in the winter of 1990-91, with an incidence of 415.6 per 100 000 and a case fatality rate of 2.2 % among the Bedouin, led which recommended an intervention programme. We report on the to the establishment of a national committee, effect of the programme implementation on the reduction of vaccine-preventable communicable diseases in a Bedouin Arab population. Methods We compared immunisation coverage and incidence of reportable vaccine-preventable communicable diseases before and after implementation of the intervention programme. Findings Implementation of the intervention programme was associated with a marked increase in immunisation coverage, from 53% for first measles immunisation among those born in 1988, and reaching 2 years of age in 1990 at the start of the outbreak, to 90% at age 2 years among those born in 2001. We noted a decrease in all vaccine-preventable communicable diseases, except for pertussis, during this period. Interpretation The implementation of a targeted programme to improve immunisation coverage, and other concomitant changes in health-care delivery, was temporally associated with reduction of vaccine-preventable communicable diseases in a population of Bedouin Arabs in Israel who are living in semi-nomadic conditions. The success of the programme could be applicable to semi-nomadic populations living in other areas of the middle east.	Minist Hlth, Reg Hlth Off, So Reg, Beer Sheva, Israel; Reg Minist Hlth, Dept Epidemiol Infect Dis, Beer Sheva, Israel; Reg Minist Hlth, Publ Hlth Nursing Serv, Beer Sheva, Israel		Belmaker, I (corresponding author), Minist Hlth, Reg Hlth Off, So Reg, POB 10050, Beer Sheva, Israel.	ilna.belmaker@lbr.health.gov.il						ABDULLAHI SA, MOBILE HLTH SERVICES; ABRAMSON O, 1995, ARCH PEDIAT ADOL MED, V149, P1237, DOI 10.1001/archpedi.1995.02170240055008; *AV IN, 1998, EV IMPR MAT CHILD PR; Beckerleg S., 1997, ANTHROPOL MED, V4, P273; *CENTR BUR STAT, 1992, STAT ABSTR ISR; *CENTR BUR STAT, 2004, STAT ABSTR ISR; FORMAN MR, 1990, AM J CLIN NUTR, V51, P343, DOI 10.1093/ajcn/51.3.343; GLASSBERG E, 1997, THESIS B GURION U BE; Kobayashi M, 2003, JPN J INFECT DIS, V56, P175; Manor Y, 1999, J CLIN MICROBIOL, V37, P1670, DOI 10.1128/JCM.37.6.1670-1675.1999; MARGOLIS CZ, 1991, EUR M MED SCH PAR FR; Shoham-Vardi I, 2004, PRENATAL DIAG, V24, P869, DOI 10.1002/pd.867; Shulman LM, 2000, J CLIN MICROBIOL, V38, P945, DOI 10.1128/JCM.38.3.945-952.2000; Swarzt T. A., 1993, Public Health Reviews, V21, P99; Tulchinsky Theodore H., 1992, Public Health Reviews, V20, P285; *WHO, 1983, WHO PUBL, V6; *WHO REG OFF E MED, 2005, POL ER; 1999, MMWR MORB MORTAL WKL, V48, P1057; 2000, MMWR MORB MORTAL WKL, V49, P758	19	19	19	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2006	367	9515					987	991		10.1016/S0140-6736(06)68425-0	http://dx.doi.org/10.1016/S0140-6736(06)68425-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028GE	16564360				2022-12-24	WOS:000236474200026
J	Nishio, J; Gaglia, JL; Turvey, SE; Campbell, C; Benoist, C; Mathis, D				Nishio, J; Gaglia, JL; Turvey, SE; Campbell, C; Benoist, C; Mathis, D			Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution	SCIENCE			English	Article							NOD MICE; IMMUNOTHERAPY; MOUSE	A cure for type 1 diabetes will probably require the provision or elicitation of new pancreatic islet beta cells as welt as the reestablishment of immunological tolerance. A 2003 study. reported achievement of both advances in the NOD mouse model by coupling injection of Freund's complete adjuvant with infusion of allogeneic spleen cells. it was concluded that the adjuvant eliminated anti-islet autoimmunity and the donor splenocytes differentiated into insulin-producing (presumably beta) cells, culminating in islet regeneration. Here, we provide data indicating that the recovered islets were all of host origin, reflecting that the diabetic NOD mice actually retain substantial beta cell mass, which can be rejuvenated/regenerated to reverse disease upon adjuvant-dependent dampening of autoimmunity.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Immunol & Immunogenet, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; Harvard Stem Cell Inst, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University	Benoist, C (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Immunol & Immunogenet, 1 Joslin Pl, Boston, MA 02215 USA.	cbdm@joslin.harvard.edu	Turvey, Stuart/HGV-1191-2022; Flerin, Christopher C/T-9447-2019	Flerin, Christopher C/0000-0003-1883-871X; Turvey, Stuart/0000-0003-1599-1065; Gaglia, Jason/0000-0003-2904-312X	NCI NIH HHS [T32 CA09382] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009382] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEKIERKUNST A, 1971, INFECT IMMUN, V4, P245, DOI 10.1128/IAI.4.3.245-255.1971; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; Chong AS, 2006, SCIENCE, V311, P1774, DOI 10.1126/science.1123510; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Kodama S, 2005, TRENDS MOL MED, V11, P271, DOI 10.1016/j.molmed.2005.04.004; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; NISHIO J, UNPUB; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; SHEHADEH N, 1994, LANCET, V343, P706, DOI 10.1016/S0140-6736(94)91583-0; Singh B, 1997, DIABETES METAB REV, V13, P320; Sreenan S, 1999, DIABETES, V48, P989, DOI 10.2337/diabetes.48.5.989; Suri A, 2006, SCIENCE, V311, P1778, DOI 10.1126/science.1123500; WANG T, 1992, DIABETES, V41, P114, DOI 10.2337/diabetes.41.1.114	13	93	106	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1775	1778		10.1126/science.1124004	http://dx.doi.org/10.1126/science.1124004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556845				2022-12-24	WOS:000236204300046
J	Sharma, SK; Liu, JJ				Sharma, SK; Liu, JJ			Progress of DOTS in global tuberculosis control	LANCET			English	Editorial Material									All India Inst Med Sci, Dept Med, Div Pulm & Crit Care Med, New Delhi 110029, India; Chinese Ctr Dis Control, Beijing, Peoples R China	All India Institute of Medical Sciences (AIIMS) New Delhi; Chinese Center for Disease Control & Prevention	Sharma, SK (corresponding author), All India Inst Med Sci, Dept Med, Div Pulm & Crit Care Med, New Delhi 110029, India.	sksharma@aiims.ac.in						*CENTR TB DIV, 2005, RNTCP STAT REP FRONT; Chen XY, 2004, LANCET, V364, P417; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Frieden TR, 2005, CLIN CHEST MED, V26, P197, DOI 10.1016/j.ccm.2005.02.001; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Kim JY, 2003, TUBERCULOSIS, V83, P59, DOI 10.1016/S1472-9792(02)00078-1; *MIN HLTH FAM WELF, 2005, RNTCP PERF REP; Sharma S K, 2003, J Indian Med Assoc, V101, P157; SHARMA SK, 2003, J INDIAN MED ASSOC, V101, P166; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; *UN STAT DIV, MILL IND DAT; *WHO, 2005, WHOHTMTB200549	12	24	26	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					951	952		10.1016/S0140-6736(06)68391-8	http://dx.doi.org/10.1016/S0140-6736(06)68391-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546549				2022-12-24	WOS:000236242100037
J	Ebron, VH; Yang, ZW; Seyer, DJ; Kozlov, ME; Oh, JY; Xie, H; Razal, J; Hall, LJ; Ferraris, JP; MacDiarmid, AG; Baughman, RH				Ebron, VH; Yang, ZW; Seyer, DJ; Kozlov, ME; Oh, JY; Xie, H; Razal, J; Hall, LJ; Ferraris, JP; MacDiarmid, AG; Baughman, RH			Fuel-powered artificial muscles	SCIENCE			English	Article							AUTONOMOUS MOVEMENT; CATALYTIC NANOMOTORS; STRAIN; GEL	Artificial muscles and electric motors found in autonomous robots and prosthetic limbs are typically battery-powered, which severely restricts the duration of their performance and can necessitate long inactivity during battery recharge. To help solve these problems, we demonstrated two types of artificial muscles that convert the chemical energy of high-energy-density fuels to mechanical energy. The first type stores electrical charge and uses changes in stored charge for mechanical actuation. In contrast with electrically powered electrochemical muscles, only half of the actuator cycle is electrochemical. The second type of fuel-powered muscle provides a demonstrated actuator stroke and power density comparable to those of natural skeletal muscle and generated stresses that are over a hundred times higher.	Univ Texas, Dept Chem, Richardson, TX 75083 USA; Univ Texas, NanoTech Inst, Richardson, TX 75083 USA; Pusan Natl Univ, Res Ctr Dielect & Adv Matter Phys, Pusan 609735, South Korea; Pusan Natl Univ, Dept Phys, Pusan 609735, South Korea	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; Pusan National University; Pusan National University	Baughman, RH (corresponding author), Univ Texas, Dept Chem, Richardson, TX 75083 USA.	ray.baughman@utdallas.edu	Baughman, Ray/A-8628-2018; Razal, Joselito M/E-6741-2011; Razal, Joselito M/G-7597-2011	Baughman, Ray/0000-0001-5845-5137; Razal, Joselito M/0000-0002-9758-3702				ASAKA K, 1995, POLYM J, V27, P436, DOI 10.1295/polymj.27.436; Barbir F, 1997, INT J HYDROGEN ENERG, V22, P1027, DOI 10.1016/S0360-3199(96)00175-9; Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Baughman RH, 2005, SCIENCE, V308, P63, DOI 10.1126/science.1099010; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; BAUGHMAN RH, 2003, Patent No. 6555945; Catchmark JM, 2005, SMALL, V1, P202, DOI 10.1002/smll.200400061; Fournier-Bidoz S, 2005, CHEM COMMUN, P441, DOI 10.1039/b414896g; Hara S, 2004, J MATER CHEM, V14, P1516, DOI 10.1039/b404232h; HOWARD RJ, 2005, Patent No. 20050028901; Ismagilov RF, 2002, ANGEW CHEM INT EDIT, V41, P652, DOI 10.1002/1521-3773(20020215)41:4<652::AID-ANIE652>3.0.CO;2-U; Kaneko D, 2002, J MATER CHEM, V12, P2169, DOI 10.1039/b109981g; Kline TR, 2005, ANGEW CHEM INT EDIT, V44, P744, DOI 10.1002/anie.200461890; Madden JDW, 2004, IEEE J OCEANIC ENG, V29, P706, DOI 10.1109/JOE.2004.833135; Nemat-Nasser S, 2002, J APPL PHYS, V92, P2899, DOI 10.1063/1.1495888; OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0; Paxton WF, 2004, J AM CHEM SOC, V126, P13424, DOI 10.1021/ja047697z; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; Rediniotis OK, 2002, P SOC PHOTO-OPT INS, V4698, P441, DOI 10.1117/12.475087; Schreyer HB, 2000, BIOMACROMOLECULES, V1, P642, DOI 10.1021/bm005557l; Smela E, 2003, ADV MATER, V15, P481, DOI 10.1002/adma.200390113; Weissmuller J, 2003, SCIENCE, V300, P312, DOI 10.1126/science.1081024; Zhang QM, 1998, SCIENCE, V280, P2101, DOI 10.1126/science.280.5372.2101	23	116	128	6	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1580	1583		10.1126/science.1120182	http://dx.doi.org/10.1126/science.1120182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543453				2022-12-24	WOS:000236029500037
J	Douek, DC; Kwong, PD; Nabell-, GJ				Douek, DC; Kwong, PD; Nabell-, GJ			The rational design of an AIDS vaccine	CELL			English	Editorial Material							EVOLUTIONARY	The extraordinary genetic diversity and immune evasion of human immunodeficiency virus (HIV) pose significant challenges for vaccine development. AIDS vaccine design requires a scientifically driven, rational approach that encompasses the latest advances in viral molecular genetics, structural biology, and immunology.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabell-, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, Room 4502,Bldg 40,MSC-3005,40 Convent Dr, Bethesda, MD 20892 USA.	gnabel@nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005024, Z01AI005024, Z01AI005078, ZIAAI005078] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806	5	110	122	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 24	2006	124	4					677	681		10.1016/j.cell.2006.02.005	http://dx.doi.org/10.1016/j.cell.2006.02.005			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RO	16497577	Bronze			2022-12-24	WOS:000237240900010
J	Voeltz, GK; Prinz, WA; Shibata, Y; Rist, JM; Rapoport, TA				Voeltz, GK; Prinz, WA; Shibata, Y; Rist, JM; Rapoport, TA			A class of membrane proteins shaping the tubular endoplasmic reticulum	CELL			English	Article							NOGO-A; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL DOMAINS; NEURITE OUTGROWTH; POLYPOSIS LOCUS; GENE FAMILY; INTERACTS; YEAST; IDENTIFICATION; LOCALIZATION	How is the characteristic shape of a membrane bound organelle achieved? We have used an in vitro system to address the mechanism by which the tubular network of the endoplasmic reticulum (ER) is generated and maintained. Based on the inhibitory effect of sulfhydryl reagents and antibodies, network formation in vitro requires the integral membrane protein Rtn4a/NogoA, a member of the ubiquitous reticulon family. Both in yeast and mammalian cells, the reticulons are largely restricted to the tubular ER and are excluded from the continuous sheets of the nuclear envelope and peripheral ER. Upon overexpression, the reticulons form tubular membrane structures. The reticulons interact with DP1/Yop1p, a conserved integral membrane protein that also localizes to the tubular ER. These proteins share an unusual hairpin topology in the membrane. The simultaneous absence of the reticulons and Yop1p in S. cerevisiae results in disrupted tubular ER. We propose that these "morphogenic" proteins partition into and stabilize highly curved ER membrane tubules.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Voeltz, GK (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu			Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [GM052586] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK060105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Calero M, 2001, J BIOL CHEM, V276, P12100, DOI 10.1074/jbc.M008439200; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chou T, 2001, BIOPHYS J, V80, P1075, DOI 10.1016/S0006-3495(01)76086-9; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; Du YR, 2004, J CELL SCI, V117, P2871, DOI 10.1242/jcs.01286; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Geng JM, 2005, EUKARYOT CELL, V4, P1166, DOI 10.1128/EC.4.7.1166-1174.2005; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Heidtman M, 2005, MOL BIOL CELL, V16, P1673, DOI 10.1091/mbc.E04-10-0873; Holmer L, 2001, CELL MOL LIFE SCI, V58, P1741, DOI 10.1007/PL00000813; Iwahashi J, 2003, Cell Mol Biol (Noisy-le-grand), V49 Online Pub, pOL467; Iwahashi J, 2002, BIOCHEM BIOPH RES CO, V293, P698, DOI 10.1016/S0006-291X(02)00282-6; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; Klopfenstein DR, 2001, J CELL BIOL, V153, P1287, DOI 10.1083/jcb.153.6.1287; Le Gall S, 2004, MOL BIOL CELL, V15, P447, DOI 10.1091/mbc.E03-05-0325; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Merz AJ, 2004, J CELL BIOL, V164, P195, DOI 10.1083/jcb.200310105; Oertle T, 2003, FASEB J, V17, P1238, DOI 10.1096/fj.02-1166hyp; Oertle T, 2003, J NEUROSCI, V23, P5393; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Ostermeyer AG, 2004, J CELL BIOL, V164, P69, DOI 10.1083/jcb.200303037; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Qi B, 2003, J CELL PHYSIOL, V196, P312, DOI 10.1002/jcp.10297; Rolls MM, 1999, J CELL BIOL, V146, P29, DOI 10.1083/jcb.146.1.29; SCHWEIZER A, 1995, J CELL SCI, V108, P2477; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Staehelin LA, 1997, PLANT J, V11, P1151, DOI 10.1046/j.1365-313X.1997.11061151.x; STELNER P, 2004, J NEUROCHEM, V89, P569; Tagami S, 2000, ONCOGENE, V19, P5736, DOI 10.1038/sj.onc.1203948; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; VANDEVELDE HJK, 1994, J CELL SCI, V107, P2403; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	37	807	820	2	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 10	2006	124	3					573	586		10.1016/j.cell.2005.11.047	http://dx.doi.org/10.1016/j.cell.2005.11.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	014FG	16469703	Bronze			2022-12-24	WOS:000235464000019
J	Sloand, EM; Scheinberg, P; Maciejewski, J; Young, NS				Sloand, EM; Scheinberg, P; Maciejewski, J; Young, NS			Brief communication: Successful treatment of pure red-cell aplasia with an anti-interleukin-2 receptor antibody (daclizumab)	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; BONE-MARROW; ANTIERYTHROPOIETIN ANTIBODIES; THYMOCYTE GLOBULIN; THYMOMA; THERAPY; ERYTHROPOIESIS; PLASMAPHERESIS; CYCLOPHOSPHAMIDE; CYTOTOXICITY	Background: Pure red-cell aplasia (PRCA) is a rare hematologic disease characterized by anemia, reticulocytopenia, and absence of bone marrow erythroid precursors. Most patients respond to some form of immunosuppressive treatment, but few prospective clinical trials have been performed. Objective: To examine the efficacy of a humanized monoclonal antibody to the interleukin-2 receptor (daclizumab) for treating PRCA. Design: Pilot study. Setting: Federal government research hospital. Patients: 15 patients with idiopathic PRCA. Intervention: Daclizumab, 1 mg/kg of body weight, every 2 weeks for a total of 5 infusions. Pure red-cell aplasia was defined as transfusion-dependent anemia with a reticulocyte count of 60 x 10(9) cells/L or less and bone marrow showing absent or diminished erythroid precursors. Measurements: Response to therapy was assessed by transfusion independence, increments in reticulocyte count, and nontransfused hemoglobin. Results: Daclizumab had little toxicity. Of the 15 patients, 6 patients (40%) responded to treatment. All responders became transfusion-independent and achieved normal or near-normal hemoglobin values and normal reticulocyte counts. Limitations: The study was unblinded, and the number of patients was too small to assess drug safety reliably. Conclusions: Daclizumab seems safe. Its efficacy in this pilot protocol suggests that expanded study in PRCA and other bone marrow failure syndromes is warranted.	NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sloand, EM (corresponding author), NHLBI, Hematol Branch, NIH, 9000 Rockville Pike,Bldg 10 CRC 4E5230, Bethesda, MD 20892 USA.	sloande@nih.gov	Scheinberg, Phillip/H-5251-2012	Scheinberg, Phillip/0000-0002-9047-4538				ABKOWITZ JL, 1986, AM J HEMATOL, V23, P363, DOI 10.1002/ajh.2830230408; ALMONDHIRY H, 1971, BLOOD-J HEMATOL, V38, P576, DOI 10.1182/blood.V38.5.576.576; Auner HW, 2002, BRIT J HAEMATOL, V116, P727, DOI 10.1046/j.1365-2141.2002.3317_3.x; Batlle M, 2002, BRIT J HAEMATOL, V118, P1192, DOI 10.1046/j.1365-2141.2002.36892.x; Bennett CL, 2005, BLOOD, V106, P3343, DOI 10.1182/blood-2005-02-0508; Brown KE, 1996, STEM CELLS, V14, P151, DOI 10.1002/stem.140151; Carswell CI, 2001, BIODRUGS, V15, P745, DOI 10.2165/00063030-200115110-00005; Charles RJ, 1996, BLOOD, V87, P4831, DOI 10.1182/blood.V87.11.4831.bloodjournal87114831; CLARK DA, 1984, BLOOD, V63, P277; Cobcroft R, 2001, BRIT J HAEMATOL, V113, P260, DOI 10.1046/j.1365-2141.2001.02693.x; DESEVILLA E, 1975, CANCER, V36, P1154, DOI 10.1002/1097-0142(197509)36:3<1154::AID-CNCR2820360349>3.0.CO;2-9; Fisch P, 2000, BRIT J HAEMATOL, V111, P1010, DOI 10.1046/j.1365-2141.2000.02429.x; FREUND LG, 1985, SCAND J HAEMATOL, V35, P315; Gershon SK, 2002, NEW ENGL J MED, V346, P1584; Go RS, 2001, BLOOD, V98, P483, DOI 10.1182/blood.V98.2.483; HIRST E, 1967, MEDICINE, V46, P225, DOI 10.1097/00005792-196705000-00001; HOFFMAN R, 1978, BLOOD, V52, P255; JACOBS EM, 1959, CANCER, V12, P47, DOI 10.1002/1097-0142(195901/02)12:1<47::AID-CNCR2820120110>3.0.CO;2-Q; KRANTZ SB, 1976, MED CLIN N AM, V60, P945, DOI 10.1016/S0025-7125(16)31841-7; KRANTZ SB, 1973, J CLIN INVEST, V52, P324, DOI 10.1172/JCI107188; Lacy MQ, 1996, BLOOD, V87, P3000, DOI 10.1182/blood.V87.7.3000.bloodjournal8773000; Maciejewski JP, 2003, BLOOD, V102, P3584, DOI 10.1182/blood-2003-04-1032; MANGAN KF, 1982, CLIN RES, V30, pA323; MANGAN KF, 1986, AM J HEMATOL, V23, P167, DOI 10.1002/ajh.2830230211; MARMONT A, 1984, BRIT J HAEMATOL, V56, P680, DOI 10.1111/j.1365-2141.1984.tb02193.x; MARMONT AM, 1991, SEMIN HEMATOL, V28, P285; Masuda M, 2000, AM J HEMATOL, V63, P102, DOI 10.1002/(SICI)1096-8652(200002)63:2<102::AID-AJH9>3.0.CO;2-P; MEANS RT, 1991, BLOOD, V78, P2564; MEANS RT, 1991, BRIT J HAEMATOL, V78, P114, DOI 10.1111/j.1365-2141.1991.tb04392.x; MESSNER HA, 1981, NEW ENGL J MED, V304, P1334, DOI 10.1056/NEJM198105283042205; Mori KL, 2003, BRIT J HAEMATOL, V123, P147, DOI 10.1046/j.1365-2141.2003.04553.x; Murakawa Tomohiro, 2002, Asian Cardiovasc Thorac Ann, V10, P150; Rossert J, 2004, J AM SOC NEPHROL, V15, P398, DOI 10.1097/01.ASN.0000107561.59698.42; Yamada O, 1997, BRIT J HAEMATOL, V97, P392, DOI 10.1046/j.1365-2141.1997.282672.x; YOUNG N, 2006, WILLIAMS HEMATOLOGY, P437; Young N S, 1983, J Clin Apher, V1, P95, DOI 10.1002/jca.2920010206; Young Neal S., 2000, Hematology Am Soc Hematol Educ Program, P18	37	10	10	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2006	144	3					181	185		10.7326/0003-4819-144-3-200602070-00006	http://dx.doi.org/10.7326/0003-4819-144-3-200602070-00006			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	008XS	16461962				2022-12-24	WOS:000235074800004
J	Yilmaz, OH; Valdez, R; Theisen, BK; Guo, W; Ferguson, DO; Wu, H; Morrison, SJ				Yilmaz, Omer H.; Valdez, Riccardo; Theisen, Brian K.; Guo, Wei; Ferguson, David O.; Wu, Hong; Morrison, Sean J.			Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; TUMOR-SUPPRESSOR; SELF-RENEWAL; CANCER; BMI-1; DIFFERENTIATION; IDENTIFICATION; INHIBITION; MECHANISMS; SENESCENCE	Recent advances have highlighted extensive phenotypic and functional similarities between normal stem cells and cancer stem cells. This raises the question of whether disease therapies can be developed that eliminate cancer stem cells without eliminating normal stem cells. Here we address this issue by conditionally deleting the Pten tumour suppressor gene in adult haematopoietic cells. This led to myeloproliferative disease within days and transplantable leukaemias within weeks. Pten deletion also promoted haematopoietic stem cell (HSC) proliferation. However, this led to HSC depletion via a cell-autonomous mechanism, preventing these cells from stably reconstituting irradiated mice. In contrast to leukaemia-initiating cells, HSCs were therefore unable to maintain themselves without Pten. These effects were mostly mediated by mTOR as they were inhibited by rapamycin. Rapamycin not only depleted leukaemia-initiating cells but also restored normal HSC function. Mechanistic differences between normal stem cells and cancer stem cells can thus be targeted to deplete cancer stem cells without damaging normal stem cells.	Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329				Aggerholm A, 2000, EUR J HAEMATOL, V65, P109, DOI 10.1034/j.1600-0609.2000.90181.x; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Avellino R, 2005, BLOOD, V106, P1400, DOI 10.1182/blood-2005-03-0929; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheong JW, 2003, BRIT J HAEMATOL, V122, P454, DOI 10.1046/j.1365-2141.2003.04452.x; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Dahia PLM, 1999, HUM MOL GENET, V8, P185, DOI 10.1093/hmg/8.2.185; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2005, BLOOD, V106, P903, DOI 10.1182/blood-2004-12-4960; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Podsypanina K, 2001, P NATL ACAD SCI USA, V98, P10320, DOI 10.1073/pnas.171060098; Recher C, 2005, BLOOD, V105, P2527, DOI 10.1182/blood-2004-06-2494; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roman-Gomez J, 2004, BLOOD, V104, P2492, DOI 10.1182/blood-2004-03-0954; Singh SK, 2003, CANCER RES, V63, P5821; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; Smith LH, 1970, EXP HEMATOL, V20, P82; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Teachey DT, 2006, BLOOD, V107, P1149, DOI 10.1182/blood-2005-05-1935; Warner JK, 2004, ONCOGENE, V23, P7164, DOI 10.1038/sj.onc.1207933	42	1056	1142	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					475	482		10.1038/nature04703	http://dx.doi.org/10.1038/nature04703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16598206	Green Published			2022-12-24	WOS:000237778900042
J	Savolainen, V; Anstett, MC; Lexer, C; Hutton, I; Clarkson, JJ; Norup, MV; Powell, MP; Springate, D; Salamin, N; Baker, WJ				Savolainen, V; Anstett, MC; Lexer, C; Hutton, I; Clarkson, JJ; Norup, MV; Powell, MP; Springate, D; Salamin, N; Baker, WJ			Sympatric speciation in palms on an oceanic island	NATURE			English	Article							LORD-HOWE ISLAND; PACIFIC-OCEAN; DIVERGENCE; EVOLUTION; ORIGIN; SELECTION; ANIMALS	The origin of species diversity has challenged biologists for over two centuries. Allopatric speciation, the divergence of species resulting from geographical isolation, is well documented(1). However, sympatric speciation, divergence without geographical isolation, is highly controversial(2). Claims of sympatric speciation must demonstrate species sympatry, sister relationships, reproductive isolation, and that an earlier allopatric phase is highly unlikely(1). Here we provide clear support for sympatric speciation in a case study of two species of palm ( Arecaceae) on an oceanic island. A large dated phylogenetic tree shows that the two species of Howea, endemic to the remote Lord Howe Island, are sister taxa and diverged from each other well after the island was formed 6.9 million years ago(3). During fieldwork, we found a substantial disjunction in flowering time that is correlated with soil preference. In addition, a genome scan(4,5) indicates that few genetic loci are more divergent between the two species than expected under neutrality, a finding consistent with models of sympatric speciation involving disruptive/ divergent selection(2). This case study of sympatric speciation in plants provides an opportunity for refining theoretical models on the origin of species, and new impetus for exploring putative plant and animal examples on oceanic islands.	Royal Bot Gardens, Richmond TW9 3DS, Surrey, England; Ctr Evolutionary & Funct Ecol, UMR 5175, F-34293 Montpellier 5, France; Aarhus Univ, Dept Systemat Bot, DK-8000 Aarhus C, Denmark; Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland	Royal Botanic Gardens, Kew; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Aarhus University; University of Lausanne	Savolainen, V (corresponding author), Royal Bot Gardens, Richmond TW9 3DS, Surrey, England.	v.savolainen@kew.org	Lexer, Christian/N-3702-2013; Anstett, Marie Charlotte/N-7977-2017; Baker, William/B-1244-2011	Baker, William/0000-0001-6727-1831; Savolainen, Vincent/0000-0001-5350-9984; Anstett, Marie Charlotte/0000-0001-7786-0357; Salamin, Nicolas/0000-0002-3963-4954; Lexer, Christian/0000-0002-7221-7482				BAILEY LH, 1939, GENTES HERBARIUM, V4, P189; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Berry EW, 1905, TORREYA, V5; Brooke BP, 2003, QUATERNARY SCI REV, V22, P859, DOI 10.1016/S0277-3791(02)00253-6; BURRETT C, 1991, Australian Systematic Botany, V4, P13, DOI 10.1071/SB9910013; BUSH GL, 1994, TRENDS ECOL EVOL, V9, P285, DOI 10.1016/0169-5347(94)90031-0; Coyne J. A., 2004, SPECIATION; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Doebeli M, 2005, EVOLUTION, V59, P691; DRANSFIELD J, IN PRESS KEW B; Filchak KE, 2000, NATURE, V407, P739, DOI 10.1038/35037578; Gavrilets S, 2003, EVOLUTION, V57, P2197; Higashi M, 1999, NATURE, V402, P523, DOI 10.1038/990087; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Kondrashov AS, 1999, NATURE, V400, P351, DOI 10.1038/22514; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; MCDOUGALL I, 1981, J GEOL SOC AUST, V28, P155, DOI 10.1080/00167618108729154; MEYER A, 1990, NATURE, V347, P550, DOI 10.1038/347550a0; Oliver WRB., 1917, T P NZ I, V49, P94; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Pickard J, 1983, CUNNINGHAMIA, V1, P133; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; SCHLIEWEN UK, 1994, NATURE, V368, P629, DOI 10.1038/368629a0; Sorenson MD, 2003, NATURE, V424, P928, DOI 10.1038/nature01863; Swofford DL, 2001, PAUP 4 0 PHYLOGENETI; Tregenza T, 1999, NATURE, V400, P311, DOI 10.1038/22419; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; Vaughan RE, 1937, J ECOL, V25, P289, DOI 10.2307/2256197; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7	30	449	466	3	343	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 11	2006	441	7090					210	213		10.1038/nature04566	http://dx.doi.org/10.1038/nature04566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16467788				2022-12-24	WOS:000237418800044
J	Willig, KI; Rizzoli, SO; Westphal, V; Jahn, R; Hell, SW				Willig, KI; Rizzoli, SO; Westphal, V; Jahn, R; Hell, SW			STED microscopy reveals that synaptotagmin remains clustered after synaptic vesicle exocytosis	NATURE			English	Article							FROG NEUROMUSCULAR JUNCTION; HIPPOCAMPAL SYNAPSES; FLUORESCENCE MICROSCOPY; STIMULATED-EMISSION; ENDOCYTOSIS; RESOLUTION; MEMBRANE; TRANSMITTER; RELEASE; DOMAIN	Synaptic transmission is mediated by neurotransmitters that are stored in synaptic vesicles and released by exocytosis upon activation. The vesicle membrane is then retrieved by endocytosis, and synaptic vesicles are regenerated and re-filled with neurotransmitter(1). Although many aspects of vesicle recycling are understood, the fate of the vesicles after fusion is still unclear. Do their components diffuse on the plasma membrane, or do they remain together? This question has been difficult to answer because synaptic vesicles are too small (similar to 40 nm in diameter) and too densely packed to be resolved by available fluorescence microscopes. Here we use stimulated emission depletion (STED)(2) to reduce the focal spot area by about an order of magnitude below the diffraction limit, thereby resolving individual vesicles in the synapse. We show that synaptotagmin I, a protein resident in the vesicle membrane, remains clustered in isolated patches on the presynaptic membrane regardless of whether the nerve terminals are mildly active or intensely stimulated. This suggests that at least some vesicle constituents remain together during recycling. Our study also demonstrates that questions involving cellular structures with dimensions of a few tens of nanometres can be resolved with conventional far-field optics and visible light.	Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany.	rjahn@gwdg.de	Willig, Katrin/AAH-5418-2020; Rizzoli, Silvio/ABG-2227-2020	Willig, Katrin/0000-0002-1860-334X; Rizzoli, Silvio/0000-0002-1667-7839; Jahn, Reinhard/0000-0003-1542-3498				Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Hell S.W., 1997, T FLUOR SP, P361; Hell SW, 2004, PHYS LETT A, V326, P140, DOI 10.1016/j.physleta.2004.03.082; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rosenmund C, 1997, J NEUROSCI METH, V76, P1, DOI 10.1016/S0165-0270(97)00061-7; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Torok P, 2004, OPT EXPRESS, V12, P3605, DOI 10.1364/OPEX.12.003605; Westphal V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.143903; Wilson T., 1984, THEORY PRACTICE SCAN; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	26	799	835	17	408	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					935	939		10.1038/nature04592	http://dx.doi.org/10.1038/nature04592			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612384				2022-12-24	WOS:000236736700041
J	Strous, M; Pelletier, E; Mangenot, S; Rattei, T; Lehner, A; Taylor, MW; Horn, M; Daims, H; Bartol-Mavel, D; Wincker, P; Barbe, V; Fonknechten, N; Vallenet, D; Segurens, B; Schenowitz-Truong, C; Medigue, C; Collingro, A; Snel, B; Dutilh, BE; Op den Camp, HJM; van der Drift, C; Cirpus, I; van de Pas-Schoonen, KT; Harhangi, HR; van Niftrik, L; Schmid, M; Keltjens, J; van de Vossenberg, J; Kartal, B; Meier, H; Frishman, D; Huynen, MA; Mewes, HW; Weissenbach, J; Jetten, MSM; Wagner, M; Le Paslier, D				Strous, M; Pelletier, E; Mangenot, S; Rattei, T; Lehner, A; Taylor, MW; Horn, M; Daims, H; Bartol-Mavel, D; Wincker, P; Barbe, V; Fonknechten, N; Vallenet, D; Segurens, B; Schenowitz-Truong, C; Medigue, C; Collingro, A; Snel, B; Dutilh, BE; Op den Camp, HJM; van der Drift, C; Cirpus, I; van de Pas-Schoonen, KT; Harhangi, HR; van Niftrik, L; Schmid, M; Keltjens, J; van de Vossenberg, J; Kartal, B; Meier, H; Frishman, D; Huynen, MA; Mewes, HW; Weissenbach, J; Jetten, MSM; Wagner, M; Le Paslier, D			Deciphering the evolution and metabolism of an anammox bacterium from a community genome	NATURE			English	Article							SEQUENCE; OXIDATION	Anaerobic ammonium oxidation (anammox) has become a main focus in oceanography and wastewater treatment(1,2). It is also the nitrogen cycle's major remaining biochemical enigma. Among its features, the occurrence of hydrazine as a free intermediate of catabolism(3,4), the biosynthesis of ladderane lipids(5,6) and the role of cytoplasm differentiation(7) are unique in biology. Here we use environmental genomics(8,9) - the reconstruction of genomic data directly from the environment - to assemble the genome of the uncultured anammox bacterium Kuenenia stuttgartiensis(10) from a complex bioreactor community. The genome data illuminate the evolutionary history of the Planctomycetes and allow us to expose the genetic blueprint of the organism's special properties. Most significantly, we identified candidate genes responsible for ladderane biosynthesis and biological hydrazine metabolism, and discovered unexpected metabolic versatility.	Radboud Univ Nijmegen, Dept Microbiol, IWWR, NL-6525 ED Nijmegen, Netherlands; CNRS, UMR 8030, F-91057 Evry, France; Tech Univ Munich, Dept Genome Oriented Bioinformat, D-85354 Freising Weihenstephan, Germany; Univ Vienna, Dept Microbial Ecol, A-1090 Vienna, Austria; Univ Zurich, Inst Lebensmittelsicherheit & Hyg, CH-8057 Zurich, Switzerland; Radboud Univ Nijmegen Med Ctr, Ctr Mol & Biomol Informat, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; Delft Univ Technol, Kluyver Lab Biotechnol, NL-2628 BC Delft, Netherlands; Tech Univ Munich, Lehrstuhl Rechnertech & Rechnerorg Parallelrechne, Inst Informat, D-85748 Garching, Germany; GSF, Natl Res Ctr Environm & Hlth, Inst Bioinformat, D-85764 Neuherberg, Germany	Radboud University Nijmegen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Technical University of Munich; University of Vienna; University of Zurich; Radboud University Nijmegen; Delft University of Technology; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Jetten, MSM (corresponding author), Radboud Univ Nijmegen, Dept Microbiol, IWWR, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	m.jetten@science.ru.nl; wagner@microbial-ecology.net	Camp, Huub J.M. Op den/F-5114-2011; Lehner, Angelika/B-2363-2018; Horn, Matthias/G-1136-2011; Snel, Berend/B-8886-2011; Huynen, Martijn A/A-1530-2014; Collingro, Astrid/ABA-2082-2021; Dutilh, Bas E./B-9719-2011; Kartal, Boran/ABD-5400-2021; Frishman, Dmitrij/AAT-7815-2020; Kartal, Boran/D-2488-2014; Rattei, Thomas/F-1366-2011; Strous, Marc/B-4064-2017; Jetten, Mike/B-8834-2011; Schmid, Markus C/D-2669-2012; van Niftrik, Laura/C-3269-2011; Huijnen, M.A./H-8051-2014; Keltjens, Jan/M-3002-2013; Daims, Holger/I-8410-2012; van Niftrik, Laura/AAQ-7724-2020; Wagner, Michael/A-7801-2011; Mewes, Hans-Werner/A-8204-2019	Camp, Huub J.M. Op den/0000-0003-1990-9030; Lehner, Angelika/0000-0003-1863-5090; Horn, Matthias/0000-0002-8309-5855; Snel, Berend/0000-0002-5804-8547; Huynen, Martijn A/0000-0001-6189-5491; Collingro, Astrid/0000-0002-4100-832X; Dutilh, Bas E./0000-0003-2329-7890; Rattei, Thomas/0000-0002-0592-7791; Strous, Marc/0000-0001-9600-3828; Jetten, Mike/0000-0002-4691-7039; Daims, Holger/0000-0002-4195-0913; van Niftrik, Laura/0000-0002-7011-7234; Wagner, Michael/0000-0002-9778-7684; Mewes, Hans-Werner/0000-0002-9713-6398; Taylor, Michael/0000-0002-0463-7813; Le Paslier, Denis/0000-0003-4335-9956; Pelletier, Eric/0000-0003-4228-1712; Kartal, Boran/0000-0003-4199-952X; van de Vossenberg, Jack/0000-0003-4497-6155; Vallenet, David/0000-0001-6648-0332; Valeeva, Aygul V./0000-0002-9968-9586				Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Brasseur G, 2004, BBA-BIOENERGETICS, V1656, P114, DOI 10.1016/j.bbabio.2004.02.008; Brochier C, 2002, NATURE, V417, P244, DOI 10.1038/417244a; Chain P, 2003, J BACTERIOL, V185, P2759, DOI 10.1128/JB.185.9.2759-2773.2003; Chopra I, 1998, MICROBIOL-UK, V144, P2673, DOI 10.1099/00221287-144-10-2673; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; Damste JSS, 2002, NATURE, V419, P708, DOI 10.1038/nature01128; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Drake HL, 2004, RES MICROBIOL, V155, P422, DOI 10.1016/j.resmic.2004.03.003; Frishman D, 2001, BIOINFORMATICS, V17, P44, DOI 10.1093/bioinformatics/17.1.44; Fuerst JA, 2005, ANNU REV MICROBIOL, V59, P299, DOI 10.1146/annurev.micro.59.030804.121258; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guven D, 2005, APPL ENVIRON MICROB, V71, P1066, DOI 10.1128/AEM.71.2.1066-1071.2005; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Layer G, 2004, CURR OPIN CHEM BIOL, V8, P468, DOI 10.1016/j.cbpa.2004.08.001; Le Paslier MC, 2000, GENOMICS, V65, P87, DOI 10.1006/geno.2000.6147; Lindsay MR, 2001, ARCH MICROBIOL, V175, P413, DOI 10.1007/s002030100280; Mascitti V, 2004, J AM CHEM SOC, V126, P15664, DOI 10.1021/ja044089a; Methe BA, 2003, SCIENCE, V302, P1967, DOI 10.1126/science.1088727; Schalk J, 2000, BIOCHEMISTRY-US, V39, P5405, DOI 10.1021/bi992721k; Schmid M, 2000, SYST APPL MICROBIOL, V23, P93, DOI 10.1016/S0723-2020(00)80050-8; Schouten S, 2004, APPL ENVIRON MICROB, V70, P3785, DOI 10.1128/AEM.70.6.3785-3788.2004; Staley JT, 2005, FEMS MICROBIOL LETT, V243, P9, DOI 10.1016/j.femsle.2004.11.034; Strous M, 2004, ANNU REV MICROBIOL, V58, P99, DOI 10.1146/annurev.micro.58.030603.123605; Teeling H, 2004, INT J SYST EVOL MICR, V54, P791, DOI 10.1099/ijs.0.02913-0; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; vandeGraaf AA, 1997, MICROBIOL-SGM, V143, P2415, DOI 10.1099/00221287-143-7-2415; Vishwanath P, 2004, MOL PHYLOGENET EVOL, V33, P615, DOI 10.1016/j.ympev.2004.07.003; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005	30	837	978	64	1062	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					790	794		10.1038/nature04647	http://dx.doi.org/10.1038/nature04647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598256				2022-12-24	WOS:000236548400040
J	Emile, O; Le Floch, A; Vollrath, F				Emile, O; Le Floch, A; Vollrath, F			Biopolymers: Shape memory in spider draglines	NATURE			English	Editorial Material							SILK; DNA		Univ Rennes 1, Phys Lasers Lab, CNRS, UMR 6627, F-35042 Rennes, France; Dept Zool, Oxford OX1 3PS, England	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Emile, O (corresponding author), Univ Rennes 1, Phys Lasers Lab, CNRS, UMR 6627, F-35042 Rennes, France.	olivier.emile@univ-rennes1.fr		Le Floch, Albert/0000-0002-4516-9817; Vollrath, Fritz/0000-0003-3484-9005				Ashley S, 2003, SCI AM, V289, P84, DOI 10.1038/scientificamerican1103-84; Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858; Bhattacharya K, 2004, NATURE, V428, P55, DOI 10.1038/nature02378; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Craig C, 2003, SPIDERWEBS SILK; Feynman R. P., 1964, FEYNMAN LECT PHYS; GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0; Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780	10	78	84	4	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2006	440	7084					621	621		10.1038/440621a	http://dx.doi.org/10.1038/440621a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572162	Bronze			2022-12-24	WOS:000236350400033
J	Jones, DH; Nakashima, T; Sanchez, OH; Kozieradzki, I; Komarova, SV; Sarosi, I; Morony, S; Rubin, E; Sarao, R; Hojilla, CV; Komnenovic, V; Kong, YY; Schreiber, M; Dixon, SJ; Sims, SM; Khokha, R; Wada, T; Penninger, JM				Jones, DH; Nakashima, T; Sanchez, OH; Kozieradzki, I; Komarova, SV; Sarosi, I; Morony, S; Rubin, E; Sarao, R; Hojilla, CV; Komnenovic, V; Kong, YY; Schreiber, M; Dixon, SJ; Sims, SM; Khokha, R; Wada, T; Penninger, JM			Regulation of cancer cell migration and bone metastasis by RANKL	NATURE			English	Article							OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN-LIGAND; MURINE MODEL; GROWTH; OSTEOLYSIS	Bone metastases are a frequent complication of many cancers that result in severe disease burden and pain(1-3). Since the late nineteenth century, it has been thought that the microenvironment of the local host tissue actively participates in the propensity of certain cancers to metastasize to specific organs, and that bone provides an especially fertile 'soil' 4. In the case of breast cancers, the local chemokine milieu is now emerging as an explanation for why these tumours preferentially metastasize to certain organs(5). However, as the inhibition of chemokine receptors in vivo only partially blocks metastatic behaviour(6), other factors must exist that regulate the preferential metastasis of breast cancer cells. Here we show that the cytokine RANKL ( receptor activator of NF-kappa B ligand)(7,8) triggers migration of human epithelial cancer cells and melanoma cells that express the receptor RANK. RANK is expressed on cancer cell lines and breast cancer cells in patients. In a mouse model of melanoma metastasis(9), in vivo neutralization of RANKL by osteoprotegerin results in complete protection from paralysis and a marked reduction in tumour burden in bones but not in other organs. Our data show that local differentiation factors such as RANKL have an important role in cell migration and the tissue-specific metastatic behaviour of cancer cells.	Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; Univ Hlth Network, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; McGill Univ, Fac Dent, Montreal, PQ H3A 1A4, Canada; Amgen Inc, Thousand Oaks, CA 91320 USA; Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea; Med Univ Vienna, Dept Obstet & Gynecol, A-1090 Vienna, Austria; Univ Western Ontario, Dept Physiol & Pharmacol, CIHR Grp Skeletal Dev & Remodeling, London, ON N6A 5C1, Canada; Univ Western Ontario, Div Oral Biol, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McGill University; Amgen; Pohang University of Science & Technology (POSTECH); Medical University of Vienna; Western University (University of Western Ontario); Western University (University of Western Ontario)	Penninger, JM (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	josef.penninger@imba.oeaw.ac.at	Dixon, S. Jeffrey/G-3657-2013; Martin, Schreiber/F-2175-2013; Sims, Stephen/G-4510-2013; Penninger, Josef M/I-6860-2013	Dixon, S. Jeffrey/0000-0001-9162-1686; Martin, Schreiber/0000-0003-1102-7789; Penninger, Josef M/0000-0002-8194-3777				Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; ARGUELLO F, 1988, CANCER RES, V48, P6876; Bakewell SJ, 2003, P NATL ACAD SCI USA, V100, P14205, DOI 10.1073/pnas.2234372100; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Guise Theresa A., 2000, Cancer, V88, P2892, DOI 10.1002/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y; Komarova SV, 2003, J BIOL CHEM, V278, P8286, DOI 10.1074/jbc.M206421200; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Moore MAS, 2001, BIOESSAYS, V23, P674, DOI 10.1002/bies.1095; Morony S, 2001, CANCER RES, V61, P4432; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Peyruchaud O, 2001, J BONE MINER RES, V16, P2027, DOI 10.1359/jbmr.2001.16.11.2027; SanchezSweatman OH, 1997, EUR J CANCER, V33, P918, DOI 10.1016/S0959-8049(97)00513-3; Sloan EK, 2002, CELL MOL LIFE SCI, V59, P1491, DOI 10.1007/s00018-002-8524-5; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; VERSCHUEREN H, 1994, J LEUKOCYTE BIOL, V55, P552, DOI 10.1002/jlb.55.4.552; Zhang J, 2001, J CLIN INVEST, V107, P1235, DOI 10.1172/JCI11685	22	587	629	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					692	696		10.1038/nature04524	http://dx.doi.org/10.1038/nature04524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572175	Bronze			2022-12-24	WOS:000236350400049
J	Thorne, SH; Negrin, RS; Contag, CH				Thorne, SH; Negrin, RS; Contag, CH			Synergistic antitumor effects of immune cell-viral biotherapy	SCIENCE			English	Article							VACCINIA VIRUS; T-CELLS; THYMIDINE KINASE; GENE-THERAPY; ONCOLYTIC VIROTHERAPY; FUTURE-DIRECTIONS; NK CELLS; CANCER; NKG2D; LYMPHOMA	Targeted biological therapies hold tremendous potential for treatment of cancer, yet their use has been limited by constraints on delivery and effective tumor targeting. We combined an immune effector cell population [cytokine-induced killer (CIK) cells] with an oncolytic viral therapy to achieve directed delivery to, and regression of, tumors in both immunodeficient and immunocompetent mouse models. Preinfection of CIK cells with modified vaccinia virus resulted in a prolonged eclipse phase with the virus remaining hidden until interaction with the tumor. Whole-body imaging revealed that the cells retained their ability to traffic to and to infiltrate the tumor effectively before releasing the virus. These results illustrate the potential of combining biotherapeutics for synergistic effects that more. effectively treat cancer.	Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Div Bone Marrow Transplantat, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Contag, CH (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.	ccontag@cmgm.stanford.edu		Contag, Christopher/0000-0002-1011-8278	NCI NIH HHS [R24 CA 92862, P50 CA114747, P01 CA49605] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA049605, P50CA114747, R24CA092862] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375; Baker J, 2001, BLOOD, V97, P2923, DOI 10.1182/blood.V97.10.2923; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BULLER RML, 1985, NATURE, V317, P813, DOI 10.1038/317813a0; BULLER RML, 1988, VIROLOGY, V164, P182, DOI 10.1016/0042-6822(88)90635-6; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; Cole C, 2005, NAT MED, V11, P1073, DOI 10.1038/nm1297; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Edinger M, 2003, BLOOD, V101, P640, DOI 10.1182/blood-2002-06-1751; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hamerman JA, 2005, CURR OPIN IMMUNOL, V17, P29, DOI 10.1016/j.coi.2004.11.001; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Heise C, 1997, NAT MED, V3, P639, DOI 10.1038/nm0697-639; HENGSTSCHLAGER M, 1994, J BIOL CHEM, V269, P13836; Kirn D, 2001, NAT MED, V7, P781, DOI 10.1038/89901; Leemhuis T, 2005, BIOL BLOOD MARROW TR, V11, P181, DOI 10.1016/j.bbmt.2004.11.019; LU PH, 1994, J IMMUNOL, V153, P1687; Mastrangelo MJ, 1999, CANCER GENE THER, V6, P409, DOI 10.1038/sj.cgt.7700066; McCart JA, 2001, CANCER RES, V61, P8751; Puhlmann M, 2000, CANCER GENE THER, V7, P66, DOI 10.1038/sj.cgt.7700075; Thorne SH, 2005, SEMIN ONCOL, V32, P537, DOI 10.1053/j.seminoncol.2005.09.007; Thorne SH, 2004, EXPERT OPIN BIOL TH, V4, P1307, DOI 10.1517/14712598.4.8.1307; Verneris MR, 2004, BLOOD, V103, P3065, DOI 10.1182/blood-2003-06-2125; Yu YA, 2004, NAT BIOTECHNOL, V22, P313, DOI 10.1038/nbt937	25	227	271	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1780	1784		10.1126/science.1121411	http://dx.doi.org/10.1126/science.1121411			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556847				2022-12-24	WOS:000236204300048
J	Shinya, K; Ebina, M; Yamada, S; Ono, M; Kasai, N; Kawaoka, Y				Shinya, K; Ebina, M; Yamada, S; Ono, M; Kasai, N; Kawaoka, Y			Influenza virus receptors in the human airway	NATURE			English	Editorial Material							A VIRUSES		Univ Tokyo, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo 1088639, Japan; Tohoku Univ, Inst Anim Experimentat, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808575, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Tokyo; University of Tokyo; Tohoku University; Tohoku University; Tohoku University; Japan Science & Technology Agency (JST); University of Wisconsin System; University of Wisconsin Madison	Shinya, K (corresponding author), Tottori Univ, Avian Zoonosis Res Ctr, Tottori 6808550, Japan.	kawaokay@svm.vetmed.wisc.edu						BAUM LG, 1990, ACTA HISTOCHEM, P35; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Shinya K, 2005, J VIROL, V79, P9926, DOI 10.1128/JVI.79.15.9926-9932.2005; Uiprasertkul M, 2005, EMERG INFECT DIS, V11, P1036, DOI 10.3201/eid1107.041313	8	986	1076	2	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					435	436		10.1038/440435a	http://dx.doi.org/10.1038/440435a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554799				2022-12-24	WOS:000236176100036
J	Mora, S; Lee, IM; Buring, JE; Ridker, PM				Mora, S; Lee, IM; Buring, JE; Ridker, PM			Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; LOW-DOSE ASPIRIN; RISK-FACTORS; PRIMARY PREVENTION; CARDIORESPIRATORY FITNESS; PROGENITOR CELLS; HEART-DISEASE; EXERCISE; OBESITY; HEALTH	Context There are few data directly comparing the effects of physical activity and body weight on cardiovascular biomarkers. Objective To examine the association of physical activity and body mass index (BMI, defined as weight in kilograms divided by the square of height in meters) alone and in combination with cardiovascular biomarkers. Design, Setting, and Participants Cross-sectional analysis of 27 158 apparently healthy US women ( mean age, 54.7 years) at the time of enrollment (1992-1995) in the Women's Health Study, a randomized, double-blind, placebo-controlled trial of low-dose aspirin and vitamin E in the primary prevention of cardiovascular disease and cancer. Main Outcome Measures The association of physical activity and BMI with high-sensitivity C-reactive protein (CRP), fibrinogen, soluble intracellular adhesion molecule 1 (ICAM-1), homocysteine, low- and high-density lipoprotein (LDL and HDL) cholesterol, total cholesterol, apolipoprotein A-1 and B-100, lipoprotein( a), and creatinine. Results Lower levels of physical activity and higher levels of BMI were independently associated ( P for trend < .001) with adverse levels of nearly all lipid and inflammatory biomarkers. High BMI showed stronger associations with these biomarkers than physical inactivity. For example, using the reference group of physically active, normal weight women ( energy expenditure >= 1000 kcal/week; BMI, 18.5-24.9) and adjusting for age, race, smoking, blood pressure, diabetes, menopausal status, and hormone use, the odds ratios (95% confidence intervals [CIs]) for having CRP > 3 mg/L were: for inactive, normal weight women 1.26 (1.15-1.37); active, overweight 2.68 (2.41-2.98); inactive, overweight 3.11 (2.84-3.41); active, obese 8.25 (7.15-9.51); and inactive, obese 9.86 (8.84-10.99). In similar analyses, the odds ratios ( 95% CIs) for having HDL cholesterol < 50 mg/dL were 1.20 (1.11-1.30); 2.25 (2.04-2.49); 2.62 (2.41-2.85); 4.21 (3.68-4.81); and 5.27 (4.77-5.84), respectively, and for having apolipoprotein B-100 > 120 mg/dL they were 1.21 (1.11-1.33); 1.86 (1.66-2.08); 2.06 (1.88-2.67); 2.35 (2.04-2.70); and 2.33 (2.09-2.59). Fibrinogen, ICAM-1, apolipoprotein A1, total cholesterol, and LDL cholesterol showed similar associations. By contrast, homocysteine, lipoprotein ( a), and creatinine showed weak or nonsignificant associations. Conclusions High BMI was more strongly related to adverse cardiovascular biomarker levels than physical inactivity. However, within BMI categories, physical activity was generally associated with more favorable cardiovascular biomarker levels than inactivity.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Donald W Reynolds Ctr Cardiovasc Res, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Leducq Ctr Mol & Genet Epidemiol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Mora, S (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave E, Boston, MA 02215 USA.	smora2@partners.org	Lee, I-Min/ABD-5409-2021	Mora, Samia/0000-0001-6283-0980	NCI NIH HHS [CA-47988] Funding Source: Medline; NHLBI NIH HHS [HL-43851] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abramson JL, 2002, ARCH INTERN MED, V162, P1286, DOI 10.1001/archinte.162.11.1286; *AM HEART ASS, 2004, HEART DIS STROK STAT; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Blair SN, 2004, JAMA-J AM MED ASSOC, V292, P1232, DOI 10.1001/jama.292.10.1232; Carmena R, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000131511.50734.44; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1208; Christou DD, 2005, CIRCULATION, V111, P1904, DOI 10.1161/01.CIR.0000161818.28974.1A; Church TS, 2002, ARTERIOSCL THROM VAS, V22, P1869, DOI 10.1161/01.ATV.0000036611.77940.F8; Church TS, 2002, INT J OBESITY, V26, P805, DOI 10.1038/sj.ijo.0802001; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; DeSouza CA, 1998, ARTERIOSCL THROM VAS, V18, P362, DOI 10.1161/01.ATV.18.3.362; Despres J P, 1998, Obes Res, V6 Suppl 1, p8S; ELWOOD PC, 1993, BRIT HEART J, V69, P183; Folsom A R, 1992, Ann Epidemiol, V2, P481; Ford ES, 2002, EPIDEMIOLOGY, V13, P561, DOI 10.1097/00001648-200209000-00012; Geffken DF, 2001, AM J EPIDEMIOL, V153, P242, DOI 10.1093/aje/153.3.242; Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2; Grundy SM, 2002, CIRCULATION, V105, P2696, DOI 10.1161/01.CIR.0000020650.86137.84; Haddock BL, 1998, MED SCI SPORT EXER, V30, P893, DOI 10.1097/00005768-199806000-00018; HAINLINE A, 1982, MANUAL LAB OPERATION; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; Manson JE, 2004, ARCH INTERN MED, V164, P249, DOI 10.1001/archinte.164.3.249; MANSON JE, 1992, JAMA-J AM MED ASSOC, V268, P63, DOI 10.1001/jama.268.1.63; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Rawson ES, 2003, MED SCI SPORT EXER, V35, P1160, DOI 10.1249/01.MSS.0000074565.79230.AB; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Sandri M, 2005, CIRCULATION, V111, P3391, DOI 10.1161/CIRCULATIONAHA.104.527135; Shamsuzzaman ASM, 2004, CIRCULATION, V109, P2181, DOI 10.1161/01.CIR.0000127960.28627.75; Steiner S, 2005, ATHEROSCLEROSIS, V181, P305, DOI 10.1016/j.atherosclerosis.2005.01.006; Tomaszewski M, 2003, ARTERIOSCL THROM VAS, V23, P1640, DOI 10.1161/01.ATV.0000087036.75849.0B; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wannamethee SG, 2002, CIRCULATION, V105, P1785, DOI 10.1161/01.CIR.0000016346.14762.71; Weinstein AR, 2004, JAMA-J AM MED ASSOC, V292, P1188, DOI 10.1001/jama.292.10.1188; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	43	270	277	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2006	295	12					1412	1419		10.1001/jama.295.12.1412	http://dx.doi.org/10.1001/jama.295.12.1412			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023WU	16551713	Bronze			2022-12-24	WOS:000236157700019
J	Kargel, JS				Kargel, JS			Perspective - Enceladus: Cosmic gymnast, volatile miniworld	SCIENCE			English	Editorial Material							ICY SATELLITES; ORIGIN; SATURN; SPECTROMETER; MAGNETOMETER; ATMOSPHERE; VOLCANISM; SURFACE; OCEAN; PLUME		Univ Arizona, Dept Hydrol & Water Resources, Tucson, AZ 85721 USA	University of Arizona	Kargel, JS (corresponding author), Univ Arizona, Dept Hydrol & Water Resources, Tucson, AZ 85721 USA.	kargel@hwr.arizona.edu						Brown RH, 2006, SCIENCE, V311, P1425, DOI 10.1126/science.1121031; CROFT SK, 1996, NEPTUNE TRITON, P879; Dougherty MK, 2006, SCIENCE, V311, P1406, DOI 10.1126/science.1120985; GREENBERG R, 1991, URANUS, P410; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; Irion R, 2006, SCIENCE, V311, P589, DOI 10.1126/science.311.5761.589; Jones GH, 2006, SCIENCE, V311, P1412, DOI 10.1126/science.1121011; Kargel JS, 1996, ICARUS, V119, P385, DOI 10.1006/icar.1996.0026; KARGEL JS, 1992, ICARUS, V100, P556, DOI 10.1016/0019-1035(92)90118-Q; Kargel JS, 2000, ICARUS, V148, P226, DOI 10.1006/icar.2000.6471; Kivelson MG, 2000, SCIENCE, V289, P1340, DOI 10.1126/science.289.5483.1340; Kivelson MG, 2006, SCIENCE, V311, P1391, DOI 10.1126/science.1124494; Lebreton JP, 2005, NATURE, V438, P758, DOI 10.1038/nature04347; LEWIS JS, 1972, ICARUS, V16, P241, DOI 10.1016/0019-1035(72)90071-1; LUNINE JI, 1987, ICARUS, V70, P61, DOI 10.1016/0019-1035(87)90075-3; McCord TB, 1998, SCIENCE, V280, P1242, DOI 10.1126/science.280.5367.1242; Pappalardo R. T., 1999, J GEOPHYS RES, V104, P24105; PLESCIA JB, 1983, NATURE, V301, P666, DOI 10.1038/301666a0; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; PRIETO O, 2002, LUNAR PLANET SCI, V33; PRIETOBALLESTER.O, 2006, LUN PLAN SCI C, V37; Ross RG, 1998, ASTROPHYS SPACE SC L, V227, P33, DOI 10.1007/978-94-011-5252-5_2; SMITH BA, 1982, SCIENCE, V215, P504, DOI 10.1126/science.215.4532.504; Spahn F, 2006, SCIENCE, V311, P1416, DOI 10.1126/science.1121375; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; SQUYRES SW, 1983, ICARUS, V53, P319, DOI 10.1016/0019-1035(83)90152-5; STEVENSON DJ, 1982, NATURE, V298, P142, DOI 10.1038/298142a0; Tokar RL, 2006, SCIENCE, V311, P1409, DOI 10.1126/science.1121061; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290	29	44	44	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2006	311	5766					1389	1391		10.1126/science.1124495	http://dx.doi.org/10.1126/science.1124495			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527962				2022-12-24	WOS:000236029400028
J	Lakadamyali, M; Rust, MJ; Zhuang, XW				Lakadamyali, M; Rust, MJ; Zhuang, XW			Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes	CELL			English	Article							LOW-DENSITY-LIPOPROTEIN; EPIDERMAL-GROWTH-FACTOR; TRANSFERRIN RECEPTOR; MEMBRANE DOMAINS; INFLUENZA-VIRUS; COATED PITS; PATHWAY; PROTEINS; INTERNALIZATION; VESICLE	Cells rely on the correct sorting of endocytic ligands and receptors for proper function. Early endosomes have been considered as the initial sorting station where cargos for degradation separate from those for recycling. Using live-cell imaging to monitor individual endosomes and ligand particles in real time, we have discovered a sorting mechanism that takes place prior to early endosome entry. We show that early endosomes are in fact comprised of two distinct populations: a dynamic population that is highly mobile on microtubules and matures rapidly toward late endosomes and a static population that matures much more slowly. Several cargos destined for degradation are preferentially targeted to the dynamic endosomes, whereas the recycling ligand transferrin is nonselectively delivered to all early endosomes and effectively enriched in the larger, static population. This pre-early endosome sorting process begins at clathrin-coated vesicles, depends on microtubule-dependent motility, and appears to involve endocytic adaptors.	Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu			NIGMS NIH HHS [R01 GM068518-05, R01 GM068518] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068518] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON RGW, 1977, CELL, V10, P351, DOI 10.1016/0092-8674(77)90022-8; ANDERSON RGW, 1982, J CELL BIOL, V93, P523, DOI 10.1083/jcb.93.3.523; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; BOMSEL M, 1989, J CELL BIOL, V109, P3243, DOI 10.1083/jcb.109.6.3243; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Cao TT, 1998, J BIOL CHEM, V273, P24592, DOI 10.1074/jbc.273.38.24592; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Conner SD, 2003, J CELL BIOL, V162, P773, DOI 10.1083/jcb.200304069; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; DICKSON RB, 1983, BIOCHEMISTRY-US, V22, P5667, DOI 10.1021/bi00293a033; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; GHOSH RN, 1994, J CELL SCI, V107, P2177; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; HUGHSON EJ, 1990, J CELL BIOL, V110, P337, DOI 10.1083/jcb.110.2.337; Hussain NK, 2003, J BIOL CHEM, V278, P28823, DOI 10.1074/jbc.M300995200; Jiang XJ, 2003, TRAFFIC, V4, P529, DOI 10.1034/j.1600-0854.2003.t01-1-00109.x; Kittel A, 1999, J COMP NEUROL, V412, P649, DOI 10.1002/(SICI)1096-9861(19991004)412:4<649::AID-CNE6>3.0.CO;2-4; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.bi.55.070186.003311; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; MUNDIGL O, 1993, J CELL BIOL, V122, P1207, DOI 10.1083/jcb.122.6.1207; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; PARTON RG, 1992, J CELL BIOL, V119, P123, DOI 10.1083/jcb.119.1.123; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Sheff D, 2002, J CELL BIOL, V156, P797, DOI 10.1083/jcb.20111048; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; STOORVOGEL W, 1991, CELL, V65, P417, DOI 10.1016/0092-8674(91)90459-C; Tanowitz M, 2003, J BIOL CHEM, V278, P45978, DOI 10.1074/jbc.M304504200; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; VANLEUVEN F, 1980, CELL, V20, P37, DOI 10.1016/0092-8674(80)90232-9; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; WALL DA, 1980, CELL, V21, P79, DOI 10.1016/0092-8674(80)90116-6; Watanabe R, 1999, J NEUROCHEM, V73, P1375, DOI 10.1046/j.1471-4159.1999.0731375.x; Wei ML, 1998, J CELL BIOL, V140, P565, DOI 10.1083/jcb.140.3.565; YAMASHIRO DJ, 1987, J CELL BIOL, V105, P2723, DOI 10.1083/jcb.105.6.2723; YOSHIMURA A, 1984, J VIROL, V51, P497, DOI 10.1128/JVI.51.2.497-504.1984; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	70	430	435	2	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					997	1009		10.1016/j.cell.2005.12.038	http://dx.doi.org/10.1016/j.cell.2005.12.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530046	Green Accepted, Bronze			2022-12-24	WOS:000237241200021
J	Spahn, F; Schmidt, J; Albers, N; Horning, M; Makuch, M; Seiss, M; Kempf, S; Srama, R; Dikarev, V; Helfert, S; Moragas-Klostermeyer, G; Krivov, AV; Sremcevic, M; Tuzzolino, AJ; Economou, T; Grun, E				Spahn, F; Schmidt, J; Albers, N; Horning, M; Makuch, M; Seiss, M; Kempf, S; Srama, R; Dikarev, V; Helfert, S; Moragas-Klostermeyer, G; Krivov, AV; Sremcevic, M; Tuzzolino, AJ; Economou, T; Grun, E			Cassini dust measurements at Enceladus and implications for the origin of the E ring	SCIENCE			English	Article							SATURNS E-RING; PLANETARY SATELLITES; DYNAMICS; CLOUDS; PARTICLES; PLASMA		Univ Potsdam, Inst Phys, D-14469 Potsdam, Germany; Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; Univ Jena, Inst Astrophys, D-07745 Jena, Germany; Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; Univ Chicago, Lab Astrophys & Space Res, Chicago, IL 60637 USA	University of Potsdam; Max Planck Society; Friedrich Schiller University of Jena; University of Hawaii System; University of Colorado System; University of Colorado Boulder; University of Chicago	Schmidt, J (corresponding author), Univ Potsdam, Inst Phys, Neuen Palais 10,Haus 19, D-14469 Potsdam, Germany.	jschmidt@agnld.uni-potsdam.de	Hörning, Marcel/F-4375-2010; Spahn, Frank/AAP-6234-2020	Hörning, Marcel/0000-0001-8934-048X; KEMPF, SASCHA/0000-0001-5236-3004				COLWELL JE, 1993, ICARUS, V106, P536, DOI 10.1006/icar.1993.1191; Dikarev VV, 1999, ASTRON ASTROPHYS, V346, P1011; Dougherty MK, 2006, SCIENCE, V311, P1406, DOI 10.1126/science.1120985; HAFF PK, 1983, ICARUS, V56, P426, DOI 10.1016/0019-1035(83)90164-1; HAMILTON DP, 1994, SCIENCE, V264, P550, DOI 10.1126/science.264.5158.550; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; HORANYI M, 1992, ICARUS, V97, P248, DOI 10.1016/0019-1035(92)90131-P; Juhasz A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020999; Kargel JS, 1996, ICARUS, V119, P385, DOI 10.1006/icar.1996.0026; Krivov AV, 2003, PLANET SPACE SCI, V51, P251, DOI 10.1016/S0032-0633(02)00147-2; Kruger H, 1999, NATURE, V399, P558, DOI 10.1038/21136; Nicholson PD, 1996, SCIENCE, V272, P509, DOI 10.1126/science.272.5261.509; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; SHOWALTER MR, 1991, ICARUS, V94, P451, DOI 10.1016/0019-1035(91)90241-K; Spahn F, 1999, J GEOPHYS RES-PLANET, V104, P24111, DOI 10.1029/1999JE001031; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Srama R, 2004, SPACE SCI REV, V114, P465, DOI 10.1007/s11214-004-1435-z; Sremcevic M, 2005, PLANET SPACE SCI, V53, P625, DOI 10.1016/j.pss.2004.10.001; Sremcevic M, 2003, PLANET SPACE SCI, V51, P455, DOI 10.1016/S0032-0633(03)00050-3; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290	20	213	214	3	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2006	311	5766					1416	1418		10.1126/science.1121375	http://dx.doi.org/10.1126/science.1121375			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BJ	16527969	Green Submitted			2022-12-24	WOS:000236029400035
J	Darst, CR; Cummings, ME				Darst, CR; Cummings, ME			Predator learning favours mimicry of a less-toxic model in poison frogs	NATURE			English	Article							EVOLUTION; DISTASTEFULNESS; SPECIALIZATION; COLOR	Batesian mimicry-resemblance of a toxic model by an edible mimic-depends on deceiving predators(1). Mimetic advantage is considered to be dependent on frequency because an increase in mimic abundance leads to breakdown of the warning signal(2,3). Where multiple toxic species are available, batesian polymorphism(4) is predicted-that is, mimics diversify to match sympatric models. Despite the prevalence of batesian mimicry in nature(5), batesian polymorphism is relatively rare(6). Here we explore a poison-frog mimicry complex comprising two parapatric models and a geographically dimorphic mimic that shows monomorphism where models co-occur. Contrary to classical predictions, our toxicity assays, field observations and spectral reflectances show that mimics resemble the less-toxic and less-abundant model. We examine "stimulus generalization"(7) as a mechanism for this non-intuitive result with learning experiments using naive avian predators and live poison frogs. We find that predators differ in avoidance generalization depending on toxicity of the model, conferring greater protection to mimics resembling the less-toxic model owing to overlap of generalized avoidance curves. Our work supports a mechanism of toxicity-dependent stimulus generalization(8), revealing an additional solution for batesian mimicry where multiple models coexist.	Univ Texas, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Darst, CR (corresponding author), Univ Texas, Sect Integrat Biol, 1 Univ Stn, Austin, TX 78712 USA.	catdarst@mail.utexas.edu						Bates HW., 1862, T LINN SOC LOND, V1, P495, DOI DOI 10.1111/J.1096-3642.1860.TB00146.X; BRODIE ED, 1980, SCIENCE, V208, P181, DOI 10.1126/science.208.4440.181; BROWER JV, 1960, AM NAT, V94, P271, DOI 10.1086/282128; BROWER LP, 1962, ECOLOGY, V43, P154; Daly M, 1999, ONCOLOGY-NY, V13, P161; Darst CR, 2005, AM NAT, V165, P56, DOI 10.1086/426599; DUNCAN C. J., 1965, BEHAVIOUR, V24, P269, DOI 10.1163/156853965X00066; Edmunds M, 2000, BIOL J LINN SOC, V70, P459; EDMUNDS M, 1974, DEFENCE ANIMALS; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Fisher R. A., 1930, GENETICAL THEORY NAT, DOI 10.5962/bhl.title.27468; Ford EB, 1971, ECOLOGICAL GENETICS; FROST DR, 2004, AMPHIBIAN SPECIES WO; GOODALE MA, 1977, ANIM BEHAV, V25, P660, DOI 10.1016/0003-3472(77)90117-8; GREENE HW, 1981, SCIENCE, V213, P1207, DOI 10.1126/science.213.4513.1207; Johnstone RA, 2002, NATURE, V418, P524, DOI 10.1038/nature00845; Joron M, 1998, TRENDS ECOL EVOL, V13, P461, DOI 10.1016/S0169-5347(98)01483-9; Lindstrom L, 1997, P ROY SOC B-BIOL SCI, V264, P149, DOI 10.1098/rspb.1997.0022; Master Terry L., 1998, Herpetological Review, V29, P164; Osorio D, 1999, J EXP BIOL, V202, P2951; Pavlov I.P., 1927, CONDITIONED REFLEXES; Santos JC, 2003, P NATL ACAD SCI USA, V100, P12792, DOI 10.1073/pnas.2133521100; *SAS I, 2000, JMP STAT GRPH GUID V; Sherratt TN, 2002, BEHAV ECOL, V13, P821, DOI 10.1093/beheco/13.6.821; Sokal RR, 1981, BIOMETRY PRINCIPLES; TURNER JRG, 1987, ECOL ENTOMOL, V12, P81, DOI 10.1111/j.1365-2311.1987.tb00987.x; Wallace A.R., 1865, T LINN SOC LOND, V1, P1, DOI [10.1111/j.1096-3642.1865.tb00178.x, DOI 10.1111/J.1096-3642.1865.TB00178.X]	27	125	130	1	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2006	440	7081					208	211		10.1038/nature04297	http://dx.doi.org/10.1038/nature04297			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	16525472	Bronze			2022-12-24	WOS:000235839500045
J	Heymann, DL				Heymann, DL			Resistance to anti-infective drugs and the threat to public health	CELL			English	Editorial Material								Increasing resistance of pathogens to anti-infective drugs is an urgent public health problem that must be addressed through more prudent use of these drugs in human medicine and in animal husbandry, agriculture, and aquaculture.	WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Heymann, DL (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	heymannd@who.int						[Anonymous], 2001, WHO GLOB STRAT CONT; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; *CDC, 2005, HIGH LEV AD RES AM I; Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Dye C, 2002, J INFECT DIS, V185, P1197, DOI 10.1086/339818; Escoto-Delgadillo M, 2005, HIV MED, V6, P403, DOI 10.1111/j.1468-1293.2005.00326.x; Fenner F., 1989, SMALLPOX ITS ERADICA, VVolume 43; HEYMANNDL, 2004, NEW ENGL J MED, V351, P1275; Jung M, 2004, CURR MED CHEM, V11, P1265, DOI 10.2174/0929867043365233; Kondro W, 1997, LANCET, V349, P1156, DOI 10.1016/S0140-6736(05)63043-7; Levy Stuart B., 1992, ANTIBIOTIC PARADOX M; *NAS, 1998, US EPA ANT RES ISS O, P53; Suttajit Siritree, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P489; World Health Organization, 1999, REM OBST HLTH DEV	16	58	60	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 24	2006	124	4					671	675		10.1016/j.cell.2006.02.009	http://dx.doi.org/10.1016/j.cell.2006.02.009			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RO	16497576	Bronze			2022-12-24	WOS:000237240900009
J	Gewin, V				Gewin, Virginia			Nanotech's big issue	NATURE			English	News Item								Lack of regulation and risk assessment could hamper the nanotechnology sector. As nanotechnological products start to reach the market place, concerns are being raised about the potential risk to health if the nanoparticles are inhaled or ingested. Companies have had to act on their own initiative because there are no regulations anywhere in the world to govern nanotech-related products. The greatest concern focuses on nano-sized particles used in consumer products, such as cosmetics or mineral supplements.										Brumfiel G, 2006, NATURE, V440, P262, DOI 10.1038/440262a	1	16	16	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2006	443	7108					137	137		10.1038/443137a	http://dx.doi.org/10.1038/443137a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16607694	Bronze			2022-12-24	WOS:000240467000013
